Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987652	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	9.8	6.4	27.0	9.2	25.2	6.4	5.4	63.6	44.9	6.2	8.0	6.4	3.8	7.3	6.2	3.1	8.4	6.8	6.1	8.0	33.8	17.4	5.5	4.2	8.8	6.2	11.7	19.1	6.7	11.7	14.8	21.3	5.1	18.5	6.8	8.0	5.5	8.7	9.1	20.1	8.6	9.0	10.5	6.5	8.7	8.0	9.0	8.8	2.7	6.5	2.9	6.5	6.5	4.7	1.3	2.2	5.7	8.1	1.1	2.7	2.1	8.0	14.4	2.7	3.8	18.1	12.6	5.6	7.8	8.7	7.4	6.6	3.6	2.2	9.5	7.6	12.2	6.3	8.2	10.2	12.2	4.2	13.3	13.2	6.0	7.8	4.0	10.4	3.5	25.8	8.7	15.3	7.0	11.0	9.0	12.3	7.4	9.7	8.7	6.9	5.3	6.2	2.2	0.4	9.6	6.0	5.4	3.0	3.7	8.4	8.5	3.7	3.2	4.9	9.0	2.4	4.8	7.9	3.5	16.3	5.9	3.5	6.2	12.7	4.4	4.7	3.4	14.4	7.0	5.7	1.0	2.2	1.8	2.7	3.0	2.1	1.3	1.2	2.5	1.4	0.9	1.8	2.0	5.7	1.1	8.1	2.2	1.1	2.1	27.0	25.2	63.6	44.9	33.8	17.4	11.7	19.1	18.5	8.8	3.0	13.7	8.3	3.5	6.2	12.1	5.9	15.3	5.3	3.4	10.4	9.8	5.2	1.7	6.8	29.0	6.9	16.3	0.0	9.8	6.8	6.8	5.5	12.7	11.9	7.7	33.4	10.9	14.1	9.2	39.5	9.5	8.0	3.3	8.2	13.1	4.3	9.1	12.4	8.9	10.5	9.6	12.9	12.3	5.2	7.6	9.2	10.4	10.2	9.5	3.4
TSPYL2	"CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX"	ENSG00000184205	"TSPY like 2"	Q9H2G4	X	53082367-53088540	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044133	Approved					NA	NA					"HPA044133: AB_10965838"	"unprognostic (3.29e-2)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (3.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (6.74e-8)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.16e-7)"	"unprognostic (6.50e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.10e-2)"	15.2	34.9	27.9	12.6	91.4	31.8	11.2	49.3	46.6	16.3	14.5	9.6	18.4	5.5	32.5	34.5	12.2	16.5	17.7	14.0	26.2	27.7	7.3	7.6	11.3	17.3	14.1	33.4	68.0	11.7	10.8	46.5	6.3	23.8	24.4	7.1	12.6	8.0	32.9	13.4	10.2	11.0	17.9	8.3	15.9	12.7	40.7	18.2	4.8	17.7	3.7	12.2	15.2	12.4	7.0	12.5	2.8	1.0	6.1	12.7	4.8	1.6	5.5	5.7	23.6	4.4	5.4	8.2	12.0	12.8	7.9	7.8	8.1	3.8	12.7	2.3	6.3	6.1	5.0	4.7	4.8	7.3	3.2	10.2	3.2	21.7	10.5	13.0	5.2	4.1	10.4	8.8	10.8	18.4	4.8	5.7	4.5	2.4	11.9	4.3	7.6	7.3	6.2	8.6	2.5	10.4	5.8	7.2	9.3	1.4	9.5	7.0	4.2	9.5	3.5	6.2	27.6	5.3	1.6	8.2	3.7	6.2	47.0	2.2	12.9	8.0	12.0	6.2	8.6	7.5	2.8	0.1	1.7	6.6	0.6	8.1	5.3	9.2	5.2	0.1	7.0	12.7	9.0	1.0	6.1	1.0	12.5	6.6	4.8	27.9	91.4	49.3	46.6	26.2	27.7	14.1	33.4	23.8	18.2	8.9	41.6	31.5	92.2	36.2	98.0	28.8	10.2	25.4	37.5	17.4	43.2	5.0	1.7	8.0	10.1	26.3	3.9	0.0	5.2	10.5	43.7	44.0	62.4	5.7	5.3	28.6	69.7	20.9	8.9	7.6	36.2	28.3	42.2	7.2	4.6	34.0	4.4	5.8	48.8	1.1	29.9	58.2	76.2	19.0	48.5	31.9	13.7	93.7	5.0	25.5
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188549	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.6	15.5	13.3	15.3	17.9	19.0	14.1	21.8	26.9	12.2	11.8	28.5	17.7	17.1	15.1	12.3	13.6	13.8	16.4	14.1	12.5	10.2	12.3	19.1	13.1	19.1	22.4	14.5	15.4	23.7	10.6	12.6	11.0	16.2	15.2	5.0	15.5	25.7	14.5	20.0	25.0	16.2	9.4	13.3	19.3	16.2	31.6	13.4	14.0	14.4	11.7	15.2	13.2	11.7	1.4	2.3	0.6	3.2	1.1	2.4	3.3	10.2	22.8	5.5	9.1	6.7	4.0	17.4	9.2	5.9	8.8	6.8	13.7	10.7	11.1	10.9	6.1	8.2	21.2	6.6	7.1	1.3	14.1	11.3	6.6	26.6	12.4	7.9	10.1	11.6	8.0	5.7	5.9	3.2	4.4	10.7	10.3	9.7	13.7	4.1	28.9	12.1	14.3	11.2	13.7	17.4	14.5	13.6	20.6	6.8	9.1	7.3	11.0	14.0	19.1	5.8	2.8	20.3	13.9	11.2	13.1	10.4	15.5	8.3	6.7	9.8	12.0	10.5	7.0	9.4	0.3	2.3	0.4	2.4	2.4	1.4	1.4	1.2	1.9	1.9	1.4	1.4	1.5	0.6	1.1	3.2	2.3	1.2	3.3	13.3	17.9	21.8	26.9	12.5	10.2	22.4	14.5	16.2	13.4	0.0	0.3	6.5	7.4	8.2	4.7	3.1	7.6	0.0	1.2	10.4	3.9	22.6	11.6	9.4	31.6	5.7	18.6	0.0	9.4	9.5	8.5	6.4	11.5	10.4	13.6	1.6	9.8	12.3	9.5	40.9	10.3	6.6	13.5	16.2	14.6	3.5	6.9	7.0	8.9	13.4	4.3	0.0	9.9	30.0	24.3	8.3	20.5	10.2	11.3	6.3
DEF8	FLJ20186	ENSG00000140995	"Differentially expressed in FDCP 8 homolog"	Q6ZN54	16	89947925-89968060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041745, HPA049434"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041745: AB_2677650, HPA049434: "	"unprognostic (4.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.39e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (9.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.09e-1)"	18.0	15.9	25.4	22.4	23.0	25.3	15.6	42.4	30.6	12.6	16.4	15.4	19.4	12.0	17.1	14.1	22.5	14.3	16.3	23.7	23.7	24.8	14.9	12.2	15.4	42.8	28.0	29.0	18.2	22.5	19.0	18.0	11.5	20.5	14.5	9.2	13.9	21.4	18.9	19.5	27.4	13.6	17.6	23.6	16.6	15.2	8.8	15.0	4.8	14.5	13.6	32.4	15.5	23.8	23.0	27.4	32.0	16.7	5.3	11.5	11.1	15.2	31.2	14.2	19.2	14.6	15.5	16.2	23.7	20.2	35.1	16.4	33.0	18.5	18.5	17.9	16.1	14.3	10.1	16.7	28.1	15.6	4.5	47.6	8.3	16.6	47.2	15.8	6.0	13.2	17.4	23.3	25.1	14.8	15.5	26.2	17.1	27.2	6.3	20.8	55.7	11.7	18.2	17.9	7.1	31.9	24.4	10.4	15.8	18.8	14.7	21.0	21.6	38.2	14.3	13.3	7.8	13.3	19.5	26.2	20.3	22.2	10.8	25.1	12.3	8.7	23.2	21.7	15.5	23.7	2.3	16.7	32.0	11.5	13.4	10.5	19.6	9.6	8.4	10.7	23.0	6.6	6.4	22.5	5.3	7.6	27.4	11.4	11.1	25.4	23.0	42.4	30.6	23.7	24.8	28.0	29.0	20.5	15.0	0.0	11.3	33.5	18.0	39.8	22.8	26.6	25.5	8.1	10.3	14.0	25.5	26.2	24.9	43.1	5.6	26.4	18.2	0.0	79.2	44.9	34.3	30.7	9.3	20.2	55.6	28.6	20.7	25.8	24.7	16.0	19.5	29.4	43.9	64.1	14.3	13.8	83.0	14.4	31.5	36.3	23.3	19.4	41.1	5.6	9.0	47.8	27.1	16.2	13.2	19.7
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	2.5	2.5	4.4	6.0	5.8	5.0	6.3	4.1	3.5	3.2	2.2	2.1	2.8	3.5	3.6	4.0	3.6	6.5	2.6	3.0	1.3	19.0	3.5	6.5	6.8	1.4	4.1	6.1	4.8	4.4	4.4	4.2	3.1	5.6	3.4	42.3	25.9	4.4	1.9	6.8	23.8	14.5	3.5	5.4	6.0	4.0	5.0	5.9	2.5	2.8	1.0	4.9	4.8	6.2	3.9	2.7	6.4	8.5	5.0	3.5	1.6	4.7	2.7	4.3	6.3	2.4	7.0	8.0	3.3	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8	8.9	8.6	3.2	2.3	2.5	7.9	5.9	2.5	4.0	2.3	1.8	3.9	5.1	3.3	2.2	1.1	2.4	4.0	0.0	3.4	2.1	3.8	3.0	1.1	5.6	3.0	9.5	8.1	7.4	2.1	2.8	5.8	3.1	3.3	3.6	4.6	5.8	2.3	3.7	4.6	2.2	5.9	0.0	6.2	12.2	4.4	1.8	5.1	11.3	5.1	1.4
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA		32000			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	10.5	4.2	17.6	20.4	13.5	45.9	9.0	18.1	18.6	18.9	13.3	9.2	10.5	28.9	16.6	7.3	10.1	14.5	11.5	5.0	16.1	9.6	9.2	3.0	17.8	22.6	10.7	12.8	7.4	4.6	10.1	9.9	12.1	10.8	16.2	9.0	6.7	6.5	17.0	3.1	9.8	29.5	22.8	9.1	29.8	12.5	9.3	10.5	12.6	6.9	4.6	16.2	30.3	23.3	5.0	13.5	11.7	12.5	4.5	8.4	5.3	1.4	1.7	5.8	0.1	21.4	16.7	3.9	11.0	8.0	2.4	4.1	2.6	1.7	8.1	2.5	12.1	7.2	1.9	3.5	4.4	1.1	7.1	1.4	3.4	3.8	3.9	8.5	2.2	0.1	9.6	2.2	5.8	4.8	9.5	7.3	5.0	0.9	14.1	14.9	1.7	2.8	12.3	3.7	2.0	1.9	7.7	3.7	1.1	5.5	3.5	1.9	10.2	1.1	1.0	17.7	3.9	1.7	53.0	7.7	6.1	2.1	3.5	4.3	10.8	3.3	7.3	5.0	7.5	4.4	10.1	6.4	11.7	6.3	12.4	3.9	3.4	6.3	5.0	11.8	5.0	4.4	3.0	8.4	4.5	12.5	13.5	8.4	5.3	17.6	13.5	18.1	18.6	16.1	9.6	10.7	12.8	10.8	10.5	41.7	15.6	8.8	1.1	5.5	3.0	2.8	0.0	14.7	6.8	1.8	3.9	1.0	1.7	6.8	11.2	3.5	32.0	0.0	5.8	10.2	8.0	1.7	14.0	0.0	28.6	0.0	30.8	4.9	26.3	14.4	19.2	34.7	15.1	41.5	28.8	2.0	10.6	31.6	35.3	4.2	16.7	0.0	30.8	5.1	9.8	4.3	4.0	12.8	9.7	1.0
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	4.8	7.7	8.1	5.1	9.1	8.0	8.3	18.3	12.6	6.2	4.4	7.5	5.3	2.9	5.1	7.3	3.5	5.5	6.4	7.5	11.5	8.2	5.9	5.1	5.7	7.2	8.8	7.8	8.9	5.4	6.6	12.7	5.4	10.7	6.6	5.0	5.7	6.9	6.4	3.7	4.5	5.0	6.0	9.3	8.8	5.5	15.4	11.1	10.3	7.6	5.0	7.3	8.5	6.6	7.6	4.0	8.9	3.6	6.1	9.7	4.0	3.9	4.6	7.9	7.1	6.1	6.2	0.4	4.2	7.6	5.0	7.8	2.4	2.6	1.4	6.6	4.7	6.0	1.3	5.4	4.0	6.3	5.8	5.9	6.5	5.8	3.8	7.6	0.2	5.9	4.7	5.5	4.1	7.1	8.0	4.6	5.8	1.2	2.8	6.2	0.5	4.4	2.6	4.7	1.8	2.3	0.1	8.4	2.1	4.2	12.4	4.2	9.7	6.9	1.3	5.7	7.2	1.7	6.3	3.4	5.5	5.3	3.2	5.2	11.3	9.2	0.1	2.9	0.1	6.1	8.9	3.6	7.0	9.2	2.3	7.7	7.4	8.7	8.9	3.6	7.6	9.7	7.3	7.5	6.1	2.8	4.0	6.0	4.0	8.1	9.1	18.3	12.6	11.5	8.2	8.8	7.8	10.7	11.1	0.0	1.0	0.0	1.7	2.3	4.9	1.9	0.0	0.0	1.2	5.2	0.0	1.8	6.6	2.3	43.5	1.8	0.7	0.0	1.1	0.9	2.1	1.0	4.6	1.0	2.0	6.4	2.9	1.3	1.2	1.5	1.7	1.2	1.7	1.0	1.7	6.5	0.8	0.0	2.1	1.2	2.6	0.0	2.7	5.1	1.2	1.5	0.9	4.1	1.2	0.6
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208867	"Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 28.5;Hepatocytes: 25.9;Leydig cells: 24.2;Peritubular cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.8;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	23.5	16.6	28.3	5.1	33.1	15.3	15.6	14.2	41.2	12.1	7.8	6.6	4.4	7.1	11.2	8.8	7.4	12.4	8.2	10.9	27.6	13.0	4.2	15.5	5.3	3.2	15.4	19.4	50.0	16.8	9.8	10.3	3.8	11.0	15.5	3.4	10.0	14.4	12.7	21.9	5.0	6.6	10.6	6.3	4.8	7.0	5.6	7.7	0.0	9.5	4.7	3.1	9.0	9.1	0.0	0.0	0.6	2.8	0.5	0.1	0.7	0.0	20.7	5.7	20.6	14.4	5.4	4.3	5.3	5.2	4.9	1.9	5.9	0.2	0.0	13.9	6.5	6.9	0.0	5.5	0.5	0.4	0.0	11.2	0.0	4.6	20.7	5.5	7.4	0.7	8.2	4.9	1.3	0.7	0.8	4.0	0.0	0.0	0.0	6.2	19.1	0.0	8.4	11.7	4.1	1.0	0.0	2.6	0.0	0.0	8.3	12.6	19.0	8.6	0.0	1.5	0.6	8.7	26.2	0.0	10.2	9.1	15.1	3.0	0.0	0.0	0.1	0.0	12.5	3.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	2.6	0.0	0.0	0.7	28.3	33.1	14.2	41.2	27.6	13.0	15.4	19.4	11.0	7.7	0.0	2.2	0.9	2.1	3.0	28.5	0.4	10.2	0.0	3.4	5.2	3.9	0.1	0.0	5.8	2.2	1.8	0.9	0.0	6.5	0.6	7.0	8.2	0.0	25.9	8.2	22.3	1.7	6.2	10.0	5.2	24.2	2.3	3.3	1.8	6.6	23.0	8.9	0.0	30.8	0.5	3.6	6.5	5.2	0.2	0.4	2.3	0.0	0.0	4.9	1.4
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 123.3;monocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 45.5"	"Lineage enhanced"	"Detected in many"		"granulocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.4;K-562: 31.9;REH: 75.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	25.2	14.3	2.6	5.1	4.1	3.6	39.6	2.3	4.3	37.9	14.2	2.4	23.1	4.3	38.8	21.4	7.7	15.0	15.5	12.4	4.9	3.1	14.6	28.2	22.7	12.3	3.3	1.4	14.1	7.1	18.7	26.7	21.9	11.0	33.5	6.9	7.0	4.9	32.5	12.0	3.7	10.7	36.9	3.3	4.3	12.3	10.3	2.9	12.7	12.7	7.1	4.3	15.6	21.3	0.8	0.6	45.5	0.1	8.2	11.5	5.1	0.8	1.0	4.0	3.5	2.3	4.1	4.5	4.9	17.9	3.5	1.6	39.4	1.8	0.2	0.1	4.5	1.0	9.1	20.7	1.4	4.1	15.8	0.5	3.2	0.1	0.5	3.3	1.0	6.8	6.7	1.2	4.1	5.5	0.3	0.5	2.0	31.9	0.6	0.5	0.4	0.2	1.4	11.2	0.7	1.6	75.7	0.0	0.8	1.0	1.6	6.8	8.1	1.6	2.7	12.6	4.0	0.0	32.6	0.5	10.6	0.2	0.0	2.7	0.4	0.2	0.2	0.2	2.4	6.7	45.5	0.0	2.2	8.4	0.1	11.5	0.1	10.5	7.7	0.0	0.8	10.7	6.3	0.3	8.2	0.1	0.6	6.0	5.1	2.6	4.1	2.3	4.3	4.9	3.1	3.3	1.4	11.0	2.9	8.9	64.9	0.0	42.5	16.0	3.8	4.4	0.0	4.0	31.8	21.0	3.9	28.9	53.0	10.2	7.0	46.6	15.5	0.0	32.8	4.5	32.4	113.6	23.1	9.7	11.0	65.2	7.9	123.3	11.9	14.7	84.8	9.2	16.9	188.4	14.6	1.3	9.3	17.5	95.1	17.2	0.7	77.6	40.1	2.6	7.9	9.3	29.3	13.8	15.6	25.7
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"		1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"pancreas: 29.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	2.7	1.7	2.2	4.0	3.9	5.1	3.2	4.4	4.7	2.6	1.9	5.8	2.2	2.4	6.0	3.6	1.5	2.4	3.1	0.9	2.3		1.7	6.1	2.8	3.4	4.2	4.2	4.3	29.8	4.2	5.0	1.8	3.8	2.5	1.8	4.2	3.5	4.0	0.9	2.5	1.9	3.0	3.2	3.1	5.3	7.0	1.1	3.3	2.9	0.9	2.9	1.2	3.9	3.8	2.6	6.1	2.3	0.9	3.5	0.8	6.7	5.4	11.4	9.8	5.4	5.0	7.4	7.0	5.3	5.0	5.1	4.9	6.4	15.1	4.4	6.0	5.3	5.0	8.1	4.0	4.8	5.6	5.7	6.6	11.7	4.2	4.5	4.9	9.8	5.3	7.2	4.9	11.4	6.5	4.5	10.9	10.4	2.6	4.0	10.3	10.6	6.2	6.6	8.2	7.1	10.3	4.2	3.6	3.8	14.9	5.7	12.0	9.2	8.2	4.6	17.8	6.9	14.9	5.3	4.4	7.3	10.0	9.7	9.2	6.8	6.3	4.8	3.5	5.0	6.1	2.3	1.8	3.5	1.1	2.0	3.4	2.3	1.9	1.0	3.8	2.6	2.0	0.7	0.9	1.4	2.6	2.2	0.8											29.8	20.0	11.1	2.6	3.4	16.0	7.2	0.0	9.4	11.4	5.2	43.2	3.3	0.0	9.6	5.2	4.5	6.5	0.0	7.5	3.0	5.0	1.4	23.2	11.3	3.3	9.5	10.3	8.6	14.3	2.5	5.2	7.1	1.7	9.0	9.9	9.5	10.0	14.0	9.9	0.8	17.2	6.5	5.0	12.2	5.7	3.8	1.6	10.9	11.5	0.9
TSPOAP1	"BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1"	ENSG00000005379	"TSPO associated protein 1"	O95153	17	58301228-58328760	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 83.7"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.0;Ciliated cells: 14.7;Club cells: 7.9;Collecting duct cells: 7.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 2.7;T-cells: 5.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 54.1;HL-60: 19.6;NB-4: 20.0;REH: 39.9;THP-1: 13.9;U-266/70: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024662, HPA025244"	Enhanced					NA	NA					"HPA024662: AB_2066340, HPA025244: AB_1845509"	"unprognostic (2.03e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.23e-4)"	"unprognostic (1.24e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.15e-7)"	"unprognostic (1.62e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-2)"	2.3	9.7	76.9	5.2	59.1	26.1	6.4	46.5	83.7	8.0	6.7	10.2	0.7	3.4	16.0	6.2	5.2	21.6	5.7	6.1	65.3	13.0	5.9	2.8	8.2	8.1	12.0	47.9	22.0	11.1	13.9	15.9	1.5	18.6	13.5	3.3	1.5	17.9	16.6	7.1	5.0	4.4	6.9	14.3	8.5	7.4	1.1	23.2	10.3	10.0	0.6	4.2	4.8	4.8	0.0	0.0	0.5	0.0	2.7	5.4	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.2	1.3	0.3	0.0	0.1	0.0	0.0	0.0	54.1	0.4	0.2	0.5	0.0	0.0	19.6	2.1	0.0	0.2	0.0	0.0	6.7	0.0	7.3	0.6	3.6	0.0	0.0	6.6	20.0	0.3	0.0	0.0	39.9	0.0	5.6	0.2	0.0	3.0	2.1	0.0	0.0	0.0	0.0	0.1	13.9	0.0	0.0	0.5	0.0	0.0	14.1	2.6	3.5	0.0	0.6	0.0	0.5	0.0	0.1	5.4	0.0	2.2	0.0	0.5	1.2	0.0	0.0	0.5	1.2	0.0	2.7	0.0	0.0	0.1	1.0	76.9	59.1	46.5	83.7	65.3	13.0	12.0	47.9	18.6	23.2	8.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	7.9	7.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569267-1628886	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 92.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced					NA	NA					"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	5.5	2.7	5.4	13.7	5.7	12.2	3.6	14.8	11.9	2.6	2.6	5.0	2.1	7.0	2.1	4.1	1.4	5.9	3.9	1.6	5.6	7.2	15.8	3.0	6.8	8.3	5.1	3.8	2.3	1.6	1.5	6.2	92.7	5.8	2.8	2.4	4.9	4.0	3.5	23.2	1.3	11.6	4.7	3.5	8.9	2.8	1.5	1.3	5.0	5.8	2.2	3.5	5.0	1.3	1.3	3.1	15.0	5.4	0.5	0.3	2.0	0.9	2.6	0.8	7.6	1.6	1.3	10.4	0.5	0.3	1.8	0.8	15.5	1.7	4.5	5.2	0.8	0.7	1.8	4.6	0.9	0.3	0.0	0.4	0.8	2.3	3.9	1.9	0.1	1.4	1.6	1.4	1.1	0.5	0.2	7.3	0.5	1.9	0.0	0.3	3.6	9.2	0.9	0.8	2.4	0.3	2.6	0.0	5.3	3.5	8.9	3.1	1.6	2.3	6.3	0.2	3.4	6.3	5.4	9.5	0.2	1.1	2.0	0.6	0.5	9.4	2.2	0.4	0.9	0.2	2.5	5.4	5.3	0.3	4.6	0.1	1.3	0.2	0.2	3.1	1.2	0.2	0.2	15.0	0.5	4.5	1.7	0.2	2.0	5.4	5.7	14.8	11.9	5.6	7.2	5.1	3.8	5.8	1.3	14.9	40.5	18.3	5.4	4.2	22.8	2.7	15.3	21.4	22.7	34.9	23.6	312.2	16.6	21.0	2.9	4.5	16.2	0.0	6.3	29.6	10.2	7.2	11.5	1.3	81.4	19.1	10.9	16.5	88.0	1.9	10.0	84.8	0.0	73.9	12.2	23.6	6.4	21.6	8.5	19.3	35.8	0.0	5.7	3.1	3.2	3.8	788.9	3.8	10.0	4.2
ZNF48	"DKFZp762K013, FLJ31751, MGC43952, ZNF553"	ENSG00000180035	"Zinc finger protein 48"	Q96MX3	16	30378106-30400108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023806	Uncertain		Approved	Mitochondria		No	No			Mitochondria		"HPA023806: AB_1859335"	"unprognostic (5.35e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (5.36e-2)"	"prognostic favorable (7.50e-5)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	5.6	7.7	8.9	9.1	9.8	4.4	6.7	15.7	16.1	9.1	11.5	10.1	12.1	9.0	12.8	5.7	5.5	10.7	9.5	6.7	8.9	8.7	6.6	6.4	8.0	10.0	9.0	8.5	6.7	15.1	18.8	8.8	4.7	7.1	7.6	6.1	8.0	9.7	12.6	12.1	6.3	6.4	11.2	5.7	7.3	7.9	3.9	9.8	16.1	7.5	7.2	7.3	9.0	8.3	1.4	1.6	1.3	0.2	2.6	3.1	0.5	4.7	8.1	19.8	15.8	2.5	2.0	6.7	3.3	6.0	7.9	7.1	3.8	6.2	8.9	6.6	3.0	2.1	3.8	9.6	5.2	4.2	6.5	11.8	3.9	3.9	5.5	3.6	5.2	5.6	1.5	6.7	6.2	4.2	6.9	6.5	8.6	6.8	4.2	3.1	15.3	12.1	6.4	16.8	3.8	3.0	28.1	4.3	11.8	4.2	3.7	15.4	19.2	1.4	10.6	1.4	5.6	7.0	5.2	2.8	4.5	5.1	4.2	4.0	5.1	5.8	8.7	2.4	3.3	1.0	0.0	0.2	1.3	3.1	0.2	2.4	1.1	1.7	1.8	0.5	1.4	2.1	2.3	0.0	2.6	0.1	1.6	1.7	0.5	8.9	9.8	15.7	16.1	8.9	8.7	9.0	8.5	7.1	9.8	3.0	2.1	6.4	2.6	2.7	10.3	4.8	7.6	0.0	4.5	3.5	7.9	3.1	1.7	8.9	0.1	3.8	2.6	0.0	6.4	1.6	2.2	2.2	17.3	2.8	2.4	15.9	9.2	3.1	2.6	0.0	2.6	1.9	1.7	10.8	3.6	6.0	7.2	5.3	6.3	3.1	7.0	0.0	3.7	3.2	3.0	4.5	0.2	3.2	5.5	1.5
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597937	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 73.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 29.2;Intestinal endocrine cells: 22.0;Late spermatids: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.9;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;hTERT-RPE1: 16.7;LHCN-M2: 14.3;SK-MEL-30: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	1.4	2.3	30.6	2.3	35.5	1.0	1.8	9.1	73.2	4.2	2.4	14.3	0.0	2.0	5.3	7.2	2.3	4.9	2.7	3.7	32.8	17.4	11.5	1.0	4.4	2.3	19.2	23.4	9.3	3.2	4.2	3.6	1.7	11.9	5.1	2.4	2.0	1.5	4.8	7.0	2.3	2.5	3.7	13.2	3.2	3.9	8.0	12.7	0.0	6.0	0.0	2.9	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.8	15.9	0.0	0.1	2.0	0.0	6.7	9.5	7.8	16.0	0.0	0.0	0.0	1.7	8.0	4.1	0.2	5.8	0.3	10.1	0.0	1.6	0.2	0.0	0.5	0.5	0.0	4.0	7.6	0.3	3.4	0.1	16.7	0.0	0.0	0.0	0.1	14.3	7.5	0.0	0.0	3.1	0.0	0.1	0.0	0.2	0.0	3.4	11.2	8.4	11.6	0.8	0.1	17.1	1.0	0.3	0.0	0.0	12.5	2.5	0.3	7.9	0.0	0.0	0.0	4.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	35.5	9.1	36.0	32.8	17.4	19.2	23.4	11.9	12.7	0.0	2.9	0.0	1.1	1.1	15.4	5.9	0.0	2.7	7.9	3.5	7.9	0.1	11.6	6.4	29.2	0.8	0.0	0.0	0.2	3.3	0.9	1.9	2.3	0.0	0.2	1.6	22.0	0.6	0.0	28.4	0.6	0.6	6.8	0.0	0.9	5.7	3.0	2.8	2.8	0.6	9.2	6.5	2.8	1.1	1.5	0.3	2.3	0.0	0.8	1.1
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132297	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 168.7;Late spermatids: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	10.6	17.4	26.3	11.4	24.2	24.5	10.4	19.4	35.4	7.4	9.2	11.8	10.1	9.8	9.4	12.1	9.9	9.3	8.3	22.1	25.7	14.1	9.7	10.7	10.9	14.6	12.0	29.5	12.4	11.4	12.1	16.3	8.8	16.0	9.5	9.0	10.6	8.9	7.6	21.9	14.9	11.9	8.9	11.7	23.3	11.6	23.3	16.8	7.1	12.8	8.1	12.5	7.7	8.5	7.3	6.7	7.5	8.6	14.0	14.1	6.3	9.4	6.8	8.9	7.3	8.6	12.5	6.8	12.2	6.5	7.3	7.3	8.7	8.2	5.1	7.7	15.4	1.5	9.3	4.7	13.8	6.4	6.9	8.5	11.4	6.7	5.8	6.2	6.9	13.1	15.9	10.6	10.4	3.8	8.9	16.2	9.7	7.7	5.6	11.6	8.3	7.1	5.2	5.1	7.2	4.4	11.5	5.3	8.0	10.2	10.2	4.2	8.8	5.7	10.4	9.3	7.1	9.9	13.5	21.6	6.0	2.3	19.4	9.5	12.6	10.5	6.7	13.7	7.6	4.3	7.5	6.3	4.7	14.1	8.5	12.0	7.3	8.1	10.4	6.7	6.7	9.1	10.3	6.0	14.0	8.6	6.3	6.8	6.3	26.3	24.2	19.4	35.4	25.7	14.1	12.0	29.5	16.0	16.8	3.0	7.2	6.2	10.5	11.8	14.2	22.2	0.0	2.7	7.9	10.4	11.8	5.3	0.0	4.0	168.7	9.6	5.6	0.0	5.2	3.5	5.5	10.7	11.5	6.7	8.0	7.9	10.3	31.9	20.6	73.7	11.5	12.1	15.1	3.6	8.4	6.1	6.4	7.6	17.0	3.3	14.2	6.5	9.5	11.6	15.8	10.8	9.5	10.2	5.7	11.6
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494571-1516888	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.9"	"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.47e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	27.9	10.5	12.7	13.8	13.5	25.9	37.0	14.9	17.7	13.4	13.4	14.9	9.8	9.1	12.8	12.2	12.0	10.4	12.9	17.5	12.8	12.6	11.6	10.5	20.8	14.3	12.8	12.0	14.3	18.9	12.0	10.8	15.9	21.2	13.5	11.4	114.9	12.9	12.2	26.4	22.3	13.9	10.9	10.7	16.2	12.8	20.8	11.3	22.1	27.3	13.8	16.4	12.5	14.1	12.1	16.5	36.4	27.0	17.0	30.8	24.6	9.5	13.2	5.4	10.4	14.1	7.9	8.1	8.0	13.5	9.1	11.6	8.2	5.7	8.5	15.4	12.2	7.5	12.5	13.0	5.2	9.3	22.0	21.8	5.3	10.1	3.2	17.9	5.0	10.3	9.3	13.8	9.1	9.0	5.8	14.4	14.5	5.7	15.3	6.0	6.8	15.1	4.1	2.3	14.3	9.0	11.6	4.3	8.0	7.3	5.9	4.3	10.9	6.3	12.3	14.3	8.4	10.4	4.1	10.2	8.0	8.2	11.5	10.3	8.1	13.5	4.5	9.0	5.2	10.0	36.4	19.9	31.9	22.2	18.7	18.2	12.1	20.7	22.4	16.5	11.3	17.7	18.9	33.3	17.0	27.0	11.9	30.8	24.6	12.7	13.5	14.9	17.7	12.8	12.6	12.8	12.0	21.2	11.3	29.8	13.1	9.5	13.9	26.7	7.5	31.5	5.1	5.3	7.9	22.7	2.0	11.5	11.6	15.2	90.2	27.4	20.9	0.0	21.2	13.3	15.4	14.1	19.6	8.9	10.7	19.1	16.7	21.5	19.1	261.4	10.6	16.0	30.4	48.7	17.0	20.3	21.3	21.0	7.1	9.0	7.6	19.4	16.4	31.6	16.7	26.5	26.0	36.3	11.0	14.4
SPRN	"bA108K14.1, FLJ41197, Shadoo, Sprn"	ENSG00000203772	"Shadow of prion protein"	Q5BIV9	10	133420666-133424572	"Predicted intracellular proteins, Transporters"		Prion		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.7"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 1.2;Horizontal cells: 3.2;Ito cells: 2.5;Kupffer cells: 2.2"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.58e-7)"	0.5	2.5	4.3	1.5	3.8	0.8	0.1	7.4	20.7	0.4	0.5			3.3	1.1	0.0	1.0	0.2	1.3	0.8	6.1	2.7	1.1	6.9	0.6	1.6	1.7		1.0	1.7	0.0	1.7	0.8		1.2	0.0		2.0	0.1	2.3	2.0	2.2	0.4	0.9	1.7	2.2	1.9			0.9		0.0	0.9	0.1	1.1	1.0	0.4	4.5	0.2	1.2	0.6	2.7	5.2	3.9	7.8	0.0	0.0	6.3	4.2	0.0	1.0	0.1	6.3	1.9	3.9	1.5	2.1	0.9	3.4	0.6	0.0	0.0	2.5	7.3	3.7	6.0	7.1	0.3	3.9	3.2	0.5	0.0	0.0	0.0	2.5	0.0	2.9	4.0	2.7	0.5	2.7	2.2	7.4	3.8	1.4	2.1	5.4	2.5	0.7	0.0	3.2	2.3	3.5	1.4	3.8	4.7	1.5	2.4	2.8	2.8	2.3	3.0	1.7	3.2	3.2	1.6	3.0	1.7	2.6	1.2	0.4	0.3	0.0	0.4	0.9	0.8	0.3	0.9	1.2	0.2	1.1	1.0	0.4	0.0	0.2	4.5	1.0	0.6	0.6											0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	2.5	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PITPNA	"PITPN, VIB1A"	ENSG00000174238	"Phosphatidylinositol transfer protein alpha"	Q00169	17	1517718-1562816	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000528	Uncertain		Approved	Vesicles,Cytosol		NA	NA		100000	Cytosol	Vesicles	"HPA000528: AB_1079622"	"unprognostic (1.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (7.88e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (1.80e-6)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.81e-3)"	20.2	22.2	31.1	28.1	34.0	38.5	20.8	43.5	54.1	27.5	22.3	21.0	35.0	27.0	29.2	29.8	37.7	33.1	22.2	18.7	30.2	34.2	20.4	22.7	22.5	17.5	34.0	37.5	18.0	17.4	29.3	21.1	31.2	60.7	27.6	27.7	88.0	38.7	33.2	14.3	44.1	42.4	27.0	26.4	21.9	19.7	25.0	18.8	12.4	31.9	15.4	26.8	21.0	23.5	6.4	5.2	12.3	4.0	5.3	7.5	2.5	20.9	23.4	23.9	20.5	26.4	29.4	37.7	23.5	27.4	24.9	18.4	26.9	8.6	27.1	21.3	32.5	15.5	26.4	22.8	23.7	35.1	22.1	23.1	14.5	20.1	12.0	26.3	10.1	18.0	21.2	32.4	25.0	26.5	25.5	42.4	22.4	20.2	15.1	26.7	11.8	25.7	9.2	16.7	34.5	11.4	20.7	9.2	15.2	24.9	24.7	8.6	18.8	27.7	20.5	16.8	25.1	17.5	8.2	38.8	15.4	13.5	44.2	32.0	9.2	15.6	9.2	26.8	15.8	19.5	5.0	3.7	4.6	3.4	4.0	6.4	6.4	5.1	4.6	5.2	4.2	4.8	4.1	12.3	5.3	2.8	4.1	7.5	2.5	31.1	34.0	43.5	54.1	30.2	34.2	34.0	37.5	60.7	18.8	32.8	34.9	20.6	13.7	27.5	27.2	20.1	20.4	12.0	19.4	24.4	7.9	40.9	11.6	13.7	8.5	30.4	46.3	0.0	16.0	40.7	19.5	30.3	18.5	27.0	35.9	38.1	21.2	33.2	25.6	12.5	11.5	25.2	18.6	33.3	28.2	32.9	20.1	20.1	20.5	14.0	14.7	6.5	17.8	33.6	37.7	36.5	100.3	13.1	20.8	25.5
PPP1R3F	Hb2E	ENSG00000049769	"Protein phosphatase 1 regulatory subunit 3F"	Q6ZSY5	X	49269843-49301461	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 35.3;Horizontal cells: 46.1;Rod photoreceptor cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"T-reg: 15.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 15.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 18.0;HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000244, HPA000918"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA000244: AB_2665949, HPA000918: AB_2268692"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.83e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.85e-6)"	"unprognostic (5.99e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.55e-1)"	3.0	7.6	15.9	3.7	13.8	2.7	2.3	17.2	21.2	4.3	3.5	7.6	4.5	2.4	4.7	15.9	5.4	6.7	3.6	16.1	16.0	13.1	3.3	2.8	3.4	4.6	12.3	5.4	7.5	2.6	4.4	8.6	2.4	9.1	4.6	1.7	5.3	5.3	6.1	24.0	3.1	3.1	4.1	11.3	5.1	2.9	4.5	7.3	3.5	5.5	1.9	3.0	3.5	4.8	0.4	0.3	0.0	0.9	0.4	15.3	0.5	2.4	5.0	4.4	4.9	6.1	4.4	2.1	2.9	4.5	1.9	3.1	3.5	2.9	2.9	0.6	2.1	18.0	3.9	1.7	1.2	1.0	15.8	5.5	0.3	2.9	0.3	4.0	0.4	1.8	3.0	3.6	2.0	1.6	4.5	0.5	4.0	0.7	1.2	2.3	8.7	1.1	3.9	13.6	0.6	9.5	6.4	3.8	0.9	1.9	1.1	5.2	4.5	1.5	0.5	7.4	9.8	4.5	2.5	2.3	5.5	1.1	4.8	2.1	3.6	4.5	1.9	1.8	6.2	6.9	0.0	0.2	0.0	0.2	0.4	1.0	0.4	3.0	1.0	0.2	0.1	2.4	1.1	0.0	0.4	0.9	0.3	15.3	0.5	15.9	13.8	17.2	19.3	16.0	13.1	12.3	5.4	9.1	7.3	0.0	0.3	0.5	2.5	1.6	35.3	13.7	0.0	2.7	0.0	3.5	7.9	0.8	6.6	0.4	0.1	1.9	0.0	0.0	0.2	0.1	3.0	1.6	0.0	0.8	0.6	46.1	2.9	1.8	0.0	0.4	4.4	0.9	0.0	0.0	0.0	9.7	0.4	0.0	2.8	4.9	15.4	0.0	3.9	0.5	5.6	1.1	1.0	1.5	0.0	2.2
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.6	2.6	1.5	2.9	0.6	0.1	18.9	2.7	0.3	0.3	0.6	2.0	1.6	1.4	0.6	0.7	0.8	2.2	0.3	1.3	0.0	2.1	0.9	0.8	5.3	2.3	1.2	0.2	4.9	0.8	1.7	1.4	0.6	1.4	0.6	2.5	2.7	1.2	0.2	4.2	1.0	3.7	1.4	1.1	0.7	1.6	0.4	2.5	0.9	1.4	1.7	2.1	0.6	1.3	1.1	1.0	4.4	0.9	0.8	7.6	4.8	1.5	0.4	3.1	1.6	0.4	1.7	2.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2	0.0	4.3	0.0	0.8	0.7	5.4	6.2	12.7	2.7	0.0	1.8	0.0	2.2	1.7	0.8	1.7	1.4	19.8	0.0	4.4	2.8	2.6	1.3	0.0	16.6	2.4	15.9	0.0	2.5	2.4	1.9	1.7	2.2	0.0	1.0	19.5	2.6	0.9	12.5	1.4	2.1	7.4	0.0	1.4	1.2	2.2	0.4	1.9	1.3	10.3	0.7
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	8.3	8.1	6.6	8.1	11.6	35.3	8.4	13.1	13.6	5.3	5.7	7.8	5.5	9.7	9.1	6.0	8.4	7.1	4.9	6.6	8.4	7.5	6.7	16.1	8.4	7.3	8.9	5.4	8.6	9.3	9.2	9.4	7.3	9.1	7.2	2.9	6.5	10.4	5.8	14.2	13.2	8.3	4.5	5.9	8.6	8.0	6.0	8.9	6.8	9.9	6.8	5.3	5.1	16.8	4.0	10.0	2.8	3.1	9.8	4.9	3.2	2.9	4.7	2.1	3.0	1.3	1.0	5.3	3.9	1.7	2.3	1.9	4.4	3.1	2.9	8.2	2.2	2.3	4.5	2.4	3.5	0.4	4.1	6.0	1.3	7.1	10.1	2.5	8.8	8.9	2.4	4.0	2.3	0.6	2.6	3.5	4.9	6.5	7.1	1.6	7.4	3.3	35.4	3.3	1.3	3.0	5.9	3.0	10.8	1.7	3.5	6.7	5.9	3.6	4.9	2.7	1.3	3.2	10.5	6.5	5.0	3.7	2.0	3.2	6.5	5.6	1.8	3.3	7.4	3.5	2.8	3.1	0.9	4.9	1.6	4.1	4.0	3.8	3.8	4.1	3.5	3.4	3.8	1.8	9.8	1.7	10.0	4.6	3.2	6.6	11.6	13.1	13.6	8.4	7.5	8.9	5.4	9.1	8.9	6.0	14.7	4.5	7.9	5.8	3.9	5.6	10.2	1.4	7.9	0.0	5.9	6.2	3.3	4.7	1.0	8.5	10.3	0.0	4.0	4.6	5.8	5.6	9.2	23.6	5.3	12.7	7.5	6.2	4.8	0.0	4.0	3.0	1.7	2.8	5.2	6.8	3.3	3.6	5.3	3.7	5.2	0.0	6.4	3.9	6.1	5.5	9.6	5.0	3.8	4.8
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	24.2	35.2	15.3	18.8	37.8	18.9	22.9	15.0	21.0	31.7	25.1	24.5	11.2	17.9	29.2	24.8	15.8	37.3	26.6	29.2	23.7	17.3	42.8	30.6	44.4	24.1	28.6	14.4	64.6	22.1	46.1	33.0	31.4	19.9	20.4	26.7	11.9	61.3	25.3	17.3	22.7	17.9	18.3	25.7	22.6	15.7	15.3	22.3	36.5	20.4	12.1	15.0	13.8	23.7	20.0	22.4	22.6	14.7	12.5	19.0	12.6	17.0	28.5	20.4	20.6	5.9	26.1	20.8	19.8	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1	0.0	3.8	37.8	33.1	60.9	40.7	13.4	66.2	2.7	2.3	47.1	19.6	101.9	48.0	68.5	41.4	35.8	73.2	46.7	58.4	102.1	39.8	31.4	13.9	83.9	52.2	17.5	30.5	38.1	36.1	68.6	45.1	42.0	37.1	57.7	40.4	45.0	52.7	40.3	50.5	53.1	25.5	38.8	27.8	111.1	83.5	72.8	104.7	90.0	54.4	39.3
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	15.9	18.7	31.6	8.7	43.9	4.4	14.5	27.2	29.8	13.9	10.4	14.3	10.5	7.2	13.2	11.2	13.0	12.5	14.2	18.0	32.3	21.2	23.5	19.2	10.4	14.8	20.3	14.4	20.9	13.8	19.2	17.5	8.8	15.2	14.7	5.2	12.4	18.0	19.6	34.1	9.3	8.3	20.0	15.1	15.6	13.0	15.9	10.8	13.7	18.0	6.5	14.1	16.9	10.0	11.1	9.0	0.0	2.4	0.6	3.4	1.5	3.9	15.5	6.8	11.9	4.9	4.7	0.9	3.4	6.0	11.9	10.0	3.3	6.1	11.5	2.7	6.3	0.3	3.4	11.5	7.4	3.4	0.6	39.5	12.2	10.4	5.9	14.7	0.8	7.0	7.5	0.9	2.8	0.6	8.3	3.7	7.5	8.9	7.4	5.8	1.0	7.3	4.8	3.2	0.4	8.6	11.5	3.5	7.9	12.3	0.3	7.5	14.0	2.7	19.4	6.7	4.2	8.4	7.9	4.1	3.7	3.8	0.3	2.5	4.4	1.5	14.9	9.9	3.9	0.2	0.0	2.4	0.0	0.5	1.6	1.5	7.8	0.5	0.7	3.0	11.1	3.4	2.0	0.0	0.6	0.1	9.0	0.3	1.5	31.6	43.9	27.2	29.4	32.3	21.2	20.3	14.4	15.2	10.8	0.0	2.2	8.3	7.6	2.3	21.3	19.5	12.7	0.0	1.2	19.2	3.9	11.2	34.9	16.1	3.0	11.3	5.5	0.0	6.3	12.7	8.9	4.6	9.2	14.9	14.5	35.0	4.7	5.5	7.8	1.5	13.0	7.1	3.3	18.0	7.0	18.8	9.0	5.8	17.7	41.5	7.1	12.9	7.2	5.9	19.6	3.1	7.3	3.8	4.7	2.0
MUM1	"EXPAND1, MUM-1"	ENSG00000160953	"Melanoma associated antigen (mutated) 1"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048063	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243"	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	6.7	5.3	14.4	3.6	20.9	2.1	5.6	21.9	19.2	7.0	5.8	13.6	4.5	3.7	10.4	5.6	4.3	13.0	5.4	5.3	13.6	9.1	4.9	8.3	6.8	3.6	14.2	11.5	18.4	4.0	7.7	7.5	6.0	11.5	6.7	4.8	5.8	6.7	8.7	5.5	8.1	4.8	11.5	10.5	6.0	4.8	19.9	13.1	1.9	6.0	0.9	4.5	5.6	11.5	4.3	3.9	11.8	2.6	3.8	4.5	1.3	7.2	9.3	13.0	13.8	10.6	14.1	15.9	12.6	7.9	11.6	8.6	6.4	4.8	14.7	5.9	16.2	4.1	8.2	13.1	8.2	8.8	15.8	8.3	7.9	9.5	9.6	10.2	6.1	17.8	9.2	5.1	6.5	4.7	14.9	11.8	9.9	12.2	7.4	11.0	8.1	10.4	6.5	14.7	8.1	5.3	16.8	10.9	6.1	7.7	10.5	9.4	21.5	11.1	13.1	8.4	11.8	6.4	14.0	11.3	10.5	14.6	8.5	11.6	15.0	12.6	6.7	14.0	9.9	14.2	11.8	1.1	6.8	4.5	2.6	3.8	3.9	2.5	3.3	2.1	4.3	3.7	4.0	2.2	3.8	2.2	3.9	1.6	1.3	14.4	20.9	21.9	19.2	13.6	9.1	14.2	11.5	11.5	13.1	32.8	18.3	29.6	30.8	15.0	192.5	23.6	48.4	30.8	14.8	17.4	133.5	16.7	10.0	30.8	84.4	21.8	35.5	0.0	19.1	20.1	33.2	18.7	32.4	72.0	15.3	151.0	36.8	28.8	14.8	101.3	53.8	14.7	28.7	20.8	26.2	51.9	24.8	28.3	53.0	11.0	82.1	116.4	31.5	168.6	74.1	12.9	11.9	20.8	29.5	16.6
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.3;liver: 31.4"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	4.0	10.1	26.1	4.9	24.6	12.8	3.1	10.1	28.3	3.4	6.6	12.9	3.7	7.6	3.2	18.4	2.7	5.2	4.4	3.6	25.3	12.7	12.7	31.4	3.7	3.6	16.0	18.6	2.9	2.7	3.4	3.1	4.5	14.9	5.2	6.8	2.6	2.1	5.4	6.3	3.2	7.3	4.5	9.6	5.2	5.1	2.9	13.3	1.6	4.3	1.7	3.7	5.0	2.1	3.0	4.2	6.4	8.9	5.8	1.3	2.1	3.4	7.4	11.8	9.1	2.8	1.9	4.3	7.0	4.0	11.2	5.9	11.4	8.9	2.1	7.3	7.3	8.1	3.0	9.1	10.1	5.3	8.5	5.9	8.6	7.3	14.9	3.6	4.3	9.4	4.9	2.8	7.8	0.9	4.0	6.5	2.6	7.4	1.8	3.0	6.7	1.2	6.6	14.5	6.7	4.7	8.1	9.7	2.6	6.5	8.2	7.6	2.1	6.5	3.3	2.7	6.7	1.7	2.2	4.7	3.4	11.2	4.8	8.0	3.0	2.9	2.5	11.7	8.1	4.0	4.8	8.9	4.2	0.9	3.9	1.3	1.6	0.5	1.0	4.2	3.0	0.6	0.8	6.4	5.8	4.3	2.9	1.0	2.1	26.1	24.6	10.1	26.3	25.3	12.7	16.0	18.6	14.9	13.3	0.0	4.1	8.8	4.0	4.1	24.0	5.4	5.1	0.0	4.5	34.9	31.4	7.6	3.3	4.4	100.9	6.0	15.1	23.3	7.9	1.9	7.5	2.9	0.0	53.3	10.6	19.1	13.2	8.6	4.0	111.2	9.8	7.0	8.5	10.0	5.8	76.6	6.2	5.3	10.6	20.2	38.4	12.9	7.7	7.9	13.0	8.2	3.5	5.7	6.8	1.6
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"Transducin like enhancer of split 2"	Q04725	19	2997638-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 85.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 3.1;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.1;RT4: 20.0;T-47d: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	13.4	9.6	9.2	4.6	5.7	1.3	38.3	85.3	16.5	10.9	11.4	4.9	28.6	8.1	15.7	6.6	5.5	13.3	8.5	19.9	5.5	7.6	11.9	3.5	12.5	5.4	8.3	5.3	12.4	16.5	13.8	6.4	7.3	9.7	12.9	4.6	20.6	55.5	27.1	38.5	6.4	5.3	26.2	13.3	10.9	7.4	6.3	4.8	1.1	17.5	5.7	3.2	19.2	27.6	3.1	0.0	0.3	0.0	0.0	3.4	0.7	0.3	1.6	0.1	25.1	4.0	0.7	5.5	0.2	0.0	1.3	0.6	7.8	2.8	0.1	3.5	1.7	0.7	4.4	4.1	1.5	0.3	0.7	1.2	0.0	1.8	0.3	5.1	0.0	0.2	5.6	0.7	2.9	0.0	1.4	10.1	7.1	9.0	0.1	0.1	8.4	0.2	0.1	0.1	0.8	1.6	2.0	1.2	2.3	3.3	20.0	1.3	6.5	1.6	12.5	0.7	0.5	14.6	0.0	6.7	8.2	8.6	0.4	0.2	0.3	0.2	1.6	0.2	1.9	1.5	0.0	0.0	0.3	3.2	0.0	2.3	3.1	2.0	1.0	0.0	0.5	3.4	2.1	0.0	0.0	0.0	0.0	0.7	0.7	9.2	5.7	85.3	16.5	5.5	7.6	8.3	5.3	9.7	4.8	17.9	14.5	0.5	30.2	3.2	37.8	24.4	12.7	5.3	1.2	34.9	2.0	1.3	1.7	9.4	3.3	5.9	3.8	0.0	2.4	3.5	6.9	26.7	0.0	3.0	0.6	1.6	13.3	14.7	0.8	7.6	10.9	1.4	5.0	0.0	12.7	18.3	3.3	8.6	14.2	1.1	2.9	0.0	13.3	1.0	3.4	1.9	5.6	1.5	24.3	27.4
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861450-38872314	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	15.0	15.0	44.7	14.5	35.1	21.7	7.4	27.8	53.8	14.0	19.5	15.3	9.8	6.5	19.3	14.2	12.9	18.8	10.9	14.0	40.6	18.3	12.1	5.9	13.0	12.0	15.8	21.8	23.4	13.1	62.2	15.5	4.7	19.3	16.1	7.4	17.0	12.5	25.4	5.5	7.7	9.2	23.8	12.1	11.2	12.0	5.0	12.0	11.3	13.4	4.5	13.8	16.6	9.5	4.7	26.9	2.6	7.4	5.2	11.7	9.2	16.6	17.7	3.9	13.4	30.4	17.1	1.2	18.2	10.5	9.5	8.9	8.8	15.6	27.3	13.7	12.4	6.6	19.9	7.3	7.7	5.2	26.2	22.9	2.7	7.6	3.0	16.6	13.4	13.6	25.4	3.9	21.6	10.3	13.1	10.7	7.9	6.1	13.9	6.4	18.8	8.2	3.9	3.5	9.6	13.7	12.5	13.2	10.7	13.4	15.8	19.3	4.3	11.7	15.6	9.8	1.4	10.7	8.0	13.8	8.3	25.5	14.3	12.4	14.3	13.7	10.0	16.2	14.1	17.1	1.1	5.5	2.6	11.7	7.4	9.7	4.2	8.1	8.2	5.4	4.7	6.7	8.2	2.3	5.2	6.8	26.9	4.6	9.2	44.7	35.1	27.8	53.8	40.6	18.3	15.8	21.8	19.3	12.0	14.9	14.3	23.1	30.9	30.1	95.1	23.3	38.2	5.3	13.6	69.8	37.3	9.4	29.9	79.7	0.5	30.3	1.3	0.0	43.0	1.9	41.4	21.2	5.8	29.7	17.5	117.6	117.7	33.7	40.3	0.9	68.7	20.0	77.6	119.0	0.7	80.1	41.4	7.0	76.0	41.9	56.5	71.1	86.3	2.1	6.0	29.6	3.9	35.8	0.5	68.7
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971569	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	4.9	2.4	4.2	3.4	4.7	6.0	2.2	16.8	7.8	5.1	2.2	6.3	1.9	2.0	5.0	3.8	1.4	7.4	6.3	2.9	6.9	2.5	2.5	1.8	3.0	3.1	3.1	3.5	4.6	1.4	1.8	3.0	2.5	10.4	3.3	2.1	2.6	1.2	6.0	0.7	1.6	2.6	6.6	6.5	4.2	2.5	3.0	2.7	1.1	2.3	0.5	3.6	3.0	3.0	0.6	1.3	1.4	0.1	0.0	0.8	0.1	0.4	1.9	0.8	4.7	6.4	5.1	1.6	1.0	4.0	2.8	1.9	1.2	0.6	1.6	3.4	3.1	0.8	0.6	0.8	0.4	2.7	2.6	3.1	1.4	1.9	0.1	2.4	0.4	2.9	13.2	1.8	5.2	0.6	4.7	0.9	2.2	1.1	3.6	2.0	3.5	0.4	10.5	2.5	0.3	0.7	1.3	0.9	1.5	3.1	1.5	0.5	2.1	0.9	0.0	2.1	10.2	2.0	1.5	2.4	0.6	2.6	0.6	0.2	2.9	3.8	3.8	1.7	3.7	2.1	0.0	0.1	0.0	0.5	0.0	0.3	0.6	0.2	0.8	0.0	0.1	0.2	0.0	1.4	0.0	0.0	1.3	0.0	0.1	4.2	4.7	16.8	7.8	6.9	2.5	3.1	3.5	10.4	2.7	0.0	1.4	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	3.4	0.6	0.8	0.0	1.7	0.0	0.0	0.0	0.2	0.3	0.1	0.0	3.5	0.0	2.8	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47144869-47186813	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	18.1	22.2	19.8	38.0	21.9	34.0	17.1	41.2	22.9	19.9	20.5	25.7	22.7	21.8	22.1	17.3	23.7	26.2	29.1	21.7	19.8	18.3	18.4	21.6	17.1	27.2	20.1	19.2	36.4	27.4	20.1	28.3	24.9	17.9	23.5	14.2	18.5	25.1	28.8	20.6	23.8	23.7	18.9	17.2	24.7	20.5	8.7	21.4	32.9	26.8	18.0	22.7	17.6	20.9	15.9	14.6	14.4	19.2	12.3	18.3	11.5	20.9	22.7	21.8	25.8	11.7	9.6	25.3	16.0	9.4	16.5	16.1	19.8	17.2	25.6	9.8	11.0	21.1	20.5	28.4	20.1	9.1	26.0	25.7	19.1	27.6	20.7	17.1	19.3	23.1	12.6	9.7	27.3	22.2	11.9	17.7	24.8	15.9	20.6	10.0	32.0	35.4	32.8	35.9	15.8	25.5	31.3	18.2	26.4	12.2	18.6	25.9	19.7	24.1	18.1	15.3	13.5	22.2	19.3	15.4	19.5	24.8	21.0	16.7	21.7	17.5	21.1	17.3	14.0	27.2	14.0	10.8	14.4	18.3	14.5	17.0	15.9	14.7	15.3	12.3	15.6	14.8	14.1	10.1	12.3	19.2	14.6	16.6	11.5	19.8	21.9	41.2	21.9	19.8	18.3	20.1	19.2	17.9	21.4	38.7	44.1	14.3	20.3	9.8	26.5	30.9	25.5	30.8	36.4	8.7	13.7	27.7	10.0	17.2	0.6	18.8	24.8	0.0	15.2	23.9	18.1	14.5	23.1	19.8	16.9	20.6	34.3	14.7	12.9	1.6	16.7	11.8	15.1	18.0	24.9	14.0	16.8	18.6	24.1	11.5	25.3	0.0	16.9	5.7	6.1	9.3	38.6	17.5	23.4	16.5
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.8	7.3	5.5	8.4	5.3	7.2	8.5	6.1	3.3	5.6	7.3	19.3	3.5	5.4	1.3	5.6	5.1	4.4	16.2	5.3	7.9	5.0	10.1	5.2	4.3	7.6	3.9	2.7	5.8	5.8	6.4	2.6	4.5	10.6	5.0	10.3	6.0	9.7	12.1	10.3	7.6	10.1	4.4	7.8	8.2	5.8	8.1	12.9	4.5	1.6	9.3	5.4	5.7	5.5	6.3	9.1	5.5	3.5	5.1	5.7	7.8	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2	3.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	7.0	0.0	2.5	1.7	4.7	0.0	0.0	0.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.4	0.0	0.0	4.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787204-128810432	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No			Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	12.5	17.4	23.0	8.3	20.8	12.1	10.1	12.0	24.7	9.8	10.7	17.3	8.4	11.7	13.3	14.2	8.4	14.7	10.9	13.4	17.8	18.5	26.0	8.9	10.5	11.0	13.9	12.7	19.3	11.3	30.2	9.7	9.5	14.9	11.6	8.2	12.5	16.9	14.3	16.6	11.6	13.0	12.6	8.7	12.0	11.2	8.1	13.3	8.6	14.1	7.6	11.2	11.2	8.5	5.0	9.0	15.7	2.8	3.4	5.6	3.4	6.3	15.2	16.0	16.0	20.8	10.1	15.6	15.2	13.1	15.8	10.3	16.5	8.5	10.6	10.6	18.0	15.8	17.2	9.7	12.1	9.4	8.4	11.1	11.4	17.8	15.1	12.9	17.1	23.3	14.1	14.4	13.7	8.3	14.1	20.3	11.4	17.5	7.2	18.8	13.6	10.3	10.2	15.2	17.6	23.0	11.7	14.8	24.1	11.6	8.3	16.2	11.3	21.2	13.6	8.9	16.3	14.5	16.1	16.0	19.9	12.5	16.1	12.3	9.3	11.9	10.5	14.5	10.3	14.2	15.7	2.7	4.6	4.9	2.8	4.9	5.0	3.8	4.7	3.1	4.0	3.3	5.6	2.2	3.4	2.1	9.0	2.8	3.4	23.0	20.8	12.0	24.7	17.8	18.5	13.9	12.7	14.9	13.3	3.0	7.0	4.2	2.6	2.1	8.3	8.9	0.0	4.0	3.4	15.7	9.8	4.3	8.3	5.6	1.3	9.5	7.8	0.0	8.6	4.1	5.7	2.8	8.1	11.6	14.2	6.4	5.2	16.0	8.6	2.3	8.6	4.1	0.0	87.4	6.1	6.7	6.8	7.0	7.1	24.8	5.8	6.5	3.5	5.1	9.3	2.8	2.1	5.0	6.0	2.0
RAD51D	"HsTRAD, R51H3, RAD51L3, Trad"	ENSG00000185379	"RAD51 paralog D"	O75771	17	35092208-35121522	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 114.4;Late spermatids: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.41e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.37e-5)"	"unprognostic (7.29e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (3.35e-6)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (7.20e-9)"	"unprognostic (7.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.22e-2)"	7.9	7.1	9.5	9.9	11.1	8.6	9.2	8.8	13.3	9.0	7.5	10.4	4.3	8.4	10.3	7.6	6.9	7.9	7.3	7.0	9.0	9.8	8.0	6.2	8.0	10.3	10.7	9.2	13.2	11.4	9.5	6.3	9.1	7.4	7.5	7.2	8.6	6.7	9.5	4.1	5.7	7.6	11.7	8.0	10.2	6.0	21.1	10.1	13.9	10.8	3.9	10.9	8.6	8.3	9.0	8.1	5.0	5.8	11.4	10.8	5.0	7.1	12.6	3.3	6.7	3.1	5.2	4.6	14.1	7.4	10.7	10.2	7.5	8.1	16.2	9.5	7.9	7.0	9.9	7.3	4.2	6.4	8.9	8.0	8.1	8.6	4.9	6.6	15.9	14.9	6.6	4.3	10.1	6.8	5.1	7.8	13.2	10.4	23.0	8.9	7.7	19.7	8.0	4.7	6.4	6.0	15.1	8.3	10.3	4.1	7.4	5.0	5.1	7.5	3.9	9.1	8.7	8.0	10.6	6.3	5.3	6.5	7.9	11.6	4.5	7.4	9.6	7.8	11.3	9.2	4.5	4.7	5.0	10.8	4.7	8.2	9.0	6.8	9.6	5.1	8.2	6.6	8.4	1.0	11.4	5.8	8.1	6.3	5.0	9.5	11.1	8.8	13.3	9.0	9.8	10.7	9.2	7.4	10.1	0.0	3.7	4.9	4.0	2.1	8.8	2.9	2.5	1.4	2.3	3.5	9.8	7.7	1.7	5.8	114.4	7.0	3.2	0.0	5.8	8.5	4.7	3.1	5.8	4.3	9.1	7.9	1.2	7.4	3.5	172.1	8.9	4.6	1.7	12.6	4.5	7.6	6.9	5.8	6.3	6.9	3.6	0.0	3.9	7.0	13.9	1.3	2.4	12.9	6.6	2.6
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614871	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 55.0"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	10.4	13.6	15.9	7.4	22.5	5.8	7.5	21.2	25.2	9.6	9.5	14.5	11.2	9.2	9.7	8.3	11.1	9.0	7.4	31.9	16.1	18.1	11.1	9.6	10.5	8.5	18.8	18.5	10.2	11.2	19.2	13.9	10.6	22.4	11.8	8.0	13.5	10.9	13.2	55.0	9.1	8.5	11.7	15.1	8.4	7.8	13.5	18.2	8.3	9.4	9.5	9.8	8.9	8.3	2.4	3.1	6.0	2.2	2.1	4.6	1.9	15.6	20.7	19.2	20.0	16.5	11.3	14.8	23.5	19.6	34.0	23.7	11.5	5.1	14.6	15.7	15.9	15.0	17.2	25.2	10.6	22.9	16.4	27.1	8.2	18.1	6.6	16.1	0.1	17.7	10.5	15.7	25.8	25.1	19.2	11.7	11.6	14.6	5.0	16.8	7.8	11.2	8.0	11.5	8.0	11.2	16.4	11.6	8.9	12.5	5.5	11.5	21.3	15.9	10.7	15.9	19.0	11.0	6.1	10.9	15.9	10.1	10.4	27.7	8.4	7.5	6.5	18.3	6.7	20.9	6.0	2.0	5.8	2.4	2.2	3.2	1.1	3.8	4.6	3.1	2.4	3.1	3.3	5.1	2.1	1.4	2.1	3.8	1.9	15.9	22.5	21.2	25.2	16.1	18.1	18.8	18.5	22.4	18.2	29.8	14.1	7.3	9.7	10.2	43.8	35.9	5.1	6.7	10.3	15.7	29.5	13.4	1.7	9.2	1.4	9.7	12.2	0.0	8.0	9.8	8.1	11.6	2.3	9.7	7.8	60.4	9.2	14.1	7.8	2.0	8.9	6.9	0.0	7.2	10.3	21.1	13.8	11.0	14.5	6.6	51.7	6.5	9.2	14.4	22.4	12.5	14.3	6.1	8.0	8.3
VAMP2	"SYB2, VAMP-2"	ENSG00000220205	"Vesicle associated membrane protein 2"	P63027	17	8159149-8163546	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 168.0"	"Cell type enhanced"	"Detected in all"	7	"Bipolar cells: 1189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB078785		Supported				NA	NA					"CAB078785: "	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.83e-6)"	"unprognostic (8.27e-2)"	"prognostic favorable (9.76e-8)"	"unprognostic (1.21e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	22.0	38.3	65.1	16.2	111.7	57.4	20.2	72.2	168.0	20.1	16.3	51.6	11.6	15.7	27.4	24.1	11.6	26.8	14.4	22.1	61.7	56.5	23.5	11.4	21.0	23.1	52.7	71.1	48.4	22.6	52.2	40.6	15.4	88.4	25.1	19.3	37.5	19.5	27.0	33.6	25.0	17.9	25.2	30.7	27.2	17.4	15.1	35.1	9.2	22.0	8.8	22.8	11.7	16.0	25.1	15.4	37.8	8.8	25.1	33.4	9.3	13.8	10.4	25.8	13.8	22.7	17.8	11.6	13.0	16.5	13.3	18.3	4.1	9.5	15.8	9.3	20.8	12.5	16.9	16.9	14.0	15.4	18.3	18.5	11.0	26.7	5.6	20.4	7.3	17.1	19.6	21.1	15.3	23.0	27.5	12.9	27.7	8.5	18.4	22.5	7.3	19.1	10.1	5.9	9.3	7.7	24.4	11.8	12.4	17.2	9.3	12.0	19.2	10.2	5.7	12.7	11.8	13.0	9.5	19.7	8.1	11.2	14.8	12.0	20.3	11.5	11.4	20.6	12.8	18.3	13.7	7.4	24.5	28.4	6.9	24.4	25.1	28.2	30.0	5.7	22.1	33.4	30.8	37.8	25.1	8.8	15.4	20.1	9.3	65.1	111.7	72.2	168.0	61.7	56.5	52.7	71.1	88.4	35.1	38.7	21.2	219.6	147.9	101.1	1189.4	24.3	147.7	17.4	34.2	219.8	233.7	157.6	334.9	66.7	5.4	128.8	97.5	23.3	73.0	75.1	142.8	110.4	150.8	68.4	95.0	440.2	310.2	154.7	94.0	5.9	242.4	101.2	183.9	129.8	134.5	437.1	85.1	111.2	202.6	152.5	445.5	291.1	199.4	106.5	119.6	131.7	267.6	252.2	82.9	115.3
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495883	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	10.8	12.4	15.2	11.2	17.8	8.6	9.6	26.9	24.0	15.4	10.7	11.8	13.1	6.5	17.8	15.7	8.5	15.1	15.9	11.2	14.2	14.9	13.7	9.0	11.1	13.1	11.5	16.3	19.8	16.3	20.7	14.7	13.2	10.9	16.6	9.2	17.0	11.3	16.2	16.3	9.9	8.0	19.0	7.8	12.5	9.9	8.3	9.6	5.0	18.5	6.8	17.1	11.1	12.3	7.1	12.9	15.1	6.6	13.7	16.0	5.1	9.0	8.9	20.1	16.7	17.2	19.8	5.0	11.6	19.2	11.9	13.1	4.6	3.4	6.0	3.9	20.4	9.2	11.6	13.9	5.2	10.6	12.3	7.5	5.7	8.7	4.5	15.8	1.4	6.7	15.3	7.9	10.3	7.3	14.7	16.5	4.9	16.7	6.4	11.5	14.2	1.2	8.5	3.5	7.1	6.4	12.5	7.4	0.3	6.9	11.0	10.9	11.3	12.0	9.3	8.4	7.3	8.2	5.0	7.3	14.4	6.9	9.7	4.8	3.6	3.7	4.5	7.6	5.6	9.3	5.4	3.6	15.1	7.3	5.1	5.7	7.1	9.3	6.6	12.9	6.1	7.3	7.3	8.7	13.7	6.6	4.9	16.0	5.1	15.2	17.8	26.9	24.0	14.2	14.9	11.5	16.3	10.9	9.6	0.0	3.0	3.7	2.7	1.4	10.8	4.1	10.2	4.0	3.4	8.7	3.9	13.9	3.3	7.6	0.2	3.0	2.1	0.0	2.2	5.8	5.5	3.4	4.7	5.0	6.9	12.7	2.9	4.3	4.3	1.3	11.2	3.4	1.7	1.8	4.8	12.8	5.3	3.2	18.7	7.3	5.9	6.5	4.7	6.2	7.7	1.3	11.2	6.9	3.5	1.3
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824239-133895836	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 86.5;parathyroid gland: 33.1"	"Cell type enhanced"	"Detected in many"	17	"Cardiomyocytes: 26.9;Erythroid cells: 93.5;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 10.5"	"Lineage enriched"	"Detected in single"	54	"T-cells: 10.5"	"Cell line enriched"	"Detected in many"	4	"HEL: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		11000000	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	5.3	8.4	38.2	2.6	26.1	7.0	2.3	18.4	86.5	2.8	3.1	4.1	2.7	2.5	2.6	2.3	3.6	11.5	2.9	14.4	29.2	29.1	3.6	1.1	2.1	2.8	25.6	43.6	2.2	3.8	33.1	4.4	2.0	26.9	2.7	2.3	3.4	6.8	5.0	2.4	1.5	1.9	6.1	12.1	4.6	4.3	3.5	7.0	0.0	4.3	0.0	2.2	1.6	1.0	0.1	0.1	0.0	0.0	0.1	10.5	1.1	0.0	0.9	1.8	4.7	3.3	3.4	0.1	1.0	1.9	2.3	0.2	0.5	0.4	0.0	2.1	0.7	6.7	0.1	4.3	0.1	1.1	0.0	3.3	70.8	1.0	0.1	0.4	0.4	2.8	1.0	0.9	0.3	0.0	0.0	0.9	2.6	16.5	0.2	0.3	1.6	0.2	6.5	5.8	3.3	0.8	0.0	0.1	0.7	1.2	0.4	15.3	3.3	1.4	1.3	8.3	7.5	5.2	3.0	1.1	2.1	5.1	1.0	1.7	1.8	0.4	0.1	0.2	0.1	1.7	0.0	0.0	0.0	1.0	0.0	10.5	0.1	0.2	2.5	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.1	1.1	38.2	26.1	18.4	54.0	29.2	29.1	25.6	43.6	26.9	7.0	0.0	0.0	0.0	1.7	1.1	6.9	26.9	2.5	10.7	3.4	1.8	2.0	0.2	3.3	2.4	0.1	2.4	0.0	93.5	1.2	0.5	4.0	2.1	0.0	0.0	0.2	63.5	0.0	3.1	0.3	0.0	1.7	0.0	1.7	0.0	0.0	6.6	3.6	0.0	6.3	0.8	17.4	0.0	9.2	0.5	3.8	1.3	0.2	1.0	0.0	0.6
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 98.2"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 421.2;T-cells: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	14.5	15.0	50.9	37.0	57.8	19.9	28.5	57.4	66.2	11.8	12.4	20.7	10.7	12.7	23.6	25.1	11.2	18.0	20.1	19.7	42.4	43.3	12.4	24.4	28.4	63.5	34.8	31.4	23.3	17.1	9.8	28.6	13.5	26.2	16.4	12.0	24.2	20.0	16.5	12.8	15.6	18.7	29.4	23.1	44.2	15.2	13.2	20.3	98.2	11.0	7.5	55.8	18.3	9.3	7.8	2.5	14.2	8.7	9.3	20.6	5.4	4.1	3.6	27.6	8.3	5.6	16.0	16.0	5.4	6.9	3.5	4.9	0.2	2.8	7.8	7.2	4.9	3.0	0.1	13.0	9.4	4.4	8.4	8.2	12.8	2.9	2.2	4.6	3.8	30.4	8.5	4.8	2.4	9.4	7.8	9.6	29.8	6.4	0.5	3.9	5.6	71.4	20.5	5.8	3.6	5.4	17.2	14.3	1.3	4.5	0.1	33.5	19.7	3.8	5.9	1.6	6.8	4.6	11.3	5.9	2.9	4.6	18.0	3.0	14.6	11.0	21.9	3.9	6.5	4.7	1.5	1.5	14.2	11.6	7.6	8.9	6.2	13.6	11.0	2.5	7.8	16.5	14.6	0.3	9.3	8.7	0.4	20.6	5.4	50.9	57.8	57.4	66.2	42.4	43.3	34.8	31.4	26.2	20.3	26.8	48.9	156.1	17.2	18.4	110.7	4.1	20.4	32.1	12.5	12.2	379.0	17.5	26.6	12.5	2.9	40.5	1.7	0.0	11.9	10.1	19.8	14.8	16.2	95.1	134.9	73.1	8.1	33.2	56.1	8.6	23.0	74.9	25.3	0.0	0.9	52.0	14.3	1.1	46.7	11.5	421.2	6.5	20.8	13.4	26.7	27.5	12.2	371.9	1.5	13.9
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205638	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	15.3	21.1	20.6	13.5	22.4	7.6	19.2	18.2	34.1	16.8	20.0	19.0	17.6	18.5	20.0	23.5	19.2	20.2	20.0	31.4	19.7	18.2	23.7	35.5	15.6	20.5	20.0	17.0	24.8	17.4	20.9	16.9	16.5	19.1	17.1	15.8	19.7	22.3	20.0	33.2	26.2	22.8	18.8	14.5	20.0	18.0	17.5	16.3	21.4	25.2	15.6	18.4	15.9	16.9	9.9	6.5	6.4	5.8	9.2	12.7	3.5	17.0	18.2	17.2	28.4	25.7	20.1	20.7	22.4	21.8	26.2	19.7	14.9	15.5	17.8	21.8	19.4	25.2	33.7	21.2	22.3	15.3	32.1	20.4	12.3	21.6	16.9	21.5	28.3	12.7	19.1	35.7	17.0	22.7	17.5	16.7	23.5	28.6	20.9	20.2	29.6	22.4	24.6	28.6	33.0	29.6	24.5	24.1	35.4	21.9	12.5	22.9	22.4	17.9	22.9	17.6	12.4	32.3	23.1	14.8	27.0	14.4	30.0	25.0	11.3	35.2	22.4	20.8	21.1	22.1	6.4	5.3	5.3	7.4	5.8	9.2	9.9	8.5	9.2	6.1	7.1	12.7	8.7	2.8	9.2	5.0	6.5	5.2	3.5	20.6	22.4	18.2	34.1	19.7	18.2	20.0	17.0	19.1	16.3	8.9	5.0	14.4	20.3	15.7	35.3	10.8	25.5	1.4	6.8	29.6	3.9	26.3	44.7	45.2	2.9	15.8	14.2	0.0	36.9	22.8	18.1	25.7	5.7	36.1	25.5	30.2	15.6	13.5	20.2	6.8	20.4	13.2	23.6	66.7	14.0	43.3	31.8	7.0	19.4	46.8	19.4	12.9	13.0	16.7	11.5	23.8	16.2	14.0	18.9	16.2
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.6	11.3	14.4	40.6	24.7	1.5	16.4	17.1	11.1	12.3	0.5	1.5	0.4	3.9	35.4	9.2	4.3	0.4	8.9	12.4	8.4	12.8	3.6	12.5	0.4	41.6	2.3	7.1	31.3	7.6	21.1	15.4	23.0	17.0	11.5	0.5	1.3	19.4	8.4	15.1	2.9	6.3	2.2	0.6	8.3	6.2	1.0	16.5	1.3	7.5	18.8	13.7	7.1	9.3	10.3	6.9	1.6	10.3	8.6	11.4	18.4	4.7	20.4	5.1	3.7	20.7	4.2	13.3	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0	11.9	7.7	10.0	12.1	6.8	21.7	5.1	12.7	10.7	9.1	10.4	11.8	2.9	10.0	14.9	2.9	30.3	1.3	0.0	5.0	10.4	36.2	8.7	16.1	2.5	5.8	15.9	9.8	23.9	4.6	3.5	35.4	7.7	13.5	3.6	3.4	26.4	4.6	0.0	38.9	15.8	6.7	19.4	40.1	10.7	3.9	6.5	8.1	25.3	1.3	8.1
ZNF18	"HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38"	ENSG00000154957	"Zinc finger protein 18"	P17022	17	11977439-11997510	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006144	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA006144: AB_1080683"	"unprognostic (2.99e-3)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (5.12e-6)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (1.52e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.53e-3)"	8.3	6.8	8.2	7.0	13.9	15.7	9.6	9.4	15.5	8.5	7.2	13.2	3.5	6.4	14.1	9.5	8.8	7.5	7.2	7.3	9.0	8.7	6.5	13.2	6.2	10.5	9.9	9.8	10.4	7.8	8.4	11.8	5.1	14.5	9.8	9.2	12.5	9.0	7.1	8.2	12.8	8.2	7.8	10.8	12.3	6.2	15.5	9.2	15.6	8.4	14.3	10.2	7.7	7.6	9.1	8.8	19.6	7.6	7.0	11.2	5.6	2.2	4.7	5.0	7.4	9.4	8.4	2.6	3.3	5.8	4.3	4.6	2.1	3.9	7.7	4.9	3.5	3.7	4.7	4.1	5.1	4.7	5.8	3.5	4.5	4.8	3.0	6.7	2.6	6.1	6.9	8.4	3.2	6.0	4.9	6.5	9.1	2.6	3.6	5.8	2.3	8.4	5.1	3.7	8.2	2.1	7.0	5.0	3.4	6.2	2.7	1.9	4.2	5.6	2.7	4.3	30.3	3.9	2.4	5.0	5.1	2.5	2.3	2.4	4.0	2.9	3.8	5.9	5.9	6.0	10.6	5.9	6.6	11.0	5.8	10.2	9.1	10.2	10.3	5.8	8.2	11.0	11.2	19.6	7.0	7.6	8.8	10.6	5.6	8.2	13.9	9.4	15.5	9.0	8.7	9.9	9.8	14.5	9.2	0.0	1.3	0.5	1.1	1.8	1.8	1.2	2.5	1.4	0.0	1.8	2.0	2.0	1.7	2.4	23.1	1.4	2.9	0.0	0.8	1.8	2.4	1.0	2.3	3.2	3.6	1.6	1.2	1.3	2.1	19.5	3.1	1.9	1.7	2.8	3.6	1.8	2.1	3.4	3.2	2.5	1.1	0.0	2.2	11.2	3.2	1.9	1.3	4.4	3.1	1.0
CYB561D1	"FLJ39035, FLJ44753"	ENSG00000174151	"Cytochrome b561 family member D1"	Q8N8Q1	1	109494052-109502932	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027028	Uncertain					NA	NA					"HPA027028: AB_1847365"	"unprognostic (2.15e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (4.68e-4)"	"unprognostic (4.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.16e-6)"	"unprognostic (4.30e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.82e-2)"	6.1	10.5	8.7	10.7	12.0	9.1	7.0	21.7	13.4	4.2	8.4	7.9	13.4	7.1	6.9	14.8	9.3	7.0	6.7	4.6	9.6	5.6	8.2	4.2	7.4	12.8	9.7	10.2	9.4	19.4	11.1	11.2	7.0	8.8	6.8	7.7	4.6	10.8	8.4	7.8	22.5	12.2	6.8	7.8	12.1	9.0	3.9	11.1	10.6	10.3	6.6	12.8	7.0	12.2	4.5	3.0	10.8	4.5	8.7	8.3	3.5	8.3	5.0	3.6	4.2	12.6	9.3	9.3	7.3	5.7	8.4	6.0	4.9	3.8	7.6	7.9	9.4	5.5	9.7	4.8	6.0	5.5	6.2	4.4	5.1	6.8	3.8	5.9	10.3	16.0	9.9	15.0	8.3	4.4	5.3	6.0	7.5	3.2	3.5	5.4	10.6	3.7	5.5	1.7	6.4	7.7	6.1	14.8	3.0	7.7	14.3	5.4	4.7	8.3	8.2	7.7	5.3	5.6	5.6	7.8	8.4	9.9	11.3	5.9	4.0	2.9	3.8	8.5	8.6	9.2	3.8	3.8	5.6	6.3	4.2	5.5	3.5	6.6	5.6	2.7	4.5	8.3	5.8	10.8	8.7	4.5	3.0	4.7	3.5	8.7	12.0	21.7	13.4	9.6	5.6	9.7	10.2	8.8	11.1	0.0	6.6	4.9	1.5	2.1	7.6	3.4	5.1	2.7	3.4	3.5	2.0	2.2	0.0	2.8	0.0	2.1	7.4	0.0	6.9	1.0	2.1	1.5	1.1	1.8	1.1	3.2	4.1	1.3	3.8	0.0	2.3	2.3	1.7	1.0	2.7	2.4	4.5	0.0	3.9	2.3	5.5	0.0	2.8	1.1	1.5	2.6	0.9	6.9	3.4	2.3
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6580001-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.8	12.0	9.6	15.1	12.6	13.3	12.3	11.1	16.3	13.5	12.2	12.7	21.4	11.7	13.2	15.1	12.7	14.2	17.6	9.6	8.9	7.5	12.9	21.6	14.3	17.1	7.0	11.3	19.9	15.8	17.1	14.0	10.7	11.4	17.2	13.2	16.9	12.6	11.7	10.9	14.4	17.2	11.3	8.8	17.1	12.9	28.2	10.3	19.9	18.4	7.4	15.9	13.0	14.4	7.5	7.8	26.7	6.8	6.6	6.4	5.3	3.9	4.8	7.6	11.1	8.5	6.6	3.9	4.0	4.8	7.7	8.4	4.9	9.1	13.1	7.2	3.5	5.3	7.4	11.5	8.0	6.2	13.3	10.9	10.6	13.9	4.8	10.1	17.0	28.8	6.6	6.2	7.5	12.1	10.4	5.6	10.0	10.4	8.6	5.7	7.6	8.3	12.2	5.7	7.7	8.3	9.5	7.1	14.4	6.9	3.7	14.9	6.9	6.0	13.8	9.2	8.3	7.9	13.7	6.3	5.3	3.5	5.7	5.0	9.4	8.1	20.3	4.9	13.7	3.0	10.9	6.8	26.7	6.0	4.2	6.0	6.5	4.7	5.7	7.8	7.5	6.4	5.5	10.0	6.6	6.6	5.0	3.8	5.3	9.6	12.6	11.1	16.3	8.9	7.5	7.0	11.3	11.4	10.3	3.0	10.5	6.7	8.5	4.1	7.1	4.5	12.7	13.4	7.9	10.4	5.9	5.1	10.0	4.1	36.3	4.7	15.8	0.0	3.2	4.1	5.8	5.2	26.5	11.6	9.6	9.5	14.9	4.3	6.2	14.2	8.1	9.8	5.0	10.0	12.7	10.4	2.7	14.0	5.3	10.5	7.4	19.4	5.2	17.7	10.4	4.8	4.2	10.1	9.5	5.8
ELMOD3	"DFNB88, FLJ21977, RBED1, RBM29"	ENSG00000115459	"ELMO domain containing 3"	Q96FG2	2	85354394-85391752	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012126	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA012126: AB_1848130"	"unprognostic (1.90e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.63e-2)"	"prognostic favorable (6.16e-6)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (5.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.85e-5)"	18.5	14.5	11.0	10.5	17.4	4.9	15.0	15.4	14.7	13.4	12.0	18.4	18.6	9.5	12.7	11.6	8.7	13.8	11.5	9.2	13.2	8.6	10.7	14.4	8.4	9.0	20.2	8.8	12.0	11.4	14.4	15.6	11.7	14.2	13.7	9.7	13.0	11.6	14.5	18.8	9.7	10.6	13.4	11.1	11.1	12.1	12.3	17.4	7.6	13.0	6.8	10.2	11.9	10.7	4.5	4.5	10.8	6.6	6.1	7.6	3.9	4.0	5.2	6.0	8.8	18.7	8.4	3.5	7.5	5.8	11.2	10.3	4.3	2.1	3.1	5.8	6.0	13.7	4.3	8.3	10.3	10.2	11.0	5.8	5.4	2.9	3.0	9.8	4.1	7.2	8.6	9.1	10.6	12.2	9.4	7.9	6.4	5.5	3.7	10.3	3.1	6.0	2.4	2.8	8.4	5.5	4.3	12.2	2.9	5.1	2.5	5.6	2.9	4.6	6.4	6.9	7.1	3.5	3.1	4.4	8.0	4.3	6.9	6.8	4.6	8.2	4.2	8.0	4.8	8.1	9.1	3.9	10.8	7.6	2.6	4.0	4.5	4.9	3.0	4.5	4.1	4.2	7.3	3.5	6.1	6.6	1.2	7.3	3.9	11.0	17.4	15.4	14.7	13.2	8.6	20.2	8.8	14.2	17.4	6.0	5.9	13.7	8.8	4.1	26.2	4.8	12.7	6.7	13.6	10.4	27.5	11.6	6.6	7.1	3.8	7.2	17.8	0.0	7.9	4.9	8.7	10.2	9.2	7.3	7.6	28.6	8.1	9.2	9.2	3.6	17.8	11.0	16.9	12.6	8.9	19.7	7.8	14.0	22.3	4.8	29.2	19.4	6.6	13.0	10.1	5.6	10.4	13.8	11.9	7.1
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 250.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA052281: AB_2681784"	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.6	26.7	8.9	27.2	4.8	6.9	18.9	18.7	9.3	16.7	14.2	18.8	17.9	12.5	12.4	12.0	21.2	26.5	10.7	22.6	3.3	11.9	21.6	11.4	18.9	25.5	19.7	14.5	7.9	9.8	18.1	15.5	14.3	7.3	11.4	10.6	20.3	12.0	7.4	60.2	6.7	38.9	21.9	18.8	39.7	19.8	3.3	20.7	7.8	11.6	20.6	29.5	15.4	18.3	25.2	6.2	43.9	26.8	13.1	9.7	43.2	28.9	24.5	10.3	13.8	11.4	19.5	24.2	30.6	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8	32.8	64.7	92.5	33.2	20.6	74.8	64.4	40.8	56.2	30.7	62.8	17.7	65.3	250.4	73.5	7.0	40.5	17.6	23.3	74.9	70.2	42.1	41.1	54.3	32.5	140.0	54.0	87.1	33.7	63.1	3.4	34.2	61.3	67.4	120.8	45.0	82.9	55.6	17.3	41.8	101.0	58.5	25.8	67.4	18.1	41.5	21.3	38.9	48.4	57.1	30.7
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 48.5;Urothelial cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (4.11e-5)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.3	5.8	2.1	4.4	15.2	3.8	3.4	3.8	2.7	5.7	5.6	3.2	12.1	2.3	3.0	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.3	6.8	5.3	1.3	6.8	3.7	8.5	4.1	2.5	3.0	3.4	8.0	6.2	4.9	1.9	8.3	5.4	0.3	1.4	12.7	4.6	6.4	3.1	2.1	1.8	18.0	0.1	5.1	4.9	10.7	4.6	1.5	7.6	4.5	4.3	2.5	6.6	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0	0.0	1.7	13.7	24.7	25.8	1.0	1.7	7.6	10.7	2.3	8.7	0.0	18.0	1.7	4.8	7.6	5.0	6.4	0.0	2.1	4.1	8.5	20.4	5.7	9.5	3.2	0.0	2.9	4.9	3.7	7.4	3.4	4.1	5.0	5.4	3.9	3.7	2.4	3.1	3.2	5.5	1.8	6.5	15.5	20.7	5.3	33.5	48.5	6.9	3.3	40.7
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940251	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		17000			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	11.8	17.5	17.8	11.9	20.8	10.3	11.7	18.2	34.3	11.1	15.7	16.3	10.3	17.3	12.4	10.1	18.9	16.1	14.3	82.1	19.8	17.7	24.2	22.6	10.6	13.3	19.5	16.3	12.1	15.3	16.0	12.3	13.3	18.7	12.0	13.7	22.2	16.8	15.6	100.8	16.9	14.6	13.0	13.8	12.8	12.3	5.2	9.6	17.4	14.6	42.4	14.0	15.1	10.5	26.9	50.1	39.3	53.9	42.7	32.4	51.4	16.5	44.9	22.9	22.4	22.6	14.0	16.2	18.8	19.3	33.0	27.4	28.1	8.3	25.8	25.6	18.3	16.1	33.2	29.7	34.0	13.1	32.5	37.7	28.3	24.9	24.3	23.1	12.1	34.5	20.1	22.2	29.1	24.7	16.0	22.8	27.9	12.4	25.1	27.8	29.9	39.0	12.0	12.0	18.4	30.1	35.5	14.1	23.3	25.4	17.4	20.5	21.3	23.7	26.8	21.5	12.0	24.8	19.3	15.3	14.8	9.7	20.0	35.9	13.4	8.1	9.7	29.2	20.6	36.4	32.7	53.9	39.3	32.4	53.0	30.0	26.9	25.1	28.9	50.1	23.0	25.3	27.5	35.1	42.7	47.8	33.3	29.1	51.4	17.8	20.8	18.2	34.3	19.8	17.7	19.5	16.3	18.7	9.6	23.8	21.8	25.3	43.8	33.9	56.9	133.9	56.0	21.4	10.3	62.8	15.7	118.0	157.5	53.9	10.7	38.3	80.6	23.3	47.0	120.4	39.9	34.3	39.2	56.3	97.1	44.5	26.5	28.3	40.3	16.2	28.1	40.6	49.0	141.5	43.6	45.0	38.7	50.7	36.0	151.2	45.3	51.8	41.5	14.1	30.9	38.8	85.7	41.5	73.0	33.1
VASH1	KIAA1036	ENSG00000071246	"Vasohibin 1"	Q7L8A9	14	76762189-76783015	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"	"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 131.6;Early spermatids: 69.4;Late spermatids: 74.4;Rod photoreceptor cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;monocytes: 5.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 23.2;HEL: 16.7;HUVEC TERT2: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000653	Uncertain				"Secreted to blood"	NA	NA					"HPA000653: AB_1080551"	"unprognostic (1.47e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (6.56e-6)"	"unprognostic (8.84e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.73e-1)"	9.6	10.7	12.9	9.6	11.2	1.8	10.4	12.3	16.6	4.7	3.7	16.0	2.7	4.4	6.5	3.7	3.5	4.5	7.5	18.4	14.9	11.5	6.0	3.4	14.0	9.1	17.6	5.7	10.3	4.7	3.5	7.6	16.8	12.0	5.1	4.3	13.6	4.5	3.7	5.4	3.7	5.5	9.6	22.3	12.7	4.0	6.8	6.3	4.4	5.7	8.6	5.2	6.6	3.4	0.8	5.1	0.1	5.3	0.5	1.5	0.9	0.5	2.7	23.2	6.8	6.0	4.4	1.2	1.9	0.6	1.6	0.7	0.8	1.6	1.0	1.4	1.5	2.1	0.7	3.6	0.6	0.5	11.4	2.6	16.7	1.5	0.7	3.6	0.7	1.7	2.3	0.1	0.6	0.1	5.3	42.4	3.1	0.7	0.2	0.5	3.6	0.6	1.4	2.3	0.7	1.4	0.6	2.3	0.5	0.4	1.3	9.5	7.4	2.2	1.0	1.1	4.8	4.0	3.6	11.7	2.2	4.9	2.5	0.9	1.0	0.5	0.6	3.1	5.5	4.0	0.0	1.8	0.0	1.5	4.3	1.1	0.3	0.7	0.7	2.8	0.8	0.6	0.9	0.1	0.5	5.3	5.1	0.4	0.9	12.9	11.2	12.3	11.6	14.9	11.5	17.6	5.7	12.0	6.3	0.0	2.9	3.5	0.0	0.6	9.8	8.3	2.5	0.0	1.2	1.8	131.6	0.3	0.0	1.0	69.4	14.3	0.0	0.0	0.0	0.2	1.7	0.0	11.5	0.5	15.1	0.0	6.4	32.5	8.0	74.4	1.7	14.8	1.7	1.8	0.0	13.1	0.4	0.0	2.8	0.0	102.6	12.9	6.2	0.9	0.9	0.1	0.2	1.5	0.0	0.0
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.8	5.3	10.2	9.0	8.9	8.4	5.4	6.8	8.4	6.2	10.1	5.6	9.9	5.6	7.5	4.3	19.1	6.5	11.4	3.3	10.4	4.9	5.4	11.4	8.8	7.2	5.9	11.4	5.1	9.4	5.7	11.0	10.8	9.0	8.2	4.7	10.3	3.7	14.6	4.1	5.1	5.0	13.4	8.9	6.7	4.8	15.4	9.1	5.0	9.8	8.1	3.5	12.1	7.1	5.3	24.9	3.2	10.5	5.6	5.7	7.0	3.7	11.4	8.5	1.6	9.3	5.5	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9	8.9	4.6	2.7	2.8	1.0	5.6	18.3	5.1	6.7	10.3	0.0	5.9	4.1	5.0	5.4	0.6	3.6	5.6	0.0	1.2	1.7	2.4	3.6	9.2	5.9	5.4	11.1	1.2	4.3	6.6	0.2	2.6	4.5	3.3	10.8	5.2	5.7	4.2	4.3	4.9	5.0	4.8	0.0	4.1	4.6	3.0	2.4	5.8	5.0	4.9	3.0
CBFA2T2	"MTGR1, ZMYND3"	ENSG00000078699	"CBFA2/RUNX1 translocation partner 2"	O43439	20	33490075-33650036	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060523, HPA072433"	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA060523: AB_2684305, HPA072433: AB_2686520"	"unprognostic (6.51e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.85e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-3)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.12e-2)"	8.7	8.5	19.2	15.6	20.8	10.2	11.6	19.2	20.3	12.3	14.7	24.6	8.1	14.8	12.8	10.0	12.7	12.8	10.1	10.5	16.4	13.2	10.9	10.1	11.3	11.6	21.2	17.0	21.0	11.0	19.5	15.9	9.7	17.5	27.9	17.3	15.2	13.9	12.7	16.2	21.7	16.9	13.4	15.9	13.3	13.7	15.4	21.2	15.8	15.6	3.9	14.2	13.4	14.9	5.6	3.1	5.9	2.4	2.7	7.3	1.4	5.2	5.3	6.4	5.2	6.0	4.7	8.3	3.2	3.4	4.6	3.7	11.4	4.5	5.8	7.3	3.9	9.6	6.7	4.3	4.9	3.8	2.5	3.2	8.1	4.5	7.4	3.8	3.2	6.3	4.0	5.8	5.0	5.7	4.6	3.5	5.7	5.3	3.8	3.2	4.4	7.4	4.6	2.2	5.7	6.1	5.8	8.1	6.1	4.1	7.5	22.4	31.9	16.3	5.5	4.6	7.2	5.6	4.3	3.9	10.9	4.7	6.5	3.9	7.9	9.1	3.6	5.4	2.8	2.9	5.9	2.4	2.8	5.3	2.3	5.0	5.3	5.2	7.3	1.0	5.6	2.9	3.9	4.8	2.7	1.4	3.1	4.2	1.4	19.2	20.8	19.2	20.3	16.4	13.2	21.2	17.0	17.5	21.2	11.9	23.7	9.7	13.6	16.9	28.7	9.6	7.6	8.1	10.3	12.2	43.2	9.6	1.7	6.8	5.7	10.6	13.4	0.0	5.5	8.2	14.1	22.5	1.1	6.6	8.2	12.7	86.8	11.6	9.9	11.0	13.0	9.9	16.9	8.2	48.4	12.3	8.8	17.3	12.0	4.2	35.5	12.9	9.8	23.1	16.7	13.4	7.4	19.3	17.8	8.9
FAM53B	"bA12J10.2, KIAA0140, smp"	ENSG00000189319	"Family with sequence similarity 53 member B"	Q14153	10	124619292-124744269	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037751, HPA037752"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA037751: AB_2675645, HPA037752: AB_10672285"	"unprognostic (7.88e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.91e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.52e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (7.00e-6)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.81e-7)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.45e-2)"	12.1	14.2	13.8	20.0	20.1	20.9	8.2	15.4	20.2	9.9	10.9	32.4	11.5	14.9	17.8	5.1	11.3	11.5	8.5	11.9	17.6	10.9	8.0	3.1	11.8	28.6	21.5	12.0	17.6	5.7	14.6	9.6	7.3	12.8	6.4	7.0	12.2	14.3	8.2	36.9	11.9	14.1	12.5	19.7	16.5	8.2	10.4	30.2	37.7	14.4	7.9	23.7	8.1	5.8	9.5	2.8	4.5	3.6	1.0	10.7	4.0	5.8	6.7	5.1	14.6	6.1	3.2	14.9	2.8	3.5	3.0	2.6	3.4	3.5	21.7	5.9	3.3	2.9	11.6	6.8	8.2	1.3	25.9	7.5	9.9	3.2	8.5	4.1	8.7	6.7	3.1	8.6	2.7	4.4	3.7	4.8	11.2	7.7	9.0	2.9	10.5	10.2	11.6	3.4	4.9	6.1	18.5	1.9	9.6	2.4	10.2	7.0	6.7	2.4	9.6	31.6	2.1	3.8	11.2	2.5	3.6	3.2	3.7	5.6	1.4	2.9	13.2	2.7	7.1	1.9	1.2	3.1	2.9	10.7	3.0	5.1	4.8	4.6	5.5	2.0	9.5	1.8	3.2	4.5	1.0	3.6	2.8	5.0	4.0	13.8	20.1	15.4	20.2	17.6	10.9	21.5	12.0	12.8	30.2	8.9	13.0	7.5	5.1	3.2	4.8	13.4	2.5	8.1	5.7	3.5	9.8	3.7	1.7	2.4	13.7	6.3	18.0	0.0	3.5	4.2	4.5	2.6	4.7	3.2	11.2	1.6	14.5	21.5	23.1	4.1	5.2	5.2	8.5	7.2	15.1	2.8	2.8	13.3	9.9	3.7	22.3	0.0	2.5	7.1	6.8	5.0	0.7	13.4	12.4	4.4
BRF1	"BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90"	ENSG00000185024	"BRF1, RNA polymerase III transcription initiation factor subunit"	Q92994	14	105209286-105315589	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051918, HPA074990"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA051918: AB_2681663, HPA074990: "	"unprognostic (1.98e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.52e-4)"	"unprognostic (2.67e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.25e-6)"	"unprognostic (8.83e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.52e-1)"	12.1	11.8	15.2	11.0	15.9	9.2	8.2	21.7	25.9	10.4	9.6	24.7	11.0	11.8	11.0	7.0	9.1	15.4	10.5	10.6	16.4	19.1	10.0	9.8	11.3	11.2	19.1	14.5	14.4	20.8	18.0	16.6	9.3	18.3	12.1	6.9	13.2	15.8	11.0	21.8	12.4	12.3	12.5	21.2	12.0	10.5	11.1	14.8	9.9	9.7	6.1	9.5	8.9	7.6	3.3	6.4	4.0	7.4	4.9	3.6	2.8	7.3	16.6	7.1	15.6	6.4	7.2	7.5	11.1	6.8	9.5	7.7	11.7	11.3	5.8	10.9	7.2	4.6	15.0	8.5	7.1	5.2	15.7	9.4	6.8	8.6	5.4	7.2	8.1	15.0	6.9	5.9	5.7	7.0	4.8	6.8	11.8	8.1	4.4	4.6	22.9	9.5	10.3	5.4	12.2	17.9	17.1	5.0	5.7	4.7	17.9	23.1	17.2	11.1	8.8	9.4	3.5	20.2	11.3	10.0	7.4	6.4	13.9	8.5	8.9	6.7	5.3	8.9	6.7	10.0	0.7	2.3	4.0	3.6	2.2	2.5	3.2	2.5	3.5	2.5	3.3	3.4	2.9	1.0	4.9	7.4	6.4	3.1	2.8	15.2	15.9	21.7	25.9	16.4	19.1	19.1	14.5	18.3	14.8	3.0	5.1	5.9	5.9	6.6	16.4	7.2	2.5	12.0	6.8	3.5	15.7	10.2	3.3	5.0	1.9	6.8	8.6	0.0	6.0	7.4	6.6	6.4	2.3	10.2	6.1	28.6	9.2	9.8	5.4	0.7	6.1	6.4	8.5	4.6	10.2	8.3	4.2	7.0	4.2	5.6	18.4	0.0	7.3	7.0	13.6	7.8	7.8	10.7	9.0	4.1
NUAK2	"FLJ90349, SNARK"	ENSG00000163545	"NUAK family kinase 2"	Q9H093	1	205302059-205321791	"Enzymes, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.4"	"Group enriched"	"Detected in all"	4	"B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA008958	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008958: AB_1080040"	"unprognostic (2.24e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.01e-7)"	"unprognostic (8.24e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (7.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.61e-1)"	1.4	2.8	0.8	12.5	2.4	8.3	0.9	9.2	1.5	18.9	10.4	3.9	2.4	13.6	2.7	3.8	31.3	3.4	1.3	1.1	1.7	1.0	14.5	3.6	16.2	20.3	5.5	1.5	3.3	13.2	0.1	2.3	7.2	2.0	1.5	7.5	9.8	9.7	2.0	0.7	12.9	15.4	0.9	2.7	10.4	2.0	5.6	2.4	5.5	14.5	20.1	31.7	2.8	24.6	15.3	3.6	42.4	5.6	5.7	10.7	5.4	2.1	11.6	7.1	0.3	0.1	0.3	22.8	2.8	2.9	7.6	3.1	12.2	0.4	3.4	1.7	0.7	12.5	4.2	1.6	4.2	3.3	0.0	0.2	0.0	0.7	2.1	4.9	0.0	0.0	1.3	3.1	4.4	2.6	1.7	0.3	0.0	0.4	0.9	1.4	0.5	0.0	0.0	4.5	1.5	0.3	0.0	0.5	17.6	20.9	0.0	1.1	0.1	0.8	3.3	0.3	24.7	3.3	0.0	0.8	2.7	1.3	0.3	4.3	6.2	0.9	2.1	0.4	0.0	1.0	3.4	5.6	13.2	3.9	4.2	2.8	14.2	4.8	4.6	3.6	15.3	10.7	8.1	42.4	5.7	4.1	1.4	2.8	5.4	0.8	2.4	9.2	1.5	1.7	1.0	5.5	1.5	2.0	2.4	6.0	5.0	9.1	0.8	1.0	0.8	1.4	20.4	2.7	0.0	31.4	0.0	6.5	5.0	40.9	1.7	2.2	20.3	0.0	1.5	27.7	4.0	1.8	0.0	2.9	4.6	0.0	10.4	1.3	11.7	1.2	0.0	6.5	6.8	48.7	40.0	1.7	7.2	2.9	0.0	15.0	0.5	6.5	2.5	0.5	0.9	4.6	3.4	4.5	18.7	0.2
TBKBP1	"KIAA0775, ProSAPiP2"	ENSG00000198933	"TBK1 binding protein 1"	A7MCY6	17	47694081-47712050	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 13.0;Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062347, HPA064856"	Approved		Approved	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA062347: AB_2684744, HPA064856: AB_2685371"	"unprognostic (2.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (8.14e-6)"	"unprognostic (5.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.59e-5)"	12.6	7.8	16.1	8.7	8.4	5.6	6.0	13.5	20.1	11.2	7.3	3.9	5.4	3.1	9.7	5.9	10.9	6.7	7.8	12.2	16.3	14.6	6.3	3.2	7.8	5.3	11.2	15.2	17.9	15.0	9.2	6.4	9.2	8.0	7.4	2.4	12.2	18.2	9.8	30.1	4.6	3.6	12.1	4.2	11.0	5.4	8.5	2.8	2.8	9.1	6.5	6.7	8.0	9.6	0.6	0.5	5.7	0.5	2.2	2.8	0.3	0.2	5.2	9.7	10.3	5.0	5.1	6.3	5.3	5.5	2.6	3.1	32.5	0.8	0.1	5.3	6.5	4.7	0.6	7.6	1.3	1.5	6.3	17.1	13.7	4.6	5.4	11.6	2.6	3.0	10.2	3.5	0.6	0.9	8.2	9.1	3.8	11.8	0.0	1.4	1.4	1.6	12.8	13.5	0.2	3.7	6.1	3.0	5.4	3.3	0.4	8.5	15.8	2.5	0.6	2.7	9.6	5.8	5.9	10.5	8.1	9.6	9.7	0.6	3.6	0.3	6.4	4.7	4.9	2.0	0.0	0.5	0.9	2.8	0.2	1.5	0.0	0.7	2.0	0.5	0.6	0.3	1.0	5.7	2.2	0.0	0.5	0.5	0.3	16.1	8.4	13.5	17.9	16.3	14.6	11.2	15.2	8.0	2.8	0.0	1.4	0.5	3.3	3.5	13.0	2.8	0.0	0.0	1.2	3.5	2.0	0.1	1.7	0.9	5.9	5.2	0.0	0.0	1.5	0.1	3.7	4.7	0.0	1.1	2.7	27.0	5.1	9.8	3.3	4.1	8.1	1.7	1.7	1.0	0.1	4.1	1.1	0.0	8.1	3.7	3.5	0.0	4.2	4.4	5.1	2.6	0.2	1.5	0.0	1.7
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7189890-7219702	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 35.6;Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;hTERT-RPE1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB001999: , CAB002000: , HPA010122: AB_1855169"	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	5.5	16.0	58.3	7.5	73.3	4.1	4.5	47.4	83.2	9.7	4.1	5.4	4.3	4.7	13.8	5.0	5.0	9.2	10.7	8.9	58.7	24.2	3.3	3.1	6.0	4.2	14.4	53.9	12.8	4.6	11.5	15.1	8.7	14.8	7.3	3.8	3.1	6.3	12.5	3.6	4.0	4.4	10.7	11.3	7.8	5.7	10.1	17.0	1.7	5.8	0.0	3.5	7.0	4.2	0.0	1.6	0.0	0.9	0.0	1.6	0.6	0.2	7.4	18.5	6.2	7.1	10.5	0.5	9.7	8.5	7.3	7.0	0.3	3.0	1.3	4.3	8.4	0.9	0.7	1.0	3.9	3.6	9.6	1.9	5.5	13.3	0.9	6.0	0.1	30.9	11.6	0.4	6.2	6.3	28.1	8.6	7.7	2.2	4.9	10.9	0.2	4.2	3.3	2.6	0.2	0.5	7.6	0.7	0.7	5.3	0.2	7.6	6.0	0.2	0.4	1.1	3.3	4.4	3.5	10.5	17.6	8.5	3.5	5.1	0.8	0.5	0.7	13.2	3.5	5.4	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.6	0.0	0.6	58.3	73.3	47.4	71.2	58.7	24.2	14.4	53.9	14.8	17.0	0.0	1.0	3.7	1.7	2.4	35.6	3.1	2.5	1.4	2.3	3.5	96.2	0.4	0.0	0.7	1.5	5.0	0.3	0.0	0.2	0.4	6.2	1.4	6.9	1.5	3.3	19.1	14.5	5.5	10.2	0.9	6.6	5.5	3.3	1.8	0.7	6.0	0.3	0.0	9.6	0.0	58.6	0.0	2.3	6.5	1.9	1.6	0.5	0.5	0.6	0.7
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85788066	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 41.8"	"Cell type enhanced"	"Detected in many"	7	"Club cells: 22.7;Hepatocytes: 31.6;Late spermatids: 19.8;Muller glia cells: 25.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;MAIT T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"monocytes: 2.9;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4;RH-30: 19.2;RT4: 12.3;TIME: 18.1;U-2197: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028406: AB_2672587"	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	36.4	2.4	3.7	2.4	4.3	0.8	19.9	2.9	4.9	10.5	4.0	4.3	4.5	2.7	11.5	2.2	5.0	7.6	5.7	12.9	5.0	2.0	3.6	30.8	21.1	4.5	6.3	2.1	9.7	4.3	1.0	2.3	3.2	5.4	9.0	1.3	6.4	3.5	12.1	25.2	8.4	3.2	5.8	4.1	8.1	4.4	2.0	4.6	0.3	41.8	4.2	1.1	10.4	24.5	0.0	0.2	0.0	2.9	0.0	1.7	0.4	0.0	3.6	5.1	11.4	5.0	0.3	0.1	9.5	1.0	2.9	1.3	0.0	0.0	0.0	3.6	7.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.5	0.5	3.3	0.0	0.0	3.7	0.0	0.0	0.0	6.0	1.9	0.0	0.0	0.0	7.8	0.1	0.0	0.0	0.1	2.5	0.1	0.0	19.2	0.1	0.0	12.3	8.5	1.8	1.8	0.0	0.6	0.0	0.0	0.0	18.1	4.5	0.2	12.5	0.0	0.0	0.0	0.0	1.5	0.0	8.9	0.0	2.9	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	3.7	4.3	2.9	4.9	5.0	2.0	6.3	2.1	5.4	4.6	8.9	16.5	0.0	6.2	2.3	0.2	11.5	7.6	2.7	22.7	1.8	0.0	0.1	0.0	7.5	11.2	11.7	0.0	0.0	2.0	0.5	9.0	5.6	1.1	31.6	2.4	0.0	4.1	5.5	2.4	19.8	3.1	3.3	1.7	0.0	1.9	25.7	0.9	0.0	0.4	0.3	0.3	0.0	9.4	1.1	0.7	1.3	0.2	0.0	0.8	1.1
SGSM2	"KIAA0397, RUTBC1"	ENSG00000141258	"Small G protein signaling modulator 2"	O43147	17	2337498-2381058	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 8.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021641, HPA024553"	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA021641: AB_2188702, HPA024553: AB_1856512"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.84e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (9.00e-6)"	"unprognostic (2.78e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-2)"	11.1	15.3	51.8	13.3	45.8	17.3	15.9	14.4	43.7	11.6	12.1	12.6	14.9	10.8	13.3	38.6	16.5	12.7	15.1	12.3	43.2	24.9	12.6	6.6	14.7	15.4	13.9	34.8	11.3	14.8	25.4	30.7	11.1	18.9	20.6	7.4	13.6	23.0	18.1	13.4	23.0	13.0	14.2	13.7	16.6	14.2	10.0	17.6	9.4	15.7	6.0	10.8	16.1	10.9	0.6	0.9	8.6	0.4	1.3	2.1	0.7	10.2	15.9	14.5	20.2	8.3	10.0	21.6	8.9	10.5	12.4	12.6	15.9	19.8	4.9	9.7	12.9	4.6	14.5	8.9	10.5	4.3	7.2	18.2	8.7	24.0	16.8	7.1	5.1	13.1	10.7	7.0	12.6	7.3	18.0	12.8	13.6	5.1	7.5	7.4	21.8	11.0	6.9	7.1	7.4	7.0	24.2	7.4	4.0	15.9	21.6	7.1	16.7	11.1	8.4	6.7	9.5	21.7	6.2	14.9	10.0	11.4	14.6	11.7	6.2	0.9	4.5	8.7	6.8	8.7	8.6	0.4	2.1	1.7	0.3	1.5	0.1	0.7	1.0	0.7	0.6	2.1	1.1	0.2	1.3	0.0	0.9	1.0	0.7	51.8	45.8	14.4	43.7	43.2	24.9	13.9	34.8	18.9	17.6	6.0	24.8	3.4	7.1	6.1	54.4	12.4	10.2	6.7	15.9	12.2	127.6	11.8	0.0	5.5	14.7	11.9	6.4	0.0	3.9	7.6	9.1	14.0	19.7	6.8	6.6	28.6	13.3	16.0	6.9	25.3	7.5	8.2	5.0	2.8	9.9	11.7	5.4	3.5	11.3	3.4	55.1	19.4	5.7	3.0	6.7	6.8	11.8	7.5	8.0	11.5
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA	1200000	2800000000	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.9	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	1.0	6.1	6.5	0.2	0.1	0.0	0.0	0.0	0.1	3.9	19.5	0.0	0.0	0.7	0.0	3.1	4.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.3	6.8	0.0	0.0	1.6	0.6	0.0	0.1	0.0	44.0	3.1	0.0	0.0	35.8	17.6	0.0	0.1	0.0	0.7	0.0	0.2	0.0	24.5	11.4	0.1	10.2	0.0	0.1	0.0	2.7	9.2	25.9	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2	0.0	0.0	0.0	0.4	1.4	108.7	109.4	0.0	1.4	0.0	0.0	35.3	0.5	1.7	14.4	4.5	0.3	0.0	0.0	0.0	0.2	7.6	0.3	1.1	0.5	0.4	165.3	5.2	6.7	5.1	3.9	14.1	1.7	0.0	0.0	0.0	263.9	1.7	0.0	9.6	0.0	95.4	0.0	3.8	0.5	2.3	1.5	0.1	11.4	0.0	0.1
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome		NA	NA			Centrosome		"HPA064875: AB_2685379"	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.3	15.2	12.9	23.6	20.0	6.3	35.1	19.7	9.9	8.3	12.0	13.1	7.2	11.4	9.8	9.8	12.8	7.7	6.5	10.8	12.7	6.0	5.3	7.3	21.7	10.6	11.3	15.6	7.7	19.0	17.8	6.7	11.5	11.9	8.9	11.2	10.3	9.8	8.8	13.4	9.6	10.3	11.8	17.4	7.9	18.5	14.7	12.2	8.3	6.2	14.1	10.2	9.4	6.0	12.7	14.8	2.2	6.4	10.0	4.0	13.0	15.2	7.4	13.8	11.2	10.2	11.3	6.5	7.2	10.3	8.2	20.2	10.7	14.0	8.7	9.2	33.2	14.5	8.0	19.7	11.6	2.6	3.1	26.3	11.3	18.6	6.8	12.8	14.6	7.3	12.0	17.5	24.9	11.8	10.6	15.1	9.0	13.4	17.5	6.7	15.6	13.0	5.1	6.9	17.2	9.1	21.5	3.8	9.8	14.8	10.2	11.1	17.8	12.3	8.5	6.2	8.5	11.2	17.0	46.8	12.2	17.3	9.4	4.7	5.1	13.0	25.4	8.7	7.9	14.8	1.7	4.5	10.0	2.2	6.3	5.4	4.3	8.0	3.7	6.0	5.2	5.7	0.7	6.4	1.4	12.7	4.5	4.0	15.2	23.6	35.1	19.7	10.8	12.7	10.6	11.3	11.5	14.7	6.0	7.4	9.3	5.3	1.4	20.0	9.1	5.1	21.4	19.4	8.7	11.8	9.9	5.0	5.6	9.2	3.0	4.9	0.0	1.7	5.6	3.6	4.5	4.7	3.9	7.5	15.9	2.9	5.5	7.9	15.4	4.0	5.9	1.7	1.0	5.4	7.5	4.9	4.0	3.5	1.5	29.7	0.0	4.1	20.1	9.8	2.4	2.5	12.1	6.1	3.3
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;esophagus: 21.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 39.9;Collecting duct cells: 22.7;Enterocytes: 42.4;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"eosinophil: 29.9;neutrophil: 43.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 43.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 10.0;HUVEC TERT2: 5.4;K-562: 4.4;THP-1: 5.0;U-937: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043669	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	0.7	0.2	0.0	0.9	0.0	2.7	0.7	0.0	0.0	5.0	7.3			13.0	0.9	0.0	21.5	0.4	0.0	1.9	0.0	0.0	1.5	0.0	4.6	0.1	0.0		0.0	0.6	0.0	0.6	0.1		1.3	2.0		2.8	2.2	0.1	2.2	12.5	0.3	0.0	4.3	1.0	0.0			0.3		0.9	1.2	8.4	0.0	1.6	43.3	6.7	0.4	8.1	1.7	0.3	0.0	0.3	0.1	0.5	2.2	0.5	0.6	0.2	0.0	0.1	3.1	0.0	0.1	0.8	1.5	0.0	2.1	0.0	0.5	0.0	0.1	0.4	0.0	0.1	1.6	0.8	0.7	10.0	2.7	1.9	0.1	0.1	0.0	5.4	0.2	4.4	0.3	0.0	0.8	0.0	2.9	0.7	0.0	0.1	0.2	0.6	0.0	0.2	1.1	1.4	0.9	0.0	0.2	0.0	0.3	0.0	5.0	1.9	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	8.1	0.0	21.7	4.3	29.9	0.7	3.3	8.1	0.0	0.3	1.5	1.6	0.0	0.0	0.1	43.3	0.4	6.7	0.1	0.1	1.7											6.0	39.9	0.0	4.4	1.5	0.2	0.4	0.0	1.4	1.2	22.7	0.0	0.5	3.3	4.6	0.0	1.0	42.4	0.0	0.6	1.9	2.3	5.7	4.7	0.0	10.9	0.0	14.5	1.8	9.1	0.0	1.4	3.2	0.0	1.8	19.3	0.0	2.2	46.0	0.7	0.0	0.2	0.0	1.4	0.0	0.0	1.5	1.9	1.3	13.6	11.3
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 119.6;Late spermatids: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 33.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 46.6;Hep G2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	10.9	24.5	11.4	13.3	11.3	3.5	10.4	15.0	15.2	9.0	19.8	11.7	37.0	17.7	9.5	17.4	8.7	6.0	9.4	9.8	10.4	9.3	8.7	25.7	8.1	7.3	12.5	10.2	6.7	12.1	5.7	5.5	13.2	8.7	18.5	6.5	12.5	9.4	28.3	22.6	11.6	17.0	44.1	10.3	11.3	13.1	30.6	9.3	1.2	9.1	6.9	4.3	42.4	9.1	2.4	33.8	6.9	5.6	1.2	6.3	2.0	1.8	7.2	3.2	7.2	0.0	0.0	10.2	2.8	1.9	4.5	2.7	46.6	1.7	2.8	6.4	1.5	7.2	9.7	3.9	4.5	1.1	2.6	6.2	0.4	5.7	27.5	4.2	0.0	3.0	0.1	4.2	0.4	1.8	2.2	3.5	3.9	2.9	6.3	1.8	13.1	0.0	0.0	5.2	10.2	11.3	1.0	4.5	7.8	4.2	19.3	5.4	3.7	6.7	11.5	2.5	4.3	7.4	1.6	3.0	0.0	4.7	0.3	6.2	19.5	18.2	4.2	3.1	0.0	3.4	0.0	3.0	6.9	4.9	5.6	3.5	2.3	1.6	3.3	4.6	2.4	0.3	1.2	0.2	1.2	5.1	33.8	6.3	2.0	11.4	11.3	15.0	15.2	10.4	9.3	12.5	10.2	8.7	9.3	8.9	9.6	5.4	6.1	9.8	11.1	6.1	7.6	5.3	4.5	5.2	9.8	66.2	13.3	12.0	119.6	7.4	15.1	23.3	14.7	10.8	11.6	11.0	6.9	23.6	59.6	6.4	11.6	12.9	12.4	229.4	10.0	8.2	25.3	8.2	13.3	14.9	15.9	21.5	11.0	12.2	7.7	12.9	8.1	38.0	10.9	9.3	56.3	6.9	15.6	5.5
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 30.6;Hepatocytes: 28.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.5	0.7	1.3	1.8	6.3	2.2	4.8	1.2	1.1	1.3	1.7	0.9	1.0	0.6	0.9	11.2	8.8	2.5	5.9	1.2	4.0	3.7	0.8	1.7	2.1	1.3	1.8	0.5	9.2	6.0	3.5	0.8	2.4	6.4	10.0	0.9	1.9	2.4	6.0	2.8	12.6	1.1	5.1	2.1	3.9	1.8	0.8	4.9	1.3	2.2	8.4	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4	6.0	2.4	0.8	0.4	3.0	7.6	0.5	30.6	0.0	1.2	0.0	2.0	0.4	0.0	0.9	2.0	1.7	5.2	0.0	0.2	0.3	1.1	1.1	0.0	28.9	0.9	9.5	10.3	0.0	6.2	3.6	0.9	1.7	3.3	1.8	1.9	1.1	0.8	0.0	0.4	0.8	3.6	0.0	0.5	1.6	1.1	1.9	0.2	4.6	1.9	1.7
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	7.1	7.2	4.5	5.1	4.5	11.3	10.3	5.6	5.5	6.0	4.5	2.4	10.9	6.0	6.3	5.1	7.1	5.4	6.6	7.4	5.5	3.4	5.2	8.3	9.3	8.3	3.8	4.2	5.4	7.3	3.4	4.5	7.3	5.3	6.0	3.7	5.5	6.5	9.5	7.1	5.5	6.2	5.2	4.8	9.0	5.5	15.6	2.9	12.5	6.2	6.1	7.8	5.5	16.3	3.4	2.2	4.5	3.0	1.6	3.4	1.5	4.8	4.2	2.7	6.9	2.5	2.3	6.1	3.7	2.2	3.2	2.6	3.3	3.9	5.9	3.3	2.3	4.5	3.6	2.8	2.8	2.6	18.0	3.7	4.4	5.0	1.9	4.2	6.0	12.4	2.1	3.4	2.4	4.0	2.5	2.9	6.7	10.3	3.8	2.9	5.6	5.8	7.3	2.9	6.6	7.2	5.6	4.3	5.3	2.4	3.0	3.9	4.5	3.6	5.1	3.8	2.0	3.9	6.0	1.9	3.8	11.9	3.1	4.2	6.2	12.9	3.9	3.6	3.9	5.0	0.0	2.2	3.3	1.7	2.0	1.4	1.1	3.4	2.5	2.2	3.4	2.6	2.2	4.5	1.6	3.0	1.7	0.9	1.5	4.5	4.5	5.6	5.5	5.5	3.4	3.8	4.2	5.3	2.9	0.0	4.0	8.8	4.0	4.2	3.3	3.9	5.1	0.0	2.3	5.2	0.0	5.0	3.3	3.1	5.9	4.7	5.1	0.0	5.8	5.0	3.3	3.0	8.1	2.4	4.8	9.5	5.2	5.5	4.7	9.2	5.8	4.4	0.0	4.6	2.5	4.1	3.4	4.0	2.8	3.4	5.0	0.0	3.3	10.8	7.6	3.3	3.9	7.2	3.1	2.0
SEC61A2	FLJ10578	ENSG00000065665	"Sec61 translocon alpha 2 subunit"	Q9H9S3	10	12129637-12169961	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.5"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 33.4;Late spermatids: 23.8;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.83e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.95e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (6.41e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.18e-2)"	"prognostic favorable (8.75e-4)"	4.0	5.6	14.3	5.1	19.7	14.1	5.3	16.5	33.5	3.8	3.8	20.3	3.2	3.7	7.8	9.2	3.9	4.1	5.2	11.3	16.8	22.1	3.1	7.8	3.8	5.8	15.6	14.6	5.8	3.3	5.5	9.4	4.5	22.7	6.0	5.9	5.7	2.7	6.3	6.9	8.6	3.3	5.9	21.1	4.8	3.6	17.3	9.9	5.0	5.2	1.3	6.1	4.1	3.6	1.3	5.8	4.1	0.5	2.0	2.7	0.4	5.9	10.8	14.1	8.7	6.0	3.7	4.7	6.0	3.3	11.8	12.5	10.2	4.0	2.2	3.3	9.4	15.9	4.9	19.5	7.8	10.2	6.6	7.4	2.7	12.6	7.2	5.9	1.6	6.5	5.5	4.7	21.5	3.4	5.2	3.0	13.3	3.2	6.5	10.0	5.2	5.4	2.7	13.9	5.3	3.3	5.8	5.8	1.4	7.3	6.2	6.7	9.9	8.8	4.7	4.3	11.5	9.0	2.7	5.4	10.3	12.0	13.1	4.1	6.0	8.5	3.5	8.0	2.2	3.1	0.0	0.4	0.3	2.1	0.1	1.9	0.7	1.3	1.3	1.0	1.3	2.7	1.7	4.1	2.0	0.5	5.8	1.9	0.4	14.3	19.7	16.5	26.4	16.8	22.1	15.6	14.6	22.7	9.9	3.0	3.2	7.5	2.3	1.5	13.1	6.5	2.5	1.4	3.4	8.7	7.9	2.8	0.0	2.4	15.5	2.7	1.1	0.0	2.0	2.1	4.1	2.8	2.3	13.2	2.3	33.4	1.2	3.7	1.9	23.8	6.4	2.5	5.0	1.8	1.6	6.9	1.7	2.9	4.2	1.3	13.8	0.0	3.8	28.9	13.9	1.3	2.9	1.9	1.0	1.4
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200386-32205387	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 86.5;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 140.1"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain					NA	NA					"HPA028589: AB_10602175"	"prognostic favorable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	2.0	6.5	7.0	4.1	7.2	3.4	1.6	12.4	6.5	2.2	3.1	2.0	1.4	2.4	3.1	3.2	3.2	2.7	3.9	8.6	6.3	4.6	2.9	1.1	2.0	6.8	5.0	6.0	3.4	3.5	4.4	10.1	3.0	4.3	2.7	1.7	4.7	4.0	2.6	66.7	2.6	1.9	3.8	3.6	3.4	2.8	11.7	5.2	4.5	3.2	11.7	4.7	3.2	1.9	9.3	14.2	3.1	4.3	15.8	15.6	8.4	4.6	1.5	10.3	9.9	3.0	3.8	0.8	3.3	4.8	5.8	3.9	3.0	5.3	10.2	5.4	3.9	0.9	1.3	8.3	3.9	1.1	11.6	11.7	13.2	7.1	1.8	4.2	0.3	4.5	4.7	1.8	6.6	0.1	5.5	7.9	17.0	8.5	1.3	3.8	0.6	17.2	2.6	10.4	1.3	2.5	18.3	5.0	8.2	5.3	0.7	19.9	8.8	4.8	1.0	5.8	6.2	3.2	3.9	4.7	3.3	4.4	4.5	2.1	2.8	0.7	0.6	5.6	17.8	3.1	3.1	4.3	0.9	15.6	2.0	7.8	7.8	7.4	13.2	9.8	9.3	12.4	12.3	0.4	15.8	0.5	14.2	9.6	8.4	7.0	7.2	12.4	6.5	6.3	4.6	5.0	6.0	4.3	5.2	0.0	6.7	6.7	5.3	8.0	29.4	12.8	10.2	2.7	1.2	12.2	21.6	1.7	29.9	17.1	11.4	9.0	0.5	23.3	6.6	3.2	31.7	3.0	3.5	0.8	9.8	22.3	86.5	8.6	3.4	22.6	18.7	4.8	16.9	107.4	5.3	16.1	9.1	1.7	15.9	3.3	43.3	0.0	21.7	2.7	11.9	6.8	1.8	22.9	3.3	1.3
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703905-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	19.2	34.3	19.9	21.2	39.0	18.7	19.8	18.3	22.4	17.1	20.8	23.1	26.1	12.9	16.7	17.0	26.5	17.9	21.6	20.1	23.2	10.5	18.6	27.9	20.3	23.3	35.3	13.1	33.5	23.6	25.8	22.1	17.7	28.5	22.1	14.6	21.6	22.2	19.8	30.0	23.1	20.3	23.8	29.0	27.0	21.7	23.3	28.3	26.9	23.0	13.6	24.4	22.7	33.5	4.8	3.0	6.3	3.3	2.4	6.2	1.8	8.8	8.9	35.7	37.3	12.5	7.6	14.7	12.1	11.0	15.0	16.5	25.8	9.3	26.3	7.4	8.4	9.5	11.3	27.4	13.2	21.8	21.0	24.4	26.2	15.7	33.6	12.8	38.2	1.6	5.7	13.9	9.6	8.9	24.9	23.6	19.0	29.0	17.1	10.7	15.2	7.2	32.9	11.2	19.7	5.6	34.7	25.3	21.1	18.6	9.5	17.1	22.8	16.5	5.5	11.8	15.6	10.8	45.9	15.8	8.5	14.3	10.8	15.3	15.2	12.9	32.8	11.1	25.7	13.5	3.0	3.0	6.3	3.4	3.2	3.3	4.8	6.0	4.8	3.0	4.2	5.9	6.2	0.5	2.4	3.3	2.8	3.7	1.8	19.9	39.0	18.3	22.4	23.2	10.5	35.3	13.1	28.5	28.3	23.8	26.7	23.0	19.5	26.6	11.6	51.3	40.8	18.7	27.3	10.4	39.3	11.2	11.6	11.6	10.8	27.7	12.3	0.0	11.1	7.8	24.4	23.2	5.8	23.7	10.0	11.1	24.9	23.9	10.0	6.1	20.8	11.8	18.6	5.4	23.0	27.0	14.2	19.5	19.8	9.5	24.7	19.4	41.5	16.3	19.4	20.6	14.5	15.0	18.0	25.0
CLSTN3	"CDHR14, CSTN3, KIAA0726"	ENSG00000139182	"Calsyntenin 3"	Q9BQT9	12	7129698-7158945	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 150.4;Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		50000				"prognostic favorable (5.08e-4)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.73e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (2.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.07e-4)"	11.0	16.2	22.1	14.9	37.1	14.4	6.8	51.4	64.0	5.9	6.0	5.7	1.7	8.1	8.1	4.2	4.9	7.2	12.2	4.1	19.2	33.3	14.1	14.6	7.8	15.4	13.3	31.6	13.2	6.9	14.4	15.0	4.1	37.6	5.8	6.0	7.6	8.1	5.7	1.4	11.1	7.1	8.9	6.0	14.1	6.1	3.5	4.0	6.7	6.5	1.0	11.3	12.0	5.6	0.3	0.2	2.6	0.0	12.4	7.2	1.9	6.6	11.1	3.8	9.2	4.6	6.7	17.2	3.9	9.2	6.8	11.2	16.1	10.5	10.7	2.9	7.7	7.9	8.7	6.9	7.6	4.0	10.8	6.6	17.7	17.4	15.1	6.3	2.7	32.2	20.1	7.6	8.7	10.7	32.6	8.2	10.2	16.5	6.6	1.6	2.0	6.9	2.9	10.9	0.4	0.7	4.6	0.0	3.1	10.4	12.4	5.0	8.2	9.4	2.3	1.5	9.8	4.5	6.4	4.9	4.3	13.0	9.8	2.1	8.1	1.9	1.4	7.6	3.7	2.6	2.6	0.0	0.0	7.2	0.0	4.1	0.3	3.2	6.1	0.2	0.3	1.1	2.5	0.5	12.4	0.0	0.1	3.3	1.9	22.1	37.1	51.4	64.0	19.2	33.3	13.3	31.6	37.6	4.0	0.0	3.8	0.0	2.3	3.7	150.4	1.2	7.6	0.0	1.2	14.0	58.9	4.9	0.0	8.1	0.8	7.7	1.7	0.0	6.4	6.3	4.3	1.9	5.7	23.1	1.0	25.4	28.2	4.3	3.5	0.6	11.8	1.7	5.0	1.0	3.4	9.5	6.3	2.9	6.0	28.2	36.4	6.5	2.5	0.7	1.1	5.0	2.7	13.6	2.8	1.6
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481237	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hofbauer cells: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA					"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	24.2	41.4	32.0	28.2	58.8	31.0	19.8	41.1	89.9	27.9	36.7	35.3	17.1	30.5	26.8	27.4	33.0	26.3	24.7	27.0	40.4	48.5	34.3	30.6	34.5	29.7	39.6	39.1	17.9	25.7	42.5	40.7	30.1	66.6	23.8	33.0	26.6	23.7	26.3	42.5	30.1	29.6	36.0	24.8	37.0	26.9	40.6	18.9	27.6	35.2	21.3	27.4	26.9	22.0	21.1	53.8	106.5	79.7	16.8	16.0	66.3	18.1	25.9	16.0	20.7	40.9	22.2	15.4	21.7	35.7	44.9	54.1	26.8	19.6	7.6	18.3	31.3	30.2	21.8	23.6	27.2	27.0	9.2	21.7	14.0	15.1	22.3	38.7	13.9	59.0	34.4	27.1	45.3	10.8	16.2	27.9	9.1	15.8	10.1	36.2	43.5	10.3	31.7	15.6	15.9	18.6	18.5	18.8	21.1	27.2	30.4	31.4	14.7	56.7	15.5	23.4	13.5	25.1	21.4	26.8	22.6	9.3	27.7	11.4	17.1	24.1	22.2	31.8	14.9	13.3	29.6	79.7	58.7	16.0	56.9	11.0	21.1	12.0	14.7	53.8	18.9	9.3	11.5	106.5	16.8	51.1	19.3	14.4	66.3	32.0	58.8	41.1	89.9	40.4	48.5	39.6	39.1	66.6	18.9	14.9	47.6	54.7	53.3	65.6	70.5	33.2	56.0	33.5	19.4	64.6	68.7	97.4	154.2	105.3	59.6	41.4	193.6	46.7	97.5	61.6	79.6	47.2	49.6	45.1	351.8	77.9	116.9	45.4	155.0	38.2	54.4	136.8	118.1	170.5	128.1	66.4	83.9	175.4	49.8	124.5	50.6	116.4	56.6	90.0	61.9	76.5	237.2	54.3	73.1	55.8
BCAS3	FLJ20128	ENSG00000141376	"BCAS3, microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 203.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17.0	8.4	13.6	16.3	10.8	11.7	20.2	20.0	16.6	13.7	7.6	13.9	17.0	11.9	9.1	6.9	26.8	8.0	11.7	12.9	6.4	3.3	8.2	4.2	14.1	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6.0	5.9	5.0	2.6	2.4	2.9	4.7	3.0	9.4	3.2	4.6	5.0	4.8	1.6	2.8	8.6	3.4	3.0	5.5	7.2	4.2	5.1	2.7	6.6	3.2	43.3	4.6	1.2	4.4	16.2	9.3	5.7	5.7	6.0	3.0	12.7	6.3	5.3	7.1	2.1	5.0	14.8	7.7	2.4	3.9	4.8	4.1	2.0	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8.0	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20.0	6.0	12.2	2.7	7.8	4.5	13.0	11.2	5.1	48.2	12.5	15.7	9.8	5.9	8.3	3.6	38.8	8.5	3.6	0.0	3.1	4.3	5.0	3.6	16.1	8.6	3.7	3.2	6.9	12.9	5.6	203.3	6.9	4.7	1.7	7.2	4.6	30.3	3.2	4.8	19.8	23.0	13.4	12.9	14.4	11.1	4.7	4.8	6.3	11.8	2.6	6.9
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.7	16.5	14.4	22.5	40.0	29.6	12.2	21.0	36.7	27.5	22.9	21.0	18.0	18.7	24.2	32.1	17.4	18.6	23.8	21.6	21.3	25.3	21.1	13.3	19.6	10.8	28.0	15.3	25.8	30.9	26.3	30.4	21.8	23.9	26.5	19.2	22.8	28.4	23.3	36.7	16.2	12.4	11.5	28.2	25.1	14.6	12.1	21.9	19.0	25.1	17.4	15.0	14.6	29.8	18.8	23.8	25.1	29.2	20.6	19.8	15.6	15.7	22.3	30.2	19.6	36.4	22.5	16.1	34.2	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0	14.9	25.3	16.7	17.9	19.8	30.2	6.7	20.4	9.4	14.8	12.2	19.6	22.5	16.6	17.6	8.9	15.8	24.9	0.0	21.6	16.5	23.4	16.5	18.5	10.9	24.5	33.4	17.7	9.8	15.9	11.5	21.6	17.4	13.5	31.5	17.8	18.9	18.2	17.5	23.3	12.4	26.6	12.9	23.7	24.7	23.0	27.1	40.7	21.0	18.0	26.9
KCTD2	KIAA0176	ENSG00000180901	"Potassium channel tetramerization domain containing 2"	Q14681	17	75032575-75065889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 30.4;Horizontal cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 8.0;HEK 293: 10.6;K-562: 9.2;U-266/70: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (5.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.58e-2)"	"prognostic favorable (1.25e-5)"	"unprognostic (7.19e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.60e-1)"	13.9	3.2	5.5	1.8	6.1	3.6	2.3	26.1	20.8	3.3	7.2	6.9	1.5	2.3	4.3	1.8	2.9	3.6	1.8	5.0	4.4	4.0	9.6	3.2	3.7	1.8	5.2	7.0	4.1	1.8	1.8	3.8	3.9	6.6	5.3	1.9	3.6	2.8	4.1	11.3	3.6	2.5	2.1	5.9	5.0	5.6	5.0	4.3	0.4	4.5	1.9	1.8	5.4	2.5	0.0	0.0	0.5	0.0	1.7	0.5	0.4	3.9	0.0	0.1	0.9	0.4	1.2	2.7	8.0	1.0	0.0	0.9	0.0	0.0	7.0	7.7	1.5	0.2	2.4	0.0	0.0	0.0	5.9	10.6	0.0	1.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	9.2	0.0	0.0	0.0	7.8	0.4	1.2	0.1	7.4	7.3	0.3	1.8	0.0	0.1	1.0	4.8	2.2	0.1	1.4	0.1	0.0	0.5	0.0	0.1	5.8	0.0	6.4	10.6	4.9	2.5	1.3	1.0	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	5.5	6.1	26.1	11.9	4.4	4.0	5.2	7.0	6.6	4.3	3.0	15.2	2.4	2.3	2.5	30.4	10.6	5.1	5.3	2.3	7.0	0.0	5.1	6.6	3.2	3.2	6.7	3.3	0.0	4.5	3.5	4.4	5.3	1.1	6.8	4.3	33.4	2.9	11.1	11.8	6.2	10.0	5.5	3.3	4.6	5.2	16.7	3.8	3.5	21.9	6.0	9.0	0.0	2.5	5.2	18.8	4.4	3.7	3.9	5.1	3.3
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 159.0;T-cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.9	4.0	2.5	4.5	3.7	2.7	12.7	7.2	3.4	3.1	4.3	4.5	1.5	3.5	13.6	3.2	6.8	3.2	1.6	1.9	0.9	4.6	8.5	2.4	3.5	5.0	1.7	8.0	26.2	3.7	1.2	2.8	0.3	3.2	3.2	5.9	6.2	12.7	1.4	3.6	8.4	27.1	8.5	1.2	7.3	3.1	3.3	18.3	1.5	2.1	3.0	12.5	3.5	2.6	1.8	2.5	3.3	10.2	5.4	4.6	12.0	9.0	6.3	38.6	14.9	1.6	3.7	4.1	7.9	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6	14.9	44.5	41.3	35.2	16.1	44.3	6.7	10.2	17.4	30.7	17.4	62.8	84.2	1.7	17.6	4.4	44.9	6.7	23.3	13.5	8.5	48.9	15.3	36.9	5.9	22.1	44.5	12.2	159.0	21.8	2.7	88.6	20.1	20.3	17.2	9.4	16.0	13.1	7.0	63.6	10.3	46.4	19.4	19.6	27.6	19.4	13.4	111.7	128.5	13.1	9.1
ZNF775	MGC33584	ENSG00000196456	"Zinc finger protein 775"	Q96BV0	7	150379335-150398631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 18.8;Horizontal cells: 28.6;Muller glia cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.5"															NA	NA						"unprognostic (9.67e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.28e-2)"	5.1	7.6	10.0	5.5	11.5	5.0	3.4	7.3	14.2	7.0	11.0	15.9	4.9	7.1	8.1	6.3	3.5	6.0	4.2	5.0	10.9	8.4	3.5	1.8	5.3	8.0	11.5	9.1	13.1	6.5	4.9	7.7	4.4	7.9	8.4	6.0	7.0	9.4	6.5	8.5	3.2	7.6	6.2	12.7	7.3	6.3	6.8	11.3	9.3	3.8	3.3	5.7	7.0	7.4	1.0	2.5	1.6	0.5	0.1	0.8	0.3	1.0	3.3	4.2	3.2	1.5	1.1	0.6	1.7	2.0	2.2	2.3	0.9	3.0	5.0	3.4	1.0	3.9	1.1	1.4	1.5	0.2	6.4	5.8	1.7	0.8	2.0	3.3	0.9	1.2	1.7	1.3	2.2	0.5	2.4	3.7	6.3	6.3	4.0	1.3	1.0	13.5	3.3	11.7	1.8	5.0	6.6	6.4	14.5	0.3	1.3	10.5	11.9	1.5	0.4	5.9	3.4	0.5	2.5	3.3	4.1	1.6	2.9	2.4	6.1	1.9	2.8	4.1	2.3	5.1	0.0	0.5	1.0	0.7	0.0	0.0	1.0	0.6	0.1	1.2	0.7	0.8	0.5	1.6	0.1	0.2	2.5	0.1	0.3	10.0	11.5	7.3	14.2	10.9	8.4	11.5	9.1	7.9	11.3	0.0	0.0	8.0	0.6	2.4	18.8	6.7	0.0	0.0	0.0	0.0	9.8	1.1	0.0	0.9	2.1	3.6	2.0	0.0	0.5	0.9	2.0	0.9	4.6	1.0	2.6	28.6	15.0	2.5	1.9	1.0	3.7	1.3	5.0	1.0	4.8	26.9	1.1	3.4	4.6	1.1	12.0	0.0	5.7	0.6	0.9	3.3	0.3	0.0	6.2	0.1
GIGYF1	"GYF1, PERQ1"	ENSG00000146830	"GRB10 interacting GYF protein 1"	O75420	7	100679507-100694037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020999, HPA023995"	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA020999: AB_2111744, HPA023995: AB_1855221"	"unprognostic (3.82e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.42e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.43e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.67e-3)"	15.5	17.3	22.1	15.9	23.0	28.2	16.3	66.8	32.4	20.6	14.0	18.9	27.3	17.1	25.1	20.2	11.5	18.3	16.4	13.2	20.3	9.4	14.4	13.3	13.5	18.5	14.1	16.3	29.8	23.8	17.8	26.3	16.2	15.7	17.1	9.3	19.6	26.5	25.7	25.5	31.7	17.6	12.9	9.3	24.0	17.0	18.9	20.4	11.8	20.5	10.4	14.2	14.3	14.0	4.1	3.9	8.8	2.6	2.5	5.1	0.9	7.1	7.3	11.8	17.3	5.7	4.4	21.1	6.7	5.5	4.2	4.9	4.2	12.3	10.0	8.8	4.9	8.6	8.6	5.8	6.8	2.6	10.6	11.8	6.9	18.1	6.1	5.6	7.8	11.9	7.0	5.5	5.4	7.7	7.0	4.2	11.9	19.1	9.9	3.8	16.1	13.9	43.5	14.4	2.8	9.0	22.3	6.2	9.9	3.1	6.5	10.6	16.8	8.7	14.2	7.7	8.4	6.4	13.2	6.5	12.3	15.3	20.1	6.2	8.1	3.5	5.4	7.1	15.8	7.2	3.3	2.6	2.2	5.1	2.3	3.8	2.7	3.4	3.2	1.0	4.1	3.1	3.2	8.8	2.5	2.5	3.9	1.8	0.9	22.1	23.0	66.8	32.4	20.3	9.4	14.1	16.3	15.7	20.4	3.0	5.6	23.1	9.7	28.2	22.4	6.0	30.6	2.7	4.5	17.4	17.7	11.2	13.3	9.7	0.8	16.3	15.7	23.3	8.1	8.8	16.6	8.6	5.7	17.4	9.9	49.3	17.9	20.3	23.8	2.4	22.7	10.7	16.9	4.6	21.7	11.8	10.5	16.9	17.0	7.6	25.7	32.3	17.2	14.0	36.4	19.6	13.6	24.1	15.1	9.2
MXD4	"bHLHc12, MAD4, MST149, MSTP149"	ENSG00000123933	"MAX dimerization protein 4"	Q14582	4	2247432-2262294	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053363			Supported	Cytosol		NA	NA			Cytosol		"HPA053363: AB_2682128"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.54e-2)"	"prognostic favorable (2.21e-5)"	"unprognostic (1.64e-1)"	"unprognostic (5.94e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.39e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.12e-2)"	31.9	21.6	20.1	11.8	17.1	23.3	26.2	63.2	23.3	16.5	17.6	15.1	29.8	17.4	19.7	19.7	13.6	24.4	19.2	19.8	16.0	13.1	23.3	12.1	20.0	19.9	13.5	12.4	12.6	18.7	11.4	32.7	24.5	14.4	17.6	7.3	18.3	32.7	26.3	19.3	24.3	16.8	13.8	11.4	29.8	15.1	11.8	11.3	34.8	17.6	8.0	16.1	16.2	21.3	3.5	10.6	8.1	4.3	2.7	5.6	1.9	1.0	3.6	5.7	6.8	20.2	15.0	1.3	7.2	7.4	5.4	5.5	0.8	3.1	3.0	16.2	10.8	2.8	4.9	1.6	5.7	1.4	2.7	17.4	0.5	12.2	10.0	14.9	2.3	6.5	23.4	10.2	1.7	2.7	11.9	12.8	4.5	4.1	5.1	5.0	6.9	5.3	13.4	2.3	4.1	16.1	3.6	1.9	6.3	6.3	5.6	9.3	17.4	6.7	3.3	5.1	7.4	15.6	14.9	30.0	6.0	2.4	4.4	1.6	7.8	5.5	1.1	8.2	2.1	1.7	8.1	4.2	4.8	5.3	4.3	4.3	3.4	4.7	5.0	3.6	3.5	2.4	2.5	1.7	2.7	4.1	10.6	5.6	1.9	20.1	17.1	63.2	23.3	16.0	13.1	13.5	12.4	14.4	11.3	17.9	14.5	26.4	14.2	16.9	79.3	15.7	15.3	5.3	14.8	57.6	82.5	34.2	13.3	14.4	8.0	36.0	42.9	23.3	15.5	42.1	33.4	28.8	24.2	29.8	42.0	62.0	32.2	108.1	54.1	22.1	30.8	25.9	21.9	4.6	47.2	66.8	16.1	28.8	53.0	18.4	95.5	25.8	30.2	4.9	21.1	23.1	27.3	29.9	29.8	10.8
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.2	9.7	7.5	4.9	3.6	11.2	4.7	5.9	10.6	6.6	9.4	1.7	0.1	9.6	4.9	7.7	3.1	5.4	3.5	4.2	11.2	9.7	0.0	10.4	8.7	12.9	0.0	1.5	6.6	5.7	5.1	2.3	1.0	8.9	1.9	4.0	11.9	6.2	7.7	0.4	0.2	4.3	2.3	8.0	0.4	1.0	4.3	9.6	9.0	3.8	11.9	4.7	11.8	12.2	15.8	14.1	0.2	6.6	8.6	5.0	7.3	0.5	13.5	5.1	1.3	4.4	0.0	6.8	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3	6.0	12.0	0.9	9.3	4.0	28.0	2.0	0.0	2.7	5.7	12.2	55.0	12.2	1.7	6.3	0.4	14.1	3.9	0.0	5.3	7.0	8.2	9.4	1.1	2.0	14.0	3.2	9.8	6.2	5.9	0.2	15.8	8.3	3.3	2.8	2.5	21.0	3.9	3.5	11.7	4.8	37.6	32.3	4.7	0.2	1.5	4.1	21.7	5.7	2.8	5.2
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041630-7043923	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 11.9;Muller glia cells: 29.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 2.9;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;NB-4: 1.6;U-266/84: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	2.0	1.3	2.1	1.0	2.8	0.5	3.2	2.0	2.8	2.4	2.3	2.4	18.8	1.3	1.8	7.2	1.9	13.5	2.4	2.4	2.0	1.4	3.3	13.4	4.8	2.4	1.4	1.8	6.2	6.1	14.7	4.4	1.3	4.1	3.7	0.6	4.7	14.2	10.7	2.6	5.8	2.1	0.7	1.3	1.9	2.0	3.4	0.7	1.1	11.9	1.8	3.4	2.5	1.4	2.9	0.1	0.0	0.0	0.4	3.8	0.5	0.6	1.4	0.4	1.1	0.3	0.2	0.1	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.5	1.1	0.5	0.0	0.0	0.0	1.1	1.0	0.0	0.1	0.4	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.5	0.0	0.2	0.9	0.3	1.6	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.1	1.6	0.1	0.2	0.2	0.0	0.0	0.0	0.0	3.8	0.0	2.0	1.7	0.9	3.5	0.1	2.9	1.7	3.1	0.0	0.4	0.0	0.0	0.0	0.5	2.1	2.8	2.0	2.8	2.0	1.4	1.4	1.8	4.1	0.7	11.9	6.7	3.0	4.4	1.5	0.2	1.7	7.6	6.7	7.9	7.0	0.0	0.0	1.7	2.1	0.1	3.2	0.0	0.0	1.2	0.0	0.9	2.0	0.0	4.0	0.0	0.0	9.2	1.3	0.0	0.0	6.4	0.2	3.3	0.0	0.4	29.4	0.1	0.0	4.6	1.1	1.8	0.0	0.4	1.2	0.6	2.8	0.1	2.9	1.0	7.1
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107489958-107660167	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.3;Horizontal cells: 87.4;Late spermatids: 46.7;Peritubular cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 3.0;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	14	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 11.0;AN3-CA: 14.2;ASC diff: 13.5;HDLM-2: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	7.6	12.0	19.3	4.4	15.6	1.3	3.6	15.1	30.2	12.7	12.8	11.0	2.5	3.7	9.0	5.5	5.6	6.2	7.6	17.0	18.0	12.4	5.8	3.6	5.0	2.9	12.5	14.9	21.6	3.9	10.9	12.0	6.1	9.6	13.0	4.2	7.4	21.1	7.0	22.1	1.5	3.4	14.3	9.6	4.7	5.6	9.1	11.1	1.0	6.1	4.1	3.3	14.8	8.0	4.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	11.0	14.2	13.5	5.2	1.3	0.1	0.0	0.3	0.6	0.0	0.0	5.8	0.4	0.0	1.0	0.0	7.3	0.2	0.2	9.3	6.9	0.7	0.0	6.8	1.8	3.0	0.6	5.4	0.0	5.3	0.0	1.1	4.4	2.7	0.0	0.3	0.0	2.9	1.4	0.3	2.6	0.2	0.9	3.3	1.4	0.0	0.0	0.2	3.6	5.9	1.3	0.0	0.1	0.5	0.5	2.1	0.1	3.5	1.2	6.0	0.5	2.8	0.5	3.8	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.2	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	19.3	15.6	15.1	20.6	18.0	12.4	12.5	14.9	9.6	11.1	3.0	9.8	8.5	8.9	0.5	36.8	20.2	28.1	16.0	5.7	22.7	0.0	0.1	0.0	1.9	68.3	2.8	0.0	0.0	0.2	0.6	7.3	8.4	0.0	0.6	2.3	87.4	10.4	3.7	7.4	46.7	41.7	1.6	3.3	0.0	0.0	6.9	0.5	0.0	46.0	9.8	9.8	25.8	16.1	3.0	2.2	0.6	0.1	0.0	0.0	0.7
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53, GARP complex subunit"	Q5VIR6	17	508668-721717	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 237.4;Late spermatids: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 15.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	10.0	9.7	15.7	9.0	19.3	13.0	8.8	34.5	21.6	10.5	11.4	11.5	11.7	8.5	10.2	9.1	16.3	10.0	9.2	9.1	13.4	14.0	10.0	8.8	11.1	8.0	11.8	17.5	10.6	8.8	14.4	13.0	10.4	15.9	10.8	12.0	9.3	9.6	11.3	13.9	19.6	9.1	10.5	10.3	9.2	13.5	13.5	11.7	12.2	14.7	6.0	12.5	8.9	9.9	2.8	2.8	15.5	7.2	1.2	2.3	0.8	9.4	13.2	5.9	6.3	9.1	7.1	3.2	10.0	5.7	9.9	8.1	7.9	3.1	6.4	5.9	9.7	6.0	9.4	8.2	8.1	10.9	6.0	9.2	5.3	9.9	5.8	5.7	4.8	6.9	6.8	5.4	8.7	6.3	6.2	8.2	6.5	4.7	6.2	7.9	4.7	6.0	1.8	4.7	3.6	5.1	8.8	2.7	3.5	6.5	10.0	4.2	6.8	11.8	4.4	5.1	5.7	4.5	2.1	13.9	6.2	4.5	9.1	6.4	3.8	2.5	3.9	9.0	3.0	4.9	15.5	2.0	2.3	2.3	3.5	1.6	1.9	1.8	1.8	1.7	2.8	1.8	1.9	2.4	1.2	7.2	2.8	1.0	0.8	15.7	19.3	34.5	21.6	13.4	14.0	11.8	17.5	15.9	11.7	11.9	23.4	12.8	12.1	22.7	47.2	15.5	15.3	18.7	27.3	38.4	66.8	8.1	1.7	14.5	237.4	14.3	19.3	0.0	15.8	6.2	12.3	15.8	23.1	14.7	18.3	60.4	23.6	16.5	18.4	133.5	17.3	19.0	10.1	18.0	21.4	20.4	20.3	14.0	21.5	7.9	53.1	6.5	13.3	29.9	19.0	33.9	7.4	24.5	16.6	14.8
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 46.1;Late spermatids: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 15.9;monocytes: 13.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		8400	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.2	11.0	20.8	8.8	30.8	14.3	2.8	57.6	57.6	6.9	8.1	4.6	1.8	4.7	3.3	3.1	7.6	2.3	4.9	4.5	19.7	14.9	3.0	1.9	6.7	5.2	11.3	27.6	2.9	13.0	4.1	14.8	4.0	17.6	6.2	6.1	2.9	8.3	5.2	5.6	9.9	6.0	5.6	6.9	7.4	10.1	5.7	4.6	0.5	2.8	1.0	6.2	8.3	3.5	0.0	3.6	15.9	13.6	0.7	0.9	3.1	5.7	6.2	4.2	6.1	7.9	5.9	1.0	5.8	9.3	8.4	4.9	2.8	2.7	2.0	2.6	7.0	5.1	5.1	3.9	9.2	5.2	4.3	3.2	3.7	1.9	1.5	3.8	0.4	5.3	10.9	4.9	9.6	1.2	3.6	4.4	4.1	16.2	4.8	7.4	9.0	0.7	1.5	4.1	6.7	5.0	0.7	5.4	1.2	7.8	4.2	12.4	1.9	6.8	11.4	2.8	4.4	9.2	1.2	8.9	5.2	3.9	7.8	2.0	7.6	1.3	4.1	6.8	2.9	5.6	11.0	7.2	10.6	0.9	8.3	0.3	0.0	0.6	0.6	2.6	0.0	0.6	0.6	15.9	0.7	13.6	3.6	0.2	3.1	20.8	30.8	57.6	45.9	19.7	14.9	11.3	27.6	17.6	4.6	6.0	7.2	3.0	6.5	3.5	13.4	5.8	2.5	1.4	2.3	1.8	5.9	0.4	0.0	2.0	38.3	3.2	5.9	0.0	4.1	0.6	3.9	11.1	2.3	2.4	6.7	46.1	10.9	5.5	18.3	149.1	15.0	8.8	3.3	5.4	8.4	2.5	6.6	7.0	25.1	1.3	5.9	0.0	3.1	3.6	4.9	3.9	2.9	4.4	3.5	26.5
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932031	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 38.7"	"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.6;U-266/70: 6.3"					"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.1	13.0	11.4	9.9	12.4	10.0	9.9	7.1	12.8	5.0	4.9	16.5	7.0	4.0	7.4	38.7	3.0	7.3	7.2	7.6	11.1	9.6	9.6	6.5	10.8	10.9	10.2	11.4	11.9	7.3	14.5	31.4	2.3	9.2	9.3	3.4	13.6	7.9	14.2	5.1	4.3	5.4	8.3	12.0	10.7	4.1	5.9	11.3	7.0	18.8	3.2	7.5	3.3	3.7	3.7	3.2	2.6	1.1	0.6	1.6	0.6	0.4	0.0	1.5	1.5	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	1.8	2.7	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.3	0.3	1.1	2.8	0.0	12.6	1.0	0.0	0.1	0.2	1.9	0.0	0.2	2.1	0.0	0.1	3.4	0.0	0.6	1.7	1.0	0.0	0.1	1.7	2.2	3.1	3.1	0.9	0.0	0.0	0.1	6.3	0.4	0.0	0.6	3.0	0.9	2.6	1.1	1.7	0.9	0.4	1.6	2.0	1.3	1.4	0.2	3.7	1.6	1.4	0.8	0.6	0.7	3.2	0.6	0.6	11.4	12.4	7.1	12.8	11.1	9.6	10.2	11.4	9.2	11.3	14.9	34.0	4.5	5.8	3.7	34.3	22.7	5.1	22.7	26.1	14.0	41.2	0.0	3.3	3.2	8.5	10.8	1.1	23.3	2.5	0.0	5.4	9.2	15.1	9.0	3.1	15.9	9.9	12.3	6.1	7.5	1.7	9.3	6.8	8.2	2.9	38.4	1.6	1.4	1.1	3.7	54.5	0.0	8.6	10.3	9.7	2.5	0.1	8.7	2.1	4.1
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A"	Q96GS6	19	1876810-1885547	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	28.1	11.9	26.6	8.9	23.9	10.0	6.8	16.4	29.4	9.0	14.1	15.3	10.3	16.5	8.8	7.0	9.9	7.1	11.7	12.9	30.9	14.4	11.9	8.2	13.0	9.1	19.0	16.7	9.4	16.6	3.8	7.7	13.4	13.2	13.9	2.1	8.4	21.0	11.2	47.4	20.7	15.8	5.2	25.5	25.7	23.3	12.1	7.9	10.9	11.4	9.6	7.1	6.3	7.3	4.5	1.5	5.9	1.5	4.7	8.5	1.0	16.7	5.8	1.7	6.6	3.1	3.8	13.2	11.3	3.5	3.1	3.1	2.7	2.9	8.2	4.6	2.4	0.7	10.5	1.1	4.4	0.1	19.0	25.0	6.1	2.2	7.4	4.5	6.0	20.8	4.1	3.5	1.7	1.2	2.0	6.5	8.3	10.4	9.3	2.2	9.4	10.9	12.0	12.8	3.2	13.1	12.8	5.8	12.3	2.2	3.4	7.8	18.0	5.9	6.4	10.7	0.4	6.6	11.1	12.4	3.7	8.7	15.2	11.0	37.4	22.4	6.9	8.5	8.1	6.1	2.5	1.5	5.9	8.5	0.9	6.2	4.5	3.9	5.5	1.5	2.4	4.1	4.4	1.7	4.7	1.0	1.5	3.5	1.0	26.6	23.9	16.4	29.4	30.9	14.4	19.0	16.7	13.2	7.9	3.0	7.2	31.2	18.9	28.6	40.6	3.0	28.1	1.4	7.9	14.0	37.3	59.5	8.3	27.9	4.8	47.9	44.2	23.3	32.7	33.7	26.8	25.1	10.3	18.7	55.3	52.4	29.3	55.9	28.5	4.0	27.9	25.8	25.3	26.2	27.8	45.9	34.1	27.9	34.3	15.9	29.8	12.9	16.4	12.3	22.9	40.1	54.9	96.5	25.1	26.6
MBD3		ENSG00000071655	"Methyl-CpG binding domain protein 3"	O95983	19	1573596-1592801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 101.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013265	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013265: "	"unprognostic (1.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.44e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	19.4	14.8	27.3	18.2	21.0	19.9	19.7	18.9	25.1	11.8	14.9	12.7	18.8	17.1	14.4	12.0	14.8	13.4	18.3	21.5	26.5	16.5	17.2	19.1	13.1	18.2	18.2	16.9	17.2	25.4	17.7	18.1	27.3	13.1	19.5	7.5	12.5	28.0	17.1	41.4	28.5	14.5	11.4	14.9	18.3	14.1	21.1	11.0	23.9	17.2	14.3	15.4	12.3	26.8	3.1	7.0	2.3	3.7	1.2	3.7	2.0	27.5	31.3	13.1	22.5	10.8	9.4	19.5	17.0	10.3	18.2	17.0	29.2	12.6	27.8	13.4	12.4	6.3	22.9	14.6	16.4	4.9	37.2	30.2	16.3	33.8	21.6	15.6	20.8	23.2	13.4	14.0	17.6	8.0	9.1	16.6	20.4	30.0	23.8	8.9	31.3	25.0	28.9	21.9	8.4	20.7	29.8	16.3	20.8	9.2	26.8	36.8	29.9	17.0	14.9	12.7	4.7	16.7	25.7	16.5	25.6	18.7	37.9	40.1	23.2	19.3	25.4	20.7	29.1	26.2	1.2	3.7	2.3	3.7	2.0	3.3	1.6	3.0	2.0	3.4	3.1	3.3	2.8	1.5	1.2	1.7	7.0	0.7	2.0	27.3	21.0	18.9	25.1	26.5	16.5	18.2	16.9	13.1	11.0	11.9	28.2	15.2	7.7	9.6	22.9	17.3	7.6	2.7	10.3	10.4	13.7	42.8	5.0	14.0	2.5	16.5	27.6	46.7	22.3	36.6	14.2	12.7	3.5	37.6	23.2	17.5	14.3	28.8	26.1	4.7	20.8	11.9	5.0	10.0	22.7	30.6	17.9	14.7	24.1	15.8	10.7	38.8	11.6	5.7	11.0	11.2	101.6	7.5	25.3	7.4
GPRASP1	"GASP, GASP1"	ENSG00000198932	"G protein-coupled receptor associated sorting protein 1"	Q5JY77	X	102651366-102659083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.0"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 41.0;Cardiomyocytes: 21.2;Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.2"	"Group enriched"	"Detected in many"	5	"B-cells: 1.4;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 6.8;REH: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000161, HPA031061"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA000161: AB_2247872, HPA031061: AB_2673718"	"unprognostic (3.92e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (1.77e-5)"	"unprognostic (3.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.23e-2)"	3.5	16.6	19.0	3.7	34.3	2.5	4.0	28.2	37.0	8.9	7.2	4.3	1.6	1.9	18.2	8.1	3.3	8.7	5.5	10.6	19.9	18.3	5.2	1.4	3.8	6.2	7.9	30.3	29.9	3.0	22.4	16.1	2.2	20.6	12.0	3.5	4.0	5.1	13.4	4.0	2.2	4.1	11.7	6.6	6.8	3.5	2.9	5.6	0.9	11.9	0.8	5.4	6.3	6.3	1.4	0.6	0.0	0.0	0.3	5.2	1.0	0.4	0.8	2.6	1.6	2.6	2.7	1.5	2.7	0.2	4.1	6.8	0.3	0.5	0.0	0.6	5.6	0.4	0.7	0.8	0.1	5.9	0.0	0.3	0.2	0.7	0.7	2.1	0.3	0.4	3.5	1.1	5.0	0.4	0.7	0.4	2.6	0.5	0.2	6.4	0.6	5.3	0.2	1.8	0.4	0.9	8.1	2.6	0.0	0.4	0.6	2.6	4.1	0.9	0.4	0.7	2.2	0.4	1.3	0.8	1.3	1.6	0.8	0.4	0.4	0.7	0.0	0.6	0.4	1.7	0.0	0.0	0.0	1.3	0.0	2.9	0.6	2.4	1.0	0.0	1.4	5.2	4.8	0.0	0.3	0.0	0.6	1.8	1.0	19.0	34.3	28.2	37.0	19.9	18.3	7.9	30.3	20.6	5.6	0.0	2.2	0.8	4.4	3.2	41.0	21.2	0.0	0.0	5.7	5.2	35.3	0.3	0.0	0.2	0.3	4.5	0.1	0.0	0.2	0.1	3.8	5.1	2.3	0.6	0.3	6.4	5.8	7.4	0.0	0.5	14.1	1.2	1.7	0.0	0.0	14.1	0.4	0.0	14.5	1.1	18.4	6.5	8.1	1.2	0.8	0.6	0.1	4.1	0.6	1.4
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 8.6;Club cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.1	16.1	4.4	10.7	13.8	10.1	12.2	12.1	18.2	20.6	13.4	15.4	7.5	17.9	15.7	35.8	7.9	7.3	14.8	13.6	11.2	4.6	33.9	4.1	7.6	9.2	13.1	5.2	6.8	15.1	13.9	16.5	13.4	14.7	9.3	10.4	14.0	7.4	8.1	12.1	9.1	3.4	4.1	11.2	16.5	10.6	3.1	13.9	9.2	5.7	8.3	9.7	10.9	12.5	12.1	4.3	18.1	4.3	6.4	14.4	6.6	17.7	10.9	7.3	5.0	4.4	14.2	7.1	5.0	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9	3.0	8.6	0.0	0.8	0.3	1.9	1.3	0.0	2.7	4.5	0.0	2.0	1.2	0.0	0.4	0.9	0.6	0.4	0.0	0.5	0.7	1.3	0.5	2.3	0.0	0.5	1.6	0.0	0.6	0.0	1.0	0.6	1.0	0.0	0.0	0.3	1.0	0.0	0.0	0.4	0.4	3.0	0.0	1.2	0.7	0.3	0.3	1.1	0.7	0.4	0.6
CRTC1	"FLJ14027, KIAA0616, MECT1, TORC1"	ENSG00000105662	"CREB regulated transcription coactivator 1"	Q6UUV9	19	18683677-18782333	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.7"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022035, HPA063619"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane, Cytosol"	"HPA022035: AB_1847255, HPA063619: "	"unprognostic (5.95e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.94e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.80e-5)"	"unprognostic (3.37e-2)"	"prognostic favorable (3.83e-5)"	"unprognostic (6.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.03e-2)"	8.6	7.7	26.0	7.4	38.8	3.2	3.8	40.7	30.1	5.0	4.4	6.5	4.3	6.5	6.8	5.6	3.1	10.5	5.5	5.6	17.7	7.8	6.6	4.5	5.7	6.3	6.4	18.1	6.7	10.0	8.4	11.3	6.4	6.0	7.0	2.6	5.1	8.8	9.4	12.4	5.5	6.2	4.3	4.8	8.1	8.0	7.5	10.2	1.9	7.4	1.1	3.7	4.6	3.5	4.1	3.8	1.8	3.4	1.1	3.0	1.3	4.4	8.1	5.9	9.4	5.5	4.6	16.7	4.9	3.3	4.7	4.5	5.4	5.8	6.2	10.4	4.6	3.3	4.8	1.8	3.0	1.1	2.7	14.1	5.2	7.2	8.9	5.3	7.1	14.6	7.5	2.9	4.0	1.2	6.2	2.6	6.4	4.1	5.7	2.6	16.1	4.6	8.1	7.6	2.3	11.9	7.3	2.6	6.8	2.9	7.9	10.8	9.7	5.5	5.2	5.8	2.0	5.8	4.3	4.7	5.3	8.2	9.7	5.6	3.8	3.0	4.1	6.2	7.7	4.0	1.5	3.4	1.8	1.7	1.3	1.8	2.3	2.7	3.0	3.0	4.1	2.3	1.8	1.7	1.1	1.9	3.8	1.8	1.3	26.0	38.8	40.7	30.1	17.7	7.8	6.4	18.1	6.0	10.2	0.0	4.0	4.2	9.5	2.4	24.9	14.0	5.1	2.7	2.3	17.4	25.5	8.5	10.0	3.6	0.7	4.5	5.1	0.0	5.3	2.1	5.4	3.0	2.3	3.4	7.8	41.3	18.4	1.3	5.4	1.7	8.6	3.7	3.3	1.8	6.9	8.9	2.6	8.6	4.6	4.3	14.1	0.0	8.2	2.9	7.2	1.8	8.7	5.1	4.8	2.5
UBOX5	"KIAA0860, RNF37, Ubce7ip5, UIP5"	ENSG00000185019	"U-box domain containing 5"	O94941	20	3107573-3160196	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028871	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028871: AB_10603140"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.80e-5)"	"unprognostic (4.02e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.33e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-2)"	10.1	9.9	9.6	10.0	13.0	17.7	15.4	14.9	16.3	11.6	12.7	12.3	9.0	8.6	14.1	8.8	11.2	13.9	8.8	10.8	10.0	9.1	13.7	12.2	10.1	19.6	10.0	10.2	15.2	17.8	12.8	11.6	11.1	11.9	11.8	8.8	9.5	13.2	13.6	34.1	16.3	10.7	12.2	7.9	10.4	10.8	15.1	9.3	14.9	10.4	11.1	11.5	12.8	9.7	8.7	7.0	11.4	7.0	7.5	8.4	5.5	6.3	6.5	5.2	3.3	6.8	3.8	2.7	5.4	4.9	6.5	6.5	6.1	5.5	4.8	2.1	4.5	7.5	8.8	3.4	8.1	4.0	1.4	2.9	8.3	2.0	5.7	5.5	3.5	3.3	4.9	6.1	5.2	6.7	5.3	4.2	4.0	6.8	4.7	3.8	4.2	7.1	5.2	4.0	6.7	3.9	4.8	6.5	3.4	4.1	6.6	6.4	6.2	3.4	20.0	4.2	4.2	8.5	2.6	4.7	4.4	2.8	4.8	4.3	6.4	9.3	4.3	2.4	3.6	3.1	11.1	7.0	11.4	7.1	7.0	7.3	8.7	8.0	5.8	7.0	6.8	8.4	8.1	11.4	7.5	5.9	5.6	7.6	5.5	9.6	13.0	14.9	16.3	10.0	9.1	10.0	10.2	11.9	9.3	11.9	5.9	4.4	3.4	1.6	6.8	1.0	2.5	1.4	2.3	0.0	5.9	6.2	0.0	3.2	1.1	2.2	4.0	0.0	3.7	3.3	3.3	4.1	2.3	3.8	4.3	6.4	9.8	6.2	4.8	1.2	6.4	2.9	3.3	5.4	5.1	3.9	3.6	3.5	3.5	4.4	4.7	6.5	2.0	8.6	4.2	2.0	8.5	2.9	5.0	5.6
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 174.9;Leydig cells: 199.9;Peritubular cells: 222.0"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 8.5;BJ hTERT+: 6.8;CACO-2: 7.2;fHDF/TERT166: 7.6;Hep G2: 33.5;HHSteC: 7.0;SH-SY5Y: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.5	0.2	4.9	5.0	0.0	8.5	6.8	0.5	0.2	7.2	0.0	0.0	0.3	7.6	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	33.5	7.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6	0.0	0.0	0.0	0.0	14.0	1.0	4.8	7.6	0.0	0.0	1.8	0.0	0.6	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.6	66.0	0.1	1.1	174.9	1.2	6.4	17.1	9.8	4.5	5.6	199.9	0.3	18.6	1.0	1.4	3.8	0.5	2.9	222.0	5.6	1.1	51.8	54.2	2.1	1.1	13.4	0.9	2.5	0.9	0.2
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 34.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 34.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	7.9	14.0	26.0	6.9	26.0	1.9	5.5	54.3	84.6	11.5	9.6	31.1	3.7	4.5	15.7	3.2	9.2	19.7	7.0	21.8	29.5	23.9	9.2	2.3	9.4	7.5	27.0	30.7	21.3	9.5	14.8	15.7	5.4	25.8	10.9	3.3	5.5	8.0	16.5	21.5	4.6	5.2	19.5	36.4	5.9	5.7	7.2	24.7	6.0	7.7	2.5	6.6	7.7	5.8	6.3	0.6	3.0	0.6	5.5	34.4	11.3	0.0	5.9	20.7	9.2	11.2	11.6	0.0	9.7	16.9	16.9	21.3	10.7	4.1	0.0	1.5	17.7	15.2	0.2	18.0	3.0	8.1	10.8	13.6	0.1	3.8	0.3	8.1	0.0	4.1	10.4	0.7	7.9	1.2	14.5	20.9	0.5	0.4	0.3	6.2	0.2	0.2	0.0	7.4	0.3	6.4	0.1	0.8	0.0	0.7	0.0	28.5	16.1	1.4	1.2	6.4	6.6	0.8	1.3	9.2	1.7	10.5	11.2	2.0	5.6	2.6	0.8	8.7	0.0	5.8	3.0	0.6	0.1	9.1	0.5	9.8	2.6	12.7	11.7	0.6	6.3	34.4	20.0	0.5	5.5	0.2	0.1	17.0	11.3	26.0	26.0	54.3	49.3	29.5	23.9	27.0	30.7	25.8	24.7	17.9	4.8	3.2	10.7	4.4	36.4	40.0	10.2	26.8	9.1	5.2	21.6	0.4	21.6	14.5	4.3	13.7	0.5	0.0	3.6	0.6	12.5	8.9	1.1	3.0	1.1	38.1	18.6	19.0	2.8	9.2	8.9	0.8	8.5	3.6	0.7	23.8	7.3	1.1	18.0	19.2	16.8	6.5	18.7	4.2	6.6	2.5	0.7	21.7	0.8	4.4
FLYWCH2		ENSG00000162076	"FLYWCH family member 2"	Q96CP2	16	2883186-2899382	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041354	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041354: AB_10795007"	"unprognostic (3.57e-2)"	"prognostic favorable (9.38e-4)"	"unprognostic (7.33e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.40e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (5.50e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	19.7	33.9	20.8	13.0	24.6	9.3	14.9	28.5	29.5	15.7	15.0	14.7	19.4	20.8	16.8	13.7	20.8	18.3	22.0	23.8	19.8	27.1	20.2	8.3	15.7	12.6	22.8	16.4	19.5	13.9	17.6	21.7	10.3	22.9	22.4	7.4	22.9	25.4	19.6	34.6	15.9	14.6	13.2	18.2	31.4	17.6	22.3	10.4	19.8	27.0	18.6	17.0	14.2	12.6	15.3	25.3	10.1	18.4	9.8	19.3	12.7	8.7	17.6	7.4	17.3	7.4	10.5	10.7	6.8	5.2	7.4	5.0	8.0	11.0	8.6	26.2	6.3	7.1	5.6	4.0	9.5	1.3	14.4	11.0	9.0	17.2	6.3	20.8	5.4	9.2	14.6	7.3	5.9	3.0	9.2	5.7	15.5	6.5	9.5	5.1	40.9	13.9	23.7	8.0	8.3	18.1	27.1	7.8	18.6	5.2	2.6	11.4	14.8	19.0	20.6	13.7	2.9	24.4	18.0	7.8	12.7	10.3	19.7	6.9	15.6	13.6	11.8	7.4	8.0	9.2	5.6	13.0	10.1	15.1	18.4	16.5	15.3	17.5	14.5	18.4	14.3	19.3	16.5	5.6	9.8	17.8	25.3	16.3	12.7	20.8	24.6	28.5	29.5	19.8	27.1	22.8	16.4	22.9	10.4	11.9	12.8	16.0	36.2	18.1	19.5	13.3	12.7	13.4	7.9	41.8	7.9	17.9	71.3	38.9	8.4	30.8	27.6	0.0	48.7	37.6	34.7	40.7	13.9	5.5	30.2	14.3	32.3	13.5	6.5	8.7	19.5	22.5	40.5	23.4	36.2	46.1	36.0	31.6	23.7	43.4	14.1	32.3	33.0	47.7	38.1	24.8	10.1	21.7	32.4	26.3
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA012531: AB_2732403, HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (1.92e-5)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	7.4	9.9	14.1	12.8	14.2	8.1	6.6	18.5	14.1	8.2	8.0	10.5	6.6	5.4	9.7	8.9	5.2	7.4	9.0	22.8	11.7	9.1	7.2	5.8	7.2	12.9	11.1	11.0	8.0	7.4	7.6	16.8	7.3	8.7	9.4	8.2	6.8	5.9	9.3	9.5	4.8	8.1	11.2	8.0	10.8	6.6	9.7	11.2	11.5	8.7	4.0	11.0	9.0	6.4	24.5	6.8	2.1	5.2	12.0	13.6	2.6	3.7	6.7	7.7	6.7	5.2	7.7	3.1	12.0	7.7	10.5	11.8	6.1	3.7	13.0	3.2	4.9	2.9	3.8	9.7	4.2	8.9	14.5	8.7	9.8	10.1	6.3	6.3	10.6	8.2	5.9	4.6	9.3	4.9	4.9	14.1	7.3	4.5	8.6	16.6	2.5	7.4	3.5	7.4	3.2	8.5	4.8	4.3	5.8	5.5	5.1	3.5	1.8	7.4	1.8	3.2	3.6	2.6	5.0	11.7	8.7	6.2	9.3	9.7	4.8	8.2	11.9	6.6	9.1	6.3	0.4	5.0	2.1	13.6	4.4	11.9	24.5	13.0	13.0	3.4	22.4	13.1	13.0	0.2	12.0	5.2	6.8	5.8	2.6	14.1	14.2	18.5	14.1	11.7	9.1	11.1	11.0	8.7	11.2	6.0	5.0	24.1	5.1	2.6	52.2	29.9	12.7	8.1	1.2	10.4	53.0	9.3	0.0	7.6	3.0	9.0	3.9	0.0	4.6	1.1	10.8	4.4	1.1	5.4	5.9	38.1	16.3	8.6	7.0	2.9	25.0	5.6	11.8	8.2	6.9	18.4	5.5	10.1	16.6	2.8	77.1	12.9	11.2	37.0	22.8	0.9	1.6	25.4	9.0	5.0
ARID3A	"BRIGHT, DRIL1"	ENSG00000116017	"AT-rich interaction domain 3A"	Q99856	19	925781-975934	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 38.3"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004793, HPA076330"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004793: AB_1847870, HPA076330: AB_2732309"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-2)"	4.0	2.3	1.7	6.2	2.3	11.5	4.4	4.8	3.8	3.6	5.0	1.6	3.3	4.2	2.9	2.9	4.1	2.7	3.2	2.1	2.2	1.5	4.4	2.6	6.1	7.8	2.8	2.0	1.6	5.5	3.4	4.1	38.3	2.1	2.3	1.8	2.6	2.8	5.6	2.0	3.3	5.0	2.6	2.4	8.3	3.4	17.8	2.5	6.6	2.1	2.1	4.6	4.0	6.9	1.5	9.2	6.4	2.9	1.9	0.5	0.8	1.1	1.5	5.3	1.3	2.2	1.7	64.0	5.0	3.2	2.7	1.8	21.6	0.1	0.4	1.2	1.7	0.6	0.4	2.1	1.1	1.2	6.6	1.5	2.1	1.9	19.4	0.9	7.4	5.5	2.4	1.7	1.7	0.4	0.4	0.9	1.7	27.8	6.2	0.7	1.7	2.8	8.4	5.1	0.8	0.3	6.5	1.6	4.1	0.3	1.1	2.5	4.9	1.6	1.3	0.9	12.3	2.3	19.9	1.5	1.8	2.4	2.5	0.5	14.6	13.0	3.8	1.1	4.3	1.2	0.8	2.4	1.6	0.5	2.1	0.5	1.5	0.3	0.4	1.5	0.9	0.5	0.2	6.4	1.9	2.9	9.2	0.3	0.8	1.7	2.3	4.8	3.8	2.2	1.5	2.8	2.0	2.1	2.5	6.0	3.2	27.9	7.8	13.2	8.8	6.5	0.0	0.0	1.2	14.0	7.9	156.8	8.3	4.8	29.9	7.8	3.2	23.3	2.8	418.2	16.2	7.5	3.5	6.7	78.2	6.4	45.1	9.8	34.1	2.0	6.6	32.5	15.1	35.1	11.2	2.3	9.8	0.0	6.0	4.5	3.3	0.0	12.8	0.6	8.5	13.4	433.4	10.9	4.3	1.8
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776483-74839779	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	11.5	15.5	10.6	11.6	12.1	15.4	7.7	10.5	13.9	8.1	7.9	19.1	9.5	7.6	7.4	8.9	9.3	6.8	9.6	9.0	11.4	8.2	10.9	19.9	14.7	19.0	17.3	9.1	9.4	18.7	21.0	14.7	12.5	13.1	8.0	6.7	10.0	15.1	9.1	7.5	9.7	7.7	9.4	18.5	10.4	8.3	17.4	14.2	7.5	11.7	6.5	10.2	10.6	6.1	4.9	8.8	5.7	7.7	3.9	7.9	5.0	6.3	15.6	8.4	9.4	11.9	7.4	5.0	11.0	11.1	14.1	15.7	12.8	6.9	3.4	3.5	12.5	14.4	7.2	8.4	6.1	7.5	2.5	11.9	8.4	6.3	8.8	8.7	13.7	7.8	5.9	6.8	14.3	3.1	4.2	10.0	8.3	4.8	5.3	9.6	6.0	8.2	5.6	4.6	8.4	12.5	5.2	13.2	5.6	6.3	5.6	7.1	9.3	6.1	7.9	8.1	6.6	10.1	21.4	7.9	29.8	7.6	11.3	14.2	3.6	3.1	3.8	11.5	14.4	11.3	2.2	7.7	5.7	7.9	6.5	4.0	4.9	7.6	7.2	8.3	1.6	6.3	4.4	3.6	3.9	6.6	8.8	7.5	5.0	10.6	12.1	10.5	13.9	11.4	8.2	17.3	9.1	13.1	14.2	6.0	7.2	0.8	1.0	2.3	2.3	36.1	10.2	0.0	3.4	5.2	2.0	3.3	0.0	3.9	1.6	2.3	3.9	0.0	4.8	3.3	2.7	2.1	1.1	11.5	10.6	0.0	7.9	3.1	6.3	1.7	2.6	5.5	0.0	4.6	4.0	4.0	5.3	3.1	2.1	1.6	3.0	0.0	1.4	4.3	4.1	1.9	3.2	2.9	2.6	1.3
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in some"	58	"Early spermatids: 515.2;Late spermatids: 237.4"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.3	4.4	1.4	2.0	0.0	0.0	2.9	3.4	0.0	0.0	0.0	2.7	1.6	0.9	2.6	0.0	7.4	4.8	0.0	0.2	0.0	5.4	2.6	0.7	27.3	0.8	0.0	0.7	3.4	0.0	0.0	0.1	0.0	1.6	0.0	2.5	3.7	4.9	0.0	3.8	1.1	1.7	1.2	0.1	1.3	1.8	2.1	5.0	0.0	2.1	3.4	3.1	5.9	3.0	16.6	0.7	3.3	1.7	4.5	2.7	3.6	8.2	3.1	3.9	1.0	1.4	8.1	3.2	59.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	515.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	6.5	0.0	2.8	1.5	0.0	0.1	0.0	0.0	0.0
ZNF785	FLJ32130	ENSG00000197162	"Zinc finger protein 785"	A8K8V0	16	30573740-30585771	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004010			Approved	Cytosol		NA	NA			Cytosol		"HPA004010: "	"unprognostic (2.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-4)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (3.37e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-2)"	5.9	8.7	15.8	7.9	13.6	4.8	8.3	26.8	16.6	10.9	7.7	14.7	8.7	14.2	12.4	9.8	6.9	10.2	8.3	6.2	12.6	7.6	7.8	6.1	6.5	8.7	15.7	12.2	14.7	9.1	11.9	12.7	6.1	11.8	10.8	8.2	10.8	10.5	9.5	9.2	12.6	10.7	7.5	9.5	9.5	12.4	3.9	19.2	8.8	9.9	4.3	8.8	10.4	9.6	5.1	5.4	4.9	5.1	3.3	3.5	1.0	4.9	0.4	4.8	6.4	6.1	6.8	1.5	4.3	3.9	4.5	3.4	6.7	7.9	5.1	5.2	4.1	0.3	7.1	0.1	2.8	2.7	3.4	1.3	6.2	13.7	1.5	4.5	0.5	10.8	4.4	6.2	3.0	2.8	3.8	4.8	0.9	5.8	6.4	4.1	8.6	6.2	5.8	2.8	1.9	2.8	16.3	5.5	2.5	4.2	5.1	13.4	9.5	3.6	4.5	2.6	3.0	5.6	5.3	7.1	1.8	4.8	4.0	0.3	0.9	2.7	2.1	5.8	3.8	7.3	4.7	2.6	1.0	2.3	1.6	2.5	5.1	2.8	1.9	1.9	3.1	3.5	2.7	4.9	3.3	5.1	5.4	3.3	1.0	15.8	13.6	26.8	16.6	12.6	7.6	15.7	12.2	11.8	19.2	0.0	4.3	4.3	6.6	0.9	9.3	1.4	5.1	5.3	2.3	7.0	19.6	1.1	5.0	3.0	0.1	5.1	5.2	0.0	3.0	0.9	3.3	5.7	0.0	3.0	2.3	12.7	11.5	2.5	4.1	0.0	12.4	4.1	5.0	1.8	4.7	5.2	3.5	8.4	12.4	1.5	12.4	0.0	3.1	4.2	1.3	2.3	0.7	4.4	6.3	3.7
ARAP1	CENTD2	ENSG00000186635	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1"	Q96P48	11	72685069-72793599	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020703, HPA070383"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA		39000	"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"CAB020703: , HPA070383: AB_2686262"	"unprognostic (3.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (4.01e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.41e-4)"	"unprognostic (7.56e-3)"	19.2	29.6	28.8	32.9	29.1	51.1	17.9	34.0	37.5	19.6	16.8	26.6	20.0	17.4	23.7	20.0	21.1	30.3	26.1	20.3	27.7	14.4	20.9	16.6	35.5	27.8	27.5	17.8	28.8	18.9	14.3	31.0	20.9	23.0	21.3	11.2	18.1	19.9	19.0	12.9	27.5	23.6	17.1	25.6	53.8	16.2	23.5	32.3	18.8	24.7	14.0	18.6	28.4	19.6	3.3	7.4	24.0	22.5	6.1	4.4	6.4	7.2	15.5	5.9	7.2	25.3	17.2	8.9	10.0	18.1	11.4	11.4	21.1	19.4	16.2	20.2	16.8	15.5	24.6	9.0	23.9	4.9	19.0	10.6	13.7	14.6	29.1	17.5	9.3	38.5	18.3	25.5	18.7	9.0	14.3	12.1	11.9	11.4	6.5	5.3	15.0	14.1	32.4	3.7	13.1	10.0	13.8	9.0	7.9	10.7	23.2	6.2	12.5	7.3	10.9	32.3	7.9	9.5	21.2	14.3	16.2	11.3	16.4	6.1	10.5	5.1	8.5	8.6	13.9	8.6	7.5	11.0	13.3	4.4	18.7	2.6	3.3	2.9	3.3	7.4	2.6	2.3	2.7	24.0	6.1	22.5	2.5	3.1	6.4	28.8	29.1	34.0	37.5	27.7	14.4	27.5	17.8	23.0	32.3	26.8	28.8	11.5	8.0	6.5	4.1	2.0	5.1	8.1	3.4	15.7	31.4	7.0	8.3	13.1	49.1	4.4	11.6	0.0	6.4	7.7	16.7	4.7	10.4	10.2	37.8	0.0	22.3	12.9	43.1	4.4	19.2	39.0	8.5	10.8	13.9	8.6	10.7	7.0	14.2	4.7	2.9	0.0	6.1	0.3	2.5	4.6	4.1	6.7	12.1	6.7
SAP30L	"FLJ11526, NS4ATP2"	ENSG00000164576	"SAP30 like"	Q9HAJ7	5	154445957-154461054	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048665, HPA078308"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA048665: AB_2680486, HPA078308: "	"unprognostic (3.79e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.09e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.69e-4)"	12.1	11.5	14.8	9.5	14.2	2.0	16.9	14.0	16.4	18.1	18.4	15.4	10.2	13.5	18.0	12.4	10.0	17.7	16.4	13.5	14.2	11.1	17.4	12.4	12.1	8.1	14.9	8.7	27.0	8.7	21.5	6.8	10.0	12.7	16.2	11.7	12.7	12.9	17.3	16.6	14.6	18.8	15.7	14.9	10.9	11.1	16.2	12.2	13.0	15.2	8.2	10.5	13.8	34.5	1.9	1.4	1.0	3.6	4.5	2.3	1.1	6.7	5.6	10.3	6.8	22.6	18.1	5.1	7.0	15.3	8.1	8.8	3.7	3.8	7.3	5.6	10.6	9.5	5.4	7.7	5.7	9.1	3.6	7.6	5.9	5.4	2.6	6.8	7.7	4.4	6.5	10.5	3.6	8.9	12.5	6.5	6.9	2.4	4.6	6.7	3.4	7.2	5.0	2.5	6.1	3.8	7.0	10.3	3.6	4.6	3.3	6.3	8.2	5.5	12.1	13.3	10.1	4.3	9.6	9.2	5.7	4.2	7.5	4.9	4.4	6.3	3.8	8.3	6.1	3.3	0.0	1.2	1.0	1.7	1.3	2.3	0.9	2.1	2.1	1.1	1.9	2.1	1.5	0.8	4.5	3.6	1.4	1.9	1.1	14.8	14.2	14.0	16.4	14.2	11.1	14.9	8.7	12.7	12.2	17.9	5.8	3.0	6.8	15.3	4.5	15.7	20.4	9.4	6.8	3.5	5.9	6.4	3.3	4.3	17.1	14.8	23.9	0.0	7.1	10.2	15.1	13.1	1.1	13.1	7.3	9.5	6.9	12.3	11.3	15.9	19.0	7.5	10.1	4.6	12.2	17.0	8.3	12.2	17.0	8.2	5.7	0.0	11.3	15.7	17.6	15.8	5.3	6.7	11.1	11.2
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.7;placenta: 79.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 26.8"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Intracellular and membrane"	NA	NA		1100000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	29.9	15.4	24.0	18.2	42.0	0.7	26.2	4.4	33.3	19.6	8.1	103.7	1.7	20.8	44.8	6.4	2.9	18.7	12.7	3.6	39.8	21.5	24.9	8.9	13.5	31.0	71.5	20.9	5.3	5.2	0.9	4.1	79.0	59.7	8.5	10.6	67.6	3.4	9.2	3.0	5.4	12.1	28.9	102.4	17.3	8.3	9.7	63.9	3.6	3.7	0.8	26.1	13.4	5.7	0.2	3.8	26.8	0.1	0.2	1.8	0.3	0.0	0.0	25.2	0.0	34.5	73.7	0.0	23.2	42.4	10.0	9.6	0.0	0.0	0.0	0.3	27.3	0.0	0.0	0.5	0.0	7.1	1.8	0.7	0.0	0.0	0.6	15.4	0.0	0.1	33.8	0.2	20.4	1.0	0.1	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	20.3	0.4	24.4	0.1	0.2	0.0	0.0	17.1	0.1	0.5	26.8	0.1	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.8	0.6	0.3	0.2	0.0	3.8	0.0	0.3	24.0	42.0	4.4	33.3	39.8	21.5	71.5	20.9	59.7	63.9	11.9	5.1	3.2	0.5	9.4	1.1	1.2	38.2	6.7	1.2	1.8	0.0	3.4	1.7	0.0	34.3	16.3	0.9	0.0	0.0	1.5	51.0	0.1	5.8	0.4	50.0	0.0	51.9	19.0	12.5	3.6	2.8	8.9	43.9	0.0	0.6	3.3	1.2	0.3	3.2	45.6	1.2	0.0	5.1	1.1	0.4	4.5	5.4	0.5	0.6	0.9
VPS37D	"MGC35352, WBSCR24"	ENSG00000176428	"VPS37D, ESCRT-I subunit"	Q86XT2	7	73667825-73672112	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 10.7;Collecting duct cells: 10.4;Distal tubular cells: 8.3;Muller glia cells: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040978	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA040978: AB_10805833"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (4.19e-2)"	"prognostic favorable (5.80e-9)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.43e-1)"	2.6	1.7	7.2	0.8	8.3	0.6	2.9	7.5	9.2	4.7	1.9	3.8	1.7	4.1	3.9	6.9	0.9	6.4	3.2	3.9	6.0	7.6	8.8	6.2	1.8	0.7	5.1	2.6	6.0	5.3	3.8	2.4	1.0	5.3	4.5	0.7	2.2	7.2	5.0	2.8	2.3	2.4	1.9	3.8	1.2	1.9	5.5	3.3	0.8	7.4	0.2	0.5	3.6	5.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.7	2.9	2.3	4.8	1.6	3.2	1.4	1.2	2.0	1.0	1.2	0.3	0.8	1.0	1.1	1.6	2.7	0.3	2.5	1.1	0.3	0.4	2.5	0.0	0.2	3.2	4.2	0.0	1.4	2.5	0.7	1.4	0.5	4.6	1.1	4.1	1.3	0.2	1.4	3.5	0.7	0.1	1.6	0.8	4.2	0.1	0.1	0.2	3.9	0.3	4.7	15.0	0.0	2.0	2.7	0.4	4.8	0.2	1.7	2.9	4.0	1.7	1.0	1.9	0.2	1.3	6.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.2	8.3	7.5	7.2	6.0	7.6	5.1	2.6	5.3	3.3	0.0	0.0	0.0	0.5	0.9	10.7	1.6	0.0	0.0	0.0	10.4	0.0	0.1	8.3	3.3	0.7	0.5	0.0	0.0	0.7	0.3	0.9	1.4	0.0	5.1	0.1	0.0	4.7	1.8	0.0	0.7	1.7	0.0	5.0	1.0	0.0	7.7	1.8	0.6	2.5	6.3	4.9	0.0	1.4	0.5	5.7	1.0	0.2	0.0	0.2	0.3
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.5	1.6	0.4	0.0	0.1	6.0	0.9	5.9	5.1	9.5	1.6	0.2	6.1	4.9	1.8	0.1	5.0	21.2	1.0	13.4	9.5	18.0	6.4	24.6	4.0	8.6	11.3	5.9	11.0	5.3	0.9	1.1	4.7	8.7	0.3	4.9	6.7	0.4	6.7	11.3	12.2	4.3	4.7	25.5	4.9	49.0	1.2	0.1	16.6	7.2	12.0	0.5	7.5	2.5	2.2	4.8	0.2	3.1	9.0	2.1	0.2	13.1	12.1	18.1	0.1	8.8	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7	14.9	6.5	15.6	20.1	26.3	67.6	23.4	2.5	0.0	6.8	15.7	11.8	1.2	44.7	11.0	75.7	16.0	12.0	0.0	7.9	1.3	12.5	12.9	23.0	15.6	16.4	66.7	9.2	24.5	12.4	17.9	16.7	12.3	13.5	2.8	2.3	40.4	9.9	14.4	15.6	47.3	13.1	6.5	13.7	6.4	19.0	13.0	5.6	23.0	3.3	10.6
TRAF1	EBI6	ENSG00000056558	"TNF receptor associated factor 1"	Q13077	9	120902393-120929173	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"monocytes: 550.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;T-cells: 11.1"	"Group enriched"	"Detected in many"	6	"HDLM-2: 35.9;WM-115: 45.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001852, CAB009593"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009593: , HPA001852: AB_1080344"	"unprognostic (1.45e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.19e-5)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.42e-5)"	"unprognostic (1.85e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.87e-3)"	5.4	8.6	9.5	21.6	20.5	8.7	5.7	4.7	13.7	5.3	6.5	17.5	9.2	4.3	6.6	7.4	5.2	6.7	8.6	7.5	11.4	5.5	7.8	4.9	7.4	33.1	14.8	11.2	10.9	3.9	5.3	11.0	3.6	12.5	10.0	5.0	9.4	10.3	7.2	2.4	8.2	8.9	7.8	7.6	15.5	6.6	3.1	19.1	3.5	7.9	2.2	24.0	9.0	10.0	0.2	2.8	0.0	0.4	1.4	11.1	2.0	1.2	0.8	0.1	0.0	1.5	3.7	0.0	0.3	2.0	0.6	1.1	0.1	0.7	2.4	0.4	0.4	6.0	0.5	0.2	0.1	0.7	35.9	0.0	0.2	0.8	0.1	1.1	0.1	2.8	1.8	1.9	2.3	1.7	0.7	0.3	0.7	0.0	4.9	0.3	0.1	0.0	1.0	0.4	0.5	0.1	0.6	0.6	4.9	0.2	0.1	0.4	0.0	0.3	0.1	0.1	1.1	0.3	0.4	0.3	0.5	0.3	2.0	6.4	3.8	1.3	1.2	1.2	0.2	45.4	0.0	0.3	0.0	3.6	0.4	6.4	0.2	8.8	7.4	0.4	0.2	2.7	4.0	0.0	1.4	0.3	2.8	11.1	2.0	9.5	20.5	4.7	13.7	11.4	5.5	14.8	11.2	12.5	19.1	6.0	0.0	6.7	4.1	8.7	0.3	2.3	2.5	0.0	6.8	3.5	17.7	0.0	1.7	24.7	0.5	2.7	0.5	0.0	1.6	0.0	2.8	2.0	36.8	1.8	2.8	0.0	1.7	0.6	3.4	0.6	1.7	14.8	6.8	550.0	0.5	1.0	9.9	0.0	1.8	0.7	6.6	0.0	5.1	1.4	0.5	9.2	0.0	25.9	0.6	1.7
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.6;Cardiomyocytes: 19.9;Cone photoreceptor cells: 29.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 35.7;SuSa: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain					NA	NA					"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favorable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	14.3	5.6	11.4	4.6	13.5	0.9	9.0	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5.0	19.1	10.0	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3.0	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5.0	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16.0	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	4.5	1.2	0.0	0.0	1.9	1.5	2.2	1.6	2.4	0.0	0.0	0.0	0.0	0.0	3.3	2.3	9.5	6.2	1.1	0.0	7.0	0.0	2.4	0.0	0.0	0.7	0.9	0.7	5.3	0.0	2.9	0.8	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.5	2.2	0.0	7.1	0.0	0.0	35.7	6.6	5.8	0.3	0.3	0.4	11.1	0.7	0.0	0.0	0.0	3.5	4.8	6.2	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	13.5	15.2	17.5	10.0	12.5	10.3	12.4	13.2	4.6	0.0	0.3	0.5	2.4	3.1	23.6	19.9	0.0	1.4	2.3	3.5	29.5	1.7	0.0	1.6	5.5	3.0	1.1	0.0	0.0	1.8	3.1	1.7	0.0	0.0	0.2	9.5	8.6	4.3	0.3	3.0	2.0	0.0	0.0	0.0	0.2	15.1	0.1	0.0	6.0	0.0	10.6	0.0	15.1	17.9	5.2	2.9	0.8	0.0	0.4	3.9
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459953-137550534	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 16.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;T-reg: 3.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;T-cells: 3.5"	"Cell line enriched"	"Detected in some"	23	"HMC-1: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.3	5.6	10.6	2.8	11.0	2.8	6.3	17.0	11.4	6.4	4.5	6.7	3.8	3.1	7.6	2.1	2.2	5.8	4.7	4.8	8.4	2.6	2.3	7.4	4.1	5.4	9.7	9.7	9.7	17.7	3.3	7.1	1.1	6.6	14.7	2.1	5.4	18.7	4.8	19.1	15.4	4.8	7.2	6.7	5.4	9.6	1.8	11.6	0.4	7.6	4.2	2.8	7.8	3.7	3.6	0.7	0.0	0.4	0.0	3.5	0.5	0.0	0.5	0.1	0.2	0.4	0.3	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.4	0.4	0.1	0.3	0.2	43.9	0.6	0.1	0.1	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.8	0.0	0.6	0.5	1.0	0.7	1.3	0.0	0.2	0.8	0.2	0.0	0.3	0.1	0.1	1.9	0.6	0.3	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.6	0.4	0.0	0.0	0.4	0.0	0.8	0.3	0.0	0.8	0.5	0.4	0.7	3.6	1.2	0.9	0.0	0.0	0.1	0.4	3.5	0.5	10.6	11.0	17.0	11.4	8.4	2.6	9.7	9.7	6.6	11.6	8.9	5.1	3.7	1.0	1.3	2.5	3.2	2.5	1.4	3.4	1.8	5.9	0.1	0.0	0.4	0.3	0.7	3.5	0.0	0.0	0.2	1.0	3.5	6.9	6.7	2.1	4.8	16.6	2.5	2.5	0.2	4.0	0.9	0.0	1.8	7.4	3.5	0.8	5.8	1.8	0.8	9.1	0.0	0.9	1.6	1.4	2.9	0.0	0.0	1.8	0.7
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavorable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.1	0.5	4.6	2.7	0.0	1.3	2.9	2.1	2.5	0.8	0.1	0.2	2.0	2.8	6.4	0.6	10.2	0.0	1.9	0.6	1.0	0.5	8.3	0.3	6.7	0.5	0.1	6.6	0.0	3.3	4.6	7.5	3.5	0.0	0.0	5.7	3.2	4.2	0.0	0.0	6.3	0.4	3.6	0.1	2.4	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	5.5	1.1	0.1	6.4	3.5	5.1	2.3	1.1	0.2	0.3	0.7	2.5	0.0	1.9	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6	0.0	0.0	0.0	0.4	0.2	6.4	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.2	6.4	3.4	1.8	0.3	0.0	2.8	0.0	1.7	0.0	0.1	2.7	0.1	0.0	4.2	0.0	2.8	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
NEURL4	KIAA1787	ENSG00000215041	"Neuralized E3 ubiquitin protein ligase 4"	Q96JN8	17	7315628-7329393	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043678, HPA055314"	Uncertain					NA	NA					"HPA043678: AB_10963092, HPA055314: AB_2682782"	"unprognostic (4.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.96e-3)"	"prognostic favorable (2.34e-5)"	"unprognostic (4.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.12e-2)"	6.7	7.6	13.4	8.3	13.6	7.1	7.0	22.2	20.7	7.6	9.3	11.2	13.3	10.6	10.8	5.1	7.9	9.4	7.8	10.5	11.7	7.7	7.6	5.2	6.4	9.5	9.5	13.2	13.2	11.1	15.7	11.5	8.2	9.7	9.1	5.1	8.1	11.8	9.9	20.6	12.7	8.7	7.5	5.8	10.2	7.5	10.1	9.8	5.3	11.5	6.3	7.8	8.7	7.5	0.4	0.2	1.8	0.6	0.0	1.0	0.1	4.7	16.9	11.0	17.4	6.8	4.4	13.1	7.4	4.8	9.1	7.4	11.7	4.1	14.7	7.8	4.3	7.4	13.9	11.5	6.9	4.0	7.9	18.2	7.4	17.4	6.7	4.8	7.1	10.4	4.2	7.2	9.3	5.3	7.1	5.6	12.6	10.3	3.1	3.8	6.1	10.7	13.4	7.6	5.6	8.4	18.4	8.8	5.9	5.5	5.0	10.3	8.5	7.6	7.8	2.9	5.9	6.5	5.1	7.1	8.3	6.4	6.9	8.0	6.4	4.0	6.3	5.3	6.7	8.2	1.8	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	13.4	13.6	22.2	20.7	11.7	7.7	9.5	13.2	9.7	9.8	0.0	2.1	0.0	0.9	2.3	9.6	1.2	2.5	0.0	2.3	5.2	13.7	1.9	1.7	2.3	1.7	1.3	4.5	0.0	1.2	1.5	1.4	1.4	2.3	2.4	2.2	4.8	4.1	6.2	2.7	1.1	2.6	1.6	0.0	1.8	4.9	2.6	1.9	2.3	1.8	5.0	8.1	0.0	1.4	4.3	4.3	2.5	1.6	0.7	4.8	0.5
ZNF580		ENSG00000213015	"Zinc finger protein 580"	Q9UK33	19	55635016-55643469	"Predicted intracellular proteins, Transcription factors"	"Chemotaxis, Inflammatory response, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEK 293: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054058	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054058: AB_2682360"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (2.36e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.46e-3)"	32.8	23.6	24.5	25.5	23.4	17.2	19.1	28.7	28.2	23.4	25.2	23.1	36.4	19.8	32.2	39.5	18.2	25.8	25.5	17.2	23.1	21.7	23.3	8.7	17.1	24.2	19.1	22.0	33.0	24.1	37.8	38.2	13.7	19.9	31.3	16.2	23.0	31.7	34.2	20.9	19.4	20.0	32.4	17.3	30.1	24.9	10.7	20.9	23.0	35.4	10.8	21.6	25.8	21.1	12.8	4.1	10.5	9.2	2.9	3.3	1.5	4.7	8.9	8.2	5.3	9.1	5.1	3.2	6.4	7.6	10.0	12.5	1.5	4.6	3.4	1.8	9.3	2.2	3.9	5.4	5.8	7.8	10.9	78.3	6.4	8.4	4.2	12.1	3.1	14.6	11.0	6.2	4.8	9.3	13.3	6.9	8.8	6.3	9.6	8.3	1.5	14.1	4.6	4.2	3.1	11.5	12.8	2.9	14.2	11.3	5.6	9.1	11.2	4.5	4.5	5.8	4.6	3.8	3.3	8.6	5.5	8.3	3.7	3.5	19.4	5.2	8.5	3.0	4.9	5.2	4.4	3.4	10.5	1.2	4.8	1.3	8.2	2.7	2.7	3.6	12.8	3.3	2.8	6.2	2.9	9.2	4.1	2.1	1.5	24.5	23.4	28.7	28.2	23.1	21.7	19.1	22.0	19.9	20.9	8.9	8.9	35.7	31.8	16.6	31.0	8.9	33.1	1.4	5.7	54.1	3.9	23.6	64.6	36.4	2.7	31.8	25.8	0.0	48.6	17.3	31.7	34.7	19.5	9.5	22.2	19.1	64.7	40.5	25.4	4.3	55.0	28.0	37.1	45.9	23.8	26.9	38.3	28.1	66.4	55.9	16.6	38.8	37.1	7.9	12.1	14.8	15.9	20.2	26.9	27.6
TRAF3	"CAP-1, CD40bp, CRAF1, LAP1, RNF118"	ENSG00000131323	"TNF receptor associated factor 3"	Q13114	14	102777476-102911500	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002933	Uncertain					NA	NA					"HPA002933: AB_1080352"	"unprognostic (4.06e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.49e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (1.31e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.12e-1)"	7.6	5.3	13.6	23.3	9.1	18.8	7.7	12.5	16.0	4.2	8.9	8.8	5.8	8.4	7.5	3.9	7.5	8.9	7.1	7.3	16.6	12.7	6.7	7.0	8.1	26.0	11.5	8.0	4.8	5.1	10.0	10.3	6.8	8.5	6.1	8.0	7.9	5.7	8.0	5.5	7.9	11.8	7.8	9.8	14.2	7.1	12.2	6.6	10.5	7.5	4.1	25.4	11.1	9.3	12.0	6.7	4.3	5.7	2.4	5.1	4.9	12.0	13.7	7.6	4.8	4.4	6.3	11.6	9.4	10.4	10.2	8.6	6.6	18.0	9.6	11.8	10.1	13.6	7.4	10.9	10.4	10.5	23.9	7.1	9.0	6.0	5.0	7.2	10.2	26.9	6.4	7.9	7.0	10.2	5.9	7.3	13.8	9.1	28.7	6.5	12.3	21.8	6.0	4.1	5.3	10.4	12.0	10.6	4.9	9.1	14.8	20.4	7.3	10.3	7.2	6.7	3.5	6.8	11.6	15.6	9.7	7.4	25.2	13.4	20.8	23.7	17.5	10.5	5.3	11.4	2.6	5.7	1.7	3.7	4.6	3.0	12.0	5.1	3.3	4.1	11.5	3.7	2.6	4.3	2.4	2.8	6.7	4.4	4.9	13.6	9.1	12.5	16.0	16.6	12.7	11.5	8.0	8.5	6.6	6.0	9.9	20.3	15.5	10.9	29.2	7.3	10.2	14.7	10.3	0.0	5.9	4.3	3.3	15.5	7.2	5.2	15.8	0.0	15.5	9.5	10.8	17.4	8.1	4.9	12.3	14.3	16.7	1.3	5.7	6.1	1.7	12.4	16.9	17.2	14.2	4.9	16.8	6.2	6.0	6.9	10.4	0.0	12.8	14.0	31.3	11.0	2.9	11.4	10.5	22.0
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150329789-150332721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"adrenal gland: 37.4;parathyroid gland: 11.3"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.8;K-562: 17.5"									"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favorable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	0.4	37.4	0.4	2.6	0.4	1.7	0.8	0.3	0.2	1.1	1.4			1.6	2.0	0.2	1.2	1.9	0.4	0.4	0.3	0.6	1.8	5.6	1.5	3.9	0.3		3.1	3.2	11.3	2.5	0.0		1.5	1.5		1.1	0.9	0.1	2.2	2.1	0.6	0.1	2.3	1.7	0.3			1.8		3.7	1.3	0.8	3.6	1.0	2.8	1.0	2.8	3.5	2.4	4.5	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	6.3	4.7	2.6	2.3	0.0	0.0	1.8	0.0	0.0	0.3	40.8	3.3	3.1	6.7	10.7	1.3	0.0	4.8	0.9	2.4	0.0	0.0	0.1	0.2	9.1	17.5	6.8	0.0	2.0	7.7	1.9	3.0	1.8	0.0	0.0	0.3	5.7	2.1	9.0	8.6	5.0	6.9	1.9	0.3	1.4	0.6	2.1	0.1	0.0	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.0	1.0	1.0	2.7	0.7	3.2	2.2	2.4	3.4	0.7	3.6	3.5	2.9	2.8	2.8	0.2	1.0	2.2	2.4											0.0	1.0	0.0	0.3	0.2	1.0	0.6	5.1	0.0	2.3	1.8	7.9	1.3	5.0	2.1	0.0	0.0	0.9	0.0	11.0	0.7	0.6	0.3	1.1	2.6	0.5	0.0	4.6	0.0	1.6	0.0	2.6	0.0	0.0	3.6	2.0	1.4	19.3	0.0	1.1	0.7	0.5	0.0	0.2	0.5	0.9	0.1	1.6	0.0	2.3	0.5
EBF4	"COE4, KIAA1442, O/E-4, RP5-860F19.3"	ENSG00000088881	"Early B cell factor 4"	Q9BQW3	20	2692878-2760108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 15.9;Cholangiocytes: 17.8;Glandular cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 5.8;SH-SY5Y: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.79e-3)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (2.68e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.87e-3)"	3.8	5.9	8.4	3.7	9.3	0.9	8.8	2.8	13.6	14.9	11.6	10.7	9.5	4.1	19.2	5.4	6.0	8.3	4.8	2.9	9.0	7.3	4.3	1.6	5.0	2.4	9.3	5.3	17.5	5.6	21.8	5.8	5.5	8.4	14.5	2.2	8.8	6.3	14.1	1.9	2.7	5.0	11.9	6.7	3.5	6.2	2.8	10.5	0.6	13.9	0.1	2.0	8.4	13.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	5.0	1.5	0.2	0.2	0.5	1.2	2.3	1.3	0.5	0.2	0.2	0.0	2.1	0.5	3.8	0.3	0.3	0.1	0.6	5.1	4.7	0.0	0.2	0.1	3.1	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.4	1.8	0.0	0.0	0.1	0.6	0.0	5.8	0.7	0.0	0.3	4.2	0.5	0.3	0.0	4.6	2.9	17.2	1.2	0.0	0.7	2.3	2.0	0.2	0.1	0.3	0.5	0.1	2.5	0.6	0.1	0.4	0.0	0.4	2.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	8.4	9.3	2.8	8.6	9.0	7.3	9.3	5.3	8.4	10.5	0.0	0.6	0.0	15.9	3.1	7.0	1.7	17.8	5.3	6.8	1.8	0.0	0.2	0.0	1.8	0.3	2.2	0.0	0.0	0.3	0.0	4.1	12.8	0.0	3.9	0.2	4.8	0.0	6.2	0.3	0.0	3.1	0.3	1.7	0.0	0.1	5.2	0.5	0.0	6.7	0.0	1.9	6.5	3.3	0.2	1.3	0.9	0.2	0.0	0.2	6.4
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 35.0;Ito cells: 55.9;Muller glia cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071906: AB_2732191, HPA075184: AB_2732281"	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favorable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	25.4	13.4	10.7	6.2	13.7	0.8	16.4	8.6	15.1	11.6	8.7	18.4	9.3	10.8	15.5	7.3	11.1	13.3	13.7	16.8	10.9	7.6	14.9	10.1	24.6	5.7	11.2	7.9	13.5	10.9	10.6	8.5	14.4	11.5	9.2	3.9	18.1	12.5	11.6	13.3	8.6	8.3	13.0	9.5	27.1	9.2	5.9	12.6	0.6	13.8	7.5	3.0	9.1	11.9	0.1	0.9	0.1	0.3	0.2	0.6	0.0	8.9	11.8	7.1	10.0	4.7	2.9	7.9	4.5	6.0	11.0	7.2	12.8	3.7	0.2	5.2	5.2	7.3	8.2	5.7	5.2	2.7	3.1	7.5	6.3	10.9	5.1	5.5	0.3	8.9	2.5	7.3	5.7	4.1	3.7	11.1	9.1	4.5	1.1	3.4	20.8	16.0	0.5	5.2	6.9	12.2	8.6	15.2	1.4	7.2	9.1	7.3	7.2	9.5	13.0	7.8	6.4	9.6	2.7	9.4	11.4	10.4	5.5	5.9	1.0	3.8	1.0	3.9	0.2	7.8	0.0	0.3	0.0	0.6	0.1	0.1	0.1	0.3	0.6	0.2	0.1	0.3	0.4	0.1	0.2	0.2	0.9	0.4	0.0	10.7	13.7	8.6	15.1	10.9	7.6	11.2	7.9	11.5	12.6	3.0	2.1	1.4	1.7	7.1	5.8	9.8	2.5	1.4	1.2	8.7	9.8	1.9	3.3	4.4	0.4	35.0	6.8	0.0	4.6	1.6	3.0	2.0	0.0	5.8	2.2	3.2	7.5	55.9	4.0	1.5	7.5	1.1	1.7	3.6	4.0	29.4	5.0	5.8	10.6	2.8	5.8	0.0	5.1	1.7	3.8	6.0	1.8	0.0	4.3	1.6
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	14.0	7.4	33.6	7.0	47.2	8.2	4.2	29.1	53.8	6.9	5.6	17.3	3.0	2.3	18.1	1.9	2.9	7.9	4.1	4.6	24.8	21.4	2.9	2.0	6.9	6.6	15.6	33.7	7.8	5.1	1.8	5.8	5.0	22.3	12.8	3.2	4.4	13.0	13.3	8.5	18.3	6.1	5.5	14.9	24.2	6.1	4.3	15.4	0.0	3.9	0.1	5.2	4.0	5.9	1.8	1.7	0.0	0.5	0.0	0.4	0.3	3.0	0.0	1.9	8.1	0.9	2.1	2.1	2.0	0.9	1.8	0.5	2.4	0.1	1.4	2.0	0.0	0.5	2.5	0.9	0.0	0.0	7.3	3.4	7.9	3.5	0.0	1.2	0.3	4.0	0.0	0.0	1.6	0.0	2.3	1.0	4.3	6.7	0.0	0.3	2.0	0.8	0.1	0.6	0.0	1.1	3.5	0.7	0.1	0.3	0.0	0.5	1.3	0.5	0.0	3.3	0.6	1.5	1.2	4.6	3.3	8.4	0.3	3.8	7.1	0.8	0.0	1.8	3.6	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	33.6	47.2	29.1	53.8	24.8	21.4	15.6	33.7	22.3	15.4	11.9	19.8	5.2	6.1	10.5	22.1	8.9	2.5	1.4	18.2	3.5	0.0	0.4	0.0	1.2	2.4	11.9	0.0	0.0	0.7	0.2	9.6	5.4	7.0	0.0	1.1	22.3	6.9	28.8	7.2	1.7	14.1	10.5	0.0	5.4	3.8	9.7	2.2	1.5	24.1	0.7	13.8	12.9	15.5	1.1	1.5	9.7	0.5	1.0	1.2	1.8
TSEN54	"SEN54, SEN54L"	ENSG00000182173	"TRNA splicing endonuclease subunit 54"	Q7Z6J9	17	75516060-75524739	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 79.7;T-cells: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024543, HPA053097"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024543: , HPA053097: AB_2682043"	"unprognostic (3.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.60e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (2.33e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (2.62e-5)"	"unprognostic (7.26e-3)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.78e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.54e-4)"	6.2	7.9	8.1	9.7	11.0	12.9	7.1	24.6	9.0	8.0	12.4	10.9	8.6	18.9	7.2	6.1	12.8	9.1	27.0	4.9	12.2	5.0	12.3	9.8	9.5	10.4	15.8	9.4	7.3	21.6	7.6	10.7	5.9	11.7	11.0	7.3	4.7	13.6	11.5	7.9	19.5	17.3	7.4	9.5	15.2	17.4	7.4	10.5	10.9	10.4	8.6	13.1	8.5	8.9	4.6	10.5	7.5	3.4	17.0	34.0	9.6	14.9	17.1	4.8	9.7	1.6	1.9	12.7	3.9	2.5	8.0	6.4	20.2	12.3	19.3	5.2	1.5	5.6	13.9	6.2	5.8	3.6	5.1	22.5	14.8	10.5	12.5	4.0	6.0	30.5	2.3	7.5	3.6	3.3	1.8	5.4	12.3	17.4	6.9	2.3	26.0	19.8	17.3	6.5	14.4	17.1	14.6	15.2	14.3	4.3	8.3	16.3	12.6	8.6	23.2	6.2	6.7	16.5	8.6	2.6	8.5	13.4	10.6	8.2	17.0	7.8	10.3	4.7	19.7	3.9	7.5	1.6	5.0	34.0	3.4	22.5	4.6	13.8	25.2	3.9	2.9	11.1	21.2	0.2	17.0	3.2	10.5	7.7	9.6	8.1	11.0	24.6	9.0	12.2	5.0	15.8	9.4	11.7	10.5	8.9	8.1	6.7	11.3	23.5	13.9	2.0	10.2	2.7	7.9	8.7	3.9	10.6	10.0	14.6	4.6	8.7	16.8	0.0	15.1	14.6	8.9	7.7	79.7	7.7	11.2	30.2	18.0	6.2	4.6	4.2	4.4	4.5	15.1	17.2	15.7	15.2	12.5	16.7	7.1	9.8	6.8	12.9	8.7	15.8	26.0	21.2	6.3	62.1	19.6	7.3
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766337-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.2"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		NA	NA		790000	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (8.74e-4)"	27.1	16.5	23.3	9.2	30.1	4.5	17.8	27.5	56.7	19.2	12.6	21.0	5.5	6.7	17.6	16.5	9.7	17.6	12.4	32.1	26.3	32.0	14.0	17.0	14.9	9.6	30.5	26.6	26.0	8.4	9.7	8.7	21.5	43.1	13.9	7.4	11.9	8.3	22.0	72.2	6.7	8.0	20.8	31.9	12.5	8.0	7.6	13.3	3.0	7.3	6.9	7.0	10.7	7.7	7.2	10.7	9.4	15.1	8.8	8.9	8.4	2.3	23.0	8.7	10.8	46.3	29.0	2.6	19.0	22.3	9.6	13.8	1.6	2.9	8.3	46.1	33.0	7.2	3.7	11.9	12.9	8.0	19.4	9.3	3.6	5.5	2.3	12.5	6.0	6.9	27.3	4.2	7.1	13.5	15.0	11.2	6.6	2.4	22.0	12.0	4.9	5.3	8.8	3.6	1.9	12.5	5.3	7.1	11.4	9.4	1.5	11.6	5.9	7.4	6.4	8.5	6.7	1.8	10.4	13.2	14.2	4.4	18.4	13.6	18.7	30.9	8.1	17.8	12.1	10.7	9.4	11.2	7.6	8.8	9.9	7.8	6.4	8.2	8.9	10.7	7.2	8.3	8.5	2.8	8.8	15.1	7.8	5.9	8.4	23.3	30.1	27.5	55.2	26.3	32.0	30.5	26.6	43.1	13.3	14.9	8.5	4.5	2.7	2.7	23.3	35.5	12.7	1.4	7.9	12.2	17.7	8.7	5.0	4.0	0.3	11.4	3.4	0.0	4.5	3.8	12.3	3.3	7.0	22.1	9.1	49.3	8.1	14.7	16.2	1.5	19.2	4.7	10.1	9.0	2.4	16.9	3.8	2.9	28.3	9.7	15.5	0.0	9.0	1.5	5.1	1.1	11.3	4.4	3.0	1.1
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell type enhanced"	"Detected in many"	19	"Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved					NA	NA					"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.0	6.0	1.0	7.1	1.1	0.1	1.1	8.3	0.5	0.5	5.5	0.1	3.7	6.2	0.2	23.0	0.0	0.6	0.0	0.6	0.2	0.4	1.6	0.1	0.8	21.7	0.0	9.7	8.4	0.2	0.6	0.2	16.3	7.8	2.1	0.0	24.6	0.0	0.2	0.5	0.2	0.5	3.5	4.1	3.3	0.0	0.7	0.0	17.6	1.6	4.1	0.0	0.8	4.6	2.6	0.2	0.2	0.0	0.1	2.3	0.2	0.0	4.2	7.8	0.2	5.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1	3.0	8.6	1.5	3.1	2.3	5.0	1.4	0.0	0.0	3.4	7.0	0.0	1.0	66.3	1.4	0.3	3.6	0.0	0.0	1.0	2.1	11.5	3.7	6.9	26.6	120.5	11.1	12.7	21.5	7.6	0.9	3.7	13.5	20.3	13.6	0.0	38.4	4.0	0.0	6.7	271.8	1.4	0.0	4.1	0.9	7.0	1.6	1.8	2.2	0.0	2.3
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 15.5;U-698: 24.3"					"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.3	0.7	2.2	0.1	0.2	7.1	5.9	1.5	5.3	6.3	5.3	0.0	0.0	3.2	4.5	0.6	0.0	0.2	0.0	1.4	3.7	4.3	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.2	0.1	3.2	1.0	0.3	1.2	2.6	9.0	7.8	2.3	0.1	15.5	4.1	3.4	0.3	1.4	1.5	0.0	9.2	0.0	0.9	4.2	4.2	0.0	2.3	0.3	3.1	2.9	0.0	2.0	0.0	0.0	24.3	0.1	2.7	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0	0.0	1.7	0.9	7.8	6.1	11.5	62.0	2.5	2.7	1.2	0.0	25.5	5.6	0.0	2.8	0.5	3.5	1.4	0.0	3.5	5.6	3.0	2.2	0.0	1.0	3.2	6.4	4.6	4.3	2.1	1.5	3.7	5.3	5.0	3.6	3.8	11.2	2.6	0.0	2.8	1.3	19.8	0.0	3.8	12.9	25.5	6.6	3.3	1.9	3.1	3.9
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 71.6"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 14.4;Ciliated cells: 8.1;Ito cells: 6.2;Rod photoreceptor cells: 12.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Group enriched"	"Detected in many"	25	"NK-cells: 1.5;T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"AF22: 16.1;NTERA-2: 8.2;RH-30: 11.4;SCLC-21H: 19.6;SH-SY5Y: 19.0;U-2 OS: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced					NA	NA					"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.3	5.8	42.8	2.6	36.7	2.5	2.0	40.1	71.6	2.3	3.5	5.1	0.4	2.5	4.4	2.2	3.3	7.9	2.8	3.3	40.8	14.8	1.6	1.7	3.0	2.6	9.9	24.9	1.7	2.6	1.5	7.4	1.2	9.0	4.5	2.3	1.8	4.3	10.5	3.6	4.8	3.3	5.0	7.0	7.0	2.3	3.4	6.4	0.0	1.6	0.0	1.6	2.4	1.4	0.0	0.0	0.0	0.0	1.5	3.5	0.6	0.0	1.0	16.1	4.1	0.0	0.1	0.0	0.4	0.0	0.5	0.5	0.4	0.0	0.0	0.2	0.0	5.2	0.1	2.9	0.0	0.1	0.0	0.5	0.0	1.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.1	0.1	0.5	8.2	0.0	0.2	0.0	11.4	0.0	0.0	0.0	19.6	19.0	0.8	0.0	5.7	5.7	1.8	0.1	0.0	0.0	9.5	0.2	1.1	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	3.5	0.0	0.8	0.0	1.5	2.0	0.0	0.0	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.6	42.8	36.7	40.1	49.2	40.8	14.8	9.9	24.9	9.0	6.4	0.0	0.0	0.0	0.0	0.2	14.4	1.4	0.0	8.1	2.3	0.0	5.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.3	1.1	0.0	0.0	1.6	1.7	6.2	1.0	0.0	0.6	0.0	3.3	0.0	0.0	2.5	0.5	0.0	3.5	0.0	12.9	0.0	1.7	0.2	3.4	0.6	0.0	3.2	0.0	0.1
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 15.8;Intestinal endocrine cells: 19.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.2	17.1	0.0	10.2	0.0	12.4	0.5	3.0	3.0	3.8	12.7	0.3	0.0	1.4	2.1	3.1	0.0	9.6	0.2	2.9	0.1	2.7	0.0	0.2	13.7	3.0	0.0	4.2	3.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.8	0.0	0.4	16.9	0.1	0.0	2.8	5.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	36.5	27.1	1.6	10.4	0.0	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1	0.0	0.0	0.0	0.9	0.3	0.9	0.6	2.5	0.0	0.0	0.0	3.9	5.3	5.0	0.8	0.3	0.0	0.2	0.0	3.4	7.0	1.9	1.7	0.0	15.8	0.9	0.0	19.5	0.0	1.3	0.0	0.6	0.0	3.3	0.0	1.3	1.8	2.8	0.0	2.8	2.1	0.0	0.0	0.9	0.3	0.4	0.3	1.9	0.0	2.0	0.5
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412598-9435578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 46.5"									"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	14.7	12.1	11.0	21.5	12.5	12.8	17.6	19.0	10.0	21.8	15.7	13.1	9.6	8.6	17.2	55.8	12.7	14.6	12.8	11.7	8.2	5.4	10.9	10.4	15.8	21.0	14.5	4.9	18.9	11.2	12.5	19.8	13.0	11.4	23.8	15.7	14.4	14.4	13.5	9.3	19.1	20.8	17.0	10.9	31.3	13.5	13.0	11.4	34.6	20.8	7.3	23.4	14.4	14.2	6.9	3.8	5.6	5.5	12.6	13.0	5.1	10.8	2.8	8.1	15.3	5.8	11.3	6.5	12.0	10.2	9.9	16.6	5.8	4.7	12.1	7.7	5.9	3.7	4.1	10.2	6.4	11.9	3.4	16.8	16.6	14.8	8.5	5.2	9.5	10.2	10.7	8.8	5.4	8.3	9.9	8.0	14.5	8.6	0.1	9.2	1.0	13.8	46.5	8.4	4.9	9.1	6.2	8.4	8.4	7.8	13.5	6.9	10.8	5.5	6.5	6.7	8.4	4.8	7.3	7.2	9.3	3.6	14.0	6.1	19.8	26.3	14.4	2.9	9.1	7.0	4.8	4.1	5.6	13.0	4.8	8.5	6.0	7.2	9.2	3.3	6.9	10.6	10.2	3.6	12.6	5.5	3.8	8.7	5.1	11.0	12.5	19.0	10.0	8.2	5.4	14.5	4.9	11.4	11.4	0.0	11.0	14.5	6.3	3.5	8.1	5.0	2.5	4.0	7.9	3.5	11.8	3.8	3.3	4.8	0.7	5.2	6.2	23.3	3.2	2.7	4.7	6.2	11.5	2.5	4.2	7.9	9.1	12.3	11.7	1.4	5.8	7.9	5.0	8.2	6.4	4.3	3.4	5.1	4.2	1.1	9.3	6.5	5.6	3.5	7.8	4.1	3.9	14.1	6.3	5.4
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 28.4;U-266/70: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: AB_2683638"	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	5.4	14.7	24.7	6.0	23.6	6.4	3.7	20.3	34.0	4.6	5.4	4.1	6.1	4.6	5.9	3.7	3.9	6.2	5.4	6.8	22.0	17.5	6.1	12.4	7.3	6.5	12.3	17.1	9.3	11.0	11.4	9.1	8.9	9.0	7.9	1.6	8.5	12.6	11.6	11.4	6.8	3.6	4.6	4.6	7.7	6.5	19.6	6.9	4.8	6.6	3.2	3.8	4.8	4.6	1.3	6.0	5.6	4.8	3.2	3.6	1.7	11.4	3.3	1.7	6.7	2.2	0.7	18.1	2.3	3.2	2.5	3.3	2.9	7.9	0.8	3.2	1.8	4.0	1.6	1.6	4.0	0.5	13.5	11.1	3.7	5.0	4.9	7.3	0.2	5.3	2.1	2.5	4.3	0.5	4.0	1.9	6.6	3.3	6.6	1.0	0.6	4.5	0.6	3.2	1.9	28.4	6.8	5.3	3.3	2.2	1.1	2.1	11.3	5.2	1.7	7.2	1.5	7.2	6.6	1.1	2.4	5.2	12.0	4.1	21.7	16.3	4.1	8.0	4.5	2.1	0.1	4.8	5.6	2.5	3.7	1.7	0.7	3.6	2.1	6.0	1.3	2.9	2.6	3.0	3.2	4.0	2.9	2.5	1.7	24.7	23.6	20.3	34.0	22.0	17.5	12.3	17.1	9.0	6.9	0.0	2.2	3.0	4.6	3.4	51.4	1.8	7.6	0.0	3.4	7.0	17.7	15.8	6.6	12.4	114.8	3.6	0.5	0.0	7.5	7.4	7.3	5.2	4.6	12.5	19.9	68.3	6.9	1.8	7.6	221.4	11.5	6.0	1.7	26.2	3.1	27.9	7.4	2.9	24.1	7.8	30.3	6.5	3.5	18.4	1.4	3.6	20.7	3.8	1.4	2.8
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.8	0.8	11.9	4.6	5.1	1.7	1.1	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.7	1.2	1.1	0.4	0.7	1.0	3.5	6.2	0.5	1.0	0.7	0.1	2.3	2.9	1.4	1.0	0.5	2.4	20.9	3.4	0.5	0.6	2.0	0.4	1.0	0.8	5.4	0.1	1.4	7.4	2.6	0.3	0.4	0.3	6.1	7.9	1.1	0.5	1.0	3.1	1.3	1.0	9.7	2.0	2.9	3.0	0.4	5.0	0.9	5.1	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6	0.0	3.2	1.7	0.8	1.4	4.2	15.3	2.5	0.0	1.2	0.0	19.6	0.2	0.0	0.3	0.5	3.1	0.3	0.0	0.4	0.4	2.1	0.5	0.0	2.4	0.3	6.4	0.0	4.9	1.6	2.1	5.2	0.0	1.7	0.0	0.0	1.7	0.4	0.0	2.5	2.7	6.9	0.0	2.0	2.8	1.1	0.9	0.1	0.0	0.2	0.5
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.9;intestine: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	2.3	0.3	4.3	0.3	13.9	0.0	1.1	2.3	7.3	0.1	0.7			12.5	0.6	0.3	0.7	3.9	2.5	3.9	2.3	6.9	0.6	1.0	9.4	0.9	2.3		0.0	0.6	0.2	3.5	12.2		0.5	0.9		3.3	11.3	2.9	4.6	16.0	1.1	1.1	0.6	2.7	0.9			1.6		0.4	0.7	0.0	1.6	0.1	0.0	0.1	0.0	0.5	0.3	0.0	5.0	2.8	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.7	0.1	1.0	0.0	2.9	0.3	3.7	0.5	0.1	0.0	4.7	1.1	0.0	9.9	0.0	0.0	1.4	0.0	1.1	0.0	0.2	0.2	0.1	0.7	16.8	7.6	0.0	0.1	0.1	0.1	3.4	1.2	0.4	0.0	0.2	0.0	0.8	0.7	0.7	2.1	0.1	0.0	0.1	1.2	0.0	0.1	2.0	0.0	3.3	0.1	0.2	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3											0.0	0.0	0.0	0.4	0.2	10.3	1.6	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.5	0.8	3.6	2.0	0.0	0.2	1.0	0.2	0.7	0.0	0.6	0.0	17.5	15.0	3.1	0.8	0.4	0.0	0.0	1.7	1.8	2.7	0.2	1.4	1.7	0.0	0.3	2.7	19.4	5.7	0.2	0.2	0.6	1.1	0.0	0.8	0.4
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	5.0	6.7	6.1	2.5	8.4	8.5	7.1	3.7	10.7	3.9	4.5	8.3	4.7	5.6	3.9	4.5	1.5	2.7	1.1	10.4	0.7	8.4	4.5	2.3	13.4	8.4	8.2	1.3	3.0	12.3	6.6	2.5	3.1	8.3	9.5	7.4	1.9	6.2	6.3	4.4	4.8	9.5	2.1	5.8	1.2	7.4	5.6	3.0	10.8	7.0	1.4	5.4	4.7	9.4	5.1	4.6	8.4	7.3	1.4	1.8	3.3	3.3	0.0	3.5	2.0	1.2	4.1	4.0	9.9	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1	6.0	23.4	12.3	13.7	19.3	40.6	20.7	15.3	6.7	10.3	15.7	45.2	59.8	24.9	16.7	6.9	12.0	18.0	0.0	6.5	29.6	13.1	4.5	19.7	52.9	21.0	44.5	15.6	20.3	11.9	31.3	17.0	13.3	20.3	14.4	15.1	18.9	8.5	21.8	13.1	29.4	37.0	6.5	10.1	4.2	4.7	17.7	49.4	23.3	19.8	7.8
COG8	"DOR1, FLJ22315"	ENSG00000213380	"Component of oligomeric golgi complex 8"		16	69320140-69339583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	91	"Cytotrophoblasts: 13.0;Extravillous trophoblasts: 7.7;Hofbauer cells: 8.0;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA041406	Approved					NA	No					"HPA041406: AB_2677459"	"unprognostic (4.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (3.12e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.47e-7)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.35e-2)"	10.6	22.9	11.3	11.0	13.9	7.3	11.9	15.1	18.5	13.3	11.0	20.5	11.9	10.4	15.2	18.4	11.2	16.1	12.1	12.9	10.9	12.3	13.2	16.9	11.2	10.6	16.6	9.3	15.5	14.2	23.6	12.7	8.9	12.4	11.9	9.5	14.3	16.7	13.0	23.2	18.7	12.7	11.3	9.1	11.5	12.0	26.4	15.6	20.0	14.3	8.6	14.1	14.0	10.9	15.1	14.8	26.2	16.5	14.6	16.9	12.3	7.0	13.6	6.9	12.2	13.1	9.7	8.6	9.1	9.0	11.7	9.6	13.6	9.8	9.2	12.7	11.9	5.5	12.2	13.7	12.2	6.8	5.7	11.6	7.8	8.7	16.4	11.0	6.2	6.7	13.0	10.5	13.0	5.7	10.3	12.6	7.7	15.2	1.7	8.2	21.1	8.1	15.9	15.7	8.9	12.8	12.9	4.8	15.4	12.3	4.8	10.9	15.1	17.6	6.9	8.6	9.2	15.3	7.6	10.5	8.2	7.6	6.4	6.7	19.0	13.5	16.0	8.7	7.5	8.7	26.2	16.5	16.1	14.6	15.0	16.9	10.1	16.4	14.6	14.8	15.1	15.0	13.7	15.4	14.6	13.0	8.7	16.2	12.3	11.3	13.9	15.1	18.5	10.9	12.3	16.6	9.3	12.4	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6"	"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.9	1.9	15.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	28.9	0.0	0.0	5.9	9.6	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	8.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1	0.0	0.0	0.0	0.0	1.3	16.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	1.2	0.0	0.0	0.0	0.0	0.2	3.3	4.6	8.1	0.1	0.0	10.4	0.6	0.0	13.2	7.8	0.0	0.0	0.0	0.3	0.8	0.7	0.0	24.4	0.8	1.0	25.8	16.5	1.8	4.5	3.0	0.0	0.0	0.0	0.5
TP53I13	DSCP1	ENSG00000167543	"Tumor protein p53 inducible protein 13"	Q8NBR0	17	29566052-29573157	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 41.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.50e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-2)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.92e-2)"	28.2	10.4	10.2	19.4	10.5	19.6	24.2	4.8	8.2	17.9	17.6	9.3	14.7	27.3	16.3	17.3	9.7	10.2	17.4	28.5	9.8	5.3	20.4	30.2	14.6	22.9	13.8	5.6	16.1	33.3	8.7	30.2	21.9	8.8	17.1	5.6	11.2	15.4	13.9	14.5	8.8	27.1	15.7	10.3	24.3	25.1	33.5	12.0	13.3	18.9	7.3	12.4	15.2	16.3	9.7	41.6	16.8	5.3	9.4	10.6	5.1	9.7	26.6	8.2	23.3	14.0	9.6	14.9	16.2	7.5	10.0	10.8	11.0	4.0	6.8	17.9	10.0	14.2	23.9	3.8	4.8	1.4	29.5	14.3	4.1	26.5	10.0	12.5	6.8	12.6	8.3	6.9	8.8	3.1	6.9	6.0	14.3	5.9	12.7	4.4	15.9	16.7	27.4	3.5	11.5	10.0	31.7	19.5	24.0	9.2	6.4	3.6	11.7	20.3	7.6	7.7	3.1	22.0	29.1	6.8	9.9	15.1	10.5	12.7	26.3	11.5	5.4	17.5	4.2	11.6	16.8	4.3	7.4	10.5	5.3	10.6	9.3	10.2	7.9	9.6	9.7	8.1	7.2	0.3	9.4	3.5	41.6	9.1	5.1	10.2	10.5	4.8	8.2	9.8	5.3	13.8	5.6	8.8	12.0	0.0	4.8	25.1	34.4	12.2	0.6	24.5	7.6	2.7	5.7	38.4	5.9	41.8	6.6	32.4	9.4	11.3	28.2	0.0	25.0	31.8	50.5	24.6	16.1	17.4	24.6	6.4	19.1	10.4	10.5	5.7	31.9	29.3	28.7	33.3	26.3	19.3	27.3	28.8	17.7	14.9	6.8	19.4	15.6	62.6	38.7	6.5	18.9	27.7	26.9	31.5
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Cell type enriched"	"Detected in many"	14	"Proximal tubular cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No			"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8.0	7.8	5.6	7.5	2.1	12.3	10.0	12.4	6.9	4.6	6.1	9.0	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8.0	7.0	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9	3.0	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4.0	6.8	5.2	5.9	0.8	23.2	1.4	1.0	2.5	6.4	0.0	1.0	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0.0	0.0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3.0	1.9	0.7	2.6	4.1	0.3
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377205-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Ito cells: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	5.5	8.6	2.1	1.1	2.9	14.7	2.6	1.3	1.7	3.9	3.3	2.8	13.3	1.0	3.6	11.6	2.4	3.2	1.8	11.2	1.9	1.4	12.1	8.4	8.5	6.9	1.9	1.6	1.9	9.2	28.1	5.2	12.7	2.3	3.1	1.4	3.3	8.7	18.3	2.0	1.1	1.7	1.5	4.0	8.0	3.7	2.2	1.0	1.6	21.5	1.0	1.5	1.9	2.1	2.6	2.5	12.2	7.7	0.9	4.8	2.9	3.5	1.2	3.5	4.1	5.4	3.4	2.1	2.2	6.8	3.6	4.6	1.2	1.3	2.4	3.9	4.0	5.0	0.9	2.7	1.4	4.2	2.0	1.6	13.1	1.1	2.0	3.8	2.7	5.5	2.5	0.5	4.8	3.3	8.4	8.3	5.1	11.6	11.7	4.0	3.1	2.5	3.3	1.9	1.9	9.4	6.7	6.0	5.3	3.3	1.8	1.4	11.0	1.4	2.0	6.1	3.9	3.6	4.7	3.4	1.9	2.7	6.5	2.0	6.0	4.3	2.6	10.5	2.7	2.0	8.1	4.2	3.3	2.1	5.1	4.5	2.6	4.2	3.1	2.5	1.6	4.8	2.8	12.2	0.9	7.7	0.1	3.7	2.9	2.1	2.9	1.3	1.7	1.9	1.4	1.9	1.6	2.3	1.0	17.9	16.8	5.3	3.5	2.1	2.5	5.1	7.6	2.7	4.5	19.2	0.0	1.8	3.3	2.0	0.7	6.5	0.3	70.0	2.9	11.5	7.6	2.4	26.5	1.9	32.5	1.6	8.1	78.5	15.6	0.0	2.6	3.1	8.5	1.0	2.3	11.1	3.8	0.0	3.9	0.8	2.2	19.4	20.8	3.3	6.4	0.9	2.5	8.7	1.4	1.1
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946696	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	14.5	9.6	14.4	21.5	13.6	30.7	9.9	23.5	19.7	8.6	8.3	11.9	3.1	9.2	10.3	7.9	7.7	8.8	9.9	12.4	10.5	9.8	8.6	7.9	14.2	25.8	12.5	8.5	12.4	11.0	8.5	8.3	10.1	12.6	7.9	6.3	8.0	10.2	7.6	40.6	8.6	12.7	8.8	9.3	25.9	9.2	5.5	12.9	15.7	9.4	5.9	21.1	10.7	7.7	3.0	4.8	3.9	6.2	2.0	3.9	3.0	5.9	11.5	8.9	8.9	5.3	5.2	9.3	5.8	6.4	9.3	8.8	6.9	6.9	15.0	10.0	3.9	7.1	10.6	8.0	5.4	4.2	13.7	7.2	13.2	12.0	6.6	7.4	13.8	26.9	4.7	9.5	8.7	9.4	7.8	6.6	16.5	14.0	8.5	5.3	12.3	16.7	12.8	12.3	7.1	11.2	18.0	6.0	8.5	4.5	8.9	10.6	13.0	6.2	14.7	8.3	9.3	10.6	34.2	6.8	10.1	9.8	8.3	9.3	25.7	18.0	19.8	6.9	10.9	12.0	2.5	3.8	1.1	3.3	6.2	3.9	2.9	2.6	1.9	3.7	3.0	1.3	2.8	3.9	2.0	4.9	4.8	1.7	3.0	14.4	13.6	23.5	19.7	10.5	9.8	12.5	8.5	12.6	12.9	8.9	13.0	8.3	3.2	4.1	20.5	18.1	12.7	4.0	5.7	7.0	5.9	3.8	5.0	4.4	1.2	10.9	4.3	23.3	5.5	4.0	4.9	4.5	17.3	8.3	15.5	33.4	4.7	11.1	26.6	0.4	6.9	22.4	5.0	6.4	4.8	6.1	5.6	3.5	7.4	2.3	16.9	6.5	5.0	5.4	8.9	3.0	2.9	14.9	6.3	4.3
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	7.7	29.1	13.9	5.6	10.5	2.3	6.4	3.8	30.0	5.7	8.1	7.1	9.4	14.6	4.9	8.4	6.5	6.9	5.5	30.5	13.2	10.0	6.4	6.3	11.9	2.9	11.3	15.0	22.4	13.6	10.9	5.5	4.9	15.5	23.8	5.4	6.9	13.7	9.7	49.7	3.3	8.3	7.4	6.8	3.4	13.6	6.5	5.5	0.4	10.6	10.8	3.3	7.7	7.8	1.2	2.6	3.5	6.5	2.4	3.0	1.2	4.4	3.9	2.9	5.9	2.3	4.6	14.2	6.3	2.4	4.1	3.6	18.4	3.0	5.0	15.1	3.7	9.6	5.4	3.0	1.8	1.5	1.7	4.4	4.7	16.6	21.4	6.2	1.1	4.6	5.8	2.7	3.8	1.2	4.4	2.7	2.7	6.8	2.7	5.2	6.9	1.7	4.7	1.2	4.8	10.0	5.3	7.6	8.6	3.7	3.4	18.6	5.2	14.6	16.3	6.4	3.3	20.7	5.7	2.2	5.0	7.1	6.5	7.0	10.2	4.2	9.1	9.8	2.2	2.1	0.0	2.7	3.5	0.8	2.5	1.9	0.5	1.3	0.7	2.6	1.2	1.0	0.3	0.1	2.4	6.5	0.1	3.0	1.2	13.9	10.5	3.8	30.0	13.2	10.0	11.3	15.0	15.5	5.5	14.9	39.2	3.4	5.1	2.7	16.0	27.9	5.1	4.0	5.7	5.2	7.9	16.1	28.2	3.2	75.4	2.9	30.8	0.0	6.5	21.8	7.5	16.3	3.5	6.6	7.6	7.9	19.1	2.5	4.0	41.0	24.5	5.4	11.8	1.8	16.2	17.7	5.0	13.3	22.3	9.2	15.9	6.5	14.7	14.0	14.7	2.8	17.3	5.1	19.1	8.2
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770547-74776367	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	9.4	31.6	20.1	11.3	17.8	11.8	13.5	20.0	20.6	13.6	11.2	9.9	21.7	8.0	11.6	24.5	9.1	16.8	12.9	11.3	18.4	12.1	12.9	16.6	10.5	12.0	18.1	17.8	21.5	14.5	18.5	25.1	13.8	23.1	15.8	9.9	11.6	18.1	13.2	9.5	10.9	8.5	11.2	17.0	12.1	11.2	12.2	20.7	7.9	14.9	7.0	10.8	11.3	10.3	19.6	13.7	9.7	16.7	10.9	21.5	8.4	9.5	13.9	8.9	8.1	14.6	18.3	10.7	18.1	16.2	19.4	16.8	24.0	10.6	26.1	7.0	14.5	12.5	10.5	12.0	20.1	12.5	5.4	18.0	16.7	10.3	21.3	17.0	8.6	10.8	16.7	15.0	19.3	29.5	16.2	21.1	16.9	20.8	8.3	14.1	9.1	17.2	7.0	6.9	18.6	20.4	11.5	26.2	15.1	14.0	15.6	12.8	17.1	7.6	22.5	35.1	12.8	20.9	11.6	12.1	22.4	18.2	9.7	17.1	11.5	4.1	14.6	9.3	5.9	14.2	9.7	11.5	4.6	6.9	16.7	13.7	14.0	12.3	10.1	13.7	19.6	21.5	15.5	2.9	10.9	9.4	10.3	6.5	8.4	20.1	17.8	20.0	20.6	18.4	12.1	18.1	17.8	23.1	20.7	6.0	12.6	22.2	30.8	31.1	35.9	5.0	5.1	5.3	6.8	17.4	45.2	18.9	6.6	13.9	4.5	17.4	10.0	0.0	17.0	16.5	18.5	26.9	1.1	8.5	15.7	42.9	25.3	7.4	8.3	2.9	27.3	15.2	10.1	19.0	12.9	12.4	16.5	16.9	15.9	9.8	39.2	6.5	18.6	17.9	24.3	26.0	18.5	12.9	16.4	31.4
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 165.2;Horizontal cells: 208.2;Rod photoreceptor cells: 212.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BJ: 13.3;fHDF/TERT166: 24.1;hTERT-RPE1: 11.8;SCLC-21H: 11.2;U-138 MG: 31.3;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced					NA	NA		2100000			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	4.9	8.7	21.1	3.9	25.9	0.6	3.8	22.3	37.3	4.6	7.8	49.6	1.1	5.1	9.1	10.4	11.3	12.0	6.6	17.4	19.5	10.8	10.7	2.4	5.7	2.6	27.9	25.2	11.9	6.4	1.6	11.7	11.2	28.7	8.7	6.8	8.1	2.6	18.4	3.3	4.2	5.6	15.3	17.5	6.8	5.3	2.0	34.0	0.0	3.0	0.2	3.4	8.9	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.2	0.4	0.0	13.3	0.0	9.7	2.9	0.0	0.0	0.0	0.0	24.1	9.1	6.3	0.2	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	6.1	0.3	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.1	0.0	1.1	0.0	0.0	0.0	11.2	0.6	0.0	0.7	0.0	1.0	0.1	0.0	0.0	31.3	6.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	7.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	25.9	22.3	35.0	19.5	10.8	27.9	25.2	28.7	34.0	0.0	1.1	0.0	1.5	1.9	165.2	19.5	0.0	0.0	1.2	0.0	11.8	0.3	0.0	0.2	5.3	4.9	0.0	0.0	0.0	0.2	10.1	1.0	0.0	2.0	0.4	208.2	36.4	2.5	0.6	9.7	6.1	0.0	1.7	0.0	4.8	12.0	0.8	0.0	5.3	1.4	212.3	51.8	51.4	1.9	3.2	4.1	0.6	0.0	0.9	0.7
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088710-2135898	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.3"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		120000			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	4.5	4.6	2.6	2.3	3.6	1.5	1.4	45.3	7.9	2.8	5.1			1.8	5.4	0.7	2.6	3.4	1.8	7.1	3.5	4.2	0.7	0.6	2.2	1.3	1.9		6.8	3.3	1.2	11.3	1.7		3.7	0.4		4.3	5.4	18.0	7.8	2.8	3.3	1.5	2.7	2.6	2.2			1.0		0.3	3.1	1.8	0.1	0.1	0.0	0.1	0.0	0.4	0.7	3.0	6.5	3.6	8.2	6.3	6.9	7.1	10.6	4.4	3.1	3.1	5.9	2.3	4.6	6.8	5.4	3.3	7.7	1.0	1.6	1.2	5.4	5.3	2.8	16.7	2.3	12.6	3.9	5.9	6.4	5.3	5.7	3.5	4.3	2.4	4.9	4.1	4.7	2.0	5.0	5.5	11.9	3.3	1.2	5.0	15.7	5.9	6.8	1.6	2.1	15.2	17.0	9.6	6.4	6.6	1.4	5.2	13.4	5.4	9.8	8.0	7.3	7.7	6.9	3.1	5.1	5.5	3.7	6.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.7											11.9	13.5	4.6	8.8	21.6	62.9	21.4	5.1	18.7	7.9	8.7	39.3	5.1	8.3	4.7	53.2	15.2	8.6	0.0	2.7	2.9	19.8	8.0	8.1	21.3	4.5	112.8	29.3	14.1	7.3	8.2	25.6	7.4	21.9	3.6	11.8	30.3	3.7	2.9	43.2	7.3	34.4	32.3	21.7	11.4	15.3	17.6	2.6	6.9	13.4	5.4
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria		Yes	No			Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	14.9	0.1	13.3	12.1	0.1	16.3	20.5	0.4	0.4	0.0	6.3	0.0	0.0	21.4	0.0	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.5	0.0	14.1	0.1	0.0	19.1	5.2	12.8	0.1	20.2	17.3	0.0	0.0	0.1	48.1	0.0	0.0	0.2	34.7	0.9	0.1	4.0	26.6	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	27.9	7.6	0.0	3.8	18.4	19.6	11.5	0.1	0.0	0.0	0.0	16.8	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7	14.9	5.4	4.4	13.8	3.8	11.2	22.2	7.6	2.7	15.9	31.4	7.9	1.0	3.3	8.0	0.1	13.0	0.0	0.0	1.8	0.4	20.2	13.8	2.3	0.4	3.6	1.6	8.7	16.0	2.1	0.4	22.5	4.0	5.0	11.8	2.2	7.0	3.1	0.0	23.0	4.2	9.7	58.2	26.4	1.4	1.1	2.6	4.2	2.5	1.2	6.2
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	12.9	19.7	25.9	25.0	29.3	22.3	17.8	22.1	35.8	10.2	15.9	26.1	10.0	26.3	13.7	6.3	16.4	12.6	14.0	12.0	22.6	19.1	17.1	13.7	30.4	17.6	36.3	19.2	12.5	14.2	15.6	21.6	13.9	29.2	13.4	8.9	15.8	13.7	14.3	27.0	15.3	28.7	14.5	23.5	28.3	12.2	31.3	33.0	7.1	14.7	6.1	8.8	15.9	14.7	3.8	7.3	21.8	19.0	5.0	3.9	4.1	13.2	31.9	6.3	15.2	11.0	16.0	14.5	17.2	17.7	13.4	12.4	7.4	18.3	10.9	29.3	22.2	8.3	17.0	5.3	16.2	6.9	26.6	12.3	7.2	17.0	5.6	12.7	8.0	22.5	13.8	9.4	17.2	10.0	21.3	26.4	13.0	5.9	15.1	11.9	6.2	8.8	10.5	6.9	6.2	29.3	7.1	3.8	12.8	11.9	12.6	8.0	13.9	14.6	6.6	18.7	8.9	5.9	11.5	27.9	16.3	9.6	22.3	18.0	17.9	11.5	4.8	27.4	9.5	15.2	7.9	6.1	21.8	3.5	12.1	3.5	3.8	2.5	3.8	7.3	2.8	2.2	2.9	1.9	5.0	19.0	2.4	3.9	4.1	25.9	29.3	22.1	35.8	22.6	19.1	36.3	19.2	29.2	33.0	6.0	11.8	6.5	2.7	4.2	10.9	8.6	17.8	8.1	6.8	31.4	25.5	14.9	1.7	13.7	60.0	10.8	52.1	0.0	6.1	12.2	4.1	4.5	11.5	19.2	24.9	20.6	16.7	10.4	55.8	82.5	8.9	23.8	8.5	10.0	13.4	10.6	8.4	12.9	7.1	17.0	16.2	0.0	6.2	58.2	10.0	4.8	10.4	10.0	14.0	3.1
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 178.4;Late spermatids: 342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HSkMC: 16.2;TIME: 15.2"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA					"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.2	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.7	2.2	1.6	0.7	1.1	1.9	2.3	1.6	2.5	15.2	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	11.5	6.9	2.9	2.8	4.5	1.6	5.0	1.4	4.6	1.7	0.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	2.9	0.8	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7	3.0	21.9	3.0	19.5	15.9	9.2	3.0	0.0	5.3	9.1	7.0	5.9	1.6	1.7	3.0	178.4	13.0	1.0	0.0	2.8	59.8	10.3	5.3	33.5	3.0	13.8	7.9	13.8	16.5	57.3	342.9	13.0	14.6	8.5	1.8	1.9	3.8	5.2	14.4	6.7	2.1	6.0	6.5	4.6	2.8	9.6	18.6	7.2	8.7	1.6	9.6
B4GAT1	"B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT"	ENSG00000174684	"Beta-1,4-glucuronyltransferase 1"	O43505	11	66345372-66347692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 71.1;Horizontal cells: 149.4;Muller glia cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015484	Uncertain				"Intracellular and membrane"	NA	NA		48000000			"HPA015484: AB_1845235"	"unprognostic (1.80e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.43e-3)"	"prognostic favorable (3.55e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.76e-3)"	8.3	24.8	29.3	3.6	47.1	1.0	5.4	28.5	69.5	7.8	6.5	11.8	4.2	9.5	10.0	9.5	5.2	10.5	6.0	19.6	33.3	57.9	15.0	9.7	9.7	3.7	24.7	32.0	18.9	12.8	11.9	15.6	12.9	31.0	10.2	4.9	10.1	9.1	14.2	12.9	5.8	7.2	8.5	13.2	5.1	7.7	4.4	11.6	1.1	10.7	1.7	2.8	5.5	4.1	5.6	6.8	0.4	1.1	3.9	9.7	4.2	4.0	10.2	11.7	14.2	13.1	11.9	15.5	7.1	16.5	11.1	9.1	7.6	5.8	3.3	30.2	6.5	9.5	6.5	12.4	7.9	5.4	6.6	22.6	0.5	8.4	29.1	7.8	2.6	1.0	11.5	6.1	6.9	2.9	36.8	13.0	5.7	3.1	5.3	5.2	6.8	6.2	7.2	7.9	4.0	10.9	9.0	9.1	5.9	11.5	1.0	7.0	13.3	6.1	4.1	27.5	7.6	16.6	2.6	7.5	8.7	6.4	11.0	3.6	10.3	7.1	1.9	14.7	2.2	10.1	0.0	1.1	0.0	7.1	0.4	9.7	5.6	7.8	7.6	2.8	3.5	9.2	8.4	0.4	3.9	0.2	6.8	5.3	4.2	29.3	47.1	28.5	59.9	33.3	57.9	24.7	32.0	31.0	11.6	20.8	9.6	6.9	1.2	0.0	71.1	36.7	28.1	5.3	3.4	19.2	55.0	47.1	5.0	5.9	0.3	19.1	8.1	0.0	5.3	19.6	10.0	1.2	1.1	22.2	11.1	149.4	4.7	22.7	2.4	0.9	30.2	0.4	0.0	1.8	9.9	83.3	5.0	3.5	38.2	15.1	37.5	25.8	8.6	1.2	2.6	0.0	15.1	2.2	7.6	0.3
IRGQ	"FKSG27, IRGQ1"	ENSG00000167378	"Immunity related GTPase Q"	Q8WZA9	19	43584369-43596135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043254, HPA050338"	Approved		Approved	Vesicles		NA	NA		18000	Vesicles		"HPA043254: AB_10794178, HPA050338: AB_2681094"	"unprognostic (1.98e-1)"	"prognostic favorable (5.17e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.48e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.24e-2)"	"prognostic favorable (3.92e-4)"	"unprognostic (2.82e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.65e-2)"	5.1	6.1	9.0	4.9	8.7	17.4	4.5	17.2	16.0	6.4	4.9	6.5	9.4	5.0	6.7	6.0	5.2	5.7	6.3	9.2	8.2	8.4	9.5	8.9	6.5	3.3	6.7	13.0	8.5	5.8	10.8	7.9	5.4	9.2	6.6	4.6	5.6	5.9	5.8	15.4	5.5	4.7	5.5	6.1	6.6	6.6	4.7	6.5	2.7	5.2	4.5	4.9	5.5	5.4	1.1	1.6	5.4	1.7	1.1	1.2	0.8	3.3	5.5	4.6	9.2	5.1	3.6	4.7	3.0	1.9	3.4	3.5	4.2	2.1	2.1	4.8	3.6	3.4	4.8	4.3	2.4	2.1	3.9	3.1	2.9	6.7	4.1	3.1	3.9	4.3	3.6	4.7	4.5	2.5	3.8	4.3	3.5	4.2	4.4	3.3	2.7	4.8	2.8	2.4	1.0	3.0	8.9	4.3	1.7	2.9	6.9	8.8	7.9	8.0	8.4	2.5	5.2	5.4	3.6	6.8	11.5	8.5	2.9	4.1	4.5	3.8	3.6	7.0	1.7	9.1	5.4	1.7	0.9	0.9	1.4	0.6	0.8	0.7	0.8	1.0	1.1	1.2	0.7	3.5	1.1	1.4	1.6	0.8	0.8	9.0	8.7	17.2	16.0	8.2	8.4	6.7	13.0	9.2	6.5	11.9	17.8	12.0	9.6	5.8	16.3	24.6	25.5	2.7	6.8	3.5	25.5	4.8	1.7	10.8	7.3	7.7	11.8	0.0	11.1	3.1	7.1	14.9	12.7	12.3	7.2	19.1	34.5	9.8	11.8	2.3	2.8	7.0	5.0	6.4	13.6	13.0	14.7	5.8	9.9	9.3	20.2	0.0	6.2	2.1	2.2	5.8	6.4	3.8	9.9	12.2
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607219-43619874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA042596: AB_2678070, HPA048072: AB_2680249"	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favorable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	18.8	31.2	36.8	15.8	37.6	18.9	9.2	25.9	48.8	13.7	14.2	14.4	8.8	17.0	18.8	14.9	8.8	13.0	18.4	19.9	31.3	28.7	17.4	15.5	13.1	15.5	27.0	31.1	19.2	19.4	9.8	19.2	12.7	18.0	20.1	6.3	14.8	21.7	13.2	37.7	6.6	13.7	17.2	22.2	16.8	16.6	19.7	17.0	17.8	16.6	8.7	8.9	10.0	11.4	7.8	7.1	9.4	3.2	3.1	8.5	1.0	11.2	9.0	14.1	23.3	5.4	4.0	6.6	8.5	3.9	6.0	6.3	5.5	7.5	19.0	19.5	6.5	3.8	2.8	5.6	1.6	2.0	15.9	23.9	20.7	9.4	9.3	10.6	16.2	17.2	7.3	3.6	5.3	2.8	6.2	8.4	13.6	21.6	12.0	6.2	11.9	40.0	29.1	9.4	5.0	6.3	39.9	6.5	13.9	7.2	6.8	27.1	31.6	12.3	7.6	19.0	3.9	4.6	23.3	16.5	7.2	20.5	6.8	13.0	13.4	16.1	33.2	10.4	16.6	15.8	2.5	2.5	9.4	7.8	1.4	4.4	5.2	7.1	7.4	2.7	7.8	8.5	3.7	1.3	3.1	3.2	7.1	4.1	1.0	36.8	37.6	25.9	48.8	31.3	28.7	27.0	31.1	18.0	17.0	0.0	3.8	39.5	61.1	28.5	98.9	17.9	63.7	4.0	3.4	62.8	13.7	115.0	126.0	77.7	112.3	58.4	31.5	0.0	69.0	37.8	99.2	49.9	36.8	47.0	89.6	54.0	155.7	74.9	36.5	48.8	82.3	46.8	108.0	43.3	49.3	108.0	64.6	46.0	85.2	176.5	53.3	71.1	93.7	20.4	56.9	22.6	46.1	73.0	46.0	41.6
INCA1		ENSG00000196388	"Inhibitor of CDK, cyclin A1 interacting protein 1"	Q0VD86	17	4988130-4997610	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 41.6"	"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 105.7;Late spermatids: 240.7;Spermatocytes: 81.7;Spermatogonia: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044359, HPA052401"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA044359: AB_10794289, HPA052401: AB_2681816"	"unprognostic (1.78e-2)"	"unprognostic (9.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-2)"	"prognostic favorable (3.61e-5)"	"unprognostic (3.14e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	1.7	2.2	5.5	3.5	6.3	0.5	2.5	10.1	7.2	2.3	2.2	3.1	1.0	7.0	3.3	1.6	3.1	2.0	4.5	3.9	4.9	2.1	2.3	2.6	2.7	5.0	5.1	3.0	5.5	2.2	0.9	4.4	1.6	5.9	2.7	0.3	1.7	3.6	1.5	6.1	5.0	4.9	1.2	4.1	4.3	3.1	41.6	3.6	0.5	5.2	1.3	0.4	2.8	9.4	1.5	1.3	0.7	4.4	0.3	2.4	0.6	4.0	4.6	3.3	3.0	2.2	0.9	3.9	4.4	0.4	1.2	1.2	3.2	4.8	19.1	2.9	1.2	3.8	11.4	0.5	0.2	0.7	8.0	4.8	4.1	5.5	2.1	1.5	0.6	10.2	1.2	0.0	0.7	0.4	7.1	0.4	6.8	5.1	9.0	0.8	2.1	5.8	1.3	1.4	1.8	1.2	7.1	1.7	1.7	0.8	1.3	9.7	2.9	2.1	2.8	2.6	3.6	5.7	0.9	8.8	4.1	1.6	3.9	3.3	1.5	0.8	0.9	4.0	10.2	2.1	0.5	2.4	0.0	0.8	4.4	2.0	1.5	1.2	1.7	0.9	1.0	2.4	1.9	0.7	0.3	3.4	1.3	0.7	0.6	5.5	6.3	10.1	7.2	4.9	2.1	5.1	3.0	5.9	3.6	0.0	0.6	0.5	1.2	1.0	0.4	0.5	2.5	1.4	1.2	3.5	2.0	0.5	0.0	0.6	105.7	0.6	6.8	0.0	1.4	0.6	1.4	0.5	4.6	1.3	1.2	0.0	0.0	0.6	0.0	240.7	6.6	1.2	1.7	1.0	1.6	4.6	1.1	7.0	1.1	1.7	0.8	6.5	1.2	81.7	50.4	0.6	0.7	0.0	1.8	0.9
RNASEH2C	"AGS3, AYP1"	ENSG00000172922	"Ribonuclease H2 subunit C"	Q8TDP1	11	65714005-65720947	"Disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065375	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065375: AB_2685481"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	10.3	18.0	16.6	16.6	17.9	29.9	16.2	33.3	21.2	13.4	18.9	13.5	19.8	15.6	19.1	12.6	8.8	15.7	16.0	25.8	14.8	11.4	14.5	10.0	10.6	22.6	20.1	9.6	24.7	17.0	19.7	22.2	10.0	14.5	20.2	7.9	14.6	13.0	22.4	10.9	20.4	14.3	11.5	11.0	25.0	13.6	7.3	19.1	20.0	14.2	12.0	14.4	14.6	17.1	12.6	20.1	3.6	13.5	9.4	10.3	9.4	5.1	6.2	8.5	6.0	7.3	3.4	3.6	3.4	2.4	9.9	7.9	6.5	8.2	10.6	4.0	3.7	12.8	8.4	6.4	5.0	6.5	8.9	18.1	9.4	18.6	3.4	0.7	1.5	10.4	3.7	1.7	8.5	2.6	5.4	4.0	10.9	4.7	13.1	3.7	8.6	17.7	11.9	5.4	2.7	9.0	16.2	4.9	16.6	2.6	3.5	10.9	8.7	1.8	6.8	3.3	2.5	9.9	5.1	3.6	10.0	8.1	7.3	4.7	13.0	4.0	2.3	13.9	8.2	8.5	2.7	13.5	3.6	10.3	9.2	10.2	11.7	6.8	7.6	8.5	12.6	8.6	6.8	2.8	9.4	6.9	20.1	6.7	9.4	16.6	17.9	33.3	16.3	14.8	11.4	20.1	9.6	14.5	19.1	23.8	32.8	96.1	92.8	28.0	25.3	54.6	91.7	34.8	23.9	64.6	7.9	68.7	89.5	55.7	29.6	77.7	75.9	140.2	40.5	92.5	63.1	75.9	64.6	90.4	112.4	22.3	123.3	101.3	90.4	104.8	125.7	55.3	60.8	65.9	45.1	30.6	48.8	66.2	94.0	205.6	23.2	109.9	87.2	53.0	71.1	32.2	173.9	62.3	50.2	83.3
ACSF3		ENSG00000176715	"Acyl-CoA synthetase family member 3"	Q4G176	16	89088375-89155846	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 74.9;U-698: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.76e-5)"	"unprognostic (3.36e-2)"	"prognostic favorable (5.97e-6)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.00e-3)"	8.2	22.5	6.5	20.7	8.4	9.6	19.1	13.7	12.4	8.5	15.8	12.1	10.6	26.7	10.2	11.7	9.6	9.2	16.8	7.8	6.7	5.8	11.3	19.2	13.3	17.7	7.9	9.0	9.8	17.7	12.6	8.1	5.4	7.9	9.7	10.1	10.0	12.8	12.3	14.5	9.7	22.3	11.9	6.7	13.6	11.6	11.2	7.0	38.8	10.6	7.5	12.7	11.1	9.8	23.5	17.8	12.0	16.7	7.3	19.5	12.1	3.6	5.4	2.5	4.3	4.6	4.1	5.9	4.8	1.9	4.9	3.2	4.8	6.2	9.7	6.4	4.1	3.2	6.3	2.5	5.7	3.0	3.4	6.2	7.6	4.5	6.8	10.9	2.3	4.1	6.1	6.8	3.7	5.6	5.6	3.5	74.9	10.3	3.0	2.7	9.8	13.1	7.5	2.9	7.2	8.8	15.4	2.1	4.0	4.8	5.2	6.2	4.6	7.9	2.1	7.5	4.3	7.3	8.4	3.4	5.2	4.0	3.1	3.7	3.8	5.0	32.2	4.7	9.0	4.3	5.2	16.7	12.0	17.5	16.1	19.5	23.5	14.3	12.6	15.7	16.0	15.6	13.5	6.7	7.3	14.4	17.8	13.4	12.1	6.5	8.4	13.7	12.4	6.7	5.8	7.9	9.0	7.9	7.0	0.0	10.7	16.7	7.3	2.9	18.8	6.9	10.2	8.1	18.2	5.2	29.5	10.2	13.3	13.9	11.6	9.0	41.6	0.0	9.2	2.7	7.5	7.1	2.3	13.4	16.0	20.6	16.1	5.5	24.1	15.4	11.2	11.9	6.8	17.2	14.2	9.5	13.4	13.5	9.6	9.2	17.6	38.8	7.3	8.0	8.0	4.0	6.1	15.8	23.3	6.2
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605013-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"placenta: 65.6"	"Cell type enriched"	"Detected in many"	8	"Syncytiotrophoblasts: 1345.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 47.8;SCLC-21H: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023606	Approved					NA	NA					"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	7.0	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12.0	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3.0	14.7	10.2	58.0	5.5	6.0	5.5	6.7	1.3	6.5	13.0	3.0	0.8	8.4	26.8	2.6	5.1	6.2	0.0	0.2	8.0	0.3	0.0	0.1	0.1	1.2	0.0	6.8	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.3	1.0	2.2	0.0	0.0	47.8	0.4	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.1	0.4	6.3	1.1	0.1	0.5	2.0	0.4	0.0	0.3	25.2	5.7	0.4	2.6	0.0	1.3	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3.0	6.0	50.9	0.5	17.9	25.3	38.5	139.3	68.8	34.8	33.0	10.4	5.9	64.8	77.9	10.9	1.3	20.7	22.6	0.0	37.3	9.4	67.6	115.9	18.5	161.3	53.6	3.2	52.5	8.6	11.6	7.4	78.2	47.7	33.7	19.0	25.9	28.3	24.6	5.7	42.8	35.3	19.1	129.4	86.5	1.1	1.6	17.1	1345.9	12.1	9.3	8.4
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	5.0	4.6	6.3	7.5	4.3	3.6	4.6	4.4	7.2	3.8	4.3	5.1	3.9	5.4	3.6	20.5	3.9	13.9	7.3	4.8	5.6	2.7	6.9	7.8	6.2	5.0	4.5	5.0	3.2	7.9	10.0	11.0	4.7	4.7	3.6	1.6	5.9	4.8	6.9	3.9	4.2	4.1	2.2	3.3	4.3	5.5	13.6	5.5	12.8	4.4	1.7	4.0	2.6	2.5	4.9	5.7	14.6	6.8	3.0	3.4	2.1	7.8	16.1	4.3	15.5	2.4	1.5	5.2	4.0	2.9	3.5	2.4	8.8	4.0	5.8	11.4	2.2	3.1	7.4	5.5	1.2	1.5	4.4	7.7	2.1	8.5	9.3	2.8	8.6	18.2	1.3	2.5	2.2	0.7	3.4	0.7	6.9	5.1	2.6	1.0	9.6	9.8	12.8	1.7	5.7	8.8	9.2	3.8	10.6	2.6	5.4	6.3	12.7	5.8	18.5	9.2	1.5	9.7	11.3	1.8	7.3	10.1	2.9	6.3	7.5	2.9	3.7	4.5	8.6	4.0	1.0	5.2	14.6	3.4	6.5	1.2	4.9	1.9	2.0	5.7	2.1	1.9	1.8	6.5	3.0	6.8	4.6	1.9	2.1	6.3	4.3	4.4	7.2	5.6	2.7	4.5	5.0	4.7	5.5	0.0	0.3	1.3	0.7	1.5	5.2	2.1	10.2	1.4	0.0	3.5	7.9	6.1	0.0	4.1	2.7	1.2	3.2	0.0	4.8	2.4	1.5	0.8	5.7	2.6	4.2	7.9	8.7	0.6	2.8	0.0	0.9	1.1	1.7	1.0	6.3	6.8	3.7	4.0	2.1	1.9	10.8	0.0	2.8	0.5	11.4	1.0	2.1	3.8	3.7	0.3
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502902-131523806	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	9.5	12.3	21.6	10.6	18.8	10.2	10.2	34.2	22.4	10.0	12.1	16.9	14.6	11.2	15.0	14.6	8.8	14.6	13.0	15.2	25.8	17.9	13.8	12.8	10.6	13.2	15.0	16.5	17.2	16.9	17.1	18.0	12.9	15.2	16.0	11.6	13.3	19.5	17.1	28.2	16.6	11.9	12.1	13.4	12.3	10.7	49.9	13.4	8.7	11.6	5.5	11.0	7.8	9.5	2.8	5.1	3.4	3.8	3.8	10.8	4.9	6.7	10.8	9.9	16.6	12.7	10.3	17.8	7.8	9.7	12.5	8.6	11.4	9.5	2.1	9.5	18.0	5.7	15.3	12.1	8.5	6.6	11.1	17.2	3.9	25.5	7.9	15.0	10.0	8.7	7.2	7.7	8.3	2.8	14.8	10.8	13.8	6.8	11.5	12.5	18.0	9.4	22.9	5.7	5.6	13.6	10.9	9.3	16.1	11.0	2.0	11.2	9.9	13.3	15.5	7.8	6.7	22.7	10.1	11.7	9.9	2.1	17.9	6.6	7.2	6.2	3.5	5.9	18.8	8.1	0.0	3.8	3.4	7.4	3.6	10.8	2.8	7.2	7.4	5.1	2.7	6.7	5.5	0.5	3.8	3.3	3.1	7.6	4.9	21.6	18.8	34.2	22.4	25.8	17.9	15.0	16.5	15.2	13.4	8.9	20.2	7.3	4.8	3.9	11.9	8.5	10.2	4.0	6.8	12.2	7.9	18.5	1.7	9.9	49.7	7.1	12.3	0.0	5.8	10.1	7.1	5.3	2.3	9.7	9.1	20.6	7.5	6.7	5.3	24.3	8.1	5.7	5.0	10.0	8.2	14.1	7.3	3.5	9.6	9.0	16.9	6.5	6.0	57.0	7.9	2.6	14.6	6.9	8.0	2.0
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.6	14.8	67.4	15.1	10.7	18.6	15.0	29.7	9.0	10.0	15.2	30.2	38.8	32.4	10.2	11.6	11.7	30.2	14.2	12.2	18.8	42.1	15.1	37.2	91.5	15.5	9.5	60.0	24.8	16.6	16.1	9.1	12.3	25.0	12.7	22.5	13.4	25.2	12.8	9.4	23.7	31.9	17.8	19.6	5.6	40.9	16.9	15.4	11.2	31.1	17.6	25.3	14.0	22.5	6.7	27.9	17.7	31.1	23.0	13.4	13.4	14.9	16.6	28.3	23.3	38.8	27.7	38.5	15.3	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2	131.0	200.7	147.3	175.2	232.4	221.8	78.3	101.9	224.9	215.0	108.2	127.6	118.5	84.6	100.9	28.5	282.9	157.6	93.5	97.9	120.4	173.1	219.9	158.9	69.6	87.5	287.6	180.1	188.4	85.6	18.1	236.2	133.0	121.4	162.3	134.2	304.1	112.4	133.3	204.7	39.4	283.1	213.4	189.5	194.6	112.8	229.2	154.9	147.4	126.3	268.6
BORCS8	MEF2BNB	ENSG00000254901	"BLOC-1 related complex subunit 8"	Q96FH0	19	19176903-19192591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045700	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA045700: AB_10968570"	"unprognostic (4.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.82e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.00e-2)"	11.3	17.0	25.0	12.9	26.8	12.2	13.3	19.3	31.0	10.1	13.5	17.3	14.5	15.5	12.9	15.8	13.8	14.0	14.8	17.9	23.9	30.0	16.0	14.1	12.0	14.0	26.3	12.2	10.5	10.1	11.7	20.1	11.3	15.6	10.9	15.3	13.6	12.4	15.5	12.0	9.6	9.5	13.0	13.9	11.9	11.2	11.1	12.9	12.4	13.0	11.1	13.8	10.9	8.5	8.7	9.8	25.6	14.6	5.0	7.1	6.7	9.7	5.5	9.1	7.4	9.9	5.4	9.1	10.3	8.7	16.2	15.0	9.6	9.6	7.2	14.4	11.9	12.7	6.4	9.8	12.6	7.7	3.9	12.5	5.4	12.5	10.2	8.1	3.9	7.7	6.5	9.4	12.4	6.2	7.3	14.2	12.4	9.7	10.5	17.1	17.6	14.8	9.1	4.9	11.7	12.1	7.1	3.6	8.2	14.0	6.0	18.5	10.2	9.4	6.2	7.6	7.3	6.8	7.6	7.2	5.6	8.3	19.0	15.5	6.6	7.8	8.3	11.1	6.7	11.4	10.6	9.6	16.0	4.9	13.7	4.8	8.7	5.7	5.6	7.4	6.3	4.7	5.2	25.6	5.0	14.6	9.8	7.1	6.7	25.0	26.8	19.3	31.0	23.9	30.0	26.3	12.2	15.6	12.9	11.9	22.9	13.7	12.0	0.0	15.5	0.0	28.1	24.1	13.6	14.0	9.8	27.4	36.5	34.2	2.6	9.7	16.6	0.0	28.6	29.2	3.1	15.0	9.3	15.3	35.2	17.5	10.5	12.9	26.3	4.5	7.2	17.5	0.0	43.3	12.4	10.6	32.6	10.5	6.3	29.8	13.3	0.0	0.0	32.2	21.5	0.0	33.1	15.0	12.5	15.3
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.9	35.0	13.9	21.9	10.8	8.0	31.2	11.6	8.1	16.1	17.3	34.1	11.8	38.5	17.9	9.1	11.4	24.6	25.8	18.1	9.2	19.9	36.8	17.1	17.6	27.5	14.0	13.8	23.1	9.8	11.3	19.8	16.7	8.3	11.9	20.8	20.6	16.9	8.8	21.9	26.0	16.3	22.8	15.5	11.8	27.5	12.3	18.9	11.2	12.1	14.0	18.7	19.9	14.7	14.9	13.9	17.7	9.4	12.0	12.5	17.7	18.9	22.3	9.1	15.6	16.0	14.1	14.3	16.0	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1	20.8	29.6	16.3	12.9	13.2	23.9	19.8	5.1	20.1	19.4	8.7	15.7	24.8	1.7	13.2	47.9	13.2	6.2	0.0	12.6	23.5	14.1	12.3	29.0	9.0	14.7	33.4	12.1	4.9	4.5	17.5	8.6	13.8	10.1	107.4	16.1	12.5	11.1	12.4	18.0	4.1	16.6	6.5	9.9	21.4	71.6	14.3	17.7	13.1	18.8	10.6
OAZ1	"AZI, MGC138338, OAZ"	ENSG00000104904	"Ornithine decarboxylase antizyme 1"	P54368	19	2269509-2273490	"Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009291	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			Vesicles	"Centriolar satellite"	"HPA009291: AB_1079519"	"unprognostic (2.37e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (4.10e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.01e-2)"	50.7	56.5	73.3	47.5	68.2	84.6	67.4	41.5	68.6	27.2	37.8	22.9	31.1	47.8	32.7	33.7	38.6	40.1	34.0	73.7	67.2	53.3	31.8	45.7	50.3	71.4	60.4	52.3	31.2	86.0	11.9	34.6	53.5	39.9	32.1	24.0	27.1	65.6	33.7	137.4	30.4	55.3	37.3	37.0	66.0	41.4	25.0	29.4	31.8	43.8	59.3	40.1	37.2	45.3	69.7	83.1	150.4	136.3	24.4	54.4	160.8	73.1	15.2	11.7	20.1	24.7	39.5	30.5	52.3	36.4	26.5	36.4	21.7	23.7	50.0	28.2	24.3	10.4	21.3	11.5	15.7	17.5	66.4	39.9	38.6	15.2	34.1	25.2	53.8	61.1	26.3	27.6	9.9	15.2	23.9	30.0	18.5	37.4	58.1	29.7	26.7	44.6	56.2	38.6	10.7	27.8	37.1	23.5	65.9	24.1	21.2	27.8	29.4	34.4	31.3	57.5	9.8	26.2	114.5	38.1	18.9	23.2	81.1	54.8	56.7	23.4	61.0	85.7	84.6	28.5	109.3	116.3	134.1	36.1	117.5	36.0	69.7	39.5	38.3	83.1	66.6	36.9	36.4	150.4	24.4	136.3	56.0	54.4	160.8	73.3	68.2	41.5	68.6	67.2	53.3	60.4	52.3	39.9	29.4	339.5	469.8	928.1	928.0	1311.0	338.1	593.5	527.4	441.6	342.4	279.2	100.1	923.2	1042.8	914.1	75.9	534.9	1129.6	817.7	884.4	1236.3	850.7	987.2	688.0	701.2	2052.3	209.7	589.4	454.8	1994.6	195.9	517.2	2135.2	1078.0	2688.9	644.4	226.4	989.3	1304.6	448.7	1061.1	197.0	452.7	966.5	272.6	281.5	1121.8	1407.9	752.7	613.6	1395.6
PPP1R12C	"AAVS1, DKFZP434D0412, LENG3, MBS85, p84, p85"	ENSG00000125503	"Protein phosphatase 1 regulatory subunit 12C"	Q9BZL4	19	55090913-55117559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043532	Approved					NA	NA					"HPA043532: AB_10961273"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.52e-3)"	"unprognostic (7.92e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.68e-3)"	27.9	18.3	22.6	24.9	23.0	25.2	20.8	21.3	33.9	31.6	49.2	22.9	24.1	32.8	40.2	16.2	35.2	23.9	24.4	48.1	22.4	19.4	16.7	16.4	19.4	21.4	20.0	19.3	20.5	25.0	17.4	20.3	19.5	20.7	25.2	10.6	33.4	20.0	34.4	15.2	21.3	28.9	52.3	15.3	30.8	25.8	27.5	13.4	14.7	15.7	12.2	17.3	36.1	30.4	4.5	3.7	5.6	5.1	1.3	2.9	1.3	18.0	23.4	12.8	14.9	14.2	8.8	29.9	20.6	15.0	12.7	13.8	8.3	12.6	26.8	9.1	11.3	12.5	17.1	4.1	8.0	4.3	21.9	42.8	17.9	20.9	13.8	29.2	12.9	31.8	13.6	10.4	12.4	8.1	10.2	13.8	13.6	13.4	29.7	11.2	11.3	15.1	18.9	9.2	11.6	24.1	21.1	10.6	10.7	11.6	31.0	16.5	13.5	14.7	12.3	12.8	6.5	7.8	26.0	29.0	30.2	15.1	15.3	21.5	15.4	12.6	14.7	27.8	26.0	18.7	0.0	3.6	5.6	2.6	2.8	1.9	2.7	2.4	2.2	2.3	4.5	2.1	2.9	4.0	1.3	5.1	3.7	1.6	1.3	22.6	23.0	21.3	33.9	22.4	19.4	20.0	19.3	20.7	13.4	20.8	16.2	6.1	4.5	10.2	30.9	46.0	7.6	6.7	10.3	10.4	21.6	5.1	1.7	7.1	14.6	19.9	22.9	0.0	12.8	8.9	10.8	6.5	5.8	15.8	13.5	35.0	5.1	24.5	19.5	5.0	15.8	15.0	16.9	6.4	16.6	17.7	12.5	14.7	24.1	6.8	19.9	38.8	36.2	20.9	12.3	7.2	8.5	9.6	9.5	6.5
C20orf96	dJ1103G7.2	ENSG00000196476	"Chromosome 20 open reading frame 96"	Q9NUD7	20	270863-290778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 105.7;Early spermatids: 80.0;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048649	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA048649: AB_2680476"	"unprognostic (1.59e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (4.62e-2)"	"unprognostic (5.12e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.05e-4)"	5.6	8.6	10.4	5.5	18.4	7.1	8.2	11.2	13.6	10.5	7.8	13.5	7.7	9.7	16.9	21.8	4.4	33.9	9.1	6.5	11.7	9.9	13.2	4.7	10.3	5.2	12.5	9.1	17.7	7.3	8.3	25.1	4.0	22.0	11.2	8.8	11.8	10.2	8.6	3.4	3.8	8.1	10.8	13.8	8.0	8.2	23.4	13.4	5.9	15.1	2.0	5.2	7.4	6.7	3.5	6.4	0.0	2.8	2.5	2.9	1.6	4.2	13.4	14.1	12.4	3.7	3.6	6.3	3.0	4.0	4.5	6.2	2.6	8.3	10.7	2.0	3.7	8.0	3.7	5.2	2.3	5.3	2.6	8.1	7.1	0.1	14.5	10.4	5.8	3.1	5.1	2.1	7.8	0.9	11.6	9.1	13.8	14.4	5.4	3.9	2.1	6.8	22.6	4.6	4.2	5.9	20.9	2.5	8.7	7.1	6.6	1.5	12.7	3.6	5.3	9.0	6.8	9.1	13.0	6.1	4.6	8.0	4.0	2.5	12.3	12.4	7.3	2.5	18.2	4.2	0.0	2.8	0.0	1.6	2.2	1.0	3.5	1.0	1.3	6.4	3.4	2.2	2.9	0.0	2.5	1.6	3.0	1.4	1.6	10.4	18.4	11.2	13.6	11.7	9.9	12.5	9.1	22.0	13.4	3.0	2.2	1.5	4.6	3.3	3.0	0.7	12.7	105.7	11.4	17.4	5.9	4.0	33.2	9.4	80.0	7.5	4.2	0.0	6.0	2.6	8.0	7.9	14.9	3.0	7.9	6.4	8.1	10.4	4.4	25.9	10.0	4.6	3.3	3.6	7.1	7.2	7.9	0.0	17.0	15.1	9.4	6.5	6.7	50.9	45.4	1.4	2.3	2.2	8.8	2.1
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22451851-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	14.1	21.0	8.3	13.5	12.3	11.2	10.8	18.0	12.6	13.9	11.7	14.1	10.9	10.6	21.5	10.5	8.8	13.1	11.9	8.4	9.6	6.4	11.7	8.2	11.5	17.8	12.9	7.3	15.3	15.5	19.0	31.6	8.5	11.6	13.6	11.6	13.5	14.6	10.6	12.7	11.5	18.1	14.4	12.8	23.2	12.5	9.2	13.0	16.6	14.4	6.8	19.5	12.9	14.8	2.5	1.7	1.6	2.1	7.6	3.0	0.8	7.0	8.0	13.3	14.0	10.0	8.4	12.0	6.1	6.7	9.4	10.3	7.2	8.7	8.2	7.3	7.3	7.7	9.1	13.5	6.5	11.3	10.8	11.3	17.4	15.2	8.5	8.7	10.2	16.9	7.0	9.7	12.5	9.6	7.4	8.1	11.7	18.5	0.1	7.7	5.2	6.9	13.0	8.0	5.9	6.7	11.8	10.4	9.3	4.7	7.6	11.2	9.2	11.5	8.5	4.9	8.6	16.1	8.7	9.9	11.6	9.6	11.9	6.0	5.7	7.5	8.4	7.0	12.8	8.3	1.6	1.0	0.6	2.4	2.1	3.0	1.8	1.9	2.0	1.7	2.5	1.9	2.3	0.4	7.6	1.0	1.1	2.7	0.8	8.3	12.3	18.0	12.6	9.6	6.4	12.9	7.3	11.6	13.0	11.9	14.7	11.3	3.1	5.0	13.1	11.0	10.2	6.7	15.9	1.8	29.5	4.2	1.7	4.9	3.6	6.3	3.4	0.0	6.4	3.7	4.7	4.3	15.1	2.9	4.1	11.1	15.5	4.9	4.5	4.7	5.5	4.5	13.5	0.0	5.2	8.2	5.8	7.0	6.3	1.9	23.1	12.9	5.2	5.9	8.5	3.6	2.4	5.1	5.1	2.4
SPATA7	"HSD3, LCA3"	ENSG00000042317	"Spermatogenesis associated 7"	Q9P0W8	14	88384924-88470350	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.6"	"Group enriched"	"Detected in many"	24	"Early spermatids: 817.6;Late spermatids: 902.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038082, HPA038083"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA038082: AB_10671738, HPA038083: AB_10671519"	"unprognostic (2.09e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-3)"	"prognostic favorable (4.16e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (2.50e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.81e-2)"	6.3	7.2	7.8	2.8	10.3	2.2	7.1	18.0	12.5	6.1	4.5	6.5	4.5	2.9	7.7	8.5	3.7	9.6	6.5	5.3	8.1	7.4	10.5	5.9	5.0	3.0	6.4	9.7	13.6	6.9	9.2	15.0	3.6	13.3	5.8	4.1	5.5	4.6	5.9	4.7	6.6	2.8	6.4	5.8	3.7	4.3	55.6	5.9	3.3	13.5	3.9	2.0	5.7	4.4	3.7	4.4	1.7	3.0	0.9	5.6	2.2	2.1	3.3	4.9	6.8	8.1	15.4	5.0	3.7	8.4	4.7	3.1	0.9	4.1	1.5	2.3	5.0	3.5	2.1	2.3	3.5	4.4	2.5	1.6	0.1	1.6	1.1	12.1	3.4	0.3	7.3	5.9	1.9	3.6	15.4	8.6	4.2	1.1	2.4	4.3	2.5	1.5	3.1	0.6	2.6	4.2	3.5	5.1	0.8	7.5	1.3	2.9	4.5	4.7	6.4	3.8	5.1	5.5	3.7	4.4	2.9	3.8	4.8	2.0	2.4	1.2	0.5	5.8	1.0	2.4	0.0	2.2	0.6	4.8	3.0	5.6	3.7	4.0	2.2	4.4	0.9	2.2	4.2	1.7	0.9	1.8	4.3	1.4	2.2	7.8	10.3	18.0	12.5	8.1	7.4	6.4	9.7	13.3	5.9	11.9	5.3	0.8	8.2	2.2	10.8	10.9	5.1	36.1	10.3	3.5	19.6	2.1	8.3	7.6	817.6	5.2	1.1	0.0	6.3	3.2	6.4	3.4	1.1	3.4	5.0	14.3	15.6	6.2	8.6	902.3	19.0	3.3	8.5	4.6	4.4	10.6	5.8	4.8	15.9	19.9	19.4	6.5	5.0	18.2	13.5	1.8	0.9	3.8	4.6	2.7
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476986-17493226	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	10.2	12.7	16.0	6.5	23.5	12.3	14.1	16.3	29.1	13.0	11.2	9.2	10.9	11.2	11.7	17.3	8.2	11.7	6.6	30.0	14.3	13.6	13.9	19.1	8.2	11.5	13.6	14.5	12.4	10.2	20.3	11.3	7.9	12.6	11.4	10.5	8.9	15.8	14.9	34.4	11.3	10.5	8.6	10.3	9.5	10.1	12.9	8.6	14.9	13.4	15.2	9.1	7.5	7.8	11.4	12.8	11.8	11.4	10.3	13.4	7.4	7.3	9.4	8.1	8.7	6.6	5.9	7.0	6.0	7.4	9.3	8.4	13.7	3.7	9.1	6.9	6.2	5.6	9.6	10.3	8.3	8.8	5.7	16.4	5.5	6.2	9.8	7.0	4.4	4.8	9.6	7.9	7.8	8.1	7.0	6.3	13.3	6.5	4.2	6.2	6.2	19.7	9.1	7.5	15.3	9.7	15.3	18.4	5.9	8.1	5.2	5.3	8.4	7.9	6.3	13.3	32.1	7.4	5.8	4.3	6.9	8.0	11.8	9.4	8.0	5.6	5.0	8.6	7.8	7.2	2.7	7.0	11.8	10.3	9.6	13.4	11.4	10.7	10.6	7.8	10.4	11.6	12.8	2.4	10.3	11.4	12.8	10.3	7.4	16.0	23.5	16.3	29.1	14.3	13.6	13.6	14.5	12.6	8.6	3.0	4.1	0.9	8.0	4.0	14.2	17.7	7.6	5.3	4.5	8.7	13.7	7.7	10.0	5.6	5.3	3.7	6.6	0.0	4.0	4.5	5.5	7.3	0.0	4.5	5.3	15.9	15.1	5.5	2.4	5.2	5.2	3.8	1.7	3.6	9.3	22.1	2.9	5.8	8.9	4.5	22.8	0.0	6.1	8.8	25.4	4.3	8.0	5.0	7.3	7.4
KCTD17	FLJ12242	ENSG00000100379	"Potassium channel tetramerization domain containing 17"	Q8N5Z5	22	37051736-37063390	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Ubl conjugation pathway"		"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018459	Uncertain					NA	NA					"HPA018459: AB_1852169"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.22e-5)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.94e-2)"	6.1	11.8	21.7	9.6	59.0	2.5	4.2	7.0	36.3	6.2	8.3	9.2	2.7	3.8	9.6	2.6	7.7	5.9	8.9	17.1	23.1	12.9	2.3	2.1	7.1	9.6	12.6	14.7	10.8	3.0	4.0	14.5	9.5	10.5	5.1	5.8	2.3	1.8	10.3	1.9	16.9	4.3	10.0	6.8	6.8	4.4	18.7	16.0	4.1	2.8	2.3	7.1	8.7	7.9	2.9	2.7	0.0	2.9	3.8	2.8	1.0	8.4	11.1	17.6	13.0	8.4	8.5	0.7	8.8	8.6	14.5	12.5	2.3	2.5	6.5	6.1	11.3	11.3	2.3	5.5	10.3	6.1	12.6	14.7	2.8	3.0	2.6	12.6	0.0	3.4	9.8	5.1	14.8	3.2	9.8	18.5	8.7	0.6	7.3	9.0	6.8	5.7	0.1	11.2	5.0	9.6	10.5	4.6	1.9	3.7	2.2	14.7	18.3	8.2	7.8	4.0	3.8	2.1	2.3	10.6	18.8	17.6	8.8	6.4	9.9	2.8	1.1	16.6	3.9	10.2	0.0	2.3	0.0	2.7	2.9	2.6	2.9	2.0	2.8	2.7	1.5	2.5	2.0	0.0	3.8	1.3	0.6	2.8	1.0	21.7	59.0	7.0	25.4	23.1	12.9	12.6	14.7	10.5	16.0	0.0	0.3	3.2	4.4	1.3	16.5	3.5	7.6	0.0	0.0	5.2	2.0	0.4	0.0	11.4	18.5	6.8	11.8	0.0	5.6	2.2	9.7	0.7	4.6	0.5	8.6	12.7	12.6	10.4	7.8	20.3	9.8	10.5	3.3	16.2	4.4	8.6	2.8	14.4	8.5	1.7	5.6	0.0	6.2	21.6	6.6	4.3	6.3	5.1	5.4	1.8
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;testis: 23.7"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.3;naive B-cell: 11.5"	"Group enriched"	"Detected in many"	8	"B-cells: 11.5;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"AF22: 14.0;SCLC-21H: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"	2.0	4.2	6.3	3.7	7.5	3.1	4.8	26.9	13.4	4.3	3.8	5.1	2.3	2.1	5.8	11.1	2.5	3.5	3.9	2.9	5.7	7.6	5.9	2.6	3.4	6.0	5.2	6.0	7.3	2.4	5.6	9.2	2.5	7.1	4.4	5.0	5.2	5.2	5.1	4.0	6.0	4.3	3.0	4.8	3.7	3.3	23.7	3.4	2.2	6.1	0.7	7.3	2.4	4.0	11.5	0.9	0.4	0.5	1.0	5.1	0.7	1.1	0.9	14.0	6.7	2.8	3.6	2.4	1.4	3.1	3.1	4.9	1.9	0.9	2.6	2.4	2.7	3.4	2.0	4.6	2.1	3.8	3.9	5.2	0.5	1.0	0.8	1.7	0.9	3.0	3.1	3.5	2.1	1.3	5.3	2.4	0.6	1.6	2.0	3.4	3.3	1.5	0.9	5.5	4.0	0.6	6.1	3.0	4.5	3.5	0.4	14.1	6.7	1.8	1.2	1.5	6.3	4.7	3.0	4.6	3.3	3.5	1.2	0.9	4.7	2.4	10.6	1.1	2.6	3.2	0.0	0.5	0.4	2.2	0.0	1.9	9.3	2.3	1.6	0.9	11.5	1.4	0.5	0.4	1.0	0.5	0.0	5.1	0.7	6.3	7.5	26.9	13.4	5.7	7.6	5.2	6.0	7.1	3.4	0.0	3.4	20.5	6.0	7.1	41.7	1.1	12.7	2.7	1.2	15.7	43.2	5.2	18.3	8.1	108.2	5.8	26.4	0.0	4.1	4.3	8.5	6.0	9.2	1.7	6.8	30.2	22.5	12.9	4.0	40.3	11.5	9.3	3.3	2.8	9.2	20.9	5.9	14.4	11.7	8.6	47.4	12.9	4.7	50.4	18.3	6.6	5.1	17.5	6.4	3.4
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821545-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.6"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.7;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"		"HPA055135: AB_2682710"	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	2.7	6.7	19.6	4.2	13.2	1.5	2.4	41.3	47.6	2.1	3.4	4.7	0.8	3.1	3.8	2.8	1.9	16.9	5.7	4.2	25.9	18.4	1.4	3.7	6.0	1.7	9.9	17.7	2.0	1.7	5.3	8.4	4.3	10.2	2.1	3.0	3.6	1.3	2.1	1.6	1.7	4.2	5.7	5.3	2.8	2.0	1.2	3.6	0.1	1.1	0.0	1.1	2.4	0.5	0.0	1.8	14.7	6.3	0.0	0.0	1.7	0.0	2.9	13.0	15.4	1.4	1.0	0.0	1.0	3.4	2.9	1.7	0.2	0.0	0.0	0.1	1.8	0.1	0.0	2.0	0.0	1.4	0.0	0.9	1.5	0.1	0.0	2.2	0.3	0.0	2.4	0.0	4.4	0.2	13.4	7.9	1.1	0.7	0.1	1.0	0.0	0.4	1.1	14.5	0.0	0.1	0.0	1.6	2.6	1.0	0.0	1.1	9.9	0.0	0.0	0.4	9.3	0.1	3.8	5.2	2.0	12.3	1.0	1.7	0.0	0.9	0.0	2.2	2.7	0.2	0.0	6.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	14.7	0.0	1.3	1.6	0.0	1.7	19.6	13.2	41.3	32.4	25.9	18.4	9.9	17.7	10.2	3.6	0.0	0.0	0.0	0.1	0.7	75.9	1.1	0.0	49.5	1.2	1.8	3.9	0.1	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.1	2.1	0.5	0.0	0.4	2.2	38.1	0.0	5.5	3.4	0.4	6.9	3.2	0.0	0.0	0.0	46.3	0.1	0.0	13.8	0.3	7.8	0.0	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
MCF2L	"ARHGEF14, DBS, KIAA0362, OST"	ENSG00000126217	"MCF.2 cell line derived transforming sequence like"	O15068	13	112894378-113099739	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.5"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 59.3;Cone photoreceptor cells: 119.8;Mucus-secreting cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"B-cells: 2.3;granulocytes: 1.8;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"OE19: 16.0;SCLC-21H: 30.5;SH-SY5Y: 13.5;SK-BR-3: 20.2;WM-115: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (1.56e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (6.01e-4)"	"unprognostic (9.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (1.17e-1)"	"prognostic favorable (9.14e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (2.63e-5)"	24.2	6.4	21.2	4.6	37.5	0.8	10.9	77.5	37.2	9.4	13.2	20.9	2.6	8.7	7.3	4.3	11.0	6.9	10.4	19.0	20.1	15.7	10.3	3.7	7.0	4.9	49.0	11.5	2.4	14.7	7.7	20.7	6.7	28.6	11.2	10.9	5.7	24.5	7.2	11.4	19.0	12.4	5.7	23.0	2.9	13.7	1.4	46.2	0.3	11.5	4.0	4.7	8.8	12.0	2.3	0.2	1.8	0.1	0.3	2.1	2.0	0.0	0.7	7.0	2.2	0.2	0.4	1.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	1.7	0.6	1.1	0.1	1.7	0.0	0.0	0.0	3.5	1.9	0.0	4.1	0.2	0.1	1.4	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	6.5	2.5	0.2	1.1	1.9	16.0	0.0	0.1	6.9	3.7	2.8	10.6	30.5	13.5	0.0	20.2	0.0	1.1	11.9	0.0	0.2	0.0	6.0	2.4	0.0	3.4	0.1	1.0	11.2	0.4	27.3	0.2	0.1	0.3	0.5	0.1	0.6	0.5	0.6	0.7	0.0	2.3	2.1	0.7	1.8	0.3	0.1	0.2	0.2	2.0	21.2	37.5	77.5	37.2	20.1	15.7	49.0	11.5	28.6	46.2	0.0	6.7	1.5	3.2	4.8	59.3	23.5	10.2	12.0	5.7	8.7	119.8	0.0	6.6	5.0	0.3	29.2	5.6	0.0	2.3	0.1	1.5	6.7	1.1	2.6	1.0	36.5	25.4	16.0	1.5	1.0	0.6	1.1	8.5	0.0	47.9	4.5	1.9	11.2	1.1	7.9	21.6	0.0	4.1	0.4	2.8	8.0	0.1	0.7	6.5	3.0
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046627, HPA073243"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.8	5.8	7.6	9.5	15.4	12.7	7.6	20.1	19.4	8.0	6.6	10.9	8.7	9.5	9.9	10.1	6.6	14.5	9.2	6.3	10.1	8.0	8.6	11.5	8.0	10.8	7.7	10.1	11.2	17.8	13.4	13.3	6.7	10.4	9.1	7.2	11.8	10.8	8.5	7.2	13.5	7.8	8.0	8.2	11.7	8.1	20.0	10.2	11.2	10.0	5.7	10.2	9.4	7.1	3.4	1.7	3.7	1.6	2.3	2.6	0.6	6.1	7.2	7.4	10.3	4.8	9.4	13.7	8.0	5.4	8.5	6.8	16.5	5.7	9.5	5.8	6.3	5.9	20.0	9.0	10.4	5.1	13.3	14.1	6.4	18.3	7.8	4.3	13.5	7.7	7.4	8.7	7.3	7.0	7.4	7.5	7.9	13.1	7.1	5.9	13.8	7.8	15.2	15.4	9.8	9.5	12.8	7.5	13.5	4.9	11.2	21.5	15.0	8.1	13.4	4.3	6.7	13.7	7.9	10.6	8.8	8.0	15.7	11.4	4.4	5.1	7.7	6.1	6.3	5.1	0.0	1.6	1.3	2.6	1.3	1.2	2.0	1.1	1.1	0.6	3.4	0.9	0.7	3.7	2.3	0.5	1.7	0.9	0.6	7.6	15.4	20.1	19.4	10.1	8.0	7.7	10.1	10.4	10.2	6.0	7.0	2.9	1.9	4.7	7.5	3.2	2.5	17.4	3.4	3.5	2.0	2.4	0.0	5.9	2.6	3.6	3.6	23.3	3.8	1.7	2.7	2.2	1.1	6.4	2.8	3.2	5.1	5.5	1.6	1.5	4.6	2.8	0.0	1.0	5.2	4.8	5.3	6.0	4.6	4.2	11.5	0.0	2.3	8.6	8.8	5.9	1.1	3.2	5.6	2.8
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		30000	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	46.9	46.5	50.1	65.8	57.0	51.9	29.8	89.6	73.1	36.7	36.2	40.5	46.5	45.8	44.0	38.8	38.9	34.0	35.4	33.3	46.5	34.6	30.6	35.0	29.3	47.6	53.8	49.0	43.3	36.1	37.8	41.8	34.3	43.4	43.0	27.3	26.6	42.7	52.7	73.5	48.1	44.6	28.5	41.5	45.6	45.2	30.5	58.1	34.9	39.8	25.6	37.3	26.9	35.0	5.3	3.2	3.2	3.7	7.9	3.9	1.2	34.5	40.0	28.1	20.1	11.5	7.1	34.5	26.8	16.5	28.1	24.2	24.3	20.4	42.3	25.9	17.3	23.4	30.9	34.8	25.3	20.8	27.7	92.8	38.6	20.1	27.6	6.0	41.7	26.0	9.9	7.0	20.0	13.6	12.7	20.9	20.2	39.5	13.1	16.7	29.9	43.0	66.6	35.6	18.6	34.6	50.0	27.9	24.7	17.1	21.6	24.2	28.7	33.6	18.9	17.8	19.3	20.0	25.1	31.1	20.6	38.7	18.0	42.9	34.9	29.4	51.5	17.4	27.2	19.3	1.5	3.7	3.2	3.6	2.5	2.1	5.3	2.3	1.5	3.2	3.5	3.9	2.3	1.7	7.9	1.9	2.8	2.4	1.2	50.1	57.0	89.6	73.1	46.5	34.6	53.8	49.0	43.4	58.1	17.9	62.4	92.3	143.3	123.9	97.6	25.0	56.0	36.1	47.8	71.5	84.4	155.8	39.7	97.0	14.1	68.1	71.8	23.3	90.8	176.6	99.6	110.3	53.2	72.3	109.6	108.1	113.3	63.3	61.9	12.5	120.6	80.2	65.8	77.5	97.3	96.3	92.5	74.8	104.0	62.4	104.8	122.9	97.6	108.5	89.7	114.3	147.5	77.8	98.4	135.5
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018022: AB_2211524, HPA051558: AB_2681534"	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favorable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	10.5	7.1	8.9	16.6	26.7	13.1	9.6	11.2	12.4	7.3	13.6	12.5	8.6	10.5	9.3	9.2	8.5	9.2	8.9	7.0	9.9	7.9	6.9	9.0	12.2	23.4	13.3	9.3	8.2	13.7	13.5	15.5	9.9	12.6	8.1	21.6	7.9	9.6	9.5	15.6	12.8	15.6	8.4	14.7	21.3	15.6	3.9	13.7	18.4	9.8	6.2	18.9	8.0	9.1	4.2	10.8	7.6	7.7	11.9	10.0	5.1	7.6	7.8	7.7	14.9	7.2	4.7	15.8	11.2	8.8	6.3	7.1	11.4	8.3	14.1	10.3	6.7	6.3	12.3	5.0	4.1	4.2	15.7	15.4	4.2	8.3	7.7	7.6	8.6	3.9	4.1	7.3	5.9	5.5	6.3	11.1	6.1	4.4	8.2	5.8	3.9	4.5	8.2	8.7	25.5	9.7	7.4	11.0	19.6	6.6	5.3	10.6	9.2	8.5	8.8	14.9	3.5	9.4	11.2	5.6	7.5	1.0	10.0	19.7	10.2	16.7	4.3	7.3	5.5	12.2	7.6	7.6	6.8	10.0	5.8	6.8	4.2	7.0	8.2	10.8	3.9	5.7	6.8	2.9	11.9	7.7	7.4	5.4	5.1	8.9	26.7	11.2	12.4	9.9	7.9	13.3	9.3	12.6	13.7	6.0	9.0	9.9	1.2	3.0	4.0	2.5	0.0	0.0	4.5	1.8	5.9	3.7	1.7	4.4	1.4	4.5	2.6	0.0	7.5	4.4	2.8	1.5	9.2	5.9	4.6	11.1	5.8	2.5	7.0	1.7	2.6	7.1	1.7	1.0	10.7	4.0	3.5	8.6	6.3	1.1	10.0	6.5	3.9	2.3	2.4	2.4	1.4	12.8	7.0	1.0
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 64.8;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: AB_2683476"	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favorable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.6	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.2	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	11.8	10.6	4.4	2.5	0.9	3.4	2.7	2.4	4.4	1.0	1.9	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	5.7	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0	17.9	22.0	4.7	6.2	3.4	17.5	37.2	25.5	9.4	11.4	17.4	13.7	3.8	6.6	12.6	64.8	12.7	8.0	0.0	9.4	2.1	13.8	7.0	19.7	11.9	15.4	20.6	4.6	11.1	8.6	48.4	12.7	9.5	8.5	10.8	7.2	12.8	12.3	2.9	16.3	27.1	12.1	71.1	17.6	44.0	5.3	2.6	4.7	7.9	5.2	6.0
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 35.6;Horizontal cells: 31.8;Rod photoreceptor cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6"									HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (3.56e-1)"	7.7	8.0	8.9	11.5	10.8	12.6	7.4	15.8	14.0	9.8	8.8	11.9	10.2	8.5	12.0	9.1	12.7	10.5	9.2	7.6	9.9	9.3	6.5	10.5	7.7	10.5	10.4	11.5	14.6	15.0	10.2	12.7	7.1	7.1	10.6	6.0	7.2	11.2	13.3	5.8	11.9	7.3	8.2	9.3	8.3	8.6	8.0	9.7	16.8	11.9	8.1	10.7	9.3	7.2	6.4	6.4	13.1	5.0	6.0	11.8	3.4	4.1	5.2	3.6	5.4	4.1	3.6	3.9	3.3	4.2	3.4	3.1	4.6	2.1	6.5	3.2	2.8	4.9	5.3	4.6	4.6	1.6	5.6	35.6	4.5	4.0	2.2	3.3	7.5	5.3	2.7	5.8	4.8	2.2	3.9	2.4	5.6	6.3	4.2	3.7	3.3	6.7	4.1	2.8	4.4	7.9	7.2	4.5	4.1	2.4	8.3	7.3	5.7	3.7	6.0	2.6	2.9	3.0	5.5	4.2	10.3	2.3	3.6	5.7	6.2	6.2	3.3	5.2	3.6	3.2	2.3	4.7	7.2	9.5	5.0	10.7	5.3	7.6	10.5	3.2	6.4	11.8	8.9	13.1	6.0	3.9	6.4	7.2	3.4	8.9	10.8	15.8	14.0	9.9	9.3	10.4	11.5	7.1	9.7	0.0	1.7	5.1	4.5	8.0	35.6	5.6	2.5	2.7	3.4	0.0	23.6	4.1	0.0	4.0	0.9	4.2	9.2	0.0	3.6	3.2	4.6	5.2	1.1	2.9	2.5	31.8	7.5	5.5	1.8	0.7	11.8	3.6	3.3	1.8	5.0	16.4	3.2	7.4	13.8	1.4	57.5	6.5	7.8	10.7	13.8	11.7	5.6	8.7	5.6	4.1
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.3	0.3	0.5	34.9	7.8	0.4	0.4	0.3	1.1	0.9	6.8	33.5	0.2	1.4	5.8	0.6	0.2	0.2	16.5	14.2	1.6	4.9	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.5	0.4	2.3	3.7	1.3	0.0	4.3	6.4	2.6	12.3	0.1	23.3	12.3	0.6	4.9	1.4	2.8	4.4	4.3	6.2	5.7	1.8	0.3	2.6	2.7	3.9	0.6	7.7	2.3	2.8	4.4	4.2	1.6	1.4	2.8	2.1	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9	80.4	286.5	25.1	1.9	5.6	52.2	3.2	7.6	5.3	21.6	14.0	137.4	5.1	0.0	16.9	1.5	10.3	2.6	0.0	11.7	67.8	9.3	5.6	8.1	4.0	21.8	22.3	14.3	18.4	26.3	1.5	10.0	16.2	6.8	10.8	9.0	28.2	22.2	0.0	14.5	4.4	124.0	0.0	12.3	1.7	9.8	3.4	26.5	26.7	2.5	1.6
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 177.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 58.2;naive B-cell: 62.1"	"Lineage enriched"	"Detected in many"	10	"B-cells: 62.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 104.3;HSkMC: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: AB_2685091"	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	21.1	25.1	39.2	22.7	31.9	7.5	18.4	12.9	37.7	28.0	44.0	13.5	15.4	12.5	31.8	19.3	31.7	31.4	29.3	107.1	23.0	17.2	22.9	14.4	39.0	17.9	16.7	25.9	17.2	13.3	13.8	19.5	32.6	14.3	30.2	13.3	26.2	18.8	32.5	25.6	8.0	17.9	52.8	11.9	13.2	24.1	41.5	11.4	3.2	25.8	18.6	18.2	42.2	20.3	62.1	6.2	0.4	0.3	0.7	1.6	3.1	5.3	5.4	8.8	5.8	13.4	27.4	1.3	12.8	104.3	14.5	11.0	12.4	2.4	20.5	10.5	11.2	12.1	2.0	1.7	2.8	4.7	10.4	3.2	3.2	0.8	8.8	12.4	0.4	0.2	42.3	5.7	7.0	1.6	7.3	32.3	5.7	2.5	0.5	1.3	6.7	3.2	5.2	4.7	0.0	7.8	0.5	0.2	0.5	8.0	1.1	3.6	11.8	3.3	1.5	8.6	4.0	4.1	2.6	20.9	19.9	8.9	8.8	6.1	2.8	7.7	14.4	9.9	0.3	8.5	0.4	0.3	0.1	0.2	0.2	0.2	58.2	0.3	0.3	1.5	62.1	1.0	1.6	0.4	0.7	0.2	6.2	0.1	3.1	39.2	31.9	12.9	37.7	23.0	17.2	16.7	25.9	14.3	11.4	8.9	6.7	86.2	15.6	22.3	17.8	177.7	22.9	76.3	13.6	43.6	19.6	11.6	107.8	61.0	80.2	91.6	30.7	0.0	27.2	12.5	63.7	12.6	46.2	28.4	7.2	9.5	42.4	39.3	3.1	23.1	67.6	9.1	47.2	11.8	13.1	46.7	31.9	44.8	57.7	115.7	24.6	116.4	170.2	111.2	27.2	26.2	30.7	5.2	21.3	9.2
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268978-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	40.6	48.6	50.9	42.7	56.8	52.8	53.0	52.5	60.5	23.4	26.2	41.2	25.9	36.5	26.3	23.4	25.8	23.6	23.1	52.6	50.8	35.5	22.1	47.9	29.1	48.8	48.6	43.6	54.1	41.8	34.9	36.4	22.1	40.2	22.5	19.7	31.7	34.0	21.6	108.9	35.1	35.8	24.4	48.5	42.9	30.6	13.0	51.2	22.7	29.9	24.9	32.5	26.8	35.6	7.1	27.3	17.8	5.8	5.8	7.2	3.7	38.7	39.0	20.4	19.2	35.2	18.0	19.1	21.0	25.0	19.1	14.5	18.1	20.1	37.2	33.7	17.9	20.9	11.8	18.8	16.4	10.0	62.5	29.0	22.1	23.4	29.0	21.4	36.9	38.1	15.6	23.2	12.5	19.5	33.3	13.0	25.0	26.5	55.8	15.0	44.4	40.4	14.7	16.9	35.8	13.2	39.7	25.9	35.1	15.9	24.8	34.4	26.1	39.1	42.6	70.6	18.6	17.2	29.7	21.9	32.5	21.9	21.3	28.2	56.2	56.2	40.4	30.1	23.6	42.3	17.8	4.7	5.7	3.9	5.8	4.8	5.6	4.0	5.1	7.1	7.1	3.6	3.5	4.2	5.8	3.5	27.3	7.2	3.7	50.9	56.8	52.5	60.5	50.8	35.5	48.6	43.6	40.2	51.2	6.0	19.0	63.3	21.7	21.1	61.7	62.0	20.4	5.3	9.1	29.6	31.4	20.0	48.0	27.2	0.6	27.9	41.8	0.0	49.5	31.8	22.8	23.4	19.7	42.9	101.1	89.0	50.1	31.3	52.2	2.4	29.7	43.7	25.3	34.3	33.1	60.1	34.5	36.6	29.4	35.6	44.7	12.9	29.9	9.5	10.4	21.7	14.6	39.9	28.2	27.4
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
MAP1LC3A	"ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3"	ENSG00000101460	"Microtubule associated protein 1 light chain 3 alpha"	Q9H492	20	34546854-34560345	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 529.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 30.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7;HSkMC: 29.8;SCLC-21H: 19.0;SK-BR-3: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007649, CAB037174, HPA042824, HPA052474, HPA052484"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.76e-1)"	29.8	15.1	38.3	10.3	33.6	10.7	16.8	45.6	59.8	15.8	22.7	17.8	9.6	24.2	16.1	15.8	13.6	16.1	18.7	30.3	39.0	46.8	15.3	31.9	11.8	20.4	41.6	46.7	11.9	20.7	17.8	26.6	9.7	38.3	16.9	16.2	13.6	14.2	15.4	29.7	23.3	26.8	18.8	29.0	12.1	13.5	15.7	18.2	1.1	17.6	10.2	24.5	13.0	13.5	3.4	1.4	30.6	1.6	1.1	4.0	1.0	0.0	1.6	1.9	0.0	12.8	17.9	0.0	9.4	9.0	7.0	6.7	0.0	0.1	0.0	0.1	9.5	14.6	1.9	0.0	3.5	1.4	2.1	0.7	0.0	6.8	0.0	19.7	0.0	4.2	29.8	0.4	4.7	1.7	0.0	4.2	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.6	1.3	1.8	0.0	0.0	0.0	0.0	0.0	19.0	10.9	10.7	26.4	0.0	8.1	0.1	7.8	7.2	15.0	0.1	3.0	4.0	0.0	2.0	0.0	9.9	0.0	6.2	1.3	1.3	3.6	1.9	1.6	1.4	3.4	2.0	2.0	0.4	1.6	0.6	1.2	30.6	1.1	0.6	1.4	4.0	1.0	38.3	33.6	45.6	59.3	39.0	46.8	41.6	46.7	38.3	18.2	0.0	10.0	22.9	100.3	51.3	101.3	26.0	38.2	0.0	4.5	43.6	80.5	21.4	96.2	37.2	114.7	50.7	91.8	0.0	21.1	13.1	62.2	110.0	18.4	30.0	30.5	66.7	158.5	72.4	15.0	529.1	88.1	21.5	59.1	34.3	62.1	64.8	36.7	74.8	102.2	83.7	109.6	135.8	103.0	48.2	14.0	44.9	177.1	20.3	71.0	69.8
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.7	8.4	11.0	8.6	11.7	9.9	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.1	13.3	22.0	17.3	13.9	11.8	18.8	13.4	24.2	14.1	9.4	6.2	12.4	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	20.4	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.6	13.9	14.2	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4	8.9	8.2	2.2	0.1	0.0	1.5	0.5	0.0	2.7	4.5	8.7	0.0	1.5	0.0	6.0	1.1	0.6	1.6	0.0	2.5	0.7	0.7	0.3	2.3	0.0	1.3	1.6	0.0	0.6	0.3	1.6	0.6	4.6	0.0	29.7	1.6	1.0	3.9	2.5	1.4	0.6	3.7	0.0	1.4	2.7	0.5	0.4	2.1	1.0	1.9	0.1
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 5.1;Spermatocytes: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	9.9	11.0	7.6	6.7	7.8	6.7	8.1	18.3	8.5	9.2	9.6	10.3	6.9	5.6	12.9	10.4	7.0	9.4	5.6	6.8	6.8	5.3	6.8	9.5	6.8	8.3	7.5	5.2	9.1	9.5	13.2	11.8	8.1	8.4	11.2	8.2	10.7	12.2	8.3	13.2	8.7	7.7	8.3	6.1	10.2	8.8	21.1	8.6	12.8	8.5	4.8	10.5	13.3	9.9	8.5	7.5	7.4	6.0	9.4	11.8	4.9	2.3	4.6	6.2	3.6	6.9	4.1	17.2	5.7	6.9	6.8	7.9	4.9	2.1	4.9	2.3	4.2	9.1	7.1	4.6	6.9	5.4	4.9	3.0	3.4	7.4	5.4	8.1	8.0	5.4	4.1	7.8	8.4	6.9	4.4	7.1	5.7	5.7	7.4	6.4	5.0	6.2	3.0	4.9	5.7	5.9	5.2	8.5	7.0	2.9	3.3	7.0	4.7	10.8	5.6	3.2	5.5	7.4	4.6	4.9	4.4	4.0	4.3	4.4	9.9	21.2	6.3	5.6	2.5	7.2	3.3	4.9	7.4	9.3	6.0	10.6	7.4	6.4	11.8	7.0	8.5	8.4	9.1	6.5	9.4	4.0	7.5	7.9	4.9	7.6	7.8	18.3	8.5	6.8	5.3	7.5	5.2	8.4	8.6	0.0	0.3	0.0	1.0	1.3	0.8	1.6	5.1	0.0	2.3	0.0	0.0	1.8	1.7	1.7	2.1	0.7	0.6	0.0	0.5	0.6	1.1	0.5	0.0	1.0	1.7	1.6	0.0	1.3	0.6	3.7	0.6	0.9	0.0	0.0	0.6	1.3	0.4	0.0	1.8	0.7	1.4	0.0	1.2	5.1	1.3	0.9	2.2	0.8	0.9	0.7
TRIM3	"BERP, HAC1, RNF22, RNF97"	ENSG00000110171	"Tripartite motif containing 3"	O75382	11	6448613-6474459	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043396, HPA048233"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043396: AB_2678460, HPA048233: AB_2680321"	"unprognostic (1.24e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (4.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	6.9	5.4	9.0	5.8	8.8	1.6	6.2	34.0	17.1	6.3	8.1	9.4	3.4	22.6	8.7	2.6	3.7	5.9	5.3	6.1	6.8	7.0	3.9	3.8	6.2	3.0	8.1	9.6	5.8	5.3	2.8	3.8	5.3	14.3	7.7	6.5	6.1	9.2	7.7	9.3	7.1	19.5	8.9	7.3	4.9	8.6	3.0	7.0	0.7	4.2	2.5	2.1	6.6	5.8	0.5	3.9	1.8	3.0	2.0	1.9	1.5	4.3	7.5	3.0	5.1	5.1	4.9	4.1	6.2	3.7	4.8	5.4	4.5	3.0	2.4	2.2	4.7	5.6	3.0	3.1	4.6	1.8	2.8	4.6	0.7	7.5	3.0	3.1	0.2	2.5	4.2	2.2	3.7	2.0	2.0	4.8	1.7	1.0	2.9	4.6	9.0	0.2	0.6	2.2	8.9	6.5	1.4	2.6	2.9	1.1	2.2	3.1	4.9	3.4	33.9	4.0	1.6	12.8	0.8	8.1	12.7	6.0	9.2	4.1	3.4	2.0	0.5	6.9	1.0	4.7	0.0	3.0	1.8	1.7	2.9	1.3	0.4	1.4	1.4	3.9	0.5	0.5	1.9	0.0	2.0	0.8	0.8	1.5	1.5	9.0	8.8	34.0	17.1	6.8	7.0	8.1	9.6	14.3	7.0	6.0	0.0	2.0	2.6	4.2	8.5	1.7	2.5	2.7	0.0	0.0	9.8	1.6	0.0	2.8	3.1	4.7	17.1	0.0	2.9	2.0	6.1	4.0	1.1	1.9	4.1	7.9	4.6	4.3	1.0	3.9	5.5	2.8	6.8	3.6	10.7	1.7	2.6	5.7	4.9	2.4	8.7	12.9	10.2	1.9	4.9	4.6	0.7	0.7	5.2	1.6
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 565.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.7"	"Low cell line specificity"	"Detected in many"											"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.5	9.0	12.9	10.4	14.1	12.1	14.1	20.3	16.6	9.9	8.5	7.6	17.1	11.8	14.2	13.7	4.2	14.9	11.2	4.7	9.3	6.8	13.0	6.8	8.8	7.9	5.4	13.7	14.0	13.7	15.9	22.7	5.8	8.9	14.9	5.2	16.7	13.6	13.8	6.2	8.9	8.9	11.3	3.8	7.7	11.4	23.7	8.8	10.6	19.8	5.2	9.6	7.9	7.2	0.6	1.6	1.9	0.6	0.4	10.7	1.5	4.4	9.1	4.8	6.3	2.9	5.3	5.7	3.5	3.5	2.6	2.2	2.7	7.1	2.4	3.3	2.8	2.6	10.6	1.3	6.3	1.4	2.5	9.5	3.9	15.2	5.8	3.8	3.8	5.0	5.3	5.0	4.9	6.4	5.9	3.1	3.5	5.0	1.3	1.7	6.6	7.2	7.3	1.6	2.6	3.7	4.1	2.0	3.3	4.9	5.6	16.5	10.3	3.1	15.0	5.9	3.1	8.8	4.4	3.2	10.1	9.2	4.3	6.9	9.7	1.0	0.8	7.8	4.3	3.9	0.5	0.6	0.7	0.9	0.2	0.4	0.6	0.8	1.2	0.5	0.6	5.2	10.7	1.9	0.4	0.1	1.6	0.3	1.5	12.9	14.1	20.3	16.6	9.3	6.8	5.4	13.7	8.9	8.8	23.8	60.8	37.4	20.2	10.4	19.7	3.1	17.8	48.2	48.9	27.9	39.3	31.4	8.3	13.7	115.3	5.7	26.4	0.0	15.5	30.4	7.5	25.4	34.6	86.9	26.3	23.8	41.0	8.0	35.8	565.2	7.5	30.7	32.1	26.2	34.7	9.8	13.9	23.2	9.6	7.5	66.2	6.5	10.3	10.8	5.3	15.9	10.4	40.5	26.6	15.3
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30556886-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.0;HAP1: 12.6;JURKAT: 8.8;U-266/84: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	7.6	5.6	9.7	5.5	7.4	4.0	3.5	15.0	13.8	5.4	4.5	5.6	3.1	2.5	7.3	15.3	3.6	6.2	4.0	3.2	10.1	12.1	4.3	3.8	4.9	6.1	5.9	7.6	13.5	5.4	10.6	8.8	3.4	8.0	4.4	5.3	6.9	2.6	6.9	3.1	6.5	3.4	3.8	4.6	5.0	5.9	8.6	5.7	11.1	4.9	1.7	5.6	6.4	4.0	2.0	2.3	1.5	1.2	1.3	1.9	0.4	0.6	1.6	5.3	10.0	2.6	0.9	0.0	0.0	0.0	0.0	0.0	4.6	0.5	4.6	3.9	0.9	3.5	0.6	12.6	1.0	0.0	2.7	4.5	6.7	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	0.0	0.0	8.8	7.3	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.2	0.0	6.8	2.3	0.6	0.0	0.0	0.0	3.1	0.7	4.0	0.0	0.0	0.0	7.6	8.5	4.4	0.0	2.6	2.9	1.5	1.2	0.3	0.5	0.3	1.0	1.0	1.6	1.2	1.0	2.0	0.9	1.9	1.0	1.3	0.6	2.3	0.0	0.4	9.7	7.4	15.0	13.8	10.1	12.1	5.9	7.6	8.0	5.7	8.9	22.1	16.0	6.3	5.0	9.0	2.4	7.6	14.7	13.6	3.5	13.7	12.1	6.6	4.0	0.6	5.0	7.9	0.0	8.1	6.2	9.1	4.6	11.5	3.9	7.0	6.4	7.5	9.2	6.2	1.8	9.5	7.7	10.1	10.0	7.6	8.0	4.9	5.3	9.6	8.2	18.5	6.5	7.2	8.1	5.9	5.0	8.2	10.2	6.5	3.4
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.9	4.3	7.2	5.5	5.3	4.7	5.6	5.4	6.6	5.1	5.8	15.3	4.2	5.0	1.7	6.2	8.0	10.0	7.8	4.1	7.3	3.2	13.1	8.4	19.6	4.1	2.8	12.9	6.3	6.9	6.8	5.7	4.6	3.5	4.3	6.9	4.7	4.8	4.9	4.9	8.7	21.2	4.6	5.0	6.8	9.2	12.0	6.6	3.8	4.5	32.2	7.2	4.1	14.5	4.0	5.3	8.3	6.1	7.1	6.7	9.1	5.1	7.7	14.2	6.0	10.0	15.3	5.7	4.5	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1	14.9	17.0	2.7	1.7	5.3	7.7	67.8	0.0	5.3	13.6	3.5	15.7	2.0	1.7	1.6	5.2	4.6	3.6	0.0	1.2	1.1	4.5	2.6	4.7	3.9	1.2	17.5	6.3	6.2	4.0	4.5	6.6	3.5	5.0	0.0	4.3	4.4	1.8	0.0	5.3	2.1	9.9	0.0	3.3	3.4	4.8	6.5	2.2	2.6	3.7	2.5
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021496	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 110.4;Cone photoreceptor cells: 117.8;Horizontal cells: 66.7;Intestinal endocrine cells: 60.0;Rod photoreceptor cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 20.0"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 20.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 40.3;SH-SY5Y: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA					"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	2.1	11.1	29.2	2.5	35.7	1.7	2.1	57.5	87.0	1.5	3.3	7.5	0.0	20.6	3.3	2.4	1.3	3.1	3.3	2.8	32.4	32.1	8.9	2.6	1.9	4.0	23.9	27.8	3.6	16.7	27.0	7.4	3.8	31.1	2.6	3.1	10.7	4.1	1.9	0.8	1.6	14.7	2.1	11.9	3.6	8.2	5.6	5.6	0.0	3.8	0.0	5.3	5.5	0.7	0.2	20.0	0.8	0.1	0.3	0.2	0.2	0.6	8.1	1.7	5.7	0.1	0.1	0.2	0.2	0.2	1.8	0.6	2.1	4.0	12.2	3.9	0.4	1.5	0.5	6.9	0.5	0.6	1.9	0.8	1.5	0.8	11.2	1.2	0.3	5.2	0.6	0.9	0.4	0.1	1.2	0.7	4.5	0.1	10.0	0.4	6.6	0.5	4.4	6.0	0.9	3.2	0.2	1.4	2.9	0.4	3.8	40.3	22.5	8.8	6.1	12.2	1.3	3.4	14.8	0.5	0.5	3.9	0.8	0.5	0.9	1.0	1.1	1.4	9.4	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.8	0.3	0.1	20.0	0.0	0.2	29.2	35.7	57.5	64.8	32.4	32.1	23.9	27.8	31.1	5.6	0.0	0.6	2.2	0.6	0.2	110.4	2.4	10.2	2.7	0.0	5.2	117.8	0.1	1.7	4.0	0.4	0.7	4.2	0.0	36.9	0.1	0.8	0.9	0.0	0.6	10.4	66.7	60.0	9.2	4.7	0.6	2.0	0.5	1.7	0.0	2.0	20.0	9.3	5.8	6.0	10.7	156.4	0.0	1.0	1.7	3.4	0.1	0.1	0.0	1.9	0.4
MADD	"DENN, KIAA0358, RAB3GEP"	ENSG00000110514	"MAP kinase activating death domain"	Q8WXG6	11	47269161-47330031	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.3"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038568	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038568: AB_10795030"	"unprognostic (3.16e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (6.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.36e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.78e-2)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.25e-4)"	7.7	18.2	18.3	11.5	27.6	16.9	8.7	66.3	46.5	9.2	10.8	15.5	13.1	8.6	9.4	8.9	6.9	9.4	8.6	13.8	20.2	18.4	9.8	7.7	11.0	13.2	15.5	19.8	14.0	12.2	18.8	26.7	11.2	20.7	12.5	12.0	16.0	10.2	14.0	16.1	14.0	9.8	10.5	11.3	12.3	13.2	19.4	11.0	14.6	8.4	6.0	12.2	11.0	7.8	3.5	4.1	20.8	5.8	4.5	5.7	4.4	6.5	13.6	14.9	13.3	10.2	7.1	3.3	9.2	12.3	11.7	12.7	9.9	6.2	13.8	2.9	10.0	15.2	12.9	12.0	6.4	10.2	15.3	12.3	24.5	25.2	8.4	7.4	16.6	33.8	6.9	6.9	6.2	7.8	8.0	10.7	8.9	15.7	10.2	10.3	9.1	7.8	17.9	8.9	15.3	9.4	10.8	24.0	9.1	6.1	31.1	23.6	15.3	11.8	14.0	8.1	9.2	11.0	12.7	9.1	11.0	7.0	15.6	6.1	12.1	12.5	7.9	10.2	11.8	10.3	20.8	2.6	4.8	4.8	4.6	4.2	3.5	3.4	4.0	4.1	3.3	4.0	3.1	0.7	4.5	5.8	2.2	5.7	4.4	18.3	27.6	66.3	44.6	20.2	18.4	15.5	19.8	20.7	11.0	11.9	8.6	9.0	3.5	9.5	72.8	22.6	10.2	1.4	3.4	7.0	117.8	3.9	0.0	7.0	11.4	9.5	12.1	0.0	4.2	1.9	6.1	7.5	26.5	5.0	10.1	125.5	15.6	17.8	18.3	4.0	6.6	10.6	10.1	9.0	17.0	13.7	8.8	10.5	12.0	4.2	106.1	6.5	6.2	14.6	21.5	7.2	3.7	6.9	11.2	4.8
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843063	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0"	"Cell type enhanced"	"Detected in many"	15	"Leydig cells: 99.8;Peritubular cells: 64.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	2.5	1.9	8.0	2.4	5.2	6.0	2.2	9.7	7.2	2.5	2.0	1.2	1.3	1.5	6.7	1.9	1.3	2.7	2.4	3.3	6.2	6.1	1.0	1.2	1.2	2.2	2.5	5.8	19.1	1.1	82.4	6.8	1.0	6.0	1.8	1.4	4.6	44.3	1.7	2.0	2.3	1.3	6.6	5.5	1.8	1.2	32.0	5.2	0.0	3.1	2.4	1.3	2.2	2.3	3.4	7.6	3.3	3.8	2.0	2.4	0.5	0.3	0.4	1.6	3.7	1.3	1.4	1.4	1.2	2.4	0.8	0.7	0.4	0.5	1.5	0.7	0.6	0.8	0.1	1.6	0.1	0.3	3.2	2.8	0.9	1.2	1.1	0.4	0.9	1.8	0.5	0.6	1.5	0.1	2.5	0.2	1.5	1.0	1.6	0.1	0.8	1.8	3.0	0.5	0.1	0.6	1.4	0.3	0.7	0.3	0.1	2.2	0.9	0.4	0.6	1.0	0.9	0.3	1.8	0.2	0.3	0.9	1.9	0.7	2.7	15.3	4.5	0.9	4.4	0.5	3.3	3.8	0.3	1.1	2.0	2.4	2.2	1.4	1.4	2.5	3.4	1.7	1.3	1.3	2.0	1.8	7.6	0.7	0.5	8.0	5.2	9.7	7.2	6.2	6.1	2.5	5.8	6.0	5.2	0.0	1.4	20.6	0.4	0.5	0.6	0.9	7.6	1.4	1.2	1.8	2.0	1.9	0.0	3.2	1.4	1.6	8.4	0.0	1.6	1.4	3.4	0.5	0.0	5.9	6.3	7.9	11.1	1.3	23.6	4.3	99.8	3.4	0.0	2.8	4.9	1.9	2.6	0.0	64.0	0.0	1.0	12.9	3.3	3.4	2.7	1.4	1.9	3.8	5.6	0.1
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60187347-60281412	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.0;brain: 26.8;parathyroid gland: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Intestinal endocrine cells: 33.7;Mucus-secreting cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	20	"basophil: 41.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 41.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 11.6;JURKAT: 11.4;K-562: 21.0;NB-4: 12.1;OE19: 18.4"	"Region enriched"	"Detected in some"	37	"cerebellum: 1413.4"	"Region enriched"	"Detected in all"	9	"cerebellum: 163.0"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA					"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	2.3	1.5	9.2	1.1	11.6	1.1	6.5	26.8	6.9	6.3	2.2	3.6	0.6	1.8	2.8	12.8	0.9	2.5	1.0	3.8	7.8	6.0	7.4	0.6	1.6	1.0	4.2	5.3	0.7	3.0	56.8	9.8	8.1	3.4	3.3	3.1	1.5	6.6	0.9	2.0	0.9	1.7	1.3	1.9	1.3	5.9	9.3	6.2	1.7	0.7	1.3	1.0	1.3	2.1	0.1	2.0	41.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.1	0.0	11.6	4.9	0.0	0.0	3.9	1.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.4	21.0	0.2	0.0	0.0	3.3	12.1	0.2	18.4	0.0	0.0	0.0	0.2	0.4	0.9	5.3	0.0	0.0	1.1	0.0	2.4	4.9	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	41.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.2	11.6	26.8	6.9	7.8	6.0	4.2	5.3	3.4	6.2	0.0	3.7	0.0	0.2	0.9	0.9	3.3	0.0	1.4	6.8	3.5	0.0	7.7	3.3	4.0	7.7	5.3	0.4	0.0	5.4	0.3	3.4	1.8	0.0	0.0	7.4	0.0	33.7	0.0	2.7	3.6	1.4	0.2	6.8	0.0	16.7	2.3	1.5	2.9	1.4	0.0	0.8	0.0	0.4	3.6	4.5	0.4	1.1	0.0	2.3	0.1
ZNF319	"KIAA1388, Zfp319"	ENSG00000166188	"Zinc finger protein 319"	Q9P2F9	16	57994668-58000453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052584	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052584: AB_2681873"	"unprognostic (1.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.87e-5)"	"unprognostic (8.69e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.80e-2)"	8.0	8.4	7.6	7.5	7.7	21.3	7.1	11.2	15.0	11.0	8.0	10.6	5.1	6.7	12.0	8.0	6.1	9.7	10.6	6.7	7.3	8.2	7.8	5.7	8.5	10.4	7.1	6.2	13.7	10.6	17.1	7.0	9.4	9.4	8.7	4.3	11.2	8.6	10.8	8.9	6.9	6.6	8.8	6.4	13.9	6.5	6.1	6.0	16.9	19.8	5.6	10.2	11.2	6.2	1.6	2.9	7.4	2.6	1.8	5.3	2.5	4.9	13.5	6.7	9.0	6.2	7.6	5.6	7.1	7.0	6.9	3.4	5.3	2.9	8.4	13.0	6.8	5.6	5.5	5.5	7.6	4.2	3.6	5.3	3.1	5.8	6.3	12.3	4.0	10.7	11.1	9.0	5.5	12.0	6.6	4.3	6.2	6.6	1.4	5.7	4.3	7.7	6.9	3.7	2.4	13.5	13.7	4.5	8.3	4.5	12.8	4.8	5.1	11.8	4.4	4.5	4.8	1.6	6.0	8.4	5.4	3.2	2.7	5.4	7.6	3.2	6.5	4.0	4.2	5.8	0.0	2.6	7.4	5.3	1.9	3.6	1.6	2.8	3.7	2.9	1.6	1.9	3.0	4.8	1.8	1.5	1.1	2.3	2.5	7.6	7.7	11.2	15.0	7.3	8.2	7.1	6.2	9.4	6.0	3.0	4.3	0.0	0.5	0.8	2.0	5.1	5.1	4.0	1.2	0.0	0.0	1.4	3.3	2.1	0.2	1.6	1.0	0.0	2.5	0.9	1.6	0.6	1.1	1.6	1.9	0.0	4.7	4.9	9.1	0.0	2.8	1.2	0.0	1.0	1.4	2.8	2.7	0.0	3.2	1.0	2.9	0.0	1.0	1.9	0.7	1.1	0.2	2.5	1.3	0.0
VPS16		ENSG00000215305	"VPS16, CORVET/HOPS core subunit"	Q9H269	20	2840703-2866732	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043229, HPA048661"	Approved					NA	NA		6600			"HPA043229: AB_2678373, HPA048661: AB_2680484"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (9.30e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.65e-2)"	"prognostic favorable (5.89e-5)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (1.33e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-3)"	17.1	16.9	16.6	19.1	21.6	21.7	16.9	29.2	29.2	16.9	14.8	18.7	13.2	18.6	23.1	14.7	16.5	17.5	15.4	13.5	17.4	14.5	14.8	16.7	17.3	17.8	22.2	20.7	20.1	22.0	22.8	17.0	15.4	19.9	17.4	12.2	15.4	20.8	15.3	16.9	23.6	19.4	23.0	15.3	23.6	17.1	14.6	17.1	20.3	22.7	12.1	18.4	17.2	17.2	8.7	20.7	17.6	17.7	21.5	23.8	14.8	14.7	20.3	16.4	15.9	15.6	17.6	9.2	13.5	17.6	15.7	14.2	12.1	14.4	9.9	9.5	14.9	24.9	19.3	14.0	25.1	8.5	16.2	11.4	11.7	8.1	13.1	16.2	11.7	12.2	22.4	11.9	18.4	12.1	10.2	15.2	19.3	16.4	17.2	13.4	15.5	10.9	21.3	15.7	22.8	17.1	14.4	11.8	15.5	14.7	13.7	13.8	22.7	14.3	32.6	14.6	11.1	16.7	14.5	13.3	15.7	14.4	10.0	8.8	23.6	23.6	9.3	7.3	21.1	14.8	11.8	16.6	17.6	23.8	15.8	13.1	8.7	10.7	15.3	20.7	6.8	11.2	14.4	9.2	21.5	17.7	6.9	15.9	14.8	16.6	21.6	29.2	29.2	17.4	14.5	22.2	20.7	19.9	17.1	11.9	15.7	10.7	10.9	5.4	11.4	6.3	12.7	8.1	3.4	12.2	7.9	11.7	8.3	15.4	1.8	12.0	26.6	23.3	11.6	15.1	9.7	5.3	6.9	13.4	20.5	22.3	5.2	8.0	19.2	3.0	12.0	12.5	13.5	25.2	11.1	19.5	13.0	9.0	8.9	17.2	13.1	12.9	10.8	18.2	14.2	3.3	11.8	15.3	10.3	8.6
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149880-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068"	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favorable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.2	5.9	6.2	4.3	8.7	3.1	6.8	10.7	11.8	6.4	4.5	11.5	6.6	3.2	6.6	8.5	5.0	8.7	5.7	4.2	7.2	6.4	6.3	11.2	4.5	8.2	7.3	6.2	8.3	5.0	8.6	8.2	5.9	6.7	5.0	4.0	7.4	4.6	5.8	4.8	4.9	4.6	5.8	6.1	6.7	4.4	41.2	8.2	9.7	6.2	2.1	8.3	6.2	7.5	12.8	6.6	8.0	6.6	17.9	14.2	9.0	4.9	8.4	8.0	7.2	15.9	9.8	9.0	12.0	8.0	10.1	8.4	6.4	4.6	6.2	7.0	7.5	16.1	7.0	8.1	6.8	10.7	11.0	7.2	7.5	5.9	6.4	14.2	6.2	7.6	11.6	13.0	9.2	11.9	10.5	9.3	8.2	6.3	24.8	12.7	4.7	8.0	8.8	5.6	8.4	9.0	7.7	10.7	11.5	8.2	6.0	6.6	6.6	6.4	11.0	12.1	5.7	4.7	7.5	7.2	8.8	6.1	8.1	9.6	13.3	13.2	6.4	7.2	10.0	7.7	1.9	6.6	8.0	11.2	6.1	14.2	12.8	11.4	13.4	6.6	11.5	13.2	13.7	7.0	17.9	6.1	6.0	12.6	9.0	6.2	8.7	10.7	11.8	7.2	6.4	7.3	6.2	6.7	8.2	0.0	2.1	11.8	2.6	2.3	6.6	2.4	0.0	5.3	1.2	5.2	0.0	7.4	6.6	3.1	194.1	2.6	2.9	0.0	2.1	3.0	4.0	2.7	2.3	5.8	3.8	0.0	1.2	5.5	3.5	86.2	6.9	2.7	3.3	1.0	2.2	7.0	1.7	2.9	7.4	5.4	3.9	0.0	3.1	42.3	11.7	3.8	8.0	6.4	2.1	1.8
PCED1A	"bA12M19.1, C20orf81, FAM113A, FLJ22376"	ENSG00000132635	"PC-esterase domain containing 1A"	Q9H1Q7	20	2835314-2841190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA050816: AB_2681246"	"unprognostic (3.20e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.97e-3)"	18.0	17.3	25.5	21.9	29.1	13.1	14.4	18.7	29.0	17.6	13.4	27.6	18.8	17.1	23.8	20.3	12.6	22.4	23.0	9.7	24.2	17.1	23.1	21.0	16.4	23.5	30.0	20.8	28.4	16.1	38.2	27.0	16.4	25.1	25.4	9.1	21.6	23.7	18.3	6.9	12.7	18.2	15.2	14.5	33.1	20.0	9.4	28.7	14.2	36.0	4.8	16.7	15.8	17.6	9.4	8.2	3.1	7.4	14.2	12.0	6.8	12.5	16.6	16.9	9.3	17.7	24.5	12.2	12.1	13.9	13.0	14.2	11.6	23.2	3.7	8.4	8.2	21.7	20.7	4.0	11.3	6.1	18.2	12.4	14.5	18.4	16.0	14.3	2.8	4.9	32.5	24.1	15.9	21.2	18.7	9.3	18.9	11.4	17.4	9.5	8.7	2.0	18.3	18.6	9.6	9.9	10.0	5.6	7.6	14.6	10.6	15.7	24.2	12.0	15.9	20.8	11.2	20.4	9.8	8.9	12.8	8.8	13.1	5.8	28.7	14.2	1.0	3.1	10.3	15.0	2.9	7.4	3.1	11.0	6.6	10.6	8.6	6.4	9.3	8.2	9.4	12.0	10.6	0.6	14.2	6.1	7.1	4.5	6.8	25.5	29.1	18.7	29.0	24.2	17.1	30.0	20.8	25.1	28.7	14.9	20.3	6.4	10.6	3.5	10.9	4.0	5.1	6.7	10.3	8.7	9.8	4.4	11.6	3.2	0.4	8.3	6.8	0.0	1.8	2.2	8.9	7.3	0.0	11.3	6.1	11.1	8.1	11.6	8.6	2.8	8.3	8.0	1.7	2.8	6.7	9.3	4.1	7.0	2.1	8.4	11.9	6.5	7.6	11.5	7.6	3.1	2.9	11.7	5.4	5.2
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL2, scribble cell polarity complex component"	Q6P1M3	17	75525080-75575208	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 157.1;Enterocytes: 176.2;Pancreatic endocrine cells: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 6.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;OE19: 28.3;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favorable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	1.7	3.9	1.5	17.3	4.2	1.4	4.2	5.1	3.7	7.1	27.5	5.2	23.0	22.9	2.8	17.1	24.3	6.4	45.7	1.7	1.7	1.0	35.6	17.1	16.0	2.1	11.2	1.8	4.6	37.5	5.0	8.3	5.1	3.6	6.6	11.9	6.3	21.4	20.0	0.7	13.9	36.0	1.2	2.5	9.6	27.7	4.3	4.9	1.5	13.4	13.0	13.6	7.0	10.6	0.6	2.2	0.3	0.6	4.1	6.2	0.9	16.5	15.4	0.0	2.9	0.0	0.0	6.5	0.1	0.1	0.3	0.2	25.9	38.2	1.1	3.9	0.0	1.4	20.9	2.9	2.8	0.0	1.4	5.2	1.1	4.3	9.8	0.1	0.1	2.5	0.0	3.9	0.0	0.6	0.3	0.6	1.6	2.1	1.5	0.0	36.7	0.9	1.9	2.1	28.3	6.1	1.9	0.0	4.1	8.2	26.1	6.4	1.2	3.3	36.6	1.1	3.7	27.7	2.6	0.1	0.0	0.1	0.0	0.2	1.8	2.4	0.4	0.1	0.1	0.7	0.0	0.3	0.1	6.2	0.6	1.4	0.6	1.5	4.2	0.3	0.6	0.2	2.5	0.3	4.1	0.2	2.2	1.0	0.9	1.5	4.2	5.1	3.7	1.7	1.0	11.2	1.8	3.6	4.9	83.4	42.2	11.5	27.2	9.4	5.9	2.8	76.5	26.8	35.2	85.5	157.1	2.8	26.6	74.4	0.5	6.7	176.2	0.0	122.1	7.5	2.2	34.1	21.9	22.9	5.2	7.9	91.3	1.8	2.4	0.2	4.4	4.7	3.3	8.2	85.6	35.2	171.3	90.5	3.9	35.9	116.4	6.5	3.9	1.6	19.4	19.1	3.7	12.9	82.9	76.2
ZNF316	"ENST00000305834, MZF-3"	ENSG00000205903	"Zinc finger protein 316"	A6NFI3	7	6637322-6656432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.74e-1)"	"unprognostic (2.82e-3)"	"unprognostic (9.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (1.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.43e-3)"	7.4	7.1	5.0	8.1	8.7	8.9	8.2	6.0	10.2	7.5	6.4	7.7	7.9	6.0	8.2	10.5	5.3	5.3	7.8	3.4	7.3		4.2	3.3	6.1	7.1	9.4	6.1	7.9	10.0	16.9	5.8	5.0	7.2	5.7	3.7	6.5	5.6	6.9	11.7	8.8	5.6	10.4	5.1	10.6	6.6	8.1	7.9	5.6	8.6	6.3	5.9	5.0	9.3	1.2	2.9	1.4	1.4	2.3	1.4	0.5	12.4	11.1	14.0	13.3	7.5	3.9	8.5	9.9	4.7	4.4	4.6	10.3	9.0	16.7	6.8	7.2	17.6	12.8	6.8	6.7	4.2	5.0	9.3	11.5	16.7	5.8	8.2	14.3	13.2	5.5	7.1	6.8	8.3	9.0	3.8	7.7	21.2	8.4	5.0	20.9	5.3	18.2	7.9	8.6	8.4	9.9	10.7	7.2	4.5	28.4	16.3	26.7	7.2	27.0	8.0	12.5	15.5	15.7	7.0	8.9	17.7	12.6	13.2	18.5	17.0	13.5	7.0	12.0	17.7	0.0	1.2	0.8	0.9	1.4	1.3	1.1	0.9	1.4	0.9	1.2	0.6	0.9	1.4	2.3	0.6	2.9	1.0	0.5											6.0	9.4	1.4	2.7	0.0	12.1	8.5	12.7	2.7	6.8	14.0	9.8	2.9	3.3	4.0	0.6	6.3	5.6	0.0	5.2	1.7	3.7	6.9	1.1	11.4	6.3	17.5	16.0	9.8	11.2	0.4	6.1	4.2	0.0	2.8	10.2	5.6	5.2	5.8	6.7	2.9	7.5	0.0	2.5	2.6	3.1	0.0	1.8	4.4	8.1	4.6
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.2"	"Cell type enhanced"	"Detected in many"	8	"Proximal tubular cells: 851.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced					NA	NA					"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	11.3	43.9	14.8	6.3	16.7	6.4	11.0	11.3	17.4	12.5	33.4	9.2	10.8	51.5	11.7	14.9	8.9	10.2	11.3	14.5	13.4	9.8	49.6	73.2	9.1	8.9	18.3	17.1	19.9	20.0	11.3	13.7	5.5	15.2	11.5	9.2	13.9	16.2	13.6	12.0	7.9	47.9	10.1	10.5	12.5	13.3	11.7	16.8	2.7	18.5	11.9	7.3	9.9	13.3	8.6	18.4	5.5	25.6	6.6	11.8	12.9	7.5	11.7	10.2	19.4	15.2	18.8	1.3	5.4	18.6	11.7	15.2	3.8	3.9	1.5	3.1	5.1	13.9	6.8	6.4	5.1	7.5	2.2	19.5	1.7	6.3	19.4	19.8	0.0	5.5	24.5	12.5	6.9	4.8	14.9	17.2	1.6	1.0	2.4	12.4	0.6	0.1	1.6	4.1	4.4	8.0	3.0	5.1	1.8	17.6	8.7	1.1	10.2	5.2	10.3	9.7	9.0	6.5	1.7	8.4	5.6	4.1	0.1	7.8	5.0	4.3	0.2	20.1	2.3	8.6	4.6	25.6	5.5	8.9	17.1	10.5	8.6	7.7	9.1	18.4	8.3	11.8	8.4	1.6	6.6	8.8	8.3	11.2	12.9	14.8	16.7	11.3	17.4	13.4	9.8	18.3	17.1	15.2	16.8	41.7	99.3	62.4	77.5	73.4	114.0	50.8	193.6	53.5	58.0	76.8	64.8	62.2	358.1	104.4	10.1	65.2	92.1	0.0	57.1	27.9	82.7	93.0	60.1	279.6	138.9	122.3	127.3	98.8	132.8	13.8	168.2	127.9	89.4	60.5	87.9	109.7	92.6	97.9	112.1	851.6	143.3	71.1	82.1	26.5	3.6	49.1	66.2	70.8	92.5	80.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.6;JURKAT: 30.1"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.2	4.4	7.1	12.1	4.6	9.0	4.9	8.9	7.0	6.4	23.6	0.1	0.0	5.1	4.8	4.5	0.3	5.3	5.9	5.4	0.0	4.9	0.0	0.0	7.5	7.7	0.0	1.9	8.1	2.2	4.9	2.6	4.3	6.0	30.1	4.8	0.4	7.1	3.0	9.2	0.0	4.1	0.0	2.6	0.0	3.4	0.7	4.3	4.6	3.6	4.7	0.0	2.9	4.1	3.7	3.1	0.8	9.3	7.0	6.1	4.6	2.5	0.0	0.9	0.0	0.8	0.0	2.5	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6	6.0	1.0	0.0	0.5	0.6	0.8	10.1	7.6	0.0	0.0	8.7	11.8	23.5	5.0	3.4	0.6	2.8	6.4	0.0	3.7	1.2	2.9	0.2	1.1	33.6	2.5	3.2	0.0	2.5	2.8	0.6	3.4	0.0	1.7	0.0	2.9	4.2	1.1	4.8	2.8	12.2	2.2	77.6	15.6	1.4	1.5	1.0	5.1	0.0	4.1	0.3
ANKRD39	MGC41816	ENSG00000213337	"Ankyrin repeat domain 39"	Q53RE8	2	96836611-96858095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042678	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042678: AB_10794532"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (9.53e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.12e-3)"	"prognostic favorable (6.12e-5)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (6.78e-9)"	"unprognostic (3.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.03e-2)"	"prognostic favorable (5.21e-4)"	8.9	16.2	17.1	9.2	19.2	12.0	6.9	29.4	20.8	7.4	8.3	15.0	7.2	11.2	11.7	5.9	7.6	10.9	7.9	17.6	14.8	14.7	6.5	12.6	7.6	13.0	13.5	14.0	7.3	11.2	11.7	14.2	7.4	13.4	10.4	5.6	10.3	9.5	10.1	6.3	10.9	8.4	9.5	10.7	8.9	7.9	3.7	13.0	5.4	6.3	4.3	8.7	9.0	5.8	15.5	29.0	7.1	9.0	14.4	27.8	8.7	6.4	4.2	2.4	5.3	0.8	1.6	5.9	5.0	2.3	6.3	4.8	10.4	2.7	4.1	7.4	3.6	5.0	2.8	3.1	4.7	1.4	4.7	9.3	2.9	3.8	14.1	4.2	6.6	7.2	3.1	2.8	5.7	2.2	2.3	4.5	8.6	6.1	73.5	2.3	10.1	6.2	5.2	3.1	2.2	9.8	4.7	1.7	23.0	3.2	3.3	5.6	3.7	3.6	8.5	6.3	2.3	2.5	3.6	2.2	3.9	3.9	4.4	8.8	3.8	4.1	6.7	4.0	7.6	4.1	7.1	6.9	5.3	19.6	8.3	16.4	15.5	19.4	17.2	6.8	13.6	10.8	13.3	3.5	14.4	9.0	29.0	27.8	8.7	17.1	19.2	29.4	20.8	14.8	14.7	13.5	14.0	13.4	13.0	6.0	6.2	15.2	17.4	8.4	22.4	15.9	22.9	45.5	11.4	8.7	3.9	39.8	21.6	26.0	4.0	12.0	12.9	0.0	27.9	33.6	16.9	10.0	12.7	24.6	26.7	31.8	17.9	9.8	9.9	2.0	11.5	10.8	27.0	8.2	17.9	14.6	32.4	8.6	13.8	20.7	27.7	25.8	24.0	12.5	17.8	15.6	18.1	24.9	16.8	13.6
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA					"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.3	8.7	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	1.6	20.7	0.9	0.1	2.0	0.2	6.1	0.0	0.2	3.9	1.1	1.8	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	13.5	0.0	13.2	0.1	0.3	3.7	0.0	1.1	2.9	5.3	13.0	7.1	0.6	0.0	0.2	49.1	21.1	0.1	1.6	0.0	0.0	1.3	0.9	0.0	1.1	1.1	0.0	0.4	1.3	0.9	4.7	1.9	7.2	0.2	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9	0.0	7.9	0.5	0.3	0.2	387.3	15.7	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	33.6	0.3	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.2	201.8	0.0	0.0	0.0	93.3	1.7	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.4	0.0	178.0	0.0	0.0	21.3	3.2	0.3	0.2	1.9	0.0	0.4
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.3	7.5	12.6	4.7	2.5	8.4	9.1	7.2	6.4	4.6	4.9	5.8	6.2	8.4	6.9	9.9	9.5	3.5	7.3	2.5	11.6	6.8	4.6	7.9	4.3	5.6	5.8	21.8	5.1	5.0	6.2	4.8	4.6	5.5	6.4	10.1	11.3	8.3	15.2	13.1	12.4	8.3	9.1	9.2	7.9	3.4	6.9	5.5	5.6	9.5	10.1	8.2	24.0	4.8	5.2	4.8	7.0	7.6	12.7	10.8	16.8	7.0	16.9	15.9	6.3	7.1	8.0	13.4	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9	0.0	3.2	2.9	4.0	4.9	7.5	1.4	0.0	4.0	1.2	7.0	0.0	4.8	0.0	4.6	3.5	3.1	8.8	0.0	7.3	5.9	2.3	5.6	0.0	1.5	7.0	11.1	4.1	5.5	5.6	2.5	2.0	5.4	0.0	9.0	5.1	5.0	9.1	10.1	1.1	2.1	5.1	6.5	2.3	14.0	5.9	9.5	16.2	4.4	5.3	4.8
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA060290: AB_2684244"	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.5	32.2	19.1	29.6	21.7	15.9	20.0	19.5	20.0	34.0	32.0	19.2	11.6	31.8	19.4	25.6	23.5	25.6	41.1	30.5	28.6	22.4	37.5	16.5	27.3	19.7	29.3	15.1	21.0	20.3	31.2	38.8	38.1	19.6	27.3	36.3	21.1	9.0	26.2	17.8	36.8	11.5	23.7	24.8	19.6	33.7	17.9	18.3	22.7	15.6	19.1	24.7	19.5	18.9	20.7	25.5	15.9	9.9	14.3	19.6	17.0	18.6	41.8	13.2	13.7	20.2	19.7	16.1	28.9	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4	3.0	4.8	2.7	5.7	7.6	5.8	5.9	7.6	1.4	4.5	1.8	21.6	2.6	0.0	1.9	1.1	4.5	2.3	0.0	2.1	1.9	3.9	4.1	1.1	2.6	1.3	6.4	6.3	9.8	6.9	0.4	3.7	4.1	3.3	1.8	2.5	5.0	1.9	0.0	2.1	0.7	8.0	0.0	3.6	2.8	3.5	10.2	3.4	4.9	3.4	5.6
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.7;Late spermatids: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.3	15.4	12.7	21.6	15.2	13.1	8.7	15.3	16.1	15.9	14.8	11.1	8.2	12.5	7.9	17.1	27.6	10.3	13.1	10.8	13.0	7.8	11.4	9.7	9.3	11.2	18.1	15.8	16.6	13.5	13.8	12.2	14.9	13.2	12.6	12.2	19.3	8.8	17.6	22.0	5.9	25.2	17.4	8.1	12.9	15.1	17.9	7.0	9.5	12.1	9.7	15.4	9.7	24.3	8.7	14.9	9.6	16.2	13.6	16.1	29.1	16.4	13.8	7.2	5.3	10.2	12.1	14.7	25.6	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3	6.0	19.2	11.0	16.6	14.7	36.2	25.7	5.1	13.4	14.8	12.2	49.1	11.9	21.6	15.1	118.7	24.8	10.2	0.0	12.0	11.1	20.5	16.4	18.5	13.4	19.2	27.0	5.8	23.9	19.0	171.4	34.5	23.8	11.8	33.3	12.5	35.8	13.1	3.5	28.3	10.6	49.0	25.8	22.7	96.9	99.0	14.2	12.7	23.0	10.8	13.1
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: AB_2684791"	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favorable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	7.8	14.6	13.6	11.2	15.5	2.9	15.6	10.8	14.4	12.9	12.6	18.3	14.1	8.8	16.9	21.8	9.1	14.2	8.4	11.4	11.9	9.8	14.2	24.1	9.9	16.0	12.2	12.1	18.6	13.4	19.2	17.3	12.7	12.3	16.8	10.2	12.3	15.2	18.5	10.9	12.8	10.6	13.5	11.9	17.7	10.8	13.9	14.8	17.9	19.3	6.4	16.8	11.8	10.0	20.5	12.5	18.2	11.2	18.4	19.3	12.8	4.5	6.3	12.8	10.5	11.6	8.9	1.6	5.4	6.5	8.8	8.8	4.4	6.6	11.1	8.4	5.0	4.4	8.0	12.3	7.1	7.6	19.8	12.4	11.6	17.3	7.9	8.6	4.4	2.5	7.7	8.7	11.0	9.1	10.8	8.9	11.0	11.2	4.8	8.6	3.6	13.2	5.9	19.1	4.9	4.7	9.0	16.1	7.6	8.2	4.3	9.2	9.2	5.5	10.0	9.3	20.0	5.5	15.2	4.6	8.8	9.3	4.9	5.8	11.7	9.2	3.2	6.2	5.4	7.4	18.2	11.2	16.0	12.2	9.7	15.7	15.9	16.4	16.4	11.1	20.5	15.8	15.7	6.3	18.4	10.0	12.5	19.3	12.8	13.6	15.5	10.8	14.4	11.9	9.8	12.2	12.1	12.3	14.8	6.0	2.4	3.0	2.1	1.5	2.4	5.7	5.1	4.0	2.3	5.2	3.9	5.4	6.6	3.9	3.0	3.6	1.7	0.0	3.3	4.4	4.0	2.4	4.7	6.4	6.4	1.6	2.9	6.2	3.3	2.5	6.6	3.5	1.7	3.6	2.7	5.2	2.4	2.9	6.7	6.8	4.2	0.0	3.9	9.1	6.4	0.6	2.7	6.4	2.3	1.0
MTG2	"dJ1005F21.2, FLJ10741, GTPBP5, ObgH1"	ENSG00000101181	"Mitochondrial ribosome associated GTPase 2"	Q9H4K7	20	62183029-62203568	"Predicted intracellular proteins"	"Ribosome biogenesis, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047379	Approved					NA	NA					"HPA047379: AB_10965845"	"unprognostic (5.52e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.16e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.56e-1)"	"prognostic favorable (6.31e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.10e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.30e-2)"	12.3	15.1	7.9	9.9	11.9	9.3	8.7	18.1	13.4	8.2	9.0	12.8	10.2	12.5	13.7	12.4	8.4	9.4	8.7	8.3	8.9	8.0	8.7	20.2	8.3	9.4	12.4	11.9	10.6	14.6	10.3	12.0	7.5	8.6	9.2	5.7	11.2	12.0	10.1	30.7	12.3	9.8	8.9	9.1	10.2	9.9	13.3	8.8	9.2	9.9	6.2	10.2	8.0	8.0	6.8	8.1	17.0	6.9	7.0	9.2	5.7	15.9	10.2	3.4	8.4	5.8	5.8	12.3	7.2	5.8	23.0	9.3	35.9	14.5	15.9	23.8	4.7	10.2	13.3	4.7	10.3	4.4	4.3	5.6	24.6	12.5	9.7	7.4	15.9	5.8	10.7	12.6	12.6	9.7	3.6	5.8	8.3	15.3	8.4	5.9	5.0	10.7	8.1	4.6	16.0	17.4	7.5	15.4	17.9	5.1	9.1	7.7	9.4	22.4	14.3	12.8	1.9	16.6	19.3	6.3	16.5	11.0	8.6	19.2	14.5	16.9	7.0	12.3	6.0	8.3	7.4	6.9	6.4	9.2	6.6	8.1	6.8	7.0	7.7	8.1	5.6	7.7	5.1	17.0	7.0	4.6	5.6	6.4	5.7	7.9	11.9	18.1	13.4	8.9	8.0	12.4	11.9	8.6	8.8	20.8	11.0	17.7	9.6	8.1	0.0	8.5	12.7	22.7	13.6	19.2	0.0	12.8	8.3	10.1	40.2	7.3	14.2	23.3	12.1	10.5	7.6	8.3	11.5	23.5	12.3	0.0	8.7	11.6	12.1	11.1	8.9	12.8	8.5	19.8	11.4	0.0	12.8	13.3	11.0	20.2	0.0	0.0	7.2	14.0	17.4	10.5	14.9	13.8	13.0	8.5
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.2	14.0	8.2	7.0	13.3	6.8	5.1	6.0	10.2	7.0	8.8	7.8	6.1	3.7	6.4	4.1	19.2	16.0	7.2	4.1	5.4	46.5	12.7	4.2	10.5	6.3	18.0	2.8	29.1	8.4	5.3	7.3	6.0	10.9	7.7	6.0	4.3	5.9	6.5	5.7	2.8	2.7	3.6	4.3	6.1	6.2	3.3	8.8	6.2	6.3	1.6	6.0	7.1	9.5	7.1	7.3	6.7	2.8	9.0	6.9	4.3	15.5	4.9	4.7	6.1	1.8	10.6	3.1	4.7	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0	3.0	2.1	0.0	3.2	1.4	1.4	3.6	7.6	2.7	1.2	12.2	9.8	5.1	0.0	5.4	33.5	6.0	2.8	0.0	5.5	5.9	4.8	5.5	8.1	5.8	20.7	4.8	2.4	13.5	7.1	23.4	8.9	8.3	5.0	12.6	2.5	6.6	5.8	2.0	12.0	7.9	3.6	6.5	2.8	11.4	8.5	2.0	7.1	4.3	1.8	2.6
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100273291-100322733	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9;epididymis: 32.6"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057366	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	1.6	23.0	8.4	0.6	32.9	0.2	2.2	21.1	15.4	5.1	1.7	1.3	2.3	0.5	19.0	32.6	2.0	17.8	1.7	4.3	5.6	9.9	1.3	0.7	1.5	0.5	3.9	7.0	10.5	4.4	9.6	7.8	0.6	6.4	3.2	0.7	1.6	1.5	3.2	4.6	0.4	0.5	19.8	4.5	0.5	1.5	1.8	4.3	0.4	3.5	0.8	0.4	1.4	1.3	0.7	0.5	1.7	0.4	0.7	0.5	0.1	0.0	6.5	2.0	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.2	0.0	1.1	0.0	8.1	0.0	6.4	0.0	0.0	0.5	6.9	0.0	0.4	0.0	0.2	0.1	5.7	0.0	0.0	0.3	0.0	0.4	0.0	1.8	3.7	0.1	0.0	4.2	0.0	0.3	0.4	1.2	5.9	0.0	0.0	0.0	1.6	0.2	14.0	3.8	0.0	0.0	1.0	2.3	3.5	0.1	0.1	0.1	0.8	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.3	1.1	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.3	0.2	0.7	0.4	0.5	1.7	0.7	0.3	0.5	0.2	0.1	8.4	32.9	21.1	9.7	5.6	9.9	3.9	7.0	6.4	4.3	0.0	13.2	0.0	1.2	0.7	74.2	34.4	5.1	5.3	5.7	5.2	29.5	1.7	5.0	2.4	0.4	1.0	0.0	0.0	1.8	0.2	1.5	5.8	5.7	0.5	0.4	104.9	10.9	0.0	0.0	1.5	3.1	0.3	1.7	0.0	0.1	10.0	2.1	0.0	11.0	0.3	18.2	6.5	3.3	0.5	0.2	0.1	2.4	0.0	0.4	0.5
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224821-8248095	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	9.9	10.0	9.9	15.2	12.2	18.0	12.2	28.5	15.3	10.3	11.3	12.4	8.7	8.9	15.6	12.7	8.2	10.5	10.7	7.0	6.8	7.5	11.8	14.4	13.8	24.1	9.7	7.4	14.5	14.5	12.2	18.5	7.9	9.2	11.2	12.2	11.5	11.0	12.2	5.0	15.5	15.7	13.4	7.4	25.0	9.9	8.8	10.6	32.9	12.5	4.0	23.0	9.1	10.6	6.1	4.6	5.1	2.4	2.7	6.3	2.0	2.5	5.6	5.2	4.9	16.4	3.9	6.5	3.0	3.2	4.3	2.9	4.3	7.6	9.2	3.0	5.1	3.1	8.6	6.1	4.4	2.7	6.7	5.9	4.5	5.4	5.5	2.8	1.4	14.2	3.9	4.9	5.6	7.7	8.5	7.6	13.4	4.3	3.1	3.0	3.3	15.6	6.2	4.3	8.3	1.4	7.4	2.0	5.9	10.9	5.9	4.6	5.3	5.8	7.6	5.0	10.2	4.6	4.3	10.0	1.4	3.2	3.2	3.4	6.5	3.8	6.1	2.6	5.5	3.9	3.6	1.6	2.4	4.7	1.9	4.4	5.0	4.5	4.1	1.5	6.1	6.3	5.8	5.1	2.7	2.4	4.6	3.5	2.0	9.9	12.2	28.5	15.3	6.8	7.5	9.7	7.4	9.2	10.6	0.0	12.0	11.5	2.6	1.6	5.9	3.9	5.1	2.7	3.4	5.2	35.3	5.2	1.7	3.0	2.7	3.1	3.3	0.0	3.3	3.5	2.5	3.2	5.8	8.1	3.3	1.6	6.4	3.7	9.7	4.3	4.0	3.2	0.0	6.4	5.5	2.3	4.5	5.3	2.1	1.5	17.7	0.0	2.8	4.3	4.4	1.8	9.3	7.0	3.2	3.3
IFFO1	"HOM-TES-103, IFFO"	ENSG00000010295	"Intermediate filament family orphan 1"	Q0D2I5	12	6538375-6556083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069344	Approved					NA	NA					"HPA069344: AB_2686126"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.43e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.25e-2)"	"prognostic favorable (6.53e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.47e-7)"	"unprognostic (5.71e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.58e-2)"	11.7	12.6	13.2	12.2	11.2	14.6	9.1	22.8	20.0	10.6	10.4	10.3	2.6	6.9	13.9	8.0	6.2	9.8	10.0	13.1	11.5	8.8	6.1	7.5	11.9	14.4	9.2	13.3	11.8	5.1	2.1	9.9	11.2	12.7	7.9	6.2	13.5	5.0	12.1	19.9	4.6	7.5	12.3	12.9	17.8	5.4	10.3	10.6	6.5	5.3	6.8	10.6	9.7	9.4	1.7	4.8	3.9	9.2	3.9	2.8	3.0	0.0	0.0	4.6	0.0	7.1	11.7	0.1	6.8	6.2	5.5	4.9	1.0	0.0	1.4	0.0	6.5	1.7	0.0	3.5	0.9	1.8	10.3	11.4	5.2	0.1	7.4	4.9	5.6	8.8	7.1	0.0	4.1	0.0	6.6	5.4	5.7	0.0	1.6	13.6	0.0	4.8	4.2	10.7	0.0	0.0	7.9	8.0	2.4	1.8	0.0	0.0	4.2	0.0	0.0	3.3	4.9	0.0	5.9	8.1	5.4	0.0	4.5	3.9	2.3	0.8	4.1	4.0	2.2	14.0	0.2	6.6	3.9	2.7	5.0	2.6	1.3	2.4	2.8	4.8	1.7	1.0	1.5	2.3	3.9	9.2	2.5	1.7	3.0	13.2	11.2	22.8	20.0	11.5	8.8	9.2	13.3	12.7	10.6	0.0	3.7	3.2	0.4	2.3	13.3	9.3	0.0	0.0	1.2	0.0	3.9	3.5	1.7	0.5	8.9	9.0	0.5	0.0	1.2	2.5	9.5	0.2	1.1	5.1	18.8	20.6	0.0	12.3	23.8	7.8	17.5	15.2	18.6	3.6	1.2	10.6	0.4	0.6	12.7	2.1	12.2	32.3	8.6	5.9	4.5	1.8	1.0	13.3	0.4	0.1
TNRC6C	"FLJ20015, KIAA1582"	ENSG00000078687	"Trinucleotide repeat containing 6C"	Q9HCJ0	17	77959240-78108835	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 119.8;Cone photoreceptor cells: 223.8;Rod photoreceptor cells: 142.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 12.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022007, HPA062051"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022007: AB_2670877, HPA062051: AB_2684670"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (6.56e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.70e-2)"	5.5	3.6	8.9	7.4	15.1	3.6	5.1	13.3	13.8	6.0	3.8	14.5	4.4	2.3	6.9	7.6	3.1	6.9	4.7	6.9	8.5	7.6	3.3	3.4	4.2	7.5	13.3	6.3	9.1	4.4	6.1	7.6	1.9	12.2	6.1	3.0	10.9	6.0	4.9	11.1	3.3	3.8	5.6	7.5	6.0	3.6	13.2	14.3	3.4	4.1	6.1	5.5	3.6	4.1	1.1	0.7	12.9	0.3	3.1	2.7	0.5	3.1	3.0	5.4	5.8	2.3	1.8	0.0	4.8	4.0	3.4	2.8	3.1	0.9	0.0	2.0	3.6	2.4	0.3	4.0	0.1	2.1	2.5	4.1	11.1	1.0	3.5	2.1	2.6	5.7	1.5	1.5	1.3	3.2	1.5	7.1	11.0	2.1	5.6	3.5	4.2	24.9	1.4	2.8	1.4	2.2	3.3	10.9	2.1	0.8	4.5	6.7	12.3	5.7	7.4	2.6	2.8	5.6	3.9	5.2	7.6	2.6	3.9	5.8	4.3	0.7	3.2	2.1	4.1	5.4	12.9	0.3	1.3	1.9	0.2	2.2	1.0	2.1	2.0	0.2	1.1	2.3	2.7	1.2	3.1	0.3	0.7	0.9	0.5	8.9	15.1	13.3	12.5	8.5	7.6	13.3	6.3	12.2	14.3	26.8	26.7	6.1	8.5	19.6	119.8	26.0	30.6	6.7	9.1	8.7	223.8	0.1	1.7	6.2	7.2	25.7	5.3	23.3	5.1	0.3	19.5	13.9	22.0	15.5	2.0	69.9	38.3	29.4	12.9	5.3	47.5	6.1	15.1	2.8	9.0	33.0	6.8	3.5	40.3	4.3	142.8	0.0	31.6	23.5	19.9	12.4	0.2	36.3	5.9	3.8
UNK	"KIAA1753, ZC3H5, ZC3HDC5"	ENSG00000132478	"Unkempt family zinc finger"	Q9C0B0	17	75784771-75825799	"Predicted intracellular proteins"	"Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 127.0;Spermatocytes: 103.3;Spermatogonia: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023636, HPA027962"	Uncertain		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytosol, Cytoplasmic bodies"		"HPA023636: AB_10601774, HPA027962: AB_10611522"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.04e-3)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.73e-2)"	"unprognostic (9.78e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-2)"	11.6	11.7	13.0	17.8	14.6	13.9	15.5	19.5	14.5	17.8	11.2	15.0	17.6	12.5	18.7	16.1	13.5	17.0	15.4	10.6	13.0	8.7	12.3	11.8	18.4	17.6	14.5	14.3	24.5	18.2	18.5	20.7	13.4	11.2	15.6	6.8	22.2	19.6	16.3	15.0	25.1	13.7	14.3	9.7	21.2	12.9	22.1	16.4	15.6	17.5	8.2	16.1	13.8	15.2	2.8	1.9	0.4	1.1	1.3	2.3	1.5	6.5	10.4	11.6	9.8	3.7	3.4	9.5	4.3	4.7	4.9	6.1	3.8	7.5	13.9	3.8	4.7	8.1	6.0	5.9	5.2	2.3	7.1	19.1	8.7	8.4	8.0	5.0	6.6	11.1	6.8	3.2	4.2	4.6	5.6	6.4	10.0	4.5	6.9	3.9	12.9	14.8	9.2	5.0	4.5	6.9	15.7	11.7	7.0	4.6	7.0	10.7	21.1	5.7	7.9	15.3	6.1	9.7	10.3	4.6	11.7	6.4	5.1	5.6	12.0	3.5	7.7	8.5	4.3	7.2	0.3	1.1	0.4	2.3	0.7	2.3	1.1	1.3	1.4	0.7	2.8	2.1	2.0	0.4	1.3	0.9	1.9	1.3	1.5	13.0	14.6	19.5	14.5	13.0	8.7	14.5	14.3	11.2	16.4	14.9	17.1	14.2	14.2	13.5	24.5	9.2	12.7	20.1	20.5	3.5	13.7	7.7	3.3	12.3	127.0	10.8	7.2	0.0	20.0	12.2	11.3	13.8	18.5	6.0	12.2	20.6	16.1	7.4	8.5	17.2	17.5	12.2	25.3	11.8	14.0	21.0	15.8	10.5	9.9	6.0	23.1	19.4	13.3	103.3	89.7	19.2	14.4	17.3	13.3	12.9
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 45.4"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	45.4	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2	0.0	0.0	24.9	0.0	0.1	1.0	1.0	68.8	0.0	0.0	8.7	0.0	0.0	39.7	0.0	75.4	0.6	0.0	0.0	0.0	0.0	0.8	0.5	0.0	338.0	0.1	3.2	0.0	22.7	22.3	92.6	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	322.0	0.4	0.0	0.1	10.7	12.2	0.4	0.0	6.9	0.0	0.0
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.4	6.6	15.4	10.7	6.0	8.7	6.7	5.9	9.7	6.0	8.7	4.7	13.3	8.8	5.0	18.5	12.4	8.7	6.2	4.4	5.1	12.6	4.9	5.9	9.2	12.6	11.8	15.9	6.9	9.3	5.8	6.1	5.2	10.6	14.4	12.9	10.1	5.7	18.8	10.2	24.4	13.0	5.6	12.5	20.9	5.2	11.2	6.3	9.8	8.6	16.0	6.5	21.7	9.0	7.1	9.9	17.8	7.6	8.1	26.6	8.8	14.6	12.3	12.1	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1	8.9	7.5	6.1	8.2	13.5	6.1	5.3	10.2	4.0	5.7	1.8	5.9	10.4	0.0	7.5	5.8	9.3	8.4	0.0	8.8	9.1	9.3	8.5	1.1	6.4	11.6	4.8	12.1	14.7	10.3	3.2	7.5	9.8	6.8	4.6	12.3	6.7	9.2	10.5	8.1	6.3	6.1	6.5	13.2	11.2	13.8	11.2	8.1	14.6	10.2	6.0
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.8	17.0	5.7	25.4	8.2	10.3	15.3	13.5	24.4	23.8	12.5	7.2	9.6	12.7	16.3	16.0	15.1	26.8	16.3	16.3	21.9	31.9	11.9	14.9	9.0	20.0	34.8	6.0	14.3	14.8	7.7	8.4	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.8	12.9	16.5	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.5	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9	3.0	11.0	18.2	26.7	22.8	52.0	42.6	10.2	13.4	11.4	17.4	19.6	17.9	53.0	15.6	5.9	18.3	10.2	0.0	16.6	13.6	21.4	23.8	20.7	12.3	17.9	36.5	40.9	17.2	30.2	7.6	31.1	18.8	25.3	27.1	12.3	32.9	15.6	14.4	27.3	25.6	28.0	6.5	37.1	38.5	44.0	27.6	18.5	15.7	14.4	19.3
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739421-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 98.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 991.0;Late spermatids: 314.1;Spermatocytes: 374.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	4.4	4.2	6.0	2.8	6.1	2.5	9.2	15.6	6.1	4.7	5.0	4.1	6.6	3.0	5.5	4.5	3.2	3.9	3.4	9.0	6.1	6.8	4.2	5.1	2.9	2.6	6.5	3.1	7.0	5.2	6.2	7.9	2.0	6.1	6.6	2.7	3.2	4.2	5.9	25.0	1.7	3.0	8.1	8.0	2.4	3.5	98.8	7.2	8.4	8.1	5.2	2.7	6.0	14.7	1.9	0.6	3.0	0.8	5.3	1.9	0.1	4.8	6.0	4.4	5.8	0.6	0.0	6.3	1.9	1.5	3.0	3.1	0.8	2.7	7.5	1.9	0.8	10.1	1.0	4.4	0.5	5.2	9.0	3.9	4.3	3.0	4.3	6.5	2.0	0.4	0.2	3.5	1.5	1.6	8.8	2.7	7.3	3.5	6.3	0.9	4.6	10.5	6.9	3.6	2.3	3.1	7.5	9.9	2.6	3.1	0.8	14.8	8.8	4.3	2.0	3.4	7.1	0.8	4.1	0.9	1.0	7.1	0.7	3.3	10.4	22.7	3.0	2.2	1.4	1.2	3.0	0.8	0.6	1.4	0.0	1.3	1.7	1.3	1.5	0.6	1.9	1.0	1.9	2.5	5.3	0.3	0.3	1.5	0.1	6.0	6.1	15.6	6.1	6.1	6.8	6.5	3.1	6.1	7.2	6.0	9.1	10.2	16.1	6.3	45.6	47.4	12.7	6.7	2.3	14.0	43.2	7.1	11.6	8.8	991.0	11.7	6.2	23.3	5.8	2.3	4.7	20.1	2.3	18.8	3.5	114.4	12.6	10.4	3.2	314.1	24.5	5.2	10.1	1.0	12.0	43.9	6.4	6.8	20.1	11.6	73.0	25.8	8.4	374.4	52.7	4.0	2.4	12.1	10.8	8.1
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266316-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.2"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	2.9	5.0	26.7	3.0	22.5	1.6	1.8	14.4	36.2	3.5	3.5	3.1	5.9	3.1	4.5	3.9	3.6	4.7	4.8	4.7	26.8	15.3	2.1	0.9	2.6	3.1	12.8	17.5	2.4	6.1	6.2	5.8	1.7	17.1	5.5	2.2	3.1	9.9	19.2	6.1	1.9	3.1	8.1	3.8	2.1	5.1	2.7	4.4	0.1	4.5	0.1	2.0	3.6	1.6	0.1	0.4	0.0	0.0	0.0	3.5	1.2	2.2	6.6	0.1	6.7	8.0	4.4	0.0	4.0	5.3	4.5	2.1	0.2	0.7	0.4	2.4	4.9	11.2	1.2	1.0	5.7	0.8	1.4	1.8	4.2	1.1	0.1	4.2	0.0	6.9	2.8	2.8	4.5	0.9	4.5	5.7	4.5	0.8	0.2	4.1	0.0	0.4	0.2	2.4	0.0	5.6	0.0	1.4	0.1	6.0	3.2	0.4	2.0	3.9	0.2	5.8	0.7	0.3	0.1	9.7	7.3	5.4	6.4	1.1	0.6	1.2	0.0	3.9	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.1	0.8	0.9	0.1	0.1	3.5	3.2	0.0	0.0	0.0	0.4	0.4	1.2	26.7	22.5	14.4	36.2	26.8	15.3	12.8	17.5	17.1	4.4	0.0	0.0	0.0	0.1	0.1	19.5	4.3	5.1	0.0	0.0	3.5	5.9	0.0	0.0	0.4	8.3	0.6	0.0	0.0	0.5	0.0	0.8	0.9	0.0	0.0	0.2	28.6	8.1	1.8	0.0	3.2	1.4	0.0	0.0	0.0	0.9	2.9	1.7	0.0	3.9	1.3	19.9	6.5	1.0	0.6	0.1	0.1	0.0	0.0	1.3	0.0
UPF3A	"HUPF3A, RENT3A, UPF3"	ENSG00000169062	"UPF3A, regulator of nonsense mediated mRNA decay"	Q9H1J1	13	114281584-114305817	"Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018325, HPA061316"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA018325: AB_1858638, HPA061316: AB_2684477"	"unprognostic (9.08e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.44e-1)"	"prognostic favorable (7.09e-5)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.71e-4)"	11.3	16.3	16.9	10.9	20.2	11.9	10.9	32.8	21.9	10.4	9.9	18.6	13.0	13.8	13.1	12.3	10.1	13.2	9.2	7.1	16.1	14.9	11.0	7.5	9.2	12.0	20.2	16.0	12.7	15.4	8.1	12.8	8.5	17.2	12.1	8.7	10.0	11.9	16.1	16.1	11.9	11.9	10.2	23.6	11.8	11.2	34.5	16.7	10.7	24.0	7.4	7.9	11.2	9.3	11.7	15.6	4.1	5.5	11.1	9.5	4.3	23.3	6.9	15.3	13.7	7.3	12.8	9.8	18.1	13.1	11.6	13.0	10.4	8.3	23.0	5.3	8.3	7.8	12.6	7.5	6.0	14.7	16.8	14.8	19.8	19.6	11.4	12.8	34.3	8.9	8.6	12.5	7.8	9.2	12.3	9.2	6.0	12.0	10.7	11.6	7.1	13.9	9.2	20.4	15.6	6.9	18.3	8.6	13.4	10.4	7.5	17.4	19.2	14.4	22.3	12.9	10.8	16.5	30.9	11.8	12.4	20.7	6.7	11.3	23.4	16.2	31.9	22.8	19.8	10.1	1.9	5.5	4.1	6.8	4.4	5.3	11.7	7.1	7.0	6.0	9.1	7.4	6.7	0.8	11.1	5.1	15.6	9.5	4.3	16.9	20.2	32.8	21.9	16.1	14.9	20.2	16.0	17.2	16.7	62.5	46.2	54.7	55.8	61.0	74.4	18.2	43.3	133.8	69.4	55.8	78.5	57.6	87.9	47.2	134.0	84.2	27.6	0.0	61.9	38.0	72.4	48.5	52.2	59.5	40.0	74.7	55.2	57.7	33.2	66.4	93.2	41.0	52.3	48.7	45.2	66.8	45.9	35.1	82.4	45.3	72.8	84.1	54.5	503.7	176.2	62.9	33.9	57.5	58.3	32.4
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	6.6	55.6	14.7	6.1	17.5	5.4	6.3	15.9	27.2	8.6	4.6	19.3	4.0	5.0	9.5	7.1	4.6	12.4	7.8	5.4	14.4	14.5	6.0	27.7	7.4	7.2	14.9	16.6	29.4	7.5	15.1	12.5	25.1	16.4	9.0	5.0	22.1	4.2	8.4	2.6	8.5	6.3	7.8	17.5	11.7	7.1	8.5	11.4	5.3	18.6	2.2	7.4	18.7	6.4	4.2	6.0	3.1	2.5	0.8	2.8	2.0	10.7	12.7	17.0	6.4	12.0	6.8	21.7	4.6	6.3	5.4	5.1	6.5	12.3	4.9	5.0	6.4	15.5	10.4	4.7	12.6	10.3	3.0	8.5	6.8	2.2	24.4	6.8	9.5	4.0	5.7	7.3	13.7	8.2	11.5	7.9	8.1	4.6	4.2	7.2	4.0	10.3	5.3	6.0	8.6	7.8	9.6	11.2	7.3	3.0	17.6	5.7	6.4	8.8	9.3	32.7	6.3	5.1	5.6	6.8	12.3	5.7	14.7	8.8	5.9	10.9	13.2	4.3	5.7	19.3	0.0	2.5	0.2	2.8	1.8	2.6	4.2	2.2	2.0	3.6	2.9	2.1	2.1	3.1	0.8	2.1	6.0	1.3	2.0	14.7	17.5	15.9	25.3	14.4	14.5	14.9	16.6	16.4	11.4	6.0	7.4	9.5	4.0	6.5	215.7	5.5	20.4	4.0	13.6	14.0	108.0	3.6	0.0	4.0	3.5	7.7	0.5	0.0	4.7	4.8	8.9	5.5	8.1	58.7	9.5	81.0	6.9	22.1	27.3	7.0	18.7	8.3	15.1	7.2	1.5	26.4	2.9	5.1	27.6	1.3	64.3	12.9	5.6	0.5	9.6	5.4	3.3	7.1	3.1	10.1
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	3.0	3.3	3.7	0.8	0.7	4.4	2.9	0.4	0.5	0.4	3.9	5.2	4.8	8.8	0.6	3.3	3.5	2.3	1.0	0.7	4.4	3.9	22.3	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	7.0	0.5	2.9	3.9	10.6	0.5	4.7	4.0	3.7	7.5	12.0	2.9	3.5	3.7	3.2	1.0	5.2	7.2	4.4	6.9	3.8	2.5	6.5	9.5	11.2	3.9	4.7	10.4	5.6	4.3	17.6	8.3	3.4	3.2	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4	527.0	437.0	3.0	5.2	3.7	2.5	7.5	2.5	459.0	396.9	8.7	3.9	0.3	10.0	2.6	101.2	2.3	2.0	0.0	2.7	0.3	4.7	3.7	256.9	2.1	1.9	1.6	6.4	3.1	2.6	164.7	7.2	4.0	6.8	0.0	5.5	7.8	0.7	3.5	6.0	12.0	18.2	6.5	1.2	39.2	2.6	8.4	0.1	0.0	11.4	3.8
ARMCX1	"ALEX1, GASP7"	ENSG00000126947	"Armadillo repeat containing, X-linked 1"	Q9P291	X	101550531-101554700	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000268, HPA005685, CAB020695"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"CAB020695: , HPA000268: , HPA005685: AB_10600781"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.09e-2)"	17.5	29.8	13.6	7.4	16.5	2.7	18.9	13.4	21.5	24.4	18.7	9.6	15.9	6.2	27.3	19.0	12.3	16.3	14.8	26.6	13.3	18.4	12.1	3.8	11.6	4.4	13.7	14.6	42.6	10.2	20.1	18.0	12.5	16.4	25.8	7.0	13.0	12.0	21.1	22.7	8.1	7.6	26.3	9.1	11.4	10.0	8.1	10.5	3.5	14.0	11.6	3.3	26.8	29.7	0.2	9.9	0.5	4.3	2.1	3.7	2.1	0.7	0.2	5.6	0.0	26.9	24.2	0.0	8.7	17.2	11.0	27.8	0.0	0.1	0.0	7.5	13.4	12.1	0.7	0.0	1.2	6.2	0.0	0.0	5.0	1.7	0.0	14.2	0.0	0.0	20.2	1.7	8.3	0.0	9.1	6.6	0.0	0.1	0.1	24.4	0.3	0.0	0.0	8.0	0.0	0.0	0.0	30.8	0.0	7.5	0.0	5.5	4.6	0.0	0.1	15.0	1.6	0.9	3.7	8.7	6.7	3.5	19.4	0.1	0.0	0.1	0.0	6.5	0.0	4.1	0.0	4.3	0.5	0.0	3.9	0.7	0.0	0.6	0.3	9.9	0.2	1.5	3.7	0.1	2.1	1.1	5.1	0.9	2.1	13.6	16.5	13.4	19.9	13.3	18.4	13.7	14.6	16.4	10.5	23.8	6.1	0.0	23.8	29.5	26.3	54.8	7.6	5.3	5.7	22.7	5.9	1.4	11.6	14.6	0.3	23.2	0.5	0.0	6.0	2.1	52.1	21.0	24.2	0.4	23.6	20.6	5.2	17.8	9.4	0.9	43.7	11.0	55.6	6.4	1.0	31.1	7.5	0.0	41.8	11.4	13.3	45.3	48.4	1.7	0.7	19.1	2.2	1.0	0.6	7.4
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378640-78425114	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA					"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.4	11.6	14.5	20.8	20.3	41.4	28.2	17.6	17.4	14.4	13.1	18.4	13.2	13.7	17.3	13.2	14.5	16.9	17.2	14.0	15.7	16.1	14.3	8.0	25.5	19.1	21.6	17.0	18.3	14.0	16.0	13.3	24.0	15.3	13.9	10.2	12.9	13.1	16.8	13.8	11.9	15.1	13.4	18.0	22.6	12.6	13.9	18.8	17.7	18.6	7.8	14.3	16.9	32.3	8.0	14.0	26.0	12.6	6.7	11.3	8.4	13.3	11.8	11.5	8.6	10.1	16.2	13.6	12.5	12.0	13.5	14.9	10.9	10.5	13.7	7.6	7.1	13.3	10.3	13.6	8.5	10.6	20.6	15.4	15.0	14.0	10.9	9.9	11.3	12.2	16.5	11.2	9.7	8.8	11.7	25.7	10.9	17.5	9.6	9.1	7.3	25.6	10.3	12.0	5.8	11.4	13.5	20.5	11.7	13.2	12.2	15.2	23.1	10.7	11.8	11.4	11.6	12.4	13.8	16.1	17.5	12.1	9.3	10.5	10.6	6.3	10.5	13.2	12.7	12.9	1.5	12.6	13.2	8.4	10.4	9.8	7.8	8.8	8.8	14.0	8.0	11.3	8.1	26.0	6.7	4.6	6.6	10.4	8.4	14.5	20.3	17.6	17.4	15.7	16.1	21.6	17.0	15.3	18.8	11.9	12.6	7.5	10.1	3.9	12.5	4.2	7.6	6.7	10.3	12.2	2.0	15.2	3.3	5.3	14.1	14.3	7.1	0.0	6.0	7.3	8.9	6.8	7.0	3.0	13.3	19.1	4.1	13.5	13.1	7.9	9.8	17.5	5.0	10.0	5.2	9.7	5.8	12.5	8.1	4.3	10.5	32.3	7.6	18.0	15.9	3.3	16.1	6.9	7.6	8.2
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"		9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in many"	6	"blood: 102.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 54.9;Distal tubular cells: 101.2;Proximal tubular cells: 50.5"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 102.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 102.4"	"Low cell line specificity"	"Detected in all"																	NA	NA						"prognostic favorable (4.18e-5)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favorable (8.39e-4)"	"prognostic favorable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	4.0	6.9	5.0	4.3	12.2	7.9	5.6	4.8	11.0	4.0	4.0	2.4	4.4	4.8	2.2	7.8	2.3	4.0	2.1	8.6	5.1		6.2	3.9	5.6	8.8	5.7	5.8	3.7	11.5	3.7	5.5	2.1	8.9	4.4	1.6	4.0	5.9	4.6	13.8	2.1	3.9	4.5	11.4	6.6	5.1	16.2	6.1	4.5	2.8	4.7	4.1	2.6	0.0	18.4	8.4	102.4	7.6	13.3	22.0	9.9	7.1	4.1	7.5	6.7	3.3	10.0	4.1	3.8	5.6	2.9	5.9	1.0	2.0	5.5	5.5	5.4	5.3	2.9	5.1	3.3	4.2	10.7	11.4	27.2	12.4	9.1	7.6	6.7	4.7	7.3	5.3	2.8	6.7	8.4	6.6	18.1	3.8	14.0	5.2	5.5	11.8	27.5	9.2	7.3	7.8	6.2	3.5	9.8	6.8	3.8	5.6	6.9	9.0	3.5	4.6	9.5	2.8	5.9	3.8	2.1	5.6	2.7	3.7	15.7	12.0	19.5	12.5	4.1	1.8	13.6	7.3	47.4	12.7	7.2	16.9	17.6	18.3	14.7	6.1	18.4	22.0	19.0	102.4	13.3	7.6	8.4	18.3	9.9											26.8	29.6	0.0	0.0	0.0	0.0	0.0	0.0	54.9	17.0	27.9	0.0	21.4	101.2	16.2	0.0	0.0	0.0	0.0	28.2	10.1	0.0	0.0	23.3	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	10.8	0.0	0.0	21.1	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0
FBXL16	"C16orf22, Fbl16, MGC33974"	ENSG00000127585	"F-box and leucine rich repeat protein 16"	Q8N461	16	692498-705829	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 102.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 36.2;Collecting duct cells: 10.4;Horizontal cells: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.0;GAMG: 8.7;MCF7: 10.5;SCLC-21H: 21.7;SH-SY5Y: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039504, HPA056354"	Enhanced					NA	NA					"HPA039504: AB_10794197, HPA056354: AB_2683105"	"unprognostic (5.51e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.34e-5)"	"unprognostic (1.62e-3)"	"prognostic favorable (1.87e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-2)"	1.7	5.7	53.5	2.0	75.8	1.6	1.8	17.7	102.2	1.6	1.8	2.5	0.1	2.2	1.6	1.6	1.7	1.8	1.6	1.6	44.9	10.2	2.1	1.6	1.7	1.8	10.2	25.8	1.6	3.6	2.6	3.8	1.6	5.1	1.9	1.6	0.0	5.5	2.4	1.6	2.2	1.9	1.5	2.5	2.0	2.8	5.0	11.9	0.0	2.0	0.0	1.7	1.6	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.3	0.4	0.6	0.2	13.0	0.1	0.1	0.4	0.4	0.1	2.4	0.1	1.2	0.1	0.2	3.5	0.0	8.7	2.4	1.0	1.4	0.1	6.4	0.3	0.0	3.0	0.5	0.0	1.3	0.3	0.0	2.0	0.0	1.2	1.1	0.0	0.5	0.7	3.2	0.0	10.5	0.3	0.0	0.6	0.1	4.1	0.0	0.0	7.3	0.1	0.0	21.7	16.2	2.2	0.4	0.2	0.0	1.1	0.0	0.0	0.1	4.5	0.0	1.7	0.6	3.7	1.6	1.8	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.5	0.2	0.0	0.0	3.3	0.7	0.0	0.0	0.0	0.0	1.2	0.3	53.5	75.8	17.7	56.5	44.9	10.2	10.2	25.8	5.1	11.9	0.0	3.0	0.0	0.8	0.9	36.2	1.1	0.0	0.0	6.8	10.4	2.0	0.4	1.7	0.2	0.9	0.0	0.4	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.1	30.2	9.2	0.6	0.0	0.4	0.6	0.0	0.0	0.0	0.8	2.6	0.4	0.0	0.0	0.2	4.2	0.0	0.0	5.5	4.3	1.4	2.1	0.9	0.4	0.2
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 12.0;HUVEC TERT2: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.2	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.8	2.3	1.1	0.3	0.0	0.8	0.1	0.5	0.4	0.3	0.2	0.1	0.4	0.9	12.0	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	0.4	3.9	1.3	0.5	0.2	0.0	2.0	1.9	0.8	0.2	2.8	0.1	0.7	0.7	0.1	0.6	0.2	2.3	0.6	0.0	0.2	2.8	0.5	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4	38.7	51.3	11.9	7.2	0.0	8.7	0.3	7.6	16.0	36.4	1.8	5.9	13.7	16.6	3.8	5.3	6.0	49.1	23.3	6.1	16.9	3.9	6.4	27.8	8.1	10.5	3.2	23.7	9.2	10.7	5.9	15.3	6.7	0.0	1.8	44.8	16.7	5.7	23.0	10.6	15.2	16.4	12.9	2.3	3.8	6.7	0.0	14.0	8.9	47.2	6.2
GPS2		ENSG00000132522	"G protein pathway suppressor 2"	Q13227	17	7311324-7315564	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Erythroid cells: 116.8;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067540	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067540: AB_2685860"	"unprognostic (1.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.50e-5)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.28e-3)"	21.8	22.8	21.1	17.6	20.9	27.8	25.0	18.2	25.4	18.5	23.4	19.1	14.4	14.4	20.0	15.5	24.6	19.9	15.5	35.3	19.9	17.1	28.7	30.1	18.5	15.2	19.5	16.9	20.9	23.0	26.6	21.1	21.9	16.5	17.5	20.2	14.3	19.7	21.5	72.4	23.0	25.7	18.2	21.2	20.6	18.0	45.8	22.1	21.2	22.4	21.0	21.1	19.2	25.0	55.2	48.3	58.1	46.4	28.2	57.0	38.8	19.8	38.5	12.3	16.8	24.6	13.9	14.2	14.4	17.0	29.1	25.1	26.7	10.2	22.4	10.9	19.7	20.8	27.2	15.6	28.0	22.6	27.3	24.5	20.7	36.6	33.0	17.5	12.4	24.2	13.1	19.4	40.1	10.7	13.1	17.0	20.2	12.5	5.3	30.2	16.8	24.1	13.1	16.8	20.9	16.1	18.5	22.8	22.9	21.6	22.4	16.4	27.5	23.4	15.0	19.7	14.4	14.8	12.1	10.2	13.7	14.1	18.9	33.4	17.5	24.8	14.9	20.5	14.6	23.8	44.1	35.3	58.1	40.8	43.0	38.4	55.2	45.5	45.8	29.5	43.3	42.5	38.5	56.4	28.2	46.4	48.3	57.0	38.8	21.1	20.9	18.2	25.4	19.9	17.1	19.5	16.9	16.5	22.1	11.9	9.6	21.7	8.7	14.1	27.6	1.0	15.3	18.7	21.6	19.2	62.8	11.4	21.6	17.7	78.1	12.8	48.4	116.8	23.3	9.1	9.8	7.6	18.5	9.5	8.9	36.5	16.1	9.8	14.9	206.1	19.5	12.6	18.6	19.8	16.9	17.6	18.7	21.0	14.5	19.3	44.7	19.4	13.6	30.3	47.1	14.8	16.4	27.7	17.5	7.3
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283532-135497776	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"	"Developmental protein"	"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 54.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 1056.4;Rod photoreceptor cells: 1624.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Uncertain	Centrosome		NA	NA			Centrosome		"HPA031698: AB_2673997, HPA046684: AB_2679752"	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	6.7	16.2	16.8	6.4	16.5	5.9	12.5	35.3	26.5	11.7	8.7	4.2	13.2	4.9	14.4	32.1	7.8	9.0	9.0	7.6	15.9	19.9	8.4	6.8	8.1	6.0	11.4	19.6	13.9	11.6	11.5	54.2	8.3	18.2	16.3	13.1	10.0	8.2	15.9	6.7	6.1	5.7	11.1	18.5	4.3	10.7	29.2	13.1	3.3	11.6	5.0	6.3	8.9	12.0	10.6	16.6	4.8	1.7	3.8	4.2	0.5	5.2	7.2	8.5	10.9	13.9	15.1	3.8	9.7	12.2	9.8	15.1	2.8	5.6	8.2	4.8	9.3	9.8	4.0	6.3	3.0	14.6	6.5	8.5	3.0	20.3	5.3	5.9	15.2	3.3	7.0	5.0	15.2	8.3	15.2	8.0	10.2	13.5	0.5	13.2	5.6	14.4	3.4	5.1	4.0	4.4	7.3	3.4	2.7	4.9	5.3	14.8	7.9	12.9	4.8	5.8	6.6	3.8	6.9	7.6	8.5	10.5	14.5	7.6	10.7	9.8	3.8	12.0	2.2	10.1	4.8	1.7	0.6	4.2	0.5	2.6	8.2	4.0	4.2	2.6	10.6	3.2	4.1	0.1	3.8	0.5	16.6	2.4	0.5	16.8	16.5	35.3	26.5	15.9	19.9	11.4	19.6	18.2	13.1	35.7	87.4	13.4	33.8	25.4	293.7	22.6	7.6	89.7	51.2	55.8	1056.4	21.3	11.6	24.5	265.7	46.0	7.7	0.0	38.6	16.0	36.7	32.6	56.6	15.8	12.0	311.4	97.8	16.5	4.7	272.8	62.7	18.8	30.4	11.8	34.2	96.6	20.6	37.4	61.2	9.7	1624.0	51.8	41.2	126.9	110.1	19.7	23.9	12.8	31.5	21.8
RAB11B	H-YPT3	ENSG00000185236	"RAB11B, member RAS oncogene family"	Q15907	19	8389981-8404434	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054396			Approved	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA054396: AB_2682474"	"unprognostic (5.81e-3)"	"prognostic favorable (2.08e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.58e-5)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.29e-3)"	41.1	38.7	38.1	34.3	51.9	36.5	32.5	43.7	89.0	27.9	29.3	70.8	27.6	46.1	31.0	26.8	38.8	31.0	31.7	56.7	39.6	37.5	40.6	35.9	32.3	32.3	43.6	34.4	35.1	60.5	27.6	35.3	37.9	62.2	32.9	15.0	40.1	57.8	32.7	47.8	40.7	46.4	26.4	48.4	42.9	45.8	25.9	38.5	30.8	71.1	22.1	28.0	33.2	27.1	20.8	28.2	45.6	24.5	24.9	23.8	16.6	22.1	29.3	21.1	19.4	10.8	10.7	15.6	13.2	9.1	10.0	10.5	19.2	18.7	13.0	37.4	11.1	13.2	17.4	7.1	18.9	3.2	25.8	34.2	13.8	24.5	23.7	10.4	16.1	25.9	14.9	12.5	10.8	7.2	12.8	12.4	17.8	14.5	34.9	10.2	21.2	27.2	76.7	29.6	10.6	26.6	18.1	14.0	21.8	10.3	32.8	22.8	29.3	16.3	13.6	16.9	8.8	17.2	18.2	23.8	37.7	21.7	28.9	20.9	36.1	23.9	15.3	28.1	18.1	25.2	19.9	20.8	45.6	22.6	21.1	15.7	19.1	20.6	23.8	21.8	20.8	20.0	18.6	32.1	24.9	24.5	28.2	19.8	16.6	38.1	51.9	43.7	89.0	39.6	37.5	43.6	34.4	62.2	38.5	17.9	21.7	62.4	69.6	55.2	59.7	15.3	53.5	34.8	12.5	90.7	13.7	131.9	107.8	81.0	25.9	59.8	123.3	70.0	83.2	137.8	70.8	71.6	29.9	54.2	94.9	63.5	110.0	67.5	62.1	27.6	80.0	52.9	67.4	93.8	87.3	89.1	70.0	108.7	71.8	86.1	25.3	90.5	75.4	59.7	27.9	60.6	175.5	66.0	81.3	83.6
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011032, HPA042299"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum, Plasma membrane"		"HPA011032: , HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favorable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favorable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.9	10.7	6.2	6.5	40.1	11.8	2.6	7.7	16.7	5.7	5.8	3.1	5.3	2.6	7.0	8.9	4.8	11.3	2.6	3.6	2.3	8.5	12.9	2.4	6.7	5.3	7.3	1.0	4.9	15.4	8.6	3.1	6.2	11.9	10.2	5.8	2.5	15.8	4.3	9.8	3.7	1.6	2.2	6.8	5.8	4.5	5.5	6.3	13.1	4.2	5.0	4.2	8.7	5.1	11.4	7.2	13.5	1.6	13.7	8.3	2.1	7.6	4.0	3.0	2.3	2.0	10.2	2.2	3.2	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1	11.9	9.3	19.5	18.9	47.7	26.3	8.5	56.0	45.5	11.4	29.6	55.0	44.7	44.7	26.6	19.7	31.6	18.6	0.0	23.9	24.3	20.3	8.4	10.5	31.1	17.8	38.1	13.3	29.4	21.3	23.3	26.7	17.5	13.5	14.4	13.8	34.2	24.3	17.3	26.9	34.9	30.0	0.0	21.2	83.1	23.6	37.5	32.3	15.2	15.8	7.8
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.2	7.9	7.8	6.0	3.0	2.5	13.6	6.7	2.8	4.5	4.3	5.8	12.5	4.0	2.3	2.3	6.3	8.9	2.0	4.5	2.3	15.1	13.8	7.3	13.1	10.1	4.9	4.7	10.3	2.2	3.1	4.7	1.9	4.6	3.3	11.5	8.1	5.0	1.8	4.6	10.5	18.0	11.7	6.3	5.5	10.0	5.5	8.4	7.0	6.2	19.7	15.4	4.3	6.1	8.5	2.7	3.1	5.8	5.8	7.7	6.6	6.2	8.0	12.3	2.8	7.1	7.3	8.6	7.2	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7	3.0	5.9	3.7	6.1	4.0	12.5	8.1	12.7	4.0	3.4	8.7	13.7	4.1	6.6	11.8	1.3	5.5	7.8	0.0	7.9	4.3	3.7	7.6	23.0	3.0	5.9	46.1	10.9	4.9	3.2	2.0	8.3	7.0	1.7	9.0	4.9	11.6	11.2	3.5	8.9	5.1	16.7	0.0	6.2	12.1	8.0	4.5	4.6	5.0	6.0	6.0
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
RUFY3	"KIAA0871, RIPx, Singar1, ZFYVE30"	ENSG00000018189	"RUN and FYVE domain containing 3"	Q7L099	4	70704204-70807315	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.2"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022952, HPA022970"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA022952: AB_2671005, HPA022970: AB_1856307"	"unprognostic (4.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.28e-4)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (8.02e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.45e-3)"	"unprognostic (5.41e-1)"	10.9	24.5	39.1	11.8	53.4	6.9	12.5	36.4	66.3	12.3	8.7	24.1	6.7	8.1	20.6	16.3	15.3	9.3	12.7	8.9	64.5	34.4	15.5	13.6	14.8	13.6	37.0	51.3	25.5	9.8	8.5	61.4	12.0	54.2	13.8	11.4	12.8	10.1	11.5	15.4	29.9	9.9	15.1	80.2	16.0	12.8	25.3	32.5	7.1	31.6	5.9	11.5	9.3	12.3	3.5	6.0	0.0	3.1	2.2	2.8	1.0	3.7	2.6	31.2	7.3	15.1	17.6	12.4	12.2	4.7	4.0	4.5	4.5	9.2	15.0	5.1	10.1	8.9	3.8	4.7	5.4	6.4	8.1	6.0	3.2	3.6	4.9	8.6	3.7	1.9	12.4	8.4	5.3	6.2	18.6	8.4	16.2	8.8	15.5	8.7	4.6	23.2	3.9	7.5	6.6	3.4	5.7	9.7	6.8	7.8	3.6	29.2	14.4	4.4	7.9	7.4	12.6	5.4	1.8	7.1	13.6	9.5	4.0	2.8	17.3	7.8	16.0	14.1	2.7	2.7	0.0	3.1	0.0	2.2	3.0	2.8	3.5	1.5	2.0	6.0	3.1	1.5	1.6	0.0	2.2	2.8	4.8	1.0	1.0	39.1	53.4	36.4	66.3	64.5	34.4	37.0	51.3	54.2	32.5	32.8	68.4	13.4	19.5	17.2	119.8	18.3	10.2	34.8	45.5	22.7	249.4	12.7	6.6	12.7	57.5	30.2	8.7	0.0	17.9	5.7	21.6	29.3	20.7	21.8	9.7	131.9	14.5	34.4	31.8	95.1	43.7	29.7	40.5	83.8	8.3	45.6	18.9	3.5	47.7	12.8	190.1	25.8	29.9	13.4	29.3	25.2	6.4	8.7	8.3	16.0
UNC119	"HRG4, POC7, POC7A"	ENSG00000109103	"Unc-119 lipid binding chaperone"	Q13432	17	28546707-28552668	"Disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 197.8"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 683.7;Cone photoreceptor cells: 807.0;Rod photoreceptor cells: 1668.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041912	Enhanced					NA	NA					"HPA041912: AB_10795267"	"unprognostic (8.93e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.95e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (2.76e-3)"	"prognostic favorable (8.09e-5)"	"unprognostic (2.65e-1)"	"unprognostic (8.08e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (9.82e-4)"	"unprognostic (1.71e-3)"	10.0	12.3	15.0	15.1	16.1	34.8	10.3	16.3	21.6	10.1	8.2	6.8	9.1	8.1	9.3	12.9	11.5	9.5	10.2	9.8	15.4	19.8	14.3	20.7	9.0	18.1	13.3	10.1	10.6	13.5	10.5	12.5	8.3	13.3	12.1	7.6	197.8	17.3	15.0	4.4	15.3	10.2	9.5	6.5	23.7	7.7	22.9	6.4	11.4	12.1	5.7	19.7	11.4	10.3	9.1	22.4	32.3	47.9	4.3	4.9	7.4	12.2	15.5	15.6	21.6	16.4	16.1	7.7	10.2	14.0	18.5	17.5	21.5	4.1	10.1	11.1	15.5	12.7	20.4	13.1	15.1	9.9	18.7	24.5	7.0	7.5	6.5	11.3	10.3	22.0	14.7	20.9	13.3	6.7	17.5	14.8	11.0	7.1	8.4	11.3	19.3	10.1	10.4	15.1	10.4	11.3	16.3	25.5	4.4	14.0	13.7	6.1	21.4	14.6	23.9	15.2	18.9	18.8	17.8	11.1	10.7	20.4	17.2	9.8	9.6	9.9	2.2	17.6	16.7	9.7	5.2	11.5	28.2	2.2	27.9	2.3	6.8	4.3	3.5	20.0	9.1	4.9	3.4	32.3	4.3	47.9	22.4	3.7	7.4	15.0	16.1	16.3	21.6	15.4	19.8	13.3	10.1	13.3	6.4	0.0	4.8	13.7	16.5	11.8	683.7	10.9	12.7	2.7	2.3	12.2	807.0	21.7	28.2	17.0	2.0	14.3	16.5	0.0	16.2	7.5	14.3	18.3	12.7	10.4	31.4	138.2	24.3	10.4	32.2	4.0	13.6	47.2	18.6	55.1	13.5	174.9	15.8	13.9	20.1	16.1	1668.5	45.3	15.3	1.7	11.3	12.5	16.7	18.8	11.4	16.9
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing, X-linked 4"		X	101418287-101533459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 10.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 24.7;Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favorable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	1.5	4.6	1.9	0.8	2.7	0.3	2.9	3.2	5.7	2.4	1.7			0.6	4.0	2.8	0.7	2.8	1.1	1.2	2.0	2.9	1.2	0.5	1.5	0.5	1.9		8.5	1.4	10.8	4.3	1.6		4.1	1.6		1.2	5.7	1.6	2.1	1.5	2.8	1.4	1.3	1.3	0.4			2.4		0.5	2.1	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.3	0.6	8.2	0.0	4.0	4.2	0.8	5.6	4.4	4.6	9.0	1.9	0.8	0.0	2.2	8.3	0.1	1.0	0.0	0.1	7.6	0.0	0.9	0.6	2.3	0.0	2.3	0.0	3.1	2.6	0.4	10.0	0.0	0.0	8.0	0.0	0.0	0.7	2.0	0.0	0.3	0.3	6.0	0.8	0.0	0.4	6.8	0.0	1.2	1.4	5.6	5.1	0.8	0.0	3.0	1.4	0.6	1.2	3.0	2.1	1.3	6.4	0.0	0.0	0.0	0.0	3.9	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0											3.0	5.0	0.5	6.3	2.2	24.7	8.7	0.0	14.7	11.4	26.2	7.9	1.4	14.9	2.2	0.2	7.7	2.6	0.0	2.0	0.6	7.0	8.5	3.5	2.1	2.0	22.3	2.9	4.3	4.6	0.4	9.8	2.0	16.9	2.8	2.7	10.8	2.1	3.5	11.7	4.4	7.4	0.0	11.4	1.0	1.2	3.0	1.3	1.8	3.6	3.9
IQCC	FLJ10547	ENSG00000160051	"IQ motif containing C"	Q4KMZ1	1	32205661-32208687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.6"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 23.3;Spermatocytes: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028602, HPA028686"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA028602: AB_10600298, HPA028686: AB_10601985"	"unprognostic (1.45e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (7.81e-6)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.97e-2)"	"unprognostic (2.97e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.12e-3)"	"prognostic favorable (3.79e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.66e-1)"	2.2	4.2	5.0	3.3	8.2	4.4	5.0	9.7	11.7	3.8	3.5	5.1	4.4	2.5	5.5	10.2	3.1	8.3	3.4	2.8	4.0	4.3	4.3	1.9	2.9	3.5	3.1	5.9	5.4	8.1	5.6	9.5	2.7	3.4	4.3	3.5	4.7	4.8	5.7	4.1	4.9	3.1	3.0	3.1	3.2	4.4	26.6	4.6	4.4	8.3	1.0	3.7	2.8	2.9	5.1	2.8	3.4	1.1	3.9	3.8	1.2	7.5	2.5	6.2	5.8	1.1	2.3	3.9	4.3	5.0	9.1	8.5	6.1	6.8	2.7	4.8	1.3	1.6	6.4	6.2	3.8	7.7	4.1	7.0	4.8	5.8	2.6	1.5	5.1	3.3	1.6	4.0	8.1	3.6	3.7	1.9	10.5	8.4	0.7	4.1	5.2	8.4	5.3	3.9	4.1	5.7	11.9	3.7	6.2	3.4	2.9	8.7	3.4	8.6	5.0	4.6	5.9	6.0	5.4	2.6	3.4	6.3	4.9	7.3	3.4	2.4	2.4	4.8	4.9	6.9	1.6	1.0	0.4	3.3	1.0	3.1	5.1	3.4	2.5	1.8	2.5	3.8	2.2	3.4	3.9	1.1	2.8	3.7	1.2	5.0	8.2	9.7	11.7	4.0	4.3	3.1	5.9	3.4	4.6	0.0	2.9	0.0	0.8	0.2	4.8	1.6	2.5	4.0	0.0	3.5	5.9	1.4	3.3	1.2	0.6	1.1	0.9	23.3	1.2	1.6	1.6	0.5	1.1	0.5	0.8	6.4	2.9	0.0	0.0	1.1	1.1	0.2	0.0	1.8	2.7	2.3	1.0	1.5	2.5	0.4	8.4	0.0	0.5	18.9	9.8	0.6	0.8	1.9	1.7	0.2
ZNF641	FLJ31295	ENSG00000167528	"Zinc finger protein 641"	Q96N77	12	48337180-48351414	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035189	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035189: AB_10603333"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (7.82e-3)"	"prognostic favorable (3.91e-4)"	"prognostic favorable (8.30e-5)"	"unprognostic (3.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.85e-3)"	10.6	28.6	11.9	11.1	10.8	6.4	10.4	11.3	17.1	14.6	9.2	11.8	7.3	10.1	15.3	10.9	7.8	12.5	13.0	11.4	13.1	8.7	10.9	10.4	13.9	12.4	9.5	17.9	25.6	16.0	17.2	12.2	15.2	13.6	11.0	9.1	11.8	9.7	11.5	22.5	6.2	9.3	19.2	12.6	14.8	10.1	12.1	9.5	14.6	15.6	8.1	13.6	12.7	12.5	1.2	4.7	9.7	5.0	6.4	4.3	2.9	3.1	4.0	8.1	13.8	7.3	2.0	5.8	7.1	5.1	3.8	2.5	9.1	8.0	5.4	10.5	6.7	7.1	4.8	2.9	4.9	1.3	13.8	5.1	9.7	7.3	2.2	7.6	11.5	13.6	3.1	7.2	2.8	6.0	6.5	3.6	8.0	9.3	5.6	3.6	3.5	4.5	4.0	1.7	3.1	2.2	3.0	8.1	4.2	6.3	14.3	3.3	5.0	8.7	3.7	5.1	7.1	8.8	11.7	1.5	4.2	7.1	4.6	3.5	6.6	5.9	4.4	2.7	12.3	4.4	1.9	4.1	8.6	4.3	3.9	2.6	0.7	2.5	4.0	4.7	1.2	2.3	4.0	9.7	6.4	5.0	1.9	1.3	2.9	11.9	10.8	11.3	17.1	13.1	8.7	9.5	17.9	13.6	9.5	6.0	17.3	7.4	12.9	2.7	12.1	7.7	12.7	6.7	6.8	7.0	9.8	1.1	6.6	7.1	1.3	9.6	3.9	0.0	8.8	0.7	6.7	4.7	3.5	6.4	6.8	17.5	5.2	18.4	16.2	1.9	14.4	13.6	0.0	2.8	1.8	15.3	6.8	0.0	22.6	3.7	16.8	19.4	9.8	5.9	5.3	1.9	0.5	12.8	2.4	5.4
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 751.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.2;THP-1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.9	11.0	0.9	0.9	13.6	10.9	1.4	10.5	17.2	7.0	4.6	10.4	5.7	13.7	11.5	6.9	0.3	15.0	8.0	2.1	0.3	13.4	0.5	6.3	15.2	0.3	30.5	16.9	35.2	13.4	8.3	3.0	6.3	10.2	9.1	17.0	13.8	10.7	4.6	19.2	8.5	16.2	3.7	25.2	10.8	12.5	0.1	57.2	11.1	7.7	17.6	12.2	12.1	31.9	29.7	0.2	11.4	54.9	11.0	17.9	6.1	11.3	7.2	13.2	7.5	3.7	21.4	10.3	8.0	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8	50.6	79.4	78.5	85.1	59.5	68.6	52.7	58.6	42.8	46.6	50.6	33.4	44.8	31.5	93.8	230.4	57.3	44.4	23.3	59.4	85.7	82.6	106.0	74.8	62.7	275.2	114.4	84.6	55.3	148.6	751.7	143.8	125.9	158.6	165.1	27.0	123.1	65.3	48.9	159.1	69.0	73.5	51.8	56.5	57.7	46.0	56.8	43.0	127.1	37.4	74.0
TSPYL4	"dJ486I3.2, KIAA0721"	ENSG00000187189	"TSPY like 4"	Q9UJ04	6	116249961-116254140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044863	Approved					NA	NA					"HPA044863: AB_10962578"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.41e-3)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (5.13e-7)"	"unprognostic (3.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.38e-2)"	5.3	24.5	24.2	4.8	43.6	6.0	9.6	42.2	51.2	10.3	4.9	12.0	5.4	4.0	14.5	12.6	6.9	14.5	7.2	13.5	23.6	35.5	10.4	4.9	6.9	6.3	18.3	28.7	17.7	8.2	25.6	16.9	7.2	29.2	15.6	5.7	6.3	5.0	13.2	3.0	6.9	4.3	10.7	13.3	7.0	9.4	9.5	14.0	5.8	9.8	1.5	6.0	5.7	8.1	6.5	5.7	5.4	4.9	6.9	8.4	5.8	2.9	1.6	23.6	19.5	9.7	8.4	4.4	11.8	8.0	15.2	9.1	4.6	2.9	2.4	4.5	18.1	8.0	6.6	10.1	10.5	23.0	9.8	3.4	4.8	8.2	10.8	7.7	9.0	3.2	8.1	4.9	11.8	6.0	11.9	10.3	13.7	7.3	8.1	12.6	9.1	17.2	5.5	5.7	1.0	3.9	9.9	1.3	2.3	4.6	4.3	27.8	18.8	10.5	4.4	2.0	8.8	8.0	5.0	11.8	12.7	10.7	7.2	6.7	3.2	3.8	0.4	5.9	6.0	7.9	0.9	3.6	4.3	6.3	3.5	7.5	4.7	7.6	6.3	3.4	6.5	8.4	5.9	5.4	6.9	4.9	5.7	6.6	5.8	24.2	43.6	42.2	48.7	23.6	35.5	18.3	28.7	29.2	14.0	3.0	4.8	7.3	8.9	4.2	19.9	31.9	7.6	37.5	10.3	10.4	19.6	2.7	16.6	4.0	15.8	8.2	0.9	0.0	6.5	1.5	8.0	9.4	10.5	3.0	3.0	38.1	30.4	12.9	4.0	5.3	9.5	4.3	5.0	2.8	5.5	19.7	5.3	2.9	10.3	4.5	27.1	0.0	9.2	15.4	2.9	4.5	2.9	7.0	3.7	8.1
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456821	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"B-cells: 169.1;Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.5;RPMI-8226: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"	6.3	7.2	13.8	28.1	15.8	24.3	8.0	18.6	15.9	4.7	5.7	5.0	5.6	5.6	7.7	6.2	2.7	7.7	6.6	4.1	11.9	17.1	6.9	1.5	6.2	25.9	9.3	4.8	5.0	4.8	13.9	24.8	4.1	10.3	4.3	2.8	4.3	5.1	7.6	1.8	1.6	10.3	4.6	7.0	21.9	7.7	1.8	5.1	9.9	10.9	1.3	20.3	10.0	4.4	14.4	2.5	30.9	2.7	7.4	2.3	2.5	6.4	14.7	5.7	10.9	5.2	5.9	0.4	6.3	7.0	7.0	6.1	8.4	6.8	46.5	17.6	10.7	14.0	2.5	2.2	1.6	2.4	5.0	4.1	6.6	6.9	2.5	7.9	15.8	8.9	5.5	1.1	11.4	1.9	7.3	12.5	6.3	8.2	37.3	5.4	13.5	23.4	7.3	7.1	2.2	6.9	9.6	5.1	45.7	4.1	4.8	9.7	24.2	6.2	2.6	3.4	3.1	3.8	6.2	11.9	16.5	18.4	11.3	8.3	36.4	25.5	34.0	12.3	9.6	8.4	4.9	2.7	30.9	2.0	2.4	2.3	13.3	1.8	1.6	1.6	14.4	1.2	1.4	25.6	7.4	1.4	2.5	0.8	2.5	13.8	15.8	18.6	11.2	11.9	17.1	9.3	4.8	10.3	5.1	3.0	11.1	169.1	8.0	3.5	25.3	2.6	12.7	20.1	15.9	15.7	62.8	1.0	5.0	18.0	2.6	20.1	0.3	0.0	10.3	1.5	12.6	8.4	25.4	0.8	14.7	41.3	16.6	23.4	19.4	4.9	7.5	17.5	10.1	29.7	2.0	11.8	9.9	0.0	9.6	7.9	21.1	0.0	5.9	3.2	9.4	2.8	2.5	25.5	1.3	5.8
U2AF1L4	"MGC33901, U2AF1L3, U2af26"	ENSG00000161265	"U2 small nuclear RNA auxiliary factor 1 like 4"	Q8WU68	19	35742464-35745445	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052083, HPA061644"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052083: AB_2681720, HPA061644: AB_2684574"	"prognostic favorable (2.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.58e-5)"	"unprognostic (3.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.67e-2)"	"prognostic favorable (8.58e-5)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.05e-4)"	5.3	9.7	12.1	4.5	15.0	4.6	4.5	9.3	12.5	4.8	5.7	8.7	8.0	2.7	5.7	6.0	4.9	6.1	5.1	24.3	11.1	10.2	7.0	4.4	4.7	2.8	9.5	10.3	10.7	4.7	11.7	6.6	5.8	8.7	6.7	2.8	10.9	2.5	9.1	19.8	3.4	5.8	6.8	8.5	5.0	4.1	10.7	6.0	2.7	7.4	4.3	5.3	4.2	3.1	9.2	8.4	2.2	3.2	0.8	9.9	5.2	3.7	13.6	1.8	3.2	0.0	1.7	3.1	3.4	3.5	8.7	8.6	5.4	3.1	1.6	6.7	7.8	7.8	1.9	6.9	5.3	5.4	10.4	1.0	1.7	3.4	5.8	10.9	2.5	5.6	2.0	2.3	3.6	2.1	3.2	1.6	4.9	4.1	4.7	5.5	8.0	7.6	2.6	3.0	9.0	2.4	1.9	3.2	0.0	2.0	0.6	4.6	4.5	5.0	3.3	0.9	4.9	3.8	5.0	2.9	5.5	2.4	1.2	5.6	5.5	6.4	3.5	3.6	5.7	6.6	0.0	2.1	1.5	3.1	3.2	3.0	9.2	6.0	5.9	2.0	6.9	9.0	8.6	2.2	0.8	2.4	8.4	9.9	5.2	12.1	15.0	9.3	12.3	11.1	10.2	9.5	10.3	8.7	6.0	17.9	23.1	37.4	12.7	9.2	24.6	4.4	5.1	8.1	5.7	8.7	13.7	13.1	23.2	9.0	9.3	13.6	20.3	23.3	11.0	8.2	16.2	10.7	33.7	13.2	17.4	19.1	12.1	9.8	13.9	11.0	14.4	21.2	28.7	36.9	12.1	10.3	8.1	23.0	11.7	22.6	28.0	12.9	12.8	37.9	13.4	7.8	24.7	42.6	10.1	10.7
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637942-48646312	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	2.3	9.6	60.2	2.3	58.2	1.5	4.1	54.1	87.7	3.8	2.5	4.5	1.7	5.3	17.7	16.0	3.5	10.5	3.5	2.9	44.1	12.2	4.2	1.2	3.2	3.0	18.5	31.6	24.6	3.3	16.7	5.4	1.3	8.9	4.6	2.0	2.7	4.0	8.4	5.0	6.6	4.0	10.7	11.0	2.8	3.1	2.7	17.8	0.1	4.3	0.8	3.4	2.1	1.8	3.4	4.5	0.0	1.1	2.6	3.7	1.4	1.0	6.3	11.6	23.3	1.6	0.6	0.3	0.7	7.4	0.8	1.7	1.5	8.1	3.8	0.9	0.8	2.2	2.5	4.7	2.3	0.7	0.8	6.7	1.7	3.4	0.1	1.5	0.1	5.2	2.8	4.7	0.7	1.0	24.4	0.9	10.4	2.9	10.7	0.3	2.4	2.0	0.7	5.1	3.7	2.5	1.3	0.5	7.9	5.1	0.2	16.7	9.7	0.8	0.9	1.4	3.3	3.3	0.4	0.0	2.1	7.8	0.0	0.2	10.2	17.0	0.7	2.9	2.2	1.0	0.0	0.9	0.0	3.7	1.1	3.1	2.4	2.9	2.8	1.6	3.4	3.6	3.3	0.0	2.6	0.0	4.5	3.0	1.4	60.2	58.2	54.1	63.8	44.1	12.2	18.5	31.6	8.9	17.8	3.0	7.2	9.7	6.4	6.4	72.7	5.3	20.4	8.1	9.1	29.6	15.7	0.6	21.6	6.9	10.0	7.1	7.4	0.0	8.7	0.3	5.1	4.8	5.8	34.1	5.9	27.0	12.6	8.0	21.9	4.7	20.4	8.8	8.5	4.6	4.2	24.9	4.6	3.5	25.1	19.8	25.0	6.5	8.0	0.9	3.6	9.5	0.3	8.7	4.5	5.8
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: AB_2686525"	"prognostic favorable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (5.53e-4)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.5	16.8	17.5	19.7	22.8	30.0	14.2	28.1	22.4	27.2	26.1	18.7	21.3	22.4	11.5	27.2	8.9	22.2	23.9	18.4	24.8	25.6	18.5	35.5	24.4	24.4	24.2	25.7	28.2	30.0	24.8	28.7	13.6	20.1	21.4	27.3	14.4	23.2	22.2	10.9	18.8	16.6	25.5	14.0	15.5	22.2	26.6	19.7	18.6	25.1	18.4	18.9	29.1	18.5	29.8	22.5	17.1	15.7	22.2	28.8	24.9	37.9	35.8	34.7	26.8	20.4	29.8	35.1	26.5	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9	20.8	21.3	7.7	9.2	7.8	13.9	7.7	10.2	28.1	19.4	14.0	37.3	8.8	1.7	15.8	11.5	15.8	11.9	0.0	14.2	12.0	17.1	10.3	12.7	28.6	15.9	25.4	25.2	16.0	12.4	13.3	22.2	11.7	5.0	20.8	15.4	13.8	18.6	2.9	19.4	11.8	24.5	12.9	21.1	21.8	24.5	10.7	5.7	10.2	12.1	6.7
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 48.5"	"Cell type enhanced"	"Detected in some"	16	"Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	5.1	5.8	3.9	20.1	4.3	3.9	48.5	20.9	6.0	4.2	13.5	1.1	2.9	9.8	9.9	3.0	5.9	7.4	6.2	9.7	7.3	9.2	1.6	2.0	4.6	27.6	5.6	11.7	2.5	0.5	2.6	3.3	11.9	3.2	3.8	4.6	4.3	6.6	5.4	3.2	4.1	6.4	7.2	8.0	3.3	2.6	27.7	0.7	5.9	3.0	3.0	3.8	6.3	2.1	0.8	5.9	1.1	1.1	2.3	0.3	0.8	1.7	2.9	1.7	0.0	0.0	3.6	2.1	0.0	0.0	0.0	4.3	2.1	2.3	0.6	0.0	0.7	1.6	0.0	0.0	0.0	1.6	2.5	3.6	4.5	0.5	0.0	4.4	2.7	0.1	0.0	0.0	0.0	4.4	0.0	2.5	2.0	5.3	0.0	1.8	2.7	2.3	2.9	1.7	0.8	1.7	3.1	1.4	0.0	2.9	2.3	3.3	1.6	2.4	0.5	5.4	1.6	0.8	2.3	1.2	1.5	1.7	3.0	0.9	0.2	3.4	2.9	2.1	1.5	5.9	1.1	0.4	1.7	0.7	0.9	2.1	1.3	1.5	0.7	2.0	2.3	1.0	0.5	1.1	0.4	0.8	0.5	0.3	5.8	20.1	48.5	20.9	9.7	7.3	27.6	5.6	11.9	27.7	0.0	0.6	0.0	0.5	0.1	4.0	1.4	0.0	0.0	0.0	1.8	5.9	0.2	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.9	0.0	9.2	25.8	17.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 733.2;Spermatocytes: 397.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.4	10.3	5.6	15.7	4.3	3.2	8.7	7.9	5.2	13.6	9.4	9.9	4.3	18.4	11.4	6.0	16.0	7.9	8.2	7.1	4.0	6.4	15.9	3.8	4.7	6.1	5.7	7.1	7.4	3.0	4.3	15.7	3.3	4.6	7.1	14.4	17.8	5.7	7.3	22.4	21.3	16.9	11.9	9.4	15.0	11.3	5.2	19.8	4.0	4.7	7.4	21.1	8.7	8.4	7.7	6.8	4.8	5.9	4.1	7.5	16.1	23.2	12.6	20.9	36.0	17.6	8.3	6.6	13.0	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8	0.0	0.6	5.2	5.8	9.3	11.7	0.7	2.5	16.0	6.8	12.2	2.0	7.7	6.6	12.2	733.2	5.8	7.9	0.0	9.2	9.8	5.7	3.5	0.0	6.8	7.8	4.8	7.5	5.5	5.7	71.5	17.5	3.9	5.0	10.0	6.3	8.6	9.9	6.0	14.9	11.5	8.1	0.0	5.1	397.6	39.9	8.5	5.1	7.0	6.3	3.3
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	25.7	11.5	10.5	6.1	12.1	5.4	22.3	39.7	18.7	10.4	14.1	5.9	9.3	9.0	13.3	7.4	10.8	11.1	6.7	17.2	8.3	8.2	5.3	11.3	5.6	6.3	6.9	10.4	13.9	13.5	8.8	16.6	5.4	8.5	9.4	6.4	7.9	10.3	12.0	50.4	8.9	11.4	14.8	4.6	5.3	8.3	9.1	5.6	4.5	6.0	7.0	5.4	12.2	22.6	2.4	0.9	1.4	0.7	0.2	3.7	1.4	4.9	9.4	3.1	8.5	16.2	9.8	9.2	8.6	8.6	8.6	4.5	8.5	4.2	11.5	9.5	9.1	4.3	7.6	6.0	7.2	5.8	5.3	11.1	3.9	5.7	23.9	9.1	3.7	3.3	11.6	6.1	11.2	10.6	5.6	5.2	6.0	11.0	4.5	4.5	7.1	8.7	5.0	6.1	5.1	8.4	11.3	3.7	4.9	3.8	3.5	14.6	7.1	19.2	3.9	5.9	2.4	6.1	3.2	7.2	8.3	6.3	7.8	6.7	10.5	8.1	14.3	6.6	6.9	5.1	1.4	0.6	0.2	1.0	0.6	1.8	2.4	1.7	2.4	0.4	1.6	1.8	1.9	0.9	0.2	0.7	0.9	3.7	1.4	10.5	12.1	39.7	18.7	8.3	8.2	6.9	10.4	8.5	5.6	0.0	2.9	3.7	4.3	13.1	12.3	19.4	0.0	4.0	1.2	5.2	31.4	8.8	0.0	3.1	6.9	8.4	17.0	0.0	4.3	2.7	7.1	3.8	0.0	23.7	3.5	0.0	8.6	3.7	5.1	22.2	7.5	1.9	3.3	4.6	10.4	3.9	3.7	11.5	10.6	4.4	11.8	19.4	9.0	13.5	5.1	11.3	6.1	5.0	13.6	3.5
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.2	12.1	7.5	8.2	11.5	7.3	16.4	12.1	6.6	6.4	1.2	3.9	2.3	2.5	18.7	5.3	10.7	3.5	1.6	2.5	11.4	10.7	0.9	12.7	1.7	8.0	0.1	4.1	16.6	5.7	5.7	2.8	16.3	3.0	1.2	7.2	5.9	9.5	8.1	1.1	2.8	7.2	3.2	2.2	3.7	44.7	3.8	3.5	8.4	6.5	10.5	8.9	18.8	5.3	6.9	15.4	3.6	9.2	7.7	7.6	7.2	12.0	11.4	9.7	2.3	7.0	1.0	10.7	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0	0.0	2.1	0.9	7.0	7.1	4.9	3.1	2.5	0.0	2.3	3.5	7.9	2.3	1.7	2.4	1.4	6.0	3.6	0.0	15.0	1.5	12.7	3.3	0.0	0.9	0.7	4.8	9.7	10.4	1.2	1.4	6.6	0.5	6.8	0.0	5.5	2.2	5.0	3.5	21.9	22.0	7.6	58.2	23.7	6.3	6.0	5.9	1.4	5.0	3.6	3.7
FAM69B	"C9orf136, MGC20262"	ENSG00000165716	"Family with sequence similarity 69 member B"	Q5VUD6	9	136712570-136724050	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive B-cell: 7.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	34	"B-cells: 7.3;dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	8.0	3.8	12.3	3.6	14.2	8.2	5.6	19.8	21.4	6.1	4.6	4.9	2.3	4.7	9.6	5.0	4.7	11.0	5.9	18.8	12.3	14.6	6.6	5.5	11.0	4.5	12.4	15.9	5.4	11.9	7.9	11.4	24.5	14.2	6.5	1.3	17.5	11.2	4.5	9.9	13.0	4.4	4.1	5.3	7.9	3.5	7.5	3.2	1.6	7.6	4.1	2.1	3.2	3.1	7.3	1.9	0.0	0.1	0.0	0.0	0.7	0.5	3.4	9.6	9.4	0.0	0.0	8.6	0.3	0.0	0.4	0.4	9.7	1.6	0.8	28.7	0.0	3.1	2.9	4.9	0.1	0.0	1.3	25.7	5.4	0.4	0.3	0.1	0.8	2.9	0.1	0.0	0.1	0.0	1.4	31.9	6.9	6.4	0.9	0.0	4.2	3.7	8.6	14.8	2.1	2.1	20.5	0.2	9.6	0.5	1.0	16.4	17.7	0.4	1.9	7.1	3.1	5.3	5.0	16.3	0.8	7.1	1.3	0.6	5.7	0.5	2.5	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	12.3	14.2	19.8	21.4	12.3	14.6	12.4	15.9	14.2	3.2	0.0	5.3	1.4	1.3	0.9	10.5	4.4	0.0	0.0	1.2	0.0	9.8	0.5	3.3	0.6	1.2	15.8	0.0	0.0	0.0	5.3	2.1	1.3	1.1	3.9	0.4	25.4	0.0	20.3	0.6	3.7	4.4	0.2	11.8	0.0	0.0	9.7	0.2	0.0	2.5	1.1	8.3	0.0	0.8	1.2	5.5	0.3	0.2	0.0	0.0	0.0
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.3	10.7	19.9	19.8	7.6	13.0	17.6	10.7	8.1	10.6	10.2	13.8	18.1	26.2	11.1	7.8	7.5	18.4	14.4	10.2	7.2	17.1	24.2	13.6	9.7	14.1	16.9	17.1	10.5	14.6	12.9	7.5	17.3	14.8	15.0	19.6	15.4	11.4	5.5	24.0	30.8	33.9	28.7	19.1	22.7	29.1	12.1	8.5	8.4	10.5	32.2	33.5	14.4	16.7	15.3	10.6	15.1	16.3	10.8	8.6	9.1	14.1	11.1	23.4	11.2	16.6	10.7	11.6	14.9	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1	3.0	13.6	15.6	26.8	13.9	0.0	8.1	15.3	2.7	7.9	33.2	0.0	10.1	14.9	11.4	24.8	18.0	14.8	23.3	17.3	6.9	18.4	25.2	5.7	11.5	9.4	0.0	17.9	12.9	12.5	9.1	33.4	11.0	11.8	8.2	18.6	0.0	14.9	7.0	30.1	7.7	0.0	19.4	23.4	21.9	11.6	16.7	7.8	15.7	21.8	39.4
GABARAP	"ATG8A, MM46"	ENSG00000170296	"GABA type A receptor-associated protein"	O95166	17	7240014-7242770	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 381.1;monocytes: 547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065883			Approved	Vesicles		NA	NA			Vesicles		"HPA065883: AB_2685574"	"unprognostic (2.58e-1)"	"unprognostic (4.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.52e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.58e-1)"	104.5	120.3	103.9	69.9	94.9	90.9	108.6	54.9	127.8	105.0	89.0	125.1	77.0	63.3	84.0	136.8	103.0	94.1	86.2	94.1	91.8	97.8	113.0	191.6	99.8	87.9	112.1	68.9	139.6	109.2	82.0	118.8	112.4	85.7	108.8	86.6	98.2	126.9	96.9	152.5	85.6	114.5	80.8	119.8	116.5	83.7	142.8	61.4	109.4	148.8	100.7	90.7	98.9	88.7	54.9	138.6	314.7	174.9	30.4	47.9	162.9	25.1	39.7	67.6	46.0	109.6	126.8	26.7	41.3	79.8	41.4	62.0	16.4	22.7	26.5	26.4	77.4	49.3	22.9	49.2	38.4	54.9	46.3	53.6	20.2	36.0	41.4	104.1	12.8	41.7	125.0	54.1	49.4	45.2	107.4	75.0	39.3	15.7	29.3	70.4	18.1	30.5	29.6	26.9	47.0	37.6	42.4	31.6	35.2	79.7	26.9	30.3	80.0	32.2	29.7	42.3	53.4	38.2	25.4	63.1	42.6	24.2	41.0	34.3	31.4	30.4	16.5	67.9	33.4	43.6	107.9	174.9	157.5	35.9	155.4	37.2	54.9	42.8	37.6	138.6	50.7	38.9	36.5	314.7	30.4	130.2	105.9	47.9	162.9	103.9	94.9	54.9	127.8	91.8	97.8	112.1	68.9	85.7	61.4	83.4	111.1	36.6	3.4	18.4	2.4	0.3	43.3	279.7	127.4	26.2	0.0	20.6	36.5	370.8	18.5	15.3	263.7	0.0	269.7	25.6	28.6	6.9	143.5	38.2	69.9	1.6	381.1	46.1	163.5	56.9	19.5	71.9	32.1	547.4	268.5	7.7	357.3	340.1	13.1	66.3	2.5	6.5	18.4	18.5	5.3	20.3	44.3	34.6	223.3	2.3
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 287.2;Late spermatids: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.6	25.8	14.7	20.3	19.4	20.8	29.6	31.9	20.1	22.9	21.5	21.2	18.7	19.8	25.3	22.7	24.3	21.0	13.8	32.3	18.5	16.8	33.4	24.6	20.5	22.6	56.4	20.2	18.9	31.4	23.0	15.5	23.2	28.6	33.3	14.7	27.7	10.5	21.6	25.3	26.0	21.2	15.8	25.7	40.7	22.4	18.2	17.6	24.1	34.0	18.2	32.9	38.1	31.8	35.7	21.4	22.8	26.6	35.1	32.9	29.6	28.6	24.2	23.1	11.1	21.2	26.4	17.3	23.8	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6	44.7	51.2	45.8	92.5	50.4	45.6	14.1	25.5	64.3	62.6	40.1	25.5	56.2	28.2	62.7	287.2	39.4	93.0	0.0	60.1	78.4	37.7	85.7	57.8	25.6	57.5	90.6	44.4	40.5	51.6	600.1	27.9	56.2	27.0	73.1	56.1	34.9	72.9	48.0	37.8	40.4	47.4	38.8	58.6	35.2	26.6	42.2	105.8	64.7	38.3	96.3
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018312, HPA078588"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA018312: AB_1850522, HPA078588: "	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.4	20.1	13.7	17.3	5.7	4.1	20.1	6.3	4.9	7.5	6.9	21.2	10.4	28.1	16.3	8.2	12.4	12.7	14.7	10.4	3.9	14.8	17.3	16.8	16.0	16.6	3.9	20.6	27.9	6.4	6.8	13.1	5.7	4.5	8.0	20.5	23.3	17.8	5.3	21.6	28.5	26.7	17.7	10.1	12.4	33.3	11.3	16.9	5.7	14.4	15.2	16.5	11.7	12.2	6.5	6.9	11.2	18.6	10.5	14.4	17.8	12.4	20.4	28.3	38.7	35.2	11.7	20.1	13.6	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9	17.9	19.1	10.4	11.5	14.7	17.2	34.6	17.8	4.0	9.1	12.2	13.7	13.4	3.3	15.2	0.4	15.8	11.7	0.0	14.1	18.9	12.9	17.4	3.5	23.1	18.5	19.1	18.4	19.0	30.2	1.3	16.1	12.5	5.0	16.2	20.4	15.0	16.1	7.0	20.5	8.6	11.5	6.5	13.7	6.5	25.1	12.2	13.3	17.5	20.9	13.1
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600400-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	11.5	19.1	10.8	19.6	12.6	5.2	17.4	18.8	16.2	20.4	13.0	24.2	17.0	12.6	14.7	13.0	14.7	15.2	16.4	9.7	15.9	10.3	14.0	20.4	14.6	14.1	14.5	12.4	16.0	21.6	28.8	17.9	10.1	10.4	14.9	15.5	19.6	12.8	21.0	14.1	12.8	13.0	15.4	14.1	17.4	15.6	21.6	11.8	33.5	16.6	12.5	17.0	14.7	13.2	4.8	6.1	6.2	5.4	1.8	5.7	3.5	5.4	6.8	8.7	7.1	7.9	5.4	4.6	5.4	7.0	7.9	6.6	7.3	3.4	5.3	4.0	4.6	7.1	8.5	10.2	10.1	6.0	5.8	5.5	6.6	5.9	3.5	8.1	5.8	6.5	6.4	5.9	6.9	14.4	6.2	7.1	10.5	6.1	6.7	6.9	6.8	7.3	4.9	4.4	4.7	4.8	7.7	9.0	10.3	7.9	6.8	12.1	5.3	7.1	6.8	6.1	7.1	6.8	7.1	4.4	6.1	5.3	6.7	4.4	12.4	6.7	5.8	5.7	6.7	5.3	6.2	5.1	5.6	5.3	4.5	5.7	4.8	3.7	4.3	5.6	4.0	3.5	3.9	6.2	1.8	5.4	6.1	3.9	3.5	10.8	12.6	18.8	16.2	15.9	10.3	14.5	12.4	10.4	11.8	29.8	32.3	50.6	46.1	62.0	63.4	50.4	25.5	45.5	28.4	26.2	123.7	37.8	29.9	22.0	27.0	59.5	73.1	0.0	20.0	22.1	35.9	41.1	42.8	30.7	28.6	33.4	68.5	38.6	27.8	7.7	42.8	51.6	35.4	33.3	69.9	54.1	26.0	52.6	28.3	33.7	94.6	32.3	49.7	44.2	23.8	68.1	74.0	50.1	58.1	29.5
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		NA	NA			Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	28.7	27.6	26.4	34.8	32.5	50.7	26.2	50.8	36.0	28.9	29.7	34.3	18.6	31.0	32.1	17.3	26.6	25.8	22.6	26.9	28.2	25.8	23.8	29.0	27.1	38.0	31.5	26.2	35.0	29.2	31.2	35.0	35.5	28.1	27.5	20.5	21.4	31.1	28.8	53.6	35.5	31.0	27.8	31.4	39.1	28.4	30.3	32.1	61.4	26.3	19.5	31.3	30.7	45.6	32.8	31.6	48.4	42.3	31.2	37.5	30.5	27.5	24.4	29.8	19.1	13.2	11.9	34.1	20.7	13.5	17.7	15.0	36.6	15.9	44.8	16.5	10.3	14.9	26.0	28.6	17.0	18.7	30.2	28.0	32.9	22.5	34.2	12.5	40.4	29.1	10.6	15.8	15.8	16.9	12.7	14.0	19.7	45.6	23.0	13.5	24.5	42.5	32.0	39.6	19.0	24.4	42.8	32.6	31.0	13.8	23.2	27.4	23.6	23.3	18.8	21.2	17.9	17.4	21.9	21.5	18.1	22.3	22.1	31.8	37.4	31.9	41.0	17.4	33.6	23.9	35.0	28.4	48.4	36.2	28.4	36.7	32.8	36.0	35.2	31.6	32.2	37.5	36.0	30.6	31.2	42.3	26.6	34.5	30.5	26.4	32.5	50.8	36.0	28.2	25.8	31.5	26.2	28.1	32.1	29.8	16.0	30.4	40.5	58.3	38.8	35.0	10.2	85.6	50.0	15.7	33.4	43.6	21.6	36.0	5.2	35.2	30.0	0.0	30.2	47.2	40.1	31.6	48.6	24.5	32.8	47.7	28.6	23.4	21.9	4.5	33.1	39.9	28.7	50.5	36.7	29.9	28.1	28.8	24.4	22.4	44.2	19.4	47.0	78.8	82.8	57.1	52.3	44.7	34.5	34.2
KLHL36	"C16orf44, FLJ12543"	ENSG00000135686	"Kelch like family member 36"	Q8N4N3	16	84648525-84667686	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023423	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA023423: AB_10962985"	"unprognostic (6.50e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.59e-2)"	"prognostic favorable (9.81e-5)"	"unprognostic (3.79e-3)"	"prognostic favorable (5.52e-10)"	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.67e-3)"	14.6	10.3	13.7	10.8	14.8	26.3	12.2	12.1	11.7	8.9	9.7	7.5	13.0	13.7	11.1	11.1	13.8	10.4	10.1	12.6	10.8	6.0	11.6	16.2	12.7	12.3	10.2	8.6	14.7	21.9	12.7	10.1	9.2	8.7	12.1	5.6	8.8	13.5	12.4	7.8	11.9	14.9	12.0	6.7	16.8	13.1	21.3	10.5	8.4	13.9	7.2	14.0	15.1	22.6	5.9	5.4	8.8	3.7	3.1	10.4	3.2	12.4	13.4	2.5	6.7	2.6	4.8	13.2	8.7	4.8	3.9	2.1	11.8	8.9	8.6	12.8	5.3	3.9	13.3	2.7	7.2	1.8	5.6	5.4	3.0	4.4	6.5	3.5	3.7	8.6	4.6	5.4	5.1	4.0	4.2	4.7	2.6	9.6	1.5	2.8	19.6	0.5	5.3	4.9	4.1	5.9	11.8	3.3	4.2	5.4	11.6	3.8	2.8	11.0	2.8	5.4	3.2	12.0	8.7	10.6	5.0	9.3	5.5	5.8	5.1	6.4	14.8	6.8	4.5	14.9	5.3	3.7	8.8	4.9	2.5	4.1	5.9	8.7	7.1	5.4	5.7	10.4	7.2	4.8	3.1	2.6	4.9	4.0	3.2	13.7	14.8	12.1	11.7	10.8	6.0	10.2	8.6	8.7	10.5	17.9	14.4	23.8	31.2	14.2	21.2	22.4	40.8	10.7	7.9	21.0	33.4	19.3	5.0	22.4	31.8	16.8	29.1	0.0	12.6	9.5	14.3	40.6	6.9	17.9	16.8	25.4	17.9	18.4	15.8	11.8	21.6	15.6	20.3	19.8	20.4	8.6	17.7	24.6	23.7	23.0	22.3	32.3	21.7	14.8	4.7	15.4	16.1	20.8	18.6	36.1
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.1	3.5	4.8	17.0	8.9	8.2	8.2	6.0	5.0	7.5	2.8	13.4	2.5	5.1	8.6	8.8	5.5	3.2	6.5	2.2	6.2	7.5	5.2	9.0	2.8	9.8	2.7	9.7	12.6	7.9	4.5	3.0	3.6	3.1	5.4	5.2	20.9	4.4	10.9	6.9	11.2	2.2	3.9	17.2	4.8	2.1	7.2	4.8	3.2	9.6	8.5	5.7	3.6	5.4	1.8	16.0	7.5	4.1	9.3	2.1	10.7	6.3	14.2	3.7	4.9	9.0	6.0	7.5	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9	11.9	9.9	12.9	8.5	5.6	24.5	8.7	5.1	4.0	5.7	14.0	3.9	21.7	1.7	7.4	4.4	8.2	12.4	0.0	10.0	9.3	12.7	8.2	6.9	23.8	13.5	44.5	15.5	8.6	15.3	3.2	11.5	11.0	18.6	4.6	8.1	43.7	8.0	14.4	15.2	6.7	25.4	12.9	9.5	22.3	10.2	6.8	15.8	13.1	7.0	5.4
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	10.5	8.6	6.7	3.8	9.8	6.0	12.7	35.6	12.4	8.8	9.6	4.3	13.5	9.7	6.0	7.7	8.6	6.6	4.6	5.2	5.3	6.2	7.9	21.7	4.9	3.3	4.1	7.9	6.9	20.3	13.0	35.9	5.3	13.6	7.4	10.6	15.5	8.2	11.4	52.8	24.0	15.5	3.4	7.6	4.3	8.9	9.0	3.9	1.7	7.9	10.3	5.9	5.5	8.1	4.2	3.9	4.5	0.7	3.0	4.2	1.2	4.2	2.0	1.6	2.5	7.9	5.7	0.5	4.5	4.9	4.7	7.0	0.6	1.6	0.0	2.4	3.9	3.7	6.4	1.0	3.7	5.3	0.1	3.0	0.0	4.8	3.0	10.5	0.0	2.7	5.6	4.6	2.0	5.4	1.0	10.2	1.6	0.0	1.7	0.4	3.7	2.6	0.0	1.6	1.6	3.0	0.3	0.1	0.4	0.9	7.2	8.9	1.4	16.1	7.4	4.6	1.5	7.6	2.7	7.4	5.3	1.5	4.9	0.9	9.2	0.2	0.3	2.2	0.0	4.8	0.7	0.7	4.5	3.1	0.2	4.2	2.4	4.0	3.4	0.5	4.2	2.1	3.4	1.9	3.0	0.1	3.9	2.4	1.2	6.7	9.8	35.6	12.4	5.3	6.2	4.1	7.9	13.6	3.9	17.9	16.9	10.2	30.0	58.2	127.4	22.1	28.1	49.5	14.8	36.6	110.0	11.6	5.0	9.2	14.9	17.1	72.6	0.0	8.6	4.9	18.8	32.6	13.9	89.4	6.2	100.1	108.2	18.4	4.8	9.5	59.0	8.9	96.2	47.7	65.8	49.9	12.8	38.6	43.2	10.2	117.6	90.5	24.0	103.0	47.0	46.9	19.8	13.8	26.6	34.4
SSBP4		ENSG00000130511	"Single stranded DNA binding protein 4"	Q9BWG4	19	18418864-18434562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071780			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071780: "	"unprognostic (2.81e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-1)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.32e-2)"	"prognostic unfavorable (2.04e-10)"	"unprognostic (4.50e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.05e-2)"	20.7	15.9	25.4	17.6	39.9	12.2	8.7	16.3	30.1	15.1	12.5	8.0	15.3	16.7	19.9	8.5	8.7	23.2	7.4	8.6	21.1	15.2	9.7	8.2	14.8	16.2	7.7	16.2	15.0	16.1	6.9	28.6	12.7	10.0	13.3	5.0	11.9	12.4	24.1	25.6	11.6	20.1	8.0	5.7	35.5	23.3	12.1	11.4	11.7	11.1	6.9	9.9	7.2	10.3	10.8	5.4	0.5	17.8	3.4	9.4	3.2	11.6	9.0	8.6	15.2	1.6	6.1	12.1	16.4	3.3	3.7	3.9	3.7	13.0	10.3	14.4	3.5	4.0	13.5	2.2	3.0	1.5	11.0	25.2	18.0	11.0	8.3	6.7	8.3	33.2	5.2	2.4	2.3	0.9	5.1	10.9	20.2	36.0	5.1	1.1	17.5	22.1	27.7	7.0	5.5	26.5	15.2	6.9	10.5	5.6	3.7	15.3	26.3	2.5	7.8	21.6	1.7	8.5	19.6	13.8	6.3	16.7	38.2	10.4	7.6	2.2	6.8	16.5	26.2	12.7	0.0	4.3	0.2	9.4	10.8	6.4	10.8	7.9	8.1	5.4	8.7	4.7	8.1	0.5	3.4	17.8	3.4	4.1	3.2	25.4	39.9	16.3	30.1	21.1	15.2	7.7	16.2	10.0	11.4	6.0	18.1	39.5	27.2	15.2	13.5	5.2	7.6	76.3	19.4	50.6	23.6	17.6	21.6	11.4	7.1	33.8	5.6	0.0	18.2	37.9	45.1	23.7	36.9	10.6	31.0	39.7	57.5	23.9	27.9	21.3	54.1	31.1	18.6	8.2	16.9	21.3	11.8	10.5	48.4	17.3	14.1	38.8	35.9	18.2	59.4	12.8	15.8	51.1	17.8	24.0
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BBS5	DKFZp762I194	ENSG00000163093	"Bardet-Biedl syndrome 5"	Q8N3I7	2	169479178-169506655	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 66.8;Early spermatids: 147.0;Rod photoreceptor cells: 60.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046125	Uncertain					NA	NA					"HPA046125: AB_2679549"	"unprognostic (4.37e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.67e-1)"	7.9	11.4	12.9	4.9	15.3	2.7	4.8	7.1	16.7	6.9	5.5	8.7	6.7	4.7	11.1	8.9	5.8	15.7	6.3	9.5	15.1	11.6	8.4	4.7	5.7	4.0	10.3	11.8	9.3	5.8	13.5	16.4	4.7	15.0	8.5	2.8	23.8	5.6	9.1	8.7	7.7	4.2	7.5	7.5	4.8	5.8	21.6	6.1	1.3	12.3	5.2	2.7	5.8	4.0	0.2	0.4	0.0	0.1	0.0	1.9	0.5	0.9	2.5	2.7	4.4	7.3	5.9	2.8	6.3	2.2	8.1	3.4	1.7	1.8	0.1	3.1	3.2	5.0	2.8	2.0	1.0	2.9	4.2	1.0	1.6	0.9	3.5	7.6	3.4	3.8	6.7	6.9	5.3	1.5	3.4	2.5	4.6	6.0	0.0	2.1	3.5	5.7	3.4	2.3	0.6	3.5	0.0	0.6	0.0	4.3	2.6	2.7	5.0	4.2	3.2	16.2	1.0	3.1	3.8	2.5	10.8	5.1	8.6	5.9	3.9	5.8	0.1	6.4	2.2	6.6	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.6	0.5	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.4	0.0	0.5	12.9	15.3	7.1	16.7	15.1	11.6	10.3	11.8	15.0	6.1	0.0	3.2	0.0	1.0	1.1	14.7	4.5	2.5	17.4	4.5	10.4	66.8	0.7	0.0	1.5	147.0	1.1	0.0	0.0	1.3	0.4	1.9	1.0	0.0	0.6	1.2	9.5	2.4	1.3	2.2	20.5	4.6	1.5	6.8	0.0	1.2	10.4	1.0	0.0	5.6	1.4	60.5	0.0	2.0	24.1	6.6	1.5	0.2	0.0	0.6	0.4
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favorable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favorable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.6	12.7	7.6	11.9	10.1	14.3	7.3	11.9	12.2	15.1	16.7	9.7	5.8	13.2	14.1	13.3	10.4	8.8	9.2	14.0	8.0	23.3	14.2	24.4	25.3	23.9	15.9	10.2	28.2	13.8	9.9	17.2	10.2	9.5	14.6	17.5	10.2	37.0	13.3	27.3	15.0	63.2	2.4	8.6	22.2	15.0	6.5	13.5	12.3	28.0	7.2	8.8	11.6	12.3	8.5	6.2	6.8	17.4	12.4	20.4	7.3	23.5	14.0	30.5	23.7	12.1	10.2	21.4	11.4	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8	11.9	19.9	6.7	4.8	6.0	8.4	23.6	12.7	5.3	10.3	8.7	3.9	6.0	44.7	6.5	1.4	7.5	10.2	0.0	9.5	6.9	9.4	5.5	18.5	20.2	13.0	0.0	4.6	14.1	30.7	6.4	6.9	18.0	15.1	15.4	8.3	7.4	9.1	11.5	9.2	19.5	9.7	0.0	8.6	1.4	4.3	6.4	5.6	19.2	9.0	4.9
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.3	1.5	1.4	0.4	0.7	1.9	1.4	0.0	0.8	0.7	2.2	0.1	2.6	1.2	0.6	0.8	3.6	3.4	14.0	0.3	1.3	0.0	44.0	0.1	0.3	0.2	0.0	0.0	0.0	2.2	0.0	5.5	0.1	1.1	0.0	1.2	1.9	12.3	9.4	0.4	0.5	1.6	0.0	10.5	4.6	5.1	0.7	0.5	0.0	1.3	0.5	12.2	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.8	20.8	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1	89.3	8.2	0.9	4.4	7.4	0.7	0.0	2.5	0.0	3.4	0.0	0.0	0.7	0.0	0.0	1.1	6.3	22.2	0.0	0.0	1.5	5.9	7.8	49.6	0.2	83.6	0.0	59.1	4.3	69.4	2.0	4.0	37.7	11.8	0.0	39.6	2.5	0.0	37.1	3.2	0.0	0.9	0.0	3.8	20.5	57.7	5.9	1.1	30.5	41.5	2.7
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 319.5"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 76804.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 810.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA					"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	56.5	83.7	174.1	20.5	149.4	34.8	55.5	47.4	106.2	30.5	90.9			76.1	27.5	46.0	40.4	26.3	28.7	290.4	159.6	111.4	190.3	143.1	21.0	22.8	120.2		27.9	38.9	60.5	26.7	32.5		37.3	95.5		79.0	64.3	319.5	70.0	55.3	39.0	61.9	21.7	60.5	36.5			31.0		31.0	26.9	18.7	247.1	126.7	244.3	245.3	141.7	181.1	106.8	130.8	155.4	238.8	339.1	475.8	196.3	130.7	170.6	101.1	67.4	104.1	208.0	195.6	292.9	73.9	141.6	73.7	359.5	37.6	204.9	119.5	99.3	164.3	155.7	810.6	345.5	96.2	92.6	205.1	188.5	291.4	74.1	110.5	238.7	124.6	168.0	123.3	296.8	222.5	267.4	94.0	540.0	53.0	208.4	112.2	100.6	75.3	211.0	420.2	231.5	107.0	148.6	79.5	87.1	164.8	347.1	182.0	408.6	199.6	113.0	193.8	211.0	111.3	122.2	78.6	163.5	112.8	302.0	74.2	132.0	245.3	121.5	110.0	128.3	137.4	198.7	119.5	127.0	126.7	247.1	153.2	181.1	244.3	141.7	122.3	107.8	79.5	106.8											1774.7	2343.8	18268.7	8249.8	7411.8	0.0	76804.5	19304.4	3075.6	3885.5	15697.2	0.0	0.0	3702.1	4549.9	1673.9	3293.3	31596.9	21118.2	5876.9	0.0	3002.6	5473.3	1979.3	30765.6	0.0	0.0	6556.1	11050.6	17592.2	7669.6	10722.1	5677.4	5267.0	6541.2	23740.6	0.0	4985.0	16907.1	7340.6	25199.2	0.0	11945.6	6322.1	9983.2	10814.8	7412.6	0.0	11568.9	24590.7	11079.5
CBX7		ENSG00000100307	"Chromobox 7"	O95931	22	39120167-39152674	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.0;U-266/70: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011574, HPA048677, HPA056480"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB011574: AB_726005, HPA048677: AB_2680490, HPA056480: AB_2683146"	"prognostic favorable (6.18e-4)"	"prognostic favorable (3.63e-4)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.03e-3)"	"prognostic favorable (2.45e-5)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.63e-2)"	17.6	23.1	26.1	14.2	34.3	4.0	14.0	45.0	44.7	20.1	29.3	17.2	24.1	12.3	27.8	21.9	18.0	24.7	19.1	36.5	23.9	19.5	17.6	6.4	19.1	17.2	18.7	29.5	36.9	15.0	33.4	17.1	6.2	19.7	27.1	10.6	21.1	24.0	44.0	38.6	15.4	15.8	35.9	12.9	22.0	18.8	6.5	19.9	4.5	16.9	10.8	15.1	26.2	21.1	3.7	0.7	5.5	0.9	1.7	5.1	1.6	4.5	1.9	0.9	7.4	9.1	3.5	2.4	4.3	5.3	2.4	2.8	0.9	3.1	0.7	5.1	3.2	4.3	1.7	0.6	2.0	1.8	24.0	2.4	0.1	3.1	0.4	3.1	1.1	9.5	1.7	3.0	1.1	0.5	3.0	0.7	3.7	1.1	12.2	1.8	4.3	1.6	0.5	0.5	5.7	3.3	1.8	1.5	6.5	1.2	1.8	2.4	0.6	2.2	3.2	4.9	1.6	3.9	1.8	1.7	4.0	7.6	4.0	1.9	20.8	11.7	2.8	8.1	1.8	1.7	0.6	0.5	4.8	3.7	0.1	3.8	2.9	4.0	4.0	0.1	3.7	5.1	4.8	5.5	1.7	0.9	0.7	3.8	1.6	26.1	34.3	45.0	44.7	23.9	19.5	18.7	29.5	19.7	19.9	6.0	8.3	29.6	11.6	4.0	49.8	60.2	22.9	4.0	13.6	14.0	33.4	2.9	8.3	2.8	7.4	14.7	7.2	0.0	3.3	1.2	8.4	9.8	10.4	10.9	3.7	57.2	4.1	20.3	12.3	6.4	32.5	5.5	18.6	10.0	8.0	16.2	2.9	3.5	26.2	11.0	57.0	45.3	27.8	3.9	2.7	4.3	3.0	17.5	6.2	6.3
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.2	6.8	5.3	8.4	2.6	2.2	10.1	4.3	2.8	5.1	2.3	4.6	2.7	5.1	5.6	2.5	2.9	4.7	3.1	2.8	2.0	2.6	9.2	6.9	5.0	7.7	6.9	6.8	8.8	2.6	2.7	4.0	3.3	2.8	5.3	8.7	11.5	3.8	2.1	8.3	15.9	44.6	8.7	1.8	9.1	14.9	3.3	13.2	2.3	1.9	4.9	5.5	9.8	2.0	5.3	2.7	5.8	23.3	7.3	3.8	5.7	5.7	5.1	8.6	5.0	12.4	3.4	25.9	5.3	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1	8.9	5.1	15.7	4.7	4.2	10.1	2.4	7.6	1.4	3.4	7.0	5.9	7.4	8.3	5.2	1.1	8.0	2.0	0.0	8.0	7.5	8.2	3.6	20.7	4.0	34.7	7.9	4.7	10.4	37.7	1.8	8.6	37.5	10.1	11.8	2.7	8.9	4.6	0.0	7.4	5.6	8.6	6.5	7.1	9.4	8.6	5.1	3.1	66.8	4.1	1.3
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616582-66627347	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"		NA	NA		13000	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	23.5	23.2	22.6	28.4	27.3	35.2	20.8	44.3	31.0	24.1	20.8	26.9	28.6	18.7	30.8	24.6	25.7	28.9	25.3	22.0	22.3	19.4	26.6	29.1	21.0	34.7	32.1	20.4	37.7	26.6	24.8	34.0	24.5	22.4	27.8	22.9	28.8	27.6	22.3	24.3	34.8	24.7	28.0	21.7	32.1	22.5	42.9	25.6	47.2	27.7	20.2	34.1	18.5	23.0	18.3	24.7	20.1	19.6	15.7	22.6	20.8	23.0	25.9	16.7	14.3	8.8	6.3	31.7	12.2	6.9	18.0	10.6	26.5	20.2	36.8	13.8	7.9	13.7	20.6	22.5	15.8	14.8	16.4	20.0	21.9	20.4	21.1	5.6	20.4	21.7	4.3	5.6	16.6	7.7	7.7	13.3	13.5	26.6	26.9	14.3	22.6	37.9	25.8	33.8	20.4	25.6	35.2	18.8	20.2	12.0	21.4	20.3	17.9	22.6	17.8	9.9	15.5	26.2	19.4	14.7	17.7	30.3	12.9	20.9	14.1	19.8	32.1	14.0	22.2	39.5	12.9	16.9	20.1	22.3	19.6	21.7	17.0	19.6	21.5	24.7	18.3	20.5	22.6	7.6	15.7	19.5	16.2	16.6	20.8	22.6	27.3	44.3	31.0	22.3	19.4	32.1	20.4	22.4	25.6	8.9	14.2	30.3	35.0	33.9	22.8	14.9	22.9	14.7	13.6	14.0	27.5	48.8	14.9	22.7	30.5	22.2	17.1	23.3	15.9	45.0	26.8	23.6	19.6	21.2	25.0	11.1	20.7	20.9	11.6	20.8	15.8	20.2	11.8	22.6	16.1	17.8	17.7	17.3	15.2	7.8	49.1	6.5	30.9	45.6	36.3	27.1	57.9	30.9	20.4	26.1
ATP1B2	AMOG	ENSG00000129244	"ATPase Na+/K+ transporting subunit beta 2"	P14415	17	7646627-7657768	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.8"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 345.9;Cone photoreceptor cells: 235.6;Muller glia cells: 268.9;Rod photoreceptor cells: 188.4"	"Cancer enriched"	"Detected in many"	17	"glioma: 200.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;HAP1: 4.1;K-562: 6.1;SuSa: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010698	Supported					NA	NA		17000			"HPA010698: AB_1845174"	"unprognostic (9.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.96e-3)"	"unprognostic (3.90e-3)"	"unprognostic (9.33e-2)"	"unprognostic (4.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.79e-2)"	4.1	6.5	54.7	2.5	61.6	8.1	2.5	62.9	148.8	9.4	3.4	25.1	0.0	2.7	8.0	15.1	3.4	10.9	4.4	5.0	46.1	33.4	6.9	3.4	3.9	2.9	42.4	41.9	23.3	3.3	3.8	10.8	5.0	68.9	4.6	3.8	28.4	3.3	7.6	4.6	2.7	3.0	5.8	58.7	4.8	2.4	4.3	25.7	0.0	4.4	0.0	2.6	3.3	2.0	1.3	0.7	1.5	1.0	1.3	2.0	0.5	0.0	0.0	13.5	0.6	0.4	0.3	0.1	0.2	0.0	0.5	0.3	0.5	0.0	0.4	0.3	0.1	0.2	0.4	4.1	0.2	0.2	0.1	1.7	0.3	0.1	0.1	0.2	0.1	1.3	0.8	0.0	0.5	0.0	0.1	0.0	0.3	6.1	0.8	0.0	0.4	0.3	0.4	2.8	0.1	0.3	0.2	0.0	0.2	0.1	0.1	0.2	2.6	0.0	0.1	0.1	8.2	0.2	0.3	0.0	0.2	1.0	0.1	0.2	0.5	0.2	0.1	1.2	0.3	0.3	0.9	1.0	0.5	2.0	0.3	1.8	1.3	0.7	1.4	0.3	0.8	1.1	1.0	1.5	1.3	0.2	0.7	0.2	0.5	54.7	61.6	62.9	50.8	46.1	33.4	42.4	41.9	68.9	25.7	0.0	0.0	0.0	0.2	1.6	345.9	2.8	5.1	0.0	0.0	0.0	235.6	0.0	0.0	0.0	0.2	1.8	0.5	23.3	0.0	0.1	2.4	0.4	0.0	0.0	0.3	17.5	0.0	5.5	1.5	0.2	17.3	0.6	0.0	0.0	0.0	268.9	0.0	0.0	43.5	0.1	188.4	25.8	22.8	0.4	6.3	1.0	0.2	0.0	0.0	0.1
APH1B	"APH-1B, DKFZp564D0372, PSFL"	ENSG00000138613	"Aph-1 homolog B, gamma-secretase subunit"	Q8WW43	15	63276018-63309126	"Predicted membrane proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;testis: 75.6"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 1096.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (9.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.57e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	6.7	8.0	5.3	5.9	7.8	4.5	6.9	6.1	7.1	5.0	3.4	12.6	4.8	2.4	6.3	8.0	3.0	10.4	5.1	5.6	5.6	5.8	5.1	2.2	5.8	15.0	6.8	6.2	9.6	2.9	4.3	5.6	5.0	7.4	7.7	2.9	8.6	5.0	5.4	2.5	3.4	4.5	4.6	7.5	9.2	3.2	75.6	3.4	8.0	12.3	2.0	5.0	5.3	4.2	8.4	5.7	16.6	37.1	2.3	4.9	6.5	0.7	4.8	5.3	4.3	12.2	21.5	1.9	6.3	12.9	4.8	8.1	4.4	7.0	6.2	3.0	7.0	9.0	0.7	9.0	2.5	9.1	4.2	1.4	10.8	1.1	0.1	10.1	2.3	17.9	13.5	4.0	7.1	4.8	8.2	10.1	7.9	3.6	4.7	14.9	2.1	3.2	7.3	5.0	1.5	2.5	3.2	2.9	0.1	2.5	4.9	4.7	2.6	2.6	2.1	0.0	5.9	7.8	14.0	6.7	14.3	5.6	2.3	0.9	11.4	18.9	8.4	10.4	14.1	8.3	10.6	12.0	14.8	4.2	22.9	3.4	8.4	4.4	3.8	5.7	6.4	4.8	4.9	16.6	2.3	37.1	2.1	4.2	6.5	5.3	7.8	6.1	7.1	5.6	5.8	6.8	6.2	7.4	3.4	8.9	19.7	15.7	9.4	4.6	7.0	4.5	7.6	22.7	14.8	21.0	2.0	5.2	1.7	24.3	1096.5	10.0	0.5	0.0	5.5	34.4	12.8	9.1	22.0	1.5	48.6	1.6	19.5	17.2	45.1	235.2	22.7	28.9	10.1	26.2	3.8	23.7	13.2	0.0	15.6	5.6	13.6	12.9	13.3	231.2	16.4	3.0	5.0	10.2	2.4	5.2
PLD6		ENSG00000179598	"Phospholipase D family member 6"	Q8N2A8	17	17200995-17206315	"Predicted membrane proteins"	"Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.1"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 15.6;Spermatogonia: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 5.0;T-cells: 11.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 25.9;REH: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA049345	Approved					NA	NA					"HPA049345: AB_2680722"	"unprognostic (1.71e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.83e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.24e-1)"	5.0	5.9	4.8	2.3	12.5	2.4	5.1	18.2	9.6	6.7	5.8	4.5	2.9	2.3	4.4	7.2	2.6	6.5	3.6	5.5	4.9	8.1	3.4	4.6	2.5	5.2	5.0	4.1	10.4	16.2	6.8	6.3	3.7	5.6	7.5	2.5	5.1	4.5	6.5	3.7	3.2	2.2	3.4	4.0	3.0	3.7	37.1	1.7	2.0	3.3	1.7	4.1	5.9	3.3	5.6	1.3	0.5	0.4	5.0	11.4	4.0	4.2	3.3	0.1	3.8	1.5	0.6	0.2	1.3	2.2	2.5	1.5	3.9	1.3	9.5	2.1	1.4	1.5	1.2	25.9	0.7	2.4	5.9	7.5	9.1	2.5	6.9	6.7	6.8	3.8	1.3	2.8	1.5	6.2	2.9	0.6	4.5	8.1	0.2	2.9	5.5	5.0	9.6	0.0	4.9	4.6	19.2	1.9	6.9	2.3	0.3	15.0	6.1	1.7	2.5	4.5	2.9	2.4	11.0	0.7	0.1	0.2	5.6	2.7	1.2	4.4	0.0	3.1	7.0	5.3	0.3	0.4	0.2	2.8	0.3	9.2	5.6	10.7	5.6	0.1	4.3	11.4	5.1	0.5	5.0	0.2	1.3	7.6	4.0	4.8	12.5	18.2	9.6	4.9	8.1	5.0	4.1	5.6	1.7	3.0	3.5	2.9	4.1	4.8	4.6	5.6	2.5	5.3	2.3	1.8	0.0	3.4	1.7	0.9	6.0	0.5	0.5	0.0	0.6	0.9	2.4	3.6	1.1	1.7	2.4	6.4	1.2	0.6	0.3	1.6	4.0	0.0	3.3	1.0	1.7	5.8	0.9	0.0	4.6	1.1	1.2	0.0	1.4	15.6	25.4	1.4	0.7	3.8	1.2	0.9
ZNF181	"HHZ181, MGC44316"	ENSG00000197841	"Zinc finger protein 181"	Q2M3W8	19	34734155-34745378	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043701, HPA062305"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043701: AB_10960859, HPA062305: AB_2684743"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.34e-2)"	"prognostic favorable (5.45e-4)"	8.5	12.1	13.4	7.2	14.2	3.9	13.0	20.8	15.1	11.1	12.0	9.4	12.7	11.7	11.6	8.1	8.3	11.4	8.9	17.0	12.4	10.1	11.2	17.2	9.7	8.3	17.4	11.2	22.8	15.7	16.3	19.3	6.7	13.7	12.2	8.9	6.9	9.3	13.9	25.5	5.7	13.6	10.6	14.6	11.2	9.8	8.3	15.8	11.0	13.1	10.1	10.7	11.8	9.3	12.0	5.8	5.4	12.1	8.4	16.1	5.6	3.6	6.1	7.4	9.6	12.0	9.3	2.2	4.4	8.0	5.0	5.8	4.2	3.9	5.8	12.8	7.0	6.7	3.5	5.0	5.0	3.8	12.0	5.1	10.9	7.5	5.9	14.2	6.4	3.8	7.4	8.1	3.5	6.9	12.3	4.7	12.6	8.7	0.2	9.8	2.6	12.4	4.3	4.7	8.4	5.0	8.5	9.0	7.3	6.8	4.4	5.0	9.4	9.9	2.7	10.0	6.3	5.7	10.0	6.6	12.8	6.4	3.1	4.8	9.0	13.1	4.8	5.1	1.6	6.4	2.6	3.6	5.4	7.5	5.0	7.7	7.5	10.2	10.2	5.1	12.0	16.1	11.4	0.7	8.4	12.1	5.8	6.2	5.6	13.4	14.2	20.8	15.1	12.4	10.1	17.4	11.2	13.7	15.8	14.9	4.0	0.5	3.6	1.4	15.3	38.2	0.0	24.1	13.6	5.2	3.9	2.6	14.9	4.6	1.7	6.0	4.7	0.0	4.4	0.9	3.9	2.4	2.3	6.7	3.2	12.7	4.1	6.7	4.7	1.8	8.6	5.0	5.0	1.8	6.6	13.2	2.4	5.7	11.3	6.7	13.1	0.0	6.6	12.7	9.6	0.6	0.9	5.7	4.7	0.9
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
ZFP3	"FLJ30726, ZNF752"	ENSG00000180787	"ZFP3 zinc finger protein"	Q96NJ6	17	5078248-5096374	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 13.4;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.5;SH-SY5Y: 7.7;SiHa: 7.0"	"Low region specificity"	"Detected in all"							"HPA053085, HPA057290"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA053085: AB_2682039, HPA057290: AB_2683400"	"unprognostic (3.71e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.45e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.89e-2)"	"prognostic favorable (7.69e-7)"	"unprognostic (8.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.29e-3)"	4.9	6.3	11.0	10.0	10.4	1.9	8.9	19.6	14.7	6.8	8.9	11.9	9.6	13.0	6.9	6.9	6.7	11.2	6.3	12.4	9.8	7.6	10.2	3.3	7.3	9.2	7.9	8.3	9.9	11.3	16.6	10.8	5.2	11.4	7.9	10.9	7.4	10.7	15.4	33.3	6.7	11.3	6.3	8.5	10.2	8.3	9.9	11.8	10.6	11.1	3.5	11.2	6.6	5.7	5.4	1.4	1.4	2.2	1.9	4.3	1.6	0.0	1.3	0.3	0.0	1.2	0.6	0.0	2.8	0.0	2.2	2.5	5.6	2.6	0.0	4.0	2.8	1.0	5.7	0.0	0.0	1.2	0.0	0.1	0.2	2.1	0.0	3.9	0.0	7.5	2.0	0.0	1.5	0.0	0.0	0.7	0.2	0.0	0.1	0.4	0.0	0.1	0.2	0.3	4.0	0.6	0.0	0.8	1.8	3.5	3.4	3.6	7.7	7.0	5.8	3.6	1.3	3.5	5.5	0.0	0.0	1.2	2.0	4.0	0.1	0.2	0.0	0.0	0.0	3.2	0.0	2.0	1.4	2.8	2.2	1.7	2.1	1.6	2.5	1.4	5.4	4.3	3.0	0.2	1.9	1.9	0.9	1.6	1.6	11.0	10.4	19.6	14.7	9.8	7.6	7.9	8.3	11.4	11.8	0.0	3.4	0.0	0.4	0.2	3.9	6.3	0.0	13.4	2.3	1.8	7.9	1.0	0.0	1.3	0.4	1.6	2.1	0.0	1.0	0.3	0.9	0.4	1.1	0.0	1.4	3.2	0.0	5.5	1.2	0.0	1.4	1.2	0.0	0.0	1.7	3.2	0.4	0.0	1.1	1.1	6.0	0.0	0.5	6.6	4.3	0.1	0.7	0.0	2.5	0.4
GDF11	BMP-11	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743280-55757278	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 35.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 71.9;Cone photoreceptor cells: 72.6;Horizontal cells: 54.0;Rod photoreceptor cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	270000	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	4.6	4.9	15.9	5.6	13.9	2.6	1.9	10.7	13.3	10.3	4.5	9.2	6.6	2.7	10.0	3.5	4.0	6.9	7.4	11.4	13.3	12.9	3.2	1.6	3.1	4.1	13.9	7.3	7.5	4.7	4.6	4.6	3.3	9.3	7.7	2.8	35.4	7.0	16.0	1.9	2.1	3.6	7.3	13.1	5.7	3.5	1.7	9.5	5.7	4.6	1.6	2.9	7.5	2.9	2.4	2.3	1.4	1.2	0.8	3.9	0.5	1.9	3.1	13.8	7.7	10.5	7.7	3.5	4.1	3.9	5.3	4.5	10.6	0.9	3.8	5.5	4.3	2.5	1.9	10.4	7.4	1.8	7.3	9.4	4.7	5.2	1.6	2.1	3.9	54.1	7.4	0.4	7.7	2.2	5.9	6.8	5.2	5.2	12.6	6.7	3.7	6.3	3.4	11.1	0.1	7.8	10.1	3.8	2.4	3.2	2.7	9.4	5.7	2.5	1.2	1.1	5.9	4.4	4.3	4.1	6.4	9.9	5.0	3.0	3.4	1.0	1.9	3.4	3.9	4.4	0.7	0.7	1.4	3.9	0.5	3.6	2.3	2.4	2.5	0.6	2.4	2.2	3.0	1.2	0.8	1.2	2.3	1.7	0.5	15.9	13.9	10.7	10.0	13.3	12.9	13.9	7.3	9.3	9.5	0.0	0.6	5.4	8.5	0.5	71.9	23.4	0.0	0.0	1.2	0.0	72.6	2.9	0.0	4.3	0.4	4.5	1.3	0.0	1.2	3.9	5.8	4.5	5.7	0.0	1.4	54.0	10.3	3.7	0.6	0.4	8.3	0.3	3.3	2.8	1.3	28.4	3.1	2.9	5.3	0.4	49.9	12.9	5.7	1.2	3.5	0.6	3.9	17.3	2.0	5.3
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060985-46089952	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	16.0	15.0	20.9	25.8	18.5	8.1	55.1	31.2	25.6	19.3	17.7	12.0	18.5	14.0	23.4	20.3	16.5	21.1	15.8	13.8	19.3	13.1	14.1	12.9	21.7	23.0	14.6	16.2	29.8	27.0	23.4	26.2	18.4	15.7	19.2	16.5	14.7	18.5	23.6	22.8	19.4	18.1	19.8	13.6	23.3	16.5	44.4	16.7	23.8	19.2	14.2	23.8	18.2	42.5	17.4	18.5	10.7	8.6	7.4	14.0	5.4	19.4	17.3	24.5	25.1	11.7	12.4	19.6	13.5	12.2	22.0	18.2	23.9	15.6	32.0	22.9	13.0	18.8	26.1	20.2	16.9	19.1	19.3	10.2	19.2	17.3	20.1	12.4	26.3	18.7	8.9	22.6	11.6	10.6	11.6	15.6	16.8	17.8	26.2	17.3	25.2	36.1	20.4	22.2	16.5	21.4	27.5	16.2	14.0	12.9	22.2	22.0	20.0	21.7	26.5	19.0	14.6	21.1	31.1	14.4	23.4	17.8	13.9	21.0	17.1	24.1	21.6	16.2	15.5	14.8	3.3	8.3	10.7	12.2	8.5	14.0	11.6	12.8	12.3	8.3	17.4	12.3	11.1	6.0	7.4	8.6	18.5	8.2	5.4	20.9	18.5	31.2	25.6	19.3	13.1	14.6	16.2	15.7	16.7	8.9	13.0	7.5	2.8	5.7	12.0	3.9	10.2	9.4	6.8	8.7	21.6	9.3	0.0	7.6	6.0	6.9	6.0	0.0	10.5	8.7	6.7	3.6	1.1	6.8	6.7	3.2	9.1	8.6	8.8	2.7	12.7	6.3	3.3	6.4	9.7	6.8	10.1	2.9	14.5	4.4	9.0	6.5	5.3	23.0	13.6	4.6	5.6	5.7	9.3	3.1
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422946-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 25.0;Erythroid cells: 23.3;Late spermatids: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA058014			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058014: AB_2683579"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favorable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	9.6	12.1	19.3	5.7	23.4	3.6	10.5	21.5	27.9	9.2	9.7	8.4	12.8	7.8	12.0	12.8	5.3	10.7	8.7	16.9	12.7	10.9	16.8	10.9	10.4	8.5	9.6	21.6	13.7	12.6	10.1	10.2	6.1	12.5	10.9	5.8	10.3	13.0	10.2	14.4	8.6	8.3	9.7	8.1	9.7	10.0	13.5	10.6	7.0	13.7	7.0	8.8	9.5	8.9	9.2	8.1	8.1	8.5	6.7	10.9	7.3	2.5	8.5	8.8	6.2	3.7	4.5	3.3	3.0	2.9	2.9	3.5	1.9	7.9	8.2	3.2	6.6	6.3	2.3	5.1	4.0	2.8	14.7	3.2	7.9	8.8	9.5	6.9	3.5	5.3	9.2	4.8	6.4	2.1	14.0	4.0	17.0	4.9	0.2	3.2	2.6	5.7	5.6	3.4	3.3	2.6	4.2	2.8	10.3	5.3	1.4	2.1	3.5	2.3	2.5	6.1	19.1	4.4	2.3	10.5	2.0	2.3	2.1	1.6	9.1	3.7	2.8	7.1	8.6	3.8	8.1	7.3	6.9	8.0	5.4	5.3	9.2	5.0	9.4	5.9	5.6	6.2	7.6	2.1	6.7	8.5	8.1	10.9	7.3	19.3	23.4	21.5	26.2	12.7	10.9	9.6	21.6	12.5	10.6	0.0	0.6	0.5	5.0	3.7	6.1	10.7	5.1	1.4	1.2	0.0	9.8	5.3	0.0	0.0	25.0	3.8	4.0	23.3	0.0	1.7	4.6	2.6	1.1	4.5	4.9	3.2	11.6	1.8	4.7	27.9	8.9	1.5	3.3	0.0	3.4	5.8	0.0	1.4	5.6	0.0	6.3	6.5	3.1	12.2	2.3	2.9	2.7	5.2	2.3	4.2
REPIN1	"AP4, H_DJ0584D14.12, RIP60, Zfp464, ZNF464"	ENSG00000214022	"Replication initiator 1"	Q9BWE0	7	150368189-150374044	"Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 66.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036022	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036022: AB_10610417"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.50e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.88e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.59e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (5.56e-4)"	"prognostic favorable (1.61e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-3)"	"prognostic favorable (6.41e-4)"	17.0	30.1	16.2	24.9	23.1	25.7	16.9	24.2	21.7	12.0	27.5	21.5	23.2	29.2	15.4	23.6	14.9	17.5	23.6	22.1	15.6	17.1	18.6	36.1	12.3	22.4	21.9	14.3	16.6	34.0	21.5	28.5	10.4	15.6	19.0	20.3	21.9	26.9	23.2	78.4	14.4	27.1	11.4	13.3	23.1	20.6	7.0	18.9	45.4	20.1	20.0	20.3	18.1	15.9	3.6	11.2	3.5	2.1	2.3	3.5	1.2	16.1	19.8	18.8	23.0	4.6	3.3	11.5	8.0	9.9	7.9	6.9	15.3	10.5	18.0	20.4	5.7	13.7	12.1	10.2	3.1	4.0	19.6	15.4	10.5	10.7	19.2	15.3	18.5	17.2	4.3	9.7	4.3	1.0	7.5	11.1	11.0	25.2	11.3	6.5	21.0	25.6	21.1	19.7	10.9	19.7	14.1	21.8	66.9	8.3	28.8	27.7	35.4	12.1	30.5	20.5	8.1	14.9	14.9	11.7	6.1	5.0	6.7	16.1	33.0	12.2	16.4	10.7	16.5	15.0	0.1	2.1	3.5	1.2	1.0	1.9	3.6	2.7	2.3	3.0	3.5	3.5	1.7	2.0	2.3	0.5	11.2	1.1	1.2	16.2	23.1	24.2	21.7	15.6	17.1	21.9	14.3	15.6	18.9	32.8	18.1	23.0	16.6	8.4	59.5	40.5	35.7	16.0	12.5	14.0	39.3	23.1	53.0	32.6	5.8	19.7	43.4	0.0	43.4	10.2	13.5	26.1	24.3	55.7	27.7	76.3	65.4	19.6	14.6	6.3	20.4	14.8	15.1	126.2	53.2	77.2	34.2	24.6	18.7	26.1	52.6	6.5	17.0	8.9	3.2	15.6	21.4	18.5	98.3	16.9
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 73.9;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"JURKAT: 30.4;MOLT-4: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	3.8	3.8	4.9	5.9	2.8	4.7	5.8	4.0	2.7	3.2	3.1	1.7	7.0	1.8	1.6	3.4	4.6	3.8	3.4	1.6	1.6	10.6	1.8	2.8	4.7	5.6	3.7	4.3	2.6	3.2	4.1	5.9	4.7	1.6	3.4	30.4	4.0	4.1	1.5	4.7	28.1	5.9	3.8	4.8	2.0	7.3	9.2	2.8	3.7	4.9	3.9	6.9	5.6	2.5	9.8	2.9	1.3	11.9	5.4	3.7	0.3	6.4	5.4	2.9	2.7	3.5	5.4	6.0	7.4	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3	3.0	9.0	3.7	2.2	7.0	11.5	10.1	7.6	0.0	3.4	10.4	2.0	1.2	0.0	2.4	73.9	5.8	4.5	0.0	1.8	1.5	8.0	5.0	2.3	5.8	2.9	15.9	5.8	13.5	22.7	47.3	10.9	5.5	5.0	0.0	5.5	10.1	1.7	0.0	11.7	1.2	7.1	0.0	5.6	2.2	2.1	8.4	1.1	8.7	5.7	2.2
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	12.7	12.1	13.5	23.1	15.5	17.0	12.7	15.5	15.8	9.9	13.8	14.6	16.1	13.1	17.5	14.4	12.8	13.1	17.7	10.2	14.7	12.9	11.4	16.1	12.5	21.0	14.7	13.6	12.1	20.6	15.6	14.2	8.7	12.9	11.0	15.8	10.7	16.6	16.3	30.7	15.9	12.0	12.7	15.5	14.9	14.5	26.6	12.9	22.7	14.0	14.5	19.5	12.7	11.8	6.1	6.1	4.4	11.1	17.6	14.4	6.4	6.7	12.4	6.3	9.5	2.5	3.4	9.8	6.4	6.0	10.6	5.0	18.3	9.7	10.7	8.6	5.0	3.7	11.1	9.6	8.5	7.6	1.6	10.7	6.1	7.8	12.0	6.5	5.6	6.4	1.5	4.5	9.5	10.7	5.2	8.8	18.1	19.5	5.6	7.0	29.0	13.1	16.6	10.6	7.6	9.3	12.7	7.3	6.1	6.3	7.9	9.7	9.3	13.4	6.9	3.1	5.4	10.9	9.0	5.5	5.9	10.1	3.0	12.1	27.3	9.3	46.5	5.7	14.5	4.0	0.0	6.0	4.4	14.4	7.8	12.6	6.1	6.0	11.6	4.4	5.5	6.1	9.2	0.4	17.6	11.1	6.1	5.0	6.4	13.5	15.5	15.5	15.8	14.7	12.9	14.7	13.6	12.9	12.9	0.0	15.6	9.0	8.9	4.0	14.4	8.5	12.7	9.4	15.9	8.7	25.5	12.5	10.0	9.5	50.2	6.7	11.1	23.3	14.4	7.3	5.9	11.1	3.5	11.3	11.7	11.1	23.1	9.8	16.5	59.9	6.1	6.8	8.5	9.0	12.0	6.2	11.7	11.5	7.1	19.2	17.7	0.0	6.2	19.4	11.7	5.8	10.0	30.2	18.5	15.3
ADGRL1	"CIRL1, KIAA0821, LEC2, LPHN1"	ENSG00000072071	"Adhesion G protein-coupled receptor L1"	O94910	19	14147743-14206187	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 59.8;Horizontal cells: 33.4;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 31.8;HMC-1: 23.1;SCLC-21H: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037974	Uncertain					NA	NA		63000			"HPA037974: AB_10675623"	"unprognostic (5.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.52e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (7.65e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.18e-1)"	10.5	4.6	12.1	3.5	18.0	1.8	3.9	27.0	30.9	7.7	6.4	12.7	4.3	6.1	9.0	4.1	6.5	10.8	4.1	5.5	12.7	9.3	3.4	0.5	5.4	2.6	8.7	9.0	4.0	5.8	12.8	9.1	3.7	11.8	5.4	3.7	9.4	9.8	8.1	1.6	9.1	5.4	8.1	8.1	4.4	5.0	5.5	6.9	2.8	9.2	2.0	1.8	4.6	3.4	0.4	1.7	1.3	1.3	4.6	1.3	0.6	10.0	3.9	8.9	31.8	2.4	0.7	3.1	0.7	1.0	1.0	0.6	3.4	3.5	0.8	10.7	1.2	2.0	0.6	10.7	3.0	0.3	1.4	9.1	1.8	1.6	0.5	5.4	0.6	23.1	1.9	2.8	0.3	0.5	1.6	0.8	10.0	8.8	0.9	0.1	16.9	0.8	0.9	13.3	5.4	7.6	4.9	1.1	11.2	1.7	3.2	24.6	6.3	1.9	12.7	4.4	3.3	12.6	4.7	1.2	8.4	12.9	2.3	2.9	2.5	2.1	13.8	2.5	11.7	3.0	0.0	1.3	0.5	1.3	1.1	0.9	0.4	0.7	0.4	0.5	0.2	1.0	0.6	1.3	4.6	1.1	1.7	0.7	0.6	12.1	18.0	27.0	27.6	12.7	9.3	8.7	9.0	11.8	6.9	0.0	5.0	0.0	2.8	0.0	59.8	7.3	2.5	0.0	3.4	7.0	9.8	0.3	0.0	3.2	0.3	4.5	3.2	0.0	2.7	0.3	3.3	3.9	4.7	0.0	0.7	33.4	7.0	9.2	2.2	2.0	8.6	0.4	0.0	1.0	3.0	32.9	2.4	7.8	15.2	0.7	22.2	19.4	0.9	0.9	22.6	0.0	0.2	1.9	6.7	1.4
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 123.5;Late spermatids: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.9	3.8	2.5	0.9	57.3	0.5	0.0	2.3	1.3	3.7	3.5	0.9	1.9	8.2	2.6	0.7	1.8	2.2	1.5	4.6	0.4	1.5	2.4	2.3	1.8	0.1	1.1	0.0	5.6	0.5	4.4	0.6	0.8	0.5	1.0	3.4	1.0	5.2	0.5	0.0	5.7	0.2	0.3	3.8	1.1	4.7	0.4	2.7	1.0	5.2	3.5	3.6	2.0	2.3	2.1	0.1	0.6	3.0	1.9	1.0	3.2	0.4	2.1	3.9	3.2	6.1	2.6	0.2	3.5	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8	0.0	3.5	1.3	10.1	3.7	8.1	2.2	0.0	0.0	0.0	1.8	9.8	0.0	1.7	6.4	123.5	4.5	3.2	23.3	2.4	0.1	1.7	5.2	0.0	0.0	0.6	7.9	0.0	17.8	1.8	188.1	2.8	1.2	5.0	0.0	1.1	3.3	1.4	0.0	1.4	1.1	12.3	0.0	1.0	26.8	12.4	2.0	0.0	6.9	2.7	9.0
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 12.7;Rod photoreceptor cells: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	3.4	5.2	11.1	2.6	10.9	0.7	5.9	21.4	11.6	5.3	3.9	5.0	2.9	4.2	4.5	3.4	3.4	7.0	2.6	5.0	7.0	5.4	4.6	6.5	6.0	5.1	10.0	6.5	5.6	6.9	6.4	7.7	3.3	6.6	5.8	4.5	5.8	4.6	5.2	5.3	5.6	3.9	5.1	7.2	5.4	4.8	3.9	8.3	2.4	4.4	2.0	5.1	3.8	4.0	3.4	1.3	2.8	0.4	6.9	7.2	1.8	3.6	8.2	3.5	8.8	6.3	4.0	0.1	3.6	2.6	3.3	3.7	5.8	1.2	0.0	4.8	2.3	1.2	2.3	10.1	5.1	4.2	0.0	4.8	2.7	4.4	4.4	3.2	3.6	2.5	3.5	4.6	3.3	4.4	1.4	5.2	7.2	8.7	0.0	5.3	2.7	2.6	1.6	4.9	8.9	4.3	3.4	2.7	0.9	2.5	3.2	4.6	6.6	0.0	0.1	3.4	3.8	3.3	1.0	3.7	7.0	3.7	2.5	4.8	2.4	11.5	1.0	1.4	0.0	4.0	2.8	0.1	0.1	4.8	0.4	4.7	3.4	3.8	2.2	1.3	2.1	7.2	7.2	0.0	6.9	0.0	1.2	3.4	1.8	11.1	10.9	21.4	11.6	7.0	5.4	10.0	6.5	6.6	8.3	0.0	0.6	0.0	0.2	0.3	5.3	2.8	0.0	4.0	0.0	1.8	5.9	0.1	3.3	0.9	0.2	3.5	0.0	0.0	1.2	0.5	0.6	0.3	5.7	1.0	0.7	12.7	1.2	5.5	1.8	0.4	2.0	0.1	1.7	0.0	1.4	3.5	1.0	0.0	2.1	1.3	10.0	0.0	1.0	2.6	2.4	0.1	0.0	1.7	1.3	0.3
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	13.6	15.1	9.1	18.0	17.2	15.1	6.7	16.6	13.7	11.9	16.1	10.9	14.2	19.3	12.8	21.0	37.8	17.9	5.6	21.4	7.9	21.5	10.8	8.5	12.1	7.7	15.2	3.5	23.1	17.0	14.1	20.9	9.0	11.1	21.6	28.3	9.8	15.7	23.8	20.6	16.9	46.8	10.5	11.4	16.8	9.0	5.2	15.6	12.1	13.2	17.5	13.6	13.6	10.7	7.3	12.3	12.3	16.1	16.3	16.2	13.8	16.2	15.8	28.1	22.0	38.9	15.9	12.7	19.5	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5	17.9	20.8	51.3	20.1	41.6	18.3	12.5	17.8	6.7	21.6	14.0	3.9	22.8	21.6	27.6	5.8	25.3	21.7	0.0	33.3	31.3	26.3	15.3	34.7	50.4	43.3	77.9	15.0	27.0	34.3	8.0	19.5	45.2	32.1	208.2	13.4	21.4	35.1	11.5	19.1	17.0	11.9	19.4	27.8	16.2	36.4	20.1	8.7	56.6	13.5	16.1
MBLAC1	MGC49416	ENSG00000214309	"Metallo-beta-lactamase domain containing 1"	A4D2B0	7	100126694-100128498	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA071574	Uncertain					NA	NA					"HPA071574: AB_2686419"	"unprognostic (8.28e-3)"	"unprognostic (4.83e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.38e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.90e-5)"	"unprognostic (7.83e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.07e-1)"	"unprognostic (5.88e-2)"	3.7	5.2	5.4	2.6	7.9	3.1	2.1	12.3	13.8	2.9	3.1	3.2	10.5	6.6	3.6	2.2	2.8	3.7	5.0	4.4	5.3	4.2	4.2	3.3	4.0	2.4	3.6	6.2	5.2	3.5	2.5	6.0	3.1	3.2	4.6	1.9	2.6	8.0	5.1	5.7	3.0	4.0	2.5	3.1	2.9	3.7	3.6	2.6	0.7	2.6	2.9	1.7	3.0	2.8	3.7	0.7	3.2	1.6	1.1	2.6	0.3	2.9	2.8	1.6	1.8	2.0	0.6	2.5	3.1	1.4	1.8	1.3	4.1	2.1	1.7	2.9	1.6	4.8	1.5	0.6	0.0	0.4	5.8	3.7	1.0	2.5	2.8	1.8	2.9	2.8	1.2	0.3	1.1	0.7	1.8	1.3	2.5	2.2	7.5	1.2	3.3	5.4	2.4	2.0	0.4	6.1	3.8	2.4	3.3	0.5	3.4	2.4	4.8	5.1	7.5	2.7	0.5	0.8	1.4	1.9	3.9	7.5	2.9	4.5	5.1	3.4	7.1	1.5	2.4	4.5	0.3	0.7	2.2	1.2	0.8	0.9	0.4	1.6	1.8	0.6	3.7	2.6	2.4	3.2	1.1	1.6	0.7	0.0	0.3	5.4	7.9	12.3	13.8	5.3	4.2	3.6	6.2	3.2	2.6	0.0	1.4	0.5	4.0	0.5	4.2	3.1	2.5	0.0	1.2	3.5	3.9	1.3	10.0	3.4	0.3	1.0	2.9	0.0	4.4	1.1	2.1	3.7	0.0	2.0	2.5	4.8	2.9	1.8	0.8	0.9	6.9	2.0	0.0	4.6	2.3	6.0	2.4	0.9	3.9	5.9	4.5	6.5	1.4	2.3	2.1	1.0	1.7	1.3	2.1	1.0
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.0	0.2	0.3	20.0	1.4	2.5	0.6	1.8	1.5	0.1	52.0	3.6	0.8	1.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.0	1.0	6.9	18.4	1.4	2.7	2.0	0.1	4.9	2.1	35.9	0.1	20.9	1.7	1.9	49.3	1.3	5.5	0.1	2.1	12.2	0.3	24.8	6.6	7.4	18.1	7.2	0.1	7.1	1.1	12.7	4.8	0.2	2.9	0.4	5.3	1.7	1.3	38.4	9.6	36.6	5.5	8.3	2.9	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9	3.0	24.0	31.6	2.0	1.0	56.1	15.1	10.2	6.7	11.4	150.1	15.7	28.2	147.6	8.4	15.2	2.7	5.3	0.0	1.4	38.9	2.1	1.2	2.3	30.8	4.7	85.8	13.8	7.4	5.4	14.9	1.7	6.2	6.8	13.6	5.6	10.9	2.5	9.9	6.3	46.6	33.3	0.0	7.1	2.3	11.5	1.3	17.6	48.4	8.8	1.4
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Horizontal cells: 90.6;Rod photoreceptor cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.7;REH: 25.4;SH-SY5Y: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.1	3.5	14.9	3.6	1.6	1.2	19.5	1.0	0.9	2.0	1.6	8.8	5.7	0.0	2.2	1.9	1.6	1.0	1.6	2.2	1.2	3.7	2.6	6.4	5.3	10.5	3.9	1.3	4.1	3.6	1.1	2.6	0.9	3.9	8.3	14.5	7.3	1.4	1.5	8.5	13.9	15.1	25.7	5.9	1.9	25.4	16.4	2.1	1.2	1.5	8.8	31.3	1.2	8.4	2.6	13.4	1.0	6.7	2.8	2.5	3.3	0.6	1.3	3.2	2.2	8.6	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2	6.0	13.3	10.0	8.3	4.6	74.9	13.7	5.1	9.4	12.5	19.2	119.8	30.2	5.0	13.8	1.5	14.6	5.3	0.0	8.5	9.4	14.7	11.7	36.9	5.5	19.8	90.6	12.6	6.2	10.5	1.1	17.8	11.9	6.8	4.6	11.5	22.7	9.2	10.5	14.5	5.6	144.9	19.4	8.2	2.3	13.4	2.3	26.9	18.7	11.0	6.7
ZNF346	"JAZ, Zfp346"	ENSG00000113761	"Zinc finger protein 346"	Q9UL40	5	177022696-177081189	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018485	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018485: AB_1859213"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (5.71e-3)"	"prognostic unfavorable (9.54e-5)"	"unprognostic (9.85e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.88e-7)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (5.11e-2)"	"unprognostic (7.86e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.44e-2)"	9.0	12.1	17.0	14.8	21.3	10.6	12.4	26.8	21.6	13.2	10.7	15.2	11.2	9.1	17.4	16.0	13.8	16.9	10.0	11.4	14.7	14.3	11.5	10.1	8.9	13.2	10.9	19.3	27.0	12.5	16.1	19.0	10.0	13.6	13.0	10.7	14.7	11.1	15.1	16.7	14.7	9.2	18.0	10.5	13.1	9.7	16.8	12.5	15.8	19.6	9.1	17.4	10.8	12.1	7.3	4.0	5.9	3.7	17.0	8.5	4.5	4.2	7.2	12.8	17.5	6.7	6.9	10.3	7.3	7.9	12.3	13.6	9.8	6.6	11.0	8.3	7.5	10.6	5.9	12.4	11.7	11.9	33.8	10.1	7.5	9.0	8.6	8.0	12.4	7.1	6.8	7.1	11.8	8.6	7.4	13.8	13.1	8.9	7.1	5.7	13.7	16.4	6.2	5.7	5.5	12.9	17.6	8.9	5.1	8.5	5.1	16.3	7.0	9.5	6.9	6.0	6.6	9.6	6.7	7.8	9.9	7.7	6.6	8.0	6.3	6.9	12.9	4.0	10.6	8.1	0.3	3.7	5.9	8.5	3.5	5.4	5.1	5.9	5.5	4.0	7.3	7.5	7.5	3.9	17.0	3.5	3.6	5.6	4.5	17.0	21.3	26.8	21.6	14.7	14.3	10.9	19.3	13.6	12.5	0.0	5.9	6.1	2.8	2.6	11.8	3.4	7.6	0.0	3.4	5.2	5.9	7.9	8.3	5.2	2.1	6.3	2.8	0.0	5.0	4.6	3.9	1.0	2.3	3.2	4.9	7.9	4.6	3.7	2.7	4.0	4.6	2.2	3.3	3.6	3.2	8.4	3.4	2.6	6.0	3.6	6.1	0.0	4.2	10.8	10.2	4.3	2.7	5.2	2.8	1.6
C19orf25	FLJ36666	ENSG00000119559	"Chromosome 19 open reading frame 25"	Q9UFG5	19	1461143-1479556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050270, HPA067491"	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050270: AB_2681069, HPA067491: AB_2685849"	"unprognostic (5.82e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.51e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-3)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.35e-2)"	"prognostic favorable (9.20e-8)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	12.1	17.9	25.8	14.2	22.1	10.4	11.2	26.4	22.6	12.7	15.7	19.0	17.7	23.2	17.2	12.5	12.1	17.6	12.5	17.2	24.5	21.8	17.9	16.8	13.0	19.9	23.4	15.6	16.4	27.0	10.4	18.2	15.4	15.3	15.3	8.2	16.5	27.0	13.9	11.7	13.7	22.2	14.0	23.0	16.5	16.8	17.6	17.2	17.3	24.1	7.4	14.9	12.6	18.0	28.2	28.6	34.1	20.2	17.1	31.2	23.0	13.1	10.2	6.4	10.1	6.2	5.7	12.7	13.0	9.1	14.2	13.1	14.7	6.8	7.6	10.3	7.0	6.6	16.3	9.7	8.3	3.3	23.5	14.6	9.2	6.0	17.1	13.5	14.5	18.3	5.3	18.9	5.9	9.5	10.0	7.3	16.2	23.8	18.0	8.9	7.4	13.6	12.1	20.3	8.2	16.6	22.4	8.9	19.4	9.8	9.0	10.8	14.7	9.7	12.5	15.4	3.4	18.3	17.1	8.9	10.9	12.4	22.0	12.4	25.6	13.8	12.6	11.3	14.8	19.4	26.5	20.2	34.1	27.4	19.7	22.2	22.1	25.2	23.4	14.4	28.2	26.1	20.9	32.1	17.1	15.7	28.6	31.2	23.0	25.8	22.1	26.4	22.6	24.5	21.8	23.4	15.6	15.3	17.2	14.9	8.3	41.0	27.9	17.1	58.8	8.9	20.4	8.1	9.1	48.8	60.9	37.2	41.4	32.8	3.5	20.3	69.8	0.0	40.0	27.2	22.8	28.7	11.5	16.6	31.1	92.2	48.6	25.2	22.2	5.2	24.5	24.1	23.6	59.5	25.9	47.3	39.9	52.6	20.5	23.9	70.3	45.3	22.8	28.8	32.4	17.2	44.3	48.4	26.4	30.6
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362799-50504244	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 86.1"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.9	1.6	1.3	11.1	1.1	1.4	14.9	6.5	1.1	1.7	0.9	0.6	1.4	1.7	1.2	0.9	1.1	0.9	7.6	1.7	9.1	1.6	0.5	86.1	1.3	3.9	3.2	2.2	4.0	3.8	6.0	1.9	6.1	3.0	2.0	6.1	1.5	1.4	1.7	2.6	1.7	1.4	1.4	1.5	4.1	5.8	2.5	0.2	2.3	0.1	0.7	0.7	0.7	1.8	0.3	0.7	0.1	2.3	3.6	1.1	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	8.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.4	66.5	0.2	0.1	0.0	2.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.2	0.0	2.7	1.8	2.6	2.0	0.0	1.3	3.6	2.2	0.0	2.3	0.1	0.3	3.2	1.1	1.6	11.1	14.9	6.5	1.7	9.1	3.9	3.2	6.1	2.5	71.5	145.9	0.0	0.3	1.3	7.2	3.0	0.0	4.0	4.5	1.8	19.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.7	19.7	0.0	0.1	0.0	1.2	0.6	0.0	2.3	0.3	0.0	0.0	0.0	3.5	4.0	0.6	0.0	1.8	0.4	10.0	12.9	0.8	1.6	11.1	0.5	0.2	1.0	0.4	0.3
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 15.2;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 23.4;NTERA-2: 37.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	6.6	9.8	15.5	10.2	17.0	5.2	7.4	42.8	16.2	7.7	7.2	10.4	7.6	4.5	8.4	22.6	9.4	8.3	5.4	6.0	13.5	6.6	6.3	3.5	9.0	12.9	18.2	7.9	16.1	6.4	9.9	16.3	3.5	14.0	20.8	7.5	10.7	9.6	18.1	6.4	11.0	14.4	9.2	13.9	22.8	7.0	5.8	14.9	5.7	18.8	3.3	13.0	7.2	9.6	4.0	13.3	1.8	3.1	1.3	5.1	2.2	2.3	1.6	6.8	5.6	8.8	4.7	8.6	2.1	1.8	2.8	3.6	3.5	3.2	9.2	1.8	2.5	2.1	2.0	23.4	5.8	2.1	5.8	5.4	10.9	6.6	2.7	1.6	2.4	3.0	1.5	3.9	3.2	2.3	2.9	4.8	7.2	7.7	2.1	1.5	2.2	3.4	2.0	37.1	2.0	3.6	1.6	2.5	3.4	2.0	2.3	2.3	4.9	1.7	2.0	6.9	10.6	2.9	3.9	7.6	1.6	3.2	3.6	1.4	4.8	5.9	7.5	1.7	6.7	4.8	1.1	2.8	1.8	3.8	2.4	4.4	4.0	4.4	4.9	2.8	2.7	5.1	4.9	1.5	1.3	3.1	13.3	3.8	2.2	15.5	17.0	42.8	16.2	13.5	6.6	18.2	7.9	14.0	14.9	0.0	4.8	0.8	1.0	1.0	15.2	3.0	0.0	2.7	3.4	8.7	19.6	1.9	3.3	1.2	1.3	2.1	1.3	0.0	0.9	0.9	1.8	0.8	0.0	1.0	3.1	1.6	1.7	1.8	3.7	1.5	2.0	4.6	1.7	0.0	2.3	4.8	0.7	1.4	4.2	1.4	11.0	6.5	1.9	0.6	2.7	1.1	0.0	2.5	2.3	0.7
ZNF248	bA162G10.3	ENSG00000198105	"Zinc finger protein 248"	Q8NDW4	10	37776526-37858106	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 46.4;Cone photoreceptor cells: 45.2;Horizontal cells: 39.7;Rod photoreceptor cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018237, HPA018287, HPA018455"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018237: AB_2669815, HPA018287: AB_2669829, HPA018455: AB_2669869"	"unprognostic (6.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-4)"	"prognostic favorable (1.04e-4)"	"unprognostic (6.37e-3)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.22e-4)"	"prognostic unfavorable (6.71e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.68e-3)"	5.1	7.7	11.0	6.4	18.3	0.7	8.2	29.8	16.2	11.7	14.0	9.5	11.4	5.7	16.1	15.5	6.1	12.6	7.0	8.0	11.5	10.3	6.3	4.9	6.4	6.3	11.2	12.7	14.1	5.8	17.7	23.8	6.7	11.4	13.5	9.6	8.4	7.4	18.1	7.9	7.4	6.8	12.3	7.7	7.4	6.7	7.0	13.3	3.1	14.2	4.6	6.7	8.0	8.9	6.7	3.8	1.4	1.8	4.0	8.9	3.0	5.4	4.6	1.0	12.9	9.3	7.9	5.7	5.6	2.9	5.8	6.3	5.6	6.9	7.2	4.9	3.9	4.4	6.9	7.4	4.0	5.1	12.5	8.2	8.9	9.5	6.8	4.7	7.3	6.1	3.2	7.6	3.0	2.5	11.7	5.3	7.9	3.8	5.2	8.5	2.6	7.4	4.8	3.9	3.6	24.9	6.9	13.1	5.1	7.2	2.7	5.4	10.4	4.8	2.7	3.2	8.4	7.1	2.1	5.2	5.3	5.7	4.2	3.4	8.2	8.6	6.0	7.1	9.8	2.5	1.1	1.8	1.4	5.7	1.2	6.2	5.8	5.1	4.8	3.8	6.7	8.9	7.6	0.2	4.0	1.6	3.5	2.6	3.0	11.0	18.3	29.8	16.2	11.5	10.3	11.2	12.7	11.4	13.3	11.9	11.8	6.6	7.0	1.8	46.4	19.3	10.2	6.7	9.1	5.2	45.2	5.0	6.6	3.3	0.6	5.6	4.0	0.0	1.4	2.6	8.5	4.5	4.7	3.9	3.7	39.7	5.2	5.5	1.3	1.5	9.2	2.8	1.7	3.6	4.0	22.6	3.4	3.6	11.3	3.3	40.3	0.0	10.3	8.4	10.8	2.4	2.2	3.3	4.9	3.7
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 57.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		NA	NA		7500	Mitochondria		"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5.0	10.9	8.0	6.0	11.0	6.6	9.3	6.2	8.0	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5.0	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.3	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.5	13.7	4.7	16.7	8.9	7.5	20.5	4.4	39.6	23.4	12.8	10.8	10.4	7.9	17.2	16.3	3.8	5.1	11.2	6.6	2.8	6.3	26.7	13.3	52.3	3.4	34.8	17.7	18.1	8.3	6.1	14.7	17.0	7.8	20.9	3.3	9.9	11.2	15.2	7.4	13.1	17.3	2.3	10.4	19.0	8.0	9.2	13.8	9.8	22.4	15.1	18.3	11.8	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9.0	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8.0	7.3	7.1	10.7	6.7	5.1	0.0	2.1	37.2	46.6	21.1	9.5	2.0	7.6	0.0	3.4	3.5	5.9	10.9	13.3	3.9	31.4	4.5	11.3	23.3	7.1	10.5	8.0	37.0	14.9	5.3	18.5	15.9	10.9	8.6	27.3	57.4	5.8	20.0	13.5	1.8	13.4	6.1	8.1	13.3	4.9	6.9	7.3	12.9	10.3	2.2	3.6	17.8	10.6	41.1	16.3	52.8
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521081-21537216	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;parathyroid gland: 36.0"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 14.3;Cone photoreceptor cells: 7.9;Horizontal cells: 12.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"AF22: 46.7;NTERA-2: 35.3;SCLC-21H: 15.9;SuSa: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	2.6	4.7	11.5	1.6	12.7	0.5	5.3	30.9	21.9	7.5	4.5	10.4	2.9	2.3	10.5	6.0	3.5	11.6	4.0	3.7	11.7	8.9	4.2	1.7	4.8	1.9	7.4	9.3	19.5	3.7	36.0	10.9	1.5	13.5	5.8	2.4	4.3	3.3	10.0	2.1	2.2	3.1	10.5	9.5	2.1	3.2	1.9	11.4	3.7	12.0	0.1	1.9	4.6	4.8	0.3	1.7	0.0	0.0	0.5	3.8	0.6	0.0	0.8	46.7	11.6	0.8	0.7	0.0	1.1	1.5	3.7	3.1	0.8	0.7	0.0	1.0	1.3	1.4	0.1	11.4	1.2	4.3	0.7	6.4	0.0	0.4	1.0	1.4	0.0	0.0	3.1	0.3	1.5	0.0	8.1	0.9	5.0	7.6	0.0	2.9	0.8	7.2	0.0	35.3	0.0	0.2	6.8	1.1	0.0	3.4	4.9	15.9	8.9	0.0	0.2	0.1	15.3	4.6	0.1	0.0	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	1.0	0.1	1.5	1.2	0.2	0.3	1.8	3.8	0.0	0.5	0.0	1.7	1.6	0.6	11.5	12.7	30.9	14.3	11.7	8.9	7.4	9.3	13.5	11.4	3.0	2.2	0.0	0.4	0.6	14.3	0.8	2.5	0.0	2.3	5.2	7.9	0.1	1.7	1.6	0.2	0.2	0.0	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.1	12.7	0.0	1.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	11.0	0.5	0.0	5.6	1.0	2.8	0.0	1.4	0.0	0.2	0.5	0.1	0.0	0.0	0.1
RGS11		ENSG00000076344	"Regulator of G protein signaling 11"	O94810	16	268301-275980	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 66.5;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;ASC TERT1: 4.0;fHDF/TERT166: 3.6;HHSteC: 5.7;hTERT-RPE1: 4.3;SCLC-21H: 5.5;SH-SY5Y: 4.2;T-47d: 4.6"	"Not detected"	"Not detected"							"HPA041692, HPA043039"	Uncertain					NA	NA					"HPA041692: AB_2677619, HPA043039: AB_2678282"	"unprognostic (8.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-1)"	10.9	7.6	10.7	2.0	8.4	0.5	1.9	50.0	19.8	2.4	5.0	14.1	5.3	10.5	2.0	2.9	5.1	2.5	3.4	16.7	11.0	12.7	1.4	0.8	4.3	1.1	9.3	8.3	0.8	17.7	2.1	15.6	4.7	9.7	6.1	1.6	10.4	5.6	5.0	1.7	1.9	7.4	2.5	13.3	2.0	7.9	0.9	7.4	0.0	0.8	0.8	0.6	3.1	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.8	4.0	0.0	1.2	0.1	0.0	0.0	0.5	0.1	0.0	2.7	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	1.5	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	2.5	0.0	0.0	0.0	0.2	0.0	0.0	5.5	4.2	2.5	0.3	0.8	0.0	4.6	0.1	2.9	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	8.4	50.0	14.8	11.0	12.7	9.3	8.3	9.7	7.4	0.0	0.0	0.0	0.2	0.1	66.5	7.0	0.0	0.0	0.0	0.0	113.9	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.9	0.1	5.0	0.5	0.0	0.0	0.2	9.5	9.9	5.5	0.0	0.0	0.9	0.0	1.7	1.0	0.1	3.0	0.7	2.3	1.8	0.0	70.8	0.0	5.2	0.4	1.1	0.5	0.7	0.0	1.2	0.1
MKS1	"BBS13, FLJ20345, MKS, POC12"	ENSG00000011143	"Meckel syndrome, type 1"	Q9NXB0	17	58205437-58219605	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021372, HPA021812"	Enhanced					NA	NA					"HPA021372: AB_1848746, HPA021812: AB_2142654"	"unprognostic (3.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.27e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.64e-3)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (9.86e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	8.0	13.6	14.7	8.9	21.6	6.1	10.9	20.8	21.6	10.6	8.9	13.7	14.4	8.5	15.3	16.1	11.3	24.8	9.1	7.9	13.7	8.6	12.2	10.5	12.0	10.5	14.8	14.3	20.6	14.4	17.5	22.4	8.5	11.7	11.3	9.3	9.9	16.8	18.6	8.6	19.6	9.4	12.0	9.6	10.7	10.2	17.3	15.8	9.5	11.8	6.6	9.4	10.2	10.6	7.1	12.8	6.0	6.6	12.7	10.0	6.4	8.4	9.2	14.5	14.8	4.1	7.0	11.6	4.7	4.5	11.5	8.8	8.3	8.8	4.6	19.6	6.7	6.0	7.3	11.0	7.4	9.1	12.9	14.1	7.0	12.9	12.0	11.0	10.5	5.3	6.1	10.4	7.7	9.4	8.1	7.2	18.3	14.7	3.3	8.1	18.7	16.1	16.1	4.3	8.7	11.0	13.5	13.9	11.6	9.9	5.9	15.8	10.8	7.2	4.8	7.8	7.7	21.5	8.7	3.3	10.6	12.1	7.1	5.4	4.7	4.7	5.2	6.7	7.4	5.9	6.0	6.1	3.1	6.9	6.6	8.8	7.1	10.0	9.5	12.8	4.3	9.3	9.7	0.1	12.7	4.3	7.2	6.5	6.4	14.7	21.6	20.8	21.6	13.7	8.6	14.8	14.3	11.7	15.8	3.0	1.9	0.9	5.2	2.3	5.2	3.4	5.1	17.4	1.2	8.7	11.8	9.7	13.3	5.6	6.1	4.6	2.6	0.0	3.5	8.0	3.5	1.6	5.7	6.0	5.3	0.0	2.4	5.5	3.0	6.3	4.9	2.5	1.7	0.0	5.5	6.2	4.5	3.5	6.3	6.6	9.0	0.0	3.4	9.1	12.4	2.9	2.6	2.6	6.9	1.7
UNC119B	"MGC5139, POC7B"	ENSG00000175970	"Unc-119 lipid binding chaperone B"	A6NIH7	12	120710435-120723640	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077812	Enhanced		Approved	"Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol"		Yes	No			"Cytokinetic bridge, Mitotic spindle"	"Mitochondria, Cytosol"	"HPA077812: "	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (9.35e-2)"	"prognostic favorable (6.69e-10)"	"unprognostic (2.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.42e-2)"	12.7	33.5	18.1	9.2	18.6	9.5	16.3	17.0	17.2	16.0	12.1	15.0	18.7	8.6	20.7	15.0	11.6	42.8	14.9	13.2	18.9	19.7	27.1	14.7	14.0	9.3	14.2	16.0	33.7	17.1	40.8	25.8	13.4	20.4	18.4	12.3	14.6	14.1	23.8	6.7	13.6	11.4	17.5	15.5	13.4	14.5	21.9	15.2	16.1	38.6	7.3	13.7	12.1	16.3	2.1	2.5	2.1	5.8	2.5	4.0	1.4	11.5	11.2	23.4	20.0	23.5	17.5	19.9	14.4	16.8	16.4	7.4	13.4	4.8	11.7	5.7	16.0	7.9	12.3	24.7	16.1	17.0	9.1	12.5	5.4	8.3	8.3	15.9	14.8	8.6	13.7	16.6	12.2	18.9	26.5	18.4	17.8	13.1	1.3	13.8	10.2	13.5	12.2	28.9	13.2	13.9	16.3	15.6	6.0	19.6	24.3	14.1	17.8	34.4	6.8	11.8	17.3	26.8	10.2	11.5	15.3	10.5	6.5	9.6	9.5	8.2	7.2	18.1	7.5	16.5	0.2	1.1	1.3	3.3	0.6	2.1	1.8	3.0	3.8	1.2	2.1	4.0	3.2	2.1	2.5	5.8	2.5	2.8	1.4	18.1	18.6	17.0	17.2	18.9	19.7	14.2	16.0	20.4	15.2	3.0	6.9	2.9	6.5	2.6	8.1	3.5	5.1	18.7	5.7	17.4	9.8	9.1	13.3	6.6	11.8	6.3	3.5	0.0	6.7	4.0	6.2	10.2	2.3	5.5	2.7	7.9	13.7	8.6	3.7	2.2	12.0	1.8	5.0	0.0	6.1	11.2	6.9	5.8	15.2	11.8	9.8	12.9	5.0	11.4	14.5	2.9	4.3	9.2	8.0	6.4
ZCCHC3	"C20orf99, dJ1103G7.7"	ENSG00000247315	"Zinc finger CCHC-type containing 3"	Q9NUD5	20	296968-300321	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042972			Approved	Vesicles		NA	NA			Vesicles		"HPA042972: AB_10959663"	"unprognostic (5.98e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (4.30e-1)"	"unprognostic (3.34e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.74e-2)"	1.5	2.1		1.8		3.1	1.1		1.2	2.1	1.2			1.5	2.0	2.5	0.6	2.6	1.0	1.4			1.4	1.4	1.1	3.3			4.4	1.8	1.5		4.5		1.5	0.9		1.2	2.0	1.2	0.4	1.4	1.0		2.7	1.6	1.4			1.3		3.1	0.9		4.5	4.8	6.1	2.9	2.1	3.7	1.6	8.4	6.6	20.8	10.3	6.8	7.0	12.3	5.3	5.8	5.9	6.1	10.0	5.0	7.6	3.5	3.3	6.2	11.7	10.5	5.9	5.6	4.1	9.7	15.5	3.1	31.3	7.9	17.6	4.3	6.7	7.0	3.6	4.3	6.2	9.4	8.8	19.1	7.8	4.5	3.7	13.4	21.7	18.5	8.2	7.0	19.8	9.9	9.8	5.2	5.4	8.8	12.8	6.3	12.8	16.1	9.3	5.9	33.1	4.1	6.1	6.1	2.4	6.3	14.4	18.3	15.0	2.2	11.5	5.9	6.1	2.9	4.5	3.4	1.4	3.3	3.2	3.0	2.9	2.0	4.5	3.7	3.5	0.8	2.1	1.3	4.8	2.7	1.6											0.0	7.8	13.0	19.4	14.1	26.8	7.0	20.4	8.1	5.7	8.7	7.9	19.5	3.3	5.8	0.4	13.4	10.7	0.0	4.7	10.9	14.8	13.5	0.0	9.2	9.1	35.0	20.2	18.4	10.5	0.0	16.1	6.7	11.8	2.8	14.5	17.7	4.9	10.5	9.9	5.7	20.6	6.5	7.3	3.9	9.7	5.0	17.3	7.5	12.4	14.0
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727523-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 7.1;naive B-cell: 10.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HDLM-2: 13.6;JURKAT: 5.4;MOLT-4: 5.6;NTERA-2: 3.2;REH: 7.8;SH-SY5Y: 3.8"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"	2.7	5.4	6.5	5.6	7.7	3.0	3.1	2.1	15.5	4.8	5.0	2.8	3.5	1.6	5.0	4.9	2.3	4.3	6.0	4.0	6.0	5.1	6.5	0.8	3.0	5.9	5.4	9.7	12.8	2.8	1.9	5.9	1.4	14.7	3.9	1.6	3.3	2.5	4.3	6.6	1.9	2.6	2.6	3.2	6.4	2.9	2.6	1.9	11.3	4.3	0.5	4.1	4.4	2.9	10.1	1.9	0.2	0.0	1.1	2.0	0.6	0.0	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	0.0	5.6	0.2	3.2	0.0	0.0	7.8	1.4	0.0	0.1	1.5	1.4	3.8	0.0	0.0	0.3	1.6	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.2	1.9	10.1	2.0	1.2	0.2	1.1	0.0	1.9	0.0	0.6	6.5	7.7	2.1	15.5	6.0	5.1	5.4	9.7	14.7	1.9	6.0	1.9	5.9	4.6	1.6	12.3	5.3	12.7	9.4	7.9	5.2	15.7	0.3	46.4	4.6	7.5	6.3	0.0	0.0	1.6	0.4	5.4	0.9	1.1	0.0	0.2	7.9	11.6	1.8	0.0	3.6	12.0	0.5	3.3	0.0	0.6	18.0	2.4	5.5	20.1	19.2	14.9	6.5	3.4	3.2	8.1	1.9	0.1	0.0	1.5	1.4
LUC7L	"hLuc7B1, Luc7, LUC7B1"	ENSG00000007392	"LUC7 like"	Q9NQ29	16	188969-229463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056424, HPA069321"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA056424: AB_2683126, HPA069321: AB_2686119"	"unprognostic (9.55e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-3)"	23.8	24.5	30.4	26.5	30.9	25.3	24.0	42.6	30.0	21.9	20.1	29.9	25.8	21.3	29.4	37.7	15.5	19.2	24.5	12.7	34.1	26.5	26.9	19.9	18.8	31.0	33.1	24.3	29.3	24.2	31.2	40.3	23.1	25.4	35.2	18.2	24.3	25.1	25.2	20.3	28.8	23.9	24.4	29.2	32.1	22.6	29.8	33.1	23.2	40.2	15.9	21.0	16.6	26.3	6.5	11.1	3.5	11.7	3.9	6.9	5.6	5.4	24.4	25.9	9.7	10.0	7.7	11.4	10.1	7.7	16.5	12.0	25.4	6.4	9.9	13.3	5.8	8.7	6.9	30.8	9.2	16.6	17.7	21.1	12.1	16.6	29.7	11.2	14.0	13.6	6.9	10.7	13.3	5.3	14.3	12.7	8.6	14.3	6.4	13.2	26.2	23.0	24.4	38.6	12.3	11.8	19.8	11.3	10.4	23.6	5.8	15.4	17.3	10.9	7.6	9.4	16.0	9.8	7.6	10.3	12.0	18.1	5.0	12.1	7.0	9.3	10.5	3.6	10.0	10.7	0.3	9.1	3.5	6.7	10.4	5.2	6.5	6.3	6.5	9.8	3.0	3.7	2.8	1.2	3.9	11.7	11.1	6.9	5.6	30.4	30.9	42.6	30.0	34.1	26.5	33.1	24.3	25.4	33.1	47.6	61.1	29.6	38.6	47.3	48.4	18.3	12.7	40.2	58.0	22.7	35.3	24.9	10.0	29.4	34.2	45.0	22.2	0.0	18.2	33.5	35.8	31.0	39.4	10.0	21.2	42.9	40.6	25.2	14.5	14.7	30.2	28.9	37.1	35.1	16.5	30.8	22.7	28.1	30.4	11.3	61.8	25.8	46.4	62.1	51.9	47.4	41.8	27.7	17.1	27.1
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.6;brain: 70.9"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 43.2;Endothelial cells: 30.4;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.0;SCLC-21H: 7.0;U-266/70: 9.3;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	3.3	29.6	68.3	1.6	31.5	0.6	5.2	10.9	55.3	4.9	1.5	5.4	1.0	2.1	6.6	2.7	2.3	2.9	3.7	5.7	70.9	10.2	3.8	24.6	5.4	1.7	10.0	23.8	9.7	2.0	3.2	2.4	2.3	8.6	3.5	1.7	11.3	1.7	2.9	1.4	10.6	1.8	4.3	2.9	0.9	5.4	3.7	11.5	0.0	4.3	0.9	1.8	4.2	1.2	0.4	0.6	1.4	0.6	0.6	0.7	0.1	0.1	0.1	2.7	0.4	0.0	0.2	0.1	0.9	0.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.2	0.5	2.3	0.6	0.3	0.1	4.8	0.4	2.3	0.0	0.0	3.0	0.8	0.0	0.7	0.0	0.0	2.7	2.9	1.3	0.0	18.0	0.1	0.0	0.2	0.2	0.3	1.5	0.3	0.0	0.6	0.0	0.0	5.4	7.0	2.6	0.1	0.1	0.9	1.4	0.1	0.1	0.8	0.1	0.3	0.0	0.2	9.3	18.0	0.0	0.3	0.1	0.2	1.4	0.4	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.4	0.6	0.7	1.0	0.6	0.6	0.6	0.3	0.1	68.3	31.5	10.9	55.3	70.9	10.2	10.0	23.8	8.6	11.5	3.0	3.2	0.9	1.0	5.5	2.5	6.7	0.0	0.0	0.0	0.0	43.2	0.1	0.0	0.6	2.1	30.4	0.0	0.0	2.3	0.0	0.9	0.5	0.0	9.9	0.1	1.6	7.5	23.9	1.9	1.1	4.0	0.0	3.3	0.0	0.2	1.2	2.4	0.0	1.4	0.0	8.9	0.0	1.4	0.5	2.0	3.3	0.1	0.0	0.0	0.6
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 delta subunit"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 9.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.4"									HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	3.2	3.8	4.0	1.9	5.1	3.6	1.2	12.8	6.3	1.7	2.0			7.0	3.2	1.1	1.1	3.9	1.5	1.5	4.1	3.3	1.4	3.2	1.5	2.5	3.1		4.6	3.0	0.8	5.9	1.3		2.3	0.2		8.6	2.4	3.9	4.6	5.1	1.0	3.2	3.8	2.4	10.2			1.3		0.7	0.7	1.8	0.5	0.9	0.0	0.2	0.0	0.8	0.2	0.6	5.0	2.0	5.2	1.4	0.8	0.9	3.3	1.0	1.7	1.9	0.9	2.8	3.6	1.8	1.5	2.5	0.8	0.9	0.8	0.3	6.7	3.1	0.4	6.0	1.3	1.4	0.1	3.6	2.3	1.1	2.6	0.0	2.2	0.5	6.5	2.4	8.5	0.4	1.8	1.4	2.4	1.0	0.6	3.7	9.3	0.4	0.8	0.8	0.2	2.7	3.8	1.4	1.5	2.2	0.8	6.6	1.8	1.4	3.2	2.7	5.0	1.1	11.4	0.7	2.9	2.9	6.1	3.6	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2											3.0	2.9	0.0	0.2	0.7	3.2	4.0	0.0	2.7	2.3	0.0	3.9	0.1	0.0	0.4	9.6	0.0	1.7	0.0	0.4	0.2	1.0	0.1	2.3	2.1	0.3	4.8	1.2	0.6	0.6	3.2	0.9	0.9	0.0	0.0	0.2	2.0	1.2	3.5	1.8	0.6	2.5	0.0	0.9	1.8	2.1	1.4	0.0	0.0	0.6	0.3
ZNF446	"FLJ20626, ZKSCAN20, ZSCAN52"	ENSG00000083838	"Zinc finger protein 446"	Q9NWS9	19	58474017-58481230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 22.8"					"Low region specificity"	"Detected in all"			"HPA052786, HPA078262"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA052786: , HPA078262: "	"unprognostic (1.52e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.94e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.94e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	3.6	4.6	5.2	5.1	6.7	4.0	5.0	8.9	8.8	6.7	4.9	5.3	15.1	3.7	7.2	6.2	3.4	11.0	10.0	5.5	5.3	4.8	6.2	6.5	4.3	8.6	5.5	5.9	11.9	13.6	9.7	8.8	2.9	6.7	7.2	3.0	4.4	9.4	7.5	3.5	5.6	4.2	8.5	4.9	4.3	4.8	7.8	3.7	17.1	6.8	3.2	6.4	5.7	10.1	6.8	6.0	5.6	9.8	3.0	7.5	3.6	3.5	7.5	5.2	4.7	5.2	9.7	5.0	2.2	6.8	1.8	2.6	3.6	3.1	3.5	3.1	2.9	8.3	5.6	2.0	2.8	0.9	5.1	22.8	4.4	5.6	3.0	7.7	2.2	6.5	8.0	5.3	3.1	3.3	8.8	4.5	6.4	2.5	2.4	2.8	4.3	5.9	2.6	1.7	3.3	4.6	5.2	3.6	4.6	3.8	6.6	6.1	5.8	4.3	5.8	3.7	3.0	4.1	2.8	3.4	9.0	3.2	2.1	4.9	8.1	10.8	2.2	4.7	1.3	3.2	5.2	4.4	4.6	6.4	5.9	3.9	4.9	7.5	4.1	6.0	6.8	5.1	6.3	5.6	3.0	9.8	3.9	6.0	3.6	5.2	6.7	8.9	8.8	5.3	4.8	5.5	5.9	6.7	3.7	3.0	2.7	1.7	1.8	1.8	8.5	0.8	15.3	5.3	4.5	5.2	7.9	4.6	3.3	6.5	4.6	2.9	6.7	0.0	4.5	3.2	4.0	1.9	8.1	2.9	3.8	7.9	10.3	1.8	4.0	4.4	6.6	2.1	3.3	1.8	5.6	10.1	4.2	3.7	4.9	4.4	8.2	0.0	3.3	20.6	8.5	3.1	2.9	2.5	5.4	1.1
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Congenital hypothyroidism, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 65.3;Hepatocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"	"Low cell line specificity"	"Detected in many"											"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: AB_2685892"	"prognostic unfavorable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favorable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	22.9	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.3	0.3	10.3	4.3	3.1	18.8	4.0	14.6	5.9	9.2	9.0	16.5	11.8	11.3	3.2	32.3	7.4	4.7	10.4	5.5	5.4	9.2	7.9	15.7	25.0	5.7	11.4	7.8	12.1	17.1	6.4	14.5	17.6	6.8	17.6	13.5	7.6	11.0	5.0	12.5	3.1	7.4	23.6	6.1	7.0	13.3	3.5	8.7	0.3	2.0	15.3	11.8	11.4	12.9	7.8	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5	0.0	5.0	15.2	9.4	5.8	11.5	9.5	22.9	12.0	6.8	29.6	21.6	65.3	11.6	9.9	0.8	9.4	2.6	0.0	6.7	2.4	10.0	18.9	10.5	59.7	10.0	6.4	21.9	11.6	32.3	1.7	13.3	19.9	5.0	10.8	4.8	38.8	8.5	3.5	26.9	17.0	22.7	0.0	25.9	1.4	17.9	10.8	37.6	10.7	4.7	22.3
C21orf2	"A2, LRRC76, YF5"	ENSG00000160226	"Chromosome 21 open reading frame 2"	O43822	21	44328944-44339402	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	18.8	13.4	19.8	11.3	21.6	19.7	9.2	10.3	23.4	13.8	14.7	18.2	14.3	13.4	12.6	19.1	6.9	14.7	13.2	11.3	19.5	16.6	18.0	11.6	12.8	12.4	16.4	19.1	15.2	14.5	7.4	17.6	12.4	13.2	12.3	3.9	14.3	16.1	17.2	21.0	22.3	15.4	5.8	12.6	16.1	21.1	16.7	11.2	10.9	16.4	8.1	13.0	8.1	7.0	10.8	21.7	1.2	8.5	12.1	9.7	4.9	8.0	3.4	3.2	4.2	2.1	1.4	12.9	4.2	2.5	1.7	0.9	6.1	2.4	5.8	8.4	1.4	3.4	3.8	0.6	0.8	0.4	8.8	8.4	6.0	2.7	7.1	2.8	6.5	6.5	2.0	1.5	0.7	1.5	2.9	1.0	4.4	7.3	10.0	1.0	9.9	7.1	15.9	8.1	4.1	5.2	18.1	4.2	12.9	1.9	11.8	8.6	7.9	5.8	1.4	6.9	2.0	6.2	14.3	4.7	3.6	4.7	3.9	3.1	16.3	8.6	4.0	8.9	13.1	6.5	1.2	7.1	1.0	7.1	8.5	8.5	10.8	7.3	9.7	7.3	8.6	8.5	8.2	0.9	12.1	6.2	21.7	4.0	4.9	19.8	21.6	10.3	22.4	19.5	16.6	16.4	19.1	13.2	11.2	3.0	16.5	25.0	18.4	14.4	43.7	2.2	35.7	32.1	9.1	12.2	35.3	25.4	66.3	24.9	73.3	10.0	27.6	0.0	51.4	12.3	38.1	21.2	19.5	18.1	31.3	35.0	31.6	9.2	14.5	196.9	24.5	17.6	40.5	31.5	29.6	34.1	20.6	31.1	29.7	36.0	24.8	12.9	18.9	40.3	10.9	13.6	27.3	20.8	31.8	18.6
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2354806	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 82.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	5.4	4.6	5.0	11.7	5.4	11.7	4.0	6.9	6.9	3.4	9.0	7.9	9.6	19.3	4.7	10.0	3.2	5.2	9.8	3.3	5.6		4.2	3.9	3.5	10.3	7.1	4.7	3.4	13.8	6.3	11.0	6.8	7.1	4.7	3.9	6.0	10.5	8.7	7.5	8.7	16.2	5.0	7.0	8.1	13.8	20.1	6.4	9.3	3.0	3.7	5.7	2.3	2.0	14.4	17.4	9.3	7.7	6.2	8.2	5.9	8.3	13.4	5.8	10.2	4.8	4.9	14.8	11.0	3.2	4.0	4.3	9.4	9.6	8.0	10.4	5.1	3.8	11.3	1.9	3.8	1.2	9.3	8.4	5.3	21.0	12.5	9.0	9.3	7.0	7.1	4.3	3.8	2.7	6.3	5.6	16.8	8.6	20.5	2.4	9.3	10.1	11.9	10.8	7.5	5.5	16.9	3.0	22.1	4.4	21.1	10.3	9.8	11.0	6.7	8.4	3.9	11.2	15.7	12.5	7.4	5.3	18.6	8.6	27.1	9.7	8.4	9.2	10.9	12.8	9.3	7.7	7.0	6.6	7.5	4.8	9.0	6.0	6.5	9.4	14.4	7.8	8.2	3.4	6.2	5.1	17.4	5.9	5.9											3.0	15.0	22.0	6.2	0.0	23.4	5.1	28.1	20.1	9.1	24.4	45.2	44.0	1.7	13.7	36.9	9.0	59.3	0.0	10.0	18.3	4.6	7.2	6.9	10.6	10.4	30.2	39.1	14.7	9.5	82.4	13.8	5.3	0.0	5.4	51.1	13.7	10.1	30.8	14.9	6.2	39.6	0.0	8.1	41.9	12.4	0.0	35.8	4.5	38.9	4.3
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 23.2;HEL: 9.5"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.1	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.0	0.1	0.0	0.1	0.2	23.2	0.5	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6	3.0	1.0	0.0	0.9	0.3	21.5	0.4	0.0	1.4	2.3	1.8	306.3	0.0	3.3	6.8	0.6	0.3	0.0	0.0	2.8	0.1	2.3	0.2	0.0	0.0	0.1	49.3	57.3	1.8	0.0	1.7	0.9	3.2	1.7	33.3	2.2	27.8	3.9	0.0	4.6	8.1	472.2	0.0	0.9	0.0	0.4	0.1	0.1	9.2	0.4	0.1
MRPL53		ENSG00000204822	"Mitochondrial ribosomal protein L53"	Q96EL3	2	74471958-74473322	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034612, HPA056185"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034612: , HPA056185: AB_2683060"	"unprognostic (2.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.16e-8)"	"unprognostic (8.76e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.45e-2)"	16.8	26.4	15.8	16.9	15.2	14.0	23.2	14.8	17.7	14.1	16.9	15.2	8.5	18.6	15.1	14.6	19.4	17.5	16.8	40.2	14.0	13.2	25.5	44.8	16.0	28.2	16.6	12.3	23.8	31.2	14.8	18.4	19.9	13.3	18.6	8.9	20.1	36.9	19.8	44.1	12.5	16.3	16.1	15.5	20.3	17.8	13.2	12.2	27.7	28.9	20.3	18.9	14.3	14.6	45.9	42.9	26.1	35.6	19.0	42.5	38.9	8.0	29.8	9.9	6.4	11.1	10.1	14.5	8.6	8.1	10.3	8.2	33.6	11.3	6.7	5.3	7.8	13.6	9.7	4.4	14.3	3.7	16.9	26.1	9.1	11.1	22.1	8.1	5.7	9.2	12.5	8.7	13.3	6.7	11.3	9.8	16.5	9.5	18.8	8.8	41.0	13.8	17.1	6.3	23.4	16.4	10.6	17.9	16.4	10.5	7.3	10.7	10.1	5.9	18.7	10.6	7.0	8.4	7.2	6.1	13.7	12.2	11.1	10.7	19.7	18.3	12.7	10.2	7.4	11.9	24.7	35.6	14.3	21.6	31.9	26.3	44.8	30.2	23.8	29.3	45.9	42.5	31.2	26.1	19.0	29.9	42.9	34.9	38.9	15.8	15.2	14.8	17.7	14.0	13.2	16.6	12.3	13.3	12.2	8.9	18.0	20.8	5.8	15.2	1.7	1.2	5.1	71.0	12.5	10.4	0.0	12.7	18.3	27.3	7.1	11.7	28.4	0.0	49.2	14.7	14.3	5.6	32.4	21.7	15.5	1.6	38.2	13.5	30.7	2.1	8.1	19.3	25.3	46.9	25.4	2.2	34.1	43.2	4.2	18.9	2.8	6.5	14.1	8.8	7.0	22.0	13.2	20.6	22.1	5.8
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030466-35040449	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 78.5;skeletal muscle: 161.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 35.4;Hofbauer cells: 24.6;Ito cells: 19.0;Kupffer cells: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.6;EFO-21: 10.1;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (8.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.78e-2)"	5.0	5.4	9.3	2.6	16.4	2.1	2.9	45.8	78.5	5.2	2.8	4.5	0.3	2.0	2.7	3.5	5.0	4.3	3.3	24.9	12.7	7.3	2.2	3.3	2.7	2.4	14.3	7.4	2.6	2.4	10.5	2.6	3.5	33.6	2.7	2.4	3.5	2.5	2.9	161.9	2.1	2.5	3.2	7.0	6.7	2.7	2.0	3.0	0.0	2.4	16.1	1.6	3.9	1.5	1.3	1.5	7.0	0.8	1.7	1.7	1.8	0.3	13.6	0.1	0.8	4.2	6.5	0.2	5.5	4.9	2.7	0.7	0.5	0.1	0.2	10.1	5.6	2.5	0.2	0.8	0.6	1.3	0.1	0.7	0.2	1.9	3.4	5.6	0.1	0.1	2.1	0.1	0.3	0.2	5.4	9.1	0.2	0.3	0.1	1.7	1.3	0.2	0.1	0.7	1.2	4.0	0.7	1.4	0.1	0.4	0.1	6.5	3.5	0.7	0.1	1.0	0.5	1.3	0.4	20.4	5.4	5.4	0.2	3.5	0.3	0.4	0.8	3.1	0.6	3.8	7.0	0.8	0.9	1.1	0.4	1.7	0.6	0.6	0.4	1.5	1.3	0.5	0.7	3.1	1.7	0.4	1.1	0.7	1.8	9.3	16.4	45.8	78.5	12.7	7.3	14.3	7.4	33.6	3.0	0.0	3.5	0.0	0.8	1.5	35.4	15.5	0.0	1.4	0.0	0.0	2.0	0.3	8.3	0.3	0.3	5.7	0.0	0.0	2.3	0.6	4.1	1.0	2.3	1.0	24.6	7.9	0.0	19.0	17.1	0.0	6.9	2.9	3.3	4.6	1.1	12.6	1.0	0.0	2.1	1.1	15.5	0.0	2.3	0.3	0.4	1.0	0.8	0.0	0.9	0.1
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193379-83198932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	5.0	10.1	8.5	3.4	10.4	1.0	5.4	11.8	14.6	5.6	4.0	5.9	11.6	4.2	5.7	15.9	3.1	6.5	7.6	7.2	9.4	11.0	7.5	8.1	4.8	3.9	6.5	11.7	7.0	13.4	7.4	9.8	4.2	11.6	19.2	4.3	3.7	16.4	11.3	4.1	3.4	4.0	5.5	4.8	4.1	5.3	14.5	3.9	1.7	10.4	3.1	4.4	5.2	2.8	3.7	6.8	0.7	3.9	0.8	4.6	2.1	2.2	2.0	4.7	8.9	5.7	4.2	3.3	5.0	10.7	3.8	4.6	2.9	1.2	1.7	4.1	6.1	8.7	2.2	3.9	3.0	5.9	2.0	4.0	2.0	3.0	6.4	8.8	0.5	1.6	5.4	5.0	4.8	10.0	12.5	7.0	4.8	3.1	3.0	4.6	3.1	0.7	1.5	1.6	2.0	2.0	2.5	9.7	1.0	7.9	2.5	1.7	5.8	3.0	4.9	4.5	7.1	3.0	3.0	7.4	2.7	1.7	3.7	2.2	6.7	2.7	1.0	3.1	0.8	3.1	0.5	1.8	0.0	2.4	1.6	3.9	3.7	3.6	3.6	2.0	2.2	4.6	4.5	0.7	0.8	3.9	6.8	4.0	2.1	8.5	10.4	11.8	14.6	9.4	11.0	6.5	11.7	11.6	3.9	0.0	7.9	5.2	3.2	3.3	5.6	5.0	5.1	4.0	0.0	1.8	0.0	6.8	5.0	7.7	27.1	2.9	2.6	0.0	8.0	2.7	5.8	7.9	0.0	4.4	4.3	1.6	5.2	4.3	1.3	11.7	8.3	2.3	8.5	3.6	4.7	8.4	6.2	3.4	5.6	9.3	4.1	6.5	5.0	20.7	7.2	2.0	4.8	2.5	2.6	2.1
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease mutation, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved					NA	NA					"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	12.5	11.6	10.9	12.5	14.0	23.8	12.0	21.4	17.9	11.0	11.2	13.8	9.1	10.3	13.3	10.4	12.1	11.8	9.5	8.4	9.3	10.5	9.3	15.6	10.8	15.5	9.4	9.0	11.4	16.1	15.0	15.1	10.7	11.1	11.0	13.1	12.8	11.6	9.0	13.0	19.1	10.8	14.1	9.0	16.6	10.5	17.9	11.8	25.9	10.3	7.4	16.2	11.6	10.7	2.1	2.7	10.4	5.9	4.1	4.0	3.3	7.6	12.8	10.5	12.8	5.4	5.4	9.6	8.1	5.8	14.3	14.0	23.4	3.4	13.2	5.3	7.3	6.6	10.7	15.8	6.8	15.1	9.8	12.6	12.1	13.3	8.0	5.3	6.0	10.7	3.5	4.4	15.1	8.8	3.3	6.6	11.2	10.4	5.4	8.3	7.9	13.4	7.6	8.1	19.2	7.1	15.3	25.0	12.5	4.2	7.9	7.5	14.1	12.4	7.8	8.0	29.6	15.5	6.3	6.2	10.2	8.1	19.4	13.9	6.0	10.7	9.3	6.3	8.3	9.7	1.4	5.9	6.5	4.0	5.8	2.6	1.7	3.0	3.1	2.6	2.1	2.6	2.7	10.4	4.1	2.9	2.7	2.2	3.3	10.9	14.0	21.4	17.9	9.3	10.5	9.4	9.0	11.1	11.8	6.0	4.5	10.0	4.0	1.8	19.7	2.8	7.6	8.1	10.3	10.4	37.3	5.4	3.3	3.5	7.2	4.7	3.4	0.0	3.2	5.9	4.3	4.8	4.7	6.4	4.6	20.6	0.0	7.4	10.0	6.2	7.5	6.8	1.7	4.6	3.4	6.0	3.3	3.5	6.0	1.2	20.6	12.9	4.9	15.9	17.9	3.0	3.7	8.5	4.1	4.1
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 82.5;Intestinal endocrine cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.8	0.0	1.2	0.8	2.2	0.9	0.6	13.3	3.3	0.1	1.8	2.0	5.7	0.9	0.0	5.2	5.0	0.3	0.2	1.9	5.7	0.0	1.2	1.4	1.6	1.9	0.0	0.0	0.4	9.1	0.8	0.0	0.0	6.8	7.2	0.2	1.1	2.9	4.5	5.9	1.4	0.0	1.7	2.8	5.9	29.7	2.5	1.5	0.7	0.3	5.7	1.6	0.2	0.1	2.0	3.7	2.3	5.7	4.3	3.2	2.5	4.6	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1	3.0	4.5	8.1	28.1	66.2	0.0	3.3	5.1	2.7	7.9	5.2	2.0	1.8	6.6	8.3	0.4	11.7	16.0	23.3	8.1	40.5	8.2	17.3	0.0	82.5	5.6	0.0	203.8	6.2	24.0	0.6	0.3	13.3	10.1	6.4	15.2	0.3	9.8	14.0	4.6	38.4	0.2	0.0	15.5	1.1	4.7	66.6	3.5	22.3	8.9	32.9
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143298061	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA057855: AB_2683545, HPA072473: AB_2686524"	"unprognostic (3.23e-2)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	8.5	6.9	10.3	8.1	10.6	6.3	6.9	13.9	13.7	5.6	5.4	9.8	5.4	13.5	8.8	4.8	5.0	6.6	7.1	5.2	10.4	10.3	7.2	8.1	7.6	8.6	12.6	7.2	9.8	13.7	8.6	6.7	5.5	10.6	7.5	4.1	7.2	11.9	5.1	7.7	13.3	8.0	10.7	8.9	8.3	6.5	6.9	12.8	6.5	7.5	3.0	6.6	7.2	5.2	6.4	6.4	2.3	3.3	5.3	7.5	3.3	6.3	5.9	5.7	6.8	2.5	1.7	12.4	5.0	1.6	3.6	2.1	3.4	5.0	0.4	7.0	1.7	2.0	4.5	6.6	2.7	3.2	7.1	14.4	8.5	5.6	5.1	2.5	3.4	10.9	1.5	4.5	2.4	5.0	2.3	1.7	5.1	17.6	3.9	2.1	12.7	3.7	7.0	8.1	6.9	15.1	7.8	3.6	6.2	1.9	4.6	9.7	13.6	7.6	4.9	6.2	3.9	8.0	6.2	3.6	4.9	11.2	4.3	8.8	8.1	5.4	7.9	3.3	7.0	5.7	1.1	3.3	2.3	5.3	1.9	5.8	4.2	4.0	5.9	3.7	6.4	7.5	6.2	1.4	5.3	2.9	6.4	1.3	3.3	10.3	10.6	13.9	13.5	10.4	10.3	12.6	7.2	10.6	12.8	0.0	0.0	0.0	2.1	2.6	4.3	2.4	0.0	0.0	0.0	3.5	5.9	1.2	3.3	2.3	0.6	2.1	2.0	0.0	1.8	2.1	1.5	1.2	0.0	2.1	1.1	3.2	0.0	1.8	0.0	1.6	3.7	0.0	1.7	1.0	0.9	2.5	1.6	0.0	1.1	1.9	3.4	6.5	1.6	2.1	5.9	1.8	0.3	1.5	1.9	0.7
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	24.4	30.2	30.2	51.3	37.1	30.0	25.1	49.4	41.1	31.2	31.0	28.9	38.5	30.3	51.4	34.3	21.8	28.8	32.6	25.3	32.1	19.8	29.2	30.6	26.8	39.8	38.1	26.0	42.6	35.9	41.9	36.9	21.9	30.5	40.1	29.8	25.6	28.1	38.3	25.3	35.9	32.4	36.7	40.9	42.6	28.0	29.7	38.0	24.9	32.6	21.9	35.9	25.1	36.6	12.8	9.9	14.7	8.6	7.3	15.6	5.9	9.7	6.2	25.4	16.9	26.0	14.3	9.0	16.5	14.3	14.6	15.4	10.7	11.1	50.1	9.7	16.4	14.9	8.1	21.7	14.5	18.6	20.1	8.1	23.2	14.2	13.9	14.8	24.4	24.1	13.3	18.0	16.5	18.6	27.0	18.4	13.1	19.0	12.6	13.9	9.3	22.9	36.2	20.3	12.1	11.4	8.8	10.9	12.8	14.4	19.0	10.1	18.2	15.1	10.9	10.3	23.6	8.5	19.3	17.0	14.6	17.4	11.9	16.7	17.4	41.2	30.2	8.4	20.5	14.3	14.7	8.6	5.0	15.6	4.7	12.1	12.8	10.2	8.5	8.8	11.9	10.5	11.5	6.1	7.3	7.7	9.9	6.7	5.9	30.2	37.1	49.4	41.1	32.1	19.8	38.1	26.0	30.5	38.0	53.6	75.9	98.3	36.2	48.0	117.7	27.5	35.7	52.2	50.0	59.3	96.2	29.5	10.0	26.7	26.1	51.5	48.5	23.3	24.1	24.9	50.1	43.0	40.6	28.4	24.2	87.4	45.4	47.3	59.4	17.2	60.7	54.9	57.3	40.5	32.6	52.2	32.6	31.6	57.0	10.3	141.3	45.3	50.9	108.1	28.1	39.5	30.3	54.2	31.0	31.9
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 270.6;Late spermatids: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.8"	"Low region specificity"	"Detected in all"							"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: AB_2682558"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (9.46e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (8.62e-4)"	7.9	24.6	21.0	13.4	35.1	22.2	10.9	15.5	28.6	14.8	12.9	30.6	28.3	17.8	13.9	21.1	11.8	14.2	19.0	13.6	22.8	11.9	13.4	18.9	12.8	14.7	38.5	22.9	19.2	15.1	34.3	20.8	7.3	28.0	24.7	9.5	17.7	14.5	17.4	6.3	14.6	14.3	12.5	24.2	24.1	16.1	28.2	43.5	7.5	17.8	8.5	11.2	13.7	12.6	9.9	16.5	21.2	28.0	15.7	15.2	11.8	2.2	2.0	1.7	5.2	6.8	9.9	1.7	3.7	3.9	4.4	5.9	0.6	2.4	1.9	9.6	7.0	1.3	1.9	1.0	5.9	2.7	9.2	1.4	4.5	1.6	2.4	12.0	1.7	6.8	11.8	15.6	3.2	4.3	4.6	12.3	3.4	4.0	21.8	2.2	2.8	2.7	3.6	0.9	3.1	7.4	3.0	0.0	12.2	4.0	3.2	0.7	2.8	3.7	4.3	6.8	3.2	6.3	7.5	8.1	3.5	1.0	6.0	3.4	20.0	4.8	3.8	4.7	9.2	5.0	21.2	28.0	19.1	12.1	23.6	11.7	8.1	8.2	11.0	16.5	9.9	7.5	5.9	13.2	15.7	16.4	4.3	15.2	11.8	21.0	35.1	15.5	28.6	22.8	11.9	38.5	22.9	28.0	43.5	14.9	9.9	9.0	13.1	6.6	11.2	9.8	12.7	21.4	14.8	17.4	39.3	4.9	21.6	7.6	270.6	9.1	14.8	0.0	8.4	4.4	8.4	23.8	33.5	9.6	20.4	6.4	10.4	12.9	26.0	182.1	10.6	15.7	11.8	13.6	10.6	14.8	7.5	23.0	12.7	31.6	28.9	0.0	8.2	4.8	3.8	7.0	5.0	21.5	8.1	17.5
FAM110B	"C8orf72, MGC39325"	ENSG00000169122	"Family with sequence similarity 110 member B"	Q8TC76	8	57994509-58204279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4"	"Group enriched"	"Detected in many"	11	"granulocytes: 13.1;monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008318, HPA011781"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA008318: AB_1853892, HPA011781: AB_1853891"	"unprognostic (2.07e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.88e-8)"	"unprognostic (4.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (1.06e-2)"	"prognostic favorable (4.31e-8)"	"unprognostic (2.23e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.15e-4)"	6.5	3.1	15.7	4.1	12.2	4.1	9.9	23.7	18.4	8.8	6.1	5.0	24.3	2.3	8.9	6.8	3.0	9.1	7.9	21.7	10.3	14.4	6.6	6.0	4.1	2.0	8.0	5.9	8.2	3.0	16.7	4.1	5.0	7.9	10.0	3.2	9.5	8.5	19.8	17.1	3.0	3.3	10.4	11.5	30.8	5.5	14.7	4.9	0.0	8.6	3.4	2.1	7.9	9.4	0.3	0.9	13.1	6.4	0.0	0.2	0.5	0.0	1.1	4.1	0.1	1.8	0.7	1.6	7.8	9.1	5.5	2.5	0.0	0.1	0.0	1.5	5.5	4.9	0.0	3.7	0.0	4.2	0.0	3.8	0.7	1.2	4.5	6.3	1.0	0.2	6.6	1.5	0.2	3.4	0.7	0.0	1.8	0.0	0.1	4.1	0.1	0.0	2.7	3.9	5.4	1.7	0.0	4.6	0.0	13.5	0.8	4.0	4.4	0.0	0.5	0.2	5.0	3.6	0.4	0.0	3.9	2.5	0.0	2.7	1.7	0.0	0.0	1.8	0.0	4.5	0.0	1.4	13.1	0.0	3.6	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	6.4	0.0	0.1	0.5	15.7	12.2	23.7	11.8	10.3	14.4	8.0	5.9	7.9	4.9	0.0	5.6	0.0	14.2	8.8	8.8	21.8	2.5	1.4	1.2	22.7	2.0	1.5	6.6	5.9	2.2	4.7	0.0	0.0	2.5	15.0	22.7	10.6	4.6	5.7	4.3	6.4	6.9	15.4	8.1	1.4	9.2	6.3	15.1	0.0	0.0	25.5	2.6	0.0	13.8	6.1	5.4	32.3	22.3	1.7	1.5	3.6	1.3	0.5	0.0	6.7
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.2	24.4	0.0	0.0	0.0	0.1	5.0	12.9	11.0	11.2	4.2	13.2	4.4	7.6	10.8	0.1	5.1	0.0	0.6	7.8	11.0	1.5	2.5	12.6	4.4	18.8	0.0	0.0	9.3	6.1	8.4	0.1	31.5	12.3	0.0	0.0	15.0	8.4	6.8	13.4	0.1	19.2	2.5	0.7	0.0	20.3	0.2	1.0	8.2	17.7	28.1	3.9	1.1	2.4	6.1	14.1	6.7	0.0	14.4	5.8	6.6	7.1	24.6	18.4	0.0	9.2	0.0	7.5	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6	14.9	14.1	2.2	9.6	5.6	45.2	9.4	5.1	32.1	15.9	12.2	47.1	0.3	11.6	7.6	1.0	4.5	0.0	0.0	1.7	0.2	9.3	8.6	5.7	0.8	0.6	66.7	15.0	14.1	1.6	1.6	31.7	0.5	3.3	1.0	1.1	25.9	3.3	0.0	29.7	2.9	41.2	45.3	29.3	3.5	4.1	2.5	1.0	10.1	0.3	2.5
PCGF3	"DONG1, FLJ36550, MGC40413, RNF3, RNF3A"	ENSG00000185619	"Polycomb group ring finger 3"	Q3KNV8	4	705748-770640	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061879	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061879: AB_2684631"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.36e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.25e-4)"	17.3	29.0	18.2	22.0	18.8	28.0	18.9	31.4	21.8	17.7	15.2	12.4	21.4	24.3	20.9	19.1	17.9	17.5	18.1	14.0	16.5	11.2	14.6	15.3	17.8	18.2	17.2	17.5	28.6	15.3	6.5	20.0	21.3	15.3	20.5	11.9	15.1	20.4	15.8	15.5	55.8	22.5	15.2	11.8	26.4	20.8	18.0	16.9	20.8	21.3	19.2	17.6	15.3	20.0	7.3	7.2	6.9	11.6	6.9	5.4	3.5	11.4	10.4	19.2	21.9	8.8	9.1	23.7	15.6	8.6	12.9	13.1	11.4	12.7	8.3	10.5	15.0	13.1	8.0	8.9	12.7	9.8	10.8	9.6	11.8	12.2	20.0	10.8	8.0	15.8	11.4	17.0	11.2	5.1	8.5	16.4	15.2	16.2	6.8	12.5	12.8	21.5	28.5	12.7	7.8	18.9	21.4	12.2	5.2	7.6	18.9	27.5	20.7	8.1	8.7	8.3	13.0	17.0	11.5	19.6	12.6	10.2	10.4	20.0	16.5	13.9	12.9	9.9	12.9	23.2	5.5	11.6	4.7	5.4	7.5	4.8	6.7	3.4	3.4	5.1	7.3	4.3	3.0	6.9	6.9	3.5	7.2	5.0	3.5	18.2	18.8	31.4	21.8	16.5	11.2	17.2	17.5	15.3	16.9	11.9	30.3	15.9	14.9	22.6	11.8	16.7	22.9	9.4	18.2	8.7	11.8	11.7	3.3	18.4	44.6	21.8	17.2	0.0	17.2	22.3	17.3	17.4	16.1	12.1	10.7	6.4	18.5	25.8	11.0	39.8	15.3	17.1	21.9	10.0	21.7	9.2	26.4	14.4	14.5	8.8	7.9	6.5	16.9	20.1	24.3	25.1	19.8	13.8	18.7	25.2
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.2	25.6	18.4	21.5	7.5	8.5	48.4	17.5	11.3	17.0	12.5	28.5	20.5	27.3	11.0	13.6	17.9	42.3	20.4	15.5	5.8	28.4	26.3	16.7	32.0	33.3	13.6	30.9	21.5	9.4	16.0	10.5	11.7	10.4	17.7	23.6	36.3	13.4	11.6	38.5	33.0	21.4	34.4	23.7	22.1	43.3	22.0	26.6	11.2	17.2	60.6	25.1	30.9	36.3	21.6	10.2	31.2	31.2	21.3	22.1	19.2	23.2	28.3	11.5	13.1	22.2	18.5	15.1	20.6	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2	26.8	48.3	8.9	15.4	16.0	37.2	29.1	0.0	8.1	7.9	24.4	19.6	20.7	26.6	28.0	10.1	16.9	100.2	0.0	49.7	27.9	22.0	31.8	15.0	0.0	27.4	36.5	49.8	0.0	0.0	10.9	18.1	26.0	38.8	26.2	55.1	18.1	55.1	51.0	25.1	38.5	38.3	0.0	17.3	15.4	26.4	16.9	23.7	12.9	57.2	21.6
TERF2IP	RAP1	ENSG00000166848	"TERF2 interacting protein"	Q9NYB0	16	75647786-75761872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006719, CAB018660, CAB018749"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267"	"unprognostic (3.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (6.14e-5)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.81e-1)"	"prognostic favorable (2.15e-5)"	"unprognostic (6.26e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.99e-1)"	22.5	45.0	51.0	17.9	71.8	35.3	18.2	70.1	64.9	20.9	12.6	30.5	12.5	12.5	21.7	28.3	13.6	17.4	17.2	30.0	44.2	68.4	21.5	19.6	17.2	28.4	47.5	53.5	30.9	16.7	37.6	41.8	12.6	48.3	23.4	13.0	18.9	15.5	22.3	18.5	15.1	12.7	18.5	39.4	22.3	14.0	24.3	32.5	20.5	26.2	10.5	27.6	16.2	15.6	20.4	8.9	40.5	12.4	17.1	23.9	7.2	6.5	6.2	14.0	10.8	15.9	16.7	4.4	19.9	17.2	17.0	12.7	6.8	7.2	33.5	26.7	13.4	8.4	9.5	13.8	5.7	14.5	12.5	20.0	17.0	9.6	15.5	20.8	22.9	24.4	14.1	16.2	13.6	21.2	18.8	11.4	22.2	19.9	14.2	19.4	19.3	27.6	29.3	7.0	8.5	14.4	31.4	9.0	27.5	12.6	6.0	34.0	20.5	25.9	6.1	15.8	5.3	14.0	22.6	12.4	16.3	8.6	14.0	15.2	59.4	51.6	47.1	17.1	15.7	15.4	20.2	9.1	40.5	13.1	8.0	16.3	16.9	20.1	21.6	8.9	20.4	23.9	15.4	14.6	17.1	12.4	8.7	18.6	7.2	51.0	71.8	70.1	58.6	44.2	68.4	47.5	53.5	48.3	32.5	44.7	58.4	95.8	104.6	173.7	401.9	88.0	58.6	66.9	62.6	89.0	88.4	58.2	114.4	66.6	5.3	93.4	31.5	373.8	44.4	27.1	105.9	83.9	122.3	51.2	54.5	267.0	93.8	76.7	65.2	15.0	107.0	85.4	114.7	101.0	37.4	289.1	40.5	40.2	122.7	55.7	146.1	135.8	124.6	277.5	103.3	169.9	102.3	207.5	28.1	86.4
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452705-25585517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 20.1;Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"AF22: 14.6;Hep G2: 22.9"	"Low region specificity"	"Detected in many"							HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	3.8	7.5	5.9	7.6	10.7	0.8	4.2	17.2	4.2	10.3	6.7	5.5	3.9	4.1	13.0	9.7	4.7	4.1	7.5	4.0	5.8	6.3	17.1	5.9	5.3	2.7	4.5	4.2	18.5	5.0	14.8	12.1	2.0	7.5	8.8	2.8	13.8	4.7	5.2	5.2	2.7	3.6	9.7	5.5	5.3	6.5	10.5	2.0	17.2	8.2	2.6	3.9	2.8	6.6	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.6	6.7	14.6	9.6	1.6	4.9	4.5	2.2	1.9	2.0	2.8	1.7	4.7	0.3	3.2	3.5	4.8	0.5	2.1	0.4	1.7	0.3	3.0	1.0	3.0	22.9	3.5	0.3	0.0	6.0	0.4	2.3	0.0	5.6	4.2	11.2	1.1	0.1	2.4	5.9	13.0	0.4	4.1	0.1	0.7	0.3	11.4	0.5	1.0	0.8	14.5	10.3	5.1	1.9	5.5	12.3	3.1	3.9	0.2	0.1	5.6	0.0	0.1	1.5	2.6	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.2	5.9	10.7	17.2	4.2	5.8	6.3	4.5	4.2	7.5	2.0	0.0	10.5	0.0	3.6	1.8	2.4	4.5	15.3	20.1	5.7	7.0	23.6	2.5	0.0	4.7	0.4	1.8	0.3	0.0	1.1	1.1	6.2	3.9	0.0	6.0	1.8	7.9	5.8	6.7	0.8	1.8	12.0	0.7	0.0	0.0	1.6	2.4	2.5	0.8	11.7	6.9	1.9	6.5	2.1	2.4	4.1	0.6	1.3	0.0	1.5	1.6
C16orf86	FLJ41802	ENSG00000159761	"Chromosome 16 open reading frame 86"	Q6ZW13	16	67666816-67668758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 83.1;Spermatocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 7.0;T-47d: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA073475	Enhanced					NA	NA					"HPA073475: AB_2686607"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (1.59e-1)"	"prognostic favorable (2.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.05e-1)"	4.6	3.4	2.0	2.9	5.9	1.6	2.6	8.6	4.0	2.5	2.9	2.6	5.8	0.9	3.0	4.2	2.8	2.8	4.7	4.1	1.9	2.3	3.7	3.6	2.4	3.6	2.6	2.1	2.3	1.9	4.6	2.2	2.4	3.9	3.5	1.3	2.6	2.9	3.1	6.7	1.3	1.9	2.6	3.0	3.1	1.6	26.9	3.0	4.5	2.6	1.3	2.2	2.9	1.8	5.9	10.2	4.1	3.3	1.2	2.6	2.5	0.3	1.0	1.4	0.5	2.0	1.8	1.3	1.8	3.6	0.8	1.2	0.1	0.0	0.1	0.9	1.9	0.0	0.2	0.2	0.4	0.3	0.0	0.2	0.2	0.2	0.0	3.7	0.1	1.9	7.0	0.2	1.5	0.2	1.2	1.6	3.0	0.3	4.3	1.8	0.0	0.2	0.9	0.6	0.6	0.0	2.6	0.0	3.0	4.3	0.2	1.0	0.5	0.0	0.0	0.2	0.3	4.4	0.6	0.1	0.2	0.1	0.9	0.1	0.5	1.2	1.2	1.5	0.2	0.3	1.7	3.3	4.1	1.1	1.0	1.8	2.9	2.6	1.5	5.3	5.9	0.9	1.7	1.1	1.2	1.1	10.2	1.8	2.5	2.0	5.9	8.6	4.0	1.9	2.3	2.6	2.1	3.9	3.0	0.0	3.0	8.1	3.0	1.3	7.1	1.4	2.5	0.0	2.3	5.2	5.9	1.1	6.6	2.1	83.1	4.6	0.0	0.0	0.6	0.4	4.3	0.8	11.5	2.9	5.3	4.8	2.9	8.6	4.8	10.7	5.2	3.4	3.3	6.4	0.6	10.4	0.9	0.0	7.1	10.9	7.4	0.0	2.3	77.5	2.7	1.4	0.7	4.4	0.3	0.8
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 183.0;Proximal tubular cells: 123.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.2	24.8	0.7	0.0	0.1	35.8	0.7	0.0	0.0	4.0	1.2	0.1	0.0	0.2	2.1	0.0	1.5	0.0	0.0	0.0	0.0	1.6	0.3	4.2	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7	0.0	1.1	2.2	0.2	0.2	1.7	0.4	5.1	0.0	0.0	0.0	3.9	0.1	8.3	0.0	1.3	0.6	0.7	0.0	0.2	4.4	0.4	0.3	5.7	183.0	1.2	0.0	1.2	2.5	3.5	1.5	0.3	1.7	0.0	3.6	0.0	24.0	0.0	0.0	1.1	123.0	1.3	0.0	0.4	0.0	1.0	0.1	0.3	0.5	0.0	0.1
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 16.9;GAMG: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	9.5	16.9	4.0	2.4	2.5	1.4	1.7	1.0	2.5	2.2	5.0	5.4	10.7	6.1	1.6	1.5	20.0	15.0	3.1	5.2	0.9	7.5	2.1	2.5	1.3	13.0	2.8	0.8	5.8	1.6	6.0	3.3	2.7	2.9	8.9	5.5	2.8	1.7	2.3	4.7	3.6	1.5	1.6	4.9	1.3	1.7	1.4	1.0	2.1	2.7	0.1	1.1	3.0	1.7	1.3	6.2	4.6	1.3	3.3	1.4	3.3	2.3	1.4	3.0	6.3	0.3	4.1	2.2	0.6	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3	0.0	1.0	2.2	0.7	0.5	0.1	0.3	0.0	1.4	0.0	5.2	0.0	1.6	0.0	0.8	0.0	1.8	1.5	0.0	0.2	0.4	0.4	0.7	3.5	6.8	0.4	3.2	0.0	2.5	0.3	0.0	0.9	1.7	0.0	1.0	0.3	0.9	0.5	0.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	1.4	2.1	4.3	0.4	0.9
APBA3	"mint3, X11L2"	ENSG00000011132	"Amyloid beta precursor protein binding family A member 3"	O96018	19	3750819-3761699	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045577	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA045577: AB_10964881"	"unprognostic (3.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (6.64e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (1.83e-4)"	10.2	7.8	5.4	12.7	8.3	6.3	7.6	8.6	7.2	7.8	8.6	10.5	11.9	11.7	9.0	4.0	8.0	6.9	7.8	7.1	5.1	4.3	8.8	14.2	7.0	12.9	11.9	7.3	10.7	10.3	4.6	10.0	7.2	7.1	8.0	3.0	6.7	16.8	9.6	20.5	8.6	11.7	8.5	6.1	14.1	11.7	6.0	9.1	13.2	11.5	7.2	11.8	8.0	7.1	13.0	8.1	10.8	7.1	6.5	18.8	8.2	7.4	5.7	1.2	2.2	2.5	1.9	6.1	4.8	3.0	2.5	3.7	5.2	2.4	5.0	4.3	1.9	6.2	3.4	1.4	4.1	0.6	18.5	4.3	2.9	3.9	3.8	7.9	1.9	11.0	3.7	5.0	3.4	2.1	2.2	3.6	5.1	4.7	8.2	1.1	4.1	5.7	7.1	3.5	2.5	8.2	5.9	2.6	8.3	1.8	4.8	4.5	4.7	3.0	4.4	6.9	0.9	1.9	4.2	5.8	4.6	4.3	7.7	6.1	17.0	6.2	4.7	4.1	5.7	4.5	8.7	7.1	10.8	13.8	5.5	12.8	10.2	13.6	13.5	8.1	13.0	9.0	10.5	10.4	6.5	4.6	7.7	18.8	8.2	5.4	8.3	8.6	7.2	5.1	4.3	11.9	7.3	7.1	9.1	6.0	6.4	11.8	5.6	3.8	4.1	4.2	5.1	1.4	3.4	7.0	7.9	8.8	6.6	13.6	0.6	5.8	8.8	0.0	8.0	8.3	6.9	8.3	2.3	7.3	7.9	3.2	4.6	7.4	4.7	0.0	5.8	4.6	5.0	23.4	7.8	3.8	10.6	5.8	2.8	9.1	6.4	6.5	5.2	1.9	6.6	6.6	12.8	13.1	5.9	5.8
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069444-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Nucleoplasm, Intermediate filaments"	Cytosol	"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	6.8	9.2	7.2	8.1	9.4	13.1	8.5	12.4	9.9	7.0	6.5	11.1	7.2	5.1	9.5	7.7	8.7	8.5	6.0	5.5	5.9	5.6	6.9	10.3	6.8	9.7	7.6	8.1	9.8	9.0	7.0	12.9	6.7	9.2	7.5	6.4	7.2	9.2	10.5	5.3	7.2	7.6	7.6	6.7	11.7	8.0	8.4	9.8	21.7	9.0	4.0	11.3	7.0	7.1	10.7	11.1	9.3	6.7	13.7	11.5	4.0	3.6	4.4	4.1	8.4	6.3	4.7	3.4	3.9	5.0	5.1	6.9	5.1	2.5	7.1	6.9	4.8	3.6	5.0	8.0	5.1	4.8	9.1	4.9	10.2	7.9	2.7	4.5	10.3	10.9	6.2	6.0	5.6	7.6	4.5	4.7	6.6	4.2	12.8	7.5	5.3	7.9	3.1	3.9	3.9	6.2	5.6	6.1	4.2	3.2	9.5	4.8	5.9	5.8	4.3	4.4	3.9	3.5	6.3	7.0	4.4	3.3	8.6	4.1	12.2	9.3	6.8	4.9	5.5	3.5	9.3	6.7	8.6	9.5	5.5	10.6	7.6	10.3	8.6	7.2	10.7	11.5	9.6	7.4	13.7	5.2	11.1	9.3	4.0	7.2	9.4	12.4	9.9	5.9	5.6	7.6	8.1	9.2	9.8	3.0	4.1	8.8	5.9	1.3	8.3	4.5	2.5	5.3	7.9	7.0	0.0	5.2	13.3	6.0	0.8	5.3	4.5	23.3	5.4	3.8	4.0	5.1	8.1	4.0	5.3	15.9	5.2	7.4	7.3	0.0	4.0	6.4	0.0	4.6	6.6	5.2	5.0	3.7	5.3	6.7	6.4	0.0	4.8	15.9	16.4	1.1	4.8	6.4	5.1	6.4
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118135858-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 260.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		62000000	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	26.8	207.3	83.0	15.2	82.3	13.5	32.3	63.3	102.7	35.5	50.4	58.0	18.9	75.3	22.9	52.8	24.3	28.5	22.6	57.6	77.6	69.7	132.7	260.7	22.1	16.0	77.8	71.5	43.5	46.2	139.2	30.8	16.5	59.1	35.4	25.4	41.2	43.6	33.1	65.1	20.9	75.4	23.4	79.1	15.3	20.6	22.7	43.5	8.7	94.9	26.1	19.7	20.2	17.8	45.2	37.3	3.0	12.1	20.9	45.3	36.4	32.2	27.6	39.1	40.6	61.7	30.2	60.8	25.7	30.0	40.6	20.9	16.4	11.1	52.0	25.9	38.4	16.2	23.2	57.8	23.9	31.7	13.0	55.3	26.1	31.1	114.3	35.7	47.2	11.4	29.9	39.7	24.0	16.7	46.7	18.8	27.8	43.3	19.4	40.6	38.2	25.7	95.7	37.9	27.1	33.4	50.8	29.1	94.8	49.8	31.5	46.9	36.4	53.4	37.1	50.3	25.0	53.4	32.2	20.4	31.2	17.8	30.5	25.8	19.0	33.7	26.8	36.7	35.4	33.8	0.7	11.0	3.0	26.9	12.1	42.4	45.2	45.3	33.3	33.3	32.5	43.9	35.3	1.2	20.9	10.3	37.3	41.2	36.4	83.0	82.3	63.3	102.7	77.6	69.7	77.8	71.5	59.1	43.5	375.2	339.6	254.0	392.9	282.7	501.7	637.3	598.7	327.9	273.0	743.2	90.3	819.2	3140.1	396.3	35.6	178.6	306.2	116.8	213.3	686.7	314.8	422.6	353.3	1736.5	486.8	681.7	307.9	178.0	167.5	50.5	502.8	218.5	705.2	448.2	324.1	1385.1	201.0	263.6	687.7	3872.6	306.7	362.2	321.6	273.2	133.6	284.3	514.8	194.5	466.9	324.1
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443158-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	18.7	15.6	22.0	20.7	22.4	19.1	16.5	20.1	28.6	18.1	22.4	22.5	22.3	18.3	22.2	14.9	26.3	19.0	20.9	20.8	22.5	17.3	15.9	14.1	15.6	18.8	23.3	29.5	21.6	23.5	20.8	18.0	17.9	22.7	17.6	13.3	14.5	23.9	20.2	47.5	24.9	17.1	26.7	16.2	18.2	20.8	40.7	21.0	13.3	19.8	20.7	17.4	20.8	17.6	3.6	3.5	31.0	6.2	9.8	6.4	4.4	12.7	21.5	7.3	16.2	12.5	10.8	18.1	11.3	11.8	11.5	13.9	10.8	18.9	10.9	17.7	14.2	14.1	14.6	5.8	9.8	8.4	40.0	10.1	11.7	45.1	8.1	11.7	17.5	29.6	11.0	7.3	12.8	11.3	12.1	12.8	7.2	8.9	7.1	8.9	15.1	12.5	20.8	6.0	7.8	12.9	10.3	8.3	13.9	9.7	16.1	7.3	9.3	28.3	16.1	11.0	7.4	21.7	20.2	9.5	11.4	14.1	8.7	9.1	12.1	8.7	7.7	12.0	21.2	10.3	5.4	5.7	31.0	6.4	6.2	5.4	3.3	5.0	5.1	3.5	3.6	6.4	5.9	7.9	9.8	4.4	2.6	6.4	4.4	22.0	22.4	20.1	28.6	22.5	17.3	23.3	29.5	22.7	21.0	20.8	26.1	14.5	14.7	38.0	13.8	26.6	12.7	33.5	20.5	14.0	33.4	20.2	23.2	23.4	22.8	15.3	23.8	0.0	25.9	19.0	15.8	14.7	23.0	15.7	20.9	60.4	5.2	13.5	24.4	44.8	18.7	21.7	25.3	21.6	18.6	16.9	24.4	20.1	15.9	20.3	19.2	19.4	22.3	30.9	16.2	47.0	28.5	19.1	20.7	20.4
ASB1	ASB-1	ENSG00000065802	"Ankyrin repeat and SOCS box containing 1"	Q9Y576	2	238426742-238452250	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003508	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003508: AB_1845065"	"unprognostic (1.02e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (4.04e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	9.2	8.4	17.0	10.9	19.7	3.8	7.7	9.3	18.4	7.1	8.7	16.2	7.8	5.8	12.0	5.9	7.5	9.3	7.8	22.0	16.1	14.7	8.0	6.2	7.6	10.5	18.0	12.7	15.3	6.6	15.1	8.8	4.9	15.6	9.8	7.2	9.3	5.4	12.1	26.2	8.3	7.8	11.8	18.8	7.8	7.6	14.0	11.3	9.0	8.2	9.3	11.7	7.1	6.5	5.5	4.2	1.4	1.1	3.0	6.7	1.9	4.9	7.1	9.8	7.8	6.3	6.6	7.9	13.6	9.0	8.1	9.2	3.4	3.5	4.3	1.9	12.7	18.3	5.4	9.6	21.5	13.0	10.8	7.9	5.4	6.4	8.5	14.6	7.4	7.2	7.0	9.9	23.9	32.5	12.9	3.5	7.6	11.3	2.9	15.0	3.3	4.0	7.8	10.4	4.3	6.1	5.8	19.9	2.8	5.9	6.7	7.9	10.7	4.2	3.1	7.0	6.1	2.3	7.9	7.5	14.9	9.7	11.6	26.9	10.6	6.5	7.4	23.4	2.3	7.4	0.0	0.8	1.4	6.7	1.1	3.5	5.5	4.7	6.5	0.9	3.3	4.1	4.9	0.3	3.0	0.6	4.2	5.5	1.9	17.0	19.7	9.3	18.4	16.1	14.7	18.0	12.7	15.6	11.3	8.9	3.0	14.1	23.6	7.0	10.6	40.0	20.4	14.7	6.8	8.7	3.9	11.2	1.7	15.7	27.1	3.8	5.1	23.3	18.1	23.0	14.5	14.7	16.1	9.9	23.2	9.5	12.2	4.9	14.2	15.0	7.2	9.5	6.8	14.4	5.2	8.0	22.5	17.3	13.8	10.2	5.7	25.8	12.7	37.9	35.5	5.9	4.8	15.8	6.0	11.6
C19orf73	FLJ10490	ENSG00000221916	"Chromosome 19 open reading frame 73"	Q9NVV2	19	49118397-49119140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7"									HPA062719	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062719: AB_2684847"	"unprognostic (3.02e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.97e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (3.05e-1)"	"unprognostic (9.00e-5)"	"unprognostic (1.19e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.13e-3)"	2.5	3.4	5.0	2.3	6.7	1.0	3.7	10.2	8.7	1.4	3.9	4.1	3.1	7.7	1.3	5.6	2.6	1.4	2.1	3.5	4.9	4.5	2.5	4.8	1.5	2.3	9.2	4.9	0.7	12.9	3.3	5.4	1.4	5.0	2.5	2.9	1.8	6.3	2.1	3.6	4.1	4.4	1.3	4.7	3.6	2.9	2.1	5.6	1.1	3.1	1.2	1.7	1.5	1.4	6.2	5.5	0.7	4.1	7.9	4.6	2.3	2.4	3.1	1.2	6.0	2.0	0.4	1.3	0.7	0.4	1.3	0.9	0.2	1.4	1.8	0.7	0.5	1.9	1.6	1.6	0.2	0.2	3.5	12.7	1.5	1.9	2.0	2.0	0.0	0.7	0.2	4.1	0.9	3.4	1.0	0.4	6.2	2.8	2.9	0.6	2.6	1.9	1.8	0.9	2.6	0.6	1.8	2.4	2.3	2.3	1.0	6.3	2.9	1.2	1.5	2.3	0.9	1.5	0.6	1.2	1.6	2.7	0.5	0.6	1.8	3.4	2.0	1.1	2.1	1.8	0.0	3.3	0.7	2.9	1.9	4.6	2.7	2.2	2.6	5.5	6.2	4.3	3.2	0.1	7.9	4.1	4.2	1.9	2.3	5.0	6.7	10.2	8.7	4.9	4.5	9.2	4.9	5.0	5.6	0.0	0.0	4.5	8.9	1.9	3.6	0.7	5.1	1.4	1.2	3.5	0.0	0.7	3.3	2.2	0.4	0.5	3.3	0.0	1.7	0.8	1.4	6.4	0.0	3.9	1.2	1.6	2.9	1.8	1.2	0.7	0.0	1.3	3.3	0.0	4.2	3.4	1.9	0.0	1.4	7.0	4.3	0.0	1.1	0.4	3.4	2.3	0.3	1.8	4.7	3.5
ATP8B2	"ATPID, KIAA1137"	ENSG00000143515	"ATPase phospholipid transporting 8B2"	P98198	1	154325553-154351307	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 12.3;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046680	Approved					NA	NA					"HPA046680: AB_2679749"	"unprognostic (1.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.40e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.52e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.77e-3)"	"unprognostic (6.58e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (5.29e-5)"	13.6	7.0	5.5	15.0	7.1	3.4	11.9	26.8	8.9	29.1	11.2	7.4	11.5	8.6	28.9	15.2	14.4	21.5	18.4	11.7	7.0	6.8	6.6	2.6	12.2	16.1	6.2	5.8	27.5	5.3	5.1	13.9	10.9	6.1	15.3	6.8	12.5	5.4	16.4	4.3	6.1	11.8	29.4	5.1	14.7	11.4	12.7	5.1	18.9	11.2	8.1	13.6	20.5	24.9	0.6	0.7	3.1	0.0	0.9	6.5	1.0	0.7	5.1	6.5	6.7	41.8	28.3	0.1	15.7	26.2	9.1	10.9	0.1	0.2	0.6	8.3	37.9	6.0	3.2	7.8	1.8	6.4	17.2	6.3	6.5	6.3	5.9	12.7	0.0	5.1	18.2	0.4	13.8	13.2	12.0	14.0	8.3	12.9	15.8	7.7	6.7	12.2	0.8	15.5	0.1	6.5	13.6	4.5	23.4	1.7	0.1	5.8	8.0	4.1	0.9	9.8	9.7	4.8	4.9	12.2	13.8	7.0	17.3	4.7	21.9	26.8	3.9	4.8	0.7	8.4	3.1	0.0	3.0	2.2	0.0	1.5	0.6	3.5	3.7	0.0	0.4	2.9	2.5	0.1	0.9	0.0	0.7	6.5	1.0	5.5	7.1	26.8	8.9	7.0	6.8	6.2	5.8	6.1	5.1	3.0	5.0	2.2	1.5	2.3	0.7	5.1	0.0	6.7	3.4	0.0	2.0	0.1	0.0	1.2	0.4	8.4	0.0	0.0	0.2	0.4	8.1	4.3	7.0	0.9	0.4	7.9	0.0	12.3	1.0	0.4	10.6	0.0	6.8	0.0	0.0	2.6	1.4	0.0	13.8	0.1	0.4	0.0	6.2	2.6	3.6	1.4	0.2	8.2	0.0	0.4
ING5	"FLJ23842, p28ING5"	ENSG00000168395	"Inhibitor of growth family member 5"	Q8WYH8	2	241687085-241729478	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042685	Approved					NA	NA					"HPA042685: AB_10797507"	"unprognostic (1.87e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (8.25e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.87e-2)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.74e-3)"	11.4	12.3	15.3	13.7	16.9	14.0	12.8	26.5	17.3	13.7	10.7	16.2	20.0	12.3	14.7	21.3	11.1	15.2	13.2	10.9	17.3	16.2	12.1	12.5	10.6	15.2	18.6	17.0	26.3	23.4	15.9	22.5	10.2	14.9	18.2	12.1	14.9	24.7	22.2	13.7	23.8	11.7	11.2	14.3	12.7	12.5	8.4	18.6	12.8	21.9	7.5	14.8	10.7	12.9	4.6	3.9	16.5	4.2	2.5	5.5	2.6	6.9	6.5	15.0	9.0	11.4	13.0	18.2	7.8	6.2	7.8	6.3	6.7	6.9	7.0	2.8	7.2	8.5	10.5	13.5	6.9	9.6	7.4	12.9	16.5	9.6	20.0	9.6	17.5	11.1	11.1	11.2	7.7	12.6	9.4	8.5	11.8	15.9	5.0	7.3	11.6	13.9	24.5	17.2	11.9	4.8	24.7	18.0	6.3	7.3	11.3	19.0	11.5	4.1	8.2	10.7	10.1	5.6	11.8	6.5	10.8	11.5	6.8	8.3	10.8	3.8	19.8	7.7	10.7	7.7	16.5	4.2	8.6	2.9	3.2	3.4	3.4	4.8	3.8	2.4	4.6	5.1	3.6	4.8	2.5	3.4	3.9	5.5	2.6	15.3	16.9	26.5	17.3	17.3	16.2	18.6	17.0	14.9	18.6	41.7	28.9	15.6	28.8	8.4	14.4	11.2	12.7	13.4	26.1	17.4	13.7	16.9	26.6	8.7	22.9	11.1	10.1	0.0	8.8	11.7	10.8	20.4	15.1	11.3	6.2	14.3	8.1	6.7	9.9	8.7	15.8	8.3	8.5	7.2	16.3	17.2	7.9	11.9	10.6	13.5	17.8	19.4	13.7	6.3	10.2	12.4	14.5	12.9	13.3	13.1
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	8.4	18.6	34.3	6.0	39.3	0.9	7.2	22.7	70.9	12.8	6.6	11.0	4.9	3.5	12.5	16.0	6.1	13.4	9.3	13.5	31.1	24.9	10.1	1.8	8.7	4.1	17.1	28.5	18.3	10.5	26.5	16.3	10.1	27.8	12.2	6.1	12.8	13.3	16.5	1.4	5.0	3.8	16.3	8.7	5.7	5.3	12.8	6.8	1.3	14.9	2.5	4.2	9.4	4.8	9.4	4.8	1.5	1.1	3.4	3.9	1.5	18.9	23.0	13.9	13.1	18.4	20.6	5.4	12.6	24.3	22.9	23.0	12.6	0.4	0.0	4.4	23.3	16.8	8.3	11.2	1.9	14.6	0.1	11.3	6.8	11.0	24.0	18.6	0.2	1.1	23.3	1.5	16.3	2.7	18.7	15.7	0.1	13.5	12.3	20.0	3.3	0.3	5.8	10.7	0.2	11.9	10.8	7.8	0.9	22.8	0.1	28.4	20.4	15.0	4.4	21.5	9.5	18.4	7.1	10.4	24.5	13.0	0.9	15.3	2.3	0.4	5.1	3.2	0.2	12.9	0.0	1.1	1.5	3.8	0.3	1.1	7.2	1.1	3.9	2.1	9.4	1.6	2.7	0.0	3.4	0.4	4.8	0.9	1.5	34.3	39.3	22.7	70.9	31.1	24.9	17.1	28.5	27.8	6.8	0.0	1.9	0.0	3.1	2.9	24.5	4.0	0.0	2.7	7.9	12.2	2.0	6.1	1.7	11.0	5.5	4.5	1.3	0.0	1.4	5.3	10.8	2.5	4.7	0.4	2.7	15.9	28.3	4.3	1.2	10.0	12.0	1.2	3.3	3.6	2.7	12.3	3.8	1.9	9.9	5.7	12.7	19.4	9.2	21.3	6.6	1.9	3.7	1.0	2.0	2.7
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.5	31.3	4.1	18.8	5.3	6.2	14.0	13.6	6.0	13.7	10.6	23.0	8.0	26.7	15.8	8.0	6.8	24.7	17.0	20.4	6.4	13.3	45.9	12.8	19.3	20.4	8.6	15.0	11.7	9.0	11.7	20.1	10.0	3.7	9.1	15.4	20.9	12.3	5.8	16.9	17.5	5.9	18.8	6.1	16.4	22.7	6.9	17.7	3.2	15.7	8.7	16.7	13.9	9.7	9.2	2.7	9.3	6.1	11.7	11.9	10.7	11.1	38.8	11.1	7.5	10.9	11.3	17.6	15.3	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6	8.9	16.4	12.7	5.2	11.4	7.6	3.6	15.3	10.7	19.4	3.5	11.8	2.6	0.0	8.1	0.4	10.8	5.9	0.0	10.7	4.1	5.9	5.4	4.7	6.6	5.7	9.5	10.9	8.6	3.4	0.4	5.2	5.0	3.3	3.6	8.1	3.5	7.2	3.5	11.3	2.2	5.7	6.5	10.3	2.6	12.0	10.5	0.9	6.9	10.3	5.1
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"		2	219597860-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075"	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	5.7	8.4	10.1	11.9	10.7	15.2	6.4	15.0	9.5	5.8	8.2	6.7	6.7	8.1	9.2	14.3	8.2	9.1	9.5	6.2	7.0	6.5	7.2	5.6	7.4	11.4	5.1	7.5	17.0	9.9	7.0	21.2	12.1	7.0	8.2	7.2	6.2	5.8	6.3	5.1	16.3	7.9	7.5	5.9	10.6	6.4	27.7	6.4	26.5	8.9	7.1	9.6	5.9	6.3	1.7	14.8	5.0	6.1	3.4	2.7	2.1	7.0	11.0	11.8	8.0	4.2	7.5	12.1	6.3	5.5	10.2	8.7	10.1	12.0	4.1	6.4	6.0	9.3	17.5	5.6	13.4	7.6	6.0	8.5	10.6	11.2	8.1	5.5	11.0	28.1	7.2	12.0	8.6	4.3	10.5	6.2	7.0	7.9	6.2	5.7	13.8	6.4	13.7	11.8	3.3	6.1	12.2	4.3	3.2	10.2	11.1	7.8	12.3	4.0	10.0	8.2	9.9	6.4	10.8	4.7	11.1	9.5	10.6	6.0	6.9	3.0	7.3	8.4	6.1	6.9	1.5	3.9	5.0	2.7	5.7	2.4	1.7	1.3	2.2	7.6	1.5	1.1	1.1	1.3	3.4	6.1	14.8	2.1	2.1	10.1	10.7	15.0	9.5	7.0	6.5	5.1	7.5	7.0	6.4	6.0	7.0	0.5	1.9	2.1	7.8	3.2	2.5	10.7	6.8	7.0	17.7	8.6	1.7	4.8	11.5	3.7	8.4	0.0	5.6	4.7	4.1	2.4	12.7	3.0	7.6	11.1	12.6	5.5	8.4	24.5	23.6	6.0	3.3	1.8	8.5	6.0	3.5	3.5	13.8	2.2	11.7	12.9	4.0	17.2	11.5	2.4	13.5	4.1	5.6	2.5
STAT5B		ENSG00000173757	"Signal transducer and activator of transcription 5B"	P51692	17	42199168-42276707	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 85.5;Late spermatids: 113.5;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004298, CAB005418, HPA042128, HPA049883, HPA051156"	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"CAB004298: AB_2197067, CAB005418: AB_632445, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.06e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.68e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.98e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (9.19e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.13e-1)"	25.7	24.0	13.5	19.5	16.3	21.8	26.2	32.1	15.9	21.6	21.0	13.7	16.3	8.6	31.9	12.0	11.6	24.5	18.1	12.8	11.9	20.1	12.4	13.5	15.8	24.6	16.0	13.9	34.4	12.1	12.0	22.6	55.4	17.2	20.8	10.3	16.4	12.9	21.7	38.3	12.2	14.8	33.1	10.6	22.1	14.4	13.2	15.7	21.7	15.4	9.6	19.8	21.5	33.1	2.5	2.4	18.8	2.8	3.5	8.3	3.8	5.3	8.4	12.5	3.3	15.6	7.9	6.0	5.5	9.8	7.9	6.9	3.6	4.5	17.4	8.3	6.3	15.7	6.9	7.4	4.8	6.3	43.9	8.6	17.0	15.8	5.6	8.6	7.5	27.5	9.7	7.4	5.9	7.6	6.8	12.5	11.8	30.6	3.8	3.2	5.2	35.1	19.7	3.1	12.4	0.0	15.1	7.8	6.0	5.0	8.6	9.2	5.4	10.1	12.9	7.7	2.9	9.1	8.8	9.5	11.1	3.9	5.7	7.6	7.5	3.4	8.7	4.4	7.9	5.7	8.8	2.8	4.6	5.9	2.5	6.4	2.5	8.3	6.7	2.4	2.5	5.9	5.0	18.8	3.5	2.8	1.8	6.9	3.8	13.5	16.3	32.1	15.9	11.9	20.1	16.0	13.9	17.2	15.7	6.0	17.9	3.7	4.7	7.9	18.0	17.3	10.2	5.3	9.1	3.5	19.6	5.9	5.0	7.2	85.5	23.3	6.2	23.3	10.1	5.7	10.8	8.0	15.1	10.2	8.1	9.5	9.8	16.0	14.2	113.5	43.7	11.1	10.1	10.0	7.2	8.4	10.7	7.8	70.0	8.1	13.8	38.8	22.8	4.2	4.1	8.5	10.6	24.5	7.5	5.4
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.4;brain: 50.5;testis: 55.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 648.7;Late spermatids: 811.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.9;fHDF/TERT166: 36.9;MOLT-4: 28.7;SH-SY5Y: 24.3;WM-115: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	22.0	10.4	50.5	17.4	18.5	25.0	11.7	4.9	46.1	5.9	13.0	5.2	1.6	6.8	5.7	4.7	6.5	3.5	7.9	6.6	30.9	50.3	4.0	5.6	8.5	19.4	10.7	20.7	7.1	3.3	1.6	12.2	8.6	8.9	6.6	9.1	8.3	4.5	4.4	2.3	3.5	9.9	8.8	8.5	41.2	7.3	55.7	2.5	39.6	3.9	4.3	19.5	8.5	4.0	8.0	13.9	68.4	34.9	5.0	36.5	27.6	0.0	0.8	20.9	13.0	3.2	4.2	0.3	3.4	4.2	1.6	1.3	1.7	0.0	0.0	0.5	36.9	2.4	0.0	2.7	0.0	1.1	9.4	0.3	0.0	0.2	0.0	1.6	1.9	0.1	6.9	0.0	1.6	0.1	8.8	0.0	18.1	0.0	1.7	10.6	0.0	28.7	3.1	11.0	0.0	2.5	10.2	1.6	0.5	1.7	0.0	3.1	24.3	0.0	0.0	9.0	0.7	0.0	0.0	0.0	5.1	0.8	0.1	2.6	0.0	0.0	1.4	4.2	10.2	66.5	68.4	13.5	36.0	36.5	23.3	24.6	8.0	20.3	29.7	13.9	7.3	12.9	22.8	39.9	5.0	34.9	6.0	28.8	27.6	50.5	18.5	4.9	44.2	30.9	50.3	10.7	20.7	8.9	2.5	6.0	11.1	29.6	0.2	10.2	12.4	0.6	0.0	0.0	0.0	3.5	2.0	0.4	1.7	0.1	648.7	6.3	0.1	0.0	0.0	0.6	18.4	0.2	31.2	0.9	39.5	0.0	168.9	12.3	83.7	811.3	9.2	65.9	52.3	14.4	1.0	0.5	0.8	0.0	5.6	0.8	1.8	38.8	8.0	11.9	3.8	5.8	0.6	100.2	0.4	0.1
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 107.2;Hepatocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 55.9;U-266/84: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA	24800000	22000000				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	8.4	4.0	4.7	14.8	5.1	9.0	6.5	1.4	6.3	6.1	16.9	4.8	1.2	9.6	6.3	4.7	5.2	7.9	6.9	5.0	5.2	2.9	8.9	38.1	20.8	15.4	7.2	2.2	5.7	5.3	0.0	7.7	3.7	7.8	4.5	6.0	3.6	5.4	1.7	59.6	4.7	12.6	5.3	5.0	11.3	6.6	3.7	5.0	4.2	2.5	6.1	13.3	6.3	4.8	0.6	14.3	35.0	11.7	0.5	8.0	5.5	0.8	1.5	0.1	0.1	0.9	1.3	0.1	0.8	0.6	0.5	0.2	0.1	1.0	0.0	1.9	1.0	3.1	0.4	0.3	4.5	0.4	15.1	0.5	0.2	0.6	3.4	0.1	2.4	1.3	0.8	2.7	0.4	6.8	0.1	0.6	0.0	0.1	6.2	0.1	0.3	0.0	3.9	0.4	0.2	3.4	0.0	0.0	13.0	2.8	1.1	0.1	0.0	0.2	9.2	15.1	1.2	0.8	55.9	0.6	0.9	0.9	0.8	0.5	10.7	65.8	0.1	1.1	15.2	1.4	2.8	11.7	10.4	0.2	7.1	0.6	0.6	6.4	0.7	14.3	0.2	6.4	2.2	35.0	0.5	3.0	5.1	8.0	5.5	4.7	5.1	1.4	6.3	5.2	2.9	7.2	2.2	7.8	5.0	107.2	76.2	9.0	41.2	33.7	0.0	8.5	25.5	37.5	59.1	1.8	0.0	0.4	0.0	3.5	35.4	7.1	43.2	0.0	1.0	0.9	20.1	71.1	57.9	81.0	36.1	0.0	7.5	3.1	36.2	9.6	0.3	29.9	23.6	39.7	5.7	5.6	4.9	5.3	0.4	12.6	0.2	0.0	27.0	0.2	0.9	26.0	0.8	4.4	11.5	12.5
ZNF517		ENSG00000197363	"Zinc finger protein 517"	Q6ZMY9	8	144798876-144811169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.0"									HPA055337			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055337: AB_2682788"	"unprognostic (9.54e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.57e-2)"	2.9	6.5	5.3	3.1	4.5	1.5	8.5	7.3	8.6	3.3	3.0	2.7	5.3	3.6	5.6	3.1	3.2	4.1	3.2	5.8	6.8	3.2	3.9	3.2	4.6	6.5	5.6	6.1	7.5	3.8	4.5	3.9	4.4	4.2	3.7	0.5	5.4	6.9	1.9	9.6	10.5	4.5	1.4	4.1	4.3	3.6	3.6	4.4	3.0	4.1	1.4	1.4	4.1	2.8	4.1	1.1	0.5	2.4	1.4	2.2	1.2	2.1	3.9	6.6	6.4	1.0	2.0	3.4	1.9	0.5	0.4	0.3	1.3	2.3	1.2	4.6	0.6	2.8	2.1	0.3	0.7	0.9	4.6	1.7	2.7	2.1	14.0	2.5	0.6	2.8	1.4	1.7	0.3	1.3	3.7	1.5	3.4	3.1	1.8	1.1	3.4	2.7	1.6	4.6	4.2	4.4	3.9	2.0	0.9	0.6	2.6	2.9	8.4	5.3	2.1	2.0	3.4	5.4	2.4	1.8	4.4	6.9	2.3	1.9	3.0	0.5	0.8	4.8	1.1	3.6	0.4	1.2	0.0	1.8	2.4	1.5	4.1	1.7	1.2	1.1	0.7	1.4	1.2	0.5	1.4	1.4	0.5	2.2	1.2	5.3	4.5	7.3	8.6	6.8	3.2	5.6	6.1	4.2	4.4	0.0	0.3	0.0	5.0	0.5	3.6	2.8	5.1	0.0	1.2	0.0	7.9	0.6	1.7	0.8	1.2	1.1	1.0	0.0	0.4	0.5	0.8	1.2	0.0	1.7	1.3	3.2	1.2	3.1	1.6	0.0	0.9	1.3	0.0	0.0	1.0	2.3	0.7	0.0	1.1	2.2	3.7	0.0	1.4	3.0	2.6	1.0	0.3	1.0	0.8	4.4
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	12.0	13.1	15.7	6.4	18.6	13.5	10.0	22.9	20.6	12.9	11.4	10.1	9.4	8.4	15.3	11.5	10.5	15.5	10.2	17.3	12.2	12.7	8.8	9.3	10.6	11.4	10.6	13.1	21.5	13.5	7.9	13.5	15.3	11.9	9.7	7.1	10.3	10.3	13.5	16.8	15.2	8.5	11.8	10.4	10.0	8.7	13.7	13.4	11.2	11.1	7.4	11.2	10.6	10.7	11.5	11.3	16.9	4.3	9.2	13.7	7.2	5.6	13.8	4.5	5.6	9.7	7.4	6.4	6.4	8.1	12.1	13.8	4.9	1.9	4.4	6.7	9.1	8.1	2.0	4.2	6.4	4.2	12.4	6.1	5.1	5.9	5.7	23.6	3.8	6.8	6.4	11.9	10.3	19.8	7.1	8.5	11.6	5.1	5.0	7.7	13.5	4.9	4.5	1.3	11.7	6.6	2.3	3.5	3.3	8.1	3.4	4.4	4.7	6.9	11.2	5.6	4.2	5.0	6.4	7.1	5.8	3.4	6.6	8.7	7.8	8.3	3.5	6.9	5.5	4.7	7.9	4.3	13.8	11.2	4.1	10.4	10.9	12.7	13.2	4.9	11.5	13.7	12.4	16.9	9.2	4.3	11.3	13.1	7.2	15.7	18.6	22.9	20.6	12.2	12.7	10.6	13.1	11.9	13.4	0.0	0.6	3.2	0.6	3.4	1.7	0.1	2.5	0.0	0.0	3.5	2.0	4.0	3.3	1.0	4.7	0.6	3.2	0.0	1.0	2.5	2.5	0.6	4.6	0.9	1.6	1.6	1.2	0.0	3.4	3.1	3.7	2.1	5.0	1.8	0.5	0.8	2.0	1.7	3.2	2.7	2.2	6.5	2.2	6.5	1.9	4.6	9.6	2.5	1.3	0.1
C20orf194	DKFZp434N061	ENSG00000088854	"Chromosome 20 open reading frame 194"	Q5TEA3	20	3249305-3407625	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Cone photoreceptor cells: 190.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052103, HPA067418"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		No	No			"Nucleoli fibrillar center, Cytosol"		"HPA052103: AB_2681727, HPA067418: AB_2685835"	"unprognostic (9.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (9.58e-3)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.52e-2)"	15.2	13.4	18.5	6.9	20.1	4.6	11.9	20.3	21.9	12.6	11.8	25.3	7.3	5.8	12.5	9.7	11.7	12.8	11.3	19.4	16.3	17.2	14.2	3.7	13.3	5.7	16.5	20.3	17.2	7.5	8.5	10.4	12.2	17.4	12.2	6.4	10.9	6.0	16.5	36.8	7.5	6.0	17.2	23.0	9.5	9.1	13.5	16.9	4.6	13.2	4.0	4.3	12.2	11.0	1.6	3.5	1.0	3.0	0.0	1.7	0.7	2.9	2.7	7.4	3.6	15.5	17.2	0.8	7.0	7.8	4.6	5.9	0.0	3.2	0.0	1.9	9.2	5.9	3.5	2.8	6.8	6.4	0.6	1.4	0.8	1.0	7.3	7.3	0.9	0.4	13.9	5.3	6.1	5.3	6.6	9.2	2.6	1.4	0.0	6.7	1.3	1.8	4.8	2.2	1.6	1.8	2.1	6.8	0.0	6.0	6.1	1.5	4.4	3.1	5.5	9.0	6.7	5.2	8.4	10.2	5.8	2.6	3.6	3.3	0.0	0.0	0.0	1.8	0.8	4.4	1.0	3.0	0.0	1.7	1.5	1.0	1.0	1.3	1.7	3.1	1.6	0.5	1.3	0.0	0.0	1.4	3.5	1.4	0.7	18.5	20.1	20.3	21.9	16.3	17.2	16.5	20.3	17.4	16.9	26.8	8.6	2.2	6.0	6.2	33.0	22.9	7.6	17.4	9.1	12.2	190.5	1.3	1.7	6.4	22.4	15.5	0.3	0.0	4.0	4.9	11.6	4.8	13.9	2.1	16.8	28.6	0.0	26.4	28.8	5.8	18.4	17.8	8.5	7.2	0.0	11.7	8.0	2.6	12.7	5.7	14.2	12.9	14.7	18.2	20.0	5.0	1.5	4.5	0.0	4.3
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 108.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1393.1;Late spermatids: 1780.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.1;RPMI-8226: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	1.6	1.1	4.4	0.9	5.6	0.6	0.9	1.3	4.4	1.0	0.8	2.9	1.2	0.6	0.9	1.6	1.0	1.4	1.3	1.6	4.4	2.1	1.1	2.0	0.9	1.1	10.5	3.3	3.0	8.3	0.8	2.7	0.6	4.2	1.9	0.8	0.6	1.4	1.6	0.9	1.4	0.7	0.7	3.6	0.8	1.0	108.2	6.6	0.4	1.3	0.8	1.4	0.9	0.6	5.3	2.8	3.4	3.1	1.0	5.1	2.6	0.8	0.7	0.4	3.4	1.5	1.6	0.5	0.5	0.8	0.6	0.1	0.3	0.7	0.6	0.8	0.8	0.0	0.7	0.1	3.8	0.2	1.6	0.3	0.0	1.3	1.0	4.3	0.0	0.6	0.6	1.4	1.0	1.1	1.2	0.0	2.0	0.0	11.1	1.4	0.2	1.0	0.3	0.3	1.4	0.9	0.8	0.0	13.4	1.7	0.4	0.6	0.9	0.5	1.2	0.5	0.2	0.6	1.3	0.5	0.5	0.2	0.1	0.3	1.2	1.4	1.0	1.8	1.2	0.3	0.0	1.6	1.4	1.6	2.2	3.5	5.3	5.1	3.7	2.2	1.8	4.1	1.7	3.4	1.0	3.1	2.8	4.7	2.6	4.4	5.6	1.3	4.4	4.4	2.1	10.5	3.3	4.2	6.6	0.0	0.0	0.9	3.8	2.2	3.7	1.2	2.5	0.0	0.0	8.7	7.9	0.4	5.0	2.0	1393.1	0.6	1.6	0.0	5.1	3.3	0.9	6.1	0.0	8.9	0.8	0.0	7.5	0.6	2.1	1780.5	26.4	1.6	11.8	16.2	1.9	6.0	2.5	0.0	18.7	7.2	8.7	6.5	1.3	339.6	12.2	1.5	1.4	5.1	2.6	3.7
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561370-38688920	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.1"	"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 113.7;Ito cells: 372.0"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 68.6;MOLT-4: 45.1;SCLC-21H: 25.2;U-266/70: 16.7"									"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA					"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	15.2	28.7	39.6	3.5	83.0	0.8	7.3	83.8	131.1	12.4	18.5	11.5	2.3	7.9	11.6	9.2	7.9	10.5	5.8	17.1	34.5	30.7	15.8	12.0	16.2	8.8	19.4	37.7	5.2	4.4	4.1	11.4	6.6	23.8	5.6	17.3	8.1	3.3	7.4	17.9	4.9	7.8	14.5	11.9	21.3	4.6	1.7	9.5	0.0	11.8	5.4	8.2	8.2	4.2	0.9	0.5	0.3	0.2	0.3	2.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	10.9	2.0	0.0	0.0	8.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.2	0.1	45.1	0.0	2.3	0.0	0.0	2.2	0.9	0.0	1.1	0.2	25.2	2.6	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	16.7	4.7	0.0	1.0	0.1	0.3	0.2	0.1	0.0	0.6	0.2	0.7	0.4	1.1	2.9	0.1	0.9	2.1	1.8	0.3	0.3	0.0	0.5	0.0	0.1	39.6	83.0	83.8	86.3	34.5	30.7	19.4	37.7	23.8	9.5	11.9	18.4	0.5	2.3	9.4	87.2	35.4	2.5	1.4	4.5	10.4	41.2	0.3	19.9	0.4	0.0	113.7	34.6	0.0	0.5	0.4	6.8	2.4	9.3	2.9	33.9	92.2	18.0	372.0	20.5	1.1	0.6	1.5	13.5	0.0	25.1	94.7	1.4	17.3	2.8	8.3	66.4	58.2	4.4	0.6	3.2	5.6	0.7	4.3	31.0	0.9
DPY19L3		ENSG00000178904	"Dpy-19 like C-mannosyltransferase 3"	Q6ZPD9	19	32405543-32485895	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008325	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA008325: AB_1847853"	"unprognostic (9.58e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.55e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.27e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	8.4	10.9	20.7	8.1	23.0	11.5	10.1	11.2	18.5	12.8	6.2	15.2	9.9	4.2	10.7	9.3	6.1	8.9	9.7	6.4	17.9	14.1	8.6	7.4	7.6	7.1	15.3	11.0	19.3	11.3	15.0	13.3	11.7	14.5	16.1	6.7	9.8	10.2	8.7	3.6	4.9	5.9	7.6	15.7	10.8	9.8	12.3	10.2	6.8	15.3	4.5	6.9	8.3	7.5	2.9	2.2	9.0	2.7	1.3	2.2	0.8	3.0	5.8	22.0	9.7	22.6	11.7	11.0	9.4	6.7	3.9	7.0	6.8	3.4	11.9	6.0	6.7	2.8	1.6	8.9	4.1	7.4	6.0	5.8	15.9	5.9	6.2	14.9	8.2	9.2	12.1	2.3	4.8	4.6	7.5	9.2	5.7	11.4	3.8	10.1	5.1	2.1	4.1	9.2	5.8	2.3	5.8	8.8	3.5	7.4	7.5	4.9	13.2	4.6	4.5	5.0	12.8	3.4	9.7	10.1	8.0	5.7	4.8	9.9	5.9	12.0	8.0	11.2	10.0	12.8	6.0	2.5	7.4	1.8	1.9	1.0	2.0	1.7	1.7	2.2	2.9	1.4	1.6	9.0	1.3	2.7	1.6	2.2	0.8	20.7	23.0	11.2	15.0	17.9	14.1	15.3	11.0	14.5	10.2	6.0	10.0	3.2	3.5	1.8	11.0	3.1	0.0	6.7	5.7	14.0	9.8	5.5	1.7	1.9	1.7	6.5	3.9	0.0	3.5	4.5	7.7	14.9	1.1	4.9	4.7	74.7	3.5	26.4	14.8	2.2	10.0	2.1	1.7	0.0	8.7	25.9	3.2	4.3	11.0	3.3	12.0	0.0	3.1	10.4	21.2	2.6	12.5	2.1	3.6	3.1
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340587-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	11.0	18.6	14.8	10.1	14.9	12.4	10.7	8.1	12.5	13.9	23.3	14.8	25.3	23.6	8.2	16.0	6.3	10.0	16.7	20.6	18.2	15.4	29.9	29.7	9.4	11.4	17.8	7.3	13.2	26.6	15.1	17.1	7.5	12.5	13.4	17.2	13.7	22.8	23.6	25.2	3.6	33.6	12.1	25.5	16.2	15.4	4.2	15.6	8.6	11.5	7.4	7.0	12.8	10.0	3.9	3.3	17.6	6.1	4.3	4.9	3.6	4.7	7.5	6.3	6.3	8.0	6.3	7.7	5.7	8.9	3.9	5.9	5.3	10.2	7.3	9.6	9.3	7.0	1.3	2.4	1.3	2.2	8.6	2.7	8.0	7.5	14.9	11.3	4.7	33.4	6.3	2.8	3.0	0.5	14.2	5.8	12.7	14.6	11.1	3.2	7.6	4.7	3.8	6.4	3.2	2.3	0.0	2.3	6.5	4.2	7.5	2.2	3.5	1.1	0.6	10.1	4.3	2.9	9.5	8.9	4.5	3.1	5.9	2.4	13.8	6.5	4.4	12.1	13.2	4.1	17.6	5.4	7.1	4.9	5.4	2.8	2.0	3.4	4.4	3.3	3.9	4.3	4.0	3.1	4.3	6.1	2.2	3.8	3.6	14.8	14.9	8.1	12.5	18.2	15.4	17.8	7.3	12.5	15.6	8.9	16.7	9.0	10.8	2.1	3.9	17.8	30.6	1.4	6.8	29.6	9.8	15.9	6.6	18.9	0.5	8.0	61.2	0.0	38.9	18.4	7.3	12.7	33.6	67.2	20.3	4.8	37.4	13.5	24.6	0.7	7.2	19.7	15.1	2.8	20.9	6.6	35.6	28.8	19.1	73.1	6.0	6.5	8.0	2.1	4.1	1.0	15.7	15.8	28.1	13.3
GTPBP6	"FLJ20977, PGPL"	ENSG00000178605	"GTP binding protein 6 (putative)"		X	304529-318819	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013336, CAB034924, HPA035467, HPA055418"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: "	"unprognostic (5.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.38e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	6.3	4.9	22.2	5.6	40.5	8.1	33.6	30.5	29.9	18.9	5.2	0.6	0.6	7.0	17.0	0.6	4.7	6.3	3.1	19.7	22.7	5.9	21.1	4.0	4.1	6.0	39.5	15.0	18.2	11.9	2.1	16.6	16.6	26.4	4.1	1.6	0.6	11.2	4.7	22.8	5.7	7.6	1.9	25.5	6.4	7.5	2.4	34.2	0.6	4.1	0.6	1.9	3.7	25.4	7.3	11.1	8.1	6.3	5.3	9.2	3.8	15.2	25.3	5.6	11.7	6.5	7.1	20.9	9.5	7.1	12.1	11.1	38.7	12.8	19.2	13.6	5.3	16.4	9.5	5.9	9.2	2.0	15.9	17.2	15.8	12.4	26.4	17.6	10.6	15.5	8.8	12.3	8.0	5.9	4.5	9.7	12.8	11.6	9.0	4.9	30.2	18.8	14.0	13.7	3.1	18.1	8.4	9.9	30.6	7.0	17.9	15.8	13.5	10.4	11.8	17.5	3.2	10.6	9.3	12.8	17.7	12.3	26.1	14.6	12.3	11.0	29.6	9.2	14.0	8.1	8.1	6.3	6.7	7.8	6.3	7.6	7.3	6.9	8.7	6.1	6.0	8.5	7.7	0.9	5.3	5.8	11.1	9.2	3.8	22.2	40.5	30.5	29.9	22.7	5.9	39.5	15.0	26.4	34.2	17.9	16.3	23.9	39.0	25.0	27.0	16.8	28.1	5.3	10.3	26.2	25.5	20.5	44.7	10.7	0.9	23.7	23.1	0.0	12.8	38.8	22.6	37.4	11.5	32.1	26.3	12.7	17.1	14.1	12.6	1.4	18.1	23.2	25.3	11.8	23.0	15.2	11.3	8.6	17.7	74.7	25.1	6.5	31.3	5.1	12.1	23.2	24.6	27.7	32.2	44.8
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064372	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 80.4;Leydig cells: 131.2;Peritubular cells: 107.1;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.2;ASC TERT1: 28.1;HHSteC: 21.7;HSkMC: 30.8;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes					"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	69.5	26.5	13.2	12.8	17.4	0.8	43.9	8.1	14.7	37.4	22.1	17.5	22.0	9.7	35.3	23.6	20.1	30.4	32.9	34.2	13.3	9.8	21.1	18.7	25.8	16.5	15.8	10.5	48.6	18.0	14.8	13.0	22.0	14.6	23.7	8.4	33.7	21.4	29.6	38.7	11.2	14.8	25.0	13.4	27.9	16.7	16.6	16.0	0.6	23.2	26.5	7.2	24.1	47.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.7	7.2	0.9	0.7	41.2	28.1	0.2	4.0	9.5	2.1	1.1	0.5	1.9	0.0	8.9	11.0	0.9	0.5	0.0	2.6	0.8	0.1	0.2	0.1	7.8	3.8	21.7	0.1	0.1	30.8	0.1	2.8	1.6	21.9	12.6	0.1	0.2	0.1	8.7	1.7	0.0	0.0	0.6	0.5	2.0	0.2	2.3	0.1	2.9	0.1	0.4	0.9	1.5	0.8	3.1	0.6	9.1	0.2	17.9	4.5	5.4	1.6	0.7	0.2	0.0	0.0	7.2	0.1	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	17.4	8.1	14.7	13.3	9.8	15.8	10.5	14.6	16.0	3.0	18.8	0.0	7.4	0.0	19.6	7.3	7.6	2.7	4.5	5.2	0.0	0.4	3.3	3.6	1.9	56.1	0.0	0.0	3.7	0.3	14.3	3.4	0.0	28.2	1.9	28.6	1.2	80.4	7.1	2.9	131.2	1.3	0.0	0.0	4.2	37.3	2.5	4.2	107.1	2.2	12.0	148.8	8.8	2.3	3.6	0.0	0.7	0.0	2.4	2.2
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	7.0	14.0	12.0	9.1	16.0	8.3	13.7	7.0	10.5	11.0	8.1	9.4	7.5	0.9	12.3	12.3	8.4	7.7	8.1	7.3	6.1	10.1	5.0	3.5	8.3	6.1	9.3	7.1	12.5	12.7	8.0	10.1	7.9	8.3	7.9	3.1	5.7	0.6	7.3	9.2	1.8	3.9	14.9	11.2	8.6	0.2	5.9	3.9	5.4	11.6	2.3	13.7	15.1	12.2	12.8	10.9	10.9	16.2	11.8	11.3	7.2	9.9	7.2	10.1	6.2	0.7	7.2	0.9	37.4	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9	3.0	3.4	0.8	2.3	1.0	47.5	11.8	0.0	1.4	2.3	1.8	88.4	1.5	1.7	1.0	5.3	3.5	14.6	0.0	1.4	0.5	3.0	3.2	9.2	4.9	3.6	20.6	5.2	2.5	7.5	6.7	4.4	4.0	1.7	0.0	4.0	12.3	1.1	5.1	4.2	0.8	54.7	0.0	4.1	3.0	4.8	1.8	1.3	0.0	3.9	2.2
TMEM220		ENSG00000187824	"Transmembrane protein 220"	Q6QAJ8	17	10699015-10730316	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 58.2"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 146.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047680			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047680: "	"unprognostic (1.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.84e-4)"	"prognostic favorable (2.23e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.97e-2)"	6.5	7.4	4.5	2.4	4.6	3.3	7.8	1.3	2.8	4.7	6.1	3.8	14.3	8.1	4.9	11.1	3.3	3.9	10.1	6.3	3.8	2.4	6.4	58.2	4.6	3.1	2.9	1.2	4.8	6.0	2.4	2.4	1.7	4.9	12.0	2.8	6.6	3.5	18.5	4.1	3.7	15.4	5.4	2.5	4.7	7.1	17.2	3.5	0.6	9.4	2.6	2.4	4.1	3.4	11.6	2.9	2.3	2.5	4.5	9.0	1.9	0.5	3.5	1.3	8.3	5.2	5.2	1.0	6.9	7.3	4.7	6.8	0.0	0.3	1.2	0.5	4.3	0.4	0.4	3.4	0.6	3.5	0.4	1.5	0.5	0.2	2.9	7.6	0.9	0.8	3.4	0.4	1.5	0.3	1.0	2.2	3.0	0.4	0.3	3.0	0.4	1.1	1.5	5.0	0.4	0.0	4.8	0.2	0.6	11.1	0.2	0.5	6.0	0.3	0.1	0.7	1.9	0.4	1.8	4.8	0.4	1.3	2.6	0.4	0.8	0.3	0.3	4.9	1.4	0.6	1.4	2.5	2.3	0.9	1.8	1.1	4.2	2.2	1.3	2.9	11.6	9.0	6.1	2.1	4.5	0.8	2.3	0.4	1.9	4.5	4.6	1.3	2.8	3.8	2.4	2.9	1.2	4.9	3.5	3.0	8.3	5.6	13.2	8.5	1.5	8.8	56.0	8.1	11.4	17.4	7.9	10.1	18.3	13.7	72.2	7.9	60.8	23.3	20.8	20.6	12.0	37.1	39.3	146.5	20.4	0.0	2.9	10.4	11.8	12.5	16.7	5.4	23.6	6.4	15.2	44.1	14.9	28.8	9.2	20.3	22.1	19.4	9.6	52.0	7.5	6.9	3.8	2.5	10.0	21.1
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	26	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA					"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	6.0	24.2	32.9	4.0	63.4	1.6	7.0	40.7	112.4	12.1	5.6	27.4	2.4	4.5	8.0	10.1	4.7	10.2	7.6	9.1	35.6	69.4	8.6	2.0	5.0	3.8	28.5	27.3	11.0	14.5	13.3	39.4	5.3	33.1	21.9	3.5	13.2	20.5	24.4	2.1	6.6	6.6	7.7	21.8	3.6	6.1	6.6	22.1	0.0	10.8	0.1	2.6	4.2	4.8	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.0	1.2	13.0	20.8	17.3	9.1	2.0	4.5	8.9	1.7	1.3	0.1	1.2	0.0	1.7	8.4	4.0	0.2	0.6	0.5	0.1	0.0	0.7	2.9	0.0	0.1	9.3	0.0	2.9	11.8	0.8	2.0	0.0	7.5	0.5	5.6	0.0	0.1	2.7	1.9	0.1	0.1	7.1	0.0	0.0	0.0	0.5	0.1	0.0	1.2	12.3	24.2	3.7	0.0	0.0	2.8	2.4	0.4	0.0	1.9	5.6	10.4	0.0	0.0	2.0	0.0	1.2	0.0	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.1	3.6	1.8	0.0	0.0	0.0	0.0	0.0	0.2	32.9	63.4	40.7	64.3	35.6	69.4	28.5	27.3	33.1	22.1	0.0	2.4	0.0	18.6	11.2	49.9	9.0	5.1	5.3	9.1	19.2	41.2	1.8	1.7	0.6	0.3	6.8	0.0	0.0	1.2	4.1	14.9	27.1	4.6	0.8	0.8	190.7	20.0	17.8	0.8	1.3	19.5	2.2	6.8	1.0	0.0	81.5	2.4	0.0	40.3	13.5	64.5	0.0	20.0	0.9	2.1	9.5	4.0	0.0	0.0	4.6
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203495-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12.0	3.1	2.2	2.1	2.5	2.5	2.0	2.7	3.2	2.3	44.9	2.0	3.3	2.3	5.1	3.0	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4.0	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2.0	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11.0	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6.0	3.8	0.9	3.0	2.3	2.2	3.2	5.7	4.1	5.7	3.0	2.1	2.2	3.7	3.8	7.7	2.3	4.0	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6.0	3.0	5.6	6.0	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0.0	1.7	0.5	0.2	0.2	1.0	1.0	0.0	9.4	2.3	0.0	2.0	1.3	3.3	0.9	0.4	1.0	1.6	0.0	0.6	0.4	0.8	0.4	0.0	46.0	1.6	0.0	5.2	1.3	1.3	0.0	0.3	1.2	0.0	1.0	1.3	1.6	0.7	0.0	1.1	1.2	2.5	0.0	0.8	0.9	2.5	0.0	1.1	0.5	1.1	0.1
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397832	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 47.6;fallopian tube: 76.2;testis: 23.7"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.5	1.2	12.7	1.0	20.0	0.8	1.0	1.5	10.8	3.3	1.6	12.2	0.0	2.1	1.3	7.2	1.1	76.2	1.0	4.8	11.2	11.0	1.9	1.0	10.3	0.9	5.3	6.4	6.2	1.5	0.8	3.1	0.9	47.6	1.5	1.3	0.0	2.0	1.1	1.6	1.2	4.3	1.2	2.0	0.9	1.4	23.7	3.0	0.0	1.2	0.1	1.0	0.9	0.0	0.6	0.4	0.1	0.1	0.9	3.6	0.5	0.8	0.0	1.6	0.6	0.3	0.0	1.3	0.6	0.6	0.3	1.4	1.4	0.0	0.3	0.6	0.0	0.7	1.2	0.5	0.2	0.0	2.3	1.3	0.0	1.6	4.1	0.0	0.1	2.0	0.3	0.2	0.4	0.0	0.5	0.6	1.0	0.0	0.6	0.2	0.0	1.3	0.9	0.6	1.2	0.9	0.6	0.1	0.1	0.5	0.1	1.6	0.6	0.0	0.4	0.1	0.1	1.1	0.0	0.0	1.3	1.0	0.5	0.9	2.5	1.4	0.4	1.4	0.2	2.5	0.0	0.0	0.0	1.1	0.1	0.0	0.6	1.3	0.4	0.4	0.0	3.6	1.1	0.1	0.9	0.0	0.0	1.7	0.5	12.7	20.0	1.5	10.8	11.2	11.0	5.3	6.4	47.6	3.0	6.0	13.7	0.0	2.6	1.9	1.0	34.3	2.5	1197.9	128.5	7.0	0.0	0.5	61.3	0.5	656.4	1.0	15.5	0.0	1.3	0.2	0.5	2.8	8.1	2.9	0.4	0.0	11.6	1.8	0.3	2140.7	9.8	2.5	0.0	0.0	9.8	1.2	0.3	6.2	6.7	5.7	0.8	32.3	0.3	10.8	3.8	0.9	0.5	0.0	16.4	1.7
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 123.1;Sertoli cells: 161.7;Smooth muscle cells: 105.1"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		770000	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.0	1.0	1.9	3.2	18.2	3.6	0.2	1.3	2.3	3.1	3.2	2.1	1.7	0.6	1.9	0.8	0.2	0.2	1.3	0.0	2.7	0.0	1.0	0.2	0.6	0.8	0.1	0.0	0.7	5.1	0.0	17.2	0.1	85.4	0.0	0.5	0.2	0.4	10.4	1.3	0.0	0.7	5.6	0.4	0.1	0.0	7.5	0.1	0.0	0.0	0.2	0.7	0.1	0.0	12.6	1.1	0.2	3.5	0.0	0.3	3.4	0.2	2.1	0.8	0.5	0.2	15.6	2.1	0.1	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3	0.0	0.0	0.0	0.5	1.6	1.0	123.1	5.1	0.0	0.0	1.8	3.9	0.0	0.0	0.2	0.1	5.1	1.1	0.0	0.0	0.1	1.1	0.6	0.0	0.9	0.5	0.0	7.5	1.3	1.8	0.0	6.1	1.2	3.3	0.0	1.1	4.4	0.4	0.0	6.0	0.6	0.2	161.7	105.1	3.7	2.2	1.9	0.1	0.0	0.8	0.3
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.0	11.6	19.0	16.7	18.5	22.8	18.9	21.8	17.8	17.3	12.3	16.4	14.3	15.5	20.4	14.9	16.7	16.9	19.5	15.5	16.2	9.1	15.8	9.7	13.1	19.8	18.2	13.0	30.4	19.1	13.0	16.9	12.4	15.5	17.5	6.3	17.2	22.7	17.8	13.6	21.3	14.2	12.1	12.0	25.1	14.9	13.0	17.0	12.7	15.2	10.3	15.6	14.3	16.3	3.1	4.0	1.0	3.4	3.5	4.7	2.2	5.9	6.6	3.7	13.2	3.3	3.4	19.2	7.2	2.9	5.9	2.1	7.1	4.6	6.7	9.7	2.7	3.4	11.8	2.3	2.9	1.4	5.8	9.9	3.8	9.9	4.9	2.4	4.0	12.2	5.2	3.8	5.0	1.9	2.4	11.6	11.0	9.2	2.3	3.0	13.2	6.3	13.4	15.2	2.2	6.8	16.0	3.2	5.3	2.5	5.3	19.2	9.3	14.6	4.1	24.2	2.6	16.2	4.2	4.5	11.0	9.4	10.8	6.5	11.1	8.5	13.9	5.6	4.9	7.0	0.0	3.2	1.0	4.1	3.4	4.7	2.3	1.6	2.6	4.0	3.1	1.9	3.4	0.2	3.5	1.4	1.5	2.3	2.2	19.0	18.5	21.8	17.8	16.2	9.1	18.2	13.0	15.5	17.0	17.9	18.6	9.0	6.3	5.8	9.1	2.5	2.5	5.3	7.9	3.5	19.6	7.5	5.0	4.4	0.4	13.9	7.4	0.0	6.1	5.3	6.5	3.3	5.8	10.9	5.8	1.6	6.9	29.4	11.3	1.8	10.9	5.4	6.8	5.4	7.5	9.4	4.5	3.5	8.5	3.8	9.7	6.5	4.4	8.8	10.9	4.5	6.2	6.4	7.6	2.6
ZBTB49	"FLJ38559, ZNF509"	ENSG00000168826	"Zinc finger and BTB domain containing 49"	Q6ZSB9	4	4290251-4321786	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024450	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			Nucleoplasm	"Microtubules, Cytosol"	"HPA024450: AB_1859311"	"unprognostic (4.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.88e-5)"	7.3	5.4	5.0	6.0	9.0	11.8	6.8	9.2	8.7	7.2	6.2	9.9	3.4	4.5	9.5	7.0	5.6	6.3	5.3	6.2	6.1	5.1	4.7	5.9	6.5	7.5	6.8	5.3	10.6	7.7	6.0	13.3	5.6	8.9	7.9	4.4	7.1	10.0	6.5	10.1	4.8	6.3	6.5	6.1	9.2	6.0	10.3	6.7	6.7	8.1	5.0	8.5	7.8	5.8	2.9	1.9	12.1	2.7	3.2	6.4	1.8	2.0	3.4	4.3	7.2	5.8	6.1	5.1	2.6	5.1	5.7	4.4	3.0	4.0	7.4	2.7	2.8	7.0	3.6	7.5	4.3	5.9	2.4	2.9	8.6	2.3	4.2	4.9	5.2	3.2	3.9	3.6	5.2	3.4	3.2	5.7	8.0	4.4	4.0	5.3	3.4	10.2	10.2	7.3	3.0	4.6	6.1	5.6	4.6	2.2	3.7	5.2	5.0	5.7	2.2	5.7	6.0	3.1	5.1	5.5	5.1	2.3	3.4	5.5	4.9	4.8	6.3	3.7	4.4	5.0	3.7	2.6	12.1	6.4	2.7	5.0	2.2	3.6	6.0	1.9	2.9	4.1	4.7	6.2	3.2	2.2	0.4	3.2	1.8	5.0	9.0	9.2	8.7	6.1	5.1	6.8	5.3	8.9	6.7	0.0	1.4	2.7	1.6	2.3	2.4	1.6	0.0	1.4	2.3	1.8	3.9	1.6	0.0	1.8	1.5	2.2	0.9	0.0	2.2	1.2	2.0	1.5	1.1	1.5	1.6	1.6	1.2	3.7	2.6	0.0	1.4	2.1	3.3	3.6	1.7	1.7	1.0	2.9	2.1	0.8	7.8	0.0	1.1	9.5	5.3	2.3	1.3	2.9	1.3	1.0
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	11.3	13.8	7.3	7.6	11.4	10.2	7.8	17.2	15.7	7.3	8.5	10.4	5.6	8.8	10.1	7.8	9.3	9.3	10.1	9.8	7.5	7.7	12.8	11.3	6.9	9.5	6.9	8.5	12.6	14.1	10.0	11.4	12.2	6.3	10.3	7.7	14.1	10.4	8.1	27.3	12.3	10.6	9.1	8.1	12.2	8.7	9.0	9.5	16.1	11.5	9.8	13.3	9.6	7.0	5.4	4.4	6.9	3.7	1.2	5.3	1.4	6.4	8.1	6.1	7.4	11.1	6.5	6.2	4.4	5.8	10.2	9.4	18.5	7.6	7.7	13.4	6.4	10.7	15.6	9.9	12.6	7.6	2.9	5.9	10.1	10.1	12.6	6.8	8.1	10.4	9.3	10.6	8.4	8.1	7.4	7.9	6.9	8.9	6.2	5.8	19.6	9.1	6.7	3.3	7.3	9.1	7.0	8.9	5.4	6.5	9.6	8.1	5.2	15.4	22.7	5.2	5.7	13.5	6.1	6.4	11.1	7.0	5.9	6.5	6.2	4.4	7.9	8.8	6.4	5.6	3.8	2.9	6.9	1.0	3.7	0.7	5.4	3.7	1.6	1.6	5.1	5.3	4.7	3.1	1.2	3.5	4.4	3.0	1.4	7.3	11.4	17.2	15.7	7.5	7.7	6.9	8.5	6.3	9.5	3.0	2.4	0.5	1.7	1.0	2.4	4.8	0.0	0.0	1.2	0.0	0.0	2.5	3.3	1.8	0.2	1.3	2.6	0.0	3.3	2.3	1.4	1.9	3.5	1.7	1.5	6.4	2.4	2.5	1.6	0.4	3.1	1.2	0.0	1.0	2.6	1.4	2.8	3.2	1.4	1.2	3.2	0.0	1.7	0.6	1.7	1.4	1.9	1.7	2.3	1.6
ZSWIM7	SWS1	ENSG00000214941	"Zinc finger SWIM-type containing 7"	Q19AV6	17	15976560-15999717	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054681	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA054681: AB_2682572"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (1.70e-1)"	10.0	16.2	14.3	11.5	21.7	7.0	21.5	9.8	28.7	9.4	10.3	9.8	13.8	13.2	11.5	14.2	11.6	11.2	8.8	18.7	17.4	13.8	15.2	14.4	13.6	13.8	16.9	12.2	14.3	13.9	8.6	15.5	10.2	16.5	9.6	9.1	9.9	14.0	13.1	49.2	13.8	9.3	11.2	22.1	12.2	10.5	10.8	12.1	6.2	12.1	8.4	7.3	11.4	11.2	17.2	26.0	15.2	17.2	10.0	12.6	12.2	10.1	14.9	8.1	18.6	3.3	3.1	9.4	6.9	2.6	7.3	5.4	2.8	3.0	4.9	6.1	7.5	2.2	3.3	2.5	5.5	3.5	5.0	9.1	5.5	6.9	5.7	7.7	4.4	9.3	7.5	9.9	4.0	6.9	1.1	9.3	12.8	3.5	2.7	3.7	13.8	15.2	10.5	4.9	14.9	8.9	9.7	19.8	7.6	6.6	5.6	2.7	11.8	10.6	10.7	6.9	21.8	7.7	1.1	13.1	11.9	4.1	3.1	5.9	1.3	3.6	5.6	10.2	5.6	10.1	15.2	17.2	7.0	8.9	16.1	9.3	17.2	10.4	8.5	26.0	14.3	12.6	12.0	1.0	10.0	11.3	16.1	7.5	12.2	14.3	21.7	9.8	28.7	17.4	13.8	16.9	12.2	16.5	12.1	32.8	55.7	24.4	28.2	22.8	38.5	59.6	68.8	41.5	26.1	38.4	58.9	74.3	72.9	53.3	8.3	29.2	35.8	0.0	45.1	51.4	24.4	30.3	54.3	39.8	44.0	17.5	48.8	32.5	52.9	9.8	42.0	43.4	52.3	18.0	36.4	46.9	43.1	35.1	37.4	102.1	54.4	25.8	26.9	89.2	59.4	24.1	60.9	27.9	31.8	20.3
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 1885.6;Leydig cells: 4659.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Group enriched"	"Detected in some"	5	"ASC diff: 40.8;THP-1: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	732000000	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	40.8	6.4	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.6	0.2	0.0	0.0	1.1	2.9	0.0	1.8	0.6	0.6	0.3	1.0	6.4	0.0	0.0	0.0	0.1	0.0	0.7	2.3	0.1	0.0	0.9	0.0	9.2	0.1	0.7	2.9	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	1.2	57.8	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.4	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.9	35.0	13.4	57.2	697.8	3.1	53.7	12.7	21.4	23.9	17.4	2.0	31.1	10.0	6.7	18.8	25.9	9.3	0.0	0.0	35.1	1885.6	17.4	16.2	1.3	255.2	1.6	4.1	49.7	345.8	28.7	4659.7	242.8	609.0	5.4	7.5	1.2	1.9	32.5	266.2	2.5	6.3	0.0	277.1	11.8	20.4	643.3	28.7	9.2	18.5	172.1
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.9	9.1	6.5	4.8	4.4	4.2	3.5	5.2	7.0	10.2	10.2	3.6	4.2	4.7	18.2	7.0	12.5	3.9	9.4	3.9	10.1	6.0	11.9	1.5	8.4	8.5	6.2	5.9	2.8	3.9	4.7	12.8	3.9	6.0	5.6	6.6	4.1	6.7	16.1	10.6	6.2	8.3	5.5	7.5	15.0	5.3	8.5	9.4	5.9	3.0	8.2	7.3	5.5	5.6	8.8	4.5	3.6	3.3	3.7	5.5	3.6	12.5	10.5	6.3	16.1	4.1	10.0	7.3	4.9	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2	6.0	2.1	8.3	6.8	8.9	8.8	3.2	7.6	26.8	1.2	3.5	2.0	8.0	14.9	9.4	9.0	4.4	3.8	0.0	7.9	7.3	6.0	4.1	3.5	3.8	4.6	6.4	8.6	4.9	3.3	5.1	4.6	5.1	8.5	2.8	4.0	8.5	7.5	4.5	7.8	8.3	12.7	6.5	6.2	21.6	39.2	7.3	4.5	7.0	5.2	4.7
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	9.4	10.3	11.9	15.0	11.9	9.5	26.5	14.3	22.3	10.4	10.5	15.1	5.0	11.0	13.7	8.9	11.5	10.6	11.3	9.7	12.4	8.2	9.4	8.9	10.0	12.2	15.3	16.0	11.2	17.5	16.9	13.5	8.4	12.7	15.6	7.9	9.4	16.8	12.9	9.8	17.6	10.6	12.7	9.2	11.9	11.0	9.6	12.1	9.7	13.8	6.2	9.8	11.9	9.4	10.6	9.8	4.7	8.6	13.1	10.3	8.7	9.6	19.9	5.4	8.7	5.8	4.7	7.7	8.7	3.8	7.0	6.0	8.8	11.8	7.9	9.2	6.4	4.3	10.6	8.4	8.6	3.2	10.5	19.4	11.7	21.2	3.6	5.4	5.0	9.7	5.7	7.4	7.0	3.5	5.8	6.0	9.1	15.4	9.5	6.8	11.9	18.3	6.5	4.4	8.5	28.8	15.7	4.5	11.1	4.2	8.5	14.7	8.2	13.3	10.7	6.2	3.3	16.4	5.5	6.4	12.0	21.3	10.6	12.7	5.3	3.1	9.8	11.3	11.6	7.3	1.9	8.6	1.8	10.3	8.1	10.2	9.0	7.7	9.6	8.4	10.6	8.6	7.0	4.7	13.1	6.7	9.8	7.2	8.7	11.9	11.9	14.3	22.3	12.4	8.2	15.3	16.0	12.7	12.1	6.0	1.9	12.4	4.6	5.7	11.7	3.5	12.7	5.3	5.7	8.7	2.0	5.7	5.0	4.8	1.1	4.5	7.9	0.0	7.0	5.8	3.9	6.7	6.9	9.0	6.6	11.1	5.2	10.4	5.2	2.4	6.9	3.7	1.7	7.2	6.6	8.9	5.7	3.5	7.4	6.0	7.6	6.5	5.2	27.9	24.3	5.1	4.6	6.9	11.4	3.5
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 140.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	27.1	23.1	21.4	22.4	21.0	24.2	38.8	21.8	26.6	25.3	24.8	26.6	16.7	20.8	31.2	22.8	26.6	27.3	18.8	29.0	21.5	12.9	23.8	20.6	26.5	39.4	24.7	17.1	31.1	27.9	30.7	26.1	30.4	20.5	25.2	27.9	20.4	23.0	23.8	140.1	35.5	30.9	26.7	25.6	38.3	24.3	26.6	24.3	43.8	26.0	31.5	34.1	22.4	26.7	13.0	17.3	18.3	11.8	7.2	11.2	3.8	38.9	58.3	32.8	35.2	51.4	63.3	24.9	29.2	48.9	47.1	40.6	27.8	27.3	36.1	31.1	52.1	32.9	32.7	43.0	45.0	52.7	53.6	36.5	25.2	39.2	47.9	47.7	28.6	47.7	51.0	54.8	53.9	57.6	48.5	50.1	35.8	22.5	26.8	44.2	24.6	31.9	30.7	22.8	34.9	24.8	38.9	29.2	28.8	37.4	20.5	12.6	36.2	23.2	23.3	31.1	33.9	22.0	23.6	28.5	34.4	29.6	27.4	54.8	23.2	20.2	18.5	44.2	39.6	35.5	6.3	11.8	18.3	10.5	11.7	8.5	13.0	10.1	11.0	8.4	12.4	7.8	11.2	15.6	7.2	7.7	17.3	9.6	3.8	21.4	21.0	21.8	26.6	21.5	12.9	24.7	17.1	20.5	24.3	23.8	21.0	48.6	41.4	41.9	42.6	10.8	30.6	9.4	25.0	38.4	21.6	54.3	10.0	54.2	3.7	44.4	63.2	0.0	73.6	98.0	42.3	51.3	19.7	33.8	80.8	28.6	70.8	40.5	83.4	5.0	53.5	53.1	27.0	36.9	73.9	45.9	67.9	46.0	44.2	29.3	28.2	25.8	33.0	14.6	35.6	58.6	69.6	36.2	58.8	56.2
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 35.4;U-266/84: 24.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	9.9	5.7	7.6	15.5	9.4	42.9	9.6	12.4	5.7	17.4	15.8	5.6	12.2	7.2	21.2	9.6	11.3	12.4	13.3	12.5	5.6	3.7	8.3	10.0	9.0	14.2	2.8	5.4	16.0	17.6	8.6	11.9	4.4	10.8	16.4	6.0	24.3	11.9	21.3	4.0	13.6	13.7	20.7	2.1	26.7	10.3	18.4	3.6	30.0	14.2	6.5	24.1	21.8	8.5	13.9	2.1	24.3	0.9	6.7	5.5	1.8	3.0	0.7	4.9	0.0	2.2	0.4	8.8	1.0	1.7	1.8	3.1	21.7	5.0	14.3	5.4	0.6	8.3	1.7	3.8	3.6	1.4	1.0	6.2	15.8	0.0	6.9	2.4	2.4	12.6	2.1	3.0	3.1	1.7	1.9	3.3	12.4	19.2	12.2	1.7	8.1	15.2	12.7	7.3	4.1	2.4	4.8	4.1	7.5	2.8	2.7	4.9	3.2	1.0	0.4	3.5	5.0	7.2	9.1	0.3	1.8	1.5	1.9	0.8	35.4	24.3	9.5	1.6	3.5	1.5	24.3	0.9	4.9	5.0	0.6	5.5	13.9	3.3	4.2	0.7	9.3	2.7	3.7	1.9	6.7	0.1	2.1	3.2	1.8	7.6	9.4	12.4	5.7	5.6	3.7	2.8	5.4	10.8	3.6	6.0	5.7	11.0	1.2	8.0	12.6	16.1	2.5	1.4	5.7	7.0	13.7	0.9	5.0	1.3	2.3	6.5	0.9	93.5	3.1	1.6	6.1	2.6	2.3	5.0	1.1	4.8	10.3	6.7	3.2	4.5	13.3	3.4	6.8	11.8	4.4	3.9	3.2	0.0	14.5	2.8	3.1	0.0	7.2	17.2	12.4	12.3	0.7	13.1	2.6	0.9
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439823	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus, Focal adhesion sites"	Nucleoplasm	"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	14.3	11.2	14.9	15.3	10.4	8.9	19.2	19.9	19.1	10.5	10.7	11.5	11.1	10.3	13.1	10.1	8.4	17.2	9.4	11.9	12.6	12.0	10.2	9.0	10.1	13.5	8.4	12.3	14.7	11.6	11.4	12.3	9.8	13.2	9.9	5.2	11.0	14.4	12.9	11.6	18.2	10.7	10.7	6.6	19.4	8.6	15.2	10.3	8.5	12.5	6.2	10.7	8.8	19.3	2.6	1.0	1.9	0.5	0.0	2.4	0.6	6.2	7.2	8.5	8.4	4.3	5.6	10.5	7.5	4.4	5.8	3.7	7.4	4.4	7.8	7.7	6.3	8.3	17.5	3.7	5.1	2.2	24.3	14.7	5.2	12.4	4.9	7.3	6.1	8.5	6.0	4.8	6.4	5.7	6.9	5.6	10.0	8.8	7.2	4.9	10.3	7.8	13.4	5.5	3.9	12.0	14.3	6.5	5.8	5.2	6.1	8.9	8.0	7.2	6.8	5.2	6.1	10.9	9.1	8.0	17.9	6.7	7.2	13.0	7.8	6.3	3.3	9.2	5.4	6.5	0.0	0.5	1.9	2.0	0.0	1.3	2.6	2.3	1.5	0.5	1.7	0.8	1.6	0.4	0.0	0.3	1.0	2.4	0.6	14.9	10.4	19.9	19.1	12.6	12.0	8.4	12.3	13.2	10.3	3.0	5.8	2.9	1.5	4.8	7.1	4.1	7.6	6.7	3.4	3.5	2.0	2.0	1.7	4.5	0.3	5.8	2.8	0.0	4.8	2.0	3.9	2.0	9.2	3.0	2.6	14.3	5.8	2.5	3.8	0.7	6.9	3.5	5.0	4.6	2.9	8.5	5.3	0.0	5.3	2.2	11.4	0.0	4.8	9.8	7.8	4.3	0.7	4.3	4.3	1.6
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome		NA	NA			Centrosome		"HPA064246: AB_2685225"	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favorable (1.51e-4)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	22.6	77.8	19.0	25.2	22.3	47.2	22.8	33.5	42.6	19.4	22.3	15.2	37.2	17.4	21.3	26.6	25.1	20.6	22.6	28.7	20.0	23.8	27.3	38.0	40.5	28.9	22.7	30.5	20.6	32.9	32.7	22.5	28.9	30.4	21.3	18.0	21.8	35.3	43.7	32.0	20.9	19.9	26.9	13.8	22.2	27.0	18.2	17.1	13.8	24.8	29.9	18.3	20.7	18.6	16.0	15.6	14.6	24.2	14.8	14.6	8.4	28.0	11.5	10.8	32.0	22.2	18.0	24.9	27.2	27.7	25.1	25.1	22.3	12.2	14.4	18.6	26.8	15.8	17.2	23.3	21.7	32.3	17.8	23.3	34.4	21.2	31.6	18.6	32.6	21.8	23.3	24.0	17.3	17.9	25.4	21.2	14.9	34.0	22.5	26.3	18.5	14.1	21.4	9.5	27.1	16.7	16.4	29.0	17.4	27.5	21.1	38.8	14.8	27.3	20.0	35.8	22.7	30.8	31.9	17.2	36.1	24.8	39.3	30.8	23.8	29.9	22.2	17.4	22.6	19.8	14.6	24.2	13.4	12.8	12.6	14.4	14.4	13.1	12.6	15.6	16.0	14.6	11.1	14.4	14.8	12.2	12.3	13.5	8.4	19.0	22.3	33.5	42.6	20.0	23.8	22.7	30.5	30.4	17.1	71.5	78.7	19.3	17.6	12.6	77.5	35.4	38.2	46.8	60.3	19.2	62.8	34.4	33.2	58.3	113.4	26.9	23.7	116.8	66.7	35.9	19.3	26.9	30.2	57.2	22.4	73.1	28.7	25.2	35.1	96.7	35.6	31.6	18.6	22.6	22.4	61.2	54.3	17.8	30.4	47.7	75.8	19.4	25.5	24.7	22.2	14.2	63.0	28.0	21.1	14.8
CPT1C	"CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1"	"Cancer enhanced"	"Detected in many"		"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA014529: AB_1847206, HPA063621: AB_2732706"	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	9.3	11.2	3.1	18.9	0.8	1.1	16.3	34.0	4.1	1.9	8.9	0.2	2.7	6.4	5.3	1.8	4.1	7.6	2.8	11.9	12.8	1.6	1.6	2.5	2.6	8.0	13.4	3.8	1.2	0.7	15.6	1.9	11.4	2.8	1.7	7.4	1.5	4.8	1.7	1.5	2.4	7.8	6.6	4.2	1.4	4.1	6.3	0.0	1.7	0.2	1.7	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	18.8	15.8	6.8	5.4	0.0	6.0	11.9	7.7	10.8	0.3	0.0	0.3	0.0	5.9	0.9	1.4	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	11.1	0.0	0.0	6.2	0.0	6.2	0.0	2.0	10.6	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.8	1.2	3.9	0.0	0.0	0.0	0.4	0.0	13.1	33.9	0.0	0.0	0.0	0.3	0.0	0.0	8.6	0.4	0.1	3.6	3.0	0.1	1.4	0.1	14.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.2	18.9	16.3	23.4	11.9	12.8	8.0	13.4	11.4	6.3	0.0	0.0	0.0	3.3	1.9	39.6	1.2	2.5	0.0	0.0	0.0	15.7	0.8	0.0	0.0	7.9	4.5	0.0	0.0	0.0	3.6	3.1	1.5	0.0	0.0	0.3	30.2	0.0	3.1	1.2	17.8	3.1	0.0	0.0	0.0	0.0	14.9	0.5	0.0	12.4	0.0	18.1	0.0	5.3	2.7	6.9	1.6	0.9	0.0	0.0	0.9
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;skin 1: 47.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 21.3;Kupffer cells: 41.4;Macrophages: 20.5;Suprabasal keratinocytes: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.8;monocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.6;Karpas-707: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003873	Approved					NA	NA					"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	7.8	2.7	0.4	3.5	1.7	9.8	2.9	1.7	2.2	8.4	2.8	0.9	0.4	3.0	2.4	4.0	27.0	2.5	2.6	6.5	1.0	0.2	3.1	10.8	9.2	27.7	1.4	0.4	3.6	3.5	0.6	2.5	2.3	1.2	3.9	1.3	2.9	5.9	2.0	2.6	47.0	2.6	1.3	2.1	23.9	1.6	1.7	1.0	2.4	2.3	14.3	7.2	2.5	11.6	0.1	4.0	36.8	13.8	0.7	1.2	4.3	2.1	4.9	1.7	1.4	1.1	1.1	7.4	1.0	0.7	1.1	1.3	3.6	2.6	3.6	1.6	0.9	1.9	17.6	1.5	2.8	1.5	9.4	5.5	3.8	5.9	2.3	0.6	5.1	5.0	0.6	5.0	2.2	2.6	1.5	2.0	6.0	3.0	14.9	0.5	4.8	2.1	8.7	1.3	0.2	3.8	7.7	1.6	6.1	0.6	3.5	3.9	1.4	5.2	2.5	2.3	3.2	4.1	5.2	1.1	3.6	3.6	3.7	1.3	8.4	1.9	5.8	0.7	13.6	2.4	4.9	13.8	13.9	1.2	1.7	0.9	0.0	0.9	1.0	4.0	0.1	0.4	0.3	36.8	0.7	0.3	0.4	0.2	4.3	0.4	1.7	1.7	2.2	1.0	0.2	1.4	0.4	1.2	1.0	0.0	1.1	0.9	8.4	21.3	3.0	1.2	5.1	2.7	3.4	0.0	5.9	0.7	0.0	2.1	0.2	3.6	2.6	0.0	5.5	0.6	2.6	2.1	1.1	3.6	12.9	0.0	0.0	8.0	41.4	0.4	3.1	20.5	3.3	0.0	2.3	0.6	3.6	2.9	1.4	0.5	11.0	6.5	1.7	1.2	1.3	41.0	0.7	10.1	2.6	2.4
UQCR11	"QCR10, UQCR"	ENSG00000127540	"Ubiquinol-cytochrome c reductase, complex III subunit XI"	O14957	19	1597172-1605490	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.4;skeletal muscle: 149.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.90e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.42e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.06e-2)"	24.9	23.6	35.1	15.8	29.5	20.3	18.5	13.2	25.1	12.5	28.5	13.1	20.3	34.4	12.4	18.2	22.9	14.1	21.7	106.4	26.9	21.1	24.4	46.1	11.9	17.2	31.0	19.2	9.8	30.0	8.8	16.7	15.4	18.5	18.3	13.3	14.5	29.6	23.6	149.2	11.5	27.5	16.8	21.5	18.3	27.6	8.8	15.1	10.9	22.0	47.1	12.9	15.8	14.1	63.8	78.6	88.2	75.6	43.8	67.9	125.4	22.5	21.2	10.5	23.8	17.5	12.0	25.5	16.3	12.8	16.0	14.3	34.2	15.2	13.3	16.9	11.5	4.1	14.4	15.4	17.3	7.5	21.8	47.1	11.7	26.2	32.1	18.2	19.3	18.3	18.5	17.9	10.1	11.8	8.3	14.5	19.5	25.8	24.2	10.1	31.0	19.2	23.4	27.4	18.2	51.0	11.6	11.0	44.4	20.9	45.5	20.8	22.3	11.2	27.1	28.7	8.2	19.2	23.1	20.2	15.6	10.1	41.1	18.9	34.2	28.1	16.3	27.4	20.2	21.1	83.7	75.6	87.0	52.6	61.8	52.9	63.8	64.3	58.2	63.1	54.1	61.7	59.3	88.2	43.8	57.4	78.6	67.9	125.4	35.1	29.5	13.2	25.1	26.9	21.1	31.0	19.2	18.5	15.1	250.1	365.3	312.4	147.9	0.0	116.7	1545.7	580.9	491.2	293.5	601.9	37.3	421.8	1518.6	593.8	133.9	281.1	1267.5	350.4	708.1	511.1	324.6	312.1	183.7	1781.4	835.4	84.2	436.5	444.4	741.4	307.4	234.1	456.9	0.0	926.1	940.5	193.7	712.8	958.2	244.0	853.5	119.2	219.9	179.7	157.0	128.1	0.0	428.8	332.1	797.4	248.2
CYB561D2	"101F6, TSP10"	ENSG00000114395	"Cytochrome b561 family member D2"	O14569	3	50350695-50358460	"Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA071862	Approved					NA	NA					"HPA071862: "	"unprognostic (4.89e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.41e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (3.26e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.57e-2)"	8.7	16.6	9.8	11.9	11.6	14.8	12.0	10.9	12.2	8.5	14.6	11.5	12.8	16.4	6.3	20.5	11.1	7.8	16.0	7.6	8.8	6.9	15.2	42.2	11.2	16.6	12.2	10.0	5.9	27.3	13.6	14.8	12.2	8.0	12.6	13.9	8.9	15.2	18.2	7.1	6.9	19.0	6.2	11.5	19.7	16.4	7.4	12.4	12.3	16.1	6.5	11.2	9.7	6.9	29.9	31.0	58.3	46.9	34.4	53.2	33.8	7.4	16.6	4.2	7.9	8.9	7.7	9.9	13.4	10.0	12.4	14.2	11.6	12.3	11.9	14.2	16.7	15.3	8.1	6.2	12.4	5.4	17.9	15.5	11.0	19.5	10.5	12.8	12.1	25.9	11.6	5.6	14.9	7.1	6.4	10.3	9.4	4.8	15.8	9.8	14.2	7.7	10.9	6.7	11.9	26.2	5.5	2.9	23.7	12.9	12.8	4.2	11.8	6.6	27.3	8.2	4.6	9.7	14.4	11.1	11.2	9.6	18.7	16.5	12.1	11.3	7.6	15.5	15.2	12.0	42.4	41.1	58.3	53.2	46.9	34.8	29.9	36.1	42.0	30.0	27.4	25.6	38.0	39.0	34.4	44.1	31.0	37.1	33.8	9.8	11.6	10.9	12.2	8.8	6.9	12.2	10.0	8.0	12.4	6.0	23.7	4.5	12.5	4.4	5.8	0.0	0.0	9.4	5.7	24.4	5.9	30.2	10.0	36.4	10.5	4.1	40.7	0.0	59.2	35.9	11.9	18.5	20.8	0.0	51.2	7.9	30.5	0.0	0.0	5.2	8.1	24.4	18.6	37.9	39.9	23.0	38.7	49.1	7.4	20.3	5.2	12.9	4.1	5.0	13.0	6.5	46.1	13.1	23.6	13.9
YIF1B	FinGER8	ENSG00000167645	"Yip1 interacting factor homolog B, membrane trafficking protein"	Q5BJH7	19	38305104-38317273	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039328, HPA055257, HPA062675"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830"	"unprognostic (2.51e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.94e-3)"	15.8	16.5	18.6	24.1	21.3	46.0	17.1	19.3	34.4	13.9	15.8	27.4	13.9	15.7	12.4	12.4	17.5	14.8	13.0	18.4	21.8	19.6	16.7	59.7	17.6	25.2	23.5	24.0	13.9	21.0	10.8	15.1	18.2	25.9	12.4	12.9	13.5	21.2	12.0	20.3	14.3	14.2	14.2	27.1	24.3	11.5	13.5	20.9	18.2	11.7	16.6	15.7	15.6	12.5	10.8	67.3	38.5	35.9	9.1	14.6	24.3	11.9	30.6	13.7	16.2	20.0	18.6	10.9	29.2	22.3	21.7	31.9	14.9	9.0	21.0	12.8	33.5	23.3	7.7	24.2	15.2	8.3	22.2	12.8	32.2	13.7	15.4	27.7	22.4	38.2	15.2	13.6	22.2	9.7	21.9	20.1	28.0	41.4	58.3	19.2	12.7	23.5	26.9	10.5	20.5	9.8	24.4	16.7	32.1	13.9	11.3	10.0	16.8	9.5	21.7	15.5	11.1	8.4	45.0	19.1	21.5	21.5	30.9	23.0	21.9	32.2	13.9	27.8	41.3	15.4	15.4	35.9	38.5	14.6	26.2	12.8	10.8	13.8	13.0	67.3	8.4	11.5	11.6	9.8	9.1	14.7	28.4	12.8	24.3	18.6	21.3	19.3	34.4	21.8	19.6	23.5	24.0	25.9	20.9	0.0	5.6	13.7	16.9	15.8	10.7	3.7	12.7	9.4	1.2	21.0	11.8	40.5	0.0	33.6	4.5	16.1	10.9	0.0	24.4	43.9	31.0	17.7	23.0	28.2	83.7	11.1	13.8	42.4	37.3	8.2	8.3	37.6	33.7	28.9	14.7	19.4	18.4	14.0	8.5	12.9	11.0	6.5	4.2	17.9	28.5	17.6	23.1	12.9	20.9	18.0
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493071	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 162.6;Peritubular cells: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	16.5	24.9	29.7	14.3	36.1	18.1	16.7	84.5	47.5	24.1	16.4	21.4	22.1	12.9	24.4	19.5	14.1	20.9	16.4	14.1	24.7	18.8	14.9	11.8	17.1	15.9	13.2	35.6	30.7	21.8	23.3	55.3	21.0	20.8	29.8	11.4	27.0	26.5	30.2	12.2	42.5	14.8	20.9	13.3	16.8	14.8	27.3	13.9	16.3	17.1	7.8	12.6	21.9	19.5	5.8	6.6	6.5	8.3	6.1	8.1	6.4	7.4	7.9	24.6	20.0	18.4	20.4	20.2	16.2	10.7	13.0	13.3	11.8	11.3	10.5	4.5	22.4	10.7	10.1	13.0	17.6	7.7	10.6	14.0	18.9	27.5	11.4	16.8	11.1	17.0	32.0	14.2	14.0	12.0	27.5	20.9	21.1	10.0	11.7	12.1	10.7	19.8	24.6	15.0	9.6	13.5	11.8	6.7	12.2	14.8	15.0	10.4	18.2	17.5	4.6	11.2	22.4	14.5	18.7	22.8	18.3	17.6	18.5	11.5	19.5	11.1	13.3	12.6	18.1	11.1	6.3	8.3	6.5	6.4	7.6	6.3	4.7	5.4	8.1	4.5	5.8	6.5	6.5	2.9	6.1	1.1	6.6	5.8	6.4	29.7	36.1	84.5	47.5	24.7	18.8	13.2	35.6	20.8	13.9	23.8	28.8	12.0	14.1	24.5	39.6	18.2	7.6	10.7	18.2	14.0	7.9	26.9	8.3	11.4	7.2	20.2	15.8	0.0	8.2	11.6	19.3	13.0	24.3	12.4	25.4	27.0	162.6	52.2	62.2	16.8	81.7	22.2	18.6	5.4	16.3	10.6	9.2	13.9	231.3	11.0	23.3	25.8	23.1	31.1	15.6	19.4	20.3	13.8	15.0	10.8
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440222	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Cholangiocytes: 2.5;Cone photoreceptor cells: 3.9;Horizontal cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	2.9	4.7	4.0	2.5	5.9	0.8	5.1	11.8	8.5	5.9	4.1	6.6	4.5	2.5	4.2	7.2	3.5	7.9	4.7	5.9	6.0	4.5	6.2	2.1	3.6	3.3	4.4	5.5	7.6	4.3	15.3	12.1	3.7	5.9	6.1	2.4	5.4	5.8	6.7	3.7	4.7	2.6	5.9	4.2	4.5	3.6	7.2	6.0	3.1	10.8	2.8	4.3	5.7	6.3	3.9	2.9	2.0	2.6	2.6	5.7	2.1	1.7	2.1	4.8	1.7	5.6	4.6	0.2	3.7	4.5	3.0	2.7	0.1	1.5	4.5	0.3	4.4	3.0	1.8	0.0	5.4	2.1	0.7	8.2	0.8	1.4	1.1	5.0	1.7	3.0	5.2	1.9	5.2	3.2	3.5	2.6	0.7	0.7	0.5	5.6	0.6	1.0	0.1	4.9	0.6	1.7	0.6	1.1	1.3	1.8	2.0	4.3	4.4	1.5	1.3	1.5	5.4	0.3	4.4	3.3	3.1	0.4	0.8	0.7	5.9	1.1	0.0	1.5	0.1	1.9	0.0	1.9	2.0	2.2	2.2	5.7	2.9	2.9	1.2	2.9	3.9	4.6	3.7	0.2	2.6	2.6	2.4	2.5	2.1	4.0	5.9	11.8	8.5	6.0	4.5	4.4	5.5	5.9	6.0	0.0	0.3	0.0	0.5	0.0	0.8	2.2	2.5	0.0	0.0	0.0	3.9	0.4	0.0	0.4	2.2	0.0	0.0	0.0	0.3	0.1	0.4	0.9	1.1	1.0	0.4	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.7	1.2	1.5	0.0	0.4	1.4	0.4	0.3	0.3	0.0	0.0	0.2
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA					"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	61.6	116.2	79.8	55.0	81.4	86.1	114.0	49.9	121.1	56.4	50.2	41.5	64.3	54.0	50.7	51.3	60.4	67.0	65.9	90.9	79.4	95.6	92.6	85.2	111.9	141.9	76.7	69.2	57.2	72.7	61.5	98.7	56.3	76.3	53.3	41.6	51.0	69.4	64.6	74.0	60.1	50.2	50.5	82.8	80.7	51.0	61.3	34.7	62.8	64.6	56.6	55.5	63.2	47.0	52.7	92.8	191.8	97.9	34.9	39.2	73.7	33.2	55.9	25.3	43.1	66.0	59.9	22.6	34.6	62.2	45.9	52.1	23.5	31.6	23.9	35.1	67.3	54.2	50.1	31.0	42.6	24.8	48.0	81.5	23.6	45.6	38.0	75.8	14.7	117.7	74.6	51.8	53.9	30.9	50.5	54.3	26.2	20.5	51.4	54.7	31.5	20.2	49.2	17.4	27.1	48.9	24.0	14.5	27.3	59.2	29.9	13.0	46.5	29.4	21.1	61.2	25.9	27.3	26.9	49.2	48.5	21.0	59.7	43.3	42.0	41.0	10.2	75.4	34.4	39.3	67.6	97.9	114.1	35.0	86.6	34.7	52.7	39.2	35.4	73.9	49.1	31.9	30.5	191.8	34.9	81.4	92.8	38.4	73.7	79.8	81.4	49.9	121.1	79.4	95.6	76.7	69.2	76.3	34.7	53.6	59.1	23.1	6.8	18.2	14.5	0.4	10.2	97.7	78.5	5.2	39.3	4.5	3.3	14.4	4.5	17.3	18.2	0.0	4.8	2.6	14.5	9.2	50.0	14.0	12.8	11.1	12.7	25.8	72.0	4.1	8.3	36.6	20.3	38.7	7.7	8.9	12.8	12.7	6.0	3.0	32.2	25.8	10.3	3.7	0.7	19.1	9.8	32.4	9.3	10.5
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		66000	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.3	3.6	2.8	8.9	9.0	5.6	19.2	9.1	10.9	9.0	12.2	8.1	2.0	25.1	18.8	5.7	46.6	2.9	11.2	6.5	3.1	5.2	3.3	12.0	2.3	5.5	0.7	2.3	10.5	7.8	9.9	7.4	9.6	10.8	3.2	1.2	2.9	13.7	11.7	1.4	1.8	0.6	15.8	8.2	1.8	8.7	5.0	14.1	21.7	4.1	3.8	8.5	11.2	6.8	28.1	5.7	1.5	13.8	10.1	2.7	20.2	7.0	2.6	2.1	0.8	11.6	1.0	24.0	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9	29.8	13.4	12.3	11.9	9.6	69.6	59.0	20.4	14.7	11.4	10.4	149.2	6.4	5.0	10.3	25.9	9.5	25.8	0.0	7.7	16.0	10.4	37.1	2.3	11.3	8.1	90.6	19.7	12.9	7.3	46.0	24.5	6.5	11.8	10.0	17.1	32.4	12.4	31.7	24.1	7.9	76.8	19.4	13.2	14.6	10.7	15.1	26.9	8.7	13.3	45.0
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.0;Fibroblasts: 4.4;Horizontal cells: 7.9;Leydig cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 17.9;SH-SY5Y: 16.1;SuSa: 37.2"					"Low region specificity"	"Detected in all"			HPA071449			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA071449: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	4.5	4.2	21.7	2.1	15.5	1.6	3.7	11.3	23.8	8.0	2.5	7.9	1.4	1.7	16.3	8.6	2.4	7.1	5.6	2.9	17.9	15.6	5.3	13.2	2.5	2.3	10.5	13.2	21.7	5.7	7.6	20.2	5.5	22.3	7.4	3.2	5.0	1.5	6.9	32.1	1.5	1.8	10.9	8.9	1.4	2.0	3.6	14.2	4.2	9.2	0.1	2.4	3.6	5.0	0.7	2.6	0.0	0.2	5.2	1.2	0.4	0.0	0.1	17.9	0.0	3.5	4.8	0.0	0.9	6.1	0.9	0.3	0.0	0.0	0.0	2.5	6.4	1.4	0.1	0.1	0.3	0.5	0.0	11.0	8.2	0.0	0.6	1.3	0.0	0.0	11.2	0.0	5.7	0.0	5.7	0.4	4.3	0.0	0.1	6.6	0.0	0.1	0.0	9.1	0.0	0.0	5.2	7.8	0.0	1.7	0.1	12.0	16.1	0.0	0.2	1.5	37.2	0.0	1.0	0.0	7.5	7.8	0.1	1.0	2.8	0.4	0.0	1.1	0.0	6.5	0.0	0.0	0.0	1.2	0.0	0.7	0.7	0.1	0.4	0.0	0.5	0.3	0.7	0.0	5.2	0.2	2.6	0.0	0.4	21.7	15.5	11.3	23.8	17.9	15.6	10.5	13.2	22.3	14.2	0.0	0.0	0.0	1.1	0.3	4.0	1.6	0.0	0.0	3.4	3.5	0.0	0.6	0.0	1.4	0.3	0.7	0.0	0.0	0.2	0.5	4.4	0.4	1.1	0.0	0.4	7.9	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.9	0.3	0.0	3.5	0.3	1.0	0.0	0.4	1.0	1.0	0.1	0.6	0.5	0.0	0.3
ZCWPW1	"DKFZp434N0510, FLJ10057, ZCW1"	ENSG00000078487	"Zinc finger CW-type and PWWP domain containing 1"	Q9H0M4	7	100400826-100428992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 42.2"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 370.4;Spermatogonia: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.8;hTERT-HME1: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020911			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA020911: AB_1858990"	"unprognostic (1.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.92e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.58e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.93e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (5.26e-4)"	3.5	2.7	3.8	2.5	8.2	2.4	4.1	3.5	4.8	2.5	3.0	7.9	2.5	1.1	3.7	4.3	2.3	4.7	2.7	3.5	3.8	3.1	3.3	5.3	2.6	3.3	8.9	3.1	5.9	2.3	4.9	2.3	1.7	5.7	3.0	1.8	2.1	1.9	3.7	3.3	4.0	2.5	3.3	6.6	3.5	2.2	42.2	6.8	1.8	4.8	1.5	3.3	3.7	3.2	11.4	3.2	13.5	7.4	2.7	4.5	1.8	5.5	2.5	1.2	2.1	7.2	5.8	0.8	2.8	3.3	2.4	3.1	0.9	1.8	14.8	11.4	2.1	5.5	1.5	1.3	0.9	3.8	1.1	1.1	4.5	0.6	0.7	2.3	1.8	2.8	3.2	6.0	1.9	13.8	1.1	0.2	3.0	3.2	4.5	2.2	5.1	1.5	4.1	0.5	2.8	0.7	3.4	1.0	0.9	2.0	1.2	4.2	1.8	7.2	2.0	4.4	1.2	3.0	3.0	0.3	6.3	2.5	5.4	1.0	1.6	1.9	6.7	2.4	5.0	5.4	3.2	1.4	13.5	2.1	2.9	3.3	11.4	2.6	2.8	1.6	11.4	4.5	3.1	5.0	2.7	7.4	3.2	1.5	1.8	3.8	8.2	3.5	4.8	3.8	3.1	8.9	3.1	5.7	6.8	0.0	9.0	5.1	8.8	7.1	11.2	4.8	0.0	28.1	11.4	5.2	2.0	1.0	10.0	4.7	24.3	5.3	3.0	0.0	3.1	0.5	6.9	5.5	20.7	9.6	3.1	4.8	2.4	4.3	7.3	43.2	15.3	5.5	1.7	2.8	2.3	11.3	4.0	2.9	7.4	7.2	4.9	45.3	3.4	370.4	163.3	4.0	1.1	7.0	3.5	6.0
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 159.9;Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006554	Enhanced				"Intracellular and membrane"	NA	NA					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.8	1.1	2.2	73.2	0.5	0.8	0.3	0.4	0.3	0.2	1.2	0.3	0.9	0.5	0.3	0.8	1.5	0.9	0.5	0.2	1.1	1.7	2.0	1.8	1.3	0.3	1.7	0.5	0.8	0.4	0.7	0.2	0.5	0.1	1.5	0.2	0.1	0.2	0.5	1.2	1.6	1.2	0.1	3.9	0.6	1.5	0.4	0.6	0.6	0.7	1.7	1.8	0.9	1.1	0.5	0.8	1.8	0.1	0.7	0.4	0.8	0.6	2.8	1.5	1.2	1.7	1.4	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9	6.0	0.6	0.0	2.5	2.1	1.3	29.0	28.1	1.4	2.3	22.7	0.0	0.4	1.7	1.0	27.5	7.1	12.9	0.0	3.6	0.4	5.4	1.4	1.1	159.9	1.6	22.3	9.8	31.3	8.6	31.3	27.0	2.2	5.0	1.0	8.8	7.5	3.5	7.0	47.4	6.5	4.7	6.5	7.6	2.7	2.5	1.4	0.1	0.0	9.7	0.7
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.9;ASC TERT1: 8.5;HSkMC: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol		No	No			Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	8.6	9.7	8.5	8.0	14.5	3.3	11.0	13.4	15.2	10.9	8.7	15.4	8.6	4.5	13.3	13.3	5.3	8.9	7.2	9.9	9.2	10.0	7.2	5.9	6.6	7.5	12.0	12.2	18.2	6.7	11.0	13.2	6.0	10.7	10.2	5.6	12.4	7.1	14.2	14.1	11.3	6.5	11.0	12.9	7.9	6.5	11.7	11.7	2.9	12.5	4.4	6.0	7.1	8.5	3.0	3.7	2.5	2.2	1.6	4.8	1.7	1.0	0.5	1.0	0.7	8.9	8.5	0.0	2.4	3.2	0.7	0.6	0.0	2.8	0.5	0.6	0.9	0.8	0.7	0.3	0.0	0.7	2.3	0.8	0.4	0.2	0.0	4.6	0.2	1.0	7.1	0.4	0.3	0.3	4.5	1.8	1.6	0.4	0.0	3.5	0.3	0.7	1.1	0.0	0.3	0.4	0.6	0.7	0.0	1.7	0.2	0.3	2.4	0.4	0.0	0.9	1.1	1.0	1.8	2.6	2.0	2.2	0.7	0.2	0.8	0.1	0.6	2.0	0.3	1.1	1.4	1.0	2.5	2.1	2.2	4.2	3.0	2.8	2.4	1.1	2.1	4.8	4.0	0.1	1.6	1.1	3.7	0.9	1.7	8.5	14.5	13.4	15.2	9.2	10.0	12.0	12.2	10.7	11.7	20.8	6.2	0.8	3.8	3.2	9.9	7.0	5.1	2.7	9.1	0.0	3.9	0.9	8.3	0.7	1.7	5.8	2.2	0.0	0.7	0.6	3.9	1.9	1.1	2.0	2.2	12.7	1.7	5.5	1.3	2.1	16.7	2.6	5.0	1.0	2.2	16.0	0.4	2.9	9.6	1.1	13.1	0.0	6.6	17.9	5.6	2.9	0.2	2.9	1.3	1.3
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672392-29681110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.7;heart muscle: 14.4"	"Cell type enhanced"	"Detected in some"	8	"Cardiomyocytes: 4.2;Extravillous trophoblasts: 3.1;granulocytes: 2.3;Late spermatids: 3.6;Pancreatic endocrine cells: 2.7"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.8"	"Group enriched"	"Detected in some"	14	"BEWO: 12.0;SuSa: 3.4"					"Low region specificity"	"Detected in all"			HPA047172	Uncertain					NA	NA					"HPA047172: AB_10960886"	"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.9	0.6	3.8	0.3	4.1	1.1	4.2	0.1	2.3	0.5	0.4	0.4	2.4	0.3	0.5	0.5	0.9	0.3	1.9	14.4	5.5	3.2	0.5	0.3	0.9	6.1	7.6	0.1	0.7	5.2	0.3	0.1	1.5	0.5	0.7	0.6	0.2	2.3	2.1	0.4	0.7	1.2	1.5	12.7	0.8	0.3	1.4	0.1	1.2	0.3	0.7	1.1	1.5	5.5	0.3	0.7	3.8	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.6	0.3	0.3	0.3	0.4	0.5	0.7	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.6	0.3	3.8	4.1	0.1	1.4	5.5	3.2	7.6	0.1	0.5	0.1	0.0	1.1	0.0	0.2	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.9	3.1	0.4	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	3.6	0.0	1.1	0.0	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.5	0.1	0.2	0.0	0.0	0.0
RTL8C	"CXX1, FAM127A, Mar8, MAR8C, Mart8, SIRH5"	ENSG00000134590	"Retrotransposon Gag like 8C"	A6ZKI3	X	135032366-135033546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 99.5;Distal tubular cells: 119.3;Extravillous trophoblasts: 82.1;Syncytiotrophoblasts: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (2.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-3)"	"prognostic unfavorable (2.69e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (8.76e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (2.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.13e-2)"	"unprognostic (6.09e-3)"	50.8	51.4	57.3	20.8	56.4	6.3	20.8	33.0	85.1	45.9	26.9	51.2	16.1	13.9	33.3	24.3	46.6	36.4	26.2	129.8	49.8	63.0	27.3	14.2	27.5	11.1	55.9	49.6	49.6	21.2	21.3	36.2	34.4	78.3	39.8	12.9	31.3	31.9	50.5	75.5	29.0	16.2	54.3	46.1	18.9	19.1	16.1	29.5	1.9	17.8	38.4	10.5	33.9	25.6	13.8	24.1	27.1	37.8	19.9	21.4	15.5	12.1	14.4	14.5	20.9	51.7	59.9	10.3	32.6	25.5	19.1	26.4	11.9	4.6	0.0	40.9	43.1	22.5	12.7	13.4	13.0	7.3	8.1	21.1	3.2	25.1	6.6	30.6	0.0	6.6	64.5	17.5	21.5	5.6	25.1	22.8	0.0	5.1	0.0	31.9	23.3	0.0	8.9	5.9	5.3	27.1	0.0	15.4	0.1	20.1	5.7	10.8	25.9	11.2	8.5	15.0	7.8	5.4	5.6	27.3	26.6	9.7	64.0	23.6	4.0	3.1	0.0	36.9	3.2	14.1	10.4	30.9	27.1	19.7	37.8	15.1	9.6	16.1	20.1	22.4	13.8	19.1	21.4	7.7	19.9	30.7	24.1	15.8	15.5	57.3	56.4	33.0	84.7	49.8	63.0	55.9	49.6	78.3	29.5	35.7	24.2	0.0	0.0	0.0	0.0	0.0	0.0	18.7	30.7	34.9	0.0	99.5	119.3	38.2	0.0	0.0	0.0	0.0	23.2	82.1	0.0	0.0	17.4	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	48.7	0.0	0.0	34.5	0.0	0.0	52.8	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.0
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861617-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	6.2	7.2	9.8	7.1	13.9	3.9	8.4	12.9	16.6	10.9	7.3	10.0	7.9	7.3	12.7	11.6	6.3	13.6	10.8	5.7	8.6	7.7	6.2	7.3	4.9	6.5	7.8	7.8	14.7	12.6	10.0	7.2	4.0	8.0	8.4	6.0	9.3	8.3	7.7	6.6	14.8	5.3	9.3	6.3	6.3	10.0	13.6	11.2	7.3	7.1	5.4	7.2	7.7	7.7	2.6	2.7	1.4	1.1	2.1	2.2	0.8	7.5	9.1	4.2	8.7	4.5	3.3	6.3	2.3	1.8	4.2	3.7	11.1	4.0	8.1	3.3	3.9	1.6	7.9	5.2	6.0	1.9	2.8	8.0	5.0	4.2	10.1	5.7	3.1	3.6	5.1	4.6	3.8	3.0	3.4	4.6	8.5	6.7	2.5	2.9	10.4	11.4	5.3	3.5	10.2	6.5	8.7	2.8	16.3	4.7	4.9	2.6	5.7	4.8	6.0	5.3	3.6	8.4	6.3	2.9	2.5	3.2	5.5	3.2	13.9	6.3	5.3	5.2	3.0	2.7	1.4	1.1	0.3	0.9	0.5	0.8	2.0	0.7	1.3	1.3	2.6	2.2	0.9	1.1	2.1	0.8	2.7	1.2	0.8	9.8	13.9	12.9	16.6	8.6	7.7	7.8	7.8	8.0	11.2	3.0	2.2	0.8	6.0	4.1	13.2	2.0	10.2	0.0	2.3	3.5	5.9	3.9	11.6	1.8	6.8	2.7	4.0	0.0	1.9	2.6	5.1	4.5	0.0	3.4	2.8	25.4	4.1	2.5	0.6	11.0	5.2	1.6	3.3	4.6	2.0	7.0	0.8	0.0	3.5	6.7	13.5	0.0	3.1	8.9	8.0	5.0	1.3	1.5	5.4	3.2
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069643-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA			"Nuclear speckles"	"Nucleoplasm, Nuclear bodies"	"HPA021518: AB_2670734, HPA053459: AB_2682159"	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	3.9	4.3	8.7	6.1	9.6	3.3	5.1	10.4	15.2	6.0	5.1	4.2	6.4	4.6	6.9	6.1	6.8	6.7	4.8	3.2	6.4	6.1	4.5	5.4	7.3	8.2	4.8	5.8	8.3	6.0	7.6	8.5	3.8	4.0	6.8	3.4	5.4	5.3	5.8	4.1	13.0	5.1	6.6	3.4	7.7	5.1	2.9	4.2	8.4	6.1	5.8	6.5	6.2	6.1	7.2	4.5	2.9	5.0	8.4	12.1	5.3	4.5	8.2	6.6	11.1	4.0	1.7	9.4	2.7	2.9	3.1	2.5	4.3	4.3	6.4	6.8	1.9	5.4	5.2	4.0	3.8	2.0	7.0	6.1	3.2	4.8	5.4	3.4	6.2	4.3	2.3	4.3	3.9	2.8	3.2	2.9	4.7	5.6	3.7	2.9	14.1	10.5	10.6	12.0	4.3	6.2	7.9	3.2	4.2	2.5	6.3	7.8	12.4	6.9	6.5	5.1	4.3	4.2	2.9	3.7	3.7	2.1	6.3	4.0	13.4	9.9	3.5	6.1	4.0	4.0	1.7	3.7	2.9	12.1	5.0	9.8	7.2	8.5	10.7	4.5	7.1	11.3	9.5	1.1	8.4	3.9	3.9	5.1	5.3	8.7	9.6	10.4	15.2	6.4	6.1	4.8	5.8	4.0	4.2	0.0	0.6	2.4	2.1	2.4	9.4	2.5	0.0	2.7	0.0	3.5	2.0	2.1	3.3	3.7	0.3	1.5	1.3	0.0	1.3	1.9	1.9	1.2	4.6	2.1	1.9	17.5	4.6	2.5	1.2	0.0	2.8	2.0	0.0	2.8	1.0	2.7	1.8	2.9	3.9	1.8	5.7	0.0	1.9	3.1	8.3	1.5	1.6	4.9	2.6	1.7
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54, GARP complex subunit"	Q9P1Q0	2	63892146-64019072	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	15.5	14.2	10.1	11.1	13.2	12.6	14.3	22.1	12.9	18.6	17.1	11.4	17.3	12.9	16.3	14.4	13.3	14.4	13.7	12.5	11.3	8.5	15.8	15.5	15.2	9.6	14.3	10.6	18.0	21.0	34.2	32.1	13.0	12.1	17.3	13.5	14.3	31.9	19.4	12.2	13.1	16.9	17.5	10.4	13.3	13.7	12.2	12.5	18.3	17.5	11.3	11.3	13.5	26.2	3.1	2.8	4.1	3.2	3.0	4.3	1.0	16.7	9.3	17.0	13.3	12.5	13.2	12.5	10.9	16.4	11.6	11.5	16.9	10.9	11.7	8.2	14.3	17.2	7.8	16.7	9.8	20.6	16.6	11.1	11.1	7.1	28.5	11.7	7.5	4.7	12.2	14.8	8.2	17.8	13.9	17.4	8.4	12.1	9.9	14.6	7.4	7.7	7.4	10.3	17.0	6.7	7.8	16.7	6.6	12.7	9.8	9.8	14.7	9.4	12.1	12.4	14.0	8.7	14.8	12.4	14.9	11.9	9.0	17.7	22.8	6.2	15.0	10.9	15.1	12.6	4.1	3.2	1.3	2.1	3.2	2.6	2.4	2.1	2.5	1.8	3.1	2.8	2.2	3.0	3.0	2.5	2.8	4.3	1.0	10.1	13.2	22.1	12.9	11.3	8.5	14.3	10.6	12.1	12.5	14.9	18.2	4.6	7.4	9.8	17.8	11.7	7.6	8.1	18.2	1.8	11.8	5.3	1.7	6.5	41.8	11.3	9.5	0.0	11.3	5.4	11.3	16.0	2.3	14.3	7.0	22.3	12.7	8.6	8.6	28.3	17.3	8.8	5.0	0.0	17.7	8.9	10.1	11.5	11.7	8.4	16.4	19.4	8.9	13.2	6.0	9.2	4.6	6.4	11.0	12.2
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235126-46286297	"Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	19.4	16.7	14.2	21.5	25.3	19.5	19.0	26.6	29.2	18.3	17.2	27.7	19.3	15.4	24.8	18.0	18.1	21.1	16.3	17.9	14.4	13.2	15.5	13.3	18.2	21.9	16.5	14.6	23.7	17.5	25.7	20.6	18.2	18.2	17.7	17.6	21.3	22.1	21.4	52.9	18.2	19.9	19.5	15.1	20.7	18.7	15.7	15.7	31.8	19.6	15.7	26.0	21.1	16.4	4.8	4.8	3.8	4.9	3.0	6.9	4.1	16.0	15.8	18.6	20.0	15.2	19.0	16.9	17.7	21.7	16.8	13.7	14.4	9.6	22.9	14.6	18.7	18.1	9.6	24.5	14.9	14.8	23.5	22.2	37.5	15.1	11.2	13.7	17.0	21.2	14.8	13.0	22.9	15.9	11.5	17.8	13.9	44.7	17.5	19.3	9.2	18.2	11.5	31.9	17.5	13.2	23.8	11.7	20.7	8.2	14.9	15.7	16.7	22.6	15.0	17.3	14.7	20.4	17.8	22.5	17.6	13.4	14.6	13.2	31.9	35.3	14.2	15.9	16.5	22.8	1.5	4.7	3.8	6.1	4.9	6.5	2.9	3.7	6.9	4.8	4.8	3.3	3.4	2.9	3.0	2.7	4.2	4.4	4.1	14.2	25.3	26.6	29.2	14.4	13.2	16.5	14.6	18.2	15.7	8.9	17.6	16.7	6.1	6.3	21.7	3.6	15.3	10.7	12.5	10.4	19.6	9.8	1.7	9.7	2.5	7.8	12.3	0.0	12.4	9.8	8.9	11.6	8.1	15.3	13.5	15.9	11.5	13.5	20.6	3.6	17.0	12.4	10.1	21.6	18.4	8.9	12.8	7.0	13.4	5.2	21.0	19.4	6.6	18.9	13.4	9.2	7.8	8.5	14.5	5.5
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favorable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.3	9.8	6.7	14.4	19.4	30.2	7.8	21.1	24.1	19.5	21.5	7.8	5.1	5.0	7.1	25.1	14.0	8.0	8.8	13.6	11.0	10.3	13.5	1.2	12.3	16.4	30.8	7.4	8.1	25.1	13.2	20.1	8.5	21.7	3.1	8.1	5.5	17.8	26.4	14.0	5.6	10.7	2.1	25.2	13.2	4.3	7.2	10.3	8.2	5.7	1.9	3.8	17.2	6.2	25.2	5.5	7.0	8.2	2.4	22.0	12.1	20.5	10.8	11.2	10.8	7.9	24.6	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2	32.8	81.3	24.1	11.2	13.2	18.0	10.2	61.1	46.8	36.4	33.2	5.9	49.2	91.2	22.6	11.4	5.8	103.9	23.3	9.6	78.2	28.7	9.3	3.5	75.7	29.4	27.0	46.8	10.4	11.3	10.8	25.9	14.0	42.2	25.2	41.2	49.6	15.1	112.2	28.7	109.0	19.6	38.8	39.8	45.9	10.4	12.3	54.6	20.3	47.6	5.5
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.5	10.3	10.0	6.5	5.7	5.8	4.2	3.6	8.6	12.7	12.7	8.0	3.8	14.7	8.2	9.0	3.6	2.4	11.5	2.0	7.6	2.3	12.8	6.8	9.4	8.3	7.8	5.4	4.2	6.0	3.4	9.4	3.7	8.0	6.6	10.4	4.5	6.1	11.8	3.3	7.7	19.3	8.5	1.8	6.0	16.6	10.9	9.7	7.0	1.5	14.5	15.6	12.3	2.6	3.8	7.7	4.0	6.0	4.7	2.4	7.1	6.7	3.6	12.8	13.7	7.2	7.1	5.1	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0	3.0	7.4	6.1	12.1	11.8	17.4	115.4	7.6	12.0	4.5	10.4	15.7	5.0	44.7	2.4	0.1	9.6	2.1	0.0	4.0	5.9	8.0	4.7	4.6	14.0	4.4	30.2	15.5	2.5	1.6	1.4	7.8	2.5	11.8	1.8	2.8	21.7	2.5	3.4	15.9	11.0	30.0	38.8	18.9	1.7	17.7	9.3	2.5	13.4	4.5	4.3
RAB4B	"FLJ78649, MGC52123"	ENSG00000167578	"RAB4B, member RAS oncogene family"	P61018	19	40778216-40796938	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (9.11e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.23e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.74e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.32e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (2.08e-4)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.99e-5)"	13.6	19.1	22.0	16.2	23.7	13.1	7.2	17.1	39.7	10.4	15.3	31.2	8.4	14.6	7.6	4.5	9.4	8.7	11.4	8.4	24.5	22.8	8.2	7.9	13.0	22.8	26.5	17.8	4.6	12.4	4.5	16.8	19.0	24.0	10.3	7.4	10.8	11.2	12.5	5.2	9.7	15.9	7.1	36.9	19.8	15.8	9.6	18.8	11.6	9.5	5.5	14.1	8.7	7.3	31.1	49.5	36.9	26.8	11.7	21.4	20.6	6.1	20.1	4.7	8.2	10.8	7.6	7.0	8.2	7.7	3.6	9.6	11.0	6.9	10.2	14.2	6.6	11.3	5.7	2.1	7.2	1.7	23.4	9.1	8.1	3.9	6.7	16.9	7.2	29.6	13.8	7.4	7.6	1.9	6.0	13.5	20.2	4.2	18.2	7.5	9.9	10.6	11.6	3.8	10.5	9.5	9.4	4.0	9.9	10.2	12.2	4.3	7.8	18.6	5.6	8.4	4.8	5.9	15.5	10.1	9.1	6.6	7.7	3.3	10.7	6.4	10.0	17.5	9.2	9.5	23.4	21.8	36.5	21.4	26.8	11.7	23.8	13.9	18.4	26.7	31.1	13.0	15.7	36.9	11.7	19.2	49.5	18.9	20.6	22.0	23.7	17.1	39.7	24.5	22.8	26.5	17.8	24.0	18.8	8.9	23.4	22.0	12.5	6.9	20.7	4.5	10.2	9.4	9.1	1.8	5.9	49.8	0.0	0.8	2.1	19.1	47.8	0.0	0.9	15.8	12.7	16.8	20.8	15.3	37.4	30.2	25.2	18.4	28.8	2.1	8.1	24.0	30.4	2.8	12.7	25.1	0.5	31.6	9.9	0.6	15.6	25.8	7.2	17.2	22.8	8.7	85.9	31.0	16.1	19.3
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357114	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1"	"Group enriched"	"Detected in many"	12	"B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054084: AB_2682372"	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	7.1	14.8	12.9	28.2	14.5	6.8	9.3	24.4	15.4	10.8	8.3	4.9	23.2	10.1	8.4	11.6	6.4	10.0	10.2	5.3	12.8	5.7	7.9	9.1	9.3	9.8	6.0	9.8	11.0	10.8	9.1	9.0	4.6	8.0	10.4	2.4	7.1	25.0	24.2	13.6	11.7	9.5	4.3	5.9	6.8	9.9	3.8	7.0	15.4	8.2	5.2	13.3	7.5	8.5	6.5	0.2	0.7	0.5	14.1	4.7	1.0	2.2	3.7	2.4	1.5	0.7	0.8	4.6	1.3	0.0	0.5	0.1	0.6	4.0	11.6	2.2	0.2	1.1	6.4	1.4	0.4	0.0	5.6	9.5	1.9	10.0	1.8	1.0	2.2	2.7	0.3	1.8	0.6	0.0	6.0	1.5	1.1	1.2	3.4	0.4	2.9	0.4	6.3	2.1	0.4	0.9	2.2	1.5	0.5	2.2	2.4	1.4	2.8	2.3	1.0	3.2	1.3	4.3	3.3	6.3	1.3	2.5	1.9	1.1	5.4	5.2	9.4	1.2	9.4	1.2	0.0	0.5	0.0	4.7	0.1	1.3	4.0	0.8	1.0	0.2	6.5	1.4	1.4	0.7	14.1	0.1	0.2	0.2	1.0	12.9	14.5	24.4	15.4	12.8	5.7	6.0	9.8	8.0	7.0	20.8	19.2	9.3	14.9	5.7	20.2	2.5	2.5	38.8	23.9	14.0	9.8	8.7	1.7	7.2	21.8	13.4	15.5	0.0	7.4	3.1	7.8	12.0	10.5	10.5	2.8	9.5	20.7	24.5	6.9	1.1	17.5	5.8	8.5	0.0	18.2	21.4	6.1	14.7	12.7	5.8	5.9	6.5	4.1	1.4	0.7	5.1	4.0	13.1	11.3	5.8
RBM4B	"MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B"	ENSG00000173914	"RNA binding motif protein 4B"	Q9BQ04	11	66664998-66677921	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042174, HPA047849"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.71e-2)"	7.1	12.3	17.6	9.6	17.3	4.0	10.2	35.9	19.3	13.4	10.0	22.8	13.5	9.3	19.0	20.2	10.1	18.3	9.8	9.2	17.5	17.4	9.9	9.8	8.8	13.8	15.4	16.2	29.8	11.8	15.7	25.6	12.2	17.3	14.6	11.5	14.5	14.1	15.0	13.9	17.4	10.3	14.0	16.4	11.8	9.8	17.0	18.7	8.5	12.3	7.6	15.5	11.3	11.5	21.8	11.4	26.8	15.1	13.2	12.5	8.4	13.1	13.2	29.1	24.2	14.3	14.7	9.8	12.7	12.7	14.2	14.6	18.5	13.9	14.7	18.2	16.0	13.9	17.2	19.1	17.5	15.1	14.2	13.0	16.0	16.6	19.7	10.5	16.2	15.8	15.3	12.0	14.5	12.4	16.3	13.7	12.0	12.1	14.8	19.1	21.2	10.0	12.5	17.3	29.7	17.8	20.6	23.2	15.1	12.9	13.3	17.9	16.4	15.1	7.8	28.3	19.5	20.8	15.4	12.6	15.7	16.2	15.3	11.3	7.3	12.3	15.1	14.5	11.5	13.8	12.7	9.6	26.8	10.8	14.1	10.4	21.8	10.1	10.4	11.4	18.6	12.5	9.2	6.1	13.2	15.1	9.4	7.4	8.4	17.6	17.3	35.9	19.3	17.5	17.4	15.4	16.2	17.3	18.7	11.9	5.1	15.9	14.0	7.1	35.5	4.5	7.6	21.4	10.3	17.4	31.4	32.2	10.0	12.0	21.2	7.0	8.5	0.0	5.0	14.2	17.8	7.3	9.2	7.4	11.1	23.8	18.4	6.7	8.7	36.0	17.0	8.2	15.1	9.0	8.6	21.8	5.3	7.4	12.7	11.2	56.8	6.5	11.3	42.1	40.0	6.1	18.5	13.4	10.3	4.3
QTRT1	TGT	ENSG00000213339	"Queuine tRNA-ribosyltransferase catalytic subunit 1"	Q9BXR0	19	10701430-10713437	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042695, HPA048651, HPA049440"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767"	"unprognostic (6.19e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (2.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.76e-3)"	"unprognostic (3.88e-1)"	"unprognostic (4.81e-3)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.14e-2)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	14.0	18.4	20.6	13.4	29.1	14.2	11.5	18.0	21.3	11.3	14.5	13.3	19.4	12.8	15.3	11.6	14.6	15.8	13.5	19.5	19.7	13.1	11.8	18.9	8.4	13.5	22.9	19.3	22.1	33.9	5.8	12.0	9.8	19.9	13.7	6.6	10.5	26.6	12.7	20.5	12.6	14.2	13.3	12.7	11.5	12.5	5.0	22.2	5.3	19.0	11.9	10.3	12.0	10.3	19.6	19.1	0.9	14.4	18.5	18.8	10.4	17.2	13.9	6.6	19.3	7.0	8.4	8.7	8.8	7.9	10.3	10.2	11.1	6.6	19.5	21.7	5.0	6.2	11.6	6.0	10.6	3.4	11.5	8.4	12.8	5.6	23.3	12.1	19.0	11.3	12.4	9.1	6.7	9.9	4.7	10.5	10.8	14.1	22.4	5.1	26.9	16.3	23.7	17.5	10.8	21.5	17.2	8.8	30.1	8.4	11.1	21.5	9.3	13.5	14.8	11.5	2.9	9.5	8.0	8.1	15.9	8.9	25.4	20.5	24.7	19.0	9.5	8.6	23.1	19.2	0.9	8.3	0.2	15.1	14.4	18.8	19.6	16.3	13.1	16.4	19.0	17.5	13.9	0.6	18.5	7.3	19.1	17.7	10.4	20.6	29.1	18.0	21.3	19.7	13.1	22.9	19.3	19.9	22.2	0.0	5.0	26.7	54.7	56.6	36.4	5.6	28.1	12.0	5.7	54.1	47.1	41.0	54.7	20.6	1.3	27.0	191.9	70.0	23.8	30.6	33.2	38.0	16.1	26.7	26.1	85.8	185.1	16.5	20.2	1.1	46.9	9.6	47.2	7.2	232.5	24.4	15.1	244.4	35.3	58.5	54.3	19.4	30.3	12.1	28.9	36.6	23.5	26.2	247.9	33.9
SPATC1L	C21orf56	ENSG00000160284	"Spermatogenesis and centriole associated 1 like"	Q9H0A9	21	46161148-46184476	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 174.7;Late spermatids: 364.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018979, HPA019165, HPA029394"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148"	"unprognostic (1.46e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.58e-1)"	4.7	11.5	21.5	4.2	31.7	5.1	4.3	13.1	19.0	8.2	5.1	5.6	8.9	5.3	5.3	6.5	4.6	4.0	5.7	5.5	14.4	9.4	4.3	1.5	4.4	5.7	7.8	16.5	10.9	11.7	5.8	7.8	4.7	7.5	16.7	3.6	2.6	9.5	10.1	8.8	7.0	6.3	5.6	5.2	8.1	8.3	23.5	13.6	2.2	3.7	5.0	4.3	4.4	6.4	4.8	5.9	23.6	4.2	4.0	6.9	2.7	1.8	0.0	2.5	4.6	1.4	3.3	1.3	2.7	1.5	1.5	1.1	0.0	1.2	5.9	5.5	3.4	1.8	0.3	0.0	2.1	0.4	5.3	4.4	14.0	0.8	3.3	0.1	0.0	5.9	3.5	1.0	0.0	0.0	2.9	4.9	6.8	24.3	8.9	2.1	3.7	4.5	1.6	10.1	2.6	12.0	10.1	3.3	6.5	2.4	0.5	0.7	4.7	2.1	1.2	5.4	1.8	3.8	5.4	0.3	4.5	5.4	6.4	4.0	14.9	7.9	4.3	5.9	7.8	4.2	1.0	3.9	23.6	3.0	4.2	3.9	4.7	4.4	4.3	5.9	4.8	6.9	6.8	0.2	4.0	2.9	4.8	4.2	2.7	21.5	31.7	13.1	19.0	14.4	9.4	7.8	16.5	7.5	13.6	0.0	0.0	6.0	12.9	20.9	5.7	1.2	17.8	1.4	2.3	3.5	0.0	2.8	13.3	16.5	174.7	13.2	5.4	0.0	17.4	11.5	17.2	25.0	0.0	0.5	11.6	3.2	58.0	8.0	7.3	364.6	30.0	15.4	27.0	5.4	16.3	5.2	14.9	2.9	29.7	9.2	3.4	19.4	12.3	11.2	8.9	35.0	2.6	16.0	17.5	3.7
ZBTB46	"BTBD4, BZEL, FLJ13502, RINZF, ZNF340"	ENSG00000130584	"Zinc finger and BTB domain containing 46"	Q86UZ6	20	63743666-63831244	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 17.7;Ito cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013997	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013997: AB_1858961"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.12e-1)"	9.2	4.6	6.3	3.8	4.3	2.3	6.0	24.2	6.1	8.1	1.9	2.6	3.2	2.2	9.9	8.0	2.3	6.7	4.4	10.1	4.3	3.8	7.3	3.6	6.4	5.7	4.3	3.0	12.4	6.2	3.4	8.8	7.1	5.3	3.8	1.3	9.4	5.1	6.6	7.3	2.9	3.0	3.3	2.5	14.8	2.4	3.5	2.7	1.8	8.5	4.4	2.0	4.0	10.7	0.2	3.4	0.3	0.6	0.7	0.7	0.2	2.5	2.5	8.6	2.8	0.4	0.9	4.7	1.2	2.9	0.5	0.3	5.9	6.7	0.4	9.1	0.1	3.2	2.5	0.5	0.1	0.4	0.9	2.3	0.5	2.5	5.4	2.0	0.8	1.5	0.5	0.1	0.1	0.0	1.3	0.8	0.3	3.2	0.8	1.6	6.2	0.4	11.8	1.5	3.3	5.4	3.2	4.2	3.6	0.5	1.7	8.6	2.6	2.1	5.2	0.8	4.9	6.4	8.1	0.7	7.3	4.1	3.5	1.4	1.8	4.9	0.8	1.3	1.7	1.3	0.0	0.4	0.2	0.6	0.6	0.3	0.2	0.4	0.6	3.4	0.0	0.4	0.4	0.3	0.7	0.2	0.1	0.7	0.2	6.3	4.3	24.2	6.1	4.3	3.8	4.3	3.0	5.3	2.7	0.0	0.6	0.0	1.1	0.3	4.2	9.0	2.5	0.0	2.3	1.8	17.7	3.5	0.0	1.4	0.4	7.5	0.0	0.0	0.5	0.7	2.5	1.9	2.3	0.0	2.6	1.6	1.2	33.2	5.4	0.9	7.5	2.5	1.7	2.8	0.0	3.8	1.8	0.0	8.1	1.1	9.0	0.0	1.8	0.5	1.7	0.4	3.1	0.0	0.1	1.6
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	9.3	0.0	0.0	2.7	0.0	2.6	0.1	0.1	0.0	0.0	5.4	0.0	0.1	12.5	2.3	0.0	0.6	0.0	3.1	0.3	0.0	0.0	0.0	1.7	0.0	0.1	10.2	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3	0.0	5.4	0.0	0.8	0.2	41.0	12.8	0.0	14.7	2.3	0.0	29.5	0.1	0.0	0.1	0.2	1.6	0.9	0.0	2.9	0.0	0.4	0.5	0.0	2.4	0.1	42.9	98.1	1.3	0.3	0.4	0.3	0.0	1.7	0.0	4.3	13.3	2.1	0.0	10.3	0.7	25.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.4
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385217-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.5;RH-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA049057: AB_2680615, HPA057379: AB_2683422"	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	9.5	20.8	8.9	6.4	14.5	0.8	7.4	9.0	11.7	6.7	9.4	2.6	5.2	2.6	10.9	3.5	5.4	4.8	10.7	3.3	6.7	7.5	4.7	5.4	6.2	5.7	3.6	9.0	4.0	4.7	5.8	17.7	7.6	6.3	10.8	3.4	11.7	4.2	11.7	12.0	6.9	4.2	7.2	2.7	10.6	5.5	2.5	3.7	0.5	1.9	1.8	4.0	7.5	6.4	0.1	0.4	0.0	0.0	0.9	0.7	0.0	1.0	0.9	6.0	3.0	5.7	3.8	10.3	6.1	4.7	2.5	1.8	0.0	0.3	3.9	2.1	2.3	13.5	0.2	1.4	5.2	1.7	0.0	6.3	0.0	5.1	0.0	2.0	0.0	7.9	2.7	7.1	3.3	9.3	0.8	4.2	0.1	0.0	0.0	1.3	0.5	1.3	0.0	3.0	0.0	1.8	0.3	15.4	0.0	4.6	1.8	9.0	1.8	0.8	0.6	3.5	2.5	0.0	0.0	4.2	2.5	11.7	5.3	2.1	0.1	0.0	0.0	9.5	0.4	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.9	0.0	0.4	0.0	0.0	8.9	14.5	9.0	11.7	6.7	7.5	3.6	9.0	6.3	3.7	6.0	4.0	0.0	9.1	4.1	2.3	2.0	5.1	1.4	1.2	1.8	25.5	0.7	0.0	1.0	1.7	1.4	0.0	0.0	0.2	0.9	1.7	1.7	0.0	0.4	0.2	1.6	4.1	0.6	0.0	0.0	4.6	0.0	1.7	0.0	0.6	1.3	0.4	0.0	3.9	1.3	23.5	6.5	5.1	0.0	1.1	5.1	0.7	0.0	0.2	1.3
WASF3	"KIAA0900, SCAR3, WAVE3"	ENSG00000132970	"WAS protein family member 3"	Q9UPY6	13	26557703-26688948	"Cancer-related genes, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 83.6;Horizontal cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037086, HPA066228"	Enhanced					NA	NA					"CAB037086: AB_1080585, HPA066228: "	"unprognostic (1.42e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.19e-2)"	"unprognostic (8.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (8.86e-3)"	"unprognostic (2.93e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.18e-2)"	18.7	17.3	27.3	3.4	33.2	1.1	11.8	30.9	55.1	7.1	3.4	18.6	2.0	1.9	8.7	6.0	4.8	7.1	4.6	7.3	22.7	19.7	8.0	7.6	7.9	3.0	22.1	22.5	22.4	6.0	6.8	4.5	1.3	18.4	10.1	4.1	8.9	6.6	10.8	7.4	3.7	2.5	8.4	17.1	5.5	5.3	12.9	14.1	0.0	17.7	0.7	2.4	4.3	5.0	0.2	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.1	17.9	0.0	39.5	7.7	1.7	6.8	10.4	10.2	5.3	0.0	1.6	6.7	0.9	15.7	4.4	1.5	5.0	5.1	8.9	0.0	4.2	0.3	0.0	6.8	5.9	2.3	5.1	16.1	5.0	2.6	8.1	2.4	15.9	2.1	0.1	0.0	3.8	1.4	0.0	0.1	4.9	0.3	1.7	0.0	10.1	0.0	1.3	2.9	4.2	8.3	3.5	3.3	5.2	3.8	0.0	0.2	7.9	8.0	3.3	3.9	3.6	0.0	0.0	6.5	4.1	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	27.3	33.2	30.9	30.7	22.7	19.7	22.1	22.5	18.4	14.1	23.8	1.3	0.0	2.6	1.9	28.6	9.0	2.5	1.4	2.3	8.7	31.4	0.1	10.0	2.2	83.6	10.5	0.0	0.0	2.3	0.3	9.9	4.2	14.9	6.7	0.2	77.9	19.7	10.4	1.6	23.6	13.6	0.3	5.0	1.0	1.3	43.9	1.6	0.0	27.3	2.3	39.7	6.5	4.7	8.1	19.3	1.3	0.0	0.0	0.3	1.7
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946939-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.5"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.4;Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA					"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	8.1	10.7	21.8	7.3	28.5	6.7	6.8	17.6	27.6	8.4	7.4	42.1	4.5	7.2	8.5	11.1	12.2	10.7	7.4	17.4	27.6	16.6	16.0	9.2	7.2	7.0	27.8	18.4	7.6	8.0	21.6	10.8	8.0	18.4	10.4	8.2	7.4	10.5	13.1	80.5	11.1	6.1	12.1	35.8	7.7	7.3	25.1	27.6	6.3	13.8	13.0	7.9	8.1	5.8	2.8	5.5	2.6	3.7	4.5	4.9	2.2	13.6	11.1	11.2	17.7	30.6	15.9	9.4	13.1	12.2	19.7	15.1	8.5	6.9	14.3	13.6	17.1	12.5	15.3	20.1	23.1	13.1	14.5	17.2	14.9	20.1	11.6	21.6	9.9	13.9	16.2	23.6	25.5	16.0	14.8	13.0	11.2	14.9	13.2	15.6	9.5	10.0	13.1	10.3	11.7	18.7	13.9	14.1	15.0	14.5	13.2	18.0	8.3	12.3	20.8	17.0	15.4	13.0	13.8	10.6	19.7	11.9	17.1	14.7	14.8	18.1	6.9	12.6	21.5	17.1	0.0	3.3	2.6	4.9	3.7	4.4	2.8	3.2	4.9	5.5	2.2	2.9	3.6	1.1	4.5	3.7	5.3	3.8	2.2	21.8	28.5	17.6	27.6	27.6	16.6	27.8	18.4	18.4	27.6	0.0	1.3	6.5	2.5	3.0	14.7	21.7	10.2	5.3	3.4	10.4	7.9	5.2	1.7	5.8	39.4	5.2	7.5	0.0	3.7	3.3	4.2	3.3	0.0	10.2	14.0	27.0	2.9	4.9	9.1	63.2	7.8	2.8	8.5	8.2	4.6	11.2	5.2	0.0	14.9	14.7	7.3	0.0	4.7	19.1	11.9	3.8	3.4	5.0	4.7	3.4
SEPT1	"DIFF6, PNUTL3"	ENSG00000180096	"Septin 1"		16	30378133-30395991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	11	"blood: 54.4;lymphoid tissue: 89.8"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 61.6;T-cells: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.7;JURKAT: 23.1;MOLT-4: 30.1;REH: 17.9;U-266/70: 10.4;U-266/84: 15.1;U-698: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.1	0.8	0.8	20.1	1.6	0.3	0.7	1.1	0.6	1.5	2.8	0.2	0.1	3.9	1.2	0.8	2.0	1.4	1.4	0.8	0.7	0.6	1.2	0.9	3.7	16.0	0.9	0.1	1.5	1.0	0.2	0.5	0.4	0.3	0.8	0.0	0.9	6.6	0.6	0.4	0.9	6.2	0.4	0.7	16.7	3.6	0.4	0.2	89.8	0.9	1.7	32.9	0.9	0.9	28.2	43.5	16.1	0.4	34.4	54.4	38.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.4	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	23.1	0.1	8.0	0.0	0.0	30.1	0.6	0.0	0.0	0.3	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	15.1	10.4	0.2	3.3	0.0	16.1	0.4	15.3	54.4	0.3	41.9	28.2	49.5	49.3	1.5	27.6	46.6	46.9	1.4	34.4	0.2	43.5	50.7	38.1	0.8	1.6	1.1	0.6	0.7	0.6	0.9	0.1	0.3	0.2	0.0	12.7	61.6	0.0	23.1	18.4	1.2	17.8	0.0	6.8	15.7	7.9	9.6	31.5	0.0	0.6	4.1	10.9	0.0	0.0	3.4	8.9	0.0	12.7	22.9	8.1	17.5	16.7	6.7	17.3	1.3	44.0	10.3	32.1	0.0	15.6	14.8	0.0	9.9	29.4	44.4	14.7	12.9	0.7	0.5	1.1	19.4	4.1	135.7	17.8	0.0
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031355: AB_10611812"	"prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favorable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	25.9	9.4	19.9	9.4	17.7	11.8	53.4	18.1	27.0	13.6	14.6	5.4	15.2	14.1	9.9	14.7	17.4	11.4	13.6	19.8	17.9	12.9	9.7	12.3	17.7	11.3	11.3	15.9	13.1	5.6	7.7	12.4	7.7	9.5	13.1	11.7	11.6	20.5	12.6	73.0	19.4	14.3	14.4	6.1	9.3	13.7	24.7	6.2	8.2	9.3	31.3	10.6	11.5	22.3	2.4	2.7	4.6	1.6	0.6	8.1	1.1	17.7	14.3	7.8	20.7	25.2	17.6	0.0	16.5	15.0	25.6	17.5	11.1	16.4	5.6	10.1	24.0	5.3	24.0	15.0	15.9	12.7	14.5	12.2	4.1	20.8	0.0	17.3	12.5	8.0	18.2	22.0	11.8	9.6	10.0	20.4	19.0	0.0	0.1	13.6	25.3	13.1	5.1	3.3	16.9	24.7	14.2	0.0	5.2	9.7	19.7	12.9	5.5	15.5	12.5	12.2	5.7	25.6	16.1	13.6	20.7	0.5	30.2	20.4	3.7	5.0	2.7	21.3	5.8	16.0	0.6	1.1	4.6	4.1	1.6	4.0	2.4	4.3	4.2	1.1	1.3	3.3	2.3	0.7	0.6	1.2	2.7	8.1	1.1	19.9	17.7	18.1	27.0	17.9	12.9	11.3	15.9	9.5	6.2	23.8	18.7	1.5	22.6	10.4	23.3	21.0	17.8	20.1	21.6	10.4	5.9	2.2	18.3	5.1	9.8	13.5	20.8	0.0	0.0	3.1	9.6	22.7	24.3	12.8	6.7	19.1	19.5	9.8	7.6	25.6	8.6	8.9	11.8	2.8	24.7	14.8	0.8	14.4	7.1	7.8	16.4	12.9	8.2	8.9	7.9	11.0	1.8	7.5	16.9	20.0
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500090	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	14.6	25.6	26.6	11.2	32.0	13.9	9.8	24.4	32.7	11.7	16.7	30.3	8.2	15.4	13.0	8.5	14.5	27.4	13.7	21.1	21.7	13.3	14.0	9.6	17.0	10.6	24.0	23.0	17.1	13.9	17.2	18.6	18.6	21.9	12.5	11.5	25.4	11.8	12.5	40.4	16.2	15.2	9.4	15.9	14.3	14.8	16.5	23.4	10.7	18.4	9.6	9.2	13.7	7.1	4.6	6.2	5.5	4.6	4.3	7.1	4.5	7.6	20.1	16.6	26.1	8.3	9.5	23.9	4.6	10.2	7.9	8.1	6.7	12.1	10.9	15.4	8.0	12.2	10.1	8.0	12.7	4.4	9.6	11.3	11.0	9.0	10.1	11.3	12.2	24.0	16.4	7.1	7.8	6.9	6.9	14.3	9.3	11.4	12.7	10.3	8.9	25.3	7.6	6.9	9.4	7.8	18.0	19.7	10.0	7.7	20.2	14.8	15.7	5.5	23.9	13.8	12.8	14.8	14.6	8.2	7.9	10.0	8.2	6.5	27.5	7.8	5.9	9.3	11.3	10.7	0.2	4.6	5.5	7.1	2.9	5.4	2.0	3.3	4.7	4.6	4.6	2.8	4.4	1.2	4.3	2.7	6.2	4.1	4.5	26.6	32.0	24.4	32.7	21.7	13.3	24.0	23.0	21.9	23.4	11.9	12.0	0.0	3.8	0.0	39.1	0.0	7.6	5.3	11.4	8.7	29.5	12.8	0.0	6.3	3.5	3.6	13.2	0.0	8.1	8.9	1.3	3.8	5.8	7.2	13.1	19.1	7.0	14.1	8.9	1.6	6.4	3.6	0.0	2.8	11.6	14.5	5.6	10.5	8.5	3.3	33.4	6.5	0.0	13.3	7.8	0.0	16.8	2.5	11.0	2.4
MCRIP1	"FAM195B, GRAN2, MCRIP"	ENSG00000225663	"MAPK regulated corepressor interacting protein 1"	C9JLW8	17	81822361-81833302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 209.6;Extravillous trophoblasts: 120.1;Hofbauer cells: 139.9;Pancreatic endocrine cells: 110.1;Proximal tubular cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045542	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045542: AB_2679363"	"unprognostic (3.11e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.08e-3)"	"prognostic favorable (2.26e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.86e-1)"	34.8	29.8	43.1	23.9	29.9	32.2	19.7	27.4	47.8	20.9	29.4	23.3	13.9	12.9	26.3	19.6	20.2	28.2	25.9	46.0	36.4	32.8	21.9	17.9	21.3	28.6	37.0	34.6	28.5	36.3	11.9	22.8	25.4	34.3	24.1	5.6	18.3	33.6	24.7	25.4	11.1	14.2	22.5	32.4	24.3	16.8	35.9	27.4	33.3	29.0	14.2	11.2	28.0	19.9	33.2	37.4	49.8	40.7	23.6	38.2	33.7	13.1	20.7	23.1	24.3	15.0	17.5	18.2	15.7	11.4	19.3	21.2	5.4	13.2	8.2	9.2	13.2	7.1	3.0	2.7	9.4	4.6	8.8	29.4	14.4	3.5	20.8	15.2	9.4	13.4	19.0	9.4	10.9	4.7	10.4	34.3	19.1	11.5	7.1	12.8	8.7	30.3	22.7	14.3	5.4	12.0	12.0	14.8	3.7	6.5	11.9	19.7	61.6	7.7	10.2	47.7	9.4	9.1	13.0	20.8	27.4	29.2	29.9	28.4	3.7	1.1	5.3	25.5	8.7	21.6	49.8	30.5	40.1	38.2	39.1	29.0	23.3	29.9	33.9	27.4	33.2	24.5	28.0	23.5	23.6	40.7	37.4	35.0	33.7	43.1	29.9	27.4	47.8	36.4	32.8	37.0	34.6	34.3	27.4	17.9	37.8	0.0	0.0	0.0	0.0	0.0	0.0	25.4	20.5	36.6	0.0	100.3	63.0	86.4	0.0	0.0	0.0	0.0	209.6	120.1	0.0	0.0	18.6	0.0	139.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	85.6	0.0	0.0	110.1	0.0	0.0	118.3	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0
WHRN	"CIP98, DFNB31, PDZD7B, USH2D"	ENSG00000095397	Whirlin	Q9P202	9	114402080-114505450	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 58.2"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0;memory CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.3;Karpas-707: 47.6;U-266/70: 29.9;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.43e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.44e-1)"	3.3	58.2	11.7	4.1	24.5	3.2	4.9	7.6	18.1	8.3	5.4	31.7	2.9	8.3	17.8	8.4	4.7	9.5	4.1	3.6	12.0	9.1	4.0	2.2	3.7	4.5	26.0	7.6	12.6	9.8	10.2	19.3	3.2	20.0	7.8	2.9	13.0	10.9	6.9	1.3	7.3	8.0	9.5	14.4	17.8	6.5	23.6	29.8	11.0	5.7	1.5	2.4	4.0	7.2	0.3	0.0	0.2	0.0	0.7	2.0	0.1	0.6	1.0	1.6	6.0	0.6	0.2	3.2	0.4	0.9	0.6	0.4	0.1	0.3	0.0	1.2	0.4	7.9	3.6	0.3	0.6	0.1	16.3	2.7	0.0	11.5	1.3	0.2	0.0	0.4	0.5	1.9	2.2	0.2	4.4	0.0	0.8	3.3	47.6	0.6	6.0	0.0	0.2	2.1	0.0	9.9	0.8	0.0	12.5	1.6	0.3	7.4	0.5	3.5	4.2	12.5	1.9	4.0	0.1	1.0	2.1	1.2	2.3	2.9	29.9	30.7	0.2	0.8	0.0	1.2	0.0	0.0	0.0	0.3	0.0	2.0	0.1	0.5	2.0	0.0	0.3	0.0	0.6	0.2	0.7	0.0	0.0	1.0	0.1	11.7	24.5	7.6	18.1	12.0	9.1	26.0	7.6	20.0	29.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	2.3	0.0	0.0	2.5	0.0	1.6	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	2.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883607-45886170	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	14.2	11.9	12.2	9.0	14.1	6.7	8.7	23.1	26.2	12.7	11.2	12.6	10.6	14.4	15.3	8.1	8.2	12.4	12.6	10.8	11.8	11.7	12.0	14.8	10.0	9.5	13.2	12.8	20.3	18.5	12.4	15.6	8.6	12.5	13.5	4.8	12.6	19.6	15.2	33.4	13.4	12.4	9.3	8.7	15.6	16.4	8.0	12.8	17.4	13.7	8.0	8.6	12.0	8.7	2.7	2.0	1.4	1.7	2.4	3.6	1.6	8.3	12.8	3.2	7.0	2.7	1.7	5.2	6.2	3.6	5.0	4.4	4.8	4.0	6.8	4.7	3.1	2.9	7.9	2.2	2.3	1.4	8.5	22.3	6.8	3.6	6.0	5.5	7.0	6.4	2.4	3.2	2.6	1.9	3.1	3.0	8.5	10.7	5.4	1.9	6.5	14.2	38.4	5.9	3.1	11.4	16.4	3.7	5.8	3.5	4.7	9.5	16.2	6.5	8.6	7.8	1.2	7.1	13.1	4.3	4.3	8.7	3.3	8.7	14.8	16.3	4.0	5.8	6.7	6.2	0.0	1.2	0.4	2.8	1.7	2.8	2.7	2.5	2.3	1.1	2.3	3.6	2.2	1.4	2.4	0.7	2.0	2.3	1.6	12.2	14.1	23.1	26.2	11.8	11.7	13.2	12.8	12.5	12.8	0.0	1.4	10.4	5.2	9.5	13.2	0.9	5.1	1.4	0.0	10.4	0.0	9.7	11.6	6.7	1.3	4.7	7.9	0.0	8.1	6.2	7.3	7.0	0.0	7.6	4.2	9.5	9.2	5.5	2.6	1.0	17.3	3.9	8.5	2.8	9.8	12.0	6.1	10.5	10.3	10.1	6.4	19.4	7.3	3.6	1.9	9.8	7.3	4.8	8.0	2.6
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.5	7.4	9.8	4.0	5.4	1.7	6.0	6.4	6.7	3.3	5.1	3.3	4.1	10.8	6.5	6.0	1.0	2.9	2.5	3.2	9.7	4.7	17.5	3.5	7.6	4.9	6.4	28.9	4.1	1.4	6.8	1.2	8.2	9.2	7.1	23.9	4.0	3.7	0.7	6.7	17.5	10.0	2.8	4.6	12.9	2.8	5.5	4.5	1.1	3.3	9.7	15.1	0.3	6.6	8.0	1.6	7.1	9.8	8.5	10.2	3.6	4.4	8.4	3.3	8.4	9.3	5.4	11.9	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9	8.9	6.9	13.0	3.6	3.0	15.1	5.6	10.2	1.4	2.3	8.7	13.7	3.7	0.0	5.4	14.0	13.1	5.1	46.7	3.8	1.6	10.6	2.2	17.3	11.5	11.6	17.5	12.7	14.7	10.0	25.8	10.9	14.4	1.7	23.4	4.0	5.1	2.4	0.0	7.8	5.0	10.2	6.5	7.1	5.4	8.1	2.0	1.5	8.6	5.2	1.8
EFHC1	"EJM, EJM1, FLJ10466"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 243.6;Early spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035307	Approved					NA	NA					"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.1	5.2	12.5	4.1	25.5	5.2	8.7	12.6	18.3	10.1	10.2	29.4	12.5	4.0	10.6	10.9	4.1	49.3	6.1	4.3	16.7	9.7	6.8	2.9	8.5	4.1	37.8	13.4	10.9	6.0	8.1	18.8	6.1	23.0	6.5	5.9	3.5	5.5	22.4	3.7	8.9	14.9	6.2	21.3	4.9	5.9	23.1	29.3	2.9	13.3	0.8	3.7	5.2	6.0	5.6	8.6	2.8	0.8	1.9	1.2	0.6	2.7	3.0	7.3	5.1	7.1	12.4	1.4	3.1	8.2	4.3	6.9	1.9	3.1	1.1	7.4	5.2	8.2	2.7	2.1	5.8	5.6	0.6	2.6	1.0	7.5	2.4	5.0	1.0	1.3	5.8	3.3	6.1	5.7	20.6	9.0	1.3	2.3	1.9	6.5	2.2	1.1	1.8	2.2	2.0	1.3	1.6	3.9	1.3	5.9	1.0	15.1	4.1	0.8	1.4	6.3	9.6	5.2	1.3	2.9	3.1	4.3	1.2	2.3	1.6	2.2	1.9	8.6	0.4	5.6	0.8	0.8	2.0	1.2	0.3	0.6	5.2	0.5	1.0	1.9	5.6	0.6	1.0	2.8	1.9	0.5	8.6	0.4	0.6	12.5	25.5	12.6	18.3	16.7	9.7	37.8	13.4	23.0	29.3	6.0	12.2	17.9	27.6	16.1	22.9	3.1	5.1	243.6	38.7	40.1	56.9	10.3	0.0	14.7	178.6	12.1	12.3	0.0	7.1	14.4	23.0	22.5	8.1	4.9	7.0	12.7	24.0	11.6	9.2	47.8	26.2	11.0	15.1	8.2	9.6	15.2	9.0	16.9	20.8	3.1	40.4	32.3	18.9	79.6	24.7	10.7	3.8	12.8	10.0	20.5
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	19.5	29.3	21.6	12.4	24.1	21.4	15.6	47.7	26.9	13.9	13.5	23.0	17.1	14.8	16.3	16.5	12.0	19.6	10.4	37.1	21.7	18.5	22.2	18.6	11.8	17.0	32.5	19.6	19.2	22.3	17.2	27.9	12.9	22.0	17.2	8.7	19.5	31.1	21.9	64.2	16.2	14.9	13.9	18.8	22.4	16.5	15.2	29.8	13.3	18.0	17.0	12.2	13.9	14.7	25.8	30.6	17.2	19.5	27.5	24.5	15.6	10.6	17.7	12.6	14.8	17.6	13.5	12.9	6.3	7.9	13.1	15.2	13.7	13.3	14.4	15.6	6.4	10.1	18.7	11.2	14.1	5.7	19.6	19.7	12.6	13.2	34.9	8.6	11.5	12.7	15.0	17.1	9.4	13.6	13.5	13.9	32.6	11.3	12.3	12.8	18.6	18.9	18.6	12.1	15.0	16.5	24.3	6.5	10.1	23.0	13.4	22.0	19.1	15.5	27.7	13.6	7.9	19.1	17.0	7.4	4.1	13.8	11.9	7.8	21.2	13.3	17.3	10.8	14.7	10.9	17.2	19.5	11.5	21.9	11.6	21.0	25.8	16.6	17.1	21.9	25.2	23.7	24.5	6.0	27.5	9.5	30.6	19.3	15.6	21.6	24.1	47.7	26.9	21.7	18.5	32.5	19.6	22.0	29.8	26.8	20.8	26.1	35.9	23.6	34.7	0.2	35.7	17.4	26.1	38.4	11.8	43.4	102.8	23.4	11.6	31.5	17.8	46.7	17.5	20.7	25.9	23.5	34.7	34.4	25.8	27.0	26.5	16.5	18.1	19.8	30.5	19.8	40.5	15.4	21.6	56.9	16.4	11.5	29.7	56.4	36.7	0.0	31.9	63.7	13.0	23.8	46.9	27.7	21.3	26.3
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2"	"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2	89.3	60.1	0.0	1.0	0.0	0.0	0.3	48.4	17.4	22.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	4.9	0.0	31.8	0.0	0.0	0.6	4.6	51.3	0.0	0.0	27.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	82.6	0.0	24.8	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	33.6	0.0
CCDC130	MGC10471	ENSG00000104957	"Coiled-coil domain containing 130"	P13994	19	13731760-13763296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056977	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA056977: AB_2683297"	"unprognostic (6.54e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.71e-1)"	"prognostic favorable (7.83e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.69e-2)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.82e-4)"	17.5	20.1	17.4	23.6	22.1	28.2	20.4	22.2	24.5	18.7	17.8	32.9	23.8	21.3	27.2	18.0	17.6	20.7	18.1	22.6	16.9	14.5	20.6	17.9	19.8	28.9	24.7	19.7	30.1	19.1	24.9	26.1	21.0	19.4	20.2	11.0	23.6	24.3	21.0	26.6	22.5	21.9	16.9	17.0	26.1	20.3	22.0	24.0	22.0	25.3	11.5	19.6	17.9	21.4	19.2	16.9	23.1	17.2	17.0	20.0	13.3	8.6	6.8	13.0	13.0	8.8	7.1	7.0	9.2	9.1	9.6	8.9	5.4	6.2	7.5	7.1	8.4	7.6	8.7	5.6	5.1	3.0	11.6	16.1	5.8	17.3	9.3	17.4	6.0	15.8	9.4	11.6	12.3	8.1	10.1	11.1	14.3	6.0	14.6	5.7	6.1	14.9	11.8	8.2	4.4	12.8	13.4	6.5	9.7	6.8	9.8	7.4	9.8	6.4	5.3	15.7	7.1	5.4	13.8	8.5	15.5	6.2	18.0	12.4	22.1	8.2	5.8	13.1	14.0	10.8	22.2	17.2	23.1	17.3	14.7	20.0	18.6	18.1	18.2	16.9	19.2	16.8	19.4	17.0	17.0	16.6	12.4	14.8	13.3	17.4	22.1	22.2	24.5	16.9	14.5	24.7	19.7	19.4	24.0	8.9	13.2	23.8	16.0	11.8	28.4	14.0	5.1	24.1	12.5	27.9	25.5	14.6	6.6	14.4	25.2	17.4	27.0	23.3	13.7	16.6	15.4	12.1	23.2	9.6	15.9	25.4	18.0	11.6	19.8	18.6	17.5	19.2	23.6	27.9	13.6	27.8	16.3	21.0	15.9	12.9	40.8	25.8	21.7	27.7	19.6	13.7	29.3	25.0	15.0	9.4
CERK	"dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4"	ENSG00000100422	"Ceramide kinase"	Q8TCT0	22	46684411-46738261	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064699			Approved	Vesicles		NA	NA			Vesicles		"HPA064699: AB_2685327"	"unprognostic (2.93e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.58e-4)"	10.6	15.5	10.6	16.7	10.8	14.5	12.9	29.3	21.7	10.8	14.6	9.8	15.8	24.9	14.1	7.5	10.0	15.3	18.9	36.5	11.4	16.8	15.2	12.1	10.6	19.1	21.7	13.1	22.7	23.2	7.2	33.3	7.9	23.9	8.2	12.2	12.3	11.8	11.6	12.8	11.9	25.1	12.5	10.2	14.5	14.0	6.0	6.5	39.2	16.1	8.7	19.5	10.7	17.4	2.0	4.9	3.6	6.9	2.0	16.4	3.6	9.4	5.7	27.8	8.7	16.0	12.1	2.6	16.6	13.0	9.5	6.7	8.3	3.2	13.2	7.8	17.7	5.8	6.2	11.7	7.5	9.8	4.6	12.6	5.9	14.4	10.8	11.1	18.4	1.5	10.1	9.7	10.4	3.6	15.4	28.2	14.2	4.4	17.1	17.4	0.7	12.4	9.2	12.5	3.8	6.3	23.3	31.5	15.0	5.7	0.1	25.9	23.6	8.1	3.9	17.5	6.7	4.3	14.1	25.6	19.7	10.5	14.5	24.0	17.8	21.5	8.3	21.0	10.5	16.0	0.6	2.6	3.0	9.4	6.0	16.4	1.8	9.9	9.0	4.5	2.0	5.8	5.4	3.6	2.0	6.9	4.9	8.6	3.6	10.6	10.8	29.3	21.7	11.4	16.8	21.7	13.1	23.9	6.5	8.9	20.5	11.9	5.1	3.1	21.3	35.3	5.1	0.0	15.9	1.8	5.9	1.9	13.3	11.3	5.0	14.8	26.5	0.0	10.3	1.3	7.3	1.3	9.3	19.8	9.7	25.4	13.8	28.8	27.0	9.4	8.9	13.6	3.3	5.4	2.7	19.0	8.9	15.0	14.2	13.0	10.1	0.0	12.0	0.9	1.6	3.9	1.5	20.8	15.1	0.9
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
SYNGR1		ENSG00000100321	"Synaptogyrin 1"	O43759	22	39349925-39385588	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.9"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029673, CAB034277"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB034277: AB_2255766, HPA029673: AB_10670430"	"unprognostic (2.68e-3)"	"unprognostic (1.84e-3)"	"unprognostic (5.90e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (1.32e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.04e-1)"	4.4	11.4	19.4	2.7	31.4	39.9	8.0	66.9	62.0	15.6	6.3	8.5	1.0	3.3	9.2	6.5	17.3	9.8	6.1	21.6	31.6	22.3	5.5	2.0	3.3	3.8	17.4	35.1	38.8	14.5	10.3	4.1	3.7	23.5	10.9	2.6	19.5	23.5	10.4	13.4	26.2	3.0	7.2	7.0	4.1	4.8	7.2	5.4	0.7	4.6	4.6	5.2	7.8	9.0	2.4	21.0	0.8	18.9	2.6	15.2	7.8	2.6	4.8	8.7	15.7	0.8	2.3	3.8	11.6	20.5	14.8	13.7	1.0	0.3	0.1	2.7	3.0	1.7	3.7	5.9	0.2	4.5	0.0	18.4	0.2	0.3	0.5	2.5	0.7	5.4	3.4	0.9	4.0	0.0	10.5	0.7	3.4	5.2	0.3	2.3	6.1	2.3	2.1	1.8	2.3	9.3	6.8	0.0	0.7	0.4	7.4	13.8	2.9	3.0	12.6	12.0	3.8	18.6	13.6	0.2	0.0	10.2	0.1	0.0	3.2	0.1	7.3	0.4	14.8	15.8	0.2	18.9	0.3	15.2	5.5	0.9	2.4	0.6	4.4	21.0	2.2	0.7	8.2	0.8	2.6	0.2	15.3	0.1	7.8	19.4	31.4	66.9	62.0	31.6	22.3	17.4	35.1	23.5	5.4	8.9	1.4	11.2	51.4	27.0	109.4	55.7	68.8	1.4	11.4	62.8	25.5	19.6	13.3	38.6	27.1	6.7	0.0	46.7	10.4	12.0	41.0	29.2	2.3	5.0	13.5	44.5	0.0	13.5	15.0	64.1	123.4	10.0	133.3	1.0	0.0	35.9	25.8	0.0	112.1	9.8	36.1	19.4	28.1	74.9	12.1	32.6	11.0	22.3	0.2	63.3
AKAP17A	"721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y"	ENSG00000197976	"A-kinase anchoring protein 17A"	Q02040	X	1591593-1602514	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043247, HPA051020"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA043247: AB_10964776, HPA051020: AB_2681314"	"unprognostic (4.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.91e-3)"	"prognostic favorable (2.42e-4)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.86e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.03e-2)"	"prognostic favorable (1.11e-5)"	7.4	10.3	28.1	14.5	42.3	18.0	24.5	27.5	25.2	32.8	7.2	2.5	2.5	14.2	40.9	9.7	9.2	9.1	7.4	12.5	27.1	3.4	20.3	16.4	12.2	15.4	37.6	27.1	38.0	15.6	5.2	31.0	42.7	33.7	12.6	4.3	2.5	17.0	7.8	6.9	12.3	11.6	3.2	27.8	21.4	14.2	7.0	37.2	2.5	16.1	2.5	8.9	6.8	47.6	1.8	1.8	7.0	1.0	1.3	1.6	0.4	9.6	12.5	10.0	11.3	4.9	6.3	24.5	10.5	4.3	8.5	7.2	13.8	9.0	14.6	6.8	5.2	12.0	8.5	6.0	5.2	5.1	12.0	20.8	18.2	12.0	12.8	10.6	7.0	30.6	5.6	9.8	6.3	7.0	10.1	5.8	7.4	11.3	9.3	4.9	6.4	15.5	30.5	14.9	2.2	10.8	11.8	11.9	12.2	5.7	6.8	11.2	16.4	8.2	13.4	12.7	8.6	8.7	12.9	11.2	13.3	6.1	11.4	9.1	40.2	6.7	20.3	5.4	11.5	3.5	7.0	1.0	1.9	0.8	0.5	0.9	1.8	1.0	1.6	0.6	1.2	0.8	0.8	4.1	1.3	0.8	1.8	0.5	0.4	28.1	42.3	27.5	25.2	27.1	3.4	37.6	27.1	33.7	37.2	23.8	25.9	29.8	31.3	39.4	23.2	9.9	7.6	10.7	21.6	12.2	9.8	20.9	11.6	17.7	40.2	26.1	21.4	0.0	13.4	24.6	26.6	35.0	25.3	19.5	20.2	15.9	21.7	29.4	20.6	11.0	35.9	36.0	38.8	27.9	23.5	23.7	19.9	24.6	29.7	5.7	13.9	0.0	25.5	16.3	30.3	41.3	60.8	37.0	20.0	42.9
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.9"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: AB_2681986"	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	13.6	10.3	27.8	10.9	27.0	4.9	7.1	26.3	56.9	7.5	6.3	23.3	3.7	7.2	13.2	8.6	6.3	6.5	7.6	17.5	25.4	27.6	6.1	5.0	11.0	7.8	30.8	31.0	10.7	8.4	9.4	10.6	16.3	34.0	9.2	6.6	5.4	7.1	9.7	28.6	12.3	6.7	15.0	25.2	9.8	7.2	6.9	25.6	2.9	7.2	4.0	6.6	6.5	6.4	0.5	0.6	3.8	0.7	0.7	1.5	0.3	12.6	4.9	11.6	6.6	10.8	4.1	11.3	7.7	5.8	6.7	8.5	3.4	2.9	2.8	8.0	7.4	13.3	5.3	9.2	4.9	6.7	43.6	5.2	1.1	6.3	3.6	6.1	2.7	6.5	4.3	5.0	10.0	5.6	8.3	11.0	5.0	2.7	14.0	5.2	2.5	4.2	3.8	7.5	1.7	7.3	5.5	1.9	2.4	4.8	2.7	3.7	11.8	6.6	4.8	3.8	11.1	2.4	2.8	13.0	7.4	5.8	15.3	10.6	3.7	5.3	2.4	21.2	6.4	13.0	2.3	0.6	3.8	1.5	0.4	0.8	0.5	0.8	0.4	0.5	0.4	0.6	0.8	2.0	0.7	0.7	0.6	1.4	0.3	27.8	27.0	26.3	40.8	25.4	27.6	30.8	31.0	34.0	25.6	6.0	3.5	2.2	2.9	5.6	18.4	10.5	0.0	1.4	1.2	3.5	3.9	8.2	0.0	5.2	12.0	14.3	0.9	0.0	4.2	12.1	5.6	5.6	2.3	2.4	5.2	50.9	10.4	5.5	4.6	25.8	3.4	2.3	8.5	3.6	1.6	8.5	5.6	1.4	5.3	2.1	10.5	6.5	8.2	10.3	2.4	5.6	17.3	4.4	0.8	2.6
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106872-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	3.6	2.7	2.9	4.4	6.4	2.9	3.6	5.3	6.8	2.0	6.1	4.3	5.4	5.3	1.6	11.9	3.7	4.3	3.8	2.5	1.7		2.9	2.9	4.5	6.3	3.2	3.3	1.2	8.6	2.1	5.2	1.8	3.7	3.6	3.8	3.8	5.6	11.0	1.0	3.6	5.4	2.7	2.5	6.0	5.6	2.8	3.4	7.1	5.0	2.3	5.8	3.2	0.0	3.6	3.6	5.0	3.2	7.8	4.7	1.5	6.8	14.5	0.5	3.2	11.5	4.3	8.0	4.0	11.1	5.5	6.2	3.4	5.4	5.1	6.6	4.9	13.8	12.0	2.1	6.7	1.8	6.3	2.0	4.3	4.1	3.3	7.6	1.3	13.5	7.9	6.4	2.2	5.7	7.1	6.9	11.3	3.1	8.6	5.1	7.2	5.7	3.9	0.8	4.2	3.5	2.6	1.3	5.5	7.9	6.0	1.6	2.4	2.9	3.5	3.5	3.6	8.2	7.2	5.5	3.5	1.9	4.7	2.1	3.8	0.4	1.6	6.2	3.9	8.6	0.1	2.9	5.0	4.7	3.2	4.3	2.6	3.7	2.7	2.0	3.6	4.0	2.2	0.7	7.8	2.3	3.6	1.4	1.5											3.0	2.1	5.2	3.9	1.8	3.0	1.6	12.7	2.7	1.2	5.2	0.0	5.5	5.0	6.8	10.6	3.0	15.0	0.0	11.8	8.3	3.9	3.7	0.0	2.5	12.8	3.2	2.9	4.9	19.5	10.0	2.8	3.0	5.0	12.6	7.0	3.7	8.6	11.5	3.2	8.8	1.3	0.0	2.8	2.6	2.0	1.6	2.6	8.5	6.3	2.2
PIFO	"C1orf88, FLJ23853, pitchfork"	ENSG00000173947	"Primary cilia formation"	Q8TCI5	1	111346288-111353013	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.9;fallopian tube: 96.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 720.1;Early spermatids: 388.2;Late spermatids: 350.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 55.9"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.5;hTERT-RPE1: 4.5;RPTEC TERT1: 6.2;RT4: 7.3;SuSa: 11.6;T-47d: 5.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (3.18e-3)"	"unprognostic (3.23e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.43e-4)"	"unprognostic (8.78e-7)"	"unprognostic (6.43e-3)"	"unprognostic (7.28e-2)"	"unprognostic (9.07e-3)"	"prognostic favorable (2.48e-4)"	"unprognostic (3.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.83e-2)"	1.1	2.0	6.6	1.2	10.1	0.8	3.8	0.7	3.9	4.4	3.0	15.9	3.5	1.1	4.9	15.5	2.8	96.8	2.7	6.4	8.6	8.6	5.4	0.8	10.8	0.9	5.0	6.5	9.2	4.2	5.1	13.8	4.3	55.9	7.5	1.4	4.2	2.2	4.3	0.9	1.6	1.1	3.4	4.2	1.0	2.6	26.5	5.4	0.4	8.8	0.1	1.1	5.4	0.6	1.6	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.1	0.7	0.8	0.8	0.9	1.4	0.0	1.7	0.4	0.0	1.3	1.4	0.0	0.3	0.0	1.5	0.0	1.2	0.2	0.0	1.8	0.2	0.0	0.2	1.1	0.7	0.0	0.0	0.9	4.5	0.0	0.0	4.5	0.0	0.4	0.2	0.1	2.6	0.1	0.7	0.0	2.6	0.1	0.0	0.0	0.0	0.0	6.2	7.3	3.1	0.3	0.0	0.2	0.2	11.6	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.5	4.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.3	1.6	0.9	1.0	0.0	0.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	10.1	0.7	3.9	8.6	8.6	5.0	6.5	55.9	5.4	3.0	14.4	0.0	7.4	3.8	0.8	12.3	0.0	720.1	70.5	5.2	3.9	7.2	18.3	11.6	388.2	0.9	0.0	0.0	1.9	3.6	3.9	10.1	0.0	0.0	1.1	0.0	2.9	0.0	0.0	350.3	5.5	2.0	8.5	0.0	0.0	10.4	1.5	0.0	3.2	19.3	5.4	6.5	2.0	97.0	7.2	2.5	5.8	0.0	0.0	2.6
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced	Approved				NA	NA					"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.25e-4)"	"prognostic favorable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.6	2.9	0.0	0.9	0.3	8.4	19.4	2.8	0.6	0.1	0.0	0.0	0.3	8.5	2.8	0.0	2.7	0.0	3.5	3.8	1.6	0.0	4.9	0.0	4.0	0.5	0.5	0.5	0.0	1.7	0.2	1.7	0.9	0.5	0.0	0.0	1.9	0.1	0.3	0.0	0.4	0.2	1.0	0.0	2.1	0.7	0.0	0.8	7.1	6.8	3.5	2.6	0.8	1.6	0.0	0.0	1.6	2.6	1.0	1.7	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9	0.0	0.0	0.0	0.1	0.5	18.2	9.1	2.5	0.0	1.2	3.5	15.7	0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.6	0.0	2.2	0.9	4.6	0.0	1.3	33.4	2.9	8.6	0.0	0.0	1.7	1.0	5.0	0.0	0.2	39.2	0.2	0.0	3.5	0.3	8.9	12.9	4.1	0.1	0.2	0.5	0.2	0.0	1.3	0.1
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 25.3;HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	6.1	0.4	0.0	0.0	0.0	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	50.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	5.6	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0	6.0	4.3	0.8	3.8	5.6	19.4	229.0	2.5	0.0	0.0	3.5	3.9	0.0	59.7	5.8	22.0	10.8	0.0	0.0	2.1	0.0	5.6	1.7	0.0	0.2	0.1	28.6	24.1	0.0	0.3	11.0	27.0	1.8	30.4	0.0	0.3	167.3	4.3	0.0	47.4	1.4	8.0	97.0	159.7	0.7	0.9	6.5	0.0	0.0	0.1	1.1
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell type enriched"	"Detected in many"	10	"Ito cells: 136.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 60.5"	"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in single"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	60.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.0	0.0	7.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2	0.0	5.8	0.0	0.4	1.3	0.0	4.8	5.1	0.0	0.0	14.0	0.0	0.1	0.0	0.6	8.0	14.2	0.0	0.0	0.0	0.9	3.9	0.4	0.0	1.5	0.2	0.0	0.0	136.2	6.0	7.9	9.5	0.0	0.0	9.0	0.0	0.0	0.7	0.0	3.9	2.8	0.0	0.0	0.9	0.2	0.1	0.9	0.6	0.0	0.0	0.0
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837386-19840684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"thyroid gland: 154.6"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 188.3;Muller glia cells: 371.8;Smooth muscle cells: 607.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 17.2;AN3-CA: 22.6;EFO-21: 51.6;HEK 293: 28.9;SCLC-21H: 46.6;SuSa: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	33.1	2.1	29.3	5.3	29.6	1.1	16.9	13.2	31.1	21.1	5.1	29.0	7.2	4.9	22.9	7.0	12.1	34.1	6.8	25.2	32.3	20.6	11.7	2.4	14.6	3.5	14.5	19.0	22.9	11.8	2.0	13.1	13.2	24.9	18.7	4.6	5.7	16.0	26.6	1.8	31.3	4.0	14.2	12.5	11.4	11.9	10.8	20.0	0.0	154.6	4.4	3.5	10.5	11.5	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	17.2	22.6	0.5	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	51.6	5.8	0.1	8.8	0.0	0.0	0.2	0.0	28.9	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	2.4	0.0	0.0	0.0	0.0	3.0	6.1	46.6	0.6	0.0	0.8	3.0	15.0	1.4	0.0	0.0	0.1	2.7	0.0	0.7	0.0	0.0	0.5	0.7	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	29.3	29.6	13.2	19.2	32.3	20.6	14.5	19.0	24.9	20.0	89.3	35.7	0.0	188.3	73.7	10.2	30.8	0.0	10.7	26.1	64.6	2.0	7.6	43.1	14.4	1.3	5.8	7.9	0.0	2.9	6.2	57.9	86.7	0.0	0.0	2.5	3.2	87.7	17.2	0.3	4.4	7.5	4.1	84.4	0.0	4.8	371.8	2.1	31.7	0.0	61.2	12.2	0.0	607.2	0.9	0.6	68.6	4.9	0.0	2.8	35.0
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.9	6.9	1.8	1.8	4.0	2.1	2.5	3.1	2.8	5.3	0.6	5.7	4.1	3.9	1.9	1.5	4.4	3.1	3.2	4.4	4.9	4.5	0.7	1.9	4.0	6.7	5.1	2.1	2.6	3.9	4.3	4.7	1.9	4.9	6.7	4.6	4.0	4.0	1.4	1.4	5.2	1.9	3.3	3.1	0.8	4.3	3.3	4.3	8.4	4.1	1.6	3.3	4.0	3.9	4.5	1.8	1.7	3.4	2.7	4.1	6.9	8.4	10.1	5.9	2.0	2.4	5.2	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2	3.0	7.4	11.5	5.5	3.3	4.9	5.2	2.5	5.3	3.4	1.8	5.9	4.0	6.6	4.2	2.7	3.6	5.8	0.0	5.3	4.8	4.4	3.2	5.7	3.9	2.9	3.2	5.2	6.7	7.2	6.6	2.6	4.4	3.3	3.6	4.4	6.5	5.1	8.6	4.2	3.3	7.7	0.0	5.0	20.2	8.1	3.6	8.4	13.8	3.7	4.7
ZNF358	"FLJ10390, ZFEND"	ENSG00000198816	"Zinc finger protein 358"	Q9NW07	19	7515292-7521026	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 103.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030887, HPA063624"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030887: AB_10602688, HPA063624: AB_2685064"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.52e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.60e-2)"	23.7	21.1	33.6	7.9	26.1	2.1	31.6	21.4	54.7	30.1	26.1	20.2	17.5	19.2	22.4	19.5	18.0	27.9	20.9	36.4	29.1	22.5	17.4	17.9	14.4	6.8	24.9	20.2	46.1	25.0	21.1	17.7	12.2	15.0	23.1	12.6	19.1	32.3	30.8	95.9	11.7	18.0	24.9	16.8	13.8	18.3	8.5	18.3	4.4	27.3	13.5	7.7	24.7	24.3	2.6	1.4	4.6	1.8	0.7	2.4	0.7	10.3	7.0	13.2	21.0	28.4	31.6	11.3	3.9	25.7	18.0	15.9	3.0	7.4	0.0	15.3	21.0	2.8	4.1	5.4	10.0	5.8	0.0	11.6	2.0	8.6	4.2	31.2	0.3	0.1	27.5	19.0	8.5	7.4	27.0	18.8	0.0	5.2	0.0	15.8	5.1	0.0	7.5	13.5	4.3	12.4	11.5	7.1	1.1	9.4	4.5	14.7	29.3	4.9	4.1	14.1	8.9	3.1	5.5	8.8	11.6	8.5	17.2	5.9	14.1	7.6	0.0	10.7	0.0	16.0	4.6	1.7	1.1	1.8	1.8	1.3	0.4	0.6	1.0	0.9	2.6	1.4	2.4	0.0	0.7	0.4	1.4	0.0	0.7	33.6	26.1	21.4	54.7	29.1	22.5	24.9	20.2	15.0	18.3	8.9	12.0	3.0	9.8	6.9	20.2	103.8	12.7	1.4	3.4	15.7	13.7	2.5	5.0	11.1	4.1	17.6	35.9	0.0	14.4	4.4	16.5	10.0	14.9	38.9	8.8	47.7	35.1	29.4	15.9	4.7	35.1	7.1	5.0	2.8	27.3	32.3	15.6	17.5	35.0	24.2	15.2	12.9	19.8	0.5	0.7	3.1	2.5	3.9	19.2	10.4
PIGT		ENSG00000124155	"Phosphatidylinositol glycan anchor biosynthesis class T"	Q969N2	20	45416067-45456934	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (6.06e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.18e-3)"	"unprognostic (6.68e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (5.48e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-2)"	35.8	36.6	14.8	20.8	27.0	34.8	33.0	18.2	42.8	40.6	43.0	58.4	24.9	27.6	46.7	52.0	24.8	35.5	36.1	63.8	19.0	21.0	36.5	44.4	27.9	22.1	39.7	20.4	34.2	51.9	53.1	32.7	40.0	33.6	28.1	46.2	34.7	33.6	34.1	38.0	29.1	35.2	40.9	33.2	25.6	35.7	34.5	30.0	20.7	32.6	27.2	26.7	33.2	28.9	11.0	36.1	23.8	31.8	20.5	23.4	27.9	15.7	21.3	7.2	27.4	45.7	33.0	14.6	18.9	35.1	26.5	20.8	40.3	25.1	9.5	24.8	28.7	21.6	29.3	9.4	26.0	16.1	5.2	12.4	9.5	19.9	21.4	21.6	19.1	38.7	25.0	24.6	21.8	23.0	38.0	24.9	8.4	12.8	34.2	22.7	36.3	8.3	14.4	6.1	45.6	38.4	6.9	22.5	32.8	21.6	11.0	12.0	15.5	36.4	35.7	18.1	13.8	31.4	34.4	20.6	62.6	29.1	11.7	26.2	18.1	27.6	6.0	40.0	14.7	28.2	16.9	30.0	23.8	23.4	31.8	17.2	11.0	16.6	21.5	36.1	10.2	14.7	16.9	11.6	20.5	28.4	27.4	22.2	27.9	14.8	27.0	18.2	42.8	19.0	21.0	39.7	20.4	33.6	30.0	38.7	25.6	36.6	35.3	26.7	17.1	144.4	43.3	34.8	28.4	41.8	13.7	53.8	11.6	95.7	25.7	50.4	91.6	0.0	101.2	63.1	72.5	39.2	32.4	35.1	69.3	36.5	63.0	45.4	48.8	59.4	56.1	37.3	84.4	40.5	121.3	22.9	66.4	42.1	52.6	20.7	11.9	64.7	44.2	57.7	99.9	24.3	43.6	52.0	96.0	43.4
THEM4	CTMP	ENSG00000159445	"Thioesterase superfamily member 4"	Q5T1C6	1	151873584-151909808	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 30.5"	"Low region specificity"	"Detected in all"							HPA028161	Approved					NA	NA					"HPA028161: AB_10603454"	"unprognostic (2.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.15e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-3)"	8.3	15.3	8.4	9.8	11.7	4.9	12.2	19.8	13.2	6.6	8.0	11.3	22.4	8.5	10.3	18.0	6.1	8.5	7.2	9.8	8.7	11.9	19.9	13.4	8.9	15.7	10.8	6.4	9.2	15.9	10.9	21.0	6.3	11.1	8.0	11.6	14.9	9.2	23.1	18.3	6.7	8.1	7.9	10.0	9.2	9.6	10.2	11.8	3.1	11.3	6.4	13.6	11.3	8.3	3.0	5.0	1.8	1.6	6.2	18.6	2.8	3.7	4.3	1.0	3.5	3.7	3.0	3.4	3.1	3.8	4.3	3.5	4.8	3.3	10.2	5.0	4.6	2.0	4.0	2.9	10.0	4.3	10.6	2.0	13.8	6.0	5.5	3.5	15.9	4.5	5.9	4.4	4.5	4.5	3.5	7.2	0.1	17.3	7.8	6.2	6.4	0.0	4.2	18.0	4.5	7.6	0.0	0.8	2.6	5.1	3.7	4.6	8.3	2.2	4.0	30.5	3.7	10.4	6.6	6.2	0.4	3.8	2.9	1.3	12.7	16.4	6.5	6.5	8.7	20.3	1.5	0.6	1.8	6.1	1.6	9.1	3.0	12.7	6.0	2.0	1.5	12.3	8.7	0.4	6.2	0.5	5.0	18.6	2.8	8.4	11.7	19.8	13.2	8.7	11.9	10.8	6.4	11.1	11.8	6.0	13.7	16.1	7.2	4.9	35.0	16.1	12.7	5.3	12.5	14.0	98.2	25.2	34.9	15.2	30.2	12.0	7.0	0.0	16.8	13.9	14.6	5.0	23.1	15.3	11.4	12.7	17.4	21.5	3.1	23.7	15.5	10.4	20.3	9.0	7.0	23.7	12.7	11.4	15.2	21.4	70.5	12.9	10.8	26.5	20.0	3.9	8.6	24.5	12.8	3.5
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
TMEM240	"C1orf70, SCA21"	ENSG00000205090	"Transmembrane protein 240"	Q5SV17	1	1535174-1540453	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 3.4;Peritubular cells: 2.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.5;HHSteC: 9.1;SCLC-21H: 10.8;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066721	Supported					NA	NA					"HPA066721: AB_2732750"	"unprognostic (2.24e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.52e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.52e-4)"	"unprognostic (9.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (9.50e-4)"	"unprognostic (2.64e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.93e-1)"	3.8	4.7	10.8	1.7	17.1	0.8	1.7	24.3	21.8	4.6	5.1	1.8	0.9	1.2	9.1	2.2	1.7	4.2	2.5	3.5	12.2	7.9	1.5	0.8	2.4	1.2	5.6	10.3	10.3	2.1	3.3	3.9	3.7	5.0	4.7	1.5	2.5	4.1	7.9	6.9	2.8	2.9	5.1	2.8	2.6	1.7	2.1	4.9	0.3	1.5	0.2	0.9	2.8	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	1.0	6.7	0.7	1.2	5.0	1.5	4.1	2.2	4.3	2.4	0.0	0.4	0.8	0.8	2.1	0.3	2.4	0.1	0.2	0.7	4.1	9.5	0.5	3.1	1.2	9.1	0.0	0.9	6.2	1.9	1.5	0.3	5.1	4.4	0.6	1.3	0.3	0.1	0.2	0.6	0.8	4.2	0.1	1.5	3.8	1.2	0.9	0.4	0.0	10.8	13.2	1.4	0.5	4.3	0.1	0.6	0.0	2.2	0.6	1.9	0.8	1.9	2.0	0.5	0.5	2.3	2.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	17.1	24.3	16.5	12.2	7.9	5.6	10.3	5.0	4.9	0.0	0.0	0.0	0.2	0.0	3.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	3.2	0.0	1.3	0.0	0.0	1.1	0.0	0.0	0.0	0.9	3.4	0.1	0.0	2.1	0.0	0.5	6.5	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.1
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4273772-4305350	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	13.7	39.3	20.8	12.0	15.9	23.6	10.4	6.1	22.3	14.4	28.3	8.1	24.3	18.5	21.9	41.9	12.2	16.5	9.1	36.9	17.5	7.3	6.0	5.7	12.8	24.5	7.9	17.0	11.6	18.4	8.3	19.2	23.5	9.3	16.4	24.2	14.1	8.3	22.4	2.0	9.2	19.6	45.5	14.0	16.5	11.1	5.2	8.6	6.2	18.5	6.9	13.6	22.3	16.3	3.9	2.1	4.6	1.0	9.1	14.8	5.4	0.0	0.0	32.3	0.0	5.6	0.8	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.2	0.0	0.0	4.1	0.9	29.5	0.0	49.7	0.8	0.3	0.0	0.2	0.1	12.6	2.7	10.8	4.9	0.0	22.3	0.2	0.0	0.9	3.4	71.8	6.3	0.0	0.0	16.6	13.3	0.2	0.0	0.0	47.0	23.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.1	2.3	0.0	9.4	0.0	0.0	1.2	12.2	0.0	0.1	9.1	0.0	4.1	1.0	4.6	9.1	0.2	13.7	3.9	13.0	11.0	2.1	1.5	8.2	9.8	1.5	9.1	0.1	1.0	14.8	5.4	20.8	15.9	6.1	22.3	17.5	7.3	7.9	17.0	9.3	8.6	56.6	49.3	25.1	24.4	94.8	6.8	305.9	0.0	9.4	43.3	12.2	0.0	2.6	0.0	2.5	0.7	38.4	26.9	46.7	59.7	1.7	135.6	5.7	54.3	0.8	12.0	3.2	62.3	17.8	13.3	0.9	48.6	38.9	37.1	6.4	146.6	155.3	32.6	35.1	116.7	1.0	3.7	25.8	50.5	0.7	3.6	34.6	5.3	61.2	109.0	7.0
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: AB_2681266"	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.12e-4)"	25.7	29.6	31.0	29.6	33.7	35.4	17.4	50.8	46.2	27.4	21.6	28.4	23.1	25.8	30.2	27.4	15.7	26.8	19.4	21.0	30.3	24.6	32.2	20.0	18.2	26.8	30.5	26.5	42.8	24.2	31.0	38.4	17.3	28.6	28.4	20.9	21.3	23.6	34.8	38.1	18.9	25.7	24.8	43.4	29.4	20.1	23.4	34.3	23.5	26.9	11.1	25.2	24.1	32.7	11.4	9.3	24.3	9.5	6.4	13.3	5.6	17.8	23.3	17.0	12.5	16.7	10.8	19.8	17.0	9.3	10.7	10.1	29.7	13.0	34.2	15.6	8.5	8.7	16.5	20.7	10.6	17.7	23.7	22.1	26.0	23.7	23.0	9.7	21.7	24.5	10.7	11.3	15.6	12.1	10.6	10.4	12.4	24.9	17.3	12.6	20.0	25.9	20.7	29.0	14.0	24.7	32.9	14.7	19.0	12.0	30.6	16.0	14.9	22.6	10.4	13.7	11.4	15.4	13.4	16.4	13.2	13.8	16.5	23.2	23.0	20.5	24.8	13.6	18.9	21.6	24.3	9.5	15.8	11.9	8.2	13.3	10.3	10.5	9.2	8.3	11.4	11.7	9.1	18.3	6.4	8.5	9.3	9.5	5.6	31.0	33.7	50.8	46.2	30.3	24.6	30.5	26.5	28.6	34.3	38.7	42.6	34.8	47.8	41.4	64.3	26.8	12.7	65.6	37.5	31.4	70.7	37.5	19.9	41.3	5.9	42.1	42.8	23.3	38.9	37.8	33.4	47.8	39.5	21.3	27.2	41.3	41.2	22.7	23.2	5.1	67.0	39.7	25.3	49.5	33.1	83.1	36.3	42.1	61.9	50.7	79.7	45.3	49.5	61.2	74.7	36.6	27.0	50.7	37.9	44.8
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	20.1	23.5	20.1	10.9	22.7	4.7	20.6	27.9	38.3	26.3	21.8	19.8	13.7	9.2	22.8	22.7	16.6	22.5	15.1	22.3	19.6	18.3	15.6	6.3	21.4	10.7	21.0	19.4	35.1	16.3	70.1	15.4	14.6	25.8	22.3	9.9	26.2	19.9	30.0	21.4	14.8	11.3	22.3	20.2	18.7	14.2	10.6	14.7	8.2	23.9	9.5	12.7	23.4	24.7	1.8	1.3	1.4	4.6	2.0	3.5	1.5	6.3	8.7	2.2	4.2	23.5	12.2	4.0	8.9	12.9	8.1	8.1	2.9	3.1	0.6	7.1	16.9	5.9	10.1	2.2	12.5	5.9	10.1	3.8	3.2	7.1	2.0	6.6	0.6	7.6	8.5	13.1	7.8	10.0	19.1	7.0	2.4	1.0	2.1	8.9	4.2	2.2	1.3	0.9	2.6	4.2	4.0	3.8	0.9	9.9	5.4	1.3	3.3	3.9	2.8	4.1	4.1	5.2	1.4	9.7	9.1	3.6	8.6	7.3	3.8	2.6	0.4	9.8	2.0	4.7	1.1	0.9	1.4	3.2	1.4	3.5	1.6	2.6	2.6	0.7	1.8	3.4	3.1	0.6	2.0	4.6	1.3	1.3	1.5	20.1	22.7	27.9	38.3	19.6	18.3	21.0	19.4	25.8	14.7	47.6	49.8	8.2	16.6	27.2	75.9	76.7	22.9	17.4	19.4	19.2	64.8	8.5	3.3	13.6	34.6	26.1	5.4	0.0	12.4	1.9	17.3	18.9	12.8	7.8	11.9	69.9	16.7	22.1	26.3	41.2	48.1	17.7	16.9	5.4	10.3	24.7	16.4	7.0	65.7	8.9	38.5	32.3	30.9	5.4	4.1	20.6	4.3	20.1	7.6	11.1
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 194.8"	"Cell type enhanced"	"Detected in many"	6	"Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (3.30e-4)"	15.4	0.7	1.0	5.2	1.0	3.9	12.5	1.3	1.1	2.5	172.9	1.1	1.2	76.6	2.4	4.4	1.8	3.2	7.2	2.1	1.7	0.8	3.7	7.0	2.2	2.9	1.7	0.8	4.4	1.3	1.1	1.3	2.0	1.7	2.2	2.4	0.8	1.4	1.2	1.1	2.1	194.8	1.6	2.3	5.7	1.7	2.4	1.4	1.0	1.8	1.3	2.3	2.7	3.0	1.0	1.8	1.7	1.2	0.8	1.9	1.4	2.2	6.9	3.7	5.8	5.8	4.7	2.5	2.2	2.8	2.7	4.0	4.6	2.6	7.4	3.9	1.4	4.5	4.2	6.1	1.3	2.7	9.2	12.9	3.4	3.9	5.9	5.1	3.8	7.5	4.5	6.1	3.6	4.7	5.9	2.2	7.5	16.0	12.1	2.1	7.7	6.0	21.9	2.9	3.3	4.8	8.2	3.2	6.1	1.6	2.8	3.6	12.7	2.0	3.8	10.6	5.3	3.5	7.7	3.2	9.0	7.8	13.6	2.6	12.8	16.0	7.9	2.5	10.0	5.2	0.2	1.2	0.1	1.9	0.7	0.6	0.4	1.9	0.2	0.8	1.0	1.3	1.4	1.7	0.8	0.9	1.8	0.8	1.4	1.0	1.0	1.3	1.0	1.7	0.8	1.7	0.8	1.7	1.4	3.0	1.4	5.2	5.3	6.1	17.9	0.8	12.7	5.3	7.9	21.0	29.5	4.1	11.6	4.4	13.8	6.7	24.5	0.0	5.8	3.2	6.0	5.3	0.0	8.1	2.4	14.3	11.6	4.9	1.9	3.0	14.1	2.9	6.8	3.6	27.6	4.1	4.8	25.4	2.1	2.2	21.1	6.5	2.5	6.0	6.3	4.5	4.2	8.2	51.4	2.7
EID2B	"EID-3, FLJ38944"	ENSG00000176401	"EP300 interacting inhibitor of differentiation 2B"	Q96D98	19	39530990-39532854	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 20.7"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 29.5;Horizontal cells: 30.2;Rod photoreceptor cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA064185	Approved					NA	NA					"HPA064185: AB_2685207"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.41e-3)"	"unprognostic (1.08e-3)"	"unprognostic (4.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.92e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.20e-2)"	3.7	7.9	9.6	4.1	20.7	2.5	3.4	17.3	16.3	3.7	3.4	4.5	2.1	2.9	7.1	6.2	2.8	6.3	2.9	6.2	8.6	14.6	3.7	1.3	3.7	6.1	6.6	12.6	11.4	3.2	3.4	10.4	2.6	9.1	4.4	2.4	5.6	3.1	4.7	3.9	2.1	2.7	3.6	4.9	5.4	3.1	7.7	5.1	3.6	7.7	1.2	3.3	2.9	2.7	5.2	3.5	5.4	3.0	6.8	10.3	3.1	2.4	5.1	5.8	6.4	3.8	3.6	1.3	3.8	3.0	6.4	5.9	0.8	1.6	5.0	2.2	2.4	3.2	0.8	2.9	2.6	4.7	7.6	7.9	2.2	5.7	3.0	3.3	2.2	4.0	3.5	1.9	3.6	1.9	2.4	2.8	11.2	2.4	7.1	3.1	2.2	4.3	3.9	1.5	0.9	2.8	5.7	5.5	2.4	3.1	0.8	8.1	5.0	7.7	0.3	3.0	2.5	0.7	1.2	1.9	4.8	8.5	4.6	4.9	5.2	7.3	3.5	2.6	5.2	2.5	0.6	2.7	5.4	4.5	2.8	4.2	5.2	5.3	6.4	3.5	5.2	10.3	6.7	0.9	6.8	3.0	3.4	3.3	3.1	9.6	20.7	17.3	14.3	8.6	14.6	6.6	12.6	9.1	5.1	6.0	0.6	9.9	0.8	1.3	29.5	3.5	0.0	10.7	10.3	8.7	23.6	2.6	10.0	3.4	1.5	2.8	0.0	0.0	2.6	0.9	4.5	0.5	4.6	1.0	3.2	30.2	5.8	1.8	4.3	0.4	14.1	4.0	8.5	3.6	0.0	20.1	1.8	0.2	10.6	3.7	28.8	12.9	4.8	22.4	8.6	0.5	0.7	8.7	0.0	0.3
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA045415: AB_10964575, HPA060791: AB_2684367"	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.5	2.0	4.0	4.1	3.0	7.7	3.5	3.8	3.3	3.6	3.0	3.4	4.3	7.8	2.7	3.4	6.9	2.9	4.0	1.1	12.9	12.1	3.3	5.4	4.7	4.7	1.9	7.3	3.1	4.3	3.0	3.5	3.2	5.3	6.5	3.6	9.2	2.0	5.3	6.5	5.6	1.4	3.0	6.3	7.9	2.4	6.5	4.5	2.8	2.3	5.3	3.7	2.7	2.9	2.0	4.0	3.1	4.4	2.1	1.8	3.4	3.7	14.0	6.2	2.0	3.0	7.0	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5											8.9	8.3	18.6	2.3	0.0	19.9	0.0	10.2	0.0	1.2	5.2	5.9	17.2	6.6	8.9	1.7	5.3	11.9	0.0	15.4	9.9	1.0	2.8	3.5	5.8	18.2	17.5	1.2	8.6	20.3	2.7	5.5	8.7	0.0	23.4	10.5	20.4	10.0	12.4	6.3	7.4	16.6	32.3	0.0	6.7	1.1	0.0	5.1	21.8	9.0	1.4
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.6	15.0	0.0	24.3	14.7	0.2	16.2	15.0	4.5	12.1	0.0	3.4	0.0	22.3	16.3	8.5	2.2	5.6	6.1	7.1	18.7	0.9	5.0	0.0	2.0	8.0	0.2	6.5	12.2	0.5	2.6	1.9	4.2	6.8	5.4	2.8	20.1	4.9	9.6	13.3	4.3	4.2	0.0	3.1	8.4	1.9	10.5	8.2	0.0	0.1	11.4	0.0	4.4	6.7	11.8	2.1	3.8	7.9	6.2	7.2	3.7	0.8	12.0	15.1	2.1	11.5	7.0	7.8	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3	6.0	11.8	20.4	7.1	7.1	37.4	7.9	22.9	9.4	18.2	12.2	9.8	2.2	11.6	27.6	0.8	20.5	1.0	0.0	9.3	1.3	39.5	9.9	12.7	13.6	12.7	35.0	15.2	30.7	2.5	2.1	43.7	7.1	20.3	10.8	6.4	51.7	5.9	7.0	60.1	14.4	15.4	25.8	37.6	1.2	1.7	5.5	1.4	10.7	4.5	3.0
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50288304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	12.1	16.9	17.5	20.0	20.3	40.3	12.4	42.4	23.1	15.7	15.2	15.7	18.7	18.3	16.8	10.2	15.5	19.8	17.5	13.6	18.2	12.2	16.5	14.9	13.9	23.6	22.6	13.1	23.6	32.8	13.7	14.3	22.4	18.7	15.6	9.1	14.1	24.7	19.4	12.1	17.2	15.1	17.7	11.7	19.3	17.3	15.5	20.3	25.8	15.5	14.0	18.6	17.5	20.1	22.0	16.6	24.5	16.9	16.0	21.1	15.0	8.3	11.3	8.6	16.2	7.0	4.9	17.8	11.0	7.6	11.0	9.7	8.3	6.3	23.7	5.7	5.0	6.5	13.7	14.3	10.4	3.1	19.4	12.7	19.1	12.4	13.1	5.0	44.7	20.8	4.8	8.1	12.0	6.2	4.0	7.4	18.7	11.8	20.3	5.5	11.8	26.5	22.0	18.9	4.2	7.6	26.7	8.9	19.1	5.9	5.0	18.1	17.4	8.6	5.6	6.9	5.1	7.1	18.9	11.2	15.4	9.8	6.8	9.3	35.0	24.6	19.5	9.7	16.6	13.1	17.7	14.1	24.5	19.2	16.9	21.1	22.0	17.7	19.3	16.6	21.7	19.6	16.2	6.2	16.0	13.1	12.1	19.6	15.0	17.5	20.3	42.4	23.1	18.2	12.2	22.6	13.1	18.7	20.3	17.9	27.2	14.9	11.2	23.8	13.6	6.3	12.7	13.4	20.5	17.4	13.7	32.2	11.6	16.2	12.1	17.9	26.6	0.0	19.0	32.2	14.6	10.7	8.1	12.8	19.3	7.9	33.9	16.0	17.5	7.0	18.4	21.2	8.5	16.2	22.0	17.1	18.2	22.4	18.4	10.6	11.7	6.5	16.4	48.7	18.1	26.3	31.0	27.4	23.1	9.4
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.8	3.4	6.3	3.6	1.5	6.6	3.5	1.8	2.9	2.0	5.2	5.0	0.0	4.2	3.5	4.8	6.8	5.4	3.8	1.6	2.7	7.3	4.1	10.0	3.1	2.7	4.7	7.8	4.1	5.3	2.5	2.8	5.6	3.0	8.9	5.9	2.9	1.8	3.9	0.4	4.5	1.5	9.5	8.8	8.6	11.7	3.0	1.5	12.9	2.9	5.7	5.6	25.9	2.6	5.3	9.1	4.4	3.9	5.6	4.2	4.8	3.4	6.9	1.2	2.0	2.3	8.7	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0	0.0	13.6	6.4	3.8	3.9	10.7	4.8	7.6	0.0	6.8	10.4	33.4	4.2	0.0	3.5	1.5	6.5	16.4	0.0	3.6	3.8	4.8	7.4	4.7	10.6	7.5	7.9	25.1	9.8	10.8	1.0	3.1	8.2	0.0	5.4	15.9	5.6	2.5	11.5	1.8	1.7	24.7	12.9	6.0	2.2	1.4	5.1	5.6	5.7	18.8	4.1
ELP5	"C17orf81, DERP6"	ENSG00000170291	"Elongator acetyltransferase complex subunit 5"	Q8TE02	17	7251416-7259940	"Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 320.1;Late spermatids: 402.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023279, HPA052411"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023279: AB_1847613, HPA052411: "	"unprognostic (3.73e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.30e-2)"	12.4	18.2	14.0	13.6	14.0	11.8	10.4	14.1	17.8	11.1	15.5	12.2	13.3	11.4	13.1	13.5	10.9	12.6	11.9	23.0	13.2	12.0	16.5	21.3	9.1	15.0	13.6	12.8	15.2	10.6	9.6	15.9	12.6	12.5	14.0	11.0	16.4	20.9	12.7	28.3	7.8	14.6	18.0	11.2	14.1	10.7	103.3	12.4	23.6	15.7	17.2	16.1	11.6	11.0	31.1	36.7	16.3	29.3	27.6	34.7	21.5	12.4	35.3	15.9	14.4	28.0	22.2	6.9	11.2	13.3	18.0	16.7	35.2	8.2	24.8	12.4	17.8	31.6	9.4	40.2	26.4	13.0	15.3	56.6	22.8	11.9	32.0	13.9	16.2	9.0	15.6	19.9	12.2	24.3	11.4	15.3	31.6	15.7	6.7	27.9	21.1	41.0	31.0	13.1	13.1	24.5	35.3	17.9	13.4	20.0	11.8	7.8	15.5	21.8	6.6	17.2	16.6	9.4	11.8	17.3	10.4	12.2	19.9	17.8	7.8	10.4	28.8	18.9	15.8	13.4	16.3	25.3	12.4	27.9	29.3	34.7	31.1	24.9	25.5	30.0	31.0	26.4	31.2	4.4	27.6	19.3	36.7	33.8	21.5	14.0	14.0	14.1	17.8	13.2	12.0	13.6	12.8	12.5	12.4	8.9	9.4	30.5	41.1	19.6	21.3	59.0	10.2	6.7	18.2	43.6	19.6	35.0	82.9	28.6	320.1	27.1	27.3	0.0	11.8	67.2	24.2	62.2	6.9	20.8	36.0	27.0	40.0	14.1	10.8	402.6	31.7	24.4	20.3	27.1	33.9	22.3	22.6	35.1	31.1	76.9	29.6	38.8	32.4	100.6	36.9	19.1	48.4	32.0	48.2	43.2
FBXO44	"FBG3, FBX30, Fbx44, Fbxo6a, MGC14140"	ENSG00000132879	"F-box protein 44"	Q9H4M3	1	11654375-11663327	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.7"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003363	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003363: AB_1078831"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (2.63e-4)"	"unprognostic (2.57e-2)"	"prognostic favorable (6.29e-5)"	"unprognostic (1.34e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.02e-3)"	6.6	21.1	26.6	8.3	39.0	5.3	7.0	61.7	45.0	6.5	5.0	12.3	8.9	14.2	8.5	10.3	7.7	12.1	10.5	13.7	28.7	26.4	12.2	7.7	8.1	16.3	20.7	27.4	11.3	17.8	21.7	19.5	2.4	23.1	13.7	3.4	9.9	25.5	15.4	6.4	22.1	7.8	6.2	14.2	13.4	8.1	8.5	15.3	3.2	13.0	3.3	9.9	7.4	7.5	10.9	5.1	1.5	2.5	1.5	11.7	6.1	7.5	12.2	4.5	17.2	6.7	7.0	6.1	6.1	7.4	6.7	5.8	8.9	14.3	0.2	13.6	6.7	11.2	1.9	9.0	20.3	2.8	8.6	11.0	0.2	6.6	14.8	9.3	0.2	1.1	9.0	13.5	6.3	4.8	13.9	5.2	14.1	4.6	1.9	1.7	4.7	12.6	1.4	4.7	6.8	8.7	5.1	0.2	2.5	10.8	2.7	13.7	11.3	16.0	6.2	27.0	5.8	11.1	6.9	6.4	4.9	11.9	6.5	4.8	12.7	7.1	4.6	11.3	3.2	11.6	1.1	2.1	0.6	11.7	2.4	9.0	10.0	8.0	8.9	3.3	10.9	10.9	7.5	1.5	1.5	2.5	5.1	7.1	6.1	26.6	39.0	61.7	45.0	28.7	26.4	20.7	27.4	23.1	15.3	0.0	9.0	9.1	10.8	16.4	20.1	3.6	5.1	2.7	5.7	15.7	13.7	1.3	26.6	8.0	3.6	3.8	0.8	0.0	5.7	2.4	10.1	9.3	3.5	3.9	5.1	38.1	4.1	5.5	6.2	9.9	21.3	5.0	10.1	5.4	2.0	14.8	6.5	1.1	27.3	9.1	6.8	0.0	6.6	11.1	7.2	14.9	0.7	20.0	2.1	4.7
PBXIP1	HPIP	ENSG00000163346	"PBX homeobox interacting protein 1"	Q96AQ6	1	154944076-154956123	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 200.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"Karpas-707: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006949	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA006949: AB_1079572"	"unprognostic (6.17e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (8.94e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (7.19e-4)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.64e-4)"	"unprognostic (1.20e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (3.89e-1)"	"unprognostic (4.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.26e-3)"	25.3	48.1	35.4	24.9	54.9	13.7	19.9	18.3	31.4	26.8	36.2	26.1	28.1	25.5	28.3	29.8	23.6	22.8	31.1	21.9	46.6	28.6	18.1	13.3	22.6	28.6	41.8	34.4	50.1	17.6	42.4	56.7	21.2	47.8	26.4	14.3	38.6	20.7	48.3	57.2	13.2	28.6	52.6	29.0	27.5	28.1	15.9	33.8	27.9	33.1	22.4	26.8	37.5	25.7	9.2	4.0	42.9	6.6	13.0	46.8	14.4	1.0	2.7	4.3	2.9	15.1	4.7	3.2	3.6	8.0	1.7	3.4	0.7	3.5	4.3	11.6	4.3	2.5	3.8	1.0	2.3	1.2	2.3	1.6	1.0	3.6	2.7	7.0	1.2	12.2	7.1	3.8	2.2	0.4	20.3	6.5	3.4	0.5	159.6	4.3	1.5	2.4	3.8	1.6	2.7	2.0	2.8	6.2	9.5	4.8	2.0	0.7	5.5	4.6	1.4	3.6	8.6	4.5	5.1	6.1	1.7	1.3	1.1	1.1	21.9	18.3	1.0	6.2	1.7	1.3	26.7	2.5	42.9	11.0	3.6	30.4	9.2	29.5	17.2	2.2	5.7	19.7	12.1	23.7	13.0	6.6	4.0	46.8	14.4	35.4	54.9	18.3	31.4	46.6	28.6	41.8	34.4	47.8	33.8	62.5	78.3	31.8	22.2	9.0	23.1	34.4	22.9	26.8	37.5	40.1	15.7	14.6	0.0	37.4	112.5	21.6	20.0	23.3	16.1	20.0	28.9	16.8	49.8	14.3	13.0	1.6	80.4	24.5	16.1	134.8	59.5	13.3	25.3	31.5	22.2	200.0	21.7	25.9	121.3	9.1	6.5	51.8	57.0	2.4	12.9	10.0	22.7	93.7	14.3	12.9
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 78.9;Late spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	13.0	20.5	6.2	8.1	5.2	7.8	15.7	8.6	4.4	5.5	6.2	27.9	7.5	7.7	15.9	5.5	6.4	7.2	5.0	7.0	2.3	9.6	28.7	6.9	18.2	18.2	11.1	7.6	10.0	8.5	4.0	8.3	5.2	3.9	10.9	5.9	10.7	4.4	2.9	18.3	9.3	19.3	13.6	8.2	24.0	15.1	4.8	7.8	7.1	20.0	11.0	12.1	4.8	7.4	8.6	4.7	4.7	8.4	16.8	10.1	8.7	19.5	12.9	8.3	10.0	7.8	11.6	12.2	11.8	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1	3.0	6.9	9.5	12.3	9.2	10.0	4.8	10.2	0.0	4.5	3.5	7.9	17.5	3.3	18.4	78.9	12.8	21.7	0.0	14.9	13.7	10.1	12.1	10.3	3.9	23.4	38.1	19.5	25.8	19.1	220.0	20.8	18.7	1.7	16.2	12.9	7.8	17.9	14.0	29.7	5.2	5.9	12.9	11.4	16.3	26.4	2.9	28.3	10.9	13.1	12.3
CAMKK1	"CAMKKA, DKFZp761M0423, MGC34095"	ENSG00000004660	"Calcium/calmodulin dependent protein kinase kinase 1"	Q8N5S9	17	3860315-3894891	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.9;salivary gland: 27.1"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 36.4;Rod photoreceptor cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 18.2;U-87 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009111, HPA028062"	Approved		Supported	Cytosol		No	No			Cytosol		"CAB009111: AB_2068406, HPA028062: AB_1845954"	"unprognostic (1.39e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.40e-3)"	"unprognostic (2.94e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.47e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.70e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.10e-1)"	4.3	10.2	15.3	5.1	21.4	3.7	4.7	23.2	38.9	4.1	3.2	2.2	4.0	3.1	7.5	5.2	4.2	3.7	3.8	5.7	13.8	6.8	1.5	1.0	4.0	2.5	5.5	16.0	6.0	7.5	5.0	10.1	2.3	11.2	3.3	3.1	2.5	27.1	11.2	2.2	7.8	3.7	6.2	2.2	4.3	2.9	6.1	5.0	1.7	7.2	2.3	2.5	5.6	4.9	0.1	1.6	5.6	4.1	0.0	1.0	1.1	4.9	8.5	0.9	4.3	3.1	5.5	0.3	3.4	3.7	3.3	1.5	3.1	1.5	3.0	3.7	6.6	3.4	14.7	2.3	4.2	2.0	0.1	7.8	3.4	18.2	1.1	3.1	0.5	2.7	4.2	3.6	6.2	2.1	2.9	1.5	4.4	2.6	0.1	1.6	1.3	4.1	1.9	1.0	7.2	8.1	2.1	3.7	3.4	3.5	3.1	5.0	2.8	1.3	10.2	2.2	0.5	3.9	1.1	2.0	5.7	7.7	7.3	2.8	0.4	0.2	0.1	20.8	2.9	0.7	0.0	1.8	3.6	0.6	3.9	1.0	0.0	0.6	0.5	1.6	0.1	0.6	0.3	5.6	0.0	4.1	0.8	0.0	1.1	15.3	21.4	23.2	38.9	13.8	6.8	5.5	16.0	11.2	5.0	6.0	15.1	8.5	1.9	3.3	36.4	5.7	0.0	1.4	5.7	1.8	15.7	0.2	0.0	0.4	0.0	4.4	0.5	0.0	1.4	0.1	4.5	1.4	16.2	0.2	3.8	7.9	4.1	3.1	1.9	0.4	1.1	3.6	8.5	0.0	1.4	3.8	0.8	0.0	1.1	0.0	24.1	0.0	2.0	0.1	1.4	4.6	0.2	0.7	2.3	0.8
AGAP6	"bA324H6.1, CTGLF3"	ENSG00000204149	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 6"	Q5VW22	10	49982190-50010499	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 78.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042490	Uncertain					NA	NA					"HPA042490: AB_2678022"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.34e-2)"	"unprognostic (7.48e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (9.93e-3)"	"prognostic unfavorable (9.70e-10)"	"unprognostic (8.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.83e-7)"	5.1	4.5	2.9	5.5	4.6	6.1	6.0	11.2	4.0	4.3	5.1			10.0	5.2	5.2	3.4	4.5	3.9	3.5	3.3	3.4	5.2	8.8	5.3	7.5	2.9		5.7	7.4	2.9	10.2	3.8		7.0	5.0		7.8	4.6	14.1	12.4	6.2	4.5	2.7	8.9	4.8	7.2			7.5		4.8	3.3	4.4	2.0	2.0	4.0	1.6	3.4	2.4	0.6	5.6	5.3	8.9	10.1	8.3	6.8	7.0	7.1	4.1	5.4	5.4	10.8	6.5	6.9	4.3	4.2	2.2	10.3	5.9	5.3	5.0	5.1	11.3	8.1	14.1	9.8	3.5	12.0	15.4	7.1	9.7	5.8	12.5	7.3	4.5	10.3	11.9	10.6	4.1	8.2	10.9	31.0	5.0	3.6	11.3	9.8	5.2	4.1	6.1	6.8	7.3	9.0	2.8	10.8	5.0	6.3	8.2	9.7	7.7	7.3	9.4	4.9	9.6	11.9	7.7	8.8	5.7	17.1	3.4	4.0	1.6	2.0	2.4	0.7	1.5	0.8	0.9	0.9	0.8	2.0	1.4	1.9	2.2	3.4	0.1	2.0	1.3	0.6											17.9	7.5	0.8	1.2	3.0	5.8	7.2	2.5	9.4	12.5	0.0	3.9	2.0	0.0	1.9	78.3	3.8	3.6	0.0	2.2	1.2	3.3	2.7	7.0	3.4	1.9	3.2	7.0	4.9	6.0	19.7	5.2	2.1	0.0	1.8	5.5	2.6	2.1	3.5	4.2	0.4	7.3	0.0	1.9	9.1	7.8	4.5	1.1	3.5	5.5	1.7
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825181-41836263	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA					"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	10.0	12.4	15.9	8.3	26.2	3.2	18.3	22.8	31.2	11.6	15.6	8.4	10.1	4.4	14.1	21.3	13.9	12.6	11.5	11.4	15.0	14.9	19.2	19.4	11.0	7.9	12.9	16.4	15.5	19.6	21.1	13.7	11.5	13.2	12.6	13.8	12.6	15.9	20.1	7.8	8.6	8.1	22.1	6.7	7.7	12.0	24.8	9.8	1.4	37.8	5.6	10.7	13.3	9.7	5.3	5.2	2.5	5.6	1.0	5.9	4.1	8.6	13.0	22.2	29.2	20.4	17.3	3.1	8.7	25.4	27.8	27.8	10.6	5.1	13.0	4.5	17.8	17.4	8.4	22.0	12.3	45.2	6.4	8.7	7.9	13.5	11.2	13.6	0.1	3.3	12.2	11.8	23.5	19.2	20.9	16.1	10.4	7.3	8.1	19.6	5.1	12.6	3.0	5.9	17.2	1.9	10.8	29.6	12.0	12.1	9.4	13.6	7.0	13.1	47.0	4.6	28.9	12.7	4.7	11.0	8.6	6.7	14.3	17.9	1.6	6.6	6.3	11.2	0.2	10.5	1.5	5.6	0.5	3.8	1.0	5.8	4.7	5.9	5.1	5.2	5.3	5.4	4.5	2.5	1.0	0.7	2.7	0.8	4.1	15.9	26.2	22.8	31.2	15.0	14.9	12.9	16.4	13.2	9.8	8.9	15.0	15.7	49.4	16.1	30.4	11.2	7.6	14.7	7.9	27.9	17.7	35.2	86.2	47.9	69.9	21.5	2.5	0.0	36.0	48.9	37.1	35.6	11.5	19.7	11.9	109.7	37.8	19.0	7.9	92.8	30.0	17.0	33.7	5.4	12.5	29.9	37.1	12.9	28.7	45.0	27.3	38.8	52.0	135.0	29.1	15.1	26.1	13.8	14.0	38.3
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1, UBX domain containing tether for SLC2A4"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	10.3	12.6	14.3	12.6	14.5	16.8	10.6	16.5	20.8	9.9	12.9	16.7	11.8	17.5	10.1	15.8	11.9	9.3	15.1	11.5	13.1	12.6	15.8	31.9	14.1	14.8	18.9	12.9	8.8	17.8	17.0	19.7	21.8	14.8	13.2	7.1	14.4	22.6	9.9	25.1	15.5	14.4	9.1	12.6	13.2	13.0	16.9	14.6	9.8	16.4	12.9	13.0	9.7	8.3	8.1	14.6	15.7	11.3	7.2	10.5	5.2	5.1	9.0	3.5	5.1	2.2	2.8	15.3	4.9	3.7	5.9	5.8	5.2	5.9	5.2	5.0	3.5	4.5	2.5	3.8	3.7	1.8	3.6	11.5	5.8	7.3	82.6	7.3	5.1	8.5	3.2	4.0	2.9	2.1	3.1	5.6	4.4	5.8	7.5	3.3	17.3	4.7	11.1	4.4	9.5	6.6	5.2	5.1	10.6	5.7	4.7	9.4	9.6	3.9	12.6	9.0	4.2	7.5	12.2	4.6	10.1	7.0	7.4	6.1	5.4	3.2	5.8	5.4	5.2	6.0	15.7	11.3	8.0	6.7	7.6	4.0	7.9	10.5	9.0	14.6	8.1	8.0	6.0	2.9	7.2	9.3	9.1	4.9	5.2	14.3	14.5	16.5	20.8	13.1	12.6	18.9	12.9	14.8	14.6	8.9	46.0	18.6	20.7	11.8	21.4	11.4	17.8	10.7	9.1	14.0	39.3	64.7	33.2	21.2	40.2	16.0	26.7	0.0	22.9	151.3	16.6	19.3	20.8	45.6	39.1	47.7	24.0	15.4	16.6	63.2	10.9	17.1	18.6	18.0	24.4	56.7	16.2	20.1	16.6	44.0	32.8	12.9	15.3	43.6	48.7	12.5	49.7	23.6	23.8	19.7
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060537			Supported	Nucleoplasm		NA	NA		33000	Nucleoplasm		"HPA060537: AB_2684314"	"unprognostic (2.77e-3)"	"prognostic favorable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	57.0	64.6	54.3	54.4	63.7	55.9	72.7	92.0	88.7	78.6	55.7	98.9	75.2	33.2	82.9	86.4	38.5	89.5	75.1	62.4	47.8	57.1	51.7	34.7	51.4	66.6	45.3	95.9	154.5	115.1	101.0	92.2	48.9	61.6	67.8	40.1	115.4	91.5	100.1	119.1	68.5	48.9	93.0	50.0	56.7	60.7	67.4	37.5	33.7	73.7	65.1	63.7	58.5	49.1	70.6	67.4	48.3	54.6	52.3	58.6	40.5	37.4	8.0	59.0	29.9	26.4	29.7	15.4	41.2	58.2	32.4	29.1	14.7	14.5	75.4	22.3	42.6	3.8	17.8	24.7	37.3	25.2	33.7	7.1	44.8	8.5	19.0	96.5	69.3	32.7	72.8	33.6	20.9	91.7	44.7	29.1	38.2	29.4	60.9	33.5	26.5	35.6	18.8	23.3	21.5	13.7	44.4	47.6	37.0	36.6	31.5	28.0	51.0	43.5	19.9	32.7	20.3	41.4	19.6	35.3	23.8	14.6	56.7	35.9	80.8	87.2	63.2	20.5	28.8	31.1	43.5	21.4	48.3	56.1	36.7	57.3	62.5	50.2	50.3	23.9	70.6	57.6	54.1	36.8	52.3	54.6	67.4	58.6	40.5	54.3	63.7	92.0	88.7	47.8	57.1	45.3	95.9	61.6	37.5	190.6	388.3	412.5	566.2	521.1	731.5	217.9	331.2	267.7	194.5	282.6	310.2	478.8	824.0	309.0	59.1	377.8	185.6	93.5	422.6	250.6	423.2	404.8	393.8	127.7	276.6	646.7	416.8	304.5	333.2	163.7	601.8	335.9	696.8	569.9	235.7	848.5	279.0	222.0	469.5	414.6	606.0	368.7	588.0	224.4	542.1	486.7	616.7	487.7	250.2	270.4
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.7	9.6	7.7	3.1	3.2	6.1	8.1	12.2	6.9	8.7	2.9	7.4	11.2	13.1	6.2	10.5	5.4	10.3	3.3	17.0	5.5	2.9	8.1	5.1	10.8	0.8	13.4	8.3	9.4	7.5	5.7	5.5	8.3	5.8	15.1	8.7	13.4	1.8	9.9	19.2	10.0	23.8	15.8	16.0	7.3	14.6	10.5	18.4	15.6	11.7	7.6	16.5	15.3	7.1	3.6	9.1	16.7	13.2	13.4	5.9	15.3	6.1	8.3	6.6	3.6	4.0	9.0	14.3	8.4	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6	11.9	28.2	16.7	22.2	13.7	17.3	4.8	45.9	18.7	9.1	26.2	23.6	25.3	36.5	23.6	5.0	17.5	42.9	0.0	11.0	16.4	18.6	26.1	9.2	37.6	16.3	17.5	65.1	19.6	16.7	5.4	22.2	13.0	18.6	14.4	38.5	10.3	14.2	35.1	11.7	45.1	33.8	6.5	11.3	23.1	29.8	13.6	23.3	17.5	50.1	18.6
FAM120B	"CCPG, KIAA1838, PGCC1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407065	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	32	"Early spermatids: 546.2;Late spermatids: 1520.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	18.4	20.6	18.5	21.1	28.7	10.7	20.5	28.4	27.7	20.5	16.6	28.5	16.3	15.8	28.3	24.1	16.5	26.8	18.1	18.4	18.1	22.8	17.3	15.6	18.3	16.7	20.6	19.5	23.4	17.0	24.7	32.0	19.5	26.1	22.4	18.6	19.1	21.4	21.2	25.7	18.4	16.2	20.1	21.1	16.9	16.9	20.7	20.4	24.7	22.3	15.3	22.0	19.8	16.3	7.4	9.2	14.7	13.6	15.9	10.2	8.5	5.9	6.1	9.3	11.1	13.4	13.0	5.5	10.0	11.7	8.9	8.9	5.4	4.6	8.4	6.0	14.3	10.4	7.1	9.6	11.5	11.7	12.1	5.9	8.9	5.7	7.1	12.0	8.8	7.2	15.7	12.3	8.2	10.9	15.6	13.7	9.4	9.8	6.9	14.9	12.2	6.4	7.9	4.6	12.3	4.2	5.5	8.7	8.7	9.2	5.3	6.6	10.1	8.6	7.7	3.0	12.0	7.6	17.6	11.6	3.8	6.3	10.0	6.9	8.5	7.1	8.9	10.4	7.3	13.9	14.7	8.1	10.0	8.3	9.0	9.5	6.6	7.9	8.9	9.2	7.4	10.2	8.1	13.9	15.9	13.6	5.3	8.4	8.5	18.5	28.7	28.4	27.7	18.1	22.8	20.6	19.5	26.1	20.4	20.8	14.5	2.7	4.7	3.2	15.0	15.7	15.3	14.7	13.6	14.0	31.4	8.9	0.0	8.3	546.2	15.3	8.6	0.0	8.0	6.4	6.5	11.1	9.3	7.6	9.5	6.4	9.2	11.1	8.2	1520.1	17.8	8.7	18.6	1.8	13.9	6.6	7.9	8.5	13.4	4.9	11.5	32.3	5.3	16.1	11.5	5.1	11.2	5.1	7.4	5.5
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: AB_2681393"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	12.0	21.3	4.7	11.0	7.7	2.3	6.8	3.1	8.8	6.2	4.2	7.5	13.6	18.8	5.6	4.9	7.3	9.6	5.7	10.8	4.7	9.3	14.6	9.3	9.3	6.6	8.5	8.1	10.8	2.2	16.9	4.3	17.7	8.5	12.8	21.2	12.2	23.0	1.6	23.5	25.8	19.4	2.1	13.9	10.4	16.9	6.0	25.6	12.5	6.5	7.1	10.4	6.3	16.6	15.4	11.4	30.8	19.0	4.9	3.2	7.7	4.0	6.1	33.5	8.7	15.8	5.9	14.4	4.2	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9	0.0	11.2	26.7	11.3	10.2	3.8	4.0	25.5	13.4	10.3	12.2	0.0	12.2	18.3	40.4	24.1	17.9	11.2	0.0	38.2	7.9	11.3	11.9	32.2	7.2	42.0	1.6	15.0	11.1	45.6	9.9	8.6	38.5	15.1	48.7	15.0	22.4	20.7	21.6	14.9	22.6	5.3	19.4	24.2	20.0	17.4	16.6	7.8	34.5	16.9	11.4
WDR19	"DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182404-39285810	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 41.1"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 41.5;Spermatocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;ASC TERT1: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favorable (2.70e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	8.5	7.6	8.1	4.8	12.9	3.4	9.2	21.0	14.5	13.2	7.8	5.7	7.8	1.9	15.5	11.2	5.4	20.9	8.6	5.1	11.7	4.1	8.6	7.0	8.6	4.4	6.0	11.0	19.0	6.6	10.1	41.1	6.3	14.6	8.1	4.3	6.9	7.6	8.2	3.1	6.0	5.7	9.5	9.7	4.3	8.0	12.7	7.3	6.8	17.1	3.8	5.0	9.9	8.9	3.9	1.1	1.5	2.0	2.3	2.4	0.8	3.2	2.3	5.5	6.6	25.4	28.5	2.5	4.3	9.7	4.5	6.0	1.4	3.7	5.3	2.1	4.1	9.7	1.9	5.4	2.8	5.0	0.3	3.9	1.0	4.4	2.7	7.9	5.2	1.4	17.3	6.1	6.0	3.8	12.5	5.4	5.4	4.7	5.3	5.4	1.1	3.5	3.6	1.8	1.9	2.6	4.3	5.6	2.4	3.7	1.3	6.1	5.6	4.2	1.4	2.8	6.9	2.8	1.9	3.9	4.4	3.0	9.7	4.2	3.9	3.6	3.7	6.6	1.5	2.0	0.7	1.2	0.9	1.7	2.0	1.3	3.4	2.1	2.4	1.1	3.9	2.1	2.1	1.5	2.3	1.7	0.7	1.4	0.8	8.1	12.9	21.0	14.5	11.7	4.1	6.0	11.0	14.6	7.3	11.9	5.7	3.2	4.9	4.2	7.6	3.8	2.5	41.5	12.5	17.4	9.8	1.0	0.0	4.5	3.0	4.5	0.0	0.0	3.1	2.0	5.6	3.1	2.3	10.6	2.7	23.8	2.4	4.3	1.9	2.6	15.3	2.9	1.7	1.0	2.2	7.3	2.9	0.0	17.7	3.4	22.5	0.0	3.8	30.3	10.2	4.1	1.1	1.0	1.0	1.8
MARCH8	"c-MIR, CMIR, MARCH-VIII, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 106.0;Early spermatids: 508.4;Late spermatids: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014597	Approved					NA	NA					"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	10.0	17.6	13.5	11.4	16.0	28.8	12.1	37.5	12.2	10.3	14.6	24.5	8.5	9.7	14.3	8.2	7.5	11.1	9.9	14.1	12.7	11.8	11.0	16.7	10.3	13.5	19.0	9.3	14.2	18.2	15.1	18.1	13.2	14.5	8.8	12.9	12.9	11.5	11.4	9.0	8.9	18.8	12.4	18.2	14.3	9.7	43.2	14.9	10.5	11.5	8.5	13.6	11.0	8.0	5.3	1.7	13.6	1.8	7.3	4.7	2.4	9.3	9.4	8.0	7.1	11.7	14.6	6.0	4.3	20.1	7.9	8.7	2.4	9.7	13.4	7.4	12.4	7.2	1.7	8.7	7.3	7.4	20.3	9.6	5.2	4.3	5.6	8.1	6.2	23.0	11.9	9.5	4.0	10.7	7.9	12.9	12.9	14.5	13.2	6.1	3.3	6.3	4.0	2.6	1.3	3.0	7.1	8.0	3.9	6.0	5.4	7.1	9.9	8.4	2.0	8.0	8.2	12.4	2.9	8.8	6.3	8.1	9.1	6.7	23.3	18.6	5.9	12.3	8.7	1.6	9.7	1.1	10.0	3.1	1.8	4.7	3.5	3.4	3.3	1.6	5.3	2.7	3.3	13.6	7.3	0.9	1.7	3.1	2.4	13.5	16.0	37.5	12.2	12.7	11.8	19.0	9.3	14.5	14.9	8.9	7.5	13.4	0.0	3.1	6.6	21.0	10.2	6.7	12.5	10.4	106.0	1.7	5.0	0.0	508.4	8.7	20.2	70.0	0.0	1.1	5.6	0.0	17.3	22.5	5.4	11.1	39.0	12.9	15.9	175.4	7.8	7.0	5.0	0.0	11.9	6.3	0.0	10.4	8.5	9.9	23.0	6.5	2.8	21.5	13.4	3.3	1.4	8.3	11.2	0.0
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 132.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29.0	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24.0	9.0	13.2	10.0	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22.0	15.6	19.7	17.4	9.6	15.6	6.5	11.0	12.0	10.4	10.6	13.2	12.1	8.0	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16.0	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9.0	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6
KRBA1	KIAA1862	ENSG00000133619	"KRAB-A domain containing 1"	A5PL33	7	149714781-149734575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 30.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 8.9;Muller glia cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021237, HPA050448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021237: AB_2134145, HPA050448: AB_2681129"	"unprognostic (2.19e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (7.48e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.01e-5)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (2.55e-1)"	"unprognostic (6.33e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.31e-2)"	3.8	4.6	5.6	6.2	8.1	4.7	5.6	8.7	12.8	5.2	5.2	7.6	11.0	2.2	7.8	4.9	5.5	5.2	5.8	30.6	6.7	5.2	5.3	2.2	4.5	5.7	6.3	9.0	7.9	7.0	9.7	16.9	3.1	7.1	6.0	1.9	9.4	17.2	9.5	7.4	6.4	3.6	8.5	5.1	6.4	5.0	5.7	6.5	2.5	4.3	5.5	4.8	5.0	5.3	4.1	3.7	1.3	3.7	0.3	4.2	1.7	6.2	3.9	7.8	16.2	3.5	3.5	6.8	3.3	4.2	5.4	6.2	0.4	1.7	1.9	7.1	4.2	11.0	6.2	5.8	11.2	2.7	8.7	11.0	3.5	5.0	3.6	4.4	0.0	9.8	7.7	5.3	3.7	2.0	6.4	4.9	10.5	14.1	2.0	2.7	2.4	9.0	5.3	9.3	2.9	3.8	9.5	3.1	1.0	4.1	5.0	6.2	10.4	5.1	14.9	3.5	3.7	2.6	5.4	5.0	6.6	2.9	0.0	4.6	9.6	3.1	8.4	3.9	6.0	6.8	0.0	1.8	0.4	3.8	1.7	2.6	1.8	1.9	2.2	2.6	4.1	3.4	2.9	1.3	0.3	3.7	3.7	4.2	1.7	5.6	8.1	8.7	12.8	6.7	5.2	6.3	9.0	7.1	6.5	0.0	2.7	1.5	2.1	1.5	6.3	8.9	0.0	0.0	0.0	3.5	3.9	0.9	0.0	4.5	0.5	0.9	0.0	0.0	2.3	1.9	2.3	2.2	0.0	0.8	4.2	7.9	0.0	0.6	3.0	0.9	3.7	1.1	0.0	1.0	0.0	11.2	1.2	0.0	3.2	1.5	4.4	6.5	1.7	0.7	3.6	1.6	1.0	1.0	0.0	1.5
RAI2		ENSG00000131831	"Retinoic acid induced 2"	Q9Y5P3	X	17800049-17861337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 45.5;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 5.1"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051054	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA051054: AB_2681328"	"unprognostic (3.45e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (3.39e-14)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.80e-2)"	23.6	9.7	2.5	10.1	4.0	0.0	28.5	4.0	4.9	41.0	13.7	1.7	15.0	3.5	29.6	17.8	12.2	27.9	21.2	16.1	2.4	2.7	9.4	1.9	14.5	12.9	2.4	1.8	32.7	7.7	4.6	11.1	7.1	2.9	28.3	4.5	10.7	6.6	18.7	7.2	8.3	8.8	20.4	2.7	2.4	12.0	16.2	2.1	2.0	15.1	6.3	5.9	24.2	53.6	0.0	0.0	0.0	0.0	0.4	5.1	0.4	0.0	0.0	0.1	0.0	49.6	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.5	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.5	5.1	0.0	0.4	0.0	0.0	0.0	0.4	2.5	4.0	4.0	4.9	2.4	2.7	2.4	1.8	2.9	2.1	11.9	5.0	0.0	8.6	3.7	13.8	11.2	7.6	8.1	1.2	21.0	0.0	0.0	5.0	6.8	0.2	14.6	0.3	0.0	8.8	0.1	13.2	11.3	0.0	0.0	0.4	25.4	26.5	9.8	0.0	1.1	45.5	0.0	5.0	1.0	0.0	13.7	4.1	0.0	66.4	1.6	2.8	0.0	6.2	0.5	1.1	2.5	0.0	0.0	0.0	4.8
MINK1	"B55, MAP4K6, MINK, YSK2, ZC3"	ENSG00000141503	"Misshapen like kinase 1"	Q8N4C8	17	4833388-4898061	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056296	Approved					NA	NA					"HPA056296: AB_2683090"	"unprognostic (2.80e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.64e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (2.77e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (8.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.62e-1)"	12.7	14.8	31.4	18.2	46.8	14.9	14.2	30.8	43.5	15.2	26.0	32.6	8.8	33.1	12.4	7.7	40.0	14.3	15.6	9.0	28.4	12.8	13.8	10.0	23.3	17.1	28.6	27.3	27.5	21.5	16.5	15.4	17.4	29.0	14.3	20.7	14.5	21.1	11.3	8.3	47.3	31.1	11.4	24.8	20.0	22.3	14.5	30.9	9.0	12.7	14.6	16.8	14.9	24.1	2.6	1.2	6.4	1.6	0.3	3.0	2.3	18.8	34.5	8.0	13.1	12.8	9.3	23.2	15.0	13.8	12.0	10.1	13.1	13.1	13.4	17.4	15.8	11.9	38.2	6.0	27.1	5.9	19.3	16.8	9.6	21.9	10.2	8.4	3.5	18.8	9.9	20.3	11.3	10.5	10.2	13.0	4.5	10.3	11.7	8.8	11.2	5.7	8.1	6.3	12.3	11.2	7.2	6.7	8.1	18.4	19.3	8.4	6.7	15.6	13.0	9.8	9.2	11.7	4.9	18.7	12.8	5.8	21.7	14.3	6.7	5.4	2.7	11.5	7.7	8.6	0.0	1.6	6.4	2.7	1.6	3.0	2.6	2.8	2.1	1.2	1.5	2.0	0.8	1.3	0.3	0.8	0.8	2.8	2.3	31.4	46.8	30.8	43.5	28.4	12.8	28.6	27.3	29.0	30.9	0.0	1.3	1.9	12.1	36.5	6.4	1.4	12.7	1.4	3.4	5.2	37.3	15.1	5.0	7.8	2.6	8.8	31.0	0.0	9.0	10.5	7.3	11.7	8.1	8.1	17.6	12.7	18.0	13.5	12.1	5.4	15.0	8.8	15.1	45.1	29.6	6.5	11.9	42.1	13.8	7.5	15.5	12.9	4.4	5.0	9.4	52.9	16.4	6.9	27.3	18.7
CLIP3	"CLIPR-59, RSNL1"	ENSG00000105270	"CAP-Gly domain containing linker protein 3"	Q96DZ5	19	36014660-36033343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 108.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 31.5;Horizontal cells: 39.7;Leydig cells: 20.4;Muller glia cells: 27.8;Peritubular cells: 23.0"	"Cancer enhanced"	"Detected in all"		"glioma: 65.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 30.7;fHDF/TERT166: 21.4;HHSteC: 19.8;HSkMC: 34.0;hTERT-RPE1: 29.1"									HPA079430	Uncertain					NA	NA					"HPA079430: "	"unprognostic (1.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.56e-10)"	"unprognostic (6.31e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.09e-2)"	6.4	10.9	38.4	7.5	35.2	1.6	4.1	52.9	108.3	17.6	15.1	14.9	2.8	5.7	24.0	10.4	12.7	10.6	17.0	5.1	33.3	37.6	4.8	2.3	4.2	5.5	30.6	37.8	28.2	3.6	2.1	10.9	7.5	30.2	16.7	7.4	4.9	3.9	25.4	2.4	3.7	5.8	27.7	20.3	6.3	6.7	6.6	16.9	2.9	2.2	0.1	5.4	17.4	7.4	1.2	0.7	1.7	0.9	2.6	1.8	0.8	0.4	1.3	11.7	0.5	19.6	30.7	0.4	6.6	16.2	5.6	8.5	1.4	0.4	0.6	2.8	21.4	0.4	0.5	0.2	0.0	4.0	0.8	0.4	0.3	1.2	0.2	19.8	0.3	0.3	34.0	0.3	4.8	0.1	29.1	6.2	4.5	0.6	1.2	12.4	1.0	6.2	0.4	1.4	0.4	0.3	0.8	0.2	0.3	0.2	0.4	11.5	13.4	0.7	0.3	0.3	5.1	0.4	0.1	1.7	9.6	8.1	0.4	0.4	1.0	0.8	0.5	14.8	0.6	3.5	0.0	0.6	1.7	1.1	0.9	0.3	1.2	1.7	0.6	0.2	1.0	1.8	1.2	0.5	2.6	0.4	0.7	1.1	0.8	38.4	35.2	52.9	50.6	33.3	37.6	30.6	37.8	30.2	16.9	0.0	0.0	0.0	0.7	0.6	31.5	1.7	0.0	1.4	0.0	1.8	2.0	0.5	0.0	0.1	9.4	3.1	0.2	0.0	0.2	0.4	8.7	0.2	0.0	0.0	0.7	39.7	2.4	4.3	0.0	15.7	20.4	0.6	3.3	0.0	0.7	27.8	0.4	0.0	23.0	0.0	9.4	6.5	9.5	2.2	2.9	1.1	1.0	0.0	0.2	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.4	10.0	60.2	18.3	28.7	39.1	11.1	22.5	40.2	17.9	31.8	10.0	13.9	7.6	59.1	45.3	14.7	7.4	17.1	17.0	12.9	13.5	14.2	15.7	11.9	19.5	24.6	4.0	12.1	51.1	7.1	18.1	9.2	36.9	33.9	8.9	3.8	9.3	34.1	15.0	8.9	6.7	22.2	9.5	12.0	5.9	21.6	10.8	24.5	4.1	9.5	24.5	8.9	10.4	52.0	73.5	42.9	6.8	29.2	15.3	23.8	22.7	6.3	6.0	5.0	5.4	22.3	10.6	77.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3	41.7	33.9	29.8	80.0	37.7	72.3	51.6	53.5	66.9	30.7	73.3	27.5	185.2	208.9	88.2	2.4	76.6	14.7	0.0	47.8	117.1	94.0	95.1	100.4	13.2	60.7	130.3	56.0	66.9	12.9	8.5	216.0	36.3	150.1	64.9	42.6	178.6	48.5	32.3	301.2	111.7	49.9	155.2	150.8	13.5	12.4	30.6	141.5	45.4	24.9	55.9
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 32.2;T-cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.7	0.2	6.9	1.3	0.6	3.5	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	1.8	0.6	0.5	0.3	0.0	13.8	1.0	4.5	2.5	0.3	0.8	1.4	4.8	1.6	0.1	0.5	0.4	0.4	0.7	8.0	0.6	18.7	0.7	1.5	3.3	0.1	0.3	0.2	2.2	6.1	0.9	13.6	0.7	0.0	2.3	3.1	1.4	3.7	0.7	0.4	1.9	0.7	1.3	0.5	1.8	4.5	0.3	7.8	4.9	1.2	1.4	1.0	2.7	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0	0.0	3.5	32.2	5.2	2.5	9.0	5.5	10.2	17.4	4.5	12.2	0.0	1.4	0.0	4.9	5.2	2.9	23.9	0.0	4.7	1.0	3.3	7.8	4.6	12.1	6.3	6.4	6.4	7.4	7.0	3.3	6.4	13.8	5.0	18.0	12.9	7.7	4.3	8.6	3.5	6.2	0.3	6.5	2.5	2.3	0.2	1.8	1.3	35.9	7.4	3.5
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451604-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 8.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 29.4"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	7.4	6.2	6.9	8.3	12.4	5.0	9.0	11.4	12.6	8.7	5.9	7.6	9.8	5.9	8.5	5.0	8.4	9.0	6.8	4.7	6.6	5.5	6.2	6.6	7.3	6.8	9.1	7.0	10.2	10.1	8.0	8.4	4.8	8.8	7.5	6.1	8.4	8.9	8.5	8.2	11.2	6.0	7.4	5.3	10.3	8.0	11.3	9.3	9.4	8.0	6.0	6.4	9.3	6.9	1.1	0.6	1.3	1.0	8.3	1.3	0.7	4.3	7.2	4.0	6.6	2.8	2.5	2.9	3.9	2.9	3.2	2.3	2.5	1.9	5.9	2.5	2.3	3.3	3.6	5.2	3.6	2.5	6.0	29.4	5.1	5.4	1.0	2.9	8.3	7.6	2.5	3.6	3.6	3.1	2.1	2.3	5.3	7.3	3.6	3.3	2.8	6.1	2.0	2.2	5.1	4.1	5.8	5.2	3.5	2.1	8.7	9.5	5.4	3.7	6.0	0.9	2.9	2.2	2.4	2.6	7.7	2.0	4.1	6.3	7.8	7.0	4.4	3.0	3.6	2.9	0.0	1.0	0.1	1.3	0.6	0.9	0.5	0.6	0.9	0.6	1.1	1.3	0.9	1.3	8.3	0.4	0.6	0.4	0.7	6.9	12.4	11.4	12.6	6.6	5.5	9.1	7.0	8.8	9.3	0.0	0.3	0.5	0.9	0.7	3.0	0.8	0.0	2.7	3.4	1.8	21.6	0.8	0.0	2.0	0.7	0.7	1.1	0.0	1.4	0.7	1.1	0.6	0.0	1.0	0.8	4.8	0.0	1.3	1.9	1.3	2.8	0.4	0.0	1.8	0.8	1.5	1.5	0.0	2.5	0.8	5.8	6.5	1.1	3.1	1.9	0.9	0.6	1.5	1.1	0.9
TUB	rd5	ENSG00000166402	"Tubby bipartite transcription factor"	P50607	11	8019244-8106112	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 39.3;Horizontal cells: 28.6;Rod photoreceptor cells: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 13.3;HEK 293: 18.2;HeLa: 24.3;SCLC-21H: 27.6;SH-SY5Y: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017997, HPA049019"	Enhanced		Approved	"Nucleoli,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"	Nucleoli	"HPA017997: AB_1858449, HPA049019: AB_2680601"	"unprognostic (2.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.35e-5)"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-2)"	5.0	18.3	18.9	2.8	16.1	0.7	4.5	12.4	36.4	18.2	4.2	6.3	2.8	2.5	24.3	10.7	3.6	20.8	5.5	10.2	20.5	17.9	11.7	1.0	3.4	2.2	25.1	22.6	17.9	5.1	11.0	18.4	4.6	17.7	8.7	2.9	11.3	5.6	9.0	3.1	6.5	2.4	12.0	9.2	2.1	2.4	5.1	9.1	0.5	10.5	2.9	1.3	5.2	8.7	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.9	7.1	8.8	6.7	2.3	0.0	4.8	1.2	5.2	6.8	0.0	0.0	0.0	0.4	6.4	2.4	0.0	13.3	1.0	4.5	0.0	18.2	0.0	24.3	2.9	1.1	0.0	0.2	3.5	1.2	2.3	0.0	0.4	0.4	8.2	0.0	0.0	2.4	0.6	0.0	0.0	4.9	0.0	0.0	6.6	0.1	0.0	0.0	0.2	27.6	20.6	3.4	0.0	1.3	3.2	0.8	0.1	0.0	2.9	6.9	0.4	2.0	0.0	0.0	0.0	2.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	16.1	12.4	36.4	20.5	17.9	25.1	22.6	17.7	9.1	0.0	0.0	0.0	1.7	0.7	14.6	2.2	0.0	6.7	1.2	0.0	39.3	0.1	5.0	0.1	3.3	0.5	0.0	0.0	0.0	0.3	6.2	0.7	1.1	0.0	0.2	28.6	1.7	1.8	0.0	3.7	13.6	0.0	1.7	0.0	0.0	11.7	0.0	0.0	13.8	6.3	51.9	0.0	1.3	1.5	1.1	0.6	0.0	0.0	0.0	0.1
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"Fanconi anemia core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	33.1	18.8	15.4	14.3	12.1	15.2	20.5	15.4	16.4	17.8	19.1	13.8	19.1	14.6	17.8	17.7	20.3	12.6	14.2	17.0	15.4	14.8	27.7	20.9	15.0	22.5	14.9	10.3	16.9	17.2	8.0	26.4	11.7	13.3	21.8	7.3	20.9	21.4	23.9	27.3	28.1	14.9	15.0	14.3	24.4	30.5	20.2	11.5	35.1	30.5	11.4	16.5	17.1	19.3	13.2	22.0	31.0	8.7	5.1	12.6	5.6	10.4	1.6	2.3	2.8	1.4	1.9	13.8	11.8	4.4	3.9	5.1	2.5	6.9	12.2	17.5	1.8	3.5	5.1	1.6	1.7	1.9	26.0	24.0	10.1	2.7	5.3	5.4	7.0	9.8	3.3	3.9	2.3	2.5	2.4	4.7	9.7	13.9	2.9	2.6	4.3	10.2	21.9	8.2	2.0	21.9	13.7	7.2	11.4	1.8	1.6	18.9	25.3	7.7	3.3	20.2	2.2	3.3	2.9	9.9	6.0	14.3	7.4	6.7	27.5	14.6	17.8	11.2	4.4	2.5	3.6	8.7	31.0	10.1	8.1	10.0	13.2	9.2	10.9	8.8	13.1	12.6	10.4	11.2	5.1	7.5	22.0	7.8	5.6	15.4	12.1	15.4	14.1	15.4	14.8	14.9	10.3	13.3	11.5	6.0	11.0	59.7	76.1	0.0	25.1	17.1	50.9	14.7	12.5	92.5	3.9	105.4	144.2	110.3	81.6	33.1	20.8	23.3	96.1	118.9	7.2	104.6	7.0	78.0	115.2	14.3	42.1	73.1	106.0	249.7	79.7	47.3	0.0	185.8	72.9	43.5	131.8	46.3	77.8	221.5	25.4	64.7	14.6	118.4	32.4	0.0	75.1	55.3	55.7	99.4
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291111-100306547	"Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 83.5"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 116.9;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA					"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	6.3	11.1	9.0	4.3	15.2	8.3	10.5	7.0	14.0	13.5	4.4	29.7	9.5	5.9	9.8	32.0	6.8	22.7	8.7	7.8	10.3	9.7	19.5	6.3	10.5	5.2	29.7	10.3	10.9	5.9	5.7	13.1	4.9	25.4	12.9	4.3	22.1	20.9	9.8	6.2	14.1	5.2	6.3	30.9	6.5	8.3	9.6	23.1	2.4	83.5	3.9	5.4	5.1	5.1	1.2	2.8	4.9	2.8	0.3	2.4	0.7	4.6	10.2	13.6	17.9	3.2	1.2	8.1	3.6	4.1	7.8	4.7	2.3	3.0	0.0	9.4	1.2	3.9	5.2	5.8	1.9	2.6	1.8	2.7	4.7	14.1	4.4	7.6	2.7	6.1	3.6	6.0	3.5	3.3	11.9	10.7	16.3	1.5	0.5	2.2	15.0	16.5	14.8	6.9	4.3	10.9	21.0	5.7	0.3	25.8	3.4	19.9	24.8	8.6	6.2	6.7	6.1	15.0	4.6	11.0	2.8	5.5	3.9	5.7	1.4	0.6	0.6	3.2	6.7	3.4	3.6	2.8	4.9	2.3	0.4	0.0	0.4	1.1	2.4	2.8	1.2	0.3	1.6	3.2	0.3	0.1	1.3	1.6	0.7	9.0	15.2	7.0	14.0	10.3	9.7	29.7	10.3	25.4	23.1	8.9	27.4	0.5	16.0	5.8	18.5	1.2	12.7	34.8	25.0	116.9	70.7	3.9	14.9	25.9	15.8	14.7	4.0	0.0	10.3	0.8	5.3	29.3	13.9	7.4	6.6	20.6	20.1	21.5	3.4	34.1	2.3	9.0	10.1	8.2	7.4	18.3	13.9	14.4	5.6	10.5	82.2	12.9	6.6	2.6	4.1	5.6	15.6	1.5	12.7	10.3
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81245000-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		44000000	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	22.8	18.6	8.1	17.0	11.3	18.5	43.0	9.9	10.2	15.8	23.8	13.8	22.0	21.8	17.4	30.7	13.2	15.2	28.4	17.3	7.4	9.2	18.0	59.2	24.6	23.7	11.6	6.7	23.7	55.1	6.8	30.2	23.2	10.0	16.0	6.5	15.1	33.3	26.1	8.7	11.2	26.2	10.9	10.4	21.0	19.1	25.0	12.3	20.2	25.9	10.3	15.8	18.4	13.0	6.6	10.0	17.2	15.4	4.6	9.8	7.9	17.3	30.5	5.3	28.1	20.6	9.7	31.9	21.4	19.3	13.1	15.5	14.1	29.2	13.3	24.5	14.7	14.5	21.0	5.4	10.7	4.9	13.3	16.0	13.4	10.9	23.9	18.4	13.1	32.1	16.8	8.0	11.8	7.7	10.7	25.1	9.7	9.9	20.6	9.8	22.1	8.0	22.5	5.3	16.1	15.1	13.0	11.2	13.4	9.2	16.4	10.3	26.7	17.2	10.8	23.3	7.8	15.4	27.5	24.6	21.2	12.4	15.8	11.4	18.1	7.9	7.6	12.6	20.4	21.7	11.0	10.2	17.2	8.1	12.0	9.8	6.6	7.8	9.8	6.3	6.6	5.4	5.8	8.2	4.6	15.4	10.0	5.5	7.9	8.1	11.3	9.9	10.2	7.4	9.2	11.6	6.7	10.0	12.3	23.8	35.2	11.2	10.8	7.3	11.5	14.7	40.8	6.7	18.2	10.4	17.7	47.8	5.0	33.0	17.9	21.0	56.4	0.0	23.2	52.2	22.1	16.5	15.0	66.3	42.5	23.8	43.3	27.6	39.2	46.8	30.5	26.6	13.5	19.0	55.6	28.3	24.6	42.1	25.8	20.3	9.1	32.3	15.3	16.7	21.5	6.4	52.3	17.5	40.8	10.0
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 92.2;Late spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	15.3	10.8	18.8	7.7	25.5	6.1	13.3	20.5	29.8	8.0	7.7	41.7	6.5	8.4	10.0	8.1	8.9	9.6	8.7	15.1	23.9	18.0	6.8	3.7	9.3	6.1	36.8	13.9	11.8	21.3	10.3	8.1	6.9	26.3	7.6	5.5	6.7	11.8	9.8	63.8	7.2	9.1	8.1	65.7	10.9	7.4	13.4	26.8	2.7	7.1	7.0	4.4	8.3	7.3	0.6	5.4	0.3	4.0	2.1	2.0	0.9	9.3	12.9	12.2	11.5	12.2	11.9	14.5	7.1	8.3	6.1	5.4	5.6	17.8	10.2	12.1	10.8	7.9	10.8	7.4	10.2	4.4	12.7	6.1	4.6	5.1	8.3	16.1	3.8	8.5	13.8	9.8	4.3	10.0	7.8	11.1	10.4	2.9	9.6	5.3	29.3	6.4	5.1	4.7	11.9	10.7	14.4	7.4	6.5	5.2	21.6	27.5	14.6	6.8	6.2	10.6	8.0	15.6	7.1	16.8	9.1	4.2	14.3	7.1	12.7	8.2	3.8	13.9	6.9	8.8	0.0	1.6	0.2	0.9	2.7	1.7	0.2	0.8	1.0	2.7	0.6	0.3	1.0	0.3	2.1	4.0	5.4	2.0	0.9	18.8	25.5	20.5	18.9	23.9	18.0	36.8	13.9	26.3	26.8	8.9	14.3	0.8	6.5	8.0	30.2	17.8	7.6	1.4	13.6	5.2	11.8	3.8	11.6	11.7	47.3	15.8	19.0	0.0	19.9	2.8	11.2	8.4	1.1	7.8	15.0	92.2	12.5	19.6	14.3	63.1	16.1	13.3	25.3	8.2	13.4	14.7	14.0	10.5	15.6	10.5	22.4	6.5	12.7	12.9	11.3	7.3	2.9	5.3	16.6	7.1
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA041220: AB_2677367, HPA058036: AB_2683585"	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	10.1	7.3	14.1	11.8	11.8	11.5	9.6	28.2	17.4	13.3	11.5	7.6	7.7	6.8	10.9	12.0	9.9	10.5	6.3	11.9	11.5	12.2	7.6	8.5	6.7	8.5	10.2	10.8	13.5	18.6	9.9	8.5	17.2	10.5	8.8	5.8	8.4	11.4	13.3	11.5	31.9	8.9	12.0	7.9	7.8	9.3	22.5	10.9	8.1	8.6	7.1	8.0	9.9	8.7	7.1	8.2	8.3	10.0	6.6	11.9	7.6	4.9	4.9	6.9	6.9	5.6	5.5	10.1	19.7	9.2	20.7	16.7	5.2	3.7	2.1	4.8	13.1	3.6	8.2	5.0	8.8	7.1	3.4	6.4	0.8	2.1	7.3	3.7	0.4	4.7	6.0	5.3	14.1	3.0	3.0	8.3	5.4	12.4	2.4	9.7	7.7	6.3	6.9	9.2	3.9	4.8	8.7	3.1	11.4	7.7	2.0	2.7	4.6	14.8	3.1	3.9	4.4	4.1	6.6	6.4	2.9	5.1	4.5	4.6	4.8	3.7	12.2	2.2	3.9	5.0	2.0	10.0	8.3	9.4	9.0	10.1	7.0	8.8	11.9	8.2	7.1	8.0	10.4	4.4	6.6	5.6	8.1	11.1	7.6	14.1	11.8	28.2	17.4	11.5	12.2	10.2	10.8	10.5	10.9	14.9	9.9	19.7	18.4	18.7	24.8	7.3	12.7	8.1	10.3	19.2	7.9	26.4	5.0	17.7	36.3	19.5	15.8	23.3	12.5	20.2	23.7	10.4	8.1	8.6	13.1	23.8	12.6	12.9	8.5	34.7	22.5	14.6	16.9	7.2	11.0	14.6	15.7	14.0	20.8	7.8	10.2	25.8	27.8	86.3	33.6	16.9	25.2	26.3	11.5	12.2
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 187.5;Late spermatids: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoli	Nucleoplasm	"HPA052590: AB_2681875, HPA053608: AB_2682205"	"unprognostic (1.38e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	11.1	11.4	7.9	11.8	12.5	9.9	15.5	20.9	11.0	19.5	17.1	10.6	16.9	11.6	21.4	10.2	9.0	17.6	11.1	10.7	7.9	6.8	9.8	12.9	11.1	17.2	16.5	7.1	31.5	17.7	8.6	9.4	8.4	10.8	13.1	6.9	12.1	14.8	20.0	36.1	12.2	13.4	21.4	13.4	11.6	13.5	35.6	14.4	17.6	19.5	9.0	10.4	17.1	25.1	25.4	27.6	18.8	18.2	19.5	36.1	20.4	7.0	12.0	9.2	6.0	6.4	6.3	16.8	4.8	5.4	12.6	11.9	13.8	6.4	21.3	12.0	3.7	7.6	8.3	7.0	8.4	3.6	6.8	13.3	13.2	7.4	18.3	15.6	11.8	14.9	6.7	11.5	7.5	7.6	6.8	4.7	13.6	11.1	10.9	4.4	23.6	13.4	23.2	12.7	5.2	11.7	21.0	6.0	18.5	6.3	10.7	14.9	6.9	7.4	14.2	7.9	3.7	11.7	9.8	3.3	8.7	7.4	5.0	8.3	12.7	18.4	12.4	6.2	20.1	7.0	5.0	18.2	18.8	22.3	15.6	26.9	22.2	31.2	27.2	18.3	25.4	36.1	27.8	5.6	19.5	12.5	27.6	29.6	20.4	7.9	12.5	20.9	11.0	7.9	6.8	16.5	7.1	10.8	14.4	14.9	11.8	6.7	16.2	0.0	6.1	0.0	5.1	12.0	13.6	17.4	13.7	15.2	8.3	9.9	187.5	3.6	9.3	0.0	11.3	10.4	9.5	6.7	5.8	14.3	12.7	0.0	3.5	6.2	12.9	270.5	28.4	12.1	0.0	11.8	9.2	11.2	11.3	12.2	20.5	18.8	13.9	19.4	0.0	8.4	19.2	0.0	17.6	13.1	14.0	11.1
TANGO2	"C22orf25, DKFZp761P1121"	ENSG00000183597	"Transport and golgi organization 2 homolog"	Q6ICL3	22	20017014-20065926	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 54.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003080	Approved					NA	NA		120000			"HPA003080: AB_1078350"	"unprognostic (4.05e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.76e-2)"	"prognostic favorable (3.01e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.95e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.62e-2)"	10.2	15.5	13.1	10.7	18.0	31.8	9.7	11.5	21.0	6.6	9.7	15.3	8.1	8.0	7.6	7.9	7.1	7.4	9.0	54.0	13.7	14.2	11.9	10.7	11.6	12.3	25.0	12.3	5.2	9.0	11.3	11.4	9.1	16.6	9.6	9.0	12.9	7.1	10.5	17.2	7.9	9.2	9.2	14.5	20.0	11.1	5.9	16.8	5.4	18.5	6.6	9.3	10.5	13.0	7.7	16.1	28.4	25.6	11.9	10.9	13.5	8.6	7.9	2.8	5.8	19.5	6.7	5.3	8.7	11.3	8.2	7.2	5.8	6.7	3.3	6.5	22.8	11.4	11.5	6.8	9.7	5.1	20.0	7.0	9.4	6.4	6.6	14.3	8.5	16.5	8.5	7.8	12.1	6.5	8.3	11.0	5.8	23.9	7.2	11.2	10.0	5.5	5.9	1.3	20.4	5.6	5.5	7.5	2.1	6.4	11.1	4.8	2.8	9.0	15.1	18.4	6.5	4.0	8.7	8.3	11.3	8.5	15.0	6.0	3.9	2.2	3.6	15.1	7.5	7.6	27.1	17.2	28.4	6.3	21.0	6.8	7.7	6.9	7.9	16.1	5.0	4.1	5.4	21.4	11.9	25.6	5.5	10.9	13.5	13.1	18.0	11.5	21.0	13.7	14.2	25.0	12.3	16.6	16.8	14.9	7.2	8.3	3.2	3.4	4.6	14.6	12.7	6.7	3.4	7.0	3.9	8.8	16.6	9.5	3.6	4.5	11.3	23.3	8.5	12.8	4.6	4.2	15.0	6.4	33.4	9.5	6.3	6.7	15.8	11.4	4.6	11.4	18.6	29.7	4.6	5.2	9.5	8.6	4.6	6.2	2.0	19.4	7.6	3.3	2.5	4.0	9.6	10.2	5.5	2.8
ZNF32	KOX30	ENSG00000169740	"Zinc finger protein 32"	P17041	10	43643859-43648856	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039148			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nuclear bodies"	Nucleoplasm	"HPA039148: AB_2676365"	"unprognostic (1.05e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.15e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.90e-3)"	"prognostic favorable (3.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (6.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	14.4	16.2	24.4	12.4	23.6	4.4	29.2	21.1	20.1	20.2	20.4	19.0	18.0	7.9	21.9	37.7	12.6	20.7	14.7	26.1	22.2	20.8	22.1	17.7	13.7	12.2	27.7	17.7	28.7	26.0	18.7	20.3	10.3	22.5	22.5	15.1	14.7	18.5	25.4	45.7	14.4	11.0	23.4	19.8	14.2	14.5	8.6	25.8	15.4	25.8	14.5	15.4	17.9	25.4	14.2	11.2	8.5	6.9	23.0	21.7	10.3	9.6	8.6	13.0	19.6	24.0	25.9	4.2	8.6	26.2	16.2	14.7	5.8	4.9	0.0	15.3	18.4	7.6	5.7	8.3	8.4	11.9	10.5	9.1	2.5	5.4	6.6	22.5	0.2	7.9	26.5	19.4	10.0	12.1	15.6	12.2	34.5	7.4	0.0	20.3	8.8	9.5	8.8	10.1	9.8	4.5	14.8	14.6	2.2	16.2	3.8	16.7	14.8	7.1	5.3	13.5	15.0	19.6	9.0	5.2	9.1	11.0	6.6	2.1	5.8	15.1	0.0	3.2	6.2	8.4	4.1	6.9	8.5	19.3	6.1	19.1	13.3	15.5	21.4	11.2	14.2	20.0	21.7	0.6	23.0	5.4	9.5	10.8	10.3	24.4	23.6	21.1	20.1	22.2	20.8	27.7	17.7	22.5	25.8	8.9	14.7	20.1	21.3	9.7	22.4	10.9	15.3	13.4	11.4	17.4	7.9	14.8	89.5	34.7	1.8	18.7	6.1	0.0	41.6	15.5	19.7	29.1	29.0	22.5	26.1	15.9	26.7	17.2	15.9	0.4	39.1	14.8	16.9	12.6	17.5	29.0	29.6	14.0	51.2	43.0	19.9	32.3	22.7	11.2	13.0	13.4	5.6	23.0	18.1	13.6
SMARCA1	"hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI"	ENSG00000102038	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	P28370	X	129446501-129523500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003335, HPA064712"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA003335: AB_1080024, HPA064712: AB_2685332"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.03e-4)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.33e-2)"	10.4	44.6	14.5	5.0	15.2	0.4	11.8	12.0	12.0	17.1	11.4	7.7	25.5	3.9	15.8	31.4	9.6	12.0	12.3	19.3	13.9	17.9	13.9	34.1	9.2	2.5	13.1	8.4	42.2	9.0	34.8	29.9	21.0	14.6	23.8	4.3	9.7	9.8	42.9	8.7	4.6	4.8	17.7	14.0	6.9	10.0	33.0	13.1	2.0	26.0	6.8	2.6	16.8	15.3	0.3	0.8	0.0	0.0	1.6	4.3	0.5	6.6	15.0	31.0	20.2	22.6	20.5	10.7	13.7	39.6	20.4	23.2	5.2	23.9	0.0	21.3	25.7	24.0	6.4	19.2	8.0	23.0	0.0	3.6	0.0	13.6	28.1	9.9	0.0	0.0	25.6	2.3	14.6	2.8	31.2	14.9	3.7	3.4	1.6	22.0	0.0	0.1	0.0	12.4	2.6	8.6	0.0	16.7	0.0	20.1	8.2	7.4	20.4	1.9	0.2	3.4	22.8	13.8	0.1	10.3	13.7	7.0	8.9	7.4	0.0	0.0	0.0	12.1	0.0	8.4	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.0	0.0	0.3	4.3	1.3	0.0	1.6	0.0	0.8	0.0	0.5	14.5	15.2	12.0	12.0	13.9	17.9	13.1	8.4	14.6	13.1	89.3	46.5	1.3	28.2	20.7	25.6	68.0	12.7	60.2	68.2	38.4	43.2	40.5	24.9	23.4	2.0	21.1	0.0	23.3	10.5	11.6	49.7	20.5	2.3	52.9	11.7	87.4	16.1	17.2	2.5	8.2	132.3	3.6	27.0	10.0	1.1	49.1	12.6	0.0	118.1	31.1	13.3	64.7	30.1	12.6	6.1	10.3	48.9	0.0	1.0	24.8
METTL16	"METT10D, MGC3329"	ENSG00000127804	"Methyltransferase like 16"	Q86W50	17	2405562-2511891	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020352, HPA059798"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020352: AB_1853828, HPA059798: AB_2684128"	"unprognostic (4.94e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.68e-2)"	12.7	14.0	13.1	11.0	15.2	13.1	14.1	22.5	14.4	14.9	13.1	19.8	11.2	8.6	21.6	10.6	11.0	16.5	9.6	12.4	12.6	9.7	11.5	6.9	12.2	13.1	18.3	9.7	22.5	13.5	19.7	22.8	7.5	13.6	13.5	10.4	18.3	12.1	13.1	14.2	14.7	10.4	16.5	14.6	11.1	11.2	11.0	17.5	15.7	16.5	8.8	17.5	15.3	12.7	5.7	3.1	2.3	3.2	2.0	8.1	2.0	6.1	16.4	9.3	8.9	7.0	8.9	8.7	7.8	6.8	8.9	7.4	21.8	4.0	19.3	8.5	7.1	9.5	8.9	21.4	10.7	12.2	7.3	13.6	9.9	13.5	9.9	7.6	9.1	8.0	7.5	10.2	12.3	18.2	6.1	9.2	11.3	12.9	10.4	6.0	6.7	13.0	5.4	10.6	7.6	6.9	21.7	9.8	8.7	6.5	5.6	4.9	7.7	11.7	6.4	6.9	10.0	8.1	5.8	6.7	8.2	5.3	11.6	11.3	6.1	7.5	13.8	11.1	7.6	11.1	2.3	3.2	1.2	5.7	2.1	7.2	5.7	5.6	5.5	2.2	5.0	8.1	5.9	0.1	2.0	1.5	3.1	3.5	2.0	13.1	15.2	22.5	14.4	12.6	9.7	18.3	9.7	13.6	17.5	11.9	31.0	7.0	19.7	10.2	26.4	14.0	15.3	34.8	36.4	7.0	43.2	7.3	11.6	8.4	12.4	12.9	15.8	0.0	9.2	7.9	8.9	15.5	24.3	7.3	8.9	25.4	19.5	19.6	9.2	5.4	13.8	8.2	8.5	9.0	12.7	25.1	8.0	3.5	12.0	7.0	38.8	6.5	13.2	11.4	17.4	11.2	5.0	20.8	14.0	13.5
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	14.4	37.1	7.8	11.6	7.5	2.3	13.5	5.5	7.3	12.0	11.2	9.3	16.5	8.5	13.8	14.8	11.2	13.2	14.2	8.5	7.9	9.3	16.3	9.9	15.1	19.9	5.5	6.7	11.3	19.5	16.5	13.8	19.2	7.7	17.2	5.8	18.1	18.8	19.5	6.1	14.9	12.3	11.2	6.8	23.3	13.2	8.1	6.7	3.6	16.6	11.4	16.1	14.5	8.9	3.9	16.0	1.8	16.1	6.4	14.4	9.5	1.2	3.7	3.2	6.7	9.4	8.5	4.7	8.4	16.5	11.6	10.6	3.2	4.3	0.0	13.6	7.2	4.6	4.1	2.0	3.5	2.1	4.0	5.1	0.0	9.4	9.4	28.3	0.0	2.9	16.1	4.3	3.3	4.5	1.7	22.8	2.2	3.5	9.4	6.2	6.5	0.1	0.1	2.0	2.8	6.6	0.5	1.8	9.8	7.2	6.5	0.9	6.7	9.3	17.4	4.5	2.5	15.7	0.2	15.6	13.5	3.9	5.1	2.9	15.7	1.8	1.7	6.2	0.0	6.6	0.0	16.1	0.0	10.9	6.8	14.4	3.1	9.2	10.8	16.0	3.9	7.5	6.3	1.8	6.4	6.0	1.1	10.9	9.5	7.8	7.5	5.5	7.3	7.9	9.3	5.5	6.7	7.7	6.7	3.0	9.6	2.4	3.7	4.5	3.1	1.4	7.6	2.7	7.9	7.0	7.9	15.1	0.0	7.2	0.2	7.7	8.5	0.0	13.8	7.3	9.3	5.1	0.0	3.9	15.7	0.0	2.9	10.4	13.2	0.0	10.6	7.9	1.7	5.4	9.9	5.2	7.6	3.5	13.4	4.1	4.0	12.9	4.2	0.2	0.7	4.8	22.5	5.4	6.7	2.4
PPP1R9B	"PPP1R6, PPP1R9, SPINO, Spn"	ENSG00000108819	"Protein phosphatase 1 regulatory subunit 9B"		17	50133735-50150630	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022461	Approved					NA	NA					"CAB022461: "	"unprognostic (4.71e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.29e-1)"	4.0	4.2	8.8	7.0	10.0	7.6	1.4	4.8	13.6	3.0	2.3	4.6	3.2	3.4	2.4	2.4	3.2	2.4	3.8	3.0	9.4		1.8	1.3	5.6	8.9	6.9	4.3	4.4	2.2	3.7	0.4	3.3	3.8	2.3	1.7	3.0	4.4	6.2	2.0	5.1	3.5	2.5	0.8	11.7	3.4	3.5	3.7	1.4	2.4	5.7	7.2	4.2	0.0	3.8	3.7	7.7	3.6	4.1	2.7	1.4	9.1	16.4	8.9	22.3	11.8	7.6	21.1	13.1	12.2	11.7	8.6	13.8	7.3	17.3	21.5	15.3	11.3	9.1	9.1	9.4	7.4	44.5	13.5	28.4	12.5	9.3	11.5	12.3	45.2	8.4	16.5	12.9	8.1	22.5	11.5	5.6	15.0	13.1	7.7	16.9	4.5	17.8	3.4	11.7	14.9	9.4	12.0	12.2	8.0	5.4	5.6	16.5	8.3	13.2	10.4	7.5	17.5	24.6	9.2	24.9	18.4	17.0	17.4	24.4	5.6	12.6	11.4	12.5	11.8	6.4	3.6	5.0	2.7	3.0	2.2	3.2	2.0	1.8	2.6	3.8	0.9	1.9	7.7	4.1	3.5	3.7	1.0	1.4											0.0	2.1	20.6	3.0	20.9	15.6	6.5	2.5	2.7	0.0	15.7	2.0	1.8	5.0	9.8	1.9	16.5	12.5	0.0	7.9	3.0	9.5	5.5	2.3	4.9	23.9	15.9	11.5	17.2	36.4	3.4	18.7	22.6	11.8	25.2	12.0	3.1	8.6	10.5	14.5	9.3	1.9	12.9	8.2	5.0	5.3	19.6	0.8	8.2	11.2	4.8
TBCB	"CG22, CKAP1, CKAPI"	ENSG00000105254	"Tubulin folding cofactor B"	Q99426	19	36114289-36125947	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Chaperone, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041428, HPA041722"	Approved		Supported	Cytosol		NA	NA		340000	Cytosol		"HPA041428: AB_10794517, HPA041722: AB_10804007"	"unprognostic (3.88e-3)"	"unprognostic (3.05e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.15e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.02e-1)"	23.0	30.2	59.1	26.0	48.8	23.2	20.0	30.9	67.6	22.1	22.3	64.3	14.3	16.8	20.7	20.9	18.0	27.7	14.9	29.2	55.8	56.7	21.0	14.1	19.9	20.7	63.5	43.8	33.9	11.2	15.1	23.1	19.0	49.7	20.0	17.4	14.7	12.2	22.7	34.5	12.8	17.6	29.8	85.5	21.0	16.3	24.1	44.4	15.0	12.2	13.7	23.9	16.2	15.0	64.6	73.4	79.4	101.2	59.7	96.3	80.6	32.4	95.7	37.0	24.8	26.3	27.9	13.0	25.3	19.5	44.1	30.7	42.0	17.6	24.0	47.6	41.8	34.7	15.5	30.8	27.0	26.6	56.0	29.8	21.4	26.7	64.0	28.6	25.0	48.2	26.3	20.4	35.3	24.8	31.2	25.5	40.4	9.3	40.8	39.1	49.1	38.4	27.8	22.2	39.6	31.4	35.7	19.1	23.1	41.2	31.6	37.2	38.5	22.8	32.5	28.9	32.5	17.1	33.6	28.0	45.7	47.9	26.9	52.1	18.5	47.1	28.2	40.0	24.3	24.2	66.4	65.0	79.4	78.8	85.2	53.0	64.6	73.6	69.1	70.9	54.8	44.0	55.2	27.6	59.7	101.2	73.4	96.3	80.6	59.1	48.8	30.9	61.4	55.8	56.7	63.5	43.8	49.7	44.4	56.6	30.1	79.2	71.3	59.4	55.0	42.3	66.2	91.0	51.2	130.9	11.8	122.5	152.5	129.6	118.3	85.4	49.9	46.7	98.1	167.7	130.9	58.0	83.0	30.6	140.7	68.3	103.0	70.6	73.2	193.4	83.4	107.5	123.2	354.3	52.1	89.1	105.9	92.1	95.1	144.2	59.8	64.7	127.8	113.8	172.0	59.1	69.1	96.9	55.1	70.7
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317424-13348298	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037645: AB_10671631, HPA062118: AB_2732676"	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	15.1	21.9	19.8	11.4	18.0	11.5	33.2	17.3	16.2	14.4	16.0	14.6	10.4	11.9	17.5	20.2	15.4	19.1	15.1	16.1	18.3	15.4	30.5	39.1	20.0	24.3	16.3	11.2	19.8	37.3	23.2	16.6	14.2	17.3	14.4	17.6	15.1	20.6	14.0	20.5	11.8	13.0	17.7	16.6	17.9	15.1	13.7	16.1	44.7	29.8	22.2	17.2	14.1	17.0	8.1	13.2	8.7	19.6	12.7	10.9	6.6	27.5	20.1	41.2	39.7	13.7	10.5	19.4	12.3	9.5	26.3	22.4	22.8	26.0	26.9	15.3	14.3	12.7	17.7	43.6	20.3	27.6	40.4	18.0	14.7	15.0	28.8	14.2	19.8	9.4	9.1	14.6	15.3	9.0	12.3	21.2	57.1	19.3	22.0	18.6	36.5	48.9	8.4	68.1	26.1	9.1	38.2	20.1	16.0	14.2	11.2	14.6	27.2	37.7	16.7	16.8	37.5	21.1	21.1	14.1	11.7	22.3	15.2	25.6	16.2	29.9	49.8	9.4	14.8	9.3	8.7	9.7	7.1	7.1	14.5	8.6	8.1	7.3	8.0	11.6	6.3	9.4	8.7	1.5	12.7	19.6	13.2	10.9	6.6	19.8	18.0	17.3	16.2	18.3	15.4	16.3	11.2	17.3	16.1	11.9	12.5	6.0	14.0	15.2	15.5	10.8	17.8	10.7	15.9	21.0	0.0	28.1	28.2	26.2	8.6	19.0	12.4	23.3	26.1	37.4	15.8	15.2	15.1	27.1	18.2	20.6	16.0	16.5	7.5	11.1	13.8	14.2	15.1	7.2	10.4	22.9	27.4	14.0	17.3	32.7	11.3	6.5	20.6	18.2	15.4	14.8	21.4	11.4	14.6	12.1
TFPT	"amida, FB1, INO80F"	ENSG00000105619	"TCF3 fusion partner"	P0C1Z6	19	54107013-54115675	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.4"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034958, HPA058534"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034958: AB_10603036, HPA058534: AB_2683745"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (6.56e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.66e-2)"	5.9	6.5	33.4	8.9	17.0	7.9	5.1	9.6	22.9	7.9	5.3	8.7	4.3	10.1	5.9	5.3	4.1	5.1	7.1	7.7	24.4	15.5	4.3	3.6	7.9	11.6	18.3	16.1	4.2	4.0	3.3	4.2	6.4	10.8	15.9	2.9	4.8	12.9	5.2	10.8	6.8	10.7	4.7	9.7	14.1	14.5	4.6	12.8	9.6	5.2	3.2	4.8	5.3	3.9	4.4	24.7	5.0	3.9	10.4	13.3	5.5	2.5	2.2	2.2	4.3	0.4	0.8	2.1	2.4	1.8	2.2	2.7	2.6	8.2	2.5	6.0	2.4	1.1	2.7	0.8	1.3	0.7	6.6	11.8	3.0	4.1	3.4	6.3	4.0	6.6	1.7	0.8	1.5	1.1	2.0	3.5	6.2	2.7	3.7	3.5	9.4	7.2	12.7	2.5	4.9	5.0	5.9	1.5	3.4	1.6	11.9	6.0	5.1	0.8	9.7	13.1	0.6	2.5	14.3	8.0	16.5	3.3	1.2	3.4	6.4	6.7	1.9	7.0	11.1	13.9	5.0	3.7	3.6	8.1	3.9	7.7	4.4	11.6	10.7	9.5	4.2	9.0	9.5	2.4	10.4	1.2	24.7	13.3	5.5	33.4	17.0	9.6	22.9	24.4	15.5	18.3	16.1	10.8	12.8	14.9	7.4	21.5	10.2	15.0	9.5	1.6	12.7	6.7	12.5	21.0	2.0	19.5	13.3	17.6	6.1	25.2	20.0	0.0	23.9	22.7	13.1	34.2	15.0	7.4	114.8	0.0	15.0	37.4	28.0	4.0	11.2	38.7	37.1	65.9	29.8	13.4	41.2	17.3	15.9	19.6	9.4	6.5	9.2	6.0	12.3	15.2	21.9	19.7	13.4	9.0
TMEM8B	"C9orf127, NAG-5, NGX6"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 27.2"	"Lineage enriched"	"Detected in many"	18	"dendritic cells: 27.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	9.7	19.5	28.2	5.7	30.4	3.4	9.4	22.9	34.4	15.5	13.0	16.9	14.9	8.7	18.4	11.5	9.3	18.3	12.1	17.8	25.3	14.1	11.3	4.7	10.4	5.9	12.9	21.2	33.3	14.6	28.4	23.6	7.7	18.3	19.3	9.4	17.5	19.9	24.0	19.1	9.2	8.4	18.1	13.0	8.7	13.1	13.6	15.4	5.6	17.3	5.1	4.9	14.2	11.9	0.9	27.2	0.6	1.5	0.5	0.6	1.1	2.9	3.1	11.0	8.6	12.4	10.4	1.3	2.6	5.1	2.9	3.6	1.3	0.8	2.3	6.3	7.1	8.5	1.1	2.9	4.3	2.4	1.8	4.9	0.7	2.2	3.1	8.8	0.2	0.3	9.7	5.6	3.0	3.2	9.4	1.6	10.7	1.0	6.5	5.1	1.1	6.0	1.3	1.6	2.4	4.3	6.7	2.2	5.7	3.0	1.3	2.6	7.7	4.0	1.9	3.9	3.8	3.0	1.1	2.6	6.9	2.2	6.7	1.0	8.7	2.6	2.6	6.3	1.1	4.2	0.4	1.5	0.1	0.6	0.3	0.5	0.9	0.6	0.6	4.7	0.9	0.6	0.5	0.6	0.5	0.3	27.2	0.4	1.1	28.2	30.4	22.9	34.4	25.3	14.1	12.9	21.2	18.3	15.4	11.9	13.5	0.9	7.2	3.9	3.9	10.1	10.2	4.0	7.9	14.0	2.0	29.0	1.7	4.4	20.2	2.9	3.9	0.0	3.4	5.3	7.2	9.2	1.1	2.9	2.9	1.6	6.4	1.3	1.9	9.9	13.6	3.3	10.1	0.0	5.6	8.2	3.2	8.6	18.4	4.1	5.0	6.5	6.1	8.0	4.4	1.4	10.9	3.8	6.3	8.2
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175602-67184040	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 69.1;Cone photoreceptor cells: 41.2;Early spermatids: 91.4;Horizontal cells: 101.7;Late spermatids: 145.2;Rod photoreceptor cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.3;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA065996: AB_2685593"	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	9.5	20.7	18.1	8.1	19.8	5.2	5.9	46.3	25.0	8.8	6.8	11.5	11.5	10.7	15.4	13.4	6.6	15.0	10.0	7.7	15.1	10.6	9.8	4.6	8.7	3.6	13.0	27.7	21.8	7.6	18.0	24.1	9.5	18.5	10.5	8.8	13.2	8.4	10.3	5.9	9.8	9.5	11.7	16.2	11.0	13.7	13.5	12.4	4.4	13.2	4.3	3.2	7.2	6.8	0.0	2.8	0.0	0.8	0.2	1.1	0.3	2.3	4.1	14.7	9.2	2.7	6.5	9.8	6.4	1.6	2.8	2.6	4.0	2.4	4.4	4.2	2.4	2.5	9.2	4.1	3.5	1.7	4.3	5.7	6.5	10.5	3.8	2.2	2.8	13.3	3.6	1.5	3.5	1.3	10.2	4.6	9.5	6.6	4.3	3.6	3.7	6.7	4.9	3.3	2.2	6.7	18.6	7.2	8.3	4.8	5.6	17.5	14.7	7.2	3.7	1.8	7.0	8.1	4.7	5.4	10.0	7.1	4.6	2.6	5.7	4.6	4.6	12.6	4.3	5.2	0.0	0.8	0.0	0.2	0.7	0.0	0.0	0.9	1.1	2.3	0.0	0.1	0.2	0.0	0.2	0.4	2.8	0.0	0.3	18.1	19.8	46.3	24.1	15.1	10.6	13.0	27.7	18.5	12.4	3.0	9.3	1.7	3.6	2.6	69.1	2.8	5.1	2.7	11.4	7.0	41.2	3.3	3.3	4.8	91.4	3.8	4.2	0.0	2.2	5.4	3.7	5.3	4.6	3.6	3.5	101.7	12.6	9.8	0.6	145.2	6.4	1.7	5.0	1.0	4.4	18.9	3.6	4.5	10.3	1.1	68.7	19.4	3.9	4.7	10.2	2.0	2.5	0.9	5.4	3.7
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039470-137046203	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4"	"Lineage enriched"	"Detected in many"	7	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	35.4	21.7	33.1	11.9	35.5	4.1	21.6	59.7	65.6	27.8	27.1	18.4	23.8	22.2	26.7	10.8	11.6	25.4	32.3	20.4	34.5	35.3	12.7	5.9	18.9	11.5	25.1	49.0	12.0	28.6	17.2	47.7	20.1	29.5	73.1	13.3	10.6	58.0	35.5	19.0	17.7	23.0	16.4	30.3	32.4	59.6	10.4	14.5	0.8	11.5	8.6	7.2	12.8	20.2	0.1	2.0	0.5	0.4	0.1	13.6	2.6	9.4	11.4	2.8	18.4	6.6	6.8	0.7	20.4	6.4	4.6	1.8	4.6	5.2	9.4	15.5	7.8	1.4	35.7	2.4	5.5	0.5	7.6	11.6	3.8	29.2	3.3	9.5	3.3	0.0	4.7	8.6	2.5	5.0	12.0	11.8	3.8	0.2	0.2	0.9	35.9	0.2	0.3	6.1	30.0	19.0	5.6	0.0	36.0	7.8	6.1	22.7	15.7	5.4	18.2	12.2	1.1	39.3	4.7	20.3	3.4	6.2	24.3	6.2	0.0	0.1	0.3	5.0	0.3	2.9	0.0	0.4	0.5	8.4	0.0	10.7	0.1	13.2	13.6	0.7	0.0	0.3	2.3	0.0	0.1	0.0	2.0	10.4	2.6	33.1	35.5	59.7	65.6	34.5	35.3	25.1	49.0	29.5	14.5	0.0	10.6	4.2	65.4	20.9	88.5	13.4	79.0	2.7	4.5	27.9	15.7	1.0	0.0	43.0	1.0	147.8	41.7	23.3	59.4	1.0	34.3	329.4	0.0	0.8	17.1	58.8	270.4	337.0	25.4	2.5	149.3	6.8	28.7	2.8	535.1	32.8	34.0	79.7	136.9	0.3	54.6	38.8	34.0	2.9	19.1	20.7	1.5	7.7	84.8	89.4
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034985-36054762	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 19.3;Spermatogonia: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	4.6	5.3	9.1	3.9	10.3	1.3	3.3	6.0	8.7	5.7	11.2	10.1	3.9	4.9	6.4	6.3	5.2	6.8	6.5	4.8	6.5	6.6	5.4	5.6	4.6	4.3	8.5	8.1	6.3	3.4	5.6	6.1	6.4	9.9	5.6	4.1	3.6	5.7	7.5	12.7	8.5	5.0	7.5	9.0	5.0	4.8	15.8	13.3	10.1	5.2	2.6	3.5	7.8	5.0	5.9	6.2	10.4	9.3	7.0	8.4	5.3	2.5	7.9	3.9	3.3	10.5	6.6	2.8	2.3	4.1	4.6	7.6	3.5	2.0	3.8	8.1	3.6	4.7	1.3	2.3	2.9	1.7	2.9	1.9	2.4	2.0	4.0	12.0	1.1	2.3	5.5	4.5	3.1	1.8	5.5	2.3	7.4	2.2	4.7	4.7	4.9	3.1	3.1	3.6	4.8	2.9	3.0	1.3	3.6	3.9	2.4	6.9	5.2	4.0	3.3	2.4	5.5	3.5	1.7	1.5	6.5	4.2	3.4	1.8	3.9	3.3	2.7	6.9	2.3	3.9	10.4	8.6	9.5	7.2	9.3	8.1	5.9	7.5	7.2	6.2	4.9	6.1	8.4	4.0	7.0	8.0	6.2	7.0	5.3	9.1	10.3	6.0	8.7	6.5	6.6	8.5	8.1	9.9	13.3	3.0	3.0	2.7	1.0	1.0	2.1	3.1	5.1	0.0	2.3	7.0	2.0	9.3	1.7	4.0	1.8	1.6	2.6	0.0	0.5	4.0	3.3	0.9	5.7	2.9	13.5	3.2	6.3	2.5	5.1	3.9	1.7	1.8	1.7	5.4	1.3	4.3	3.7	1.5	3.9	7.4	2.2	0.0	2.5	19.3	19.8	1.9	8.8	3.2	2.3	1.0
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol		NA	NA			Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.7	23.2	19.3	24.2	29.7	15.7	23.6	21.4	31.8	41.6	36.0	24.9	26.0	22.1	19.8	22.6	49.4	19.7	45.0	32.2	19.6	20.7	46.9	27.6	40.1	35.8	47.1	42.9	53.7	19.3	42.5	45.8	40.6	26.7	20.0	31.0	27.5	48.5	34.0	25.1	17.7	71.5	31.8	34.5	49.6	25.1	18.5	60.2	43.3	29.3	45.5	22.5	14.4	57.1	53.6	22.8	23.4	77.2	10.1	21.5	18.3	38.7	51.4	39.3	57.7	24.5	29.2	61.2	33.5	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8	74.5	137.9	144.5	130.3	298.3	238.3	92.4	122.3	100.4	66.0	268.7	96.2	165.0	170.8	307.8	2.7	147.4	174.0	23.3	286.0	191.3	151.0	308.8	203.1	213.0	743.7	122.3	214.8	101.3	356.6	8.6	73.1	420.3	266.6	357.1	190.7	203.9	311.9	371.7	61.5	175.0	164.2	77.6	135.2	133.6	224.9	313.3	415.2	116.5	165.6	262.4
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 571.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	26.2	24.1	18.0	16.7	6.3	5.6	10.6	19.7	8.5	14.7	14.2	22.3	8.4	16.3	31.4	7.3	15.3	13.5	12.4	11.9	4.7	34.7	52.6	42.4	29.6	19.2	10.3	19.7	24.9	7.7	8.0	9.5	4.5	11.0	11.9	29.3	19.1	24.8	8.8	18.4	29.9	77.2	17.2	11.0	37.1	27.4	18.7	27.3	10.5	12.9	22.7	26.7	19.0	9.5	22.0	7.7	12.2	23.7	20.1	20.4	16.3	31.5	31.5	32.1	30.1	21.9	21.7	25.3	25.0	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0	26.8	21.5	49.1	53.7	42.8	68.5	65.3	43.3	56.2	14.8	59.3	11.8	107.3	139.3	95.7	197.0	54.9	69.5	46.7	95.4	80.4	81.4	55.2	63.4	41.4	123.0	57.2	95.8	47.3	50.0	571.0	83.4	67.4	118.1	174.1	57.9	60.8	85.6	73.7	122.0	109.4	50.6	64.7	97.1	136.8	72.0	57.6	46.0	94.4	62.6	47.8
KCTD7	"CLN14, EPM3, FLJ32069"	ENSG00000243335	"Potassium channel tetramerization domain containing 7"	Q96MP8	7	66628767-66649067	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.53e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (1.30e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.49e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.19e-2)"	7.1	12.2	14.5	9.2	17.6	5.6	8.0	16.4	18.3	11.6	11.9	27.6	6.0	6.1	16.7	16.3	5.7	11.4	9.4	11.0	14.4	13.9	7.1	4.0	8.5	13.5	27.3	15.4	20.6	4.1	14.1	10.5	9.6	21.7	12.9	8.4	16.8	6.3	13.8	6.1	7.2	9.6	15.4	26.7	11.1	8.6	18.6	20.7	3.9	9.9	3.0	13.8	10.8	8.9	4.7	2.0	10.2	2.1	3.9	6.3	2.0	3.1	6.2	13.9	9.9	6.2	8.3	1.0	5.3	6.6	9.2	8.3	9.2	4.3	10.2	1.4	7.1	22.6	1.8	12.1	1.5	7.9	10.5	5.1	1.1	15.5	5.5	3.6	2.7	8.7	4.8	5.4	7.4	4.2	10.7	4.3	5.7	9.9	9.6	6.1	1.3	3.1	3.9	8.1	1.2	5.4	3.6	5.1	4.7	5.0	1.4	7.1	12.3	4.0	2.7	10.5	13.0	4.6	3.1	4.8	10.0	7.3	3.8	4.2	4.5	3.0	8.0	12.9	3.8	7.6	3.9	1.9	10.2	5.8	1.5	6.3	3.7	5.0	4.4	2.0	4.7	3.3	4.6	1.7	3.9	2.1	2.0	5.0	2.0	14.5	17.6	16.4	17.7	14.4	13.9	27.3	15.4	21.7	20.7	3.0	7.0	6.9	1.3	1.0	15.0	9.8	0.0	2.7	3.4	0.0	35.3	3.9	1.7	1.0	6.5	3.8	2.0	0.0	1.1	1.8	2.5	1.9	4.7	1.6	4.8	17.5	8.1	6.7	3.4	12.3	6.1	3.2	1.7	3.6	2.1	19.3	0.8	3.5	11.7	1.3	54.7	6.5	3.1	12.2	8.2	1.0	2.3	8.5	2.0	0.3
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 314.4;skeletal muscle: 398.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 72531.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 314.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 314.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 673.1"	"Low region specificity"	"Detected in all"							"CAB033779, HPA066847"	Approved					NA	NA					"CAB033779: AB_2149736, HPA066847: "	"prognostic favorable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	83.5	48.0	118.0	15.2	136.1	17.7	31.8	45.0	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96.0	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45.0	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	101.9	104.3	85.6	77.9	325.0	59.2	110.1	88.0	26.0	24.4	25.8	181.3	111.3	125.2	56.0	66.3	24.8	68.2	9.4	53.0	49.0	89.2	73.5	139.3	673.1	257.0	69.8	65.9	137.7	140.2	144.8	37.8	54.6	99.7	26.2	36.7	64.0	78.3	72.4	140.2	53.0	273.1	22.9	64.3	78.6	55.9	38.9	67.2	135.5	165.5	35.6	56.7	48.8	78.1	85.3	108.9	69.7	228.7	137.9	81.8	73.9	104.2	73.1	86.9	53.5	58.0	55.0	116.9	22.3	314.4	54.4	103.0	25.7	31.4	37.3	54.3	30.8	34.0	20.6	60.8	41.1	46.4	157.8	35.8	32.0	32.2	22.0	19.5											1256.6	1138.7	6703.3	2831.5	2012.7	0.0	72531.4	10000.0	1801.4	2082.6	4374.0	0.0	0.0	875.4	1190.4	925.4	1519.1	10706.5	9881.7	3135.3	0.0	1058.8	2565.3	1330.0	13675.3	0.0	0.0	3018.7	7368.9	9328.1	4287.1	6527.3	2029.2	1420.6	1887.4	12938.3	0.0	1718.0	6638.7	3334.2	5210.0	0.0	6305.8	2437.5	5090.3	4626.8	1812.2	0.0	3284.5	11055.0	4223.0
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.6	6.2	12.9	18.1	7.7	9.1	6.8	18.0	12.4	23.3	17.9	14.3	8.7	4.5	10.3	17.5	8.5	6.5	9.0	15.1	8.9	10.9	14.8	7.7	11.7	15.1	16.3	12.2	13.6	10.5	2.4	26.6	15.1	13.0	13.5	13.0	18.6	5.1	16.0	6.1	7.1	8.1	5.9	11.6	10.9	13.8	9.2	3.8	6.7	11.2	7.5	8.2	16.0	11.3	6.4	10.2	10.7	16.2	17.5	22.3	12.2	9.4	40.0	11.9	6.8	6.5	6.6	7.4	9.8	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8	6.0	4.3	3.6	3.9	5.6	0.0	6.0	10.2	6.7	5.7	5.2	0.0	9.4	11.6	7.6	4.1	3.8	2.9	0.0	7.0	10.0	6.8	3.5	0.0	11.5	9.8	0.0	6.9	9.2	7.3	2.2	6.1	4.6	3.3	1.8	7.8	0.0	6.2	3.5	7.4	11.3	0.0	0.0	5.2	33.8	11.0	5.0	4.0	2.9	7.7	3.3
C6orf203	"HSPC230, PRED31"	ENSG00000130349	"Chromosome 6 open reading frame 203"	Q9P0P8	6	107028213-107051342	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049535	Approved					NA	NA					"HPA049535: AB_2680808"	"unprognostic (1.34e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.09e-5)"	"unprognostic (2.64e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.19e-2)"	"prognostic favorable (2.11e-5)"	12.5	26.4	18.6	11.4	21.9	4.3	11.9	19.4	18.1	9.8	16.6	11.5	14.2	14.9	9.2	19.4	11.0	10.3	7.7	26.4	17.0	15.3	22.8	20.8	7.6	9.5	16.3	17.0	11.0	18.8	9.8	15.2	8.0	13.5	10.8	16.7	11.1	14.5	11.6	33.1	10.4	12.4	15.6	13.2	9.9	10.9	6.9	12.4	14.1	15.1	11.9	11.0	10.4	9.1	15.9	17.0	10.4	12.6	15.5	21.1	11.0	6.7	4.5	13.7	18.5	26.6	23.0	4.9	14.9	12.1	10.1	13.3	2.5	4.8	19.2	11.2	11.1	10.2	9.2	9.1	13.0	14.2	15.2	6.9	11.5	3.9	4.7	17.6	13.9	6.4	16.4	18.5	8.2	12.8	13.8	14.7	15.3	12.6	13.8	22.0	9.6	5.7	21.2	6.0	22.3	7.6	10.8	11.2	8.3	25.9	10.0	8.0	8.9	7.3	9.3	12.4	10.5	7.2	25.2	10.9	6.8	6.2	8.5	7.6	2.5	3.9	9.6	12.0	21.8	14.0	1.1	12.2	10.4	13.4	12.6	13.7	15.9	15.6	14.5	16.8	14.4	21.1	18.6	1.6	15.5	10.4	17.0	19.5	11.0	18.6	21.9	19.4	18.1	17.0	15.3	16.3	17.0	13.5	12.4	6.0	10.9	9.3	8.0	6.5	12.7	41.2	15.3	25.4	12.5	21.0	7.9	27.4	86.2	18.7	2.6	8.7	20.7	0.0	15.1	12.3	8.4	7.6	19.7	21.3	21.2	12.7	7.5	9.2	5.9	3.0	19.5	10.5	6.8	10.8	17.1	30.3	14.5	17.5	23.7	52.2	15.0	12.9	10.3	22.6	29.9	4.4	15.2	6.9	27.0	6.3
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3;Late spermatids: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053752: AB_2682250, HPA058032: AB_2683584"	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	7.1	6.5	11.7	6.1	10.4	4.1	4.6	5.2	17.8	5.9	9.3	7.6	3.8	27.9	5.6	3.2	5.6	5.1	6.3	5.4	10.8	10.3	6.0	11.0	4.9	5.2	10.3	8.8	4.7	10.9	5.8	7.4	4.9	8.9	5.0	4.0	5.6	6.0	6.7	15.2	6.9	17.6	5.9	9.7	4.6	5.8	12.6	6.6	6.6	6.3	4.1	4.5	4.6	4.4	8.8	7.8	3.3	6.4	13.6	13.5	7.8	4.6	3.9	2.4	7.5	7.7	4.6	3.4	6.7	3.3	6.5	7.3	5.8	3.1	14.2	6.1	6.2	5.6	5.9	5.2	8.4	2.7	11.8	13.1	6.2	4.6	7.4	9.7	7.2	9.0	6.3	9.1	12.6	4.4	3.3	9.4	6.1	9.6	5.0	4.9	7.7	8.2	10.6	5.4	10.1	20.1	5.1	2.7	10.9	4.6	3.4	7.0	4.2	2.8	5.6	6.7	1.7	4.3	4.9	7.4	4.3	5.1	11.9	10.6	10.5	10.3	8.8	6.6	11.2	6.4	0.1	6.4	3.3	11.9	4.9	13.5	8.8	10.0	11.9	7.8	4.8	12.4	10.0	1.9	13.6	3.9	3.9	10.1	7.8	11.7	10.4	5.2	17.8	10.8	10.3	10.3	8.8	8.9	6.6	3.0	4.8	4.3	1.7	13.3	2.8	5.3	0.0	4.0	3.4	1.8	3.9	3.7	1.7	4.2	11.9	3.8	9.3	23.3	5.8	2.6	3.5	3.7	4.6	12.9	4.7	0.0	6.4	4.3	3.8	25.2	3.1	2.5	5.0	1.8	4.0	4.6	9.6	5.8	5.3	10.5	2.2	0.0	6.2	14.0	5.7	8.0	3.3	4.9	4.9	1.8
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	12.7	12.2	8.9	12.1	8.4	10.7	22.9	7.0	11.7	12.6	9.1	10.5	26.4	11.3	14.9	11.6	7.4	12.8	9.3	9.0	8.4	4.3	9.6	22.7	17.2	21.4	9.2	4.4	18.5	8.3	3.5	9.9	8.9	8.5	11.9	4.6	10.6	10.1	21.8	13.1	16.7	12.7	11.6	5.0	19.0	8.4	6.3	8.2	17.3	8.1	5.2	10.3	11.6	16.2	2.8	6.9	5.1	5.0	4.2	3.0	1.9	0.5	10.8	1.5	7.3	10.5	5.8	8.0	0.6	0.1	0.4	0.0	1.4	4.0	4.2	5.8	4.3	5.6	10.2	5.3	7.2	0.3	7.9	11.3	0.1	7.4	4.9	18.0	3.4	6.6	14.5	7.4	5.2	3.2	2.1	4.0	3.4	0.3	5.4	6.0	5.2	1.1	5.8	3.4	3.2	7.6	5.5	2.5	5.6	3.0	1.5	2.1	4.6	3.9	3.3	12.6	0.1	4.9	5.0	6.0	4.2	5.0	6.7	5.5	0.4	0.9	2.4	6.5	5.5	2.9	0.0	3.1	5.1	2.6	5.0	3.0	2.8	2.7	2.6	3.8	2.3	1.8	2.4	0.6	4.2	4.3	6.9	2.4	1.9	8.9	8.4	7.0	11.7	8.4	4.3	9.2	4.4	8.5	8.2	11.9	9.3	4.7	2.5	2.3	4.7	2.6	5.1	4.0	3.4	0.0	3.9	2.1	1.7	2.5	0.5	2.9	5.9	0.0	3.8	1.7	3.1	2.4	4.6	20.9	20.3	4.8	1.2	5.5	17.2	0.4	15.3	9.1	0.0	5.4	4.0	2.8	4.7	3.4	14.2	11.1	1.7	19.4	2.0	0.5	1.5	1.5	1.9	2.9	3.5	1.3
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.5	14.2	3.5	11.8	26.5	22.4	0.0	11.3	22.9	27.1	23.3	13.8	15.7	27.9	23.5	10.8	29.6	17.0	17.0	15.2	15.2	23.8	13.5	18.0	11.0	15.3	22.7	21.5	13.0	10.0	25.6	14.1	30.0	12.9	17.9	19.2	4.4	17.1	13.7	19.1	24.0	15.5	2.2	23.7	27.6	17.2	11.7	17.6	15.8	22.6	6.8	6.4	8.9	14.3	26.2	2.3	19.4	17.5	11.9	12.7	9.1	19.5	11.7	9.7	18.5	4.6	12.3	14.8	4.9	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5	32.8	17.5	11.5	7.3	16.5	8.7	7.0	12.7	20.1	20.5	8.7	27.5	4.1	0.0	16.7	2.1	22.4	32.6	0.0	18.7	8.3	7.8	14.6	3.5	28.7	12.5	3.2	17.9	28.3	31.6	1.2	8.9	23.3	13.5	5.4	26.1	5.2	26.1	26.4	8.9	6.3	19.2	6.5	6.4	0.3	0.0	26.7	13.3	8.6	21.8	16.6
CSAD	"CSD, PCAP"	ENSG00000139631	"Cysteine sulfinic acid decarboxylase"	Q9Y600	12	53157663-53180909	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 39.2;T-47d: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039487	Approved				"Intracellular and membrane"	NA	NA					"HPA039487: AB_10672776"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (1.57e-1)"	"unprognostic (7.99e-2)"	"prognostic favorable (6.33e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.46e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (4.59e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (6.81e-6)"	30.3	11.4	23.4	12.4	17.8	24.8	26.0	26.4	20.8	17.8	13.1	23.5	24.7	12.4	27.7	39.4	12.3	16.5	14.6	9.9	19.3	10.2	14.9	39.5	12.7	12.5	18.3	22.4	24.6	15.3	16.4	18.4	9.5	17.6	24.8	12.1	19.5	23.2	19.6	12.9	41.9	12.0	14.8	18.9	16.5	12.4	18.5	18.9	12.1	16.0	9.9	10.2	10.5	16.2	2.1	2.2	16.3	2.0	1.5	3.0	0.4	1.6	3.0	7.2	3.0	39.2	16.2	2.6	6.4	1.4	2.7	2.3	1.8	3.9	2.1	4.9	3.4	0.9	5.6	3.2	5.0	1.6	2.8	3.9	3.4	7.3	3.8	3.5	1.4	2.2	19.8	6.3	4.1	5.1	14.1	2.5	4.6	3.6	19.4	2.6	13.6	0.7	4.0	1.4	0.8	2.8	2.8	0.4	4.9	3.6	4.2	3.7	2.8	6.3	9.1	2.3	4.7	23.8	2.8	5.6	8.0	1.6	2.3	1.8	5.5	1.3	1.1	6.7	3.6	3.2	3.5	2.0	2.2	1.3	1.1	0.8	1.2	1.9	0.8	0.9	2.1	2.5	1.4	16.3	1.5	1.2	2.2	3.0	0.4	23.4	17.8	26.4	20.8	19.3	10.2	18.3	22.4	17.6	18.9	3.0	15.8	22.3	24.0	14.7	28.3	7.8	12.7	14.7	11.4	22.7	15.7	10.2	3.3	9.7	0.2	18.9	19.5	0.0	7.8	5.7	17.7	30.0	9.2	34.8	7.2	25.4	13.8	12.3	11.0	1.1	25.0	11.5	13.5	11.8	12.9	30.0	8.0	28.1	29.0	2.4	27.8	38.8	21.7	50.6	58.8	15.9	7.4	12.5	11.5	20.2
SPIN2B	"SPIN-2, TDRD26"	ENSG00000186787	"Spindlin family member 2B"	Q9BPZ2	X	57118551-57121546	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA000162, HPA069835"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000162: AB_1080079, HPA069835: AB_2686211"	"unprognostic (3.21e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.73e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (3.39e-4)"	"unprognostic (9.04e-3)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-3)"	8.9	11.8	14.6	11.1	19.4	5.6	16.1	17.0	24.3	13.0	13.9	8.5	9.9	6.4	12.3	16.2	8.5	9.8	12.0	11.5	14.4	17.3	11.1	8.4	9.3	13.1	15.7	15.8	12.2	9.6	11.6	14.3	9.1	14.4	15.9	16.6	8.2	10.6	15.3	12.0	12.1	9.0	18.2	15.1	12.4	11.1	6.3	13.4	8.8	12.5	6.6	11.9	10.9	14.2	10.8	9.4	1.2	6.1	11.3	13.1	8.3	11.6	8.8	10.5	8.0	10.9	12.3	7.1	7.9	5.1	10.3	6.8	11.4	9.8	2.5	13.3	7.2	9.0	1.8	12.2	4.0	10.7	4.6	14.6	7.1	25.9	14.9	8.9	6.0	5.5	10.2	7.7	6.6	6.9	10.1	8.0	6.5	8.6	8.3	10.7	16.7	8.7	10.9	10.3	3.3	9.9	8.5	13.8	10.7	10.9	5.5	7.2	7.4	13.8	3.4	6.8	16.8	7.6	4.2	8.1	8.7	8.4	14.9	4.7	8.3	5.7	7.3	6.8	11.7	4.8	1.2	5.3	0.6	9.0	6.1	13.0	10.8	11.4	12.3	6.5	8.5	13.1	10.5	0.3	11.3	5.5	9.4	13.1	8.3	14.6	19.4	17.0	24.3	14.4	17.3	15.7	15.8	14.4	13.4	17.9	5.3	4.7	6.7	4.7	10.0	8.4	0.0	1.4	1.2	10.4	0.0	6.7	13.3	5.2	0.0	10.5	5.5	0.0	4.6	4.8	9.3	5.0	10.5	2.9	4.4	11.1	11.1	5.5	2.5	0.0	11.2	2.6	8.5	1.8	7.8	5.2	2.9	10.5	17.7	8.5	5.4	25.8	8.6	0.0	0.4	7.9	2.5	10.1	10.5	4.8
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 481.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		63000	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.7	7.0	5.2	9.5	7.1	8.9	4.6	6.0	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5.0	7.5	5.1	6.5	4.3	3.8	3.5	9.0	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1.0	6.0	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3.0	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6.0	7.4	6.8	0.0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12.0	25.2	13.8	15.7	10.7
MAP6	"FLJ41346, KIAA1878, MAP6-N, STOP"	ENSG00000171533	"Microtubule associated protein 6"	Q96JE9	11	75586918-75669120	"Predicted intracellular proteins"	Transport	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.9"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 77.0;Cone photoreceptor cells: 149.2;Horizontal cells: 47.7"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"B-cells: 2.4"	"Group enriched"	"Detected in some"	6	"AF22: 19.5;CACO-2: 19.0;HDLM-2: 10.6;SCLC-21H: 32.4;SH-SY5Y: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015442, CAB022600, HPA039061, HPA039062"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326"	"unprognostic (3.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.99e-2)"	"unprognostic (7.99e-2)"	"prognostic favorable (3.41e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.09e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	3.0	16.6	23.7	2.1	26.4	0.6	2.6	14.9	35.9	6.9	6.4	10.0	6.1	1.9	10.0	18.6	4.2	34.6	5.8	5.4	21.3	26.6	7.3	1.3	6.5	1.1	17.0	19.9	7.1	3.4	28.7	24.9	1.8	33.2	12.9	3.6	7.5	2.9	18.7	1.1	2.4	2.0	11.5	13.7	1.7	3.6	12.4	9.9	0.0	6.2	0.0	1.0	2.6	3.1	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	19.5	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.0	19.0	0.0	0.3	0.7	3.1	0.6	0.0	1.7	0.2	0.0	10.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	32.4	16.4	2.3	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	26.4	14.9	29.1	21.3	26.6	17.0	19.9	33.2	9.9	3.0	3.0	0.0	1.3	0.7	77.0	7.6	2.5	28.1	4.5	10.4	149.2	0.1	1.7	0.1	21.3	0.7	0.0	0.0	0.2	0.0	0.8	1.6	0.0	0.4	0.1	47.7	12.6	0.6	0.0	31.1	6.9	0.0	5.0	0.0	0.0	16.8	0.3	0.0	17.3	0.8	8.8	0.0	2.3	20.6	1.9	0.4	0.0	0.0	0.0	0.5
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Ciliated cells: 4.0;Club cells: 3.4;Distal tubular cells: 1.7;granulocytes: 2.3;Hofbauer cells: 3.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;AN3-CA: 6.3;SCLC-21H: 7.6;SH-SY5Y: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	5.4	7.2	7.0	2.7	12.5	1.9	7.7	22.7	14.2	4.9	4.5	3.5	6.2	2.8	9.6	10.1	2.6	4.9	6.0	4.0	10.3	8.9	4.4	4.2	5.5	2.4	5.2	11.2	10.5	1.1	7.4	16.3	5.2	6.3	5.7	3.0	3.0	3.7	6.9	2.3	2.1	3.2	6.7	9.5	2.7	5.4	12.4	4.8	0.0	11.7	0.8	2.0	5.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	5.6	6.3	1.5	1.8	0.3	2.1	0.8	0.3	0.9	0.4	0.0	0.0	0.9	0.4	1.0	0.0	1.1	0.1	1.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.7	3.4	0.1	0.9	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.6	10.6	0.4	0.0	0.0	2.4	0.2	0.0	0.7	0.8	0.7	1.4	0.0	0.1	0.0	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	12.5	22.7	14.2	10.3	8.9	5.2	11.2	6.3	4.8	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 4236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3.0	0.3	5.0	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2.0	3.3	2.6	2.6	10.4	2.9	2.2	4.0	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2.0	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68.0	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0.0	65.1	47.9	24.6	55.0	11.5	83.9	50.1	151.0	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24.0	35.3	15.8	33.9	10.7	48.8	46.9
TIMM22	"TEX4, TIM22"	ENSG00000177370	"Translocase of inner mitochondrial membrane 22"	Q9Y584	17	997117-1003671	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045138	Uncertain					NA	NA					"HPA045138: AB_10962055"	"unprognostic (2.69e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-3)"	11.3	14.1	11.5	8.9	12.5	9.9	10.8	13.4	22.4	10.3	10.7	8.5	9.5	9.9	11.1	15.4	12.1	11.9	7.4	22.2	11.4	14.7	17.1	11.4	9.6	9.4	12.3	9.4	13.0	16.4	14.5	15.7	15.5	17.2	11.1	9.1	10.6	14.2	11.5	16.8	11.4	10.9	12.3	8.0	14.6	11.1	14.8	7.1	18.4	13.9	12.1	12.3	9.4	9.7	12.7	9.3	7.4	9.7	11.4	14.0	11.2	5.5	9.8	5.2	6.8	7.9	7.4	5.3	7.1	6.1	10.4	9.2	12.5	3.1	5.1	5.5	8.4	5.2	7.2	10.3	9.8	8.6	5.3	12.0	3.7	7.0	6.8	7.7	4.0	3.9	7.3	6.7	10.1	8.4	4.3	10.2	5.8	7.9	5.2	8.5	5.0	6.6	3.4	6.3	4.4	6.9	6.7	2.6	4.0	8.5	4.4	3.7	4.3	6.1	3.6	6.1	5.2	4.4	3.9	7.4	6.3	4.3	7.9	9.7	2.5	2.7	2.9	6.7	5.7	6.0	4.8	8.9	7.4	11.4	9.1	12.7	12.7	12.1	11.5	8.3	12.4	14.0	12.2	2.5	11.4	9.7	9.3	10.4	11.2	11.5	12.5	13.4	22.4	11.4	14.7	12.3	9.4	17.2	7.1	3.0	15.7	33.0	8.8	38.7	25.2	23.1	25.5	4.0	10.3	7.0	31.4	54.7	31.5	31.1	4.2	27.7	11.0	0.0	24.6	50.0	27.5	14.7	3.5	10.2	33.8	25.4	19.5	14.7	9.5	6.8	18.7	16.1	15.1	31.5	11.1	16.5	23.6	7.0	20.1	21.4	40.3	12.9	17.9	33.0	40.5	47.3	51.5	18.5	15.0	9.9
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	14.2	15.5	14.4	17.6	22.1	17.2	18.6	42.2	21.7	16.2	14.6	25.3	12.5	13.4	23.2	14.1	17.6	17.7	12.1	13.4	14.4	12.1	13.4	16.5	14.2	29.8	19.2	19.4	25.7	20.9	11.7	25.7	11.6	20.4	28.9	17.2	16.3	19.5	18.1	38.8	15.5	19.6	17.3	17.8	20.3	14.7	12.7	22.3	23.7	29.4	20.5	29.7	14.3	15.2	16.6	6.2	11.4	5.4	8.0	24.9	10.2	8.7	8.3	16.5	9.5	22.5	10.1	12.3	14.9	16.6	14.5	20.7	5.7	13.2	13.6	5.4	17.3	16.5	9.9	22.5	21.3	19.7	18.4	16.3	17.4	15.9	25.1	14.8	20.7	13.3	17.2	20.9	17.0	19.7	18.9	16.5	18.6	15.5	6.0	17.4	12.4	15.1	14.3	18.9	18.1	14.3	14.8	18.8	7.7	13.8	17.6	15.2	13.2	12.2	15.2	11.3	11.7	11.2	10.7	22.8	13.4	13.1	15.7	13.3	16.1	4.1	33.2	11.3	13.2	12.3	4.2	5.4	11.4	10.0	5.2	12.5	16.6	15.5	13.7	6.2	15.4	24.9	19.5	1.9	8.0	4.4	4.7	15.8	10.2	14.4	22.1	42.2	21.7	14.4	12.1	19.2	19.4	20.4	22.3	11.9	23.0	29.4	17.6	0.0	0.0	17.5	25.5	32.1	23.9	19.2	0.0	24.9	34.9	21.1	40.5	13.6	19.2	23.3	21.3	22.9	13.5	15.6	10.5	27.2	22.0	0.0	10.5	14.7	21.8	48.5	21.6	18.0	0.0	19.8	26.7	0.0	20.5	25.8	24.8	32.1	0.0	38.8	15.9	42.6	38.1	0.0	19.8	30.5	22.5	14.8
WRAP73	WDR8	ENSG00000116213	"WD repeat containing, antisense to TP73"	Q9P2S5	1	3630767-3652761	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026893	Uncertain					NA	NA					"HPA026893: AB_10603459"	"unprognostic (3.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-3)"	11.9	13.4	12.6	22.5	17.3	28.1	16.7	22.4	15.4	11.5	13.4	14.7	12.2	18.2	13.7	11.6	14.2	12.3	12.0	19.3	14.7	10.3	12.0	11.7	22.1	21.1	18.6	10.6	13.9	20.7	11.7	16.8	12.8	15.8	12.4	12.3	11.4	13.9	20.6	13.7	13.1	18.3	11.9	10.2	20.1	13.9	13.5	19.1	14.5	13.7	11.4	18.1	16.5	11.9	12.3	13.0	36.1	16.2	11.5	14.3	9.8	13.4	7.9	7.9	15.3	10.6	6.7	7.8	6.8	6.7	11.5	10.1	12.4	18.0	15.0	12.8	8.6	9.4	10.3	22.8	13.5	6.0	26.3	34.7	8.5	10.6	14.0	11.4	10.0	13.6	6.2	9.6	9.3	11.9	6.4	10.1	18.1	13.9	9.2	8.3	12.2	20.8	15.1	10.8	13.5	17.0	13.0	11.3	8.0	6.1	5.7	20.4	28.6	8.0	10.8	19.1	7.0	10.7	16.1	8.1	8.9	9.0	15.1	9.7	12.7	14.9	29.8	4.6	20.6	4.0	24.7	12.8	36.1	12.5	11.4	12.1	12.3	13.0	12.0	13.0	12.0	11.8	12.2	15.4	11.5	16.2	11.0	14.3	9.8	12.6	17.3	22.4	15.4	14.7	10.3	18.6	10.6	15.8	19.1	3.0	12.0	15.9	9.3	6.3	22.8	6.5	15.3	10.7	6.8	14.0	33.4	18.3	11.6	12.1	9.9	9.2	16.2	0.0	12.4	10.5	10.5	11.2	4.6	6.0	15.9	39.7	9.9	9.2	10.0	18.6	11.5	11.7	11.8	15.4	11.7	15.8	13.2	8.6	9.2	7.8	23.6	6.5	11.9	29.2	14.7	5.9	12.1	17.5	10.9	8.1
LMBR1L	"FLJ10494, KIAA1174"	ENSG00000139636	"Limb development membrane protein 1 like"	Q6UX01	12	49096551-49110900	"Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 90.1;Late spermatids: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (4.45e-7)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-3)"	12.5	10.7	7.7	9.8	9.4	9.9	11.5	19.7	10.4	11.3	12.7	7.4	14.8	9.3	13.8	15.3	11.0	9.0	9.0	7.8	7.9	7.6	8.1	9.2	8.7	11.2	10.7	6.9	11.7	11.0	5.6	14.4	13.7	8.1	9.3	8.6	10.9	6.7	16.2	10.1	6.3	15.0	13.8	6.9	12.8	7.5	33.5	9.3	12.5	6.7	6.0	12.0	12.2	15.1	9.6	7.3	27.5	11.7	3.1	11.5	8.0	4.5	6.8	8.8	8.2	6.5	8.2	8.3	4.0	6.8	6.0	5.4	6.0	2.6	1.4	3.5	9.4	3.9	1.5	6.9	2.0	3.8	7.5	10.7	4.7	3.9	4.9	7.6	3.0	8.2	8.1	3.2	8.0	5.5	17.9	19.4	7.9	12.5	2.0	5.3	1.5	6.6	6.2	4.1	12.3	5.1	4.3	2.6	2.2	2.3	10.0	4.4	5.1	3.6	3.3	6.8	10.2	2.1	4.0	16.8	2.9	2.0	1.8	1.9	5.7	3.7	3.2	5.8	2.5	2.2	10.8	10.0	27.5	7.3	8.6	6.1	9.6	7.9	8.4	7.3	9.5	11.5	9.6	5.5	3.1	11.7	5.2	11.1	8.0	7.7	9.4	19.7	10.4	7.9	7.6	10.7	6.9	8.1	9.3	6.0	21.9	11.5	12.1	13.7	33.7	5.5	5.1	4.0	5.7	8.7	19.6	13.1	3.3	13.2	90.1	22.9	18.4	0.0	9.0	33.4	20.1	13.4	17.3	7.5	14.5	30.2	45.2	16.5	11.9	124.2	12.7	20.7	20.3	32.5	11.0	8.4	14.6	12.7	6.3	2.8	35.1	12.9	17.6	10.2	12.6	12.9	18.7	27.7	10.9	13.7
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.8	6.4	10.0	3.0	1.7	2.1	18.9	1.4	1.1	2.9	1.8	9.4	9.0	5.3	2.7	1.0	6.2	7.4	10.8	3.2	2.9	3.1	4.7	3.1	6.3	8.5	2.0	8.3	5.1	1.6	2.1	3.1	4.0	1.5	2.2	3.7	8.3	4.4	1.9	1.8	2.3	4.1	33.1	6.4	4.6	5.2	9.2	6.1	3.6	4.7	10.9	7.7	6.6	6.6	6.0	8.7	10.8	3.9	1.3	1.4	3.4	4.6	6.5	2.7	5.5	6.3	2.1	4.8	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5	11.9	13.6	12.6	8.8	12.7	22.7	3.3	7.6	9.4	15.9	19.2	33.4	3.0	1.7	3.8	3.2	7.7	17.9	0.0	11.7	5.3	7.8	10.1	6.9	4.9	5.5	15.9	31.2	10.4	10.3	5.3	5.8	9.0	5.0	8.2	8.6	6.3	7.3	10.5	2.5	4.1	31.2	6.5	7.2	10.1	5.9	8.2	2.1	8.9	6.5	3.7
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favorable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.6	9.5	7.5	12.3	4.4	3.0	6.5	1.8	5.2	3.9	5.3	7.3	3.9	3.5	5.3	2.9	7.2	4.1	6.3	3.6	3.5	7.2	9.7	4.5	5.5	15.4	3.8	2.8	3.6	4.4	4.3	5.1	4.9	5.4	11.8	18.7	5.9	2.8	4.8	4.7	13.0	6.7	13.7	3.3	5.7	13.6	4.2	6.6	4.2	12.1	10.5	18.5	5.7	3.2	8.8	11.7	6.6	8.0	7.7	4.9	9.4	2.3	2.3	4.9	6.4	11.8	3.2	6.6	3.0	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0	0.0	1.3	2.2	1.1	0.8	3.5	2.2	7.6	2.7	0.0	7.0	2.0	1.4	5.0	5.4	11.3	1.9	1.1	0.0	7.3	3.9	2.2	2.8	1.1	7.8	3.1	0.0	2.9	0.6	3.2	9.5	0.9	3.1	1.7	7.2	2.9	2.4	10.1	3.5	1.4	14.3	2.9	6.5	1.4	3.4	8.1	0.4	1.1	3.2	2.4	1.3
C14orf132	C14orf88	ENSG00000227051	"Chromosome 14 open reading frame 132"	Q9NPU4	14	96039324-96093889	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 49.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 35.7;Bipolar cells: 42.6;Horizontal cells: 60.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.1;SCLC-21H: 24.4;SH-SY5Y: 24.2;U-87 MG: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.33e-5)"	"prognostic unfavorable (4.95e-4)"	4.1	14.3	22.4	3.6	16.6	0.9	5.8	43.5	49.2	20.4	6.2	15.1	10.9	2.8	17.8	14.7	6.8	21.8	5.5	4.2	24.4	16.7	3.9	2.0	12.5	1.5	15.0	16.6	3.9	3.5	1.0	17.5	1.5	13.8	6.3	5.1	4.6	1.9	20.7	1.8	13.5	4.7	21.5	19.8	3.7	5.7	2.0	8.0	0.0	1.8	3.1	1.9	4.5	3.9	1.1	0.6	0.4	0.1	0.1	3.5	0.8	0.0	2.9	14.2	4.4	10.4	10.5	0.0	4.8	10.8	6.3	3.9	0.0	0.0	0.0	1.1	10.7	4.2	0.3	1.7	0.4	5.5	0.0	0.6	0.0	0.5	0.0	1.2	0.0	0.1	5.6	0.5	5.9	0.4	0.0	0.1	1.4	0.0	0.0	2.9	22.1	0.3	0.0	6.9	0.0	0.0	12.6	2.3	0.0	5.1	10.1	24.4	24.2	3.7	0.4	0.6	4.0	13.2	0.6	0.0	5.1	3.0	8.3	0.0	0.0	0.0	0.0	21.5	0.0	2.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.4	0.0	1.1	3.5	0.7	0.4	0.1	0.0	0.6	0.3	0.8	22.4	16.6	43.5	25.7	24.4	16.7	15.0	16.6	13.8	8.0	35.7	8.8	0.0	2.5	2.4	42.6	1.1	2.5	21.4	5.7	7.0	19.6	0.1	5.0	4.8	3.0	6.5	0.0	0.0	0.2	0.6	12.0	1.8	1.1	3.9	0.2	60.4	8.6	20.3	1.2	2.7	14.7	0.5	8.5	0.0	0.0	3.4	1.6	0.0	12.7	0.0	5.6	0.0	6.1	0.3	0.6	6.8	0.2	0.0	0.0	1.6
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 84.4;Horizontal cells: 68.3;Intestinal endocrine cells: 18.7;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	14	"glioma: 1.7;pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;U-266/70: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced					NA	NA					"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"	1.8	26.5	27.1	2.7	57.4	1.8	1.8	12.7	67.1	1.7	2.6	3.6	0.0	5.0	1.7	1.9	1.8	2.0	1.8	1.7	31.8	98.9	1.7	1.7	1.9	2.0	25.1	39.8	1.7	6.3	1.7	47.7	1.7	33.9	1.8	2.4	0.7	2.1	2.0	1.7	1.9	3.8	2.1	14.3	1.9	4.1	4.3	4.8	0.0	1.9	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.1	0.8	0.3	0.0	0.0	0.0	0.3	0.6	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.8	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	1.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	2.7	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	27.1	57.4	12.7	45.9	31.8	98.9	25.1	39.8	33.9	4.8	0.0	0.0	0.0	0.0	0.2	84.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	68.3	18.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	8.1	0.9	0.0	0.4	0.2	31.1	0.0	0.8	1.4	2.6	0.0	0.2	0.0	0.0	0.0
KAT2A	"GCN5, GCN5L2, PCAF-b"	ENSG00000108773	"Lysine acetyltransferase 2A"	Q92830	17	42113108-42121358	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048958	Uncertain					NA	NA					"HPA048958: AB_2680571"	"unprognostic (1.71e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (1.41e-8)"	"unprognostic (3.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-3)"	16.9	15.9	30.2	13.6	28.6	8.6	14.0	24.0	42.0	11.2	11.9	10.9	13.1	14.9	13.9	8.9	11.4	14.2	11.8	7.6	27.8	11.5	10.0	11.8	7.2	11.2	27.6	18.0	23.5	16.5	14.8	11.9	10.7	26.0	12.9	9.6	6.0	17.3	14.5	20.1	19.9	13.4	9.7	13.9	15.6	13.0	7.8	29.7	5.3	11.7	6.4	10.4	11.2	21.7	2.0	1.6	0.1	0.4	0.6	2.7	0.8	10.8	21.0	3.1	11.6	4.4	3.6	13.7	7.1	3.8	15.8	7.8	14.2	8.9	21.4	17.9	5.4	11.9	16.3	12.7	11.3	5.6	11.9	26.4	5.3	12.9	12.8	4.6	14.2	14.3	4.3	9.6	8.8	5.6	4.3	6.2	5.4	13.3	4.1	4.2	11.7	33.8	10.4	6.6	27.2	0.0	8.1	6.1	14.1	4.2	11.0	15.0	6.6	7.6	16.7	5.7	2.4	12.3	6.8	4.8	8.0	8.1	11.6	12.6	11.0	10.5	11.9	5.8	12.2	4.4	0.0	0.4	0.0	0.8	0.0	1.7	2.0	1.9	2.4	1.6	1.6	2.7	0.7	0.1	0.6	0.1	0.4	0.3	0.8	30.2	28.6	24.0	42.0	27.8	11.5	27.6	18.0	26.0	29.7	11.9	11.5	13.1	11.2	10.9	14.2	4.7	20.4	4.0	5.7	17.4	9.8	20.4	3.3	7.9	1.0	17.1	3.8	0.0	6.8	15.3	10.1	8.2	11.5	13.7	10.6	9.5	15.1	19.0	8.5	1.3	30.2	7.2	6.8	6.4	8.6	5.8	6.5	5.8	27.3	2.5	7.4	12.9	10.0	4.7	19.6	12.2	9.4	6.4	16.9	7.3
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 7.8;Rod photoreceptor cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.4"					"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favorable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	3.3	7.9	9.1	6.3	10.1	5.6	6.6	28.5	10.4	5.4	6.7	4.5	4.5	2.7	3.3	8.4	3.2	6.9	4.2	8.1	9.0	6.7	6.2	3.3	5.6	13.2	8.0	7.5	5.4	4.1	16.1	11.3	5.9	7.9	6.6	3.7	7.8	4.5	9.4	10.3	3.2	7.1	6.6	9.0	15.1	3.8	7.1	8.9	15.6	10.4	1.1	12.1	6.2	2.5	22.2	11.0	13.7	10.0	13.9	19.4	10.9	0.1	0.2	2.4	0.0	0.4	0.1	0.0	2.7	1.6	5.4	1.9	0.3	0.4	5.5	0.9	3.9	1.7	0.1	2.0	2.2	6.3	6.0	3.9	0.1	0.9	0.0	4.7	0.0	8.1	7.0	1.6	3.4	1.8	6.2	0.8	5.9	0.8	2.7	4.7	0.1	10.4	0.1	3.5	0.0	5.6	4.1	7.5	3.3	2.0	0.2	0.2	0.0	0.0	0.1	3.6	6.3	1.6	7.7	0.0	0.6	2.9	0.0	2.0	4.9	0.1	3.0	0.6	1.3	1.8	12.1	7.6	13.7	6.4	7.0	16.7	17.2	13.3	11.0	11.0	22.2	19.4	15.5	5.6	13.9	10.0	10.0	13.1	10.9	9.1	10.1	28.5	10.4	9.0	6.7	8.0	7.5	7.9	8.9	0.0	1.1	0.9	0.6	0.6	5.3	4.8	2.5	0.0	1.2	3.5	0.0	1.8	1.7	2.6	0.1	1.0	0.0	0.0	0.0	0.9	1.0	0.5	2.3	1.0	3.3	6.4	0.0	1.3	1.6	0.4	0.0	1.6	1.7	1.8	0.0	7.8	0.5	0.0	0.4	1.3	6.8	0.0	0.4	5.6	4.5	0.4	0.7	4.3	0.3	0.1
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677682-88686493	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;skeletal muscle: 33.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NB-4: 14.7;RPMI-8226: 23.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"			HPA071127			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.9	0.8	2.4	6.3	2.3	2.3	0.8	1.9	2.9	1.3	3.4	2.1	0.2	2.2	0.8	1.3	1.3	1.4	2.6	2.4	2.5	1.7	1.3	1.0	5.3	4.5	3.1	0.8	1.5	6.1	2.1	1.0	0.9	2.2	1.6	0.8	1.4	3.6	0.7	33.9	1.1	4.6	1.1	2.4	9.2	3.5	2.1	2.2	2.1	3.0	9.5	13.0	2.7	2.4	4.6	9.2	25.5	7.7	0.5	11.6	5.4	0.2	0.8	0.2	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	2.9	0.2	1.9	0.5	0.0	0.7	0.6	0.2	0.2	0.0	0.3	1.1	0.9	0.1	0.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.7	3.6	0.0	2.6	0.1	14.7	0.3	0.3	0.3	3.2	0.2	23.2	0.0	0.4	1.4	0.2	0.6	0.0	0.2	0.4	1.0	1.8	0.3	0.1	0.9	0.2	0.0	0.6	3.3	3.3	0.2	4.0	0.4	2.8	7.7	25.5	6.1	2.9	10.9	4.6	9.9	5.7	9.2	3.8	6.1	3.8	17.1	0.5	0.7	6.5	11.6	5.4	2.4	2.3	1.9	2.4	2.5	1.7	3.1	0.8	2.2	2.2	3.0	0.0	8.0	0.1	0.5	0.2	2.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	9.2	0.0	7.0	0.0	0.0	0.6	14.2	0.0	0.0	10.3	5.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.8	0.0	1.1	0.3	0.1	10.9	0.0	0.0
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490822-3500940	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	8.1	6.5	10.5	6.6	13.0	9.3	3.4	5.5	13.0	3.9	5.5	6.9	2.6	18.9	3.7	4.1	4.1	3.1	4.9	5.1	14.9	9.1	6.0	6.4	4.0	4.5	18.2	6.2	3.8	7.6	3.8	3.9	3.8	8.4	5.1	2.0	3.2	6.0	4.0	23.1	7.0	12.3	2.4	25.5	5.9	7.3	4.2	6.1	4.7	2.9	7.8	4.5	3.1	4.7	11.6	11.0	1.8	6.6	6.9	12.3	4.4	9.2	11.0	1.7	3.6	0.9	1.1	7.4	8.8	1.8	4.3	3.4	15.3	3.8	7.2	6.9	1.3	3.9	9.6	2.7	3.0	0.9	10.6	12.4	7.5	6.2	18.2	3.5	10.0	10.5	1.2	3.0	4.2	1.8	1.5	2.2	8.0	16.3	8.5	1.7	10.5	10.8	11.4	9.8	3.7	14.9	12.3	4.0	10.4	2.6	5.2	10.5	7.7	6.2	5.5	8.8	0.8	7.5	5.5	5.0	5.4	7.4	14.3	16.1	11.3	8.2	9.6	6.4	22.8	6.4	1.1	5.3	1.8	6.2	6.2	8.1	8.1	8.5	12.3	8.7	11.6	12.3	10.4	0.3	6.9	6.6	11.0	9.6	4.4	10.5	13.0	5.5	13.0	14.9	9.1	18.2	6.2	8.4	6.1	6.0	2.1	18.5	14.9	20.9	17.4	7.1	10.2	1.4	2.3	5.2	9.8	25.8	18.3	21.7	7.1	12.1	9.7	0.0	18.5	26.0	13.9	16.8	13.8	8.2	19.0	23.8	12.6	11.1	7.2	17.2	13.0	8.6	18.6	24.4	11.0	13.1	19.1	14.4	14.2	23.9	11.8	0.0	13.7	11.1	12.3	24.1	29.1	12.8	16.1	15.3
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932163	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8"	"Cell type enriched"	"Detected in some"	15	"Intestinal endocrine cells: 65.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.4;U-266/70: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA					"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.1	7.4	0.1	0.8	0.1	0.0	4.5	0.1	0.4	0.2	6.9	0.2	0.0	3.4	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.1	8.3	0.0	2.1	1.5	0.0	0.5	2.0	0.0	1.2	4.0	0.1	0.1	9.2	0.0	0.1	0.1	11.8	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	65.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain					NA	NA					"HPA049749: AB_2680866"	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	14.4	11.7	20.3	12.9	23.5	28.9	15.5	30.4	29.7	17.4	15.3	14.7	13.8	7.0	15.8	8.9	10.3	10.7	12.1	17.6	19.4	14.3	11.9	11.4	14.9	15.2	12.8	23.7	23.8	11.5	44.8	20.1	12.7	19.1	11.4	11.8	11.0	11.4	14.0	31.7	14.6	13.9	15.7	11.7	17.4	13.5	13.5	15.8	16.6	17.2	11.3	15.3	12.9	11.6	9.8	7.0	17.6	5.7	2.8	6.6	1.4	7.5	9.9	11.1	3.8	19.7	12.7	3.7	6.0	7.7	6.2	7.2	6.1	3.0	11.3	5.5	11.2	5.7	8.3	17.9	5.1	8.5	8.7	6.1	24.5	14.1	4.4	3.2	18.1	14.7	9.0	5.0	8.7	8.6	5.4	13.0	7.7	24.6	5.0	5.3	12.3	6.3	3.6	5.5	5.8	5.1	6.9	12.3	6.6	2.5	18.7	10.0	5.0	10.6	7.2	6.3	14.0	3.6	7.2	14.5	8.1	7.5	6.9	7.8	5.6	9.5	7.9	4.6	13.5	2.8	17.6	3.7	7.4	5.0	3.3	3.8	5.3	5.5	4.4	3.2	9.8	5.6	5.6	12.9	2.8	5.7	7.0	6.6	1.4	20.3	23.5	30.4	29.7	19.4	14.3	12.8	23.7	19.1	15.8	6.0	36.1	26.8	9.3	13.3	57.2	57.0	7.6	18.7	20.5	21.0	62.8	7.2	1.7	8.7	18.5	26.3	11.5	0.0	12.2	9.1	17.5	12.6	48.6	17.9	15.0	81.0	9.8	51.5	39.1	12.5	25.6	22.8	18.6	23.4	12.8	25.1	10.8	13.6	37.4	13.2	54.8	6.5	17.8	45.5	28.9	13.4	7.4	34.8	12.0	9.3
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 227.2"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Group enriched"	"Detected in some"	4	"HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.8	23.2	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.7	46.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.1	0.0	2.1	0.0	0.0	0.0	7.7	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0.0	0.6	0.0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0.0	23.6	0.8	0.0	0.0	13.2	0.5	0.2	0.0	0.0	0.7	2.1	6.2	0.0	0.4	15.8	227.2	51.9	0.0	15.9	14.4	2.6	24.4	10.1	1.8	0.0	13.1	2.2	0.0	1.1	0.3	29.4	0.0	2.1	2.1	2.5	5.6	2.1	0.0	0.2	0.3
PRPSAP2	PAP41	ENSG00000141127	"Phosphoribosyl pyrophosphate synthetase associated protein 2"	O60256	17	18840085-18931287	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 82.5"	"Low region specificity"	"Detected in all"							HPA021881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		28000	"Nucleoplasm, Cytosol"		"HPA021881: AB_1855782"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (4.57e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.08e-2)"	9.5	15.5	18.9	22.7	20.0	16.0	12.7	42.9	23.0	13.6	16.1	27.2	13.7	19.0	16.3	14.6	15.9	16.6	16.6	13.9	20.5	22.0	22.9	16.2	13.7	35.9	23.6	19.4	20.9	16.2	18.5	24.9	10.4	20.2	13.1	19.1	16.2	13.4	13.6	9.8	15.3	16.4	13.5	35.0	14.8	17.0	22.7	22.6	28.1	20.5	10.3	41.1	12.7	13.5	26.0	18.9	17.0	14.7	21.4	29.9	16.7	11.2	12.4	18.0	12.9	7.9	5.0	18.5	8.5	6.6	11.1	10.4	15.5	5.3	28.7	8.7	7.3	11.2	13.7	21.1	10.6	12.2	12.9	16.9	9.0	10.4	12.9	10.9	5.7	8.1	5.7	7.1	14.0	10.8	11.3	10.4	16.2	13.2	4.8	9.9	12.4	12.0	6.7	12.8	22.2	8.2	17.0	29.7	12.7	6.9	7.1	10.6	13.8	12.9	5.1	13.0	82.5	14.2	8.3	6.8	4.6	9.1	15.5	10.4	7.8	9.1	11.9	9.4	8.4	9.4	12.7	13.8	17.0	16.7	14.1	18.5	26.0	21.2	17.1	18.9	24.3	29.9	22.3	5.8	21.4	14.7	13.1	21.1	16.7	18.9	20.0	42.9	20.1	20.5	22.0	23.6	19.4	20.2	22.6	14.9	24.8	27.4	16.5	14.1	35.2	8.6	28.1	30.8	13.6	10.4	27.5	11.2	23.2	20.4	42.2	12.0	14.5	0.0	19.3	30.7	13.4	14.7	45.1	16.3	20.6	15.9	25.4	18.4	14.5	33.2	13.0	15.5	11.8	23.4	21.1	23.3	18.4	11.5	12.7	22.8	31.0	19.4	12.4	47.7	58.0	18.2	11.7	17.5	20.0	13.4
UNC13B	"hmunc13, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No			Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	11.9	12.1	9.3	9.0	18.3	1.4	10.4	16.6	18.8	12.2	21.4	10.1	35.0	11.5	10.6	8.4	14.9	11.1	14.6	11.1	9.2	7.1	22.1	21.5	37.6	2.2	9.5	9.5	7.9	28.7	21.7	13.7	6.3	10.1	20.5	25.1	27.2	20.7	33.6	21.1	14.6	13.0	12.2	9.4	5.0	15.8	16.2	9.1	0.8	12.5	11.6	5.8	8.6	10.4	0.9	1.9	0.0	0.4	0.0	0.3	0.4	5.4	7.2	8.1	13.0	15.6	8.7	6.8	8.9	4.0	6.6	9.0	6.0	2.5	0.0	4.1	11.6	11.7	2.6	20.3	10.3	8.5	0.0	6.5	3.3	20.6	7.7	7.5	1.2	3.7	6.9	8.1	10.4	10.8	10.6	21.3	9.0	7.4	4.6	7.7	4.1	1.1	0.1	7.3	16.9	7.6	0.0	5.0	1.9	9.1	7.1	8.7	9.1	6.2	3.9	6.5	14.0	6.6	4.2	19.5	4.6	4.3	7.1	6.8	7.4	8.8	0.0	5.0	10.3	4.6	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.3	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	9.3	18.3	16.6	18.8	9.2	7.1	9.5	9.5	10.1	9.1	53.6	55.9	0.8	1.2	2.7	37.4	11.0	17.8	10.7	25.0	8.7	90.3	3.2	3.3	6.0	5.6	6.7	14.8	0.0	10.6	1.9	3.1	10.8	2.3	11.1	4.1	6.4	23.6	4.9	2.2	8.5	2.0	3.1	6.8	0.0	28.6	6.7	8.2	14.1	2.8	6.8	42.9	6.5	4.7	7.5	8.3	6.5	2.4	0.0	16.7	2.6
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702709	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 115.9"	"Group enriched"	"Detected in many"	5	"B-cells: 132.4;Cardiomyocytes: 52.7;Distal tubular cells: 104.5;Hofbauer cells: 49.0;Horizontal cells: 160.5;Melanocytes: 49.0;Muller glia cells: 53.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 115.9"	"Group enriched"	"Detected in many"	4	"memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	4	"B-cells: 23.9;dendritic cells: 19.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;REH: 31.0;SK-MEL-30: 14.3;U-266/70: 29.8;U-266/84: 13.7"	"Region enriched"	"Detected in many"	6	"basal ganglia: 1142.7"	"Region enriched"	"Detected in all"	6	"basal ganglia: 484.6"	HPA057790	Supported	Supported				NA	NA					"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.1	4.8	19.8	4.5	115.9	5.4	4.1	9.7	28.2	2.6	3.8	23.4	0.8	4.7	4.8	4.9	11.1	6.5	3.3	22.5	20.3	11.4	6.0	2.2	3.0	8.0	20.0	10.0	10.0	7.2	5.4	4.6	1.4	20.9	7.1	3.0	12.2	22.8	5.7	2.9	1.7	4.9	3.4	28.5	11.0	5.8	5.5	22.0	0.1	3.7	0.4	8.2	3.4	1.4	23.9	19.9	5.0	0.6	0.0	0.5	1.3	0.1	0.0	1.5	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	10.5	0.5	0.1	0.1	0.1	1.7	0.0	0.0	0.0	1.4	0.2	0.0	1.2	0.8	0.0	6.3	0.2	0.2	0.0	0.1	0.1	0.0	1.2	0.1	6.8	0.0	1.0	0.2	0.6	1.2	0.2	0.6	31.0	0.0	2.8	0.1	0.0	0.0	4.5	0.0	0.0	14.3	1.1	0.2	2.6	0.0	0.0	1.5	0.1	0.1	29.8	13.7	2.2	0.1	3.3	7.9	1.1	0.6	3.2	0.1	0.2	0.4	23.9	0.2	0.1	2.5	20.5	0.5	0.3	5.0	0.0	0.0	19.9	0.0	1.3	19.8	115.9	9.7	20.0	20.3	11.4	20.0	10.0	20.9	22.0	6.0	3.4	132.4	10.1	2.3	5.4	52.7	10.2	5.3	5.7	8.7	7.9	0.5	104.5	10.7	4.3	12.1	0.5	0.0	4.2	0.9	1.7	8.1	12.7	11.6	49.0	160.5	5.8	14.7	7.2	7.4	2.3	6.6	49.0	12.6	2.6	53.2	3.9	1.5	2.5	15.8	10.2	6.5	8.0	1.7	2.9	1.8	2.9	2.2	1.7	6.7
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407955-33443892	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 67.6;skeletal muscle: 130.8"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 153.6;Muller glia cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	4	"B-cells: 6.7;dendritic cells: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8"	"Low region specificity"	"Detected in all"							"CAB037059, HPA067154"	Approved					NA	NA					"CAB037059: AB_261497, HPA067154: "	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	13.7	6.5	28.8	3.3	36.2	2.1	4.8	5.9	28.4	6.4	4.3	14.4	2.9	4.4	4.5	5.3	12.2	5.6	4.8	67.6	20.0	15.9	8.5	5.1	3.7	3.8	23.6	19.1	8.5	7.5	7.6	2.5	2.7	11.9	7.3	2.7	10.0	16.0	10.7	130.8	3.8	4.2	9.4	8.8	2.6	4.8	6.7	11.8	0.3	33.0	22.0	3.7	8.6	5.4	6.7	11.1	0.0	0.0	0.0	2.2	0.4	6.0	3.1	1.4	13.5	32.8	6.5	1.3	4.6	6.5	8.8	7.4	7.8	2.0	4.3	5.6	7.9	16.2	8.0	4.0	2.5	1.5	0.8	5.1	0.2	7.5	11.0	9.3	0.4	0.7	5.9	3.2	3.8	1.5	4.9	1.3	4.2	10.3	1.6	4.4	0.7	8.0	1.0	0.8	0.8	17.8	5.1	10.0	4.7	1.8	5.4	5.9	5.1	18.2	5.5	9.1	1.1	8.5	0.7	2.2	4.4	8.7	17.4	4.2	10.3	5.3	2.6	9.5	0.8	0.6	0.0	0.0	0.0	1.0	0.0	2.2	6.7	1.0	1.0	0.0	2.7	0.3	0.8	0.0	0.0	0.0	11.1	1.2	0.4	28.8	36.2	5.9	28.4	20.0	15.9	23.6	19.1	11.9	11.8	3.0	1.3	3.2	3.7	2.9	4.9	153.6	7.6	0.0	1.2	1.8	3.9	1.0	33.2	1.6	0.7	2.3	1.7	0.0	2.2	1.3	6.8	7.5	0.0	7.9	1.5	0.0	4.1	3.7	1.5	1.1	23.3	1.4	5.0	0.0	1.0	54.5	2.8	0.9	26.5	25.4	33.6	25.8	21.4	1.8	3.8	2.5	0.7	5.0	1.7	5.0
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 9.4;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045445: AB_10959608, HPA055817: AB_2682933"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	3.6	8.1	10.4	1.9	12.4	0.6	6.7	20.1	8.8	11.1	6.3	9.9	5.2	2.9	10.5	13.5	3.8	9.4	4.4	6.8	7.9	6.6	6.7	2.5	4.2	2.5	14.2	6.4	18.8	4.4	6.3	21.7	7.6	9.7	8.3	3.5	5.6	7.9	10.3	4.1	4.8	2.8	8.2	9.5	3.6	4.6	7.0	12.5	2.1	9.5	1.5	3.1	5.5	9.0	0.8	2.9	1.1	3.1	3.3	2.4	1.6	5.5	4.4	10.9	9.5	8.7	6.4	4.5	4.8	4.5	5.9	8.9	3.9	4.4	4.6	9.2	1.6	13.9	6.0	6.2	2.8	7.9	4.7	6.2	2.9	6.4	5.0	3.3	1.9	3.7	2.5	5.9	4.3	2.9	5.4	3.0	3.9	2.0	4.4	6.2	2.2	1.7	3.1	2.6	2.3	4.7	2.3	12.6	3.0	2.7	1.6	11.2	3.8	6.3	1.8	5.2	4.5	4.2	1.9	2.1	8.8	5.9	2.7	3.9	4.0	6.8	1.1	6.3	2.8	8.6	0.0	2.4	1.1	2.4	1.9	1.4	0.8	2.2	1.7	2.9	0.6	1.7	1.3	0.3	3.3	3.1	2.6	0.0	1.6	10.4	12.4	20.1	8.8	7.9	6.6	14.2	6.4	9.7	12.5	0.0	0.3	0.0	0.7	0.0	4.6	2.4	0.0	9.4	1.2	1.8	2.0	3.5	1.7	1.1	0.8	1.5	0.0	0.0	0.4	1.2	0.9	0.8	0.0	0.0	1.2	3.2	0.0	0.6	1.2	0.0	6.1	0.0	0.0	1.8	0.6	5.8	0.7	0.0	5.3	1.0	3.9	12.9	0.5	1.6	4.9	0.0	1.1	0.0	0.6	0.3
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600872-63608365	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 76.5;Proximal tubular cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	8.3	11.3	8.7	6.3	11.1	4.9	6.9	6.4	14.2	5.9	12.1	7.6	6.2	13.0	7.6	7.2	7.5	6.7	10.1	21.2	7.6	8.6	20.7	42.5	7.0	7.3	9.3	7.2	6.0	10.7	8.3	5.7	7.5	9.3	6.4	11.4	8.1	11.4	6.9	37.5	6.1	15.7	6.9	6.5	7.3	8.0	8.1	6.2	8.7	8.7	15.9	8.1	6.3	5.1	8.9	9.9	7.9	8.1	16.6	13.6	7.9	17.3	27.4	8.8	9.1	7.7	11.1	11.8	12.7	12.1	25.7	20.5	18.0	10.4	14.3	9.8	14.6	17.9	16.0	19.3	18.6	24.3	7.6	26.9	14.1	14.0	31.4	21.3	16.6	9.9	13.5	13.0	22.2	23.6	9.6	13.3	11.0	19.1	10.9	12.0	31.3	19.3	12.6	7.6	18.8	28.5	12.2	21.7	17.9	15.0	12.2	13.5	14.8	8.7	29.0	24.2	12.1	24.1	13.0	11.7	18.4	13.9	12.5	22.4	11.9	11.6	17.0	14.0	11.4	13.3	2.1	8.1	7.9	9.5	7.5	10.6	7.1	13.6	9.5	9.9	8.9	12.8	10.3	1.4	16.6	6.6	6.4	9.0	7.9	8.7	11.1	6.4	14.2	7.6	8.6	9.3	7.2	9.3	6.2	3.0	4.6	12.3	7.4	2.3	7.5	50.4	10.2	6.7	5.7	14.0	2.0	28.9	46.4	24.0	12.5	12.8	41.2	0.0	23.8	23.1	9.4	8.0	9.2	76.5	23.2	6.4	13.3	10.4	10.3	37.7	10.9	8.5	10.1	29.7	21.7	13.2	23.6	24.1	10.6	101.0	10.4	19.4	9.0	23.2	15.5	3.8	16.6	11.5	31.0	5.7
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 144.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 21.4;Club cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol		NA	NA			Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	5.2	11.3	33.4	6.0	144.3	3.4	3.6	28.7	104.9	9.9	3.5	8.7	1.2	3.9	6.2	4.8	4.5	8.1	6.5	12.0	45.4	25.0	4.0	2.5	4.5	5.9	15.8	32.3	9.2	6.1	6.2	5.5	4.7	26.4	7.1	2.9	3.6	6.7	8.0	5.3	5.6	3.2	6.5	10.7	5.0	4.7	5.8	15.6	0.8	6.5	0.6	4.6	6.0	2.4	5.9	2.7	0.8	4.5	3.0	6.5	5.5	8.8	10.7	9.0	14.1	13.1	16.2	6.2	11.7	12.2	12.3	9.9	10.7	13.1	10.1	11.4	10.8	8.9	13.6	8.8	14.2	4.5	9.8	18.2	12.5	15.7	5.5	18.1	11.3	14.5	15.5	12.0	21.8	8.8	10.2	6.5	6.1	13.5	16.2	10.0	15.9	10.3	7.3	40.3	9.8	18.9	8.5	5.0	13.0	8.3	9.9	11.2	16.1	13.3	12.3	16.5	7.5	11.8	7.4	8.9	15.8	11.3	11.5	16.0	22.8	16.1	7.5	19.6	18.2	14.3	0.0	4.5	0.8	3.1	2.6	3.8	5.9	4.8	4.8	2.7	2.7	6.5	5.3	0.7	3.0	4.2	1.6	2.7	5.5	33.4	144.3	28.7	61.4	45.4	25.0	15.8	32.3	26.4	15.6	3.0	11.8	0.8	0.5	3.1	3.4	12.0	5.1	21.4	15.9	7.0	0.0	5.0	1.7	3.2	2.2	2.8	1.0	0.0	3.7	2.2	5.0	0.4	3.5	3.6	3.3	6.4	3.5	3.1	7.0	0.7	6.1	1.9	5.0	1.0	2.8	1.6	3.5	2.8	3.9	3.0	2.4	0.0	4.1	3.2	2.2	2.6	4.7	3.2	2.1	0.4
HNRNPA0	"hnRNPA0, HNRPA0"	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754376	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		110000	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	25.6	30.9	18.1	31.8	21.4	40.7	62.9	35.2	43.8	27.0	21.2	11.5	17.2	21.0	38.1	26.3	25.7	29.3	29.5	29.1	15.7	18.0	17.4	18.5	40.4	61.2	16.5	22.5	42.7	34.8	15.1	20.4	30.7	16.6	22.1	17.2	20.0	18.6	20.8	38.1	23.2	23.1	33.4	16.8	24.2	24.3	25.7	13.6	50.1	26.2	22.5	21.6	24.8	24.2	5.2	6.1	8.0	4.4	7.8	7.1	1.5	14.4	14.5	28.2	28.4	13.9	8.9	29.0	11.1	9.2	10.0	11.6	27.0	11.4	26.3	16.1	9.5	11.0	13.3	15.2	17.3	12.2	13.2	21.2	17.0	9.3	16.3	12.8	15.5	18.1	14.3	12.2	7.9	9.2	11.0	13.8	23.9	13.8	17.7	10.0	18.8	29.0	20.9	22.0	6.9	10.6	34.9	20.6	13.2	9.8	16.7	35.8	29.1	14.3	10.0	18.8	32.3	12.7	18.0	13.4	16.0	13.7	8.8	21.1	17.9	14.4	18.7	10.4	18.0	15.8	4.2	2.4	8.0	5.9	4.1	7.1	4.2	5.6	5.9	4.2	5.2	6.1	6.0	2.6	7.8	4.4	6.1	3.2	1.5	18.1	21.4	35.2	43.8	15.7	18.0	16.5	22.5	16.6	13.6	80.4	53.0	188.3	346.9	489.4	73.3	31.1	99.3	37.5	62.6	96.0	35.3	296.0	145.9	218.1	24.7	188.8	85.5	70.0	128.8	402.7	254.2	247.7	94.6	65.2	171.4	79.4	226.9	148.0	122.8	31.9	146.2	137.9	266.6	273.3	165.1	127.6	167.3	162.1	141.8	99.3	53.7	84.1	348.8	141.2	79.6	423.3	305.8	240.4	208.3	323.0
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.1	32.0	13.0	23.4	19.1	13.3	11.3	16.0	19.8	26.3	24.5	36.1	8.8	21.0	23.7	17.6	13.9	21.9	19.6	16.9	13.6	23.9	26.7	15.4	18.2	20.1	17.8	11.1	20.7	12.7	11.5	19.7	11.7	16.7	15.2	16.4	16.7	9.6	14.6	24.6	23.9	12.4	11.0	13.9	16.4	21.7	25.7	36.8	7.7	11.4	13.4	17.7	20.0	13.9	18.2	42.7	14.0	9.6	15.4	25.4	17.7	37.2	31.3	11.2	8.5	12.7	46.1	18.2	16.6	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6	32.8	25.7	39.8	24.5	57.5	79.0	78.7	25.5	28.1	18.2	26.2	37.3	28.1	71.3	24.0	48.1	37.6	35.4	46.7	27.3	36.7	47.3	36.0	41.4	52.9	29.7	112.8	58.5	27.6	39.9	29.1	38.0	25.6	47.2	17.2	41.8	72.5	28.5	42.4	48.8	81.8	52.8	19.4	44.3	106.7	98.2	48.9	26.3	48.4	31.6	21.6
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 91.2;Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.9	14.4	8.8	32.9	7.4	10.0	6.1	11.9	7.0	6.6	11.8	12.9	8.2	23.2	8.0	11.0	16.7	9.8	19.5	10.1	6.9	17.6	10.9	6.5	3.9	21.7	15.9	6.5	10.0	12.5	19.0	10.5	12.2	9.4	6.5	22.0	15.5	15.0	10.0	6.3	9.9	15.5	14.1	16.8	20.2	13.0	5.3	13.3	6.3	2.4	16.1	18.6	8.6	5.3	23.8	7.5	15.9	13.7	5.5	5.8	9.2	17.9	10.8	10.4	18.0	26.3	8.3	14.3	18.2	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3	3.0	1.0	9.7	8.3	6.1	4.4	9.4	17.8	34.8	9.1	5.2	2.0	11.9	91.2	7.9	131.4	3.6	1.3	0.0	6.8	6.3	5.3	5.3	1.1	7.3	7.9	1.6	4.6	6.7	6.5	38.2	7.8	4.8	6.8	4.6	3.9	41.4	7.8	3.5	5.6	39.1	2.8	12.9	5.7	23.6	26.0	7.4	3.9	5.0	7.5	4.7
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		230000	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	15.9	13.9	13.0	15.5	17.7	10.8	25.5	17.7	15.7	12.3	18.5	17.2	15.1	17.2	14.9	10.6	17.3	13.8	12.2	15.4	12.3	8.0	13.3	13.9	18.1	17.4	19.9	9.0	18.9	22.5	23.4	13.7	12.0	13.8	13.1	18.6	13.6	15.3	22.4	39.4	22.1	17.0	17.1	13.7	12.7	15.8	5.9	17.1	15.1	14.6	14.0	14.3	18.2	21.6	5.1	5.6	6.4	6.9	5.9	4.8	4.6	16.6	19.4	7.9	9.8	21.8	14.9	6.2	10.1	13.0	10.8	7.9	15.1	10.8	7.2	6.2	14.1	30.8	21.0	9.4	15.1	11.1	4.4	4.6	13.9	7.2	24.0	12.1	8.7	5.9	15.0	12.9	18.3	10.9	10.8	10.9	9.5	15.6	5.6	10.5	15.0	13.1	7.4	5.0	8.3	10.7	9.9	11.0	7.2	11.4	16.7	5.9	6.2	11.5	22.5	9.7	11.7	12.0	8.1	16.4	14.8	5.5	17.4	11.7	11.4	13.7	5.1	5.8	10.7	7.5	4.4	6.9	6.1	4.8	5.1	3.6	3.8	3.8	3.7	4.4	5.1	4.4	4.4	6.4	5.9	5.5	5.6	3.0	4.6	13.0	17.7	17.7	15.7	12.3	8.0	19.9	9.0	13.8	17.1	53.6	40.3	27.3	12.5	1.9	31.8	52.6	66.2	25.4	35.2	27.9	15.7	28.8	11.6	21.9	0.9	25.1	79.6	23.3	26.2	23.2	18.1	15.7	8.1	39.0	21.3	42.9	33.4	41.1	29.1	1.5	28.4	13.1	1.7	17.2	28.4	23.6	28.0	21.0	26.5	18.3	34.3	32.3	8.1	4.2	3.8	1.8	15.1	19.2	45.8	14.3
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.0"									"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.6	3.4	0.7	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	1.6	2.2	3.2	0.9	0.9	2.3	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	8.4	0.7	2.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	1.7	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.3	0.8	12.0	2.7	2.1	6.2	0.8	0.5	0.7	1.2	0.7	0.8	7.1	1.9	3.3	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2	17.9	12.9	16.6	8.2	2.9	57.0	29.0	7.6	8.1	4.5	24.4	280.8	7.0	11.6	4.7	5.9	3.3	3.4	0.0	4.9	7.6	4.5	8.0	2.3	5.8	5.2	35.0	10.4	4.9	3.1	8.5	8.6	4.2	3.3	2.8	4.9	15.4	3.5	2.9	9.2	20.7	194.1	0.0	6.2	3.9	5.1	2.8	16.7	7.5	7.3	5.4
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225341-7234545	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	14.6	16.7	16.9	11.0	24.6	12.5	14.2	22.3	16.2	20.2	15.7	20.0	12.3	12.6	24.3	12.3	22.6	18.0	15.3	12.8	14.5	8.2	13.2	7.8	12.2	14.8	16.7	12.3	30.6	12.7	15.7	26.3	14.9	12.5	18.9	8.6	18.9	14.4	19.3	11.9	21.2	12.9	18.2	10.9	12.7	11.4	14.5	17.0	24.6	16.1	9.5	16.3	16.7	19.7	11.7	7.8	11.6	5.4	7.2	12.1	6.9	13.1	19.2	23.1	23.0	17.7	16.0	10.0	9.2	16.8	22.3	28.6	16.3	11.2	18.8	14.0	10.2	17.4	19.0	19.1	12.4	8.5	18.5	22.0	12.2	20.4	17.1	31.1	6.8	10.6	24.0	21.4	21.1	11.5	15.6	9.2	22.0	10.3	8.9	13.3	12.3	25.9	6.8	7.9	8.8	7.4	38.2	15.0	11.4	12.2	11.7	10.2	20.8	16.7	8.4	20.1	11.0	12.1	9.5	7.6	12.6	11.4	23.5	17.0	13.9	11.6	8.6	14.7	10.3	19.5	11.6	4.7	10.7	12.1	5.4	10.1	10.4	8.3	10.7	5.6	11.7	9.9	10.1	2.1	7.2	5.1	7.8	5.0	6.9	16.9	24.6	22.3	16.2	14.5	8.2	16.7	12.3	12.5	17.0	8.9	8.9	5.7	20.2	15.5	14.9	5.6	7.6	5.3	9.1	17.4	23.6	17.9	5.0	9.3	0.7	9.0	9.3	0.0	9.0	13.9	17.8	13.7	14.9	4.3	12.2	9.5	12.7	7.4	8.2	1.5	24.2	7.4	10.1	12.6	13.0	12.8	6.9	10.5	20.8	4.2	30.2	12.9	11.3	18.9	30.6	16.8	30.6	10.0	20.8	12.0
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 236.1;ASC TERT1: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"		NA	NA		1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	25.0	26.1	20.9	31.9	236.1	134.3	17.5	47.4	105.1	38.4	38.8	24.4	0.1	21.4	17.1	132.9	24.5	33.0	12.9	33.7	15.8	10.1	39.7	3.2	9.9	0.0	78.1	13.9	28.2	97.5	48.3	15.6	23.8	59.6	36.7	15.6	14.6	37.6	53.6	19.2	11.7	17.7	25.1	22.9	21.1	24.2	10.5	13.6	41.2	16.9	22.6	25.0	15.1	39.8	28.6	17.5	13.2	25.4	48.8	19.6	14.4	36.6	16.2	27.9	6.3	39.1	28.4	8.3	33.4	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3	226.3	220.8	55.9	245.9	159.7	80.4	246.3	147.7	72.3	130.8	197.1	25.5	19.0	29.9	103.9	13.1	213.4	6.4	46.7	46.5	23.9	217.2	129.6	79.7	450.6	229.2	139.8	69.1	262.8	169.7	26.3	360.5	166.2	143.4	23.4	40.0	752.2	58.2	11.5	236.2	26.2	63.6	116.4	236.9	12.0	13.4	144.2	16.8	56.5	36.6	204.6
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768909-132828858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	17.5	14.2	14.7	17.6	17.0	13.8	14.5	23.7	21.4	20.1	19.9	17.6	20.6	12.3	18.2	20.0	18.3	14.3	20.7	17.0	14.6	16.7	11.2	18.7	15.5	16.0	15.8	13.2	20.5	39.1	16.1	32.1	18.8	16.2	18.0	16.8	14.3	26.9	19.8	20.5	21.4	15.5	24.6	12.9	18.2	22.2	13.9	14.1	9.8	15.3	15.4	18.2	17.1	16.1	7.3	8.0	5.1	4.6	7.3	7.5	3.5	9.8	20.1	7.2	12.1	25.3	17.1	13.3	16.9	12.8	10.7	9.3	19.0	4.4	13.4	9.1	24.9	9.0	10.3	7.8	10.2	7.3	3.5	9.0	13.5	20.3	12.4	14.7	14.7	19.9	12.9	12.5	14.4	14.5	13.7	10.3	9.3	13.1	5.3	11.1	15.2	12.8	13.7	7.4	7.7	13.6	10.2	8.0	4.8	6.8	23.5	9.1	5.8	14.0	12.5	8.0	8.1	16.3	10.9	21.1	12.6	9.3	14.1	10.8	16.4	13.7	18.2	15.8	8.8	16.0	5.1	4.2	3.6	7.5	4.5	6.6	4.6	5.5	5.9	4.1	7.3	6.3	6.6	3.2	7.3	4.6	8.0	4.5	3.5	14.7	17.0	23.7	21.4	14.6	16.7	15.8	13.2	16.2	14.1	41.7	37.6	16.4	9.3	19.3	25.8	31.4	10.2	16.0	26.1	14.0	94.2	11.6	6.6	14.1	23.9	20.0	46.6	23.3	24.0	20.0	25.5	24.2	11.5	23.7	14.3	17.5	21.4	18.4	8.8	27.7	23.9	11.4	16.9	12.6	43.4	20.3	26.8	27.5	21.2	8.4	104.5	6.5	19.6	19.4	23.9	29.0	19.3	14.1	19.7	22.6
FRS3	"FRS2B, FRS2beta, SNT-2"	ENSG00000137218	"Fibroblast growth factor receptor substrate 3"	O43559	6	41770176-41786542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 12.7;Spermatocytes: 8.6;Spermatogonia: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030162, HPA030174"	Enhanced		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030162: AB_10599976, HPA030174: AB_10602093"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (4.23e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.29e-3)"	6.4	7.0	12.1	4.5	13.6	4.2	3.7	20.4	22.2	4.4	5.1	9.1	2.7	5.4	7.1	3.6	5.4	6.9	5.1	8.2	12.3	15.2	4.0	3.1	5.6	6.0	12.2	12.9	7.5	5.9	4.9	4.9	5.2	13.1	5.5	3.4	5.3	8.1	9.3	13.3	2.5	5.3	5.0	8.0	6.4	5.3	18.5	7.0	3.4	7.4	1.7	3.5	4.7	5.0	1.0	1.7	2.3	1.7	1.4	1.4	0.3	3.1	2.7	4.5	6.3	3.7	4.0	9.5	3.4	4.9	4.0	4.1	3.6	1.9	5.4	3.8	2.9	5.3	2.1	2.9	3.6	3.4	5.5	2.8	3.3	5.0	5.7	4.6	2.7	4.9	3.9	4.3	3.9	3.6	5.3	4.2	13.1	3.6	4.5	3.5	5.1	7.9	6.0	2.3	6.9	2.7	7.5	4.1	3.8	3.5	6.0	6.6	9.9	2.4	3.4	6.9	3.5	4.2	5.4	3.6	7.1	7.5	4.6	3.4	8.0	6.5	8.8	1.9	4.6	2.1	0.0	1.7	2.3	0.9	0.5	0.9	0.3	1.4	0.6	1.1	1.0	0.7	0.3	0.3	1.4	0.4	1.7	0.6	0.3	12.1	13.6	20.4	22.2	12.3	15.2	12.2	12.9	13.1	7.0	0.0	3.0	0.9	1.0	0.9	5.8	2.4	12.7	1.4	1.2	0.0	0.0	1.5	0.0	1.5	0.5	2.8	0.4	0.0	1.2	0.8	1.9	0.9	0.0	0.8	1.7	4.8	1.7	1.3	1.3	0.0	2.3	1.3	3.3	0.0	1.6	2.7	1.0	1.5	4.2	0.5	4.0	0.0	1.2	8.6	10.1	0.5	0.5	0.0	1.4	1.3
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: AB_2680944"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	25.1	15.9	19.7	21.5	21.3	22.8	26.9	38.1	23.2	29.7	24.0	27.0	26.7	18.4	33.2	26.9	20.7	29.2	27.0	23.2	17.9	14.7	18.2	18.3	22.9	27.5	22.9	18.8	37.4	21.4	28.0	25.1	30.6	17.6	24.3	19.2	27.0	26.3	25.5	27.6	34.0	25.2	27.5	17.5	25.8	21.2	24.1	23.1	35.1	25.1	20.5	29.6	26.1	35.6	9.7	8.6	20.9	7.6	10.1	15.3	7.1	11.7	9.1	15.3	8.7	7.9	9.7	8.2	8.9	7.6	33.3	9.7	39.0	12.3	11.7	12.4	10.9	19.3	18.5	13.9	17.3	21.6	6.4	9.4	16.8	15.0	27.8	10.0	15.0	17.4	10.0	23.8	11.5	6.5	7.6	9.1	22.5	16.4	10.7	8.4	11.4	30.3	13.2	12.2	14.4	13.3	21.5	19.6	7.4	5.5	10.5	18.9	11.2	17.9	17.4	11.7	9.6	17.3	17.2	11.3	27.2	19.0	9.0	12.6	7.1	4.6	15.6	12.4	7.6	9.8	20.9	5.6	15.1	12.9	7.6	13.3	9.7	11.3	12.3	4.1	8.2	15.3	14.1	8.6	10.1	5.8	8.6	9.0	7.1	19.7	21.3	38.1	23.2	17.9	14.7	22.9	18.8	17.6	23.1	23.8	26.7	14.9	30.5	21.5	23.5	22.9	17.8	49.5	23.9	24.4	31.4	23.6	19.9	15.5	30.5	21.1	20.9	0.0	12.0	13.2	18.7	23.2	22.0	17.4	12.1	36.5	18.5	19.6	13.2	7.9	32.5	16.3	20.3	17.2	22.7	15.8	17.0	21.0	31.8	9.2	22.1	6.5	17.6	18.9	31.8	22.3	16.5	26.1	20.8	28.8
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.4;testis: 33.8"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046810: AB_2679818, HPA048782: AB_2680519"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	1.2	1.2	2.8	1.3	6.4	0.6	1.8	2.0	3.8	2.6	1.1	6.8	1.7	0.6	2.3	6.3	1.8	22.4	1.4	1.6	3.8	3.2	3.4	0.6	3.0	1.3	4.8	1.5	2.5	1.4	5.4	8.7	1.2	11.4	1.1	1.2	1.6	1.2	1.7	0.7	0.9	0.7	1.4	2.5	0.6	1.0	33.8	6.4	0.0	4.0	1.1	3.3	1.6	1.0	0.6	3.7	3.6	2.8	0.0	0.1	0.5	2.7	3.2	1.1	0.8	1.2	1.3	0.7	0.4	22.4	1.1	1.5	0.5	8.7	3.0	2.4	0.6	8.9	0.5	0.5	0.9	1.8	0.2	0.9	1.0	1.1	0.5	0.7	0.3	0.7	0.5	0.7	3.5	1.1	6.1	0.7	1.2	0.2	0.2	0.2	3.2	0.2	5.8	0.2	1.4	0.8	0.2	0.5	0.8	11.1	3.4	2.5	1.0	0.7	1.1	3.5	0.9	4.0	1.7	0.3	0.5	1.7	1.1	0.6	0.9	0.7	12.0	1.6	0.1	1.9	3.6	2.8	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.1	0.2	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.5	2.8	6.4	2.0	3.8	3.8	3.2	4.8	1.5	11.4	6.4	3.0	1.7	0.0	2.7	2.2	0.4	3.4	5.1	124.5	11.4	5.2	13.7	1.2	11.6	2.3	118.9	0.1	1.3	0.0	0.7	0.2	2.4	1.7	0.0	0.4	1.9	0.0	6.3	1.8	0.0	69.7	2.0	1.3	3.3	2.8	0.6	6.5	0.7	0.3	4.9	11.8	4.8	0.0	1.4	74.6	4.7	1.5	1.6	0.8	0.0	3.5
IGIP	"C5orf53, LOC492311"	ENSG00000182700	"IgA inducing protein"	A6NJ69	5	140125935-140129392	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 13.9"	"Low region specificity"	"Detected in all"							"HPA041877, HPA048615"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA041877: AB_2677721, HPA048615: AB_2680462"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.94e-1)"	"prognostic favorable (6.25e-6)"	"unprognostic (2.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.98e-2)"	"unprognostic (7.77e-2)"	5.1	7.6	13.9	2.0	13.1	0.0	5.3	16.0	13.7	7.3	3.8	3.4	1.6	2.8	3.8	8.0	2.5	3.5	3.8	4.6	13.4	13.7	7.6	6.2	3.8	3.1	17.8	3.3	5.3	3.6	16.2	6.1	3.7	9.8	5.8	3.1	3.7	4.3	7.3	7.7	7.5	3.7	8.2	14.4	3.8	3.4	1.9	9.4	2.0	7.1	2.8	3.0	3.7	3.4	0.6	0.1	1.0	0.5	0.5	2.2	0.1	2.0	0.6	1.0	2.9	14.4	13.9	1.3	5.1	5.1	1.2	1.5	2.0	1.6	3.8	5.5	6.9	0.7	2.1	1.1	3.1	2.3	3.3	1.9	0.8	2.8	1.5	3.4	1.0	1.4	4.7	7.9	2.3	4.4	8.9	1.5	2.8	0.6	1.5	4.4	1.7	1.1	2.5	0.2	1.6	1.6	1.2	2.4	1.7	6.8	1.8	1.0	1.5	2.8	1.8	2.9	1.1	1.4	3.0	8.9	3.6	0.3	1.2	2.8	3.7	2.4	1.3	3.8	2.6	2.6	0.0	0.2	1.0	0.7	0.1	1.9	0.6	1.0	0.8	0.1	0.5	2.2	1.8	0.0	0.5	0.5	0.1	1.1	0.1	13.9	13.1	16.0	12.9	13.4	13.7	17.8	3.3	9.8	9.4	11.9	3.2	0.5	1.7	1.8	19.0	13.8	10.2	2.7	5.7	3.5	13.7	1.9	0.0	2.5	1.5	3.7	3.9	0.0	1.6	1.1	2.9	3.5	8.1	4.7	0.9	27.0	8.6	4.3	2.6	0.5	6.1	2.2	6.8	1.8	4.4	5.6	2.5	5.1	15.9	2.2	9.4	0.0	5.0	2.3	0.9	3.4	1.5	0.8	3.4	1.7
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.5	15.6	37.1	19.1	55.0	41.2	13.9	31.5	37.9	32.9	27.9	22.9	23.6	9.7	16.6	54.0	38.6	11.9	27.7	26.5	27.6	12.4	12.7	27.5	13.5	22.0	26.9	16.3	19.6	40.6	24.9	28.9	11.6	34.3	40.9	18.5	28.5	23.6	37.5	10.9	50.2	22.8	20.8	17.1	22.2	22.3	20.6	11.4	24.1	41.3	22.2	28.9	22.8	9.3	19.5	29.4	21.8	15.5	49.4	27.0	13.9	22.1	26.0	19.0	15.4	12.4	26.0	20.3	26.0	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0	65.5	42.1	48.2	25.8	23.9	91.0	71.2	40.8	34.8	51.2	57.6	379.0	29.9	13.3	33.6	44.3	61.8	38.1	0.0	39.8	26.5	52.3	36.5	35.9	41.0	35.3	104.9	55.5	59.5	43.4	29.2	71.9	38.1	33.7	57.7	42.6	228.9	44.9	31.6	114.5	36.3	557.2	97.0	52.0	40.7	36.8	32.0	30.6	55.8	35.2	27.7
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427724-76431353	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 9.4;Horizontal cells: 27.0;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 9.4"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	2.6	5.8	13.8	3.0	23.5	1.1	3.3	18.7	33.9	4.7	1.9	3.2	0.5	1.5	5.4	3.5	2.3	4.8	2.3	3.9	18.9	20.3	4.1	1.1	2.6	4.1	10.2	22.0	8.4	4.1	15.1	5.1	0.8	19.8	5.9	2.1	2.3	3.4	7.4	2.2	3.3	2.0	4.8	5.4	4.5	2.6	1.3	4.9	1.1	4.0	0.1	3.6	2.4	1.8	1.0	0.0	0.0	0.0	1.5	2.4	0.4	0.2	4.5	4.7	8.9	3.3	1.9	4.1	3.4	3.4	2.9	1.6	1.0	0.7	0.9	1.7	3.0	9.4	3.4	6.9	6.4	2.4	2.2	0.1	0.0	0.0	2.9	0.7	1.8	0.6	1.4	2.9	0.8	0.8	0.1	1.1	4.9	0.3	0.0	4.4	0.6	4.9	0.2	5.6	0.0	6.9	3.9	3.5	0.0	3.7	0.0	0.0	2.4	0.0	0.4	0.6	5.0	2.1	0.1	0.6	4.4	5.6	4.6	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.8	0.8	1.1	2.3	0.0	1.0	1.4	1.3	0.0	1.5	0.0	0.0	0.0	0.4	13.8	23.5	18.7	33.9	18.9	20.3	10.2	22.0	19.8	4.9	3.0	1.6	0.0	0.6	0.5	9.4	1.6	0.0	0.0	1.2	1.8	3.9	0.1	1.7	1.5	0.0	1.0	0.0	0.0	1.3	0.4	0.7	0.2	1.1	0.0	0.1	27.0	0.0	0.6	0.3	0.0	1.4	0.0	0.0	0.0	0.2	4.3	0.8	0.0	4.2	0.9	5.1	19.4	1.4	0.2	0.2	0.1	0.1	4.3	0.0	0.1
HDAC3	"HD3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636870	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	15.9	28.8	19.6	12.2	17.6	18.1	18.6	22.6	20.8	15.6	14.1	11.2	13.1	10.6	17.3	17.6	22.8	16.3	14.0	16.8	18.0	8.9	14.5	23.3	24.4	36.4	13.4	14.2	17.3	24.7	20.9	17.3	14.3	18.8	13.6	14.4	13.6	17.5	13.7	24.5	26.7	15.2	17.2	10.8	20.1	15.5	11.9	12.6	18.5	14.4	9.6	23.7	17.5	17.0	22.1	46.7	16.4	22.6	14.1	23.1	16.9	21.3	14.5	27.0	40.9	26.1	20.8	17.5	15.6	34.3	35.4	50.8	31.0	18.3	31.1	20.2	20.2	25.2	18.6	27.1	36.5	43.9	26.5	29.1	24.3	13.3	17.6	18.4	29.2	22.3	17.7	23.5	20.5	26.8	18.4	22.8	28.1	23.7	16.6	22.3	20.2	32.4	25.3	23.8	13.3	11.5	23.5	28.2	22.4	18.9	21.5	22.6	18.3	20.6	21.4	25.7	17.9	22.8	18.5	11.5	22.0	13.8	16.8	25.5	13.5	16.6	29.3	18.5	27.8	18.8	13.2	22.4	16.4	15.9	22.6	20.8	22.1	19.8	19.2	46.7	20.1	21.7	18.0	9.5	14.1	19.0	23.9	23.1	16.9	19.6	17.6	22.6	20.8	18.0	8.9	13.4	14.2	18.8	12.6	8.9	10.4	32.3	23.0	39.3	30.6	12.3	15.3	5.3	11.4	12.2	56.9	47.2	18.3	28.5	7.6	20.2	15.4	0.0	31.4	44.3	29.3	18.8	18.4	14.8	34.9	47.7	17.2	20.9	15.4	3.4	20.8	33.0	30.4	66.7	17.7	27.7	27.2	14.0	20.8	15.7	30.4	25.8	24.0	22.3	24.5	44.9	51.1	31.9	22.7	26.5
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 50.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	9.9	9.8	14.8	10.0	13.6	19.9	7.4	16.7	16.3	8.0	11.7	10.9	9.4	12.4	11.9	8.4	9.7	11.5	10.0	9.2	13.4	11.6	12.8	15.0	9.1	11.4	11.3	10.0	10.8	11.3	25.6	11.4	7.6	9.8	7.6	9.4	8.9	8.6	8.7	15.3	10.8	12.1	10.3	8.3	10.2	10.1	10.5	10.6	20.3	50.0	4.6	10.0	8.9	18.2	8.2	2.9	6.1	1.2	3.6	2.4	1.2	8.1	7.1	10.1	10.4	9.9	6.5	7.1	6.8	7.9	11.3	11.2	16.2	4.7	15.7	3.4	8.8	6.8	9.6	14.3	8.6	7.3	9.8	16.6	14.6	7.7	14.8	10.8	33.7	10.8	7.9	8.4	8.8	8.7	6.1	8.1	15.9	74.9	8.4	6.4	10.0	16.5	12.0	9.2	19.2	7.2	13.2	14.4	4.6	6.5	9.0	14.8	9.9	7.8	7.9	9.4	5.3	5.0	11.8	9.4	7.8	11.6	7.9	8.0	9.0	8.9	16.5	9.0	10.9	6.4	6.1	1.2	5.0	2.3	1.2	2.4	3.7	1.3	2.3	1.5	8.2	0.6	1.7	2.2	3.6	0.6	2.9	0.6	1.2	14.8	13.6	16.7	16.3	13.4	11.6	11.3	10.0	9.8	10.6	6.0	0.3	6.9	1.9	8.1	8.5	2.0	5.1	0.0	0.0	5.2	2.0	3.2	5.0	5.3	5.7	3.6	7.0	0.0	7.7	3.0	4.1	3.8	0.0	18.1	5.6	15.9	2.4	7.4	10.8	1.6	4.6	2.5	10.1	3.6	8.5	4.5	6.6	10.8	6.3	9.3	4.0	6.5	4.2	7.1	7.5	9.3	2.5	3.3	13.3	1.8
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.9	18.6	5.9	14.2	22.1	10.0	9.9	12.8	17.4	10.9	13.1	12.8	13.7	3.8	17.5	17.3	20.1	10.3	5.7	15.3	2.9	10.9	10.2	4.6	4.6	10.8	28.1	3.2	10.5	13.0	22.5	12.6	9.3	8.9	12.8	9.5	6.8	8.0	12.6	31.9	7.8	9.2	9.9	19.8	21.8	5.2	7.1	11.8	14.8	10.9	7.1	7.4	16.9	26.2	17.0	5.3	14.1	12.7	10.4	13.9	3.0	13.0	11.3	21.4	13.0	2.4	27.7	7.2	15.9	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9	0.0	6.5	32.8	35.2	21.9	39.2	16.5	28.1	2.7	12.5	24.4	23.6	42.5	72.9	43.5	7.1	22.2	63.6	0.0	41.8	23.0	34.8	27.1	39.1	31.6	38.4	35.0	43.1	22.7	26.6	11.6	33.6	25.5	89.4	34.3	42.5	51.0	35.5	39.6	32.2	50.2	48.9	12.9	27.8	47.1	68.2	22.1	50.6	38.4	50.8	26.7
TBC1D17	FLJ12168	ENSG00000104946	"TBC1 domain family member 17"	Q9HA65	19	49877425-49888749	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068119	Uncertain					NA	NA					"HPA068119: AB_2685958"	"unprognostic (5.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.33e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.18e-4)"	"unprognostic (6.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.02e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.52e-2)"	17.3	13.9	16.8	8.3	18.4	5.9	11.7	14.3	27.5	16.5	13.2	23.5	10.2	12.1	15.3	11.2	11.6	15.2	11.2	18.5	16.5	14.4	11.2	23.2	12.1	8.2	16.4	13.4	22.7	22.7	14.3	10.6	16.4	18.0	14.0	6.0	13.0	24.0	17.1	72.8	20.3	10.9	11.0	16.6	11.1	12.5	8.3	16.8	10.0	17.8	11.0	8.4	16.5	10.2	11.9	5.6	11.0	4.4	12.1	10.0	6.2	6.3	12.8	4.0	5.4	18.5	13.1	9.3	7.3	23.9	8.4	13.4	6.5	9.0	3.9	7.2	13.6	14.2	6.8	3.7	10.2	4.6	9.7	10.0	4.4	10.3	7.7	16.1	2.3	6.5	15.2	10.2	7.9	5.9	14.4	7.9	6.2	5.0	19.1	6.8	7.3	3.1	4.2	7.5	6.7	11.0	4.5	5.9	9.5	10.5	11.2	7.2	8.4	9.9	10.0	6.3	5.3	9.5	3.0	9.2	18.4	6.5	6.8	3.7	12.8	16.0	2.6	19.9	2.5	6.7	11.0	4.4	8.8	9.4	4.3	8.6	10.0	8.7	10.0	4.3	11.9	9.0	7.3	6.0	12.1	4.0	5.6	5.0	6.2	16.8	18.4	14.3	27.5	16.5	14.4	16.4	13.4	18.0	16.8	11.9	12.6	14.3	16.0	12.9	28.1	7.8	20.4	1.4	4.5	19.2	37.3	43.1	21.6	13.0	1.9	12.3	22.2	0.0	16.3	14.7	15.5	13.3	4.6	21.9	11.8	46.1	46.8	18.4	9.7	3.2	25.3	7.4	13.5	28.9	23.5	21.6	11.4	17.5	29.4	19.4	49.6	12.9	15.1	7.9	9.1	11.3	55.5	15.8	12.8	8.9
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 49.8;Smooth muscle cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		1600000	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.6	20.1	10.8	0.0	0.0	1.0	3.2	0.8	0.8	0.0	0.0	27.6	0.2	0.6	2.5	0.0	2.0	0.0	1.6	0.7	2.2	9.2	0.0	0.0	3.0	0.1	1.3	0.1	0.0	0.0	0.0	0.9	12.1	1.5	16.6	0.8	0.0	2.0	3.7	0.1	4.9	0.0	0.8	1.1	0.0	0.0	0.0	0.0	3.3	4.8	1.5	0.3	1.0	6.9	0.6	1.9	6.8	1.0	2.6	0.0	1.9	0.6	0.0	71.0	0.7	4.8	9.6	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6	3.0	1.0	0.8	1.4	2.2	29.0	26.0	10.2	6.7	1.2	7.0	9.8	0.0	0.0	1.7	6.2	15.5	0.0	0.0	0.0	0.4	5.1	5.9	4.6	0.0	1.5	4.8	0.0	14.1	14.0	4.7	27.6	10.4	16.9	13.6	0.5	5.5	0.2	2.6	49.8	0.6	9.1	19.4	35.8	1.6	4.5	2.0	0.0	2.9	1.9	3.9
SOWAHA	ANKRD43	ENSG00000198944	"Sosondowah ankyrin repeat domain family member A"	Q2M3V2	5	132813587-132816797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 52.0;intestine: 35.0"	"Cell type enhanced"	"Detected in some"	22	"Enterocytes: 43.3;Horizontal cells: 125.5;Muller glia cells: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 11.5;T-47d: 27.3"	"Group enriched"	"Detected in many"	5	"amygdala: 59.1;basal ganglia: 89.2;cerebral cortex: 40.5;hippocampal formation: 66.1"	"Low region specificity"	"Detected in all"			HPA064621	Approved					NA	NA					"HPA064621: AB_2685302"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.75e-3)"	"unprognostic (5.34e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.65e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.92e-2)"	"prognostic favorable (9.38e-5)"	"unprognostic (4.36e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.42e-1)"	0.7	1.2	27.5	1.0	52.0	0.4	0.9	5.1	16.3	0.7	7.9	3.4	2.2	33.4	0.5	6.5	0.5	1.8	2.0	0.4	20.1	3.1	5.1	2.1	0.5	0.5	6.0	11.1	0.6	2.3	2.4	0.8	0.6	2.8	2.9	6.7	0.7	3.4	3.3	0.4	0.5	35.0	0.5	3.7	0.4	5.2	0.6	11.0	0.1	1.6	0.0	0.5	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	1.2	0.0	0.6	0.0	0.1	0.0	2.2	0.3	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.8	1.4	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	11.5	0.5	0.1	0.0	0.0	1.4	27.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	52.0	5.1	16.3	20.1	3.1	6.0	11.1	2.8	11.0	0.0	0.0	0.0	0.4	0.0	0.6	0.2	10.2	0.0	0.0	5.2	0.0	0.2	0.0	0.4	0.0	0.0	43.3	0.0	1.0	0.0	0.0	3.3	0.0	1.7	0.1	125.5	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	24.2	0.4	20.1	0.4	3.7	3.4	0.0	0.0	0.2	0.9	0.0	0.1	0.0	14.0	0.1
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 68.3;Muller glia cells: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		300000	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.7	1.9	3.9	0.2	4.0	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	1.9	0.0	0.5	2.5	5.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	6.9	9.2	0.0	0.0	0.0	1.3	0.0	0.1	5.8	7.9	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5	11.9	9.8	0.0	4.7	0.8	11.0	8.1	7.6	68.3	9.1	22.7	3.9	4.2	1.7	6.9	0.8	0.1	1.4	0.0	6.5	2.4	3.3	16.0	4.6	0.0	0.3	9.5	7.9	0.6	0.0	1.5	2.6	0.7	0.0	1.0	3.4	94.1	2.7	2.9	11.3	16.2	2.9	6.5	0.7	0.2	2.3	0.5	0.2	3.8	2.5	2.6
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417656	"Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		290000	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.1	6.7	14.6	3.9	18.7	2.6	5.0	12.6	28.2	6.2	4.1	12.1	2.4	2.2	11.4	13.5	4.1	9.7	5.3	10.1	12.4	9.5	4.4	1.2	7.8	4.0	9.8	12.2	12.9	5.3	8.8	8.6	7.8	9.3	8.1	2.4	7.3	5.5	5.4	5.1	1.6	2.5	11.7	8.9	3.7	3.4	5.8	7.6	3.1	9.8	1.6	5.1	5.8	4.9	2.3	3.1	0.0	0.0	0.1	3.5	1.0	0.1	7.7	15.3	7.8	4.7	6.6	7.7	8.8	6.3	12.1	7.8	0.1	4.5	10.6	7.7	5.3	21.5	0.0	10.7	1.1	7.8	15.0	11.3	5.4	4.2	11.9	5.6	10.9	14.3	4.8	1.5	5.7	1.0	5.8	9.5	10.3	15.7	0.0	5.1	2.4	9.7	8.7	22.5	0.1	9.4	7.0	9.4	0.1	3.3	3.4	16.5	13.5	0.6	0.0	12.2	11.3	4.1	15.1	8.6	8.4	13.4	6.3	8.1	0.0	0.0	10.9	10.3	9.8	9.9	0.0	0.0	0.0	3.5	0.0	1.3	2.3	0.6	2.9	0.6	1.8	0.8	2.3	0.0	0.1	0.0	3.1	0.0	1.0	14.6	18.7	12.6	24.8	12.4	9.5	9.8	12.2	9.3	7.6	14.9	1.9	0.8	1.0	0.8	11.4	4.7	0.0	1.4	7.9	1.8	0.0	4.2	3.3	3.0	0.4	3.3	0.0	0.0	2.5	8.4	3.1	1.0	0.0	0.0	4.8	6.4	1.7	0.0	1.2	0.0	2.0	1.1	0.0	5.4	0.0	17.6	1.9	0.0	4.9	1.0	4.3	0.0	2.5	1.1	4.5	0.5	1.1	2.5	0.0	0.1
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Cell type enriched"	"Detected in many"	49	"Intestinal endocrine cells: 6314.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	134	"SCLC-21H: 44.3;SH-SY5Y: 120.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	78000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.3	120.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7	0.0	0.0	0.0	0.2	0.8	10.3	2.2	0.0	0.0	0.0	0.0	27.5	0.3	0.0	0.0	1.0	0.1	14.4	0.0	0.3	0.1	0.2	4.0	0.0	0.0	1.2	15.9	6314.9	0.0	0.0	3.6	36.8	0.0	6.8	3.6	28.7	3.2	76.4	23.0	129.0	0.0	11.3	0.0	0.3	4.9	2.2	0.0	0.2	0.0	9.0	0.1
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301448-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 99.7;Late spermatids: 120.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	28	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol		NA	NA		2700000	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	5.8	1.1	2.2	6.1	1.7	1.4	5.8	0.9	3.1	16.6	6.2	1.4	6.8	1.8	6.1	10.9	2.9	4.5	4.8	1.9	3.4	2.2	3.9	0.7	7.0	8.7	1.6	1.4	4.3	22.4	1.5	6.3	2.9	2.1	6.9	2.4	5.6	2.6	9.4	1.8	2.9	4.2	16.5	1.9	16.3	3.6	7.7	1.9	1.8	1.5	3.6	3.4	9.5	13.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	1.7	7.9	0.0	0.0	0.0	9.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.3	0.0	3.1	0.1	0.8	0.0	0.2	0.0	4.6	0.0	0.3	0.2	3.9	0.0	0.0	1.6	0.0	0.3	0.5	0.0	0.6	0.1	0.0	0.0	3.9	2.0	0.0	0.0	2.7	0.1	0.0	5.6	5.5	0.0	8.2	10.2	4.9	7.2	0.0	0.0	0.0	9.9	0.0	2.5	0.2	0.0	12.3	0.0	3.4	0.0	0.0	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.9	3.1	3.4	2.2	1.6	1.4	2.1	1.9	0.0	4.0	0.0	0.4	1.1	10.0	20.4	2.5	9.4	7.9	5.2	0.0	2.3	0.0	1.0	99.7	0.6	0.0	0.0	4.7	0.8	4.1	0.6	0.0	0.0	0.5	1.6	4.7	1.3	0.0	120.8	1.7	0.5	5.0	0.0	0.5	0.3	3.5	0.0	5.3	1.4	0.7	6.5	2.1	6.6	5.1	0.4	1.6	0.0	0.0	0.3
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	24.8	28.6	23.6	38.3	23.5	85.9	24.5	27.7	25.8	25.9	28.9	29.2	44.2	18.8	45.7	28.9	24.7	26.0	25.6	22.4	23.8	18.3	29.9	37.3	23.9	30.2	27.0	18.6	31.4	28.6	47.3	55.0	44.3	22.7	33.4	22.7	30.3	33.2	32.6	28.1	40.1	26.4	33.2	25.5	42.4	27.5	23.0	29.6	35.9	34.6	26.9	35.7	22.7	30.8	14.4	20.6	19.7	22.5	17.1	20.6	12.8	19.6	21.9	38.4	25.9	32.9	24.0	23.2	30.6	27.5	41.2	24.5	29.8	15.9	31.1	18.3	24.5	16.5	24.5	40.8	19.1	37.4	24.6	27.9	23.5	35.3	25.1	25.0	29.0	34.2	35.4	27.8	30.2	14.6	31.0	26.8	27.7	30.1	23.4	29.3	26.9	35.1	37.8	23.1	24.4	19.0	34.2	21.2	33.0	28.5	23.5	20.2	17.0	30.0	24.2	21.8	29.0	27.6	26.0	27.3	24.0	19.4	29.9	27.2	28.4	24.4	31.5	18.5	24.6	24.0	6.0	17.4	19.7	17.9	22.5	19.2	14.4	17.2	17.2	20.6	12.9	18.8	17.2	14.7	17.1	19.2	16.0	20.6	12.8	23.6	23.5	27.7	25.8	23.8	18.3	27.0	18.6	22.7	29.6	35.7	44.2	24.1	23.4	74.0	12.3	19.4	17.8	14.7	18.2	21.0	29.5	40.9	8.3	14.4	17.8	29.2	26.6	0.0	10.6	21.6	30.5	19.0	47.5	18.4	25.3	4.8	30.3	22.7	38.2	10.4	33.9	42.4	30.4	11.8	21.5	11.6	13.1	16.7	24.4	9.6	16.2	25.8	35.9	20.6	19.6	61.2	83.0	29.4	19.6	12.9
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
SPOUT1	"C9orf114, CENP-32, HSPC109"	ENSG00000198917	"SPOUT domain containing methyltransferase 1"	Q5T280	9	128819651-128829821	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 29.4;Extravillous trophoblasts: 18.6;Hofbauer cells: 18.6;monocytes: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076946	Approved					NA	NA					"HPA076946: "	"unprognostic (1.85e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.70e-2)"	14.8	14.1	23.3	18.6	35.0	16.8	12.8	20.6	27.9	11.9	11.3	14.6	19.6	15.9	14.5	12.7	18.4	13.6	12.8	15.2	19.5	14.3	15.7	28.8	11.8	23.7	24.8	12.3	19.6	25.1	13.1	15.3	13.6	21.5	22.3	8.2	10.6	22.2	16.3	20.3	25.0	14.0	16.0	20.9	21.7	15.3	9.4	27.7	15.5	16.6	9.6	18.4	14.6	17.5	13.7	11.8	4.1	8.6	16.5	18.7	11.5	6.0	14.3	11.6	16.8	7.0	6.7	20.4	6.8	3.9	12.0	6.7	19.5	10.8	12.3	7.2	6.7	12.3	25.2	10.5	10.4	4.0	11.6	11.2	9.8	21.9	15.9	7.1	14.2	17.8	6.9	8.6	8.5	8.7	5.4	8.7	18.1	19.4	10.7	6.6	37.9	17.5	28.8	15.1	27.9	18.0	19.3	11.3	21.1	7.8	11.1	13.6	13.4	12.6	18.1	8.4	6.9	18.0	15.8	9.2	17.1	7.8	11.5	16.6	12.3	20.4	12.7	10.8	12.4	13.7	4.1	8.6	4.0	18.4	8.3	18.7	13.7	14.9	16.6	9.8	13.7	14.9	14.8	2.6	16.5	6.8	11.8	13.2	11.5	23.3	35.0	20.6	27.9	19.5	14.3	24.8	12.3	21.5	27.7	3.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.8	8.7	0.0	29.4	10.0	13.8	0.0	0.0	0.0	0.0	15.3	18.6	0.0	0.0	12.8	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	27.1	0.0	0.0	13.2	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.8;liver: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 100.1;Distal tubular cells: 116.0;Hepatocytes: 115.6;Proximal tubular cells: 151.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.5;MCF7: 18.0;SK-BR-3: 19.6;SK-MEL-30: 47.0;T-47d: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved					NA	NA					"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.51e-4)"	0.8	1.0	0.5	1.4	0.5	0.0	4.7	0.4	0.8	1.2	21.4	1.2	10.3	19.2	0.8	9.5	1.8	2.9	5.2	1.0	1.1	0.5	20.6	37.0	7.9	0.4	0.5	0.4	0.8	25.4	9.8	6.1	6.5	5.3	2.9	4.2	1.9	13.5	15.2	0.7	0.9	57.8	0.6	0.4	0.5	10.0	0.9	0.4	0.6	22.9	0.9	1.2	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	4.1	0.1	0.0	8.1	0.0	0.1	16.5	0.0	0.0	0.0	0.0	11.0	10.0	0.0	2.7	0.0	0.0	0.2	0.0	4.9	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	18.0	0.0	0.2	0.2	8.4	0.0	0.4	0.0	1.0	4.5	9.0	4.3	0.0	0.0	19.6	47.0	5.0	12.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.4	0.8	1.1	0.5	0.5	0.4	5.3	0.4	56.6	26.4	0.5	4.0	1.5	1.6	0.8	61.1	16.0	13.6	43.6	100.1	13.2	116.0	28.3	0.0	1.0	61.9	0.0	24.3	3.1	0.5	6.9	0.0	115.6	1.6	0.0	29.0	0.6	1.3	0.2	8.1	0.7	5.0	1.0	18.1	0.2	29.1	52.6	3.5	151.7	0.6	0.0	0.3	0.0	0.2	0.5	10.3	1.5	18.8	6.2
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	19.5	30.2	24.8	25.2	31.5	20.9	18.6	38.2	40.9	21.2	29.8	31.6	18.3	24.7	28.2	16.5	23.4	23.9	20.3	30.8	25.0	26.5	19.3	24.6	21.9	26.7	24.3	21.2	29.2	33.1	22.4	26.1	22.3	28.8	25.6	14.2	30.1	27.9	28.0	33.9	21.2	25.1	27.9	25.0	24.9	24.9	36.7	28.0	33.5	21.9	14.7	27.7	28.0	20.9	20.7	21.3	25.0	21.4	14.9	28.7	20.1	30.2	21.3	18.1	20.2	13.7	13.9	12.9	19.4	18.3	22.7	24.7	26.9	10.7	28.6	21.8	15.0	14.3	18.9	16.1	18.9	14.0	29.2	26.3	15.3	16.7	31.9	14.9	22.4	22.6	13.6	13.1	14.2	16.2	10.6	16.5	15.7	27.7	27.1	12.8	12.7	37.2	10.9	33.2	13.2	27.0	27.6	17.4	26.0	14.7	23.5	20.0	22.5	17.2	18.2	17.1	11.1	13.9	17.0	17.1	19.2	14.1	33.5	28.4	28.1	28.3	24.6	24.3	28.2	23.6	13.2	20.8	25.0	22.7	21.4	23.3	17.0	22.0	22.7	21.3	20.7	19.6	25.1	24.0	14.9	20.6	20.2	28.7	20.1	24.8	31.5	38.2	40.9	25.0	26.5	24.3	21.2	28.8	28.0	23.8	18.7	17.9	17.1	10.9	15.9	13.3	17.8	20.1	13.6	7.0	23.6	23.8	36.5	25.9	39.7	15.2	15.8	23.3	18.2	26.3	16.4	14.7	17.3	9.5	21.6	22.3	12.7	6.7	14.3	57.9	15.5	17.0	20.3	44.1	14.6	18.9	18.6	10.5	23.3	14.7	16.8	19.4	13.7	51.1	37.9	10.3	29.6	21.7	13.3	20.9
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"B-cells: 2.7"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 17.6;SH-SY5Y: 34.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.9	11.9	14.1	1.1	13.0	0.6	0.6	1.1	24.7	6.1	1.5	1.6	0.0	2.5	2.5	2.4	0.8	6.6	1.1	0.4	15.3	11.0	2.8	0.6	0.7	0.5	5.6	12.9	2.1	2.3	49.1	42.7	0.4	4.9	1.3	1.8	4.1	0.6	1.4	0.5	2.4	2.3	2.3	5.6	1.1	5.2	2.3	1.6	0.0	0.9	0.0	0.5	0.8	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	4.2	0.0	0.0	17.6	34.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.0	1.1	24.7	15.3	11.0	5.6	12.9	4.9	1.6	0.0	0.0	0.0	0.0	1.8	19.7	0.8	0.0	1.4	0.0	0.0	29.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.5	72.5	0.0	0.0	1.7	0.9	0.0	0.0	0.0	1.2	3.1	0.1	0.0	0.7	0.0	13.7	0.0	0.0	1.1	1.2	0.5	0.0	0.0	0.6	0.0
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819224-36829104	"Disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032035			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA032035: AB_2674120"	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favorable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	8.5	6.7	15.0	8.8	14.4	9.2	9.0	31.8	15.6	12.7	9.5	12.3	8.4	5.7	13.1	10.2	5.8	10.9	7.7	6.4	13.0	9.1	6.2	5.0	8.1	11.5	13.3	10.8	13.9	9.3	11.9	14.2	7.0	11.3	10.3	8.1	9.8	8.8	11.3	8.1	6.5	8.7	11.1	10.5	9.1	7.9	11.7	14.5	19.7	11.2	4.6	9.8	8.0	8.1	1.4	1.9	2.4	0.6	0.7	1.3	0.0	4.5	1.1	6.6	9.3	2.5	3.4	4.3	3.7	3.9	7.0	4.3	3.2	3.7	19.9	3.1	3.3	6.2	4.2	6.8	2.2	7.9	14.8	11.3	9.5	5.0	6.2	4.5	17.4	7.0	3.1	4.1	3.4	2.6	2.0	5.2	15.3	5.4	4.0	2.1	2.2	17.3	12.5	7.1	3.9	2.0	15.2	12.3	6.0	3.0	2.8	5.4	6.8	3.6	2.4	2.8	4.2	2.4	10.4	4.0	1.8	3.9	6.3	3.3	3.8	3.1	15.0	5.1	12.1	2.8	0.0	0.1	2.4	1.0	0.0	0.8	1.4	0.6	1.1	0.1	0.5	0.7	1.3	0.0	0.7	0.6	1.9	1.1	0.0	15.0	14.4	31.8	15.6	13.0	9.1	13.3	10.8	11.3	14.5	3.0	3.8	3.9	2.8	3.2	14.7	2.4	2.5	1.4	2.3	3.5	2.0	5.2	13.3	2.8	3.1	4.5	2.0	0.0	4.7	2.8	9.3	1.5	10.3	2.4	2.7	22.3	6.9	8.6	1.6	2.9	10.3	5.0	6.8	2.8	2.4	21.6	2.7	2.9	10.3	1.2	16.3	6.5	6.4	14.6	23.3	1.8	1.0	12.8	4.0	0.7
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 29.3"									"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.1	5.6	14.8	9.2	1.5	2.0	8.2	7.5	2.8	5.3	5.2	2.5	9.0	8.8	1.9	2.1	6.2	9.8	3.9	3.2	1.6	9.2	8.6	14.1	14.6	1.4	0.3	4.0	8.1	0.9	0.7	3.7	0.9	1.9	3.3	22.0	8.0	23.5	4.3	5.0	19.8	5.4	6.3	3.4	2.8	29.3	6.7	7.8	1.6	2.3	12.2	7.6	5.6	4.0	1.8	3.3	9.9	8.0	2.2	3.2	9.3	3.2	4.5	9.5	4.2	4.2	5.7	17.5	8.4	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2	3.0	1.6	3.0	1.2	0.8	17.1	3.6	0.0	203.4	22.7	1.8	25.5	3.5	0.0	1.9	13.4	1.1	2.3	140.2	0.9	5.4	3.6	1.8	2.3	1.6	3.4	4.8	66.7	3.7	1.8	25.4	4.9	2.7	0.0	1.0	3.5	4.3	1.1	3.5	2.5	0.6	28.6	0.0	2.1	52.4	42.1	1.3	1.1	2.6	5.9	0.7
C8orf44	FLJ11267	ENSG00000213865	"Chromosome 8 open reading frame 44"	Q96CB5	8	66667615-66685564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043660, HPA054753"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043660: AB_10794889, HPA054753: AB_2682592"	"unprognostic (6.19e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (7.35e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (4.01e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.68e-6)"	5.8	4.5	15.8	6.1	18.1	8.6	9.6	16.6	14.9	6.6	5.3	10.4	7.2	4.3	8.4	27.7	4.2	7.7	5.6	5.8	10.6	7.7	5.9	4.0	4.7	10.1	11.4	9.0	10.2	4.6	6.8	14.6	5.8	8.6	6.8	8.3	8.9	7.7	7.0	11.6	12.4	5.3	5.9	9.2	7.5	6.4	15.3	11.5	9.4	10.8	3.0	8.0	6.8	6.0	5.8	4.4	5.7	3.1	0.6	3.8	1.5	8.7	3.4	5.8	4.1	3.5	6.9	3.2	2.4	2.3	3.3	3.9	3.5	9.9	9.8	1.6	4.1	4.7	6.0	5.5	2.1	4.6	7.3	5.3	8.3	10.5	7.2	2.8	3.7	5.9	5.8	4.9	4.4	4.8	6.5	4.1	10.9	9.4	6.5	3.3	3.2	4.1	5.1	5.0	6.5	4.3	4.0	1.9	2.0	4.8	1.8	4.7	3.8	2.6	1.7	3.1	4.3	5.8	2.4	5.9	3.5	4.7	3.4	1.5	7.7	2.6	4.0	5.7	4.0	1.8	5.7	3.1	4.0	1.9	2.5	1.4	5.8	2.4	2.2	2.6	4.8	3.8	2.8	3.6	0.6	1.3	4.4	3.4	1.5	15.8	18.1	16.6	14.9	10.6	7.7	11.4	9.0	8.6	11.5	3.0	3.4	3.7	5.3	0.6	8.6	26.0	0.0	5.3	4.5	7.0	7.9	2.7	10.0	2.0	0.9	3.8	2.6	0.0	3.4	1.6	4.4	4.8	3.5	2.4	2.6	1.6	6.3	3.7	4.4	1.3	8.6	4.9	1.7	1.8	3.6	7.0	2.4	4.3	8.5	3.3	6.0	12.9	3.9	16.4	5.7	1.4	1.4	2.9	3.3	3.4
ZNF746	"FLJ31413, PARIS"	ENSG00000181220	"Zinc finger protein 746"	Q6NUN9	7	149472696-149497817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.0;neutrophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020272	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020272: AB_2670398"	"unprognostic (2.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.32e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.33e-1)"	"prognostic favorable (4.22e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (7.47e-6)"	"unprognostic (2.21e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.06e-1)"	11.9	9.9	10.6	12.0	11.6	33.9	9.1	15.6	17.2	10.5	9.0	11.7	9.1	8.0	11.5	8.7	8.5	10.3	8.7	7.6	11.2	9.7	10.0	10.9	10.3	12.1	9.5	8.7	10.4	13.7	10.2	13.5	21.0	11.4	10.6	6.3	11.4	10.7	8.5	8.9	10.8	9.2	9.5	9.0	20.2	9.8	22.0	10.4	18.7	10.6	5.5	10.3	10.9	15.9	0.6	0.9	10.4	1.0	0.5	1.6	0.5	7.1	11.5	6.1	16.6	6.9	6.0	9.3	7.3	6.0	5.9	5.1	7.3	5.4	10.3	10.7	6.4	8.6	8.0	7.9	8.3	3.5	13.0	11.0	5.0	5.8	10.0	8.4	9.7	13.4	6.6	10.1	4.8	5.3	5.3	6.1	8.5	15.2	8.0	7.4	11.0	21.9	13.1	15.1	4.4	8.0	14.6	5.7	9.0	5.6	8.6	8.7	12.0	9.7	10.7	6.8	3.8	5.0	12.0	8.5	7.5	2.7	12.7	10.6	14.8	7.0	8.3	9.8	7.8	13.0	3.0	1.0	1.1	0.7	0.7	0.7	0.4	0.9	1.6	0.6	0.6	1.1	0.9	10.4	0.5	0.5	0.9	1.5	0.5	10.6	11.6	15.6	17.2	11.2	9.7	9.5	8.7	11.4	10.4	0.0	7.4	3.4	4.9	3.2	15.5	6.7	5.1	4.0	4.5	10.4	3.9	5.9	0.0	2.8	8.2	5.3	2.0	46.7	2.1	5.2	3.6	5.1	5.8	6.8	7.0	25.4	5.8	3.1	15.5	10.8	5.8	6.8	3.3	5.4	4.0	8.8	4.0	3.5	6.3	3.1	10.8	0.0	3.7	16.2	7.0	3.0	7.3	4.1	3.7	4.4
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898643-75905413	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (9.21e-5)"	10.8	14.1	12.4	6.7	14.8	6.0	8.2	8.4	20.8	9.6	11.7	23.3	6.5	10.6	9.5	7.8	11.2	15.4	10.2	21.2	11.7	9.2	11.7	17.6	8.4	8.1	15.7	18.1	12.0	17.5	8.7	7.7	7.3	14.8	8.7	8.2	8.8	17.1	13.6	41.8	9.5	8.9	17.9	11.3	8.8	10.3	15.1	14.7	8.3	8.8	14.1	9.5	10.9	7.5	28.5	29.4	9.9	21.8	24.0	24.6	21.3	17.7	24.9	5.0	6.1	7.4	6.1	20.5	6.0	10.5	23.4	17.0	30.4	10.7	17.2	7.1	10.3	12.2	12.6	17.9	16.3	6.1	5.1	33.7	11.4	7.0	27.2	18.5	15.2	10.3	8.8	18.6	15.1	12.2	5.9	22.7	20.5	14.3	7.8	8.3	37.1	18.3	15.1	6.4	23.2	24.7	13.8	17.3	18.5	17.4	8.9	9.8	11.0	11.2	26.3	24.3	5.0	24.6	15.2	6.9	8.9	15.4	7.0	15.8	10.2	6.4	4.9	10.8	11.8	8.2	4.5	20.0	9.9	23.7	21.8	23.8	28.3	24.5	22.2	29.4	28.5	24.6	23.7	1.6	24.0	17.5	20.9	24.5	21.3	12.4	14.8	8.4	20.8	11.7	9.2	15.7	18.1	14.8	14.7	17.9	5.3	2.7	0.6	1.3	0.9	1.7	0.0	16.0	7.9	3.5	0.0	4.3	3.3	19.9	0.9	1.0	9.8	0.0	18.4	3.7	2.3	1.2	3.5	2.0	2.9	1.6	9.9	3.1	0.3	0.9	2.8	2.7	6.8	22.6	12.2	0.9	17.8	18.7	2.8	5.1	2.7	0.0	3.1	2.3	1.7	1.3	2.9	2.9	18.8	0.5
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942460	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	15.0	25.2	15.7	8.0	20.8	4.1	10.7	14.0	27.5	12.2	13.9	9.8	12.7	11.1	11.7	18.5	12.9	14.5	11.6	32.2	13.1	13.6	13.3	26.3	9.5	9.9	18.8	12.3	15.9	18.0	22.1	12.9	13.3	21.3	13.6	6.6	13.7	15.4	16.6	81.6	10.3	11.1	12.1	9.4	12.7	10.6	8.9	11.9	13.7	18.4	10.6	8.1	10.9	10.5	4.0	2.4	8.2	0.7	3.9	7.0	1.2	9.5	13.9	7.5	13.2	30.6	16.9	6.9	14.7	15.4	9.7	9.2	6.5	10.0	11.3	22.2	16.6	10.5	12.4	8.8	15.8	8.3	26.6	19.8	5.6	9.1	27.5	17.6	9.6	10.7	17.1	18.3	9.4	11.0	15.7	13.9	16.2	12.8	11.4	10.7	16.8	11.9	10.5	10.5	11.8	14.5	11.1	9.9	17.3	11.9	7.1	15.5	13.6	14.0	15.5	11.7	6.6	12.3	16.8	15.2	9.8	10.5	23.0	9.6	15.1	11.6	3.3	8.6	20.7	11.0	1.7	0.6	8.2	6.0	0.7	5.6	0.6	5.2	7.0	0.4	4.0	6.4	6.0	0.7	3.9	0.3	2.4	3.9	1.2	15.7	20.8	14.0	27.5	13.1	13.6	18.8	12.3	21.3	11.9	6.0	8.9	13.4	27.4	29.7	18.1	0.0	48.4	8.1	2.3	26.2	11.8	20.0	64.6	22.3	6.3	18.5	9.7	0.0	31.5	17.9	28.6	35.2	1.1	87.3	33.0	22.3	14.3	38.1	12.3	11.5	69.6	8.7	15.1	16.2	13.5	38.1	25.7	13.9	80.6	56.2	12.9	19.4	35.5	2.4	2.7	28.4	9.7	18.1	16.8	37.0
ACCS	"ACS, PHACS"	ENSG00000110455	"1-aminocyclopropane-1-carboxylate synthase homolog (inactive)"	Q96QU6	11	44065925-44084222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018873, HPA021654"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA018873: AB_1855273, HPA021654: AB_1855274"	"unprognostic (3.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.86e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (6.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.92e-2)"	10.6	17.0	6.2	34.7	5.3	10.3	11.1	4.5	6.0	10.0	8.0	6.9	15.5	5.9	14.8	29.9	6.5	15.7	18.8	5.8	4.9	2.5	10.2	17.7	32.5	7.5	6.7	4.2	11.6	13.1	4.0	16.1	2.8	7.0	10.9	8.0	10.7	10.3	14.4	4.7	7.8	9.7	9.5	6.1	14.6	9.7	10.2	5.2	6.1	12.7	4.3	7.1	10.5	8.3	2.7	6.9	8.1	4.8	1.4	2.2	2.7	4.4	9.8	0.0	1.1	2.7	4.8	0.0	2.3	3.0	2.1	2.3	0.8	6.2	1.6	1.8	5.1	0.0	7.4	2.6	0.5	1.2	0.5	2.8	6.8	3.2	0.1	5.0	0.0	0.0	5.4	9.3	2.7	1.2	3.0	3.9	0.0	5.3	0.0	6.4	3.2	0.0	2.6	3.8	5.5	1.4	6.0	0.0	0.0	5.4	2.8	1.3	4.0	2.3	1.3	2.7	2.6	9.7	4.2	4.2	2.4	2.7	4.0	1.2	0.0	0.0	0.2	6.1	0.0	2.6	1.3	4.3	8.1	1.3	4.8	1.3	2.0	1.3	2.2	6.9	2.7	1.9	1.1	0.1	1.4	3.9	5.1	1.9	2.7	6.2	5.3	4.5	6.0	4.9	2.5	6.7	4.2	7.0	5.2	11.9	24.3	1.9	2.5	2.4	2.1	2.2	2.5	2.7	10.3	8.7	0.0	2.2	0.0	2.2	1.7	5.3	5.9	0.0	3.8	0.4	3.3	2.4	9.2	6.7	5.1	0.0	6.9	8.6	7.3	1.9	8.9	6.1	0.0	7.2	8.3	2.9	2.5	8.2	7.1	5.9	0.9	0.0	2.8	0.7	1.7	1.9	1.6	3.8	7.0	1.3
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5;stomach 1: 23.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"REH: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023394, HPA076992"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA023394: AB_1850492, HPA076992: AB_2686822"	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.7	3.2	11.7	1.1	16.2	0.8	2.0	5.6	13.1	4.8	1.3	3.8	2.2	5.2	4.6	3.5	0.9	2.8	3.1	0.6	10.1	30.5	1.1	1.2	1.4	0.9	6.6	6.6	1.0	2.2	0.5	6.8	3.1	15.5	1.6	1.4	0.4	3.4	3.0	1.0	1.6	2.5	1.7	8.3	3.3	23.3	3.4	2.2	0.0	7.2	0.0	1.0	0.9	1.2	1.2	0.8	2.6	0.6	1.5	1.0	0.1	0.1	1.5	0.7	1.5	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.5	0.1	0.2	6.3	3.3	0.2	0.0	0.0	1.6	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.8	9.0	0.4	45.8	0.0	1.7	0.3	0.5	0.2	0.0	0.3	0.2	0.0	0.8	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	0.6	0.5	0.6	0.3	0.4	0.5	0.5	0.6	0.2	1.2	0.8	1.0	2.6	1.5	0.6	0.8	0.8	0.1	11.7	16.2	5.6	9.3	10.1	30.5	6.6	6.6	15.5	2.2	0.0	1.7	0.0	5.8	2.7	1.4	2.0	0.0	2.7	2.3	0.0	2.0	1.2	0.0	0.3	0.2	2.5	0.2	0.0	0.8	0.6	2.3	3.9	0.0	0.8	0.4	0.0	0.0	0.6	0.8	0.0	0.3	1.9	0.0	0.0	0.2	0.8	0.8	0.0	0.7	0.0	1.2	0.0	1.0	0.0	4.5	2.8	13.2	0.7	1.0	3.1
HNRNPA1L2	LOC144983	ENSG00000139675	"Heterogeneous nuclear ribonucleoprotein A1-like 2"	Q32P51	13	52640786-52643796	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 86.8;Suprabasal keratinocytes: 76.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"prognostic favorable (2.58e-4)"	"unprognostic (1.37e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (7.38e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.92e-2)"	1.8	1.7	2.3	2.2	3.4	7.8	2.9	3.9	2.9	2.8	1.9			0.9	3.1	3.6	1.2	2.7	0.9	1.7	2.2	2.6	1.9	1.1	2.0	3.6	2.6		5.0	1.7	1.4	2.7	1.4		2.5	2.2		1.7	2.5	1.7	2.4	1.6	1.8	2.5	3.2	1.2	2.0			2.7		3.3	2.5	1.8	4.8	6.1	4.4	1.2	5.3	4.9	4.3	3.8	2.9	7.1	9.1	3.4	3.9	3.7	5.4	4.4	3.0	2.5	4.2	4.9	7.6	1.6	3.0	2.4	6.7	5.5	6.0	5.3	7.5	4.5	7.6	8.0	6.0	5.6	12.8	2.0	4.9	5.2	3.5	7.8	6.7	6.8	7.2	4.1	3.7	3.5	4.8	9.3	14.2	5.9	1.6	3.7	7.8	5.0	4.3	4.8	6.7	3.6	6.4	2.5	3.5	4.7	5.0	3.5	8.0	4.7	4.2	4.3	4.0	5.2	4.5	4.2	8.6	2.0	6.4	3.9	1.4	1.2	4.4	4.4	1.0	4.9	4.6	4.0	4.5	2.0	4.8	4.9	3.7	0.1	5.3	0.9	6.1	3.2	4.3											3.0	2.2	22.5	4.7	86.8	2.8	11.8	15.3	2.7	6.8	0.0	2.0	45.0	0.0	4.3	12.9	12.3	5.2	0.0	5.9	62.3	30.3	2.1	10.3	2.4	19.1	1.6	27.7	15.4	16.7	3.0	37.4	6.3	32.1	6.4	20.8	2.8	5.1	21.0	22.3	1.4	2.5	6.5	9.9	12.1	20.3	76.9	40.7	30.5	39.7	2.0
POMGNT1	"FLJ20277, LGMD2O, MEB, MGAT1.2"	ENSG00000085998	"Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)"	Q8WZA1	1	46188682-46220305	"Disease related genes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044518	Approved					NA	NA		6300000			"HPA044518: AB_10795985"	"unprognostic (4.59e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (5.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	12.8	17.8	17.9	8.2	26.7	2.8	14.3	12.9	21.6	13.9	9.7	29.5	11.1	12.4	11.7	19.1	9.2	15.8	12.4	43.6	18.8	16.7	19.1	19.2	13.8	7.1	39.4	18.0	10.0	17.2	47.1	19.4	16.6	24.7	21.1	10.7	13.0	13.8	17.2	29.7	13.3	11.3	16.3	36.3	11.7	12.5	16.1	25.0	7.7	22.4	7.5	9.1	11.3	9.0	3.2	6.4	1.6	5.2	9.4	6.2	1.9	12.3	13.3	16.3	15.7	18.0	19.7	21.1	16.7	28.2	22.8	18.0	7.5	10.4	11.5	27.7	27.7	39.0	7.1	11.6	23.9	13.7	15.0	13.2	9.1	11.9	11.3	15.8	7.0	8.9	19.8	31.3	25.5	23.8	41.1	23.2	15.9	10.7	7.5	37.2	8.6	12.3	5.0	13.5	7.1	18.7	9.0	16.7	10.7	20.1	15.4	6.2	22.2	15.4	17.9	23.3	24.5	11.9	9.9	16.8	17.2	15.3	19.4	31.9	18.9	21.0	5.3	26.2	6.9	18.2	0.0	1.6	1.6	5.1	2.8	3.5	2.1	3.4	4.0	2.2	3.2	6.2	4.8	0.0	9.4	5.2	6.4	3.3	1.9	17.9	26.7	12.9	21.6	18.8	16.7	39.4	18.0	24.7	25.0	11.9	45.5	9.8	35.8	7.4	40.4	36.8	20.4	21.4	33.0	33.2	47.1	21.1	11.6	38.1	28.2	13.4	14.6	0.0	34.5	23.8	14.1	34.3	25.5	18.4	13.6	25.4	25.9	8.6	11.0	10.4	18.7	11.0	23.6	25.2	11.8	23.2	31.7	14.4	12.4	17.7	36.4	12.9	15.5	5.0	11.0	6.6	19.6	13.1	15.8	26.0
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.2	32.5	23.0	24.2	18.4	12.6	20.6	15.8	16.9	16.4	14.8	22.2	17.8	17.2	16.1	18.0	11.7	19.3	22.7	18.4	16.0	25.8	15.3	20.9	20.5	26.0	19.9	26.7	27.7	15.4	14.3	11.2	21.7	20.2	26.2	15.4	22.0	24.5	11.5	37.8	16.8	19.7	28.0	21.9	9.5	21.1	17.4	26.0	16.9	17.4	12.2	26.4	23.5	26.2	12.5	23.0	23.4	18.9	19.3	21.1	18.1	6.8	14.6	20.5	19.0	16.7	6.7	16.6	16.1	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0	8.9	16.5	13.7	11.2	0.1	21.2	12.6	35.7	6.7	10.3	12.2	5.9	22.8	36.5	27.5	41.1	18.6	61.4	0.0	36.4	33.1	15.4	16.7	30.0	42.3	27.8	11.1	25.9	27.6	28.5	44.0	10.6	14.5	0.0	26.2	34.4	20.8	29.9	45.6	14.9	32.7	14.2	25.8	11.2	14.9	20.2	0.3	27.6	21.0	31.9	22.0
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.2	20.9	8.5	12.0	11.8	7.9	19.6	8.3	7.0	10.9	9.7	9.2	12.0	13.4	9.1	7.3	14.5	10.8	8.8	10.0	10.4	7.2	16.4	24.4	25.3	13.2	11.9	7.9	12.2	11.2	12.3	10.8	13.1	12.5	14.2	14.9	12.3	11.9	8.0	10.0	16.1	10.7	5.5	10.8	16.2	13.1	19.8	13.5	9.2	13.4	10.2	9.9	9.1	16.4	11.2	12.2	29.5	6.3	7.2	14.1	16.2	7.7	8.6	17.0	9.7	12.9	11.6	7.9	10.1	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0	0.0	9.9	5.4	2.9	0.9	7.9	6.1	5.1	14.7	2.3	26.2	17.7	6.8	5.0	4.6	3.7	3.6	11.1	0.0	2.9	4.2	3.1	2.9	1.1	6.0	4.4	9.5	4.6	8.0	5.9	1.5	3.7	3.9	3.3	1.8	8.5	7.4	5.3	8.2	2.5	3.7	12.8	0.0	1.0	10.9	10.5	1.8	9.7	4.4	6.3	8.9
IKZF4	"Eos, ZNFN1A4"	ENSG00000123411	"IKAROS family zinc finger 4"	Q9H2S9	12	56007659-56038435	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.3;T-reg: 5.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046270, HPA049016"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046270: AB_2679607, HPA049016: AB_2680600"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.42e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (6.52e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.74e-3)"	5.6	14.5	7.7	7.4	8.5	6.7	8.1	13.9	7.6	7.2	6.9	6.5	7.1	3.4	7.7	8.5	4.1	10.0	5.9	5.6	6.3	6.3	5.6	4.1	7.3	4.2	5.9	9.8	16.2	5.7	20.8	22.1	5.9	9.2	8.1	4.3	9.2	3.7	8.6	16.8	4.1	4.5	10.8	8.4	4.1	5.7	9.1	5.9	5.2	8.8	4.5	4.5	6.4	14.0	0.3	0.3	0.0	0.4	0.1	5.3	0.3	1.3	1.5	9.2	3.1	1.9	2.0	2.1	1.5	2.5	1.7	2.5	4.7	2.0	0.8	1.6	2.3	1.9	0.9	1.1	1.2	3.8	28.2	1.4	5.2	1.5	2.3	2.1	2.4	2.1	3.4	1.7	1.8	1.4	3.2	1.7	0.2	8.1	4.5	2.7	1.5	3.0	1.2	4.0	1.4	1.1	2.6	2.5	1.1	2.5	1.4	3.6	3.0	2.0	0.6	3.3	2.4	2.4	2.6	0.9	1.5	2.6	1.4	1.1	2.7	1.6	1.3	3.0	2.4	1.9	0.0	0.3	0.0	0.3	0.3	0.5	0.3	1.3	0.0	0.2	0.2	0.3	0.4	0.0	0.1	0.4	0.3	5.3	0.3	7.7	8.5	13.9	7.6	6.3	6.3	5.9	9.8	9.2	5.9	3.0	10.3	1.4	1.5	3.2	18.9	5.7	10.2	1.4	4.5	3.5	7.9	2.7	1.7	2.4	8.5	3.4	1.6	0.0	3.8	2.1	5.0	1.9	1.1	5.6	2.4	7.9	5.8	4.9	8.6	1.6	8.1	2.3	5.0	5.4	2.7	16.7	2.9	2.5	10.3	3.3	11.5	0.0	9.2	18.4	4.9	2.9	3.3	2.5	2.2	1.4
SIN3B	KIAA0700	ENSG00000127511	"SIN3 transcription regulator family member B"	O75182	19	16829400-16880353	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050329	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050329: AB_2681089"	"unprognostic (2.71e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (4.37e-4)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (1.18e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-1)"	19.1	17.9	22.2	17.2	28.1	9.8	21.5	25.1	38.6	24.4	16.0	20.8	50.0	12.8	37.5	21.5	14.5	23.3	17.3	15.7	24.2	20.8	15.9	9.8	21.7	20.8	16.5	30.4	32.5	16.2	60.8	17.7	53.2	24.8	22.7	11.0	15.5	20.2	54.7	17.1	22.7	17.7	26.5	14.8	25.1	13.7	30.2	13.4	9.3	22.5	9.6	15.8	17.2	22.2	4.8	2.6	6.1	6.7	1.9	2.0	2.3	14.7	7.9	13.4	17.2	11.1	10.2	42.4	12.6	10.4	17.5	15.6	19.4	13.9	13.3	14.1	14.5	14.8	12.7	11.1	11.3	16.2	13.8	20.0	14.2	17.3	8.8	14.6	8.3	11.5	16.8	14.9	11.7	10.1	13.9	15.8	10.7	11.5	8.2	12.2	17.7	11.2	13.4	16.6	7.7	25.4	14.9	12.3	8.7	9.9	12.6	9.9	12.4	15.9	12.3	9.9	18.8	8.6	7.8	20.7	17.0	10.4	24.5	14.0	11.8	8.6	13.3	11.8	10.9	12.6	0.1	6.7	6.1	1.8	6.0	1.2	4.8	1.7	2.0	2.1	3.8	2.0	1.4	3.3	1.9	5.3	2.6	0.5	2.3	22.2	28.1	25.1	38.6	24.2	20.8	16.5	30.4	24.8	13.4	20.8	14.8	10.7	8.6	7.0	18.1	6.9	2.5	5.3	7.9	3.5	13.7	17.1	3.3	9.2	7.9	11.7	4.7	0.0	7.4	24.5	8.6	10.0	4.7	5.6	15.1	9.5	4.7	8.0	13.0	18.2	46.9	6.6	5.0	10.0	7.9	8.7	12.5	3.5	62.6	4.5	15.7	6.5	6.6	9.3	10.4	7.0	104.5	6.4	5.8	11.2
SH2B1	"FLJ30542, SH2B"	ENSG00000178188	"SH2B adaptor protein 1"	Q9NRF2	16	28846600-28874212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060663, HPA076175"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060663: , HPA076175: AB_2686782"	"unprognostic (3.60e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (6.10e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.38e-4)"	"unprognostic (1.39e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.60e-4)"	18.1	29.5	31.5	22.2	32.0	24.6	19.7	45.0	42.3	23.3	24.1	27.7	32.7	33.6	26.0	21.6	19.4	25.7	22.0	23.6	26.0	22.9	27.0	18.2	18.9	26.0	30.1	36.2	39.7	27.1	50.6	33.1	15.4	25.5	25.4	21.6	29.1	35.3	32.6	37.7	29.5	32.0	20.3	22.2	28.9	21.7	19.9	28.0	17.0	33.1	18.8	18.2	20.9	21.2	4.7	4.7	7.1	3.4	1.7	5.3	2.0	12.9	19.1	14.7	18.9	15.5	13.2	12.3	13.6	7.7	10.8	11.7	12.9	22.1	12.1	19.2	10.9	9.3	20.8	9.6	15.1	6.1	15.6	12.4	10.7	44.1	19.6	11.8	10.7	10.3	18.4	12.4	15.0	6.1	18.4	12.3	12.5	17.0	17.8	14.1	17.8	16.0	16.0	19.0	6.8	7.8	27.2	8.8	20.1	12.4	9.9	16.9	22.8	6.5	19.2	9.9	9.2	15.1	11.6	17.3	12.4	10.5	10.8	10.2	33.9	16.7	13.3	19.3	18.9	12.4	7.1	3.4	2.0	5.3	2.8	5.1	3.9	4.3	3.7	3.0	4.7	3.4	3.1	6.0	1.7	2.7	4.7	4.5	2.0	31.5	32.0	45.0	42.3	26.0	22.9	30.1	36.2	25.5	28.0	6.0	10.7	9.8	15.5	9.6	24.3	15.8	15.3	9.4	14.8	21.0	31.4	13.5	13.3	8.1	1.8	11.7	24.4	0.0	11.3	6.7	11.9	10.3	5.8	4.9	10.7	27.0	26.6	11.1	7.6	3.4	20.4	10.0	3.3	10.8	22.2	16.9	10.5	22.1	22.3	7.0	26.8	25.8	12.2	9.3	11.3	9.7	11.4	10.2	26.5	9.5
CRY2		ENSG00000121671	"Cryptochrome circadian regulator 2"	Q49AN0	11	45847118-45883248	"Predicted intracellular proteins"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation"	"Photoreceptor protein, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 128.4;Horizontal cells: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037577	Supported		Supported	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Cytosol	"HPA037577: AB_10672497"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (1.31e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.09e-2)"	"prognostic favorable (6.82e-5)"	"unprognostic (1.48e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.07e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.44e-15)"	"unprognostic (8.13e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.24e-1)"	17.4	13.3	18.2	8.8	27.4	17.2	16.7	29.8	36.5	17.7	12.1	15.4	10.5	7.6	16.2	12.4	11.2	20.8	18.7	39.5	15.6	13.1	15.7	27.8	15.7	6.7	12.7	15.0	26.3	23.4	20.6	16.4	9.3	11.5	15.0	7.3	35.5	14.4	17.1	58.2	24.3	8.5	18.7	10.4	9.2	12.2	17.4	9.6	5.9	23.6	22.4	10.3	17.4	10.6	7.8	5.2	7.6	10.6	10.4	10.4	7.1	1.2	3.6	5.6	6.6	15.2	7.7	12.2	4.3	7.8	5.5	4.1	5.8	2.9	8.3	3.4	9.0	5.3	7.4	5.3	4.5	3.8	8.8	4.8	5.5	6.3	8.0	5.8	6.7	7.5	9.0	6.7	4.2	6.8	6.3	3.8	6.5	10.6	14.3	4.9	4.5	5.7	8.0	15.1	15.2	4.3	9.7	8.0	3.9	4.0	6.8	9.0	3.4	7.2	6.6	3.7	7.4	8.8	4.7	4.8	7.8	4.8	11.9	3.0	13.3	9.1	6.9	4.8	2.9	4.7	5.7	5.0	7.6	8.7	7.1	7.2	7.8	8.4	9.3	5.2	7.7	10.3	10.4	2.6	10.4	10.6	3.8	6.9	7.1	18.2	27.4	29.8	36.5	15.6	13.1	12.7	15.0	11.5	9.6	11.9	15.6	3.2	9.8	15.0	128.4	29.0	12.7	14.7	13.6	7.0	25.5	6.2	24.9	3.9	19.1	8.3	11.3	0.0	4.0	4.6	16.6	11.6	14.9	37.0	3.3	95.3	6.8	9.2	9.4	7.2	29.1	7.2	15.1	2.8	5.4	32.7	4.7	6.5	37.4	10.5	25.6	19.4	17.6	21.0	12.7	15.3	7.8	4.5	4.5	9.5
FAM200B	C4orf53	ENSG00000237765	"Family with sequence similarity 200 member B"	P0CF97	4	15681662-15705565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA017855	Uncertain					NA	NA					"HPA017855: AB_1847703"	"unprognostic (7.38e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.00e-3)"	"unprognostic (3.82e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.23e-3)"	"prognostic favorable (4.39e-4)"	"unprognostic (3.46e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (3.35e-5)"	12.2	14.9	16.1	10.1	21.0	6.8	15.9	27.0	18.2	14.5	10.5	10.2	13.4	18.0	14.1	21.2	11.8	10.3	11.7	10.4	15.1	14.8	21.4	14.4	9.9	11.7	20.1	12.2	19.2	10.6	11.4	27.7	13.5	15.7	13.7	14.0	12.2	12.0	15.3	7.3	12.3	13.9	16.2	17.3	13.0	9.9	11.5	20.4	17.3	21.4	7.7	9.0	13.6	13.0	0.9	2.5	6.5	4.5	1.3	5.8	2.1	3.5	2.9	12.3	7.1	4.9	3.4	3.7	4.4	2.7	5.4	5.9	4.9	3.3	5.4	2.4	3.5	10.8	3.5	8.5	5.2	10.8	0.7	4.5	4.2	8.4	6.2	4.0	2.6	2.0	3.5	4.2	4.6	2.4	7.0	3.3	2.9	5.2	2.5	12.9	2.3	3.5	4.1	7.2	2.0	4.5	3.6	15.2	0.7	5.4	3.8	16.8	9.5	3.1	0.9	5.8	7.3	2.2	3.8	2.9	8.3	5.7	6.5	7.2	1.5	3.1	2.0	5.3	4.4	21.0	1.8	4.5	6.5	2.6	3.0	2.8	0.7	3.0	1.9	2.5	0.9	5.8	4.3	1.0	1.3	2.1	0.5	2.2	2.1	16.1	21.0	27.0	17.9	15.1	14.8	20.1	12.2	15.7	20.4	26.8	43.4	26.0	55.4	47.9	52.7	84.3	76.5	50.9	37.5	73.3	11.8	62.6	344.8	44.8	183.4	47.0	46.7	70.0	51.7	50.8	60.9	54.0	12.7	78.8	60.3	50.9	63.4	36.2	80.5	191.6	86.9	51.3	59.1	28.9	67.9	53.2	40.9	63.1	65.7	137.3	19.5	45.3	58.5	87.4	28.2	44.7	28.9	49.8	73.4	49.3
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490870	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 52.1;PC-3: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053905	Uncertain				"Secreted to blood"	NA	NA					"HPA053905: AB_2682303"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	17.8	24.4	21.9	12.4	21.2	17.2	11.1	10.8	32.1	14.5	22.4	41.1	23.1	23.4	17.4	24.9	14.4	22.7	24.9	21.9	21.8	19.2	33.8	43.2	15.3	19.8	23.0	20.0	22.4	25.6	32.5	48.2	21.1	22.2	20.5	8.7	29.8	29.4	19.0	147.8	13.9	28.7	8.5	31.4	14.6	33.1	24.3	19.1	15.4	34.0	13.7	16.4	12.6	11.7	12.2	10.8	11.2	10.5	4.7	10.3	6.8	17.2	21.4	0.8	8.3	2.4	3.0	0.2	16.8	3.1	1.5	1.6	0.2	11.9	5.7	0.2	3.0	2.7	14.5	1.0	2.7	0.5	22.0	52.1	1.2	9.5	0.0	4.1	4.9	33.5	3.7	3.1	1.5	1.2	1.4	3.6	5.0	11.0	12.2	3.0	12.1	7.8	0.1	0.0	6.8	37.2	13.5	2.6	18.4	6.8	15.8	13.3	29.6	24.8	8.0	8.8	1.0	8.4	9.1	6.9	1.0	23.0	6.3	9.1	13.6	33.8	4.7	6.8	3.5	8.3	7.8	10.5	11.2	8.1	8.0	6.9	9.4	8.6	8.6	7.7	12.2	10.3	10.0	4.5	4.7	5.9	10.8	6.8	6.8	21.9	21.2	10.8	32.1	21.8	19.2	23.0	20.0	22.2	19.1	59.6	135.5	78.7	47.6	26.4	78.3	8.1	86.6	29.4	64.8	66.3	76.6	114.1	19.9	150.7	157.7	33.8	118.0	0.0	98.3	126.3	46.9	69.4	51.9	61.8	121.6	35.0	203.6	53.4	97.1	29.5	63.9	74.5	79.2	85.6	93.3	93.2	107.1	129.8	108.2	56.1	61.3	6.5	41.2	14.0	52.6	27.4	126.3	73.4	108.6	54.5
RANGRF	"HSPC165, HSPC236, MOG1, RANGNRF"	ENSG00000108961	"RAN guanine nucleotide release factor"	Q9HD47	17	8288497-8290092	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 361.7;Late spermatids: 822.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057280, HPA057888"	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA057280: AB_2683393, HPA057888: AB_2683549"	"unprognostic (2.87e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	14.5	14.7	24.7	11.7	29.1	11.8	26.5	10.9	19.2	31.5	15.4	7.9	13.5	10.5	20.0	22.5	10.6	21.5	10.9	23.4	15.1	17.8	17.0	11.5	18.9	26.9	16.2	19.2	21.0	6.3	16.2	17.1	14.6	18.8	15.9	10.8	17.2	6.0	19.4	11.4	9.8	11.9	18.8	12.2	15.4	16.7	70.1	15.9	16.8	11.6	9.1	20.3	14.1	10.5	26.8	22.3	25.3	16.3	21.8	40.2	18.2	16.0	18.9	13.9	14.2	10.2	12.9	11.7	9.4	18.6	26.1	24.4	10.1	6.4	30.7	10.2	11.3	10.4	18.2	25.6	12.7	18.7	21.4	32.4	15.3	14.9	13.9	23.1	9.6	22.4	12.6	23.2	22.2	21.3	12.5	20.6	29.8	6.7	8.7	15.9	0.4	29.4	31.5	9.7	9.7	7.3	26.0	10.8	18.3	14.1	7.1	5.4	15.1	7.6	11.3	20.0	9.1	0.9	9.3	11.4	5.7	10.0	11.0	19.0	14.8	11.7	37.0	12.1	19.1	8.3	4.9	16.2	25.3	24.2	16.3	22.6	24.2	29.3	27.4	17.3	26.8	26.2	22.4	2.1	21.8	12.5	22.3	40.2	18.2	24.7	29.1	10.9	19.2	15.1	17.8	16.2	19.2	18.8	15.9	8.9	25.0	41.4	21.7	16.1	23.2	4.0	0.0	14.7	14.8	24.4	11.8	83.8	58.0	22.9	361.7	25.3	11.9	23.3	16.5	38.1	26.0	20.4	26.6	13.6	42.0	19.1	19.0	19.6	11.9	822.0	26.2	23.5	16.9	36.1	15.2	23.5	17.8	24.5	29.7	43.5	28.7	19.4	20.8	112.7	18.1	17.1	94.4	41.5	22.9	11.9
HKR1	ZNF875	ENSG00000181666	"HKR1, GLI-Kruppel zinc finger family member"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	13.0	25.8	14.6	13.2	22.4	12.6	24.9	29.8	27.2	20.5	14.5	22.9	21.5	7.7	24.8	24.1	12.4	22.9	17.9	26.9	14.6	15.6	19.3	12.3	12.9	14.3	14.9	17.4	22.6	14.2	31.0	35.5	17.2	21.2	27.5	13.8	49.4	18.7	19.3	18.1	27.1	13.4	17.0	13.3	20.2	14.2	22.6	15.5	16.4	30.9	13.7	20.1	15.0	15.6	12.4	7.9	10.0	5.1	9.9	14.8	5.7	4.1	10.4	13.5	17.9	9.9	8.6	9.4	7.0	10.7	13.1	14.2	5.2	4.9	14.6	17.1	7.4	5.9	3.5	8.8	9.4	13.6	7.6	15.0	5.1	12.6	5.6	13.0	4.7	12.5	12.7	11.6	8.8	19.4	13.4	7.9	10.5	0.9	0.9	9.4	8.4	10.5	9.3	27.1	7.2	6.0	7.1	5.9	5.6	11.4	16.8	16.8	22.8	7.0	9.0	8.8	20.6	12.8	9.0	7.1	10.4	7.5	7.8	10.9	18.8	19.7	15.1	1.1	5.8	11.6	10.0	4.2	6.6	8.0	5.1	14.8	10.7	10.6	11.4	6.3	12.4	14.4	12.0	4.0	9.9	3.6	7.9	12.2	5.7	14.6	22.4	29.8	27.2	14.6	15.6	14.9	17.4	21.2	15.5	6.0	2.9	7.8	6.4	4.6	45.3	16.5	2.5	18.7	11.4	10.4	102.1	9.3	16.6	7.7	9.5	11.1	2.9	0.0	6.8	4.6	6.1	9.7	11.5	5.9	6.1	39.7	9.2	9.2	3.7	5.9	11.2	5.5	8.5	9.0	5.0	22.8	5.1	3.5	12.0	10.9	129.7	6.5	7.6	15.5	16.3	5.4	8.2	8.5	5.4	7.3
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
SIRT3	SIR2L3	ENSG00000142082	"Sirtuin 3"	Q9NTG7	11	215458-236931	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026809, CAB037142"	Approved					NA	NA					"CAB037142: AB_1079982, HPA026809: AB_10601160"	"unprognostic (1.76e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.85e-9)"	"unprognostic (1.04e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.75e-2)"	8.2	9.3	15.1	8.2	26.3	8.6	17.4	16.7	24.5	8.4	9.9	16.2	8.2	11.2	11.2	36.8	8.4	13.2	6.9	19.8	14.7	14.8	10.4	15.2	8.6	10.7	11.9	16.2	17.4	12.8	15.0	18.7	6.1	17.1	12.6	12.9	15.4	12.0	11.9	21.2	17.3	11.3	9.2	8.8	11.1	9.0	16.5	11.9	4.4	13.4	9.3	12.6	7.9	7.1	7.2	6.3	3.7	8.0	10.5	9.3	4.0	7.1	9.7	13.2	14.0	16.6	19.6	6.5	10.2	9.4	8.8	7.1	8.1	17.1	4.5	4.8	7.0	7.8	13.2	6.6	6.1	8.2	8.5	9.5	5.5	9.9	10.0	7.0	7.2	13.8	15.3	12.1	8.1	9.0	14.2	5.5	8.8	11.3	8.9	4.0	8.8	3.0	11.2	6.0	7.3	10.8	8.0	10.9	7.4	8.8	4.9	7.7	6.1	8.6	13.4	4.5	8.9	9.7	1.8	7.4	9.0	4.3	2.5	3.0	15.6	12.4	6.0	9.5	6.0	4.8	0.0	4.2	3.7	5.6	3.6	6.2	7.2	5.2	6.4	4.0	6.8	9.3	7.6	2.4	10.5	8.0	6.3	5.5	4.0	15.1	26.3	16.7	24.5	14.7	14.8	11.9	16.2	17.1	11.9	3.0	6.2	7.6	6.9	4.4	6.6	20.2	10.2	6.7	4.5	5.2	7.9	10.1	28.2	6.4	17.0	6.0	8.0	0.0	5.1	9.1	7.5	4.8	10.3	16.3	7.6	9.5	5.8	8.0	2.7	17.6	8.3	3.8	10.1	3.6	8.4	11.5	4.4	8.7	8.5	15.7	8.4	0.0	5.2	17.0	11.4	3.6	5.7	6.1	9.8	3.9
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: AB_2686097"	"unprognostic (3.82e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	0.6	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	3.0	10.5	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.0	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	3.0	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3	3.0	7.5	2.4	3.0	1.3	7.3	5.6	0.0	8.1	2.3	0.0	3.9	1.9	6.6	5.6	1.3	6.3	5.5	0.0	5.0	1.7	4.6	3.4	3.5	7.8	6.1	6.4	7.0	6.2	6.5	0.0	5.5	4.0	0.0	10.8	6.3	5.2	4.6	10.2	9.2	6.4	6.8	12.9	5.2	11.8	2.7	1.0	1.0	4.5	6.0	2.0
FLCN	"BHD, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 34.9"									"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	11.9	15.3	23.6	10.8	41.6	15.6	13.9	49.4	26.9	18.0	21.3	18.5	10.4	25.0	22.1	15.8	11.0	14.5	17.6	17.2	17.2	8.6	9.6	15.5	15.6	11.6	24.2	13.5	25.2	13.7	6.1	20.3	13.3	18.1	15.4	10.7	14.8	10.5	14.8	22.7	12.6	20.2	15.4	14.8	16.5	15.3	12.5	29.1	6.6	15.8	3.9	8.0	15.0	14.8	6.0	2.4	10.5	6.8	4.5	5.0	3.1	5.9	14.5	5.3	6.9	17.4	9.9	7.9	5.3	8.9	8.5	11.8	11.0	4.9	2.9	7.4	6.4	19.6	6.9	6.5	3.3	4.4	5.6	5.5	6.0	4.3	6.3	16.1	2.2	16.8	14.6	11.4	13.3	9.9	7.7	6.9	4.3	8.2	7.7	8.1	7.7	3.9	3.7	5.4	8.2	3.6	8.0	24.7	3.4	5.1	6.6	6.5	4.1	5.6	3.4	9.3	34.9	5.1	4.2	8.1	20.0	8.7	27.6	7.0	3.8	3.6	2.8	12.7	5.1	7.9	3.6	4.7	2.8	2.9	6.8	4.1	5.3	3.5	2.5	2.4	6.0	3.9	3.4	10.5	4.5	2.2	2.4	5.0	3.1	23.6	41.6	49.4	26.9	17.2	8.6	24.2	13.5	18.1	29.1	23.8	13.0	15.9	10.7	16.4	17.0	17.3	7.6	4.0	4.5	7.0	74.6	8.1	1.7	10.3	10.9	10.1	26.4	46.7	7.2	5.4	15.2	11.3	1.1	20.2	14.4	44.5	24.6	23.4	23.7	13.4	25.9	13.7	10.1	5.4	9.4	18.9	9.6	12.2	19.1	4.3	16.8	19.4	11.4	5.2	10.2	15.8	28.3	11.3	10.6	11.6
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Group enriched"	"Detected in many"	8	"Horizontal cells: 158.9;Intestinal endocrine cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.6	6.3	24.5	0.3	0.1	1.2	0.9	0.0	0.8	0.4	6.0	0.2	0.0	1.2	0.9	4.1	0.1	2.4	0.2	0.2	0.0	1.3	0.1	0.3	8.7	1.9	0.1	1.5	0.8	8.2	0.1	0.4	1.5	0.7	2.2	1.7	0.1	0.6	5.2	0.9	0.4	8.0	0.7	0.6	4.0	1.0	0.9	1.6	0.2	4.2	35.6	0.6	2.2	0.4	5.7	2.7	2.8	0.3	8.8	12.3	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.9	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1	3.0	0.3	0.0	0.2	0.1	1.8	2.3	0.0	1.4	0.0	0.0	15.7	0.2	0.0	4.3	0.0	0.0	1.3	0.0	0.2	0.2	1.1	2.2	0.0	0.6	0.4	158.9	98.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.2	4.4	1.9	0.0	0.4	0.0	1.3	0.0	0.9	0.3	6.0	0.3	0.2	0.0	0.6	0.0
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751561-51816368	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.6"	"Cell type enhanced"	"Detected in many"	11	"Horizontal cells: 82.6"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.8;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	5.9	6.3	25.4	6.1	29.6	1.6	5.1	22.0	68.6	7.0	6.1	9.1	4.6	3.1	6.0	4.4	4.9	6.0	5.2	4.9	21.6	18.1	3.5	2.2	4.5	4.9	16.9	22.6	6.5	3.1	6.7	4.4	3.0	29.5	3.7	5.1	2.9	3.8	9.6	2.7	4.6	4.7	6.7	11.4	4.5	3.7	3.1	9.6	1.2	4.3	0.2	4.7	4.7	4.6	2.5	1.6	12.8	8.8	1.3	2.2	1.1	0.8	0.5	1.7	4.0	8.2	8.9	0.3	4.5	1.5	3.5	3.7	0.0	0.4	3.6	0.1	3.5	3.6	2.4	7.2	4.0	1.1	0.0	3.5	0.0	0.7	0.0	1.4	1.4	0.2	5.1	5.5	0.5	1.0	4.6	0.7	9.6	0.0	0.1	4.3	0.6	2.9	0.5	1.1	0.0	0.8	2.3	1.0	0.1	0.5	1.2	26.5	6.5	4.2	0.0	1.2	2.3	1.0	0.2	1.6	9.4	0.7	5.9	3.2	0.0	0.0	0.0	2.9	9.8	4.3	0.1	5.9	7.8	2.2	2.3	1.0	2.5	1.3	1.0	1.6	1.8	1.7	0.7	12.8	1.3	8.8	1.2	0.4	1.1	25.4	29.6	22.0	38.3	21.6	18.1	16.9	22.6	29.5	9.6	0.0	5.5	3.0	2.9	4.2	24.2	5.4	0.0	4.0	2.3	10.4	21.6	0.1	6.6	3.4	20.6	11.4	0.3	0.0	1.5	0.0	2.8	1.7	0.0	0.2	4.2	82.6	22.4	13.5	7.8	15.1	10.3	5.7	1.7	27.9	0.3	11.6	2.1	0.0	5.3	1.0	19.7	6.5	4.2	6.3	4.7	6.6	0.2	4.4	0.4	1.8
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.8	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	7.0	0.5	29.8	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.6	0.0	0.6	56.6	33.4	5.0	0.0	0.0	43.3	27.4	0.0	0.1	0.3	14.6	0.2	0.0	1.7	1.0	7.2	0.6	0.6	3.8	0.5	0.0	2.5	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5	0.0	1.4	0.0	0.0	0.3	117.0	0.8	0.0	0.0	0.0	0.0	17.7	0.1	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.1	3.1	0.4	0.0	0.0	0.4	198.6	2.4	0.0	0.0	3.8	0.6	0.0	1.7	0.0	0.0	68.8	0.7	0.0	0.4	0.0	20.1	6.5	2.5	0.6	9.8	0.1	0.2	0.0	0.0	0.0
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 47.5;Distal tubular cells: 33.2;Kupffer cells: 44.2;Muller glia cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.1;EFO-21: 11.0;HMC-1: 12.8;MCF7: 10.6;SK-BR-3: 10.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.2	22.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.8	0.1	11.0	0.1	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.2	0.0	0.0	6.8	0.0	12.8	4.6	1.1	0.0	0.1	8.0	2.4	0.5	2.0	0.5	0.0	10.6	0.4	1.1	0.3	0.9	6.9	1.7	0.0	8.2	1.5	0.0	1.2	1.0	0.0	10.0	0.0	1.1	12.4	1.3	5.4	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.8	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0	0.0	0.3	0.0	0.5	3.2	47.5	1.7	0.0	1.4	1.2	0.0	2.0	0.2	33.2	4.8	0.3	15.5	0.0	0.0	2.5	0.1	4.7	1.2	0.0	5.7	19.3	6.4	2.9	24.5	44.2	0.0	1.4	17.6	1.7	8.2	0.0	69.9	2.2	0.0	1.8	7.5	5.5	0.0	3.1	0.1	2.0	6.5	0.3	1.5	0.0	0.3
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.8	11.4	11.7	7.4	8.0	2.7	4.9	4.0	0.9	6.0	5.8	7.0	9.5	4.6	7.3	7.0	4.4	3.2	4.2	18.3	1.7	7.7	3.1	4.5	2.2	4.2	13.8	4.8	2.4	4.9	12.0	6.8	3.9	5.9	4.5	5.0	0.5	2.0	2.5	1.7	7.1	14.3	3.6	2.0	6.3	7.4	5.1	9.5	8.1	8.9	7.3	1.1	5.3	4.3	0.8	10.6	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.9	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7	35.7	17.9	12.7	10.5	12.7	45.7	11.3	22.9	20.1	14.8	59.3	56.9	33.3	33.2	32.3	35.0	28.7	39.6	23.3	15.9	35.6	25.3	20.9	26.5	52.5	68.3	95.3	33.7	81.0	78.2	20.9	31.9	26.9	8.5	30.7	27.3	29.4	24.3	20.1	26.2	42.7	64.8	25.8	14.4	46.9	25.1	9.9	23.8	20.8	32.0	9.7
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289793	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Supported	"Nuclear membrane,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	"Nuclear membrane"	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.3	13.8	17.8	16.7	21.8	12.4	10.4	29.2	28.9	16.0	16.6	27.1	15.3	14.8	17.3	17.9	13.4	16.0	20.0	14.3	17.5	17.2	13.7	14.8	13.1	16.6	26.0	19.9	16.7	32.8	13.7	40.9	17.9	19.2	16.2	11.7	20.1	21.3	18.1	10.4	21.9	15.7	14.8	15.9	17.2	21.1	19.9	22.7	11.2	15.0	10.3	15.5	16.0	11.9	7.4	8.2	8.3	12.6	6.6	9.9	7.0	11.2	21.4	9.3	11.1	11.2	12.7	18.3	16.5	13.6	33.6	16.9	50.9	12.6	8.6	15.1	19.8	15.3	15.6	8.5	26.6	10.4	5.6	9.4	6.6	20.7	42.9	17.2	9.9	13.9	10.9	17.2	16.2	9.1	11.9	11.8	9.1	12.0	10.0	9.0	18.5	17.9	9.4	12.4	11.9	18.5	10.1	13.5	8.3	8.3	13.8	10.0	11.0	19.7	21.1	20.6	7.9	15.5	12.8	15.3	20.5	27.9	12.4	13.0	10.2	6.6	9.3	20.8	7.0	12.7	6.9	7.6	8.3	8.8	10.5	9.9	4.8	4.8	8.0	8.2	7.4	4.9	4.6	3.6	6.6	12.6	6.2	5.9	7.0	17.8	21.8	29.2	28.9	17.5	17.2	26.0	19.9	19.2	22.7	20.8	30.7	9.0	5.8	9.0	25.4	10.6	10.2	14.7	13.6	12.2	31.4	9.8	8.3	10.5	10.4	9.5	21.3	23.3	13.4	20.9	14.6	11.1	16.1	19.2	13.1	20.6	23.5	17.8	17.2	16.3	11.5	10.5	11.8	10.8	27.0	11.5	20.5	12.7	9.2	10.2	19.1	6.5	9.2	9.5	7.0	7.4	12.7	10.7	15.8	5.8
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	8.9	9.9	10.9	10.6	14.1	11.3	15.7	11.6	16.9	11.1	10.2	14.4	9.0	8.1	15.3	11.2	8.4	19.7	7.8	8.4	11.1	10.1	9.7	13.0	6.8	11.0	8.8	13.4	12.9	15.6	14.3	13.2	9.0	8.9	10.1	9.5	13.0	11.9	13.4	18.6	21.6	10.3	10.6	8.3	15.2	8.7	39.7	7.8	11.3	12.9	8.8	11.8	7.8	9.5	1.9	2.1	3.5	1.9	0.3	2.6	0.4	8.7	8.0	10.4	18.7	4.8	8.3	17.8	6.8	5.6	8.6	7.1	3.0	7.5	9.0	5.6	4.6	3.5	8.6	6.7	17.2	6.6	12.0	12.8	6.3	7.2	5.0	4.3	5.8	5.5	6.6	13.0	16.6	15.5	13.1	11.4	12.8	13.3	11.9	12.0	16.2	8.9	9.4	13.9	4.8	8.0	19.3	6.3	5.7	7.6	7.2	5.6	17.7	5.7	7.2	6.0	10.3	16.3	9.7	4.4	5.5	5.0	7.6	6.0	11.7	8.4	10.3	4.3	7.0	9.1	0.0	0.7	2.3	2.4	1.9	2.6	1.9	1.6	1.5	1.3	1.4	2.6	2.2	3.5	0.3	0.4	2.1	2.1	0.4	10.9	14.1	11.6	16.9	11.1	10.1	8.8	13.4	8.9	7.8	0.0	7.7	0.0	2.3	2.7	6.8	2.0	5.1	6.7	4.5	10.4	7.9	4.6	10.0	3.1	12.3	1.8	3.9	23.3	2.5	2.5	2.1	2.0	3.5	4.7	2.6	3.2	1.2	5.5	2.2	1.4	4.6	2.1	3.3	1.0	5.8	6.0	2.1	0.0	3.9	5.5	9.0	0.0	0.9	12.5	12.7	2.3	4.7	2.5	5.2	1.4
ZNF414	"MGC15716, Zfp414"	ENSG00000133250	"Zinc finger protein 414"	Q96IQ9	19	8509678-8514164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053769	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053769: AB_2682255"	"unprognostic (7.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.26e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.67e-6)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.71e-4)"	16.6	16.2	14.3	13.6	22.7	20.8	10.6	17.6	28.6	13.2	10.9	22.4	5.6	21.4	16.6	10.0	11.6	11.6	9.7	9.9	14.1	11.4	12.0	13.1	10.7	15.8	15.5	14.8	16.7	13.7	9.2	15.3	14.0	17.3	15.8	4.6	13.4	20.5	14.1	23.6	25.5	16.6	7.7	12.5	22.8	19.1	13.6	20.3	19.9	15.7	6.1	13.5	11.8	12.3	3.0	3.4	5.4	2.1	2.5	2.7	1.2	5.4	4.7	2.6	4.2	0.7	1.7	5.8	4.1	1.6	2.7	2.5	4.2	2.7	7.6	12.2	1.3	2.0	7.7	0.8	3.4	0.4	6.8	19.1	4.8	4.4	4.9	3.8	4.1	6.5	3.1	2.5	2.2	0.9	1.5	1.1	4.8	6.3	11.2	1.7	6.8	9.3	24.2	7.7	1.4	13.5	10.9	1.3	7.6	1.9	4.5	9.0	14.0	4.6	3.5	3.7	0.5	6.7	4.8	4.3	8.1	4.1	11.7	5.4	16.4	6.8	5.9	6.5	3.5	4.3	3.0	1.6	0.8	1.8	1.4	1.0	2.5	2.7	2.7	1.6	3.0	2.6	2.6	5.4	2.5	2.1	3.4	1.4	1.2	14.3	22.7	17.6	28.6	14.1	11.4	15.5	14.8	17.3	20.3	0.0	0.6	4.9	12.9	10.5	17.5	1.7	7.6	0.0	0.0	3.5	9.8	23.8	13.3	3.0	21.5	6.7	11.9	0.0	4.7	18.3	12.7	8.8	4.6	9.7	11.4	11.1	21.4	11.1	9.1	59.9	19.0	9.6	8.5	5.4	12.8	17.9	3.8	11.5	15.2	13.5	18.9	12.9	7.8	24.4	30.2	10.7	26.3	10.5	11.7	8.1
ATP5F1D	ATP5D	ENSG00000099624	"ATP synthase F1 subunit delta"	P30049	19	1241746-1244826	"Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 337.3"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 1442.3;Exocrine glandular cells: 487.7;Proximal tubular cells: 1282.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002865	Approved					NA	NA		4200000			"HPA002865: AB_1078244"	"unprognostic (4.80e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.77e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	30.4	25.7	27.4	13.7	30.1	19.5	19.8	22.6	51.7	14.4	36.7	16.7	16.0	42.7	14.3	14.9	23.9	15.3	18.1	59.3	25.9	20.6	33.3	51.8	12.2	33.4	25.6	24.1	15.2	46.5	15.5	18.4	12.4	28.5	17.6	14.1	17.9	48.1	23.1	337.3	24.3	33.2	21.1	14.5	19.2	33.4	10.2	9.8	21.5	23.0	60.6	22.9	17.6	14.5	67.7	78.2	33.9	64.6	52.8	64.3	50.8	24.4	13.4	4.2	15.7	4.9	7.2	15.7	16.8	7.1	10.0	7.3	14.0	6.5	24.9	10.9	5.8	2.5	21.1	4.7	17.5	1.3	17.2	45.6	15.0	16.5	18.2	12.2	26.3	22.4	14.3	4.8	4.0	5.6	5.6	10.6	16.8	21.8	19.9	4.6	37.2	28.5	19.0	18.2	15.7	66.3	27.2	11.1	51.7	16.6	16.2	16.8	19.3	11.2	17.9	27.7	1.7	13.3	12.5	15.3	9.1	12.5	21.9	13.9	51.0	25.7	9.2	16.9	12.5	13.7	33.9	64.6	27.1	50.7	61.3	61.1	64.8	64.3	55.7	72.1	67.7	59.9	54.9	22.5	52.8	49.0	78.2	62.0	50.8	27.4	30.1	22.6	51.7	25.9	20.6	25.6	24.1	28.5	9.8	14.9	23.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.0	361.2	0.0	333.1	1442.3	304.6	0.0	0.0	0.0	0.0	487.7	366.7	0.0	0.0	4.7	0.0	365.7	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	232.6	0.0	0.0	350.7	0.0	0.0	1282.8	0.0	0.0	0.0	0.0	0.0	0.0	285.4	0.0	0.0	0.0
ELMO1	"CED-12, CED12, ELMO-1, KIAA0281"	ENSG00000155849	"Engulfment and cell motility 1"	Q92556	7	36854361-37449249	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.3"	"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 37.9;Ito cells: 37.4;Kupffer cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;JURKAT: 31.3;Karpas-707: 27.9;U-266/70: 24.0;U-698: 34.5;U-937: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.77e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.62e-4)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.16e-3)"	13.5	9.5	33.7	16.8	39.9	28.5	7.7	39.7	58.3	7.7	7.0	34.9	1.4	4.3	5.0	3.6	6.8	5.4	11.7	7.5	33.6	21.1	3.4	15.8	14.6	24.0	30.5	17.2	8.5	8.4	2.9	5.6	21.8	37.0	4.5	7.9	4.0	4.3	6.7	3.1	4.5	6.6	8.9	36.4	28.4	5.3	4.5	29.7	9.3	47.4	2.1	26.0	11.3	6.5	14.3	20.4	41.4	13.7	10.8	15.3	13.4	0.0	1.1	1.9	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.5	0.0	0.3	0.1	0.0	0.0	0.0	15.9	1.0	20.4	0.1	0.0	0.0	13.2	8.9	0.4	0.0	0.0	0.0	0.0	10.9	31.3	0.3	27.9	0.0	0.2	16.6	20.1	4.5	0.0	0.0	17.8	2.1	16.1	0.0	0.0	2.5	10.2	0.0	5.7	0.1	7.5	0.0	9.5	2.8	0.0	0.3	0.0	0.1	24.0	22.5	34.5	5.6	27.8	1.2	10.9	13.7	41.4	9.0	11.7	9.8	14.3	15.3	10.5	20.4	12.8	14.4	10.6	32.4	10.8	9.9	11.6	14.7	13.4	33.7	39.9	39.7	52.8	33.6	21.1	30.5	17.2	37.0	29.7	0.0	7.4	19.0	3.6	4.4	16.7	2.2	10.2	0.0	1.2	0.0	0.0	1.2	0.0	0.2	0.9	37.9	0.0	0.0	1.0	20.6	12.0	1.7	34.6	10.6	17.5	0.0	3.5	37.4	44.8	0.9	5.8	32.7	6.8	24.4	0.7	1.2	0.8	0.0	23.3	1.6	1.6	12.9	3.1	1.4	3.2	3.8	16.5	28.0	0.1	1.3
ACBD4	FLJ13322	ENSG00000181513	"Acyl-CoA binding domain containing 4"	Q8NC06	17	45132600-45144181	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051772	Approved		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA051772: AB_2681603"	"unprognostic (1.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (2.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.86e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (8.24e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.53e-4)"	7.5	9.5	8.1	8.5	15.3	3.5	6.7	10.8	10.9	8.6	19.6	4.9	14.4	25.9	9.2	6.8	8.3	10.1	10.7	6.2	8.1	6.8	12.3	43.1	6.3	8.0	6.1	11.1	10.4	14.2	13.6	8.5	5.4	6.3	11.1	5.4	9.9	12.3	13.6	5.4	7.5	29.0	10.3	4.8	8.3	7.3	2.5	6.3	3.9	11.3	4.4	7.3	8.5	7.2	8.8	3.5	5.6	4.3	6.3	7.7	5.4	5.9	11.6	1.5	3.3	2.7	5.2	4.1	2.2	4.7	3.7	7.3	4.5	8.4	6.3	5.8	3.2	2.2	5.7	2.0	3.8	1.5	9.1	4.6	3.1	7.5	8.9	6.1	1.2	8.7	5.1	3.6	1.3	1.9	12.7	3.6	5.9	2.0	10.2	1.8	4.0	4.4	1.6	0.2	6.3	3.2	3.7	0.3	14.0	9.2	3.8	2.5	1.1	1.6	2.4	6.4	0.8	15.6	2.2	1.3	0.9	2.9	1.4	1.4	16.0	4.4	1.9	5.4	1.6	1.6	5.5	3.8	5.6	5.3	4.3	5.7	6.8	6.2	5.9	3.5	8.8	6.7	7.7	1.0	6.3	2.8	2.2	7.1	5.4	8.1	15.3	10.8	10.9	8.1	6.8	6.1	11.1	6.3	6.3	3.0	4.8	2.9	5.7	1.6	14.6	8.0	17.8	1.4	0.0	3.5	21.6	5.5	6.6	5.7	1.3	5.3	10.5	0.0	6.3	1.0	4.3	3.8	8.1	20.8	4.6	11.1	5.8	4.9	1.6	2.7	6.4	1.7	3.3	5.4	5.8	12.3	5.2	10.5	7.1	15.1	15.8	6.5	7.2	0.7	3.8	1.6	5.3	4.4	7.0	1.7
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	12.0	13.1	20.4	16.2	22.8	32.8	14.3	17.5	31.6	15.5	13.8	15.8	17.5	14.2	17.2	17.9	16.4	12.6	14.5	13.8	18.3	14.0	14.3	12.2	14.3	21.6	13.7	19.2	22.4	20.8	25.8	16.9	11.1	13.8	17.6	17.2	16.2	20.4	15.3	12.0	19.5	15.2	15.8	13.0	20.6	13.7	10.1	13.5	37.5	18.8	8.6	25.2	12.5	15.2	3.3	3.5	2.5	2.5	2.2	6.0	2.3	9.5	16.1	9.0	7.6	11.6	12.8	38.2	11.5	12.1	15.4	10.1	11.7	8.6	23.3	8.8	17.1	16.2	7.0	15.6	11.0	12.4	14.7	17.8	12.3	15.7	12.4	7.7	17.1	12.9	9.7	12.4	21.7	7.2	10.1	12.5	14.4	13.6	21.2	14.1	18.4	22.6	14.3	12.3	12.8	16.1	12.3	9.6	13.3	9.7	13.9	9.9	11.7	9.8	11.7	5.3	8.9	11.4	16.1	10.1	18.0	11.5	14.6	20.7	13.0	21.2	41.5	15.7	17.5	12.1	2.5	1.6	1.2	4.6	2.5	4.5	2.5	3.9	3.7	1.5	3.3	4.0	6.0	1.3	2.2	1.3	3.5	4.4	2.3	20.4	22.8	17.5	31.6	18.3	14.0	13.7	19.2	13.8	13.5	6.0	14.1	6.5	3.7	11.2	4.4	5.0	12.7	1.4	4.5	10.4	5.9	3.0	1.7	4.8	1.3	7.1	6.2	0.0	7.8	3.4	7.2	8.4	4.7	10.2	8.7	4.8	16.1	9.2	12.3	1.5	6.6	7.7	13.5	1.8	8.9	4.1	6.7	0.0	7.1	4.4	2.7	6.5	4.1	1.7	5.1	10.8	2.1	14.9	9.3	6.4
FBXW4	"dactylin, Fbw4, SHFM3"	ENSG00000107829	"F-box and WD repeat domain containing 4"	P57775	10	101610664-101695295	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043496	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA043496: AB_2678514"	"unprognostic (4.31e-2)"	"unprognostic (5.43e-3)"	"unprognostic (8.40e-3)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (4.67e-4)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (2.94e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.85e-2)"	15.3	11.8	26.4	10.9	27.2	9.5	22.5	16.3	22.1	13.5	22.1	15.9	16.4	11.0	9.4	21.3	17.0	15.1	16.8	40.3	28.1	22.3	14.1	13.3	17.1	10.9	34.6	20.0	14.0	28.5	38.1	16.9	17.2	19.1	17.6	11.5	10.0	27.9	19.9	41.4	19.6	12.0	32.8	36.1	10.5	15.5	7.9	24.2	5.2	15.5	14.8	11.9	18.6	37.1	7.1	5.6	2.8	2.1	5.4	6.7	1.7	10.8	12.9	2.0	14.7	10.6	8.7	9.8	5.7	15.9	6.6	5.2	6.0	11.5	12.4	9.1	11.7	6.8	6.7	5.5	8.4	2.2	13.2	7.7	2.9	4.4	12.8	18.8	4.9	3.9	8.0	26.8	3.5	22.3	15.4	5.6	8.9	3.0	7.8	7.2	22.6	5.5	7.0	5.8	5.6	6.3	4.6	15.3	5.2	12.9	7.3	6.4	11.1	11.0	4.1	10.1	3.2	17.1	8.8	5.9	7.2	0.9	2.9	5.7	16.5	7.4	5.6	5.8	6.2	4.1	1.7	2.1	2.8	6.5	1.1	3.7	4.9	6.2	6.1	1.5	7.1	6.7	5.4	0.3	5.4	1.8	5.6	1.8	1.7	26.4	27.2	16.3	22.1	28.1	22.3	34.6	20.0	19.1	24.2	3.0	41.2	10.7	14.1	10.0	28.3	30.5	12.7	5.3	10.3	10.4	17.7	12.8	3.3	12.6	47.9	7.7	21.6	23.3	22.8	7.7	9.3	18.8	4.7	22.1	7.9	35.0	19.5	6.7	7.6	20.2	13.3	6.6	13.5	10.8	24.6	25.1	16.8	17.5	15.9	10.2	20.7	12.9	17.5	4.4	6.3	10.9	13.0	10.2	19.6	14.9
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	3.8	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	3.0	0.4	4.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.2	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	4.2	1.4	1.8	0.0	0.4	1.0	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5	11.9	15.1	0.9	2.6	1.1	4.1	2.8	2.5	8.1	6.8	0.0	7.9	1.9	3.3	2.0	0.4	2.5	3.8	0.0	1.2	1.0	2.0	2.5	0.0	1.9	1.3	3.2	3.5	2.5	1.0	0.2	2.8	2.0	0.0	1.0	1.7	4.6	1.7	0.0	2.5	2.1	4.7	0.0	1.5	4.4	10.4	1.3	7.3	4.5	2.2	1.5
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 65.1;MCF7: 80.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.4	5.7	10.3	23.1	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.6	9.0	6.4	1.6	10.6	10.4	9.3	4.4	3.9	26.8	17.8	9.3	65.1	24.7	13.7	21.9	8.4	11.5	4.0	14.6	2.7	7.1	11.1	20.2	13.6	6.7	80.0	11.4	32.8	6.6	40.3	13.1	10.5	7.7	24.2	9.4	12.8	16.0	9.4	6.5	55.1	8.0	3.6	41.3	13.5	3.6	6.7	8.4	9.1	8.6	13.9	10.2	8.8	5.8	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7	47.6	155.8	118.2	185.0	52.0	15.8	102.4	124.9	20.1	28.4	169.3	17.7	343.4	688.1	41.9	5.1	35.2	135.9	23.3	37.0	376.5	68.0	203.5	64.5	2593.4	145.3	20.6	52.6	88.4	114.9	15.1	65.6	57.1	170.4	47.7	117.0	81.8	32.4	105.2	44.6	1817.7	18.5	19.4	66.5	6.6	48.3	64.0	286.5	126.9	129.4	155.9
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	17.1	21.5	24.4	22.0	30.7	23.3	21.3	20.4	28.9	17.1	15.3	22.6	29.8	19.0	38.3	23.1	12.6	21.3	11.8	19.2	10.8	43.5	23.2	21.1	30.1	17.7	25.0	17.6	27.0	27.6	20.3	15.2	22.1	19.0	26.4	24.6	19.0	35.0	15.8	16.3	22.7	17.6	17.5	22.6	21.4	22.3	14.4	37.1	19.6	30.6	16.6	16.0	34.2	38.3	22.9	24.7	35.9	26.7	31.7	21.1	10.9	12.9	18.8	57.5	39.2	30.9	23.5	16.6	17.2	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5	53.6	45.7	13.9	17.0	16.4	43.6	50.1	22.9	48.2	38.7	24.4	60.9	25.4	53.0	18.8	1.7	23.6	23.7	0.0	18.8	17.5	22.0	14.7	31.4	60.2	20.7	38.1	24.1	17.2	29.6	1.9	25.9	19.5	13.5	30.7	19.1	36.1	17.3	10.5	30.8	27.6	56.3	12.9	25.5	27.5	17.9	21.1	37.1	28.0	19.0	8.2
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.4	6.9	33.2	24.3	13.3	9.3	10.6	8.9	11.5	18.0	15.3	16.6	1.8	12.1	11.0	9.7	18.9	10.1	14.4	16.0	10.5	3.4	7.7	0.8	11.5	19.5	10.1	4.7	3.3	11.9	9.0	13.3	10.4	16.3	20.0	26.0	9.0	8.0	16.2	40.4	29.2	3.7	12.3	7.0	12.7	23.3	24.2	5.9	9.9	10.0	11.8	22.5	16.0	7.5	16.0	19.4	8.7	5.6	21.6	43.1	14.0	13.7	10.8	8.9	3.9	10.0	10.2	5.2	17.8	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9	14.9	6.5	0.8	1.8	4.9	3.7	9.2	0.0	1.4	3.4	3.5	9.8	1.3	0.0	2.7	5.1	15.8	6.4	0.0	1.4	1.6	6.1	1.9	1.1	2.5	3.2	3.2	1.7	13.5	2.2	5.3	14.1	1.7	3.3	1.0	9.8	7.2	2.8	3.7	17.3	2.4	4.6	12.9	5.1	11.6	11.5	6.0	0.7	6.9	5.1	0.9
ASCL2	"ASH2, bHLHa45, HASH2"	ENSG00000183734	"Achaete-scute family bHLH transcription factor 2"	Q99929	11	2268495-2270952	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.8;placenta: 16.0"	"Cell type enriched"	"Detected in many"	12	"Extravillous trophoblasts: 947.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 76.1;stomach cancer: 23.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 18.5;NB-4: 5.4;OE19: 10.0;SCLC-21H: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.71e-3)"	"prognostic favorable (5.11e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.22e-2)"	"prognostic favorable (4.73e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.45e-6)"	"unprognostic (8.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.12e-4)"	"unprognostic (1.07e-3)"	0.5	0.3	0.7	2.2	1.3	0.9	1.1	0.0	1.2	2.7	7.3	1.4	21.8	9.2	3.6	1.2	2.5	0.7	0.4	0.8	0.6	0.4	2.5	1.1	0.9	0.9	1.5	0.6	0.4	1.5	0.0	0.1	16.0	1.1	3.3	3.4	0.1	9.7	9.5	0.6	10.0	7.3	0.2	3.7	3.0	2.8	1.6	1.1	1.1	0.7	0.8	2.7	3.6	3.3	0.1	1.0	8.6	2.0	0.0	3.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	5.4	0.4	10.0	0.0	0.0	0.0	0.0	0.0	0.4	15.1	0.0	0.0	0.3	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.5	1.4	8.6	3.0	2.0	0.2	0.1	0.7	1.7	1.0	0.0	0.2	1.7	1.2	0.0	1.7	0.0	0.0	0.3	0.7	1.3	0.0	1.2	0.6	0.4	1.5	0.6	1.1	1.1	0.0	0.0	1.9	12.4	12.0	0.0	0.8	0.0	1.4	0.0	19.2	0.0	15.5	6.6	0.1	0.0	0.7	6.8	0.0	0.0	947.6	0.8	3.8	0.0	0.2	28.4	0.0	75.2	20.3	18.4	0.0	1.7	8.5	1.7	1.0	19.5	0.0	0.0	3.4	1.4	0.3	0.0	0.0	0.3	0.3	11.3	4.1	19.5	8.5	77.9	4.6
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.2;Daudi: 19.1;OE19: 25.5;U-698: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049532			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049532: AB_2680807"	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	8.6	6.4	10.2	16.8	20.7	8.9	6.8	8.6	15.0	6.4	10.5	34.4	8.2	6.8	7.1	4.3	9.3	7.2	9.1	19.3	14.6	8.2	12.2	5.0	8.3	24.1	30.0	6.8	6.7	11.4	26.1	14.9	18.5	16.2	10.7	5.3	6.9	18.0	8.6	45.2	7.9	15.5	8.4	27.4	27.3	7.9	2.5	24.0	2.8	11.1	10.9	18.3	10.8	11.1	22.2	8.5	29.0	9.6	0.8	2.6	4.4	1.7	1.8	0.4	7.0	2.4	1.4	30.2	2.7	5.5	2.4	1.8	4.0	2.0	19.1	3.7	2.9	1.8	4.8	1.1	2.8	0.6	17.5	1.9	0.0	6.9	7.3	4.7	0.5	2.6	0.5	5.4	2.8	1.8	5.8	1.8	2.1	2.3	4.7	0.9	1.2	1.1	1.4	0.1	25.5	0.9	12.6	0.2	2.6	4.3	1.4	7.9	2.3	2.3	4.9	0.6	1.8	1.4	9.5	3.8	0.9	1.9	0.1	1.9	12.3	1.9	28.2	1.4	8.1	0.9	0.1	9.6	8.8	2.6	9.3	0.4	22.2	0.7	1.0	8.5	15.1	0.2	0.9	29.0	0.8	6.5	1.7	0.4	4.4	10.2	20.7	8.6	15.0	14.6	8.2	30.0	6.8	16.2	24.0	8.9	9.4	20.8	7.5	12.6	5.8	16.4	12.7	4.0	1.2	12.2	11.8	37.8	18.3	3.0	0.7	7.7	14.0	0.0	6.2	3.4	5.2	6.4	1.1	3.9	25.2	25.4	12.7	8.6	22.7	4.0	3.1	12.9	0.0	4.6	8.4	16.7	6.9	17.3	10.3	2.4	4.7	6.5	6.2	0.5	0.9	12.7	100.7	5.4	7.9	6.0
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ito cells: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.6	13.9	9.3	18.1	20.7	11.1	14.0	13.1	17.2	15.1	12.2	17.6	14.9	9.4	17.6	10.7	10.4	7.6	18.9	22.7	13.1	21.7	17.2	10.1	12.9	25.3	10.9	9.1	14.9	6.0	9.8	23.4	11.7	11.8	12.4	13.3	20.8	15.0	18.3	11.4	8.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.2	11.8	15.8	6.2	7.9	19.8	14.6	32.6	24.2	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.6	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2	8.9	11.5	2.2	4.2	9.5	13.3	8.1	5.1	4.0	7.9	8.7	37.3	6.7	1.7	7.6	3.1	27.6	23.3	0.0	10.2	4.8	9.3	5.8	3.5	9.7	8.4	9.5	12.6	44.2	12.4	2.1	11.5	5.5	6.8	4.6	14.9	8.7	12.7	14.2	12.0	6.4	19.2	6.5	7.6	21.1	17.2	8.4	10.1	9.2	13.3	5.7
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 145.7;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.3	34.9	5.8	26.7	16.4	0.6	5.5	17.5	4.7	8.5	0.2	0.3	3.9	3.6	10.7	4.1	0.2	4.9	7.6	9.2	0.1	12.8	10.7	2.6	0.5	15.8	3.6	3.7	15.8	11.6	17.7	15.2	12.4	19.2	19.2	0.9	27.3	16.8	0.2	17.1	3.3	5.0	0.6	3.5	5.4	4.7	0.2	0.0	1.7	24.5	9.9	1.0	0.4	23.3	8.1	0.2	10.8	12.2	14.3	2.6	105.3	3.5	3.9	3.5	6.0	26.9	8.4	24.8	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3	0.0	11.7	18.8	1.9	15.1	53.9	9.2	12.7	5.3	3.4	7.0	0.0	2.2	14.9	8.1	2.8	56.2	3.5	0.0	0.9	2.1	36.8	1.4	51.8	59.3	2.8	44.5	12.7	71.8	42.5	0.9	24.5	33.6	35.4	3.6	2.4	88.8	6.3	0.0	6.7	145.7	7.8	12.9	23.1	2.6	4.3	11.7	43.5	208.1	1.2	0.9
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.0;heart muscle: 52.0;parathyroid gland: 13.5"	"Cell type enhanced"	"Detected in some"	27	"Cardiomyocytes: 15.7;Distal tubular cells: 26.6;Horizontal cells: 84.2"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.2;naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.8;REH: 24.7;SH-SY5Y: 14.6;THP-1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.3	2.9	12.8	1.7	20.1	1.2	2.0	20.6	48.0	3.4	1.7	3.0	0.1	1.7	6.9	2.8	5.2	2.8	1.3	52.0	14.8	8.5	2.5	0.7	1.0	1.2	10.0	16.2	1.8	6.1	13.5	8.2	1.0	19.1	3.1	1.6	2.4	6.0	2.3	1.4	1.6	1.8	6.8	2.9	2.2	2.6	4.2	1.3	0.0	1.0	1.8	1.3	1.6	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.6	12.5	0.4	1.7	0.0	4.2	1.4	0.2	0.0	0.7	0.2	0.0	0.5	11.1	6.4	0.0	5.2	0.0	0.0	0.0	8.1	0.3	0.4	0.4	0.5	0.0	22.8	0.7	2.6	0.0	0.1	2.4	0.0	0.1	7.4	3.7	1.4	1.8	0.1	0.2	7.9	0.0	1.7	24.7	0.0	5.9	0.0	0.0	1.6	14.6	0.1	0.5	7.9	0.6	0.6	17.2	0.0	2.8	3.5	0.1	1.3	8.7	6.0	4.5	6.2	0.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	20.1	20.6	48.0	14.8	8.5	10.0	16.2	19.1	1.3	0.0	0.0	0.0	0.5	1.0	2.0	15.7	0.0	0.0	0.0	1.8	0.0	0.0	26.6	1.3	0.3	0.0	0.0	0.0	1.6	0.2	0.7	0.8	0.0	0.0	4.6	84.2	0.0	0.0	0.0	0.5	1.1	0.3	3.3	0.0	0.0	4.3	1.8	0.0	0.0	0.0	4.3	0.0	1.9	0.5	0.2	0.4	0.2	0.0	0.0	0.1
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25617468-25786207	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 51.1;Ito cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.3"	"Cell line enhanced"	"Detected in many"		"AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1200000	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	4.6	4.5	4.2	3.0	3.8	0.0	2.2	9.9	8.8	8.6	3.6			1.2	6.6	2.5	2.4	3.9	7.3	3.4	5.2	3.2	10.3	12.1	3.2	4.0	4.2		7.1	0.7	4.4	7.8	8.3		7.2	1.2		1.8	7.5	0.9	2.7	1.9	8.0	6.0	7.0	3.1	1.0			10.7		3.2	4.3	4.0	1.0	0.6	1.1	1.6	0.8	8.3	1.1	0.0	0.1	12.7	2.7	9.5	7.4	3.7	0.1	2.4	0.6	0.2	0.2	0.0	0.1	0.1	0.9	1.7	0.1	1.2	0.1	0.2	4.0	0.5	0.2	0.2	0.0	1.1	2.1	5.3	47.0	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	2.3	3.3	0.0	0.1	0.2	7.8	0.2	0.1	0.2	7.5	0.2	0.3	2.0	0.6	2.4	1.0	1.5	0.0	0.0	0.7	8.6	0.3	14.0	0.0	0.0	1.9	4.5	0.6	0.4	1.6	0.7	0.6	1.0	0.8	0.4	3.6	1.6	0.6	1.0	8.3	4.8	1.1	0.8	1.3	0.4	0.8	1.1											3.0	2.7	1.9	2.9	6.0	19.1	6.4	5.1	2.7	7.9	21.0	51.1	8.3	8.3	0.5	0.3	11.1	0.0	0.0	3.4	1.0	9.9	2.6	2.3	37.6	19.1	20.6	2.9	82.9	16.5	0.9	25.0	3.6	1.7	0.0	0.0	20.6	2.2	0.0	20.8	12.8	4.5	6.5	3.1	0.2	2.0	4.5	35.7	5.3	0.0	1.3
FAM193A	"C4orf8, RES4-22"	ENSG00000125386	"Family with sequence similarity 193 member A"	P78312	4	2536631-2732565	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043116	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043116: AB_10795767"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.84e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.96e-3)"	17.1	14.1	17.8	25.5	17.7	22.4	19.7	33.0	23.2	17.4	14.5	18.2	21.3	15.3	23.5	16.0	12.1	16.4	17.2	11.9	16.7	14.3	12.4	13.7	20.2	17.3	18.0	11.8	23.7	17.4	20.4	21.5	15.3	16.1	16.4	11.9	18.8	16.4	19.3	18.1	16.6	15.8	16.0	13.9	17.0	14.7	29.1	17.2	26.3	15.4	13.7	16.0	14.6	30.7	2.5	3.9	5.7	6.3	3.2	2.9	1.0	7.1	9.0	16.7	9.5	10.2	10.5	9.1	11.0	9.4	10.8	9.1	9.1	11.7	14.0	6.8	11.9	13.3	6.2	11.6	7.8	8.9	8.7	7.6	21.0	11.1	9.4	12.4	12.6	14.8	11.5	8.3	10.6	10.8	9.8	10.6	8.4	14.7	15.5	8.8	7.5	20.5	20.5	13.7	7.1	10.2	20.3	8.8	6.9	7.2	9.4	14.7	12.6	9.3	6.5	9.5	9.4	12.0	13.0	14.3	16.5	9.8	8.9	14.2	15.7	11.5	13.6	9.3	10.6	11.7	5.7	2.2	1.8	2.2	1.5	1.5	1.5	1.9	2.9	1.4	2.5	1.9	2.7	4.2	3.2	6.3	3.9	1.4	1.0	17.8	17.7	33.0	23.2	16.7	14.3	18.0	11.8	16.1	17.2	11.9	15.6	2.7	6.0	8.4	24.2	13.1	0.0	4.0	21.6	1.8	45.2	5.9	1.7	7.9	6.7	12.6	11.6	0.0	6.5	5.7	10.8	9.1	8.1	4.9	7.5	14.3	13.8	10.4	8.2	11.0	15.8	11.3	13.5	8.2	9.0	15.4	8.7	9.0	13.8	2.2	24.7	6.5	10.0	29.8	28.5	8.7	4.7	6.4	8.9	6.4
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808433	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 208.8;Late spermatids: 575.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (1.11e-2)"	"prognostic favorable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	27.4	24.3	24.8	24.7	28.5	23.3	33.5	22.6	28.9	22.2	21.2	21.9	26.4	17.8	24.2	17.8	16.7	18.6	23.4	18.6	25.5	18.7	18.4	19.1	31.6	29.0	21.8	25.7	22.8	16.6	10.6	16.9	42.5	16.9	20.9	15.3	16.5	19.4	25.7	15.5	13.4	16.8	28.1	15.0	42.4	18.0	74.1	18.0	14.4	29.7	17.2	22.7	19.6	25.1	25.1	16.3	68.2	21.5	15.1	30.2	26.5	16.6	45.3	21.0	20.4	27.4	20.1	13.7	18.2	15.3	26.1	28.7	37.4	16.9	14.9	15.5	21.8	23.7	10.8	26.5	20.8	14.0	18.6	15.0	19.8	26.4	14.1	29.5	15.2	27.0	24.6	22.2	24.9	14.3	16.5	32.0	16.4	28.0	14.0	27.4	11.9	28.0	25.2	18.2	26.4	15.8	26.2	10.4	10.1	28.1	25.7	19.4	17.7	29.8	23.6	24.1	18.8	31.1	41.5	29.6	32.7	23.7	13.4	21.4	7.0	10.2	26.2	23.9	22.2	24.2	20.9	19.1	46.8	24.1	21.5	25.3	23.2	28.5	24.9	16.3	25.1	30.2	25.2	68.2	15.1	19.9	11.9	25.6	26.5	24.8	28.5	22.6	28.9	25.5	18.7	21.8	25.7	16.9	18.0	20.8	12.6	13.6	49.3	43.4	36.7	18.6	28.1	2.7	14.8	3.5	13.7	50.5	0.0	14.1	208.8	56.4	58.0	23.3	8.8	21.0	50.6	59.3	17.3	25.1	58.5	20.6	43.0	62.6	37.2	575.5	58.4	26.7	38.8	20.8	28.8	16.5	12.3	49.1	49.1	1.1	12.9	38.8	30.7	124.4	56.4	33.5	110.9	40.2	33.0	59.3
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Approved	Nucleoplasm		No	No		450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: AB_2673989"	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.5	9.5	2.8	9.6	7.2	6.3	12.3	8.9	5.2	4.3	3.4	5.8	6.8	2.2	6.4	14.1	8.8	5.3	1.9	7.7	0.9	2.9	10.0	3.2	2.3	23.6	35.5	1.2	7.1	11.5	5.2	7.3	12.5	8.4	8.0	7.5	4.0	8.4	3.4	11.7	7.1	3.3	2.8	6.4	10.0	5.0	3.4	5.0	4.8	5.8	5.0	12.4	3.4	5.8	26.3	3.2	16.1	6.8	3.0	6.8	9.2	6.4	4.8	11.3	2.1	2.3	8.5	2.0	5.8	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6	6.0	11.3	5.2	11.2	8.7	28.3	10.0	7.6	4.0	3.4	22.7	23.6	4.8	6.6	7.0	2.9	9.2	17.1	0.0	12.8	2.8	17.9	13.2	1.1	42.9	8.3	11.1	10.9	17.8	9.7	8.5	20.1	6.1	10.1	2.8	13.3	30.4	11.9	17.3	18.7	28.9	24.4	0.0	7.0	17.9	3.1	8.9	3.1	7.5	11.1	7.0
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.9	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	12.0	0.2	0.1	1.0	0.3	0.7	0.5	0.8	0.0	0.2	7.7	1.8	1.5	0.4	2.7	0.1	1.1	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.5	0.2	0.1	4.8	0.3	1.5	1.3	1.4	2.4	1.0	3.5	0.5	1.5	0.6	8.5	51.4	1.1	1.6	3.4	0.2	1.9	1.3	0.1	0.2	1.4	0.6	1.0	1.3	1.7	1.0	0.1	0.8	1.7	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0	0.0	0.0	0.5	0.6	1.9	21.6	6.1	2.5	0.0	0.0	1.8	31.4	0.1	6.6	1.4	23.4	0.8	0.6	0.0	0.7	0.1	1.7	1.4	0.0	1.3	0.3	73.1	7.5	0.0	0.0	11.0	1.1	0.3	6.8	0.0	4.1	10.0	0.8	0.0	0.4	0.6	48.4	0.0	1.4	0.7	2.6	1.6	0.7	0.0	0.8	0.2
INTS1	"DKFZp586J0619, INT1, KIAA1440, NET28"	ENSG00000164880	"Integrator complex subunit 1"	Q8N201	7	1470277-1504367	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021658, HPA053009"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021658: AB_1852402, HPA053009: AB_2682016"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (7.72e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (4.30e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.81e-3)"	15.4	14.6	17.8	16.1	17.2	28.5	15.2	26.5	28.1	12.2	14.5	19.2	10.1	19.0	15.0	11.0	15.8	13.3	14.4	13.0	13.5	11.0	13.8	13.8	12.0	18.2	13.5	10.1	18.2	23.0	11.6	15.8	12.6	15.2	14.7	6.0	15.6	25.6	14.5	43.3	20.4	17.6	15.1	10.0	19.3	17.9	27.3	14.0	18.0	15.9	10.8	14.9	13.7	14.8	6.0	3.7	4.4	2.7	3.1	4.8	2.1	20.6	18.0	7.0	18.2	5.2	4.0	24.5	8.8	4.9	6.8	6.0	19.8	16.1	11.1	9.3	6.3	13.7	21.4	3.9	10.4	1.9	5.4	21.7	7.9	25.6	13.0	6.0	13.7	11.9	5.4	4.9	7.0	5.0	4.1	7.4	15.9	22.0	8.9	4.1	25.0	7.7	37.6	38.5	7.6	16.2	19.6	8.0	11.3	3.2	15.7	13.3	32.8	12.6	23.2	8.0	4.2	18.4	13.8	13.6	11.2	32.2	9.3	14.3	18.7	9.8	10.8	12.6	11.9	22.9	4.4	2.7	2.9	4.8	2.1	3.0	2.7	3.5	3.8	3.7	6.0	2.2	2.8	2.2	3.1	1.8	2.1	4.2	2.1	17.8	17.2	26.5	28.1	13.5	11.0	13.5	10.1	15.2	14.0	11.9	29.1	6.0	4.2	5.3	30.1	38.9	20.4	4.0	9.1	10.4	23.6	10.7	0.0	14.5	18.4	11.3	33.3	0.0	19.9	8.3	10.3	8.7	1.1	21.2	12.9	46.1	17.3	16.5	23.4	32.2	12.4	11.6	5.0	8.2	18.2	15.8	17.3	15.6	14.5	12.9	36.0	25.8	8.2	19.4	11.0	6.9	12.7	10.1	20.1	5.4
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Cell type enriched"	"Detected in some"	123	"Intestinal endocrine cells: 716.0"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 19.1;SH-SY5Y: 24.5"	"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	35	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	716.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	5.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.1
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 25.3"					"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.86e-4)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.8	3.2	2.0	9.1	9.4	3.8	1.5	1.9	4.7	2.4	3.2	1.7	4.6	3.7	5.3	5.0	6.8	4.4	2.5	2.1	3.7	8.3	4.2	4.0	5.0	4.4	3.5	8.7	8.2	2.9	4.4	2.7	4.2	3.5	3.0	4.6	4.4	7.8	3.3	2.5	5.1	5.0	4.4	4.7	4.2	3.2	2.8	5.8	5.1	4.7	7.4	25.3	4.0	8.1	3.0	3.8	4.0	2.6	2.6	1.6	5.1	3.4	5.5	11.2	8.4	1.8	4.8	11.4	8.9	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1	0.0	6.2	8.8	8.1	5.6	8.3	21.8	5.1	2.7	6.8	15.7	2.0	9.7	46.4	15.9	5.0	11.9	8.4	0.0	24.7	17.3	10.8	9.8	4.6	22.2	24.7	11.1	18.0	9.2	7.3	8.0	11.2	12.9	15.1	24.4	7.1	9.1	14.6	5.8	20.5	38.0	10.4	6.5	12.0	15.1	8.3	9.8	6.4	6.9	7.9	9.3
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608475-37633564	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.8"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 173.5;Spermatocytes: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	10.7	15.8	13.5	12.2	14.0	17.3	10.8	21.8	18.4	11.6	10.6	19.3	14.5	13.1	12.9	14.1	13.3	13.8	11.8	10.2	12.5	10.6	12.0	14.1	10.9	14.0	17.7	13.2	18.1	13.9	20.6	19.4	12.5	13.5	12.0	9.6	17.7	16.7	16.7	17.1	17.1	12.0	9.3	14.2	15.8	12.8	83.8	16.6	12.1	15.4	9.9	14.2	10.6	11.0	6.4	5.0	4.9	7.7	7.6	18.0	7.6	18.4	12.9	16.2	15.7	14.2	11.7	17.8	15.2	12.3	13.5	15.0	11.5	10.5	28.3	10.4	10.9	8.3	17.2	14.3	17.0	12.4	24.2	23.8	11.2	23.2	12.3	13.9	27.5	21.9	14.2	15.2	19.1	12.1	22.1	12.6	14.4	22.6	18.4	13.8	17.6	12.2	29.5	12.7	18.6	13.3	13.6	13.0	12.1	13.9	15.0	14.9	26.5	9.7	20.4	23.6	16.1	21.3	20.0	15.1	18.4	18.0	16.5	12.1	39.7	15.9	29.3	20.6	16.7	16.1	4.9	7.7	4.3	14.0	7.6	17.3	6.4	5.6	18.0	5.0	4.1	4.2	13.0	3.3	7.6	5.5	4.3	5.8	7.6	13.5	14.0	21.8	18.4	12.5	10.6	17.7	13.2	13.5	16.6	23.8	36.3	43.5	27.8	21.5	53.9	15.9	15.3	34.8	22.7	41.8	78.5	30.7	5.0	30.2	118.6	26.2	53.9	0.0	17.7	31.6	17.1	20.5	48.5	18.1	69.1	23.8	31.2	32.5	44.8	173.5	24.5	44.5	15.1	46.9	35.7	41.0	27.7	42.1	21.2	10.3	73.2	25.8	21.2	198.9	40.2	25.0	47.5	91.4	34.6	30.1
NCKAP5L	KIAA1602	ENSG00000167566	"NCK associated protein 5 like"	Q9HCH0	12	49791146-49828750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 106.0;Leydig cells: 63.3;Peritubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041034	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA041034: AB_10796235"	"unprognostic (3.35e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.87e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.15e-1)"	15.8	21.5	8.2	13.1	13.4	6.3	8.8	12.7	15.3	11.1	8.8	26.2	4.0	6.6	10.5	10.8	8.0	10.1	11.7	16.3	10.1	9.0	10.1	8.2	13.4	8.6	19.7	6.0	13.0	10.9	11.2	11.6	18.8	14.4	11.8	2.9	16.0	11.3	11.0	14.8	6.7	5.7	10.4	11.1	12.7	6.7	12.3	17.1	16.2	11.4	10.0	6.5	9.7	8.1	0.6	2.3	1.0	2.6	0.8	0.7	1.0	3.4	5.8	10.3	10.2	6.6	5.0	13.8	5.8	6.3	8.5	7.1	8.0	1.0	2.0	10.1	5.9	3.3	1.1	4.2	6.1	2.3	2.1	5.9	7.5	6.9	7.7	16.7	2.9	16.4	11.6	7.2	9.2	4.3	10.8	10.0	7.7	7.2	0.0	5.4	8.2	7.5	10.5	12.4	1.1	6.6	9.3	10.7	0.6	6.6	4.7	3.6	16.3	8.9	9.7	16.2	5.9	16.9	6.1	7.8	8.1	8.6	4.1	2.7	0.2	0.0	2.6	6.5	3.4	2.3	0.2	2.6	0.0	0.5	1.9	0.6	0.2	0.2	0.6	2.1	0.6	0.4	0.7	1.0	0.8	1.8	2.3	0.1	1.0	8.2	13.4	12.7	15.3	10.1	9.0	19.7	6.0	14.4	17.1	6.0	1.4	2.2	7.6	11.3	44.8	2.5	5.1	5.3	6.8	10.4	106.0	9.2	0.0	5.2	1.0	9.8	0.5	0.0	3.3	10.9	19.9	4.5	0.0	4.9	14.2	28.6	8.6	9.8	10.4	1.7	63.3	14.0	5.0	3.6	1.1	8.0	2.8	0.0	77.8	1.7	23.5	0.0	14.2	2.6	4.9	6.4	2.1	5.0	0.8	3.1
MRPL34	"L34mt, MGC24974, MGC2633"	ENSG00000130312	"Mitochondrial ribosomal protein L34"	Q9BQ48	19	17292609-17306843	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 341.5;Proximal tubular cells: 347.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049276	Uncertain					NA	NA					"HPA049276: AB_2680697"	"unprognostic (1.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-2)"	22.2	36.9	23.5	15.7	28.2	13.5	35.1	18.6	26.2	13.1	36.7	14.0	21.7	43.5	17.1	18.6	22.8	12.2	22.3	62.1	20.6	21.7	44.6	80.3	14.0	17.3	20.5	14.4	12.8	30.5	22.2	21.4	12.7	16.3	18.9	18.9	25.8	34.4	23.9	109.3	17.5	39.5	23.9	16.7	18.5	27.1	40.4	13.5	19.4	28.3	36.3	19.5	19.4	22.8	54.8	63.7	41.9	49.1	33.6	60.1	69.7	21.5	11.4	8.1	10.4	20.7	10.9	26.8	10.2	10.4	8.2	10.2	10.9	14.6	24.1	30.8	5.5	11.3	17.6	13.0	11.9	6.0	38.4	34.6	17.1	19.9	24.4	16.8	19.3	24.5	13.3	16.1	8.7	12.1	9.0	12.9	19.8	24.7	31.2	7.9	18.6	25.8	34.2	22.7	32.9	53.9	22.8	10.4	32.4	24.1	15.2	17.8	28.0	9.4	15.4	21.7	9.0	13.0	16.1	9.9	11.4	7.8	35.5	19.3	45.5	74.8	27.6	14.8	36.1	11.0	38.2	47.5	41.9	50.3	49.1	54.9	54.8	60.1	50.7	50.2	53.6	59.0	50.4	14.7	33.6	28.5	63.7	55.8	69.7	23.5	28.2	18.6	26.2	20.6	21.7	20.5	14.4	16.3	13.5	32.8	30.0	50.0	32.5	53.9	48.8	132.7	109.5	28.1	29.6	78.5	19.6	93.2	341.5	87.0	44.4	50.4	149.4	46.7	60.0	96.5	59.9	30.5	38.1	245.2	150.6	39.7	65.5	40.5	59.6	25.8	75.9	65.1	77.6	100.0	86.9	23.7	60.4	87.5	86.3	347.4	35.8	71.1	61.8	123.9	15.1	63.0	65.4	66.0	101.3	26.5
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7042939	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 52.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 53.5;Early spermatids: 56.9;Late spermatids: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047546	Enhanced					NA	NA					"HPA047546: AB_2680082"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	1.4	1.7	0.5	3.9	1.1	1.2	1.1	2.6	0.8	0.6	2.4	0.6	0.9	0.9	3.3	0.8	10.5	1.0	0.5	2.4	2.7	1.2	0.5	1.7	0.7	1.5	2.4	3.0	1.3	1.1	3.0	0.5	4.0	0.9	0.6	0.8	0.9	1.2	0.6	1.6	0.6	0.7	1.2	0.8	1.0	52.9	1.5	0.0	1.5	0.5	0.6	0.6	1.0	0.6	1.6	0.5	3.8	0.4	1.6	0.6	1.6	4.6	2.4	2.0	3.2	2.2	0.5	4.6	2.8	5.2	3.1	1.6	4.1	1.0	1.3	2.6	6.9	2.1	0.9	2.1	1.6	0.1	0.7	1.0	2.1	1.1	1.6	1.3	2.6	2.0	2.2	3.1	0.4	0.6	2.1	3.2	0.7	0.4	3.3	3.9	2.7	1.6	1.0	1.5	2.8	1.1	1.6	0.3	9.1	1.6	6.7	1.5	3.7	1.7	0.8	2.4	1.7	2.4	2.3	4.3	1.2	2.7	3.5	0.0	0.1	0.9	3.4	0.1	1.4	0.0	1.6	0.0	0.3	3.8	0.7	0.6	0.4	0.0	1.6	0.0	0.3	1.6	0.5	0.4	2.9	0.0	0.0	0.6	1.7	3.9	1.1	2.6	2.4	2.7	1.5	2.4	4.0	1.5	0.0	3.7	0.0	0.7	0.6	2.5	0.8	0.0	53.5	10.3	3.5	11.8	0.6	1.7	2.0	56.9	1.4	0.5	0.0	1.0	0.5	0.7	1.1	0.0	0.8	1.1	0.0	5.2	2.5	1.8	64.6	2.8	2.6	1.7	1.8	1.1	6.7	1.4	2.9	3.9	4.3	18.2	0.0	0.4	13.7	4.0	0.9	0.5	0.0	0.8	0.7
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 147.7;Late spermatids: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		6600	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.53e-5)"	52.2	22.6	25.0	16.8	23.2	3.3	56.5	31.4	27.0	49.3	28.9	21.9	19.2	19.6	40.6	32.0	27.5	33.8	42.8	32.8	27.3	12.8	28.1	41.8	38.9	28.7	21.3	18.0	49.0	21.7	27.0	24.1	43.3	22.8	38.0	23.7	45.8	36.6	34.5	29.5	32.0	34.5	41.9	24.1	28.6	20.4	36.0	21.2	3.4	29.7	36.2	15.7	38.4	44.7	0.8	5.6	0.4	3.2	4.0	17.4	3.3	22.6	28.6	15.6	17.6	25.4	33.9	16.0	23.3	36.2	27.3	17.0	28.9	10.2	0.2	15.9	36.3	11.0	19.5	23.4	21.3	14.2	15.9	10.2	1.9	16.1	13.2	28.9	0.2	0.1	21.3	15.9	9.5	14.0	30.5	21.1	12.1	4.9	0.7	19.4	8.9	1.9	0.7	5.5	3.9	12.0	21.7	10.6	2.1	12.4	4.4	0.9	14.1	11.4	2.8	14.4	17.1	4.7	8.1	32.8	24.3	17.4	17.7	16.4	0.4	0.6	3.0	14.2	5.4	16.4	0.0	1.6	0.4	8.6	3.2	17.4	0.6	9.4	9.9	5.6	0.8	9.7	5.6	0.4	4.0	0.7	1.9	0.4	3.3	25.0	23.2	31.4	27.0	27.3	12.8	21.3	18.0	22.8	21.2	17.9	4.5	3.0	20.1	26.0	2.0	8.0	25.5	9.4	11.4	12.2	0.0	21.8	8.3	18.5	147.7	38.9	46.6	0.0	16.9	25.1	46.3	33.6	17.3	37.5	30.7	4.8	14.0	75.5	27.9	378.2	56.7	18.7	23.6	1.8	35.7	20.2	20.5	48.2	55.2	20.3	3.1	58.2	68.3	5.5	6.1	18.6	17.2	14.1	25.3	21.6
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397892	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	15.0	11.9	19.8	17.7	20.2	12.6	21.1	11.1	20.9	12.3	20.8	9.5	16.7	11.9	14.2	19.1	15.0	11.4	15.7	28.2	18.6	19.7	17.3	21.3	11.8	27.3	17.7	14.4	14.6	18.6	12.1	16.4	13.2	17.0	16.2	11.0	13.8	16.9	19.5	82.0	10.1	13.0	17.8	12.5	21.1	14.5	12.1	10.3	10.3	18.9	22.0	26.8	19.1	25.0	73.8	45.9	66.7	50.5	19.1	31.0	49.9	18.9	29.0	10.9	29.2	25.8	25.3	11.3	17.1	25.1	27.5	21.1	12.9	18.2	44.9	23.7	23.1	20.4	10.5	18.5	22.2	18.3	30.4	22.1	22.5	17.2	30.3	31.4	16.9	33.1	21.2	19.8	24.7	17.6	15.0	28.1	25.8	20.7	22.0	19.3	33.7	18.8	19.3	28.1	23.6	30.1	14.3	10.5	30.3	26.5	11.6	14.0	10.5	13.9	17.8	41.5	18.4	9.2	14.6	18.6	12.6	17.4	32.7	26.6	29.1	39.1	35.1	25.2	26.0	28.3	35.7	50.5	61.4	25.6	48.7	27.8	70.6	25.5	26.5	36.0	73.8	23.1	25.0	66.7	19.1	44.9	45.9	31.0	49.9	19.8	20.2	11.1	20.9	18.6	19.7	17.7	14.4	17.0	10.3	11.9	15.6	88.7	31.6	28.6	15.4	45.2	15.3	5.3	11.4	43.6	5.9	48.1	119.3	34.9	7.6	35.4	23.8	46.7	41.3	51.7	42.8	37.2	40.4	54.6	93.0	17.5	27.1	30.1	72.9	16.5	35.9	85.7	49.0	44.1	20.4	20.9	37.9	34.5	44.2	91.1	12.7	12.9	49.5	8.4	23.0	35.0	33.4	57.3	25.4	24.3
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913657-75941051	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 89.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 97.1;Kupffer cells: 106.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 89.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 89.9"	"Cell line enhanced"	"Detected in many"		"U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA					"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	11.2	6.7	5.8	12.3	10.3	6.5	16.9	10.2	10.5	10.8	26.4	6.0	6.0	13.1	9.8	7.1	12.5	8.4	6.8	9.5	7.0	8.2	18.2	29.6	10.0	52.2	11.8	5.3	6.1	6.9	5.5	9.0	8.2	9.1	32.4	31.2	16.6	19.8	5.1	6.2	11.2	34.0	10.2	11.2	44.9	9.8	3.4	6.9	10.2	11.2	8.0	19.5	10.3	12.6	8.1	19.7	14.3	89.9	4.5	15.1	25.9	4.4	10.1	0.4	0.3	24.6	25.0	0.4	6.6	4.4	4.6	1.5	3.4	15.7	0.4	3.5	16.3	0.1	8.8	13.2	5.1	2.8	6.3	0.5	3.1	7.5	8.3	5.7	11.5	11.5	6.3	3.9	4.0	1.4	7.1	7.3	7.1	3.4	13.8	4.0	16.2	7.3	7.5	5.1	19.8	4.0	5.0	0.1	20.5	4.8	2.5	6.1	0.9	6.8	21.6	1.9	0.7	24.3	20.1	10.8	0.2	0.6	30.4	0.3	3.4	1.3	2.2	5.8	16.6	2.8	5.5	37.2	14.3	9.0	89.9	9.7	8.1	11.5	8.9	19.7	5.3	9.7	8.1	12.5	4.5	74.4	7.3	15.1	25.9	5.8	10.3	10.2	10.5	7.0	8.2	11.8	5.3	9.1	6.9	0.0	8.2	28.2	16.1	10.1	9.6	3.9	28.1	24.1	6.8	5.2	17.7	21.0	11.6	4.6	0.4	11.7	97.1	0.0	7.4	16.3	27.2	69.0	14.0	30.2	35.4	11.1	46.1	17.8	106.0	0.0	9.8	77.1	16.9	16.2	28.2	6.5	3.9	28.5	7.1	9.2	78.9	0.0	18.4	0.7	0.9	16.6	11.1	36.2	21.4	12.1
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA011397: AB_1858854"	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.1	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.3	10.2	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.4	0.2	0.4	0.0	0.0	0.0	1.9	12.5	0.0	0.1	10.6	0.7	0.8	4.2	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8	3.0	7.5	0.0	3.4	14.8	0.0	0.6	0.0	2.7	6.8	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.9	3.8	0.0	0.4	0.1	0.0	28.3	1.3	0.0	0.0	0.0	0.0	5.0	0.0	10.2	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.2	0.0	0.5	2.6
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	4.2	7.9	4.9	6.0	0.1	22.1	12.7	7.0	7.7	0.3	0.0	0.0	0.3	8.3	0.2	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.4	0.5	0.0	6.5	0.2	3.4	1.9	15.7	7.4	0.7	2.0	0.0	3.3	0.0	0.0	0.2	15.7	0.0	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.4	2.1	0.1	0.1	12.9	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	3.8	0.0	28.3	9.0	2.5	2.7	3.4	5.2	94.2	0.3	1.7	1.6	0.7	2.3	0.0	0.0	2.3	0.4	7.4	4.6	0.0	0.0	1.2	41.3	1.2	3.7	0.0	1.3	46.1	0.0	0.0	1.8	2.5	4.8	1.9	0.0	36.0	0.3	26.9	6.5	9.2	0.7	0.9	0.0	0.8	0.0	0.4	1.4
SPG7	"CAR, CMAR, SPG5C"	ENSG00000197912	"SPG7, paraplegin matrix AAA peptidase subunit"	Q9UQ90	16	89490719-89557768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.22e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.56e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.25e-4)"	14.6	23.6	15.6	11.7	19.9	14.5	17.5	25.2	33.2	14.2	14.9	19.1	19.5	18.0	18.3	16.1	14.2	13.9	15.9	34.3	15.6	15.6	22.3	24.5	14.1	16.2	13.9	23.7	21.6	22.1	17.9	21.0	10.2	19.3	15.9	14.0	16.5	17.4	18.1	75.6	27.9	17.7	17.8	16.9	17.8	16.5	24.1	12.9	13.3	28.4	18.4	16.1	16.6	13.4	6.6	5.0	7.9	4.9	7.2	6.4	2.0	5.5	15.2	7.9	14.1	15.1	9.3	6.2	14.9	10.4	8.7	5.2	12.0	11.6	8.7	16.0	9.2	8.4	14.9	10.7	11.1	9.5	5.0	13.4	4.2	7.6	21.8	6.6	3.5	5.7	5.2	7.7	5.4	6.3	12.5	12.1	10.3	9.5	3.7	8.2	10.9	7.6	12.8	14.0	13.1	11.0	14.1	13.9	5.3	8.4	8.5	8.5	5.6	21.8	3.8	4.5	9.0	12.4	9.1	18.9	6.9	9.6	4.8	6.9	6.2	9.8	7.6	8.9	10.1	8.2	7.9	4.9	7.4	5.6	4.7	5.4	3.3	3.5	2.8	5.0	6.6	6.4	4.3	7.2	7.2	3.3	4.9	3.6	2.0	15.6	19.9	25.2	33.2	15.6	15.6	13.9	23.7	19.3	12.9	44.7	49.6	31.3	24.6	14.2	52.0	39.7	25.5	26.8	43.3	33.2	90.3	32.7	16.6	35.1	57.2	38.6	49.1	23.3	22.6	24.1	28.8	23.0	19.8	33.4	28.0	38.1	35.7	52.2	37.1	16.2	39.7	32.7	20.3	39.7	41.2	36.4	31.8	45.6	31.5	18.3	70.5	6.5	29.3	44.2	37.0	15.7	21.6	38.3	44.4	23.8
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961538-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 122.1;Late spermatids: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	7.4	7.4	13.1	8.7	13.1	9.8	7.0	36.2	19.3	10.3	6.0	6.2	10.2	10.6	8.0	4.6	8.0	8.5	6.3	7.0	11.7	5.9	7.9	8.6	7.0	7.2	8.6	9.5	10.2	12.5	11.9	18.9	8.0	9.5	8.5	3.1	9.8	12.7	12.4	11.0	7.0	9.2	4.4	6.8	12.0	11.2	21.0	10.8	11.6	10.9	3.4	9.3	6.8	13.6	3.9	3.5	10.8	3.5	3.4	2.0	1.1	6.2	6.3	3.4	4.1	2.1	2.6	10.3	3.5	2.3	4.0	3.5	6.5	6.3	3.5	7.0	1.8	3.5	8.2	2.5	2.5	1.4	3.5	14.1	4.0	7.1	5.8	3.9	4.1	8.6	1.9	2.7	3.6	2.1	3.6	3.2	3.1	10.2	4.0	2.1	9.5	7.4	8.9	7.7	3.4	9.7	6.5	3.5	5.0	4.0	3.4	14.2	7.5	6.0	5.3	4.8	1.9	5.6	4.3	3.7	7.1	5.8	7.7	5.9	9.4	4.2	2.4	5.6	4.0	6.2	0.7	3.5	1.6	1.4	1.1	1.3	2.9	1.6	1.5	1.7	3.9	1.7	2.0	10.8	3.4	2.0	3.5	1.0	1.1	13.1	13.1	36.2	19.3	11.7	5.9	8.6	9.5	9.5	10.8	14.9	9.9	15.9	8.0	4.9	27.9	7.7	5.1	1.4	12.5	21.0	33.4	8.2	8.3	8.7	122.1	9.8	14.9	0.0	8.4	10.4	9.6	6.2	11.5	14.4	9.2	22.3	16.0	13.5	17.5	79.7	23.9	8.5	1.7	3.6	14.5	13.8	9.3	12.5	26.2	6.7	47.6	12.9	6.1	31.2	17.5	6.6	15.9	15.3	12.7	5.6
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	28.1	14.8	0.0	8.0	20.0	2.4	1.5	7.5	0.0	0.0	0.0	10.7	0.3	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	4.7	0.0	0.0	20.5	0.0	6.7	0.0	2.9	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.8	5.1	0.0	3.7	5.8	4.7	2.2	0.0	0.0	10.1	0.7	11.3	1.0	0.3	0.0	0.1	14.8	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9	0.0	0.0	0.0	9.3	2.2	9.5	61.9	0.0	0.0	0.0	5.2	5.9	0.6	1.7	0.0	0.4	1.3	0.0	0.0	0.4	0.2	24.4	12.7	0.0	0.0	0.7	0.0	20.3	0.0	0.0	0.4	21.6	0.9	15.1	0.0	7.0	20.0	0.4	0.0	26.5	6.3	1.5	0.0	15.5	0.2	4.1	1.6	0.7	0.0	2.3	4.3
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222872271-223005995	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 12.7;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	8.3	7.7	2.7	3.8	8.5	0.1	3.9	2.5	2.9	3.8	10.3	4.2	6.7	3.3	5.9	11.5	6.9	3.1	24.0	4.9	3.3	3.1	7.9	8.1	33.3	1.5	2.6	2.1	6.5	3.2	6.9	3.9	6.9	6.6	14.2	2.9	9.2	2.5	4.0	4.7	4.2	4.8	18.8	2.1	4.9	6.9	28.1	2.7	0.7	7.5	5.1	2.5	12.3	3.3	3.1	1.4	0.1	1.2	2.5	4.4	1.1	0.6	2.2	5.8	3.8	11.5	7.9	2.6	3.9	2.7	1.6	2.3	2.6	1.8	0.3	4.3	1.7	2.7	0.5	1.7	1.0	1.8	7.2	2.8	1.0	8.4	1.2	5.2	0.8	0.9	5.3	3.4	2.7	1.4	7.0	2.4	1.4	0.1	0.1	3.8	1.3	1.1	1.1	3.5	7.3	1.3	1.8	15.9	0.2	8.7	1.0	1.5	2.6	1.7	0.9	2.1	3.0	3.4	1.9	2.2	2.3	1.6	4.1	4.2	1.1	0.6	0.4	3.7	0.7	5.3	0.0	0.7	0.1	2.6	1.2	4.4	3.1	1.5	2.9	1.4	2.4	2.0	1.3	0.0	2.5	0.9	0.7	0.7	1.1	2.7	8.5	2.5	2.9	3.3	3.1	2.6	2.1	6.6	2.7	6.0	1.7	0.9	0.5	0.5	2.8	3.3	12.7	4.0	4.5	10.4	0.0	1.2	0.0	1.6	1.7	1.4	1.7	0.0	2.3	1.5	4.9	0.5	0.0	3.4	4.8	0.0	0.0	8.0	1.0	3.1	1.4	3.5	0.0	1.0	1.7	1.2	1.3	1.7	3.2	4.6	2.0	0.0	1.4	1.9	1.5	1.0	0.7	1.3	1.1	0.1
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 211.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	23.0	8.1	9.5	24.0	11.2	5.8	19.4	10.5	4.9	12.1	10.6	9.9	6.2	10.0	4.8	4.4	12.2	12.2	3.1	8.4	4.9	6.6	24.6	9.4	23.2	19.9	17.0	11.1	13.1	12.5	5.2	10.2	7.4	6.6	11.0	11.0	12.4	15.0	8.1	10.0	10.3	15.6	16.1	12.7	17.3	7.1	9.1	19.7	6.7	10.1	10.3	13.0	20.5	6.8	19.8	5.6	7.0	9.4	9.7	6.7	22.0	31.6	21.3	17.5	19.0	21.9	36.8	20.9	9.2	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6	44.7	44.8	30.4	29.5	24.2	16.1	211.3	61.1	62.9	77.3	50.6	11.8	35.0	180.8	36.8	15.8	36.5	60.3	0.0	74.3	16.7	27.7	17.7	56.7	143.5	98.6	3.2	76.2	60.8	84.6	8.0	60.1	52.8	35.4	17.2	57.4	43.6	50.1	28.1	95.1	134.6	12.7	45.3	51.1	7.7	15.8	30.2	23.1	25.9	67.6	18.2
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857678-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 73.1;U-698: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA					"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	13.5	11.0	15.2	23.3	19.9	15.1	16.0	12.0	16.8	12.3	11.9	12.6	10.2	18.0	13.4	20.3	7.6	12.7	22.3	9.6	14.9	8.8	16.9	12.2	17.9	25.1	12.5	13.1	20.7	14.3	10.2	17.3	9.4	18.8	14.7	14.4	25.2	14.8	7.1	8.2	16.0	19.7	9.8	10.2	24.0	14.8	8.7	12.6	19.2	14.6	6.5	23.5	15.9	10.3	7.9	7.3	11.0	7.5	2.7	6.8	1.8	4.5	6.0	5.6	9.0	5.2	3.7	5.8	8.5	3.1	5.9	5.8	4.4	12.6	18.6	4.7	3.5	6.1	4.2	4.1	11.1	5.8	4.4	7.1	5.4	9.1	3.9	4.1	9.9	4.7	4.3	5.0	6.8	3.2	6.0	5.8	6.5	4.7	3.7	11.0	4.9	7.7	9.7	6.1	8.3	8.2	73.1	10.7	4.2	4.1	9.9	11.3	3.9	6.8	4.8	2.5	3.9	2.5	7.2	6.3	7.9	4.2	5.2	6.8	8.9	8.4	34.1	7.9	9.7	11.1	11.0	2.5	1.7	6.0	2.0	3.8	6.0	6.5	5.0	1.7	7.9	6.8	5.9	4.0	2.7	7.5	7.3	3.3	1.8	15.2	19.9	12.0	16.8	14.9	8.8	12.5	13.1	18.8	12.6	11.9	24.0	31.8	12.6	14.5	33.9	8.1	28.1	100.4	19.4	31.4	76.6	9.6	11.6	8.4	8.0	32.1	14.4	0.0	17.7	7.3	8.6	10.8	35.8	9.6	6.8	28.6	43.9	33.7	17.0	5.0	14.1	22.7	8.5	7.2	25.9	22.7	10.0	10.1	6.7	3.3	56.8	19.4	7.8	15.6	24.2	13.6	4.1	34.6	11.5	10.5
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Nucleoli,Mitotic chromosome,Mitochondria"		NA	NA			Mitochondria	"Nucleoli, Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	5.7	19.7	9.5	15.6	16.3	13.3	3.4	10.2	9.9	13.1	11.1	19.5	7.4	15.7	22.6	7.1	13.0	5.5	10.7	14.2	11.3	17.3	19.5	21.1	8.8	18.9	11.4	12.7	14.9	9.7	15.7	8.7	16.9	10.9	12.7	38.8	16.3	15.0	10.9	13.5	21.2	9.3	3.8	24.6	21.3	8.7	10.9	14.2	15.8	8.8	5.2	17.8	2.6	12.2	13.1	12.6	18.4	13.0	8.9	13.7	14.6	10.4	11.9	23.5	16.4	6.1	10.3	18.2	9.5	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1	3.0	12.5	11.2	4.6	9.0	12.3	23.6	12.7	1.4	6.8	15.7	2.0	15.8	19.9	10.9	7.3	13.7	8.7	0.0	25.4	9.6	10.3	5.5	3.5	15.8	14.2	7.9	24.2	6.7	7.8	5.4	14.4	9.6	16.9	10.8	12.6	30.7	11.1	3.5	10.3	8.7	7.4	12.9	12.4	8.4	21.2	8.7	8.5	13.1	13.0	2.8
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826198	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 98.8"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 30.5;Horizontal cells: 17.5;Intestinal endocrine cells: 20.6;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	7.8	6.5	13.1	2.9	40.7	1.5	2.4	26.3	98.8	2.2	2.5	3.9	0.0	2.8	4.2	1.5	1.6	2.3	1.9	3.0	16.9	7.6	2.4	2.4	2.8	2.4	16.3	18.3	2.4	3.0	3.4	1.7	1.8	52.8	4.4	1.7	3.8	4.4	2.5	4.5	3.0	2.8	2.0	5.4	5.6	3.2	4.9	4.2	0.0	1.8	0.0	1.6	1.7	1.7	0.2	2.3	0.1	0.0	0.0	0.8	0.0	2.7	0.2	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	0.9	2.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.1	0.0	1.2	1.1	0.0	1.3	2.2	1.3	0.0	0.0	0.8	0.0	0.2	43.0	6.0	0.2	2.8	0.0	0.1	4.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	13.1	40.7	26.3	98.8	16.9	7.6	16.3	18.3	52.8	4.2	0.0	0.0	0.0	3.4	0.9	30.5	3.0	0.0	0.0	3.4	0.0	3.9	0.0	1.7	0.4	1.2	10.8	0.5	0.0	0.7	2.6	0.7	2.0	0.0	3.8	0.2	17.5	20.6	8.0	0.3	1.9	1.7	0.0	1.7	0.0	1.7	13.7	0.7	2.9	0.0	0.8	15.0	0.0	1.4	4.7	8.2	1.0	0.8	1.0	1.5	1.1
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047465-2089487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	13.9	11.9	16.9	12.4	20.0	10.9	13.2	35.1	26.9	20.5	17.0	19.4	17.9	14.0	20.1	12.2	13.0	18.6	15.0	14.0	13.3	8.8	11.8	9.8	12.7	10.1	13.8	14.7	21.1	16.1	20.0	18.1	10.6	14.6	13.8	10.8	16.7	22.9	19.6	31.7	14.5	13.2	13.5	11.4	12.9	16.6	21.4	12.9	14.1	20.1	11.3	10.9	18.0	14.0	4.7	5.6	7.7	4.9	3.6	7.0	3.7	7.2	11.6	16.1	18.2	19.2	16.2	13.6	17.4	11.9	13.1	11.2	13.9	13.8	10.9	15.5	14.3	6.1	12.0	9.6	12.6	9.8	8.3	15.8	10.3	22.5	5.7	13.2	12.8	12.5	19.1	8.0	10.6	7.9	15.8	12.3	7.9	10.0	9.8	11.6	14.4	15.2	3.7	16.7	5.4	11.4	24.2	17.6	13.9	5.3	6.5	12.2	23.1	24.8	16.4	8.8	16.7	15.0	9.5	19.4	13.8	9.4	12.3	8.8	21.9	21.8	21.8	5.7	5.2	16.3	6.2	4.9	5.4	7.0	4.7	6.7	4.4	4.4	4.1	5.6	4.7	3.1	4.8	7.7	3.6	3.7	1.5	3.2	3.7	16.9	20.0	35.1	26.9	13.3	8.8	13.8	14.7	14.6	12.9	23.8	17.6	14.9	7.2	8.1	44.2	38.9	20.4	9.4	10.3	19.2	88.4	10.1	3.3	12.8	11.0	19.5	25.8	0.0	12.2	6.5	14.6	9.4	8.1	29.2	9.8	42.9	31.2	34.4	10.5	22.4	26.2	16.6	8.5	7.2	23.8	24.1	15.9	17.5	24.4	6.7	69.1	12.9	11.8	19.4	39.6	8.5	7.8	20.0	24.7	9.2
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133421307	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037826, HPA037827"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.03e-5)"	14.5	29.4	16.5	20.2	19.0	14.8	17.9	23.9	19.2	16.1	19.7	23.0	16.7	26.6	19.9	13.5	21.7	20.5	17.9	14.1	14.4	13.1	26.6	47.0	14.4	19.3	17.3	14.5	20.0	27.9	18.1	22.3	16.6	16.4	19.8	16.4	16.9	23.8	24.4	26.4	18.2	22.5	17.7	14.1	27.3	21.3	29.1	20.8	21.3	19.5	12.3	21.2	15.1	15.8	22.9	20.2	10.4	18.2	21.0	14.2	9.9	16.7	20.5	12.9	27.9	7.8	6.1	18.5	9.9	10.6	18.6	15.7	25.9	12.1	12.5	15.1	10.1	7.7	14.5	14.1	19.7	8.8	11.6	18.7	12.0	10.6	23.3	19.9	8.8	13.2	15.7	11.1	17.6	28.2	13.0	26.7	12.8	10.5	2.2	14.2	21.4	8.6	12.3	17.4	21.4	7.1	12.1	12.4	2.9	16.3	13.7	4.9	16.0	14.1	14.6	21.7	7.7	13.3	13.2	15.1	6.5	12.4	6.7	11.2	4.0	2.8	17.7	11.8	8.0	9.2	0.2	10.6	10.4	13.9	16.1	14.2	18.7	12.4	11.6	9.7	22.9	9.7	10.2	1.5	21.0	18.2	20.2	12.5	9.9	16.5	19.0	23.9	19.2	14.4	13.1	17.3	14.5	16.4	20.8	8.9	2.2	13.7	5.3	3.8	0.0	1.4	2.5	6.7	4.5	3.5	0.0	7.7	5.0	11.3	2.0	6.2	9.7	0.0	8.5	6.5	4.3	5.7	5.8	4.3	4.7	0.0	12.1	7.4	4.6	3.8	8.3	4.1	5.0	10.0	6.7	0.0	9.0	8.6	4.6	5.4	0.0	12.9	5.2	8.6	7.9	3.0	5.6	10.0	9.2	6.5
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	9.2	20.0	16.0	14.6	18.4	8.5	11.3	27.2	17.8	11.4	11.5	18.1	14.5	11.9	12.5	18.5	10.4	13.7	12.7	20.8	14.8	9.6	14.1	13.0	10.6	15.0	15.3	12.3	19.5	13.9	19.5	31.4	19.7	16.9	15.6	10.2	21.8	16.0	16.6	45.1	10.5	13.1	10.6	13.6	18.3	12.2	19.9	16.4	12.6	24.0	10.3	14.6	12.4	11.0	10.5	7.4	5.4	9.3	9.3	16.0	8.8	6.6	6.1	13.5	14.9	5.7	8.8	9.7	5.7	9.8	9.8	7.8	4.5	9.0	14.5	8.6	8.6	9.4	3.8	11.3	8.7	5.7	21.6	17.0	13.9	9.4	7.2	11.4	7.0	8.3	10.8	5.5	11.2	10.6	6.0	8.8	14.9	10.2	15.3	8.8	14.6	11.7	8.2	6.6	5.4	5.9	11.3	7.0	13.3	8.7	9.3	21.2	7.8	7.0	9.0	17.3	4.7	13.5	22.7	6.7	6.9	6.0	4.7	8.2	15.5	10.7	13.5	6.0	11.0	18.0	3.8	6.6	5.4	16.0	8.6	12.7	10.0	11.7	11.3	7.4	10.5	12.5	13.0	2.0	9.3	9.3	3.7	9.0	8.8	16.0	18.4	27.2	17.8	14.8	9.6	15.3	12.3	16.9	16.4	14.9	8.1	9.5	6.7	5.0	27.5	18.5	7.6	6.7	7.9	8.7	47.1	20.4	18.3	10.5	17.1	10.1	10.5	0.0	13.4	11.0	8.5	5.8	12.7	7.4	9.8	28.6	11.6	6.2	7.8	12.0	10.3	5.8	5.0	6.4	12.5	10.3	7.1	9.7	5.6	10.5	30.2	19.4	8.6	20.9	10.0	5.5	19.0	8.6	9.0	5.8
MTMR4	"KIAA0647, ZFYVE11"	ENSG00000108389	"Myotubularin related protein 4"	Q9NYA4	17	58489529-58517905	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.07e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.92e-2)"	8.7	9.9	16.6	10.3	18.7	14.4	11.6	32.7	22.7	8.3	11.4	18.3	6.7	17.7	10.3	16.2	9.5	10.1	6.7	8.3	15.8	14.4	14.6	32.0	8.0	13.4	16.5	15.4	13.3	10.4	16.2	11.2	29.8	36.9	10.9	14.8	11.1	8.7	9.1	6.1	11.8	17.3	9.4	10.9	13.3	9.4	15.2	17.3	15.5	13.9	3.4	18.2	9.7	8.2	8.4	6.3	9.9	7.9	3.3	5.8	3.8	9.5	10.5	16.0	15.5	9.9	10.1	12.4	5.8	10.0	15.4	14.3	10.2	6.3	20.1	8.3	6.0	12.2	5.7	17.2	10.0	16.6	20.7	11.9	13.7	8.4	13.5	11.1	14.2	12.5	10.4	8.1	10.5	16.9	10.1	11.1	13.6	11.7	14.6	7.6	14.4	28.0	9.5	3.9	18.3	10.7	18.0	12.0	9.9	7.2	20.3	25.5	24.6	5.7	6.8	7.9	8.6	13.2	9.9	5.9	24.1	15.5	6.8	7.0	12.1	13.3	15.1	38.7	10.8	7.2	4.7	5.4	9.9	4.3	6.8	3.9	8.3	5.2	4.7	6.3	8.4	5.6	5.8	6.6	3.3	7.9	3.7	4.9	3.8	16.6	18.7	32.7	22.7	15.8	14.4	16.5	15.4	36.9	17.3	8.9	6.1	17.6	11.6	6.8	0.0	8.1	15.3	0.0	10.3	3.5	0.0	10.3	0.0	8.0	4.3	8.8	40.4	0.0	5.7	15.3	8.3	13.3	5.8	54.3	11.8	0.0	16.6	12.3	13.2	4.5	13.3	9.9	11.8	36.1	15.8	0.0	7.8	20.7	16.3	9.0	0.0	0.0	8.2	4.6	5.3	7.2	41.6	14.6	14.6	7.3
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	16.5	21.7	14.4	11.5	15.2	22.6	23.3	11.0	17.0	9.0	11.1	8.2	11.3	16.3	11.7	21.9	11.1	9.6	9.9	15.1	13.3	15.5	12.4	16.2	11.0	25.8	13.1	11.7	10.5	15.5	8.7	16.4	5.8	14.5	13.1	4.1	12.2	11.9	16.4	22.1	17.5	12.3	16.3	13.8	13.8	12.1	12.9	8.2	14.0	9.4	12.6	7.4	11.4	7.2	13.6	20.9	17.3	18.8	18.7	19.5	12.2	6.5	5.1	4.6	9.4	5.1	4.5	5.6	4.1	2.2	5.0	6.5	1.9	2.3	1.4	8.6	1.9	3.2	5.3	1.2	2.6	1.5	6.2	9.6	5.2	4.7	13.0	5.3	1.4	3.8	5.1	3.5	2.5	1.1	1.4	3.9	5.6	0.3	7.7	3.1	13.2	10.5	8.9	1.7	6.5	4.3	4.7	3.3	6.8	2.7	5.2	9.2	11.1	7.8	3.4	10.1	1.7	8.3	4.1	5.1	4.0	11.9	7.4	3.8	18.7	14.1	21.6	2.5	2.8	2.7	6.1	18.7	17.3	15.6	14.2	11.6	13.3	19.5	15.8	20.9	13.6	15.4	18.8	8.3	18.7	18.8	19.7	15.7	12.2	14.4	15.2	11.0	14.4	13.3	15.5	13.1	11.7	14.5	8.2	11.9	7.2	11.5	17.4	12.8	27.5	13.9	20.4	26.8	9.1	21.0	5.9	20.1	56.3	17.3	1.0	15.3	8.8	0.0	28.6	7.4	14.0	14.0	6.9	16.3	19.3	28.6	9.4	8.0	23.1	1.3	13.6	18.6	28.7	16.2	9.8	38.9	17.4	11.9	12.7	30.5	22.4	0.0	13.7	1.4	3.6	14.9	14.0	22.5	8.8	17.3
IFT88	"D13S1056E, hTg737, MGC26259, Tg737, TTC10"	ENSG00000032742	"Intraflagellar transport 88"	Q13099	13	20567069-20691437	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 141.8;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 130.4;Spermatocytes: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (5.17e-4)"	"unprognostic (4.11e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.53e-2)"	4.9	8.1	7.7	4.9	10.2	5.0	6.7	6.6	9.9	10.5	6.3	12.3	7.6	7.2	11.4	12.7	4.0	15.8	7.3	5.4	8.2	9.0	19.0	12.9	7.2	4.3	9.8	7.1	11.9	6.9	9.7	36.5	4.5	12.5	7.3	7.1	11.5	4.7	9.1	5.7	4.4	7.0	8.9	10.1	5.5	5.4	53.1	13.7	10.3	15.8	3.6	5.0	6.2	7.2	10.1	4.4	11.0	6.2	9.0	8.9	3.3	6.3	8.7	12.5	15.1	6.8	13.7	8.7	5.1	7.7	7.6	5.5	5.1	11.4	5.5	5.3	7.9	8.7	12.0	8.8	7.3	11.5	5.5	3.8	7.1	4.4	9.5	10.3	7.3	5.5	7.4	7.7	17.5	9.5	15.3	11.1	10.9	9.2	2.3	13.4	5.9	8.8	6.3	4.4	14.8	3.0	10.4	9.0	1.1	15.0	3.5	5.7	12.2	10.0	4.6	10.6	9.6	13.0	9.3	6.8	5.4	5.3	8.8	6.3	3.0	6.3	4.5	6.8	3.4	8.5	1.8	5.2	4.1	5.7	5.9	5.1	8.3	5.8	5.7	4.4	10.1	6.2	8.9	11.0	9.0	6.2	3.6	5.1	3.3	7.7	10.2	6.6	9.9	8.2	9.0	9.8	7.1	12.5	13.7	29.8	9.6	3.7	9.6	3.0	24.2	15.4	15.3	141.8	30.7	33.2	111.9	10.4	23.2	12.2	71.8	10.8	14.0	0.0	5.2	5.8	9.4	6.0	11.5	19.1	6.4	20.6	9.2	10.4	6.0	70.7	24.7	8.8	3.3	4.6	13.0	30.3	6.7	14.2	19.1	41.1	130.4	25.8	7.3	215.8	55.3	2.9	4.9	7.0	12.3	4.3
ZNF512	KIAA1805	ENSG00000243943	"Zinc finger protein 512"	Q96ME7	2	27582969-27623215	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031430	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031430: AB_10603844"	"prognostic favorable (9.79e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.75e-3)"	"prognostic favorable (5.08e-9)"	"unprognostic (6.08e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (1.10e-2)"	"unprognostic (8.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-2)"	"unprognostic (5.60e-3)"	11.0	12.8	12.0	13.3	19.9	5.2	15.6	18.5	22.4	18.1	14.8	20.4	12.1	7.4	23.7	14.7	9.9	20.8	12.3	12.0	11.0	14.3	12.1	6.7	12.9	14.5	12.1	15.4	33.7	8.1	28.0	27.6	12.1	18.8	17.8	11.7	18.7	11.3	19.1	7.2	6.8	12.5	17.4	14.2	15.0	11.0	12.0	11.6	21.3	19.6	6.6	15.8	17.2	14.0	9.6	6.3	14.6	5.2	17.0	14.6	8.5	11.6	10.3	21.4	9.5	10.6	12.1	0.0	5.8	8.2	11.0	13.0	7.9	7.4	10.2	6.5	6.6	9.1	4.0	18.9	5.4	11.7	9.4	15.2	21.3	8.4	12.0	8.2	13.8	9.7	11.0	6.0	8.5	2.5	8.8	17.4	17.9	18.4	7.5	16.1	1.4	1.4	10.6	14.8	7.7	0.0	23.2	30.2	8.8	7.8	3.2	21.0	20.9	5.5	3.5	16.2	10.7	4.3	8.0	14.3	3.9	9.4	3.9	7.5	7.6	5.3	17.6	5.8	17.3	7.9	14.6	4.2	7.3	8.7	5.2	11.7	9.6	10.9	12.4	6.3	8.0	14.6	12.2	1.2	17.0	4.1	4.5	7.5	8.5	12.0	19.9	18.5	22.4	11.0	14.3	12.1	15.4	18.8	11.6	8.9	13.9	9.3	8.3	3.4	20.9	14.5	7.6	9.4	9.1	17.4	15.7	1.4	8.3	5.9	8.4	10.5	1.8	0.0	1.6	0.9	8.0	7.3	5.8	3.9	4.5	17.5	8.6	11.6	6.0	5.4	13.8	5.5	1.7	4.6	5.5	16.6	3.2	0.0	16.3	2.9	13.9	19.4	11.7	8.9	7.9	2.6	1.0	8.2	4.9	6.7
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 25.4;RH-30: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.8	2.8	2.2	3.3	8.4	5.3	4.7	1.5	0.8	1.0	1.2	25.4	1.7	1.8	0.8	1.7	5.6	1.5	6.8	0.8	1.6	0.7	4.6	1.8	1.4	6.6	4.0	2.3	3.4	3.1	1.1	2.6	3.8	0.8	3.6	2.4	2.7	2.7	2.9	1.8	0.8	0.7	3.2	4.2	1.4	1.1	39.3	2.8	3.8	2.9	3.8	2.7	2.2	2.2	3.1	8.7	1.9	1.1	1.8	1.0	2.1	7.8	0.9	2.3	6.9	4.1	1.7	3.8	5.1	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3	8.9	5.9	1.5	1.6	6.4	19.5	1.6	5.1	5.3	0.0	12.2	2.0	5.2	10.0	3.7	1.1	3.8	10.9	0.0	2.9	2.2	5.7	3.1	2.3	21.7	8.9	7.9	0.0	0.6	9.5	0.0	4.9	8.9	3.3	5.4	5.7	2.8	5.8	6.2	12.4	32.4	4.3	0.0	3.3	1.0	0.7	8.3	4.2	0.0	6.4	4.6
RPAIN	"hRIP, MGC4189, RIP"	ENSG00000129197	"RPA interacting protein"	Q86UA6	17	5419641-5432876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023924, HPA031526"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA023924: AB_10601890, HPA031526: AB_10601555"	"unprognostic (1.68e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (5.20e-4)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.00e-3)"	12.4	19.5	24.4	12.1	26.4	14.9	22.1	18.3	24.0	14.6	13.4	12.1	18.4	12.1	13.8	21.6	11.9	17.0	12.2	25.4	20.2	21.0	17.1	19.3	11.5	12.8	18.0	24.9	17.4	15.8	10.9	25.5	12.0	19.7	14.5	14.6	12.9	11.9	14.0	41.6	12.3	9.5	13.5	17.5	10.5	14.6	11.4	18.9	16.2	12.1	15.8	15.0	12.2	10.5	25.3	19.3	22.3	13.4	12.1	24.7	13.0	8.6	19.4	20.3	16.6	15.4	11.7	8.8	8.7	16.6	19.3	17.3	11.4	3.1	10.4	12.3	5.6	13.6	9.2	26.2	8.3	16.7	10.7	19.0	8.1	9.5	14.4	19.9	10.4	18.7	10.0	17.0	11.7	23.8	23.1	17.0	34.3	8.6	6.7	10.5	7.4	23.9	19.0	10.4	10.6	9.9	11.5	14.6	9.2	14.2	10.1	13.5	24.0	7.9	6.2	22.5	15.6	9.0	14.5	8.3	6.0	8.2	4.9	16.8	6.6	10.9	10.4	8.9	10.7	9.1	11.2	13.4	22.3	12.5	12.0	15.8	25.3	17.0	16.2	12.8	21.4	20.4	18.2	2.4	12.1	10.5	19.3	24.7	13.0	24.4	26.4	18.3	24.0	20.2	21.0	18.0	24.9	19.7	18.9	65.5	50.7	59.6	66.4	56.1	44.3	29.4	56.0	84.3	62.6	38.4	49.1	68.2	87.9	61.5	70.6	39.1	37.3	70.0	50.2	37.9	52.2	69.0	59.1	35.8	48.9	44.5	105.7	37.4	42.9	8.5	65.6	45.6	45.5	56.9	46.6	59.2	64.8	60.0	67.5	60.9	56.8	71.1	54.6	90.7	27.9	65.5	49.9	57.9	50.1	82.7
GSE1	KIAA0182	ENSG00000131149	"Gse1 coiled-coil protein"	Q14687	16	85169525-85676204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.9"	"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;K-562: 48.4;T-47d: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036365, HPA042090"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036365: AB_10601762, HPA042090: "	"unprognostic (1.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.88e-1)"	15.8	11.1	4.9	18.2	6.6	17.3	21.4	18.0	9.5	13.5	14.9	2.9	14.6	9.7	11.0	11.7	11.6	10.9	16.1	18.7	3.8	5.8	11.1	10.1	23.5	6.5	3.8	5.7	17.8	28.0	34.4	26.9	81.9	3.7	8.7	7.2	18.2	17.7	25.2	22.5	13.3	14.8	8.8	4.2	12.1	13.2	10.4	2.1	59.0	14.9	12.0	17.4	10.2	16.9	3.5	2.5	4.5	6.0	1.9	3.2	1.1	4.5	8.2	5.5	13.8	3.5	3.2	43.6	6.2	4.3	3.5	1.3	7.0	6.3	2.7	7.5	7.0	3.1	4.3	8.7	2.3	1.8	5.0	7.3	19.8	7.7	8.6	4.6	9.1	11.3	6.1	5.7	3.7	1.8	3.6	0.9	16.1	48.4	0.5	1.1	30.7	32.6	8.0	9.6	5.0	2.4	21.5	1.8	6.9	3.2	1.7	35.9	24.9	12.2	22.9	1.1	5.2	49.9	22.8	1.5	7.2	9.0	1.9	1.6	7.5	4.5	15.9	4.1	5.8	6.3	4.0	1.6	4.5	3.2	2.9	3.1	3.5	1.2	2.0	2.5	3.4	0.6	2.4	1.3	1.9	6.0	0.0	0.0	1.1	4.9	6.6	18.0	9.5	3.8	5.8	3.8	5.7	3.7	2.1	62.5	65.7	11.5	7.5	12.5	61.9	31.4	33.1	24.1	29.6	36.6	137.4	45.4	1.7	14.3	3.8	19.0	19.6	46.7	10.5	65.7	18.6	12.3	41.7	26.7	11.0	33.4	57.4	15.4	8.9	4.7	43.7	13.5	10.1	3.6	60.0	5.2	16.5	17.3	57.7	4.4	61.6	6.5	7.1	1.8	17.8	26.2	152.4	17.0	22.4	10.5
LRRC29	"FBL9, FBXL9"	ENSG00000125122	"Leucine rich repeat containing 29"	Q8WV35	16	67207139-67227048	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA034998	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034998: AB_10601938"	"unprognostic (5.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.55e-3)"	"prognostic favorable (4.33e-4)"	"unprognostic (1.80e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.44e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-1)"	2.4	4.9	8.2	1.6	10.3	2.7	3.0	7.4	8.2	2.0	1.7	7.1	3.6	3.1	2.4	2.7	1.5	4.5	3.8	2.4	8.3	4.2	5.6	3.8	3.7	2.7	7.0	6.0	3.1	5.1	4.2	8.1	2.7	5.0	5.4	1.4	3.9	6.6	4.1	4.0	5.0	3.8	3.2	5.0	2.5	2.9	4.3	5.9	2.6	6.3	0.6	1.8	2.1	1.6	1.4	2.3	3.6	2.9	3.9	4.5	2.3	1.0	3.0	0.9	0.4	1.8	1.3	0.2	0.8	1.7	1.6	1.8	0.4	0.6	0.8	2.4	2.2	0.8	0.2	0.4	2.0	0.6	1.0	0.8	0.7	0.2	1.6	2.0	0.1	2.7	1.7	2.1	2.4	1.4	1.2	1.0	0.5	0.6	0.4	3.2	0.1	0.3	1.6	0.4	0.0	1.1	1.4	0.8	2.2	2.0	0.1	1.1	1.4	1.1	1.1	1.8	0.4	3.0	1.3	0.4	3.1	0.9	0.6	0.2	4.4	0.9	1.3	2.2	0.8	0.9	0.0	2.6	3.6	0.9	2.9	1.0	0.8	2.5	3.6	2.3	1.4	4.5	1.9	3.4	3.9	2.7	1.6	0.5	2.3	8.2	10.3	7.4	8.2	8.3	4.2	7.0	6.0	5.0	5.9	0.0	1.3	0.8	2.7	0.5	2.9	1.0	5.1	1.4	0.0	8.7	3.9	3.1	3.3	2.0	4.0	2.4	2.4	0.0	0.8	0.9	3.1	2.8	1.1	0.8	3.4	6.4	2.9	0.0	3.1	6.7	0.9	2.2	3.3	4.6	1.1	1.4	1.2	0.3	1.4	7.7	1.8	0.0	1.9	7.7	2.3	1.3	0.8	0.0	0.7	0.8
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 18.6;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.5	13.0	6.1	2.2	3.8	10.1	10.8	7.6	5.4	1.2	1.7	2.3	3.9	19.7	5.8	14.1	0.9	2.2	4.6	1.2	3.7	4.2	5.2	29.0	0.0	15.3	4.4	1.0	6.1	5.1	5.1	8.4	3.5	1.1	8.6	7.2	6.2	0.3	3.7	1.2	13.2	4.0	5.9	0.1	5.2	4.3	0.5	4.5	2.8	0.9	21.2	8.6	1.9	11.4	10.2	6.6	19.6	4.2	13.6	1.8	9.5	13.5	3.6	17.0	4.0	5.5	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1	0.0	5.9	2.9	0.5	5.5	4.8	3.5	7.6	0.0	1.2	0.0	2.0	0.3	10.0	1.3	0.1	2.1	0.2	0.0	0.8	4.6	4.4	1.9	4.6	0.2	18.6	19.1	1.7	7.4	12.7	0.0	2.3	8.1	8.5	5.4	1.7	6.5	0.9	1.9	3.5	3.1	4.7	0.0	3.4	0.5	1.5	3.9	1.1	2.6	2.3	0.1
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57549998-57586632	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 138.6"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	1.8	7.6	85.4	3.0	47.6	1.9	1.9	15.2	138.6	2.1	2.8	4.0	0.0	2.4	3.4	2.1	1.9	2.0	1.9	1.7	52.4	18.3	2.0	1.7	1.8	1.8	12.9	43.6	1.8	2.3	6.0	2.5	1.7	21.6	1.9	2.8	0.6	2.0	2.0	1.7	1.7	3.0	2.8	9.0	1.8	2.1	4.4	12.9	0.0	2.8	0.0	1.8	1.8	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.8	3.3	0.0	0.0	0.1	0.2	0.7	1.3	1.7	0.0	0.0	1.6	0.0	0.7	0.6	0.1	2.0	0.0	1.0	20.4	1.5	0.1	0.1	1.6	0.6	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.2	1.8	8.6	4.5	0.0	0.0	0.3	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.8	4.9	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.0	2.4	0.0	0.9	2.9	3.5	0.3	8.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.4	0.8	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.3	0.0	85.4	47.6	15.2	112.0	52.4	18.3	12.9	43.6	21.6	12.9	0.0	0.0	0.0	0.1	0.0	36.9	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	25.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	5.8	0.2	0.0	0.4	0.0	8.7	0.0	0.9	2.3	9.3	0.1	0.0	0.0	0.0	0.0
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.2	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	2.6	0.1	0.1	0.1	0.0	0.4	26.5	0.3	0.0	0.1	14.7	0.7	0.2	0.3	0.1	0.2	4.0	0.0	17.0	0.0	4.7	0.0	0.0	35.5	31.3	0.6	0.0	0.2	7.6	2.2	0.6	0.3	0.0	23.9	0.7	0.0	0.0	0.1	0.2	0.0	14.8	2.4	1.2	0.6	0.1	1.0	11.4	6.4	2.0	0.9	9.9	10.8	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1	3.0	0.3	0.0	0.1	0.0	0.4	0.7	0.0	52.2	7.9	0.0	17.7	0.0	8.3	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.8	20.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
DYNLL2	"Dlc2, DNCL1B, MGC17810, RSPH22"	ENSG00000264364	"Dynein light chain LC8-type 2"	Q96FJ2	17	58083415-58095536	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 366.0;Late spermatids: 723.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039954			Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (7.22e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.12e-12)"	"unprognostic (2.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.02e-2)"	15.4	28.3	38.6	11.1	55.2	9.9	11.6	41.1	41.1	12.9	14.5	22.6	16.3	16.2	12.0	15.6	11.9	13.5	13.3	43.8	32.2	40.2	28.1	23.1	11.8	9.4	48.3	28.7	14.4	11.8	36.2	15.0	19.7	40.6	20.6	13.7	15.5	19.2	18.8	64.8	12.6	15.6	14.3	32.5	11.2	12.7	19.0	27.2	7.6	22.0	15.1	11.8	9.9	16.4	1.5	0.8	3.5	3.0	1.5	3.1	0.8	20.7	14.1	29.1	13.2	18.1	10.0	46.3	21.0	8.4	10.2	8.0	31.3	10.1	18.6	23.9	13.0	12.2	11.2	13.4	16.6	17.6	18.3	9.7	20.1	8.3	18.3	14.4	21.5	12.5	10.0	11.4	11.8	9.4	10.7	6.7	15.8	20.0	11.3	9.8	31.4	24.3	8.9	20.0	13.7	14.5	22.5	17.1	7.7	8.8	22.7	19.9	15.9	18.8	7.6	16.0	15.7	22.5	10.1	12.2	20.1	25.3	13.3	15.4	21.2	25.7	22.7	10.3	17.3	14.0	3.5	1.1	2.0	2.6	0.6	2.9	1.3	2.1	2.3	0.5	1.5	2.2	3.1	1.7	1.5	3.0	0.8	1.4	0.8	38.6	55.2	41.1	41.1	32.2	40.2	48.3	28.7	40.6	27.2	11.9	49.9	27.4	30.9	43.6	58.8	158.5	38.2	14.7	29.6	57.6	37.3	88.3	26.6	31.4	366.0	29.3	47.1	23.3	27.0	62.0	29.2	30.1	22.0	85.9	36.0	66.7	64.5	22.1	21.7	723.4	27.3	23.1	62.4	27.1	52.5	69.7	32.5	40.3	25.1	66.7	36.2	25.8	38.5	40.0	41.2	40.3	50.2	19.2	44.1	28.3
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037490-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 22.5;placenta: 23.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	1.0	0.9	6.5	0.9	8.4	0.8	1.6	1.7	10.1	0.8	7.8	9.9	0.0	2.3	0.8	1.1	0.9	0.9	1.8	0.8	7.7	4.7	1.4	22.5	1.2	0.8	5.1	7.9	0.8	6.1	1.7	1.7	23.9	8.2	2.0	2.5	0.8	1.0	0.9	0.8	0.8	2.6	1.0	2.2	0.8	4.2	0.9	5.9	0.0	0.8	0.0	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	3.0	0.0	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.1	1.5	0.8	0.8	0.9	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.4	1.7	10.1	7.7	4.7	5.1	7.9	8.2	5.9	0.0	0.0	1.9	0.0	0.1	0.6	0.3	33.1	0.0	0.0	0.0	0.0	1.4	1.7	2.0	7.3	0.0	15.3	0.0	1.8	9.0	0.0	0.9	0.0	111.5	0.5	0.0	4.7	3.7	2.5	25.8	0.3	0.0	1.7	0.0	13.2	9.7	1.0	62.8	3.9	1.4	0.3	0.0	0.1	0.5	0.9	0.0	4.3	0.0	24.3	0.1
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99398051-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	24.7	28.5	48.9	28.3	49.8	53.7	29.9	123.3	69.7	35.5	38.3	22.8	39.9	26.7	43.1	58.7	19.8	29.4	22.3	31.0	46.9	17.5	25.5	21.7	26.6	42.2	48.0	29.8	49.3	24.7	34.7	83.9	21.7	41.0	34.1	28.2	24.1	30.8	34.5	39.4	31.9	34.4	31.5	61.0	39.3	28.2	17.4	57.1	32.1	44.7	18.0	30.7	29.5	30.3	18.0	13.1	20.4	7.4	15.6	12.3	2.2	11.1	7.5	40.3	27.6	14.4	21.4	18.7	17.6	9.7	10.5	13.1	13.5	20.2	34.1	11.8	9.9	12.3	17.0	20.2	15.4	21.4	28.0	22.6	19.8	37.4	13.5	10.9	27.4	28.0	21.0	21.9	11.7	15.3	38.3	15.4	18.1	23.0	22.4	13.9	11.1	13.0	31.5	22.5	10.2	7.0	26.3	11.4	12.2	20.7	19.3	16.3	21.6	8.8	11.4	15.1	33.0	15.3	24.2	16.9	10.6	12.6	10.3	15.0	15.6	10.7	31.3	16.0	28.2	12.3	6.9	7.4	6.6	8.6	4.2	8.5	12.0	8.4	6.8	3.3	18.0	12.3	11.8	20.4	15.6	4.8	13.1	7.7	2.2	48.9	49.8	123.3	69.7	46.9	17.5	48.0	29.8	41.0	57.1	172.7	197.8	329.9	282.6	173.4	521.3	112.2	109.5	187.4	202.4	169.3	420.2	132.4	63.0	108.9	13.5	170.1	148.0	70.0	90.8	86.5	187.1	270.2	182.8	89.8	87.1	470.4	237.9	98.8	88.1	13.3	549.4	181.7	158.6	221.0	84.6	269.4	105.3	147.3	414.8	35.6	432.5	245.8	215.3	310.7	171.1	151.8	151.3	236.8	126.4	254.3
NCALD		ENSG00000104490	"Neurocalcin delta"	P61601	8	101686543-102124907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;salivary gland: 48.5"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 37.5;Melanocytes: 97.8;Muller glia cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 32.8"	"Group enriched"	"Detected in many"	13	"NK-cells: 32.8;T-cells: 17.1"	"Group enriched"	"Detected in some"	4	"AF22: 44.4;HDLM-2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043245	Approved					NA	NA					"HPA043245: AB_2678385"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.30e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.00e-2)"	9.6	3.4	21.2	5.6	26.8	0.7	21.2	2.7	57.2	6.9	8.8	7.3	1.3	2.7	3.7	2.0	6.1	18.6	5.8	5.1	25.1	16.4	7.0	7.0	9.4	5.6	7.2	18.4	18.2	4.3	0.6	6.6	4.6	7.8	5.9	4.2	20.8	48.5	7.4	6.4	7.3	4.6	5.7	4.4	3.6	5.7	3.4	2.8	0.3	2.6	3.1	4.9	5.4	2.1	0.3	1.9	0.5	0.1	32.8	17.1	4.6	2.1	3.2	44.4	0.2	0.4	7.8	0.0	0.7	0.1	0.0	0.0	0.0	0.0	2.8	1.0	3.3	0.1	0.0	0.3	0.0	0.0	54.8	0.3	0.2	0.0	0.1	0.0	1.8	0.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.3	0.7	0.5	0.0	0.0	1.0	0.0	0.0	7.3	0.1	0.2	4.3	0.0	1.0	1.8	7.7	0.3	1.5	0.0	0.7	0.1	0.0	0.1	12.1	1.7	0.0	0.1	0.0	0.7	0.1	0.1	0.1	17.1	0.1	15.4	0.3	6.6	10.1	1.9	0.2	1.6	8.5	0.5	32.8	0.1	0.1	6.5	4.6	21.2	26.8	2.7	57.2	25.1	16.4	7.2	18.4	7.8	2.8	0.0	1.6	0.0	0.4	3.8	13.0	3.6	7.6	37.5	4.5	0.0	23.6	2.6	6.6	4.8	9.8	6.4	0.0	0.0	1.0	7.7	16.2	1.7	2.3	13.1	1.6	12.7	20.2	14.7	2.7	5.0	2.6	2.4	97.8	0.0	2.7	42.7	2.3	0.0	1.4	14.6	4.4	25.8	10.3	0.5	0.9	2.8	2.5	22.3	0.4	0.9
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	14.5	10.2	11.7	15.9	18.2	22.3	12.8	25.4	16.1	15.3	18.3	21.0	9.4	9.3	19.5	13.7	9.9	15.0	13.7	14.3	12.2	9.0	11.7	16.2	18.7	21.1	23.2	11.4	28.7	11.4	13.1	14.4	14.3	15.9	12.0	13.7	18.9	9.4	16.0	9.7	12.0	13.9	17.5	18.5	19.0	14.7	8.6	21.8	17.4	13.8	4.7	22.3	17.4	13.2	6.7	5.3	19.1	4.7	5.3	9.1	3.8	3.7	2.8	6.7	10.7	8.4	10.8	11.8	4.7	8.3	6.0	8.6	4.4	5.7	14.0	2.2	8.6	3.0	5.2	8.8	3.4	7.8	9.0	3.8	21.3	9.2	2.9	12.2	11.3	31.1	12.6	2.1	6.2	4.0	6.2	7.1	9.4	7.3	18.3	8.1	3.2	9.1	12.0	9.4	5.7	2.2	11.1	13.2	6.6	3.5	3.5	2.6	4.5	5.0	2.4	12.2	9.9	3.0	10.0	7.1	6.0	5.6	5.6	4.3	14.9	7.2	11.3	7.1	10.6	5.1	19.1	2.5	13.2	6.3	2.0	9.1	6.5	4.5	6.1	5.3	6.7	5.8	5.3	3.4	5.3	4.7	4.8	5.6	3.8	11.7	18.2	25.4	16.1	12.2	9.0	23.2	11.4	15.9	21.8	26.8	22.9	10.2	5.0	1.9	15.6	2.4	0.0	5.3	9.1	1.8	23.6	3.4	0.0	1.9	8.1	4.3	3.1	0.0	3.7	12.1	4.3	3.5	8.1	6.4	4.3	22.3	3.4	6.2	6.5	12.4	7.8	6.7	6.8	10.0	4.1	4.5	2.4	3.7	8.5	2.2	20.1	6.5	5.3	4.1	7.5	2.9	3.9	10.7	4.3	3.4
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 79.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.7	18.3	11.3	12.4	6.2	5.3	25.8	8.6	4.0	11.6	14.8	7.8	10.2	9.3	12.8	5.9	15.3	6.0	15.1	12.2	21.6	22.6	31.3	13.1	20.6	29.4	6.1	16.8	11.7	3.2	11.0	12.9	10.5	6.2	12.9	15.6	20.3	12.8	9.9	79.0	23.8	23.4	3.0	10.5	17.0	15.3	17.9	17.5	7.0	9.9	14.0	13.0	6.9	3.4	13.0	3.0	10.2	17.8	4.1	9.8	26.0	8.8	10.5	12.0	44.5	27.2	9.9	16.6	11.2	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7	17.9	11.5	15.2	17.6	10.5	14.6	54.1	10.2	10.7	13.6	15.7	5.9	46.3	49.7	22.6	78.9	14.9	4.2	70.0	16.3	78.6	13.4	14.4	23.0	12.5	29.2	15.9	6.4	14.1	13.4	51.1	16.1	22.9	23.6	22.6	13.1	21.7	12.0	10.5	14.5	19.5	23.0	32.3	22.1	113.9	80.6	9.4	30.3	21.3	12.5	8.4
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.3	6.3	8.2	7.3	5.0	4.1	3.8	5.3	3.8	5.4	4.7	3.8	4.7	10.0	3.9	4.0	3.2	6.2	3.9	6.4	4.9	4.3	6.9	8.7	15.6	3.9	9.2	8.9	6.3	4.7	6.6	4.7	9.1	6.5	5.5	12.1	7.0	4.4	4.1	3.8	9.1	7.0	7.3	5.6	7.8	9.3	2.9	5.2	5.2	4.9	11.2	10.8	4.3	5.4	4.7	5.4	5.9	6.5	5.4	4.2	6.1	6.7	4.6	5.0	6.8	7.9	2.5	7.1	8.5	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4	3.0	6.2	23.8	10.8	6.5	15.5	7.4	10.2	8.1	9.1	3.5	5.9	13.3	10.0	9.6	1.6	12.0	7.8	23.3	11.0	7.0	7.4	11.1	13.9	6.6	7.2	15.9	13.3	9.2	11.4	0.2	13.6	12.3	10.1	7.2	12.9	12.8	8.8	7.0	22.3	6.7	12.8	25.8	8.6	4.4	3.2	6.6	10.2	19.2	9.0	7.8
TAPT1	FLJ90013	ENSG00000169762	"Transmembrane anterior posterior transformation 1"	Q6NXT6	4	16160505-16227410	"Disease related genes, Predicted membrane proteins"	"Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis"	"Developmental protein, Receptor"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 108.0;Late spermatids: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042567, HPA048658"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA042567: AB_2678055, HPA048658: AB_2680482"	"unprognostic (2.34e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (9.75e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.30e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (7.07e-2)"	"prognostic favorable (8.52e-4)"	"unprognostic (9.00e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.25e-3)"	"prognostic favorable (4.18e-4)"	10.2	19.2	18.6	7.4	18.0	26.2	13.1	15.0	17.3	10.2	10.1	20.2	8.2	8.3	15.1	12.2	8.2	10.7	10.8	14.4	17.5	13.5	15.8	35.9	14.7	11.0	20.1	10.8	10.8	9.8	14.4	14.5	17.2	13.5	10.2	10.7	11.3	9.4	11.0	38.0	9.8	12.8	12.0	18.5	11.2	9.2	13.1	19.1	15.3	17.8	7.8	9.9	10.1	16.8	6.5	1.8	2.6	0.7	0.9	2.4	0.7	3.0	2.2	3.8	4.4	5.7	4.4	1.6	5.0	3.7	4.7	5.2	3.0	5.3	19.4	5.4	3.1	6.9	2.5	3.2	2.5	6.0	1.8	4.0	3.8	3.2	3.2	5.5	7.6	4.0	2.7	4.9	4.6	3.4	5.8	2.3	12.1	5.8	9.1	4.5	2.1	11.2	6.2	2.5	5.7	5.3	27.4	5.3	3.5	7.6	3.1	6.3	5.1	4.6	3.9	5.7	2.7	7.2	7.5	4.4	3.9	2.6	2.6	6.3	8.9	7.3	14.8	8.0	19.0	4.5	2.6	0.7	0.2	0.6	0.6	0.2	2.1	1.8	1.0	1.1	6.5	2.4	1.7	1.6	0.9	0.7	1.8	1.3	0.7	18.6	18.0	15.0	16.2	17.5	13.5	20.1	10.8	13.5	19.1	29.8	50.5	7.1	5.3	8.0	20.4	13.4	12.7	17.4	10.3	7.0	108.0	3.6	3.3	6.4	69.0	8.4	8.4	0.0	7.0	2.3	6.6	5.8	2.3	37.6	3.6	66.7	13.8	6.2	7.5	117.7	9.2	11.5	15.1	2.8	10.1	28.6	7.9	8.6	14.2	7.9	54.9	6.5	7.2	23.1	5.5	6.9	5.8	5.9	7.3	5.6
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.2	13.0	16.8	30.6	29.8	19.7	14.1	21.3	21.3	19.6	22.5	16.8	9.7	28.4	26.8	24.6	17.6	23.5	13.2	36.4	21.0	11.5	34.4	11.4	19.3	30.4	18.9	18.7	6.9	23.0	28.5	20.1	19.6	20.4	18.6	12.6	20.1	22.1	27.2	29.1	12.4	11.0	8.3	12.7	12.2	11.5	14.5	15.5	33.8	25.9	14.8	14.6	17.7	23.8	10.2	19.9	31.3	23.3	22.4	13.2	11.8	10.6	23.0	12.1	13.1	15.6	21.8	12.2	8.5	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2	32.8	41.6	47.2	90.2	147.6	76.3	93.6	53.5	20.1	39.8	99.5	25.5	48.1	131.0	34.9	24.0	35.6	43.4	0.0	38.5	23.1	50.3	71.7	31.1	71.3	35.6	36.5	71.6	63.3	55.3	16.8	69.9	47.1	82.7	28.9	56.9	82.6	40.7	56.1	89.8	169.2	50.8	129.4	74.1	48.1	24.5	141.5	49.9	52.4	55.2	61.6
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.3	11.0	10.2	14.9	11.2	10.2	6.8	13.7	12.8	23.4	18.9	22.2	5.4	13.9	10.8	23.0	13.2	7.5	18.6	22.4	14.7	12.7	23.0	8.3	17.5	10.6	11.6	34.4	14.2	12.7	14.6	30.8	8.3	8.9	11.4	13.9	17.4	8.9	13.0	15.5	8.8	9.4	7.2	21.7	14.3	13.5	8.0	14.5	10.9	9.6	9.8	5.9	17.9	18.2	8.7	6.6	7.2	9.8	10.2	14.0	15.2	24.3	18.1	6.8	12.6	21.0	24.4	12.3	13.3	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5	0.0	23.5	18.2	9.8	15.8	16.9	5.1	12.7	9.4	21.6	15.7	15.7	29.8	39.7	26.3	30.8	8.2	2.9	23.3	25.7	23.4	15.5	13.0	11.5	29.7	27.4	20.6	13.7	9.2	6.9	113.5	15.5	10.0	23.6	22.6	4.1	18.5	23.5	7.0	19.1	28.8	20.6	0.0	10.5	44.7	55.2	22.3	15.0	10.2	8.5	11.3
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 24.8;Horizontal cells: 17.5;Muller glia cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;Karpas-707: 10.2;NTERA-2: 13.0;U-2197: 10.5;U-266/84: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054050: AB_2682357, HPA057065: AB_2797258"	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.4	0.1	6.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.1	0.0	6.5	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.8	0.0	0.2	4.7	0.2	10.2	0.0	1.2	4.0	0.0	13.0	0.0	6.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.8	0.0	2.7	1.2	0.0	0.1	0.0	7.6	10.5	0.8	4.8	21.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9	0.0	4.0	0.0	4.6	5.7	24.8	10.9	5.1	0.0	1.2	12.2	0.0	0.0	11.6	0.8	0.0	2.2	0.0	0.0	0.2	0.0	0.5	2.4	4.6	0.8	0.1	17.5	6.9	2.5	0.8	0.0	0.3	0.0	0.0	0.0	0.2	12.4	1.1	0.0	0.4	3.1	8.7	0.0	3.3	0.2	0.0	2.6	0.0	3.2	0.2	0.8
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli	Nucleoplasm	"HPA074391: AB_2686685"	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.2	13.9	10.1	14.5	11.5	13.0	10.3	10.1	7.3	12.1	9.8	9.7	12.6	11.5	20.3	13.3	7.2	13.5	19.3	13.0	9.9	12.1	11.3	7.2	21.2	4.6	7.8	10.7	13.0	11.7	6.5	10.4	9.5	11.0	11.6	8.6	10.1	9.4	9.3	10.8	10.0	5.7	12.4	15.3	12.9	13.6	5.7	7.4	6.2	17.4	8.0	11.7	9.6	23.2	6.4	14.7	13.4	14.5	8.5	12.0	5.2	11.8	9.1	8.4	7.7	12.7	13.1	6.6	8.3	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0	20.8	21.4	8.8	8.7	9.3	22.5	4.0	10.2	13.4	10.3	29.6	19.6	11.5	0.0	10.1	12.1	12.6	8.1	0.0	7.1	11.7	11.9	9.9	5.7	13.6	10.7	20.6	11.6	27.0	11.8	5.9	8.9	14.3	6.8	13.6	16.1	19.3	9.6	10.8	11.3	12.4	23.9	25.8	9.0	9.3	13.0	8.9	8.6	7.7	12.2	11.2
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666800-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (3.12e-4)"	6.4	7.8	10.2	6.2	9.1	8.8	6.5	17.2	14.5	7.1	5.2	9.1	2.3	4.9	5.8	6.1	5.9	11.3	5.2	9.2	8.5	8.9	8.1	5.9	6.0	8.3	12.4	11.6	9.2	11.6	9.4	6.7	4.9	9.1	6.9	2.6	7.7	14.6	6.9	4.6	11.3	6.3	3.8	7.0	7.4	7.1	9.2	10.6	11.7	9.2	2.6	5.8	6.0	5.7	8.8	19.4	5.4	11.1	17.6	11.3	8.6	4.9	8.3	4.7	6.5	9.3	3.5	3.8	4.7	4.4	5.7	6.0	9.6	4.3	7.5	6.9	4.2	3.2	5.6	5.5	7.3	1.0	7.6	12.2	5.9	5.5	6.0	7.4	8.2	7.0	6.4	5.9	4.6	3.8	3.8	5.7	16.3	5.2	0.8	2.6	18.8	11.9	6.7	3.8	5.8	14.4	8.5	6.1	7.0	5.4	5.9	9.9	6.6	5.1	7.0	4.1	2.7	3.9	8.1	3.1	6.4	2.0	5.1	4.9	19.1	12.8	3.3	10.0	6.3	4.1	4.5	11.1	4.6	9.2	9.6	10.7	8.1	8.9	8.6	11.1	8.8	8.7	11.3	5.4	17.6	4.7	19.4	9.8	8.6	10.2	9.1	17.2	14.5	8.5	8.9	12.4	11.6	9.1	10.6	0.0	15.6	12.6	11.4	13.7	20.5	4.2	12.7	10.7	7.9	17.4	11.8	11.1	14.9	13.6	13.8	10.5	9.3	0.0	15.2	11.6	11.0	13.4	13.9	7.2	11.5	19.1	9.2	9.2	11.6	43.7	14.7	14.8	15.1	18.0	6.7	15.0	11.1	5.9	17.0	22.6	20.4	19.4	13.2	25.0	16.9	14.1	7.6	16.2	8.1	12.2
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299450	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		110000	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	75.9	73.7	105.0	82.3	85.4	119.3	142.4	53.8	66.7	97.0	77.1	56.3	102.5	39.7	94.3	156.8	80.3	94.6	91.0	77.0	82.7	76.7	81.8	83.5	64.9	117.2	94.3	69.2	134.5	155.8	49.6	81.2	67.3	63.3	96.1	65.4	60.1	116.4	99.9	87.0	71.6	54.1	108.1	91.0	83.8	64.7	60.5	64.9	60.5	128.1	108.9	101.1	91.8	144.9	163.9	98.0	63.7	127.8	69.4	158.4	329.0	34.6	53.5	51.8	46.6	100.5	139.9	37.8	86.8	118.2	80.9	54.7	48.8	53.4	46.9	52.5	93.3	31.5	31.9	45.0	62.2	78.4	44.3	63.0	42.7	66.1	67.0	64.6	69.4	46.7	133.3	91.4	57.2	44.7	142.1	71.9	57.5	49.8	63.3	80.3	122.5	48.6	103.5	48.8	38.2	82.7	39.6	56.2	55.4	92.3	51.3	43.8	50.0	55.8	49.3	63.0	55.5	64.1	88.7	62.9	45.8	34.9	21.6	38.8	47.5	50.6	69.0	50.2	55.5	41.8	63.7	127.8	46.5	80.9	97.0	110.9	163.9	123.2	97.6	98.0	156.8	158.4	125.9	38.3	69.4	100.2	91.0	95.8	329.0	105.0	85.4	53.8	66.7	82.7	76.7	94.3	69.2	63.3	64.9	244.2	498.3	821.4	978.4	1337.0	168.6	512.1	654.7	603.6	410.6	537.3	96.2	782.3	1197.0	474.2	740.9	714.2	762.1	327.1	835.6	808.8	895.0	782.4	633.6	473.3	1556.7	68.3	634.1	613.9	1908.4	2168.6	878.5	1189.4	1459.3	1100.1	742.2	240.0	653.0	927.0	616.0	1515.7	241.4	543.3	956.8	450.5	191.9	1334.3	732.5	827.4	772.2	931.8
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786178-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 45.0;Late spermatids: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	7.2	13.0	14.7	8.1	16.4	4.3	9.0	10.0	16.6	7.2	7.1	17.9	3.3	6.6	11.0	18.8	5.1	9.1	8.0	11.6	15.1	10.8	7.0	11.3	10.5	8.6	22.5	11.7	15.2	35.8	13.1	18.9	7.7	14.5	6.7	8.2	11.7	10.7	6.7	8.1	4.7	6.3	9.2	16.5	18.6	11.5	27.5	14.9	6.1	9.3	4.6	7.8	7.2	5.3	9.0	9.3	1.9	8.3	6.6	10.2	6.7	9.5	10.4	11.6	10.4	9.5	8.7	10.8	5.7	8.3	6.0	7.7	9.9	13.6	17.5	8.5	5.0	8.2	12.1	11.0	10.3	10.1	7.3	9.9	10.5	6.5	7.6	6.2	5.6	6.7	9.2	12.9	5.6	11.1	8.6	15.1	18.7	10.4	4.6	6.2	18.6	10.1	8.5	13.3	15.3	13.9	12.3	7.9	10.3	9.1	13.6	16.5	7.3	8.7	12.0	5.4	11.0	23.5	5.9	7.2	7.0	6.2	5.2	4.7	12.0	9.0	10.8	6.0	9.9	8.7	0.7	5.9	1.9	7.9	6.7	9.6	9.0	7.1	7.4	9.3	7.7	10.2	7.5	1.8	6.6	8.3	6.2	5.7	6.7	14.7	16.4	10.0	15.0	15.1	10.8	22.5	11.7	14.5	14.9	6.0	10.9	4.5	1.4	1.0	2.2	6.1	10.2	0.0	2.3	3.5	9.8	1.3	0.0	2.9	45.0	5.8	1.3	0.0	2.8	2.3	1.9	2.3	1.1	8.1	6.4	0.0	4.1	6.2	4.7	52.1	2.0	4.3	1.7	0.0	4.1	4.3	2.5	0.0	4.6	1.0	8.0	6.5	1.4	17.4	3.2	0.4	1.0	2.5	3.7	1.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.5;U-937: 15.3"									"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.2	7.2	1.8	2.1	0.0	1.5	3.2	1.8	5.6	0.6	2.6	6.2	5.3	1.3	4.5	4.6	7.0	2.0	1.4	4.6	2.5	5.2	0.5	0.0	1.6	5.3	0.4	2.8	2.0	2.1	2.1	3.2	2.3	4.1	3.3	9.8	1.3	4.5	5.2	16.5	2.9	6.4	2.6	4.3	2.2	5.0	1.5	2.5	1.0	2.3	2.1	2.1	0.2	2.8	2.2	10.0	1.3	4.8	2.7	0.0	1.7	11.3	8.9	9.2	1.6	15.3	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4	11.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	3.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	23.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171199-55180441	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 73.0"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 12.6;Intestinal endocrine cells: 55.3;Late spermatids: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.3;HMC-1: 27.4;K-562: 9.6;OE19: 41.7;SCLC-21H: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA					"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	1.2	9.8	20.0	2.7	30.9	1.4	1.0	1.3	73.0	1.8	1.7	1.0	0.0	2.2	1.2	1.0	1.2	1.3	1.3	1.1	22.0	18.8	1.1	1.1	1.2	1.2	6.1	19.8	1.1	2.6	1.1	16.3	1.1	8.3	1.1	1.7	0.0	1.1	1.0	1.2	1.4	1.8	1.5	1.9	1.2	2.9	3.5	3.6	0.0	1.2	0.0	1.3	1.1	0.0	1.0	1.8	3.6	0.8	1.1	0.5	0.5	0.1	0.1	0.2	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.5	0.7	12.3	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	27.4	0.3	0.1	0.0	0.0	0.0	0.2	0.2	9.6	1.7	0.0	0.2	0.2	0.0	0.0	41.7	1.7	0.0	0.1	0.1	0.0	0.0	7.2	3.2	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.6	0.6	0.8	0.0	0.1	0.5	0.3	0.2	0.0	0.1	3.6	0.8	1.1	0.4	0.5	0.4	0.7	0.3	0.5	1.8	1.0	0.4	0.5	3.4	1.1	0.4	0.8	0.3	0.5	20.0	30.9	1.3	36.6	22.0	18.8	6.1	19.8	8.3	3.6	0.0	0.0	0.0	0.1	0.6	1.2	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.3	12.6	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.2	6.4	55.3	0.6	0.0	27.9	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.4	0.0	0.3	0.0	0.4	4.5	2.6	0.1	0.0	0.5	0.3	0.3
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Cell line enhanced"	"Detected in some"		"AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		4700000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	41.8	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	5.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	10.9	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	16.4	0.0	5.4	0.0	5.0	0.0	0.0	0.0	30.4	0.7	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.2	1.5	0.0	0.7	11.1	11.1	15.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4	0.0	2.2	0.0	0.0	1.0	38.4	0.4	0.0	40.2	11.4	0.0	31.4	0.1	0.0	0.0	0.2	0.5	5.4	0.0	0.2	0.2	1.4	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	5.2	0.3	0.0	0.4	0.1	43.8	0.0	1.4	1.5	3.4	1.0	0.1	5.3	0.6	0.0
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 30.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 48.2;Early spermatids: 113.3;Late spermatids: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;HHSteC: 5.7;MOLT-4: 6.9;SH-SY5Y: 30.2;SuSa: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favorable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	2.8	4.6	3.1	2.9	4.6	8.2	1.5	20.3	6.1	3.0	2.7	5.2	9.9	2.0	3.3	3.0	1.5	17.4	30.4	1.6	3.8	3.8	6.3	1.7	3.6	4.0	3.8	5.4	2.2	1.7	0.9	21.4	1.0	10.8	3.2	0.9	8.0	2.1	10.3	1.3	1.4	2.2	3.7	5.1	4.2	8.5	13.3	3.4	22.3	2.0	0.0	4.4	1.7	1.7	2.1	6.2	10.7	6.3	3.3	6.9	1.3	0.0	0.1	6.7	0.0	0.2	0.3	0.3	0.3	0.3	0.6	0.5	0.0	0.7	0.1	0.0	0.0	0.4	0.3	0.2	0.0	0.4	0.6	0.1	0.2	0.3	0.0	5.7	0.1	0.9	3.1	0.3	0.2	0.0	2.6	1.2	0.2	0.0	0.9	0.0	0.1	6.9	1.1	2.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.1	30.2	0.0	0.0	0.2	17.5	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.1	0.3	0.1	0.0	0.1	0.1	2.6	0.1	10.7	6.1	1.2	6.9	2.1	2.2	3.3	3.8	1.6	1.0	3.1	0.1	3.3	6.3	6.2	3.5	1.3	3.1	4.6	20.3	6.1	3.8	3.8	3.8	5.4	10.8	3.4	11.9	13.3	7.0	4.4	1.6	15.5	1.7	22.9	48.2	13.6	26.2	0.0	1.1	5.0	2.2	113.3	4.1	3.5	0.0	2.4	2.8	2.4	1.0	3.5	2.5	2.0	6.4	4.6	4.3	5.9	57.2	4.4	5.6	1.7	1.0	2.3	23.8	3.6	0.0	2.8	23.3	1.6	0.0	1.4	1.9	37.5	1.8	0.3	8.7	1.7	1.8
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 124.4;Intestinal endocrine cells: 272.8"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	4.0	1.1	25.5	0.1	0.2	0.9	1.8	4.7	0.2	0.4	0.0	0.4	0.3	2.9	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.3	0.3	2.1	21.8	0.1	2.7	0.9	21.8	0.0	0.0	0.1	0.2	2.3	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	22.2	9.7	0.0	0.2	1.1	0.8	0.0	0.0	0.0	2.5	1.0	0.1	1.6	0.0	0.0	0.1	0.7	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0	6.0	0.0	0.0	0.2	0.0	124.4	0.2	0.0	1.4	2.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.1	7.9	272.8	1.3	0.8	0.0	0.6	0.0	1.7	0.0	0.7	11.9	24.2	2.9	0.4	0.0	12.7	0.0	0.5	0.1	0.2	0.1	0.1	0.0	0.3	0.6
STK40	"MGC4796, SgK495"	ENSG00000196182	"Serine/threonine kinase 40"	Q8N2I9	1	36339624-36385896	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 181.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.2"	"Group enriched"	"Detected in all"	5	"granulocytes: 19.2;monocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008026	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA008026: AB_1857603"	"unprognostic (3.32e-1)"	"unprognostic (3.00e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.69e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	22.9	7.2	9.8	15.3	9.4	9.2	26.5	8.9	11.1	10.2	19.1	7.4	16.7	9.4	11.8	12.2	22.3	11.3	18.2	25.6	10.0	7.1	14.3	23.5	16.6	15.4	13.1	7.4	22.2	34.4	9.2	14.7	19.2	12.1	15.7	9.1	9.0	25.1	17.7	53.9	17.2	10.8	26.0	10.3	17.2	17.0	32.0	8.9	9.2	14.6	20.7	16.6	19.5	26.6	2.4	2.7	19.2	8.5	1.6	2.9	2.4	7.1	3.1	15.7	16.3	11.1	6.5	8.8	7.2	9.8	8.8	9.5	17.2	10.3	30.2	5.9	6.7	9.3	7.2	14.3	3.1	6.5	13.1	11.2	19.7	2.9	21.9	11.1	11.5	26.3	5.8	11.9	6.7	3.5	4.7	5.5	23.4	24.2	11.0	5.4	11.2	11.9	15.2	10.1	12.9	4.3	13.7	10.7	20.0	5.5	8.0	19.3	9.8	5.5	8.7	24.1	10.4	5.9	13.6	9.1	5.5	11.6	16.2	15.9	11.5	6.4	25.5	28.9	10.1	18.1	1.0	3.0	4.9	2.6	6.7	2.9	2.3	1.7	1.7	2.7	2.4	1.0	1.5	19.2	1.6	8.5	2.6	1.0	2.4	9.8	9.4	8.9	11.1	10.0	7.1	13.1	7.4	12.1	8.9	11.9	18.3	19.8	48.5	54.5	12.0	21.1	2.5	6.7	7.9	10.4	3.9	4.7	14.9	14.5	92.4	11.0	27.7	0.0	27.1	8.3	15.3	55.1	12.7	19.5	21.4	9.5	22.4	12.9	20.3	181.6	21.3	21.3	28.7	14.4	12.9	4.5	23.4	14.4	31.5	10.5	9.5	25.8	30.9	12.6	8.7	65.9	47.8	14.6	10.8	43.7
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 199.1;Cardiomyocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	7	"K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	59.8	0.0	0.0	0.3	0.5	29.8	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.2	25.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.5	0.0	0.0	1.7	0.0	0.6	0.0	3.7	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6	0.0	0.0	0.0	0.1	0.0	199.1	76.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.8	0.8	0.0	0.0	23.3	0.2	1.0	0.9	0.1	26.4	0.0	0.3	15.9	15.6	2.5	0.0	2.5	2.3	0.0	0.0	0.0	0.7	2.7	0.5	0.0	12.4	0.0	9.6	0.0	1.9	0.7	2.6	0.0	0.2	0.0	0.2	0.3
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408261	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 176.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018558, HPA044999"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	47.5	28.1	141.5	26.9	148.2	57.2	21.5	149.6	176.0	27.4	55.9	49.4	20.7	53.9	20.3	41.7	58.8	48.6	29.5	52.3	139.8	86.1	61.5	39.0	38.7	27.8	85.2	100.1	20.9	22.6	41.4	27.6	38.6	106.1	33.7	60.5	22.2	33.2	43.5	100.2	19.3	50.6	42.6	71.1	29.3	35.6	22.3	49.8	12.6	22.7	18.8	37.8	32.7	21.8	45.7	42.8	90.3	53.7	88.8	118.3	109.4	26.9	37.6	44.9	17.2	50.5	44.5	38.4	49.8	42.7	38.5	41.8	40.0	47.9	29.2	26.0	58.7	18.1	45.2	28.1	69.2	64.2	56.8	18.0	30.9	32.4	36.6	27.7	46.8	24.9	27.9	34.6	37.7	13.4	25.6	86.8	20.3	14.2	40.1	52.7	91.7	15.4	45.8	26.1	74.4	52.6	30.9	40.1	19.7	31.8	83.3	94.1	39.5	43.5	76.2	27.8	38.9	50.4	16.4	53.8	32.5	20.8	34.0	41.4	22.4	50.6	32.1	51.4	39.4	45.1	90.3	31.8	71.0	96.0	37.9	118.3	45.7	102.5	101.0	42.8	35.7	74.8	88.1	47.0	88.8	53.7	40.5	105.6	109.4	141.5	148.2	149.6	176.0	139.8	86.1	85.2	100.1	106.1	49.8	360.3	314.0	329.2	485.1	503.7	1352.9	743.7	341.4	1962.0	494.8	378.6	115.8	358.0	389.6	484.7	100.9	794.0	1033.1	23.3	391.9	774.4	358.4	298.0	468.8	297.5	680.0	570.5	576.0	585.0	268.2	58.5	195.1	732.5	595.5	1203.7	393.5	1076.8	427.8	540.1	470.2	1073.9	291.0	310.4	582.3	94.1	162.2	507.4	959.8	581.7	530.3	385.0
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 67.0;Cone photoreceptor cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA					"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.6	13.8	7.8	2.8	16.0	4.4	2.1	20.6	22.3	2.2	3.5	2.6	0.0	7.7	2.5	2.2	4.8	2.5	7.2	3.8	10.7	7.9	3.7	2.7	1.8	1.2	6.1	10.0	4.3	2.1	7.3	14.8	2.7	16.3	5.8	3.6	13.2	4.6	4.4	3.3	2.2	9.7	1.7	3.1	1.5	3.4	5.4	2.3	5.0	2.1	1.5	1.0	3.6	2.1	0.0	0.5	0.0	0.4	3.8	1.1	0.3	2.3	5.4	9.7	5.4	0.1	0.2	3.6	0.7	0.0	0.1	0.0	10.0	2.0	3.7	4.5	0.9	11.7	0.9	5.1	4.3	0.6	14.5	4.5	4.8	0.5	0.2	1.1	8.8	0.8	1.0	0.9	1.4	3.1	4.9	5.3	8.8	0.7	0.0	0.0	1.4	9.8	0.6	4.2	2.8	2.9	18.4	1.7	0.0	1.1	4.9	5.1	8.1	3.5	0.6	6.3	8.2	0.6	2.7	5.3	11.0	2.3	0.0	5.9	3.6	0.2	7.6	4.5	8.0	51.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.1	0.9	0.5	0.0	0.0	1.1	0.0	3.8	0.4	0.0	0.0	0.3	7.8	16.0	20.6	22.3	10.7	7.9	6.1	10.0	16.3	2.3	0.0	0.3	0.0	0.7	4.8	67.0	6.7	0.0	0.0	1.2	1.8	37.3	0.4	3.3	1.3	3.6	2.3	3.1	0.0	1.0	0.2	1.7	1.5	0.0	1.7	0.6	12.7	2.9	3.7	0.8	3.3	1.1	0.0	0.0	0.0	2.6	3.3	1.7	2.5	2.5	1.1	4.7	0.0	0.9	0.5	10.2	1.5	0.2	0.5	2.9	0.6
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 74.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 67.6;Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.1;MCF7: 25.1;SCLC-21H: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA					"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	7.0	30.0	10.8	3.2	12.8	1.5	12.4	0.6	16.0	8.4	4.4	8.3	12.9	4.4	3.2	74.9	2.5	4.6	3.9	7.4	12.7	7.9	9.7	7.7	3.6	8.1	7.5	10.3	18.0	2.2	1.7	10.5	5.5	7.3	7.1	2.6	12.4	10.3	4.7	3.5	3.1	4.4	4.0	5.4	7.6	3.0	4.2	6.8	2.7	7.0	1.6	6.9	3.2	3.3	5.5	1.4	5.0	0.9	1.3	0.7	0.3	0.3	0.9	7.0	9.1	0.0	0.1	0.7	1.5	3.8	1.0	1.1	0.0	0.4	0.2	0.7	0.2	2.8	0.2	4.3	0.0	1.1	0.4	2.1	0.5	0.8	0.0	0.0	0.0	1.0	4.2	0.4	0.0	0.0	0.6	2.2	4.4	0.0	0.1	0.1	25.1	0.5	0.6	3.2	0.0	0.4	0.9	0.1	0.8	0.3	3.4	17.7	2.7	0.5	0.3	2.4	3.3	0.4	0.2	0.5	0.4	0.2	0.1	0.8	0.1	0.4	0.3	0.5	0.3	1.9	5.0	0.9	1.0	0.7	0.4	0.4	3.5	0.7	0.6	0.2	5.5	0.5	0.6	3.7	1.3	0.6	1.4	0.2	0.3	10.8	12.8	0.6	16.0	12.7	7.9	7.5	10.3	7.3	6.8	0.0	0.6	0.0	3.0	2.2	0.4	7.2	5.1	12.0	9.1	14.0	2.0	67.6	0.0	5.2	2.6	16.1	0.0	0.0	2.3	0.9	4.8	7.9	5.8	20.3	5.1	1.6	1.2	19.0	1.8	2.2	13.3	0.9	1.7	13.6	0.0	16.7	1.7	0.0	9.2	1.8	1.6	0.0	2.0	0.7	3.4	1.0	98.1	0.5	0.5	0.9
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell type enhanced"	"Detected in some"	15	"Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	NA	NA	6540000000	46000000000			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.53e-4)"	"prognostic favorable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	51.1	101.9	0.0	6.7	10.5	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	20.5	0.0	0.2	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5	0.0	0.0	0.0	0.0	3.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.8	10.5	0.0	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.8	0.0	0.0	43.0	1.2	15.2	27.9	0.8	3.3	1.0	0.0	0.0	0.1	0.0	6.0	0.0	0.1	0.0	4.2	0.0	0.0	3.3	0.1	0.0	0.0	0.0
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000				"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.2	1.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3	0.0	2.1	11.0	1.4	3.9	1.8	2.6	0.0	0.0	1.2	0.0	0.0	0.3	13.3	7.0	92.7	6.9	0.0	0.0	14.7	5.6	3.3	3.9	6.9	1.3	29.5	6.4	0.0	9.8	6.3	265.2	4.4	7.2	16.9	8.2	0.0	4.1	9.1	0.0	12.4	2.1	7.1	12.9	3.1	70.4	22.9	4.8	0.3	8.7	0.0	3.0
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	14.9	15.9	10.7	12.6	14.9	80.6	14.3	20.5	18.7	9.9	17.5	8.5	10.5	11.7	12.2	6.6	12.2	11.5	14.7	26.0	11.9	7.3	9.7	11.1	14.6	11.0	17.8	7.8	16.7	13.7	10.6	13.3	12.3	16.9	11.9	8.6	8.3	9.7	10.2	19.6	8.6	10.5	13.7	13.8	12.7	14.7	11.2	18.6	5.4	11.0	8.6	10.0	16.1	57.5	13.4	17.3	25.2	24.8	8.6	20.4	12.8	16.4	22.7	8.0	10.4	10.4	9.0	7.8	15.2	11.8	22.1	21.6	22.9	8.2	10.8	6.7	16.4	32.5	12.6	25.3	7.5	21.4	7.7	20.1	16.1	15.9	23.1	16.7	8.4	24.7	10.6	11.9	24.3	8.2	14.1	18.4	5.9	23.9	20.2	16.4	10.3	14.5	12.0	7.0	15.9	27.5	11.5	15.1	16.7	7.5	5.2	13.9	13.7	13.2	19.6	18.1	14.4	17.5	12.5	11.8	25.9	15.1	13.3	28.1	22.4	11.9	10.0	25.0	7.4	14.3	25.1	19.4	25.2	17.6	24.8	17.0	13.4	20.4	19.5	17.3	9.2	17.0	15.8	15.4	8.6	23.7	14.9	19.5	12.8	10.7	14.9	20.5	18.7	11.9	7.3	17.8	7.8	16.9	18.6	23.8	25.1	29.2	77.6	73.8	14.6	19.8	20.4	12.0	22.7	8.7	47.1	25.1	14.9	26.0	22.7	26.3	38.4	0.0	23.8	37.8	34.9	35.0	63.6	8.6	28.6	6.4	37.7	27.0	17.6	8.6	15.0	33.2	55.6	37.9	18.1	14.1	24.5	19.9	16.6	6.7	34.5	12.9	62.8	45.9	25.9	64.4	25.5	38.3	20.4	33.1
GPRASP2	"FLJ37327, GASP2"	ENSG00000158301	"G protein-coupled receptor associated sorting protein 2"	Q96D09	X	102712176-102717733	"Predicted intracellular proteins"			"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017438	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA017438: AB_1849504"	"unprognostic (8.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.14e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.71e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (4.60e-6)"	"unprognostic (1.19e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (6.63e-5)"	3.7	12.2	13.8	1.5	22.6	0.2	6.1	16.9	30.0	7.7	3.7	3.4	1.7	1.3	13.8	7.4	3.3	8.8	4.0	10.9	15.8	22.3	8.1	5.2	3.9	1.2	8.7	22.5	24.8	7.1	13.3	11.5	2.8	18.7	10.2	2.5	3.6	6.6	9.8	5.2	4.4	1.8	8.3	7.2	3.0	2.2	3.6	4.1	0.8	12.0	1.3	1.3	3.6	3.8	0.4	1.6	0.0	0.6	2.1	4.7	1.2	0.5	5.1	13.7	10.5	4.3	5.2	1.0	7.8	7.0	6.7	13.1	1.7	2.4	0.0	2.7	8.0	3.4	1.8	16.3	4.2	8.5	0.0	6.3	0.7	1.5	0.4	3.1	1.2	1.0	5.4	4.5	7.5	0.3	7.9	4.7	1.3	1.9	0.5	8.1	2.4	3.6	0.5	6.8	1.6	7.1	4.7	2.2	0.0	4.2	1.9	3.0	9.4	7.8	1.6	1.0	4.4	4.4	2.7	4.2	4.8	10.0	9.6	7.4	0.2	0.3	0.0	6.4	0.8	2.6	0.0	0.4	0.0	0.9	0.6	0.8	0.4	1.1	1.3	0.8	0.4	4.7	1.9	0.0	2.1	0.2	1.6	1.6	1.2	13.8	22.6	16.9	30.0	15.8	22.3	8.7	22.5	18.7	4.1	0.0	1.0	0.0	5.3	2.1	16.1	14.9	10.2	0.0	4.5	5.2	2.0	5.0	8.3	1.3	0.4	4.3	0.2	0.0	0.8	0.6	4.9	3.2	0.0	7.3	0.8	15.9	2.9	8.0	1.6	0.8	11.2	0.3	0.0	0.0	1.3	10.0	1.5	1.9	11.7	7.7	6.4	6.5	4.1	4.4	4.3	2.6	1.8	0.0	1.1	0.5
TUBGCP6	"DJ402G11.6, GCP6, KIAA1669"	ENSG00000128159	"Tubulin gamma complex associated protein 6"	Q96RT7	22	50217689-50244992	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043928	Approved					NA	NA					"HPA043928: AB_10960352"	"unprognostic (4.26e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.90e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.53e-2)"	"prognostic favorable (3.18e-5)"	9.5	13.9	18.2	15.6	17.0	14.9	10.5	35.4	20.0	13.4	9.7	16.2	12.7	12.4	15.0	11.2	10.9	13.5	13.7	11.6	15.3	10.6	12.8	10.1	12.0	19.8	18.6	15.6	17.1	21.9	24.5	21.4	10.6	13.7	14.3	6.6	14.1	18.9	14.5	13.0	17.8	13.7	13.0	9.1	16.9	12.6	17.1	18.8	17.9	17.5	5.5	14.5	11.9	9.3	3.2	3.4	2.4	1.9	2.5	6.0	2.4	5.9	5.5	10.5	12.5	8.5	7.9	6.6	6.6	4.9	5.4	6.3	3.7	5.4	5.4	4.9	7.7	4.6	7.1	5.3	7.8	2.4	4.8	15.5	5.4	20.5	4.9	6.1	11.0	11.1	12.0	7.2	6.7	5.8	9.2	7.6	11.3	5.4	15.7	5.1	6.6	8.2	8.6	3.2	3.1	3.0	9.8	5.9	10.9	4.7	7.9	3.7	7.0	5.6	11.1	2.9	4.7	5.4	6.5	7.7	7.7	4.8	6.6	5.0	14.7	2.8	6.3	6.6	5.0	5.0	1.6	1.8	1.4	5.6	1.9	4.0	2.3	4.3	6.0	2.4	3.2	3.7	4.1	2.4	2.5	1.7	3.4	5.3	2.4	18.2	17.0	35.4	20.0	15.3	10.6	18.6	15.6	13.7	18.8	8.9	18.8	8.2	2.6	5.7	8.6	5.6	10.2	9.4	7.9	10.4	15.7	3.7	3.3	3.6	1.6	6.3	6.9	0.0	3.1	2.3	5.0	4.4	5.8	7.8	3.9	6.4	8.6	6.2	11.1	3.1	8.9	5.7	6.8	1.8	7.3	3.7	4.3	3.5	6.3	1.3	10.6	6.5	3.1	8.3	7.9	4.8	2.9	10.0	6.3	2.6
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801243	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.4"	"Cell line enriched"	"Detected in single"	21	"MOLT-4: 16.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036313, HPA052147"	Enhanced					NA	NA		13000			"HPA036313: AB_10795355, HPA052147: "	"unprognostic (9.81e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (8.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (3.56e-4)"	3.6	0.2	0.3	13.0	0.6	8.0	0.9	0.2	0.2	0.6	9.6	0.2	0.0	4.9	0.4	0.4	2.0	1.5	2.7	0.2	0.5	0.4	0.3	0.3	25.9	8.1	0.3	0.0	0.9	1.2	0.5	0.4	0.1	0.2	1.2	2.0	0.2	1.8	3.9	0.3	0.6	20.2	2.0	0.7	1.4	3.6	1.6	0.1	3.1	1.0	1.5	5.3	1.9	2.5	0.2	0.1	0.0	1.0	0.0	7.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.7	16.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	1.0	3.1	0.2	1.0	7.4	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.9	0.9	0.3	0.6	0.2	0.2	0.5	0.4	0.3	0.0	0.2	0.1	6.0	25.5	50.2	35.5	26.7	15.9	58.6	43.3	28.1	21.6	14.0	7.9	24.2	77.9	33.2	38.9	29.2	23.6	0.0	57.0	49.7	37.3	38.0	67.9	39.4	49.2	6.4	27.1	40.5	43.7	30.3	24.7	54.5	55.6	41.5	24.9	35.9	42.9	21.0	28.0	67.5	13.0	25.8	38.1	61.9	29.7	36.1	11.0	55.3	34.6	29.8
ATP6V0E2	"ATP6V0E2L, C7orf32"	ENSG00000171130	"ATPase H+ transporting V0 subunit e2"	Q8NHE4	7	149872968-149880698	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 92.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 112.2;Horizontal cells: 108.1;Muller glia cells: 136.8;Proximal tubular cells: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 51.0"															NA	NA						"unprognostic (8.72e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.26e-7)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.48e-3)"	11.8	17.3	60.1	6.5	56.5	3.6	8.6	70.5	92.7	6.4	6.7	26.4	14.2	5.0	4.3	6.2	6.0	13.4	5.9	27.9	73.7	55.3	26.9	27.9	6.8	12.1	61.1	39.7	4.9	11.7	14.0	25.3	3.1	57.1	26.2	5.3	18.7	37.0	24.8	8.7	4.7	4.6	6.3	29.4	8.3	7.3	3.2	12.2	8.4	26.6	2.0	8.1	4.9	1.7	7.0	6.4	1.5	6.9	12.0	30.6	11.2	7.5	21.2	8.8	28.6	3.6	0.6	5.5	3.9	5.4	10.8	11.1	7.4	9.5	15.4	16.6	5.2	11.2	6.7	18.7	6.6	4.6	19.8	20.8	4.8	6.5	42.5	5.3	3.5	10.6	1.2	6.9	11.9	0.7	8.4	8.9	19.5	5.1	7.6	0.7	12.9	2.5	8.0	7.6	9.7	14.9	16.8	0.3	7.2	8.4	8.1	51.0	28.9	5.1	17.8	11.9	2.2	10.0	2.3	1.6	3.1	3.3	32.7	14.5	10.6	13.5	7.4	19.9	6.1	10.1	1.5	3.1	0.7	16.7	5.8	15.4	7.0	21.0	19.5	6.4	6.3	27.5	24.7	0.4	12.0	6.9	3.0	30.6	11.2	60.1	56.5	70.5	66.4	73.7	55.3	61.1	39.7	57.1	12.2	14.9	13.7	15.9	4.7	3.8	112.2	25.4	22.9	6.7	10.3	26.2	23.6	17.3	46.4	40.1	0.1	3.2	0.9	0.0	11.2	2.1	6.7	22.5	10.4	50.4	21.2	108.1	21.4	9.2	6.6	1.3	4.9	9.6	42.2	5.4	16.3	136.8	6.3	0.0	10.6	94.9	61.7	6.5	10.3	0.5	12.4	3.9	4.2	28.7	2.6	3.3
SFI1	"KIAA0542, PISD, PPP1R139"	ENSG00000198089	"SFI1 centrin binding protein"	A8K8P3	22	31488688-31618586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 112.8;Rod photoreceptor cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (7.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.82e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.31e-4)"	3.9	7.3	6.9	14.4	12.1	17.9	5.6	34.0	9.2	5.1	5.7	5.6	11.9	12.7	6.3	6.5	5.1	7.3	5.7	3.2	6.3	6.5	6.7	3.8	5.9	16.0	6.7	6.1	6.5	6.1	6.7	17.5	3.9	7.7	6.4	4.0	10.0	6.9	7.2	2.2	8.9	11.0	5.5	5.5	11.9	8.3	13.6	7.3	22.2	7.6	2.4	22.1	5.7	5.1	4.0	1.7	6.0	4.5	9.6	11.0	4.9	9.4	6.0	5.6	6.9	3.1	3.2	3.4	7.5	3.2	5.5	6.6	5.5	6.6	14.6	3.0	2.4	3.5	8.9	2.7	4.8	3.7	12.3	8.8	3.5	13.0	6.5	4.2	13.9	11.8	2.2	3.2	5.8	4.1	4.3	4.7	13.9	4.6	7.2	4.4	14.3	9.9	8.8	2.5	6.8	3.5	11.0	6.6	10.5	3.4	9.5	8.6	4.7	6.7	9.5	6.1	2.2	7.1	6.0	9.0	7.7	6.9	6.8	5.3	8.7	6.4	7.7	7.7	7.8	6.0	5.7	1.2	3.1	9.7	1.3	4.5	4.0	7.9	11.0	1.4	3.7	10.7	9.4	6.0	9.6	4.5	1.7	6.0	4.9	6.9	12.1	34.0	9.2	6.3	6.5	6.7	6.1	7.7	7.3	6.0	28.7	11.5	6.7	3.5	43.2	2.2	10.2	28.1	23.9	15.7	33.4	6.2	1.7	6.3	11.2	9.0	24.2	0.0	4.5	2.1	4.8	6.0	19.7	2.6	4.5	112.8	10.9	4.3	7.3	4.0	4.9	5.7	3.3	4.6	13.2	9.2	6.0	10.5	1.8	2.4	65.6	0.0	2.2	27.8	27.7	2.9	15.8	26.2	8.0	5.5
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.1	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	1.4	2.6	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.3	2.9	5.0	2.1	3.1	5.1	3.5	5.9	4.9	5.3	1.1	5.7	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	1.6	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9	77.4	85.3	270.8	168.6	148.1	59.5	296.6	234.4	179.3	92.1	193.7	19.6	251.6	485.7	138.8	92.3	121.8	346.2	0.0	174.6	167.3	105.2	269.9	91.0	309.5	220.1	52.4	331.5	110.5	164.5	80.6	175.2	186.8	200.8	116.4	276.7	86.2	148.7	295.1	140.0	446.7	82.0	122.9	137.7	196.7	54.5	239.6	258.2	167.5	271.3	230.0
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 374.6;Late spermatids: 209.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.5	14.3	1.7	1.0	1.5	1.7	2.7	4.5	3.7	2.2	2.9	1.0	3.2	5.8	0.8	4.1	1.5	3.2	1.6	1.9	4.4	2.0	2.9	2.9	3.9	0.0	2.7	2.2	2.9	1.8	3.0	2.2	6.6	1.1	2.5	3.2	1.8	4.4	0.1	2.4	0.7	1.9	0.1	0.1	2.0	1.8	5.3	0.8	7.4	5.6	3.3	1.4	3.7	0.5	0.0	4.5	0.9	0.8	4.9	2.8	3.7	1.9	3.4	2.4	2.6	4.6	2.2	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3	6.0	11.1	11.2	13.5	7.6	12.9	6.5	7.6	8.1	6.8	3.5	15.7	12.3	16.6	7.5	374.6	6.3	6.1	0.0	10.8	7.9	10.8	9.4	5.8	9.7	5.9	4.8	15.5	6.7	4.9	209.7	16.4	6.7	11.8	4.6	7.0	16.2	6.4	8.6	11.7	11.7	14.7	12.9	10.8	58.1	11.8	4.8	16.8	13.1	6.8	7.3
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.4;testis: 25.5"	"Cell type enhanced"	"Detected in many"	25	"Early spermatids: 201.0;Late spermatids: 43.8;T-cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"NK-cells: 16.9;T-cells: 29.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 30.9;U-266/70: 17.4;U-266/84: 6.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA001860, CAB013108"	Enhanced					NA	NA					"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	4.2	3.6	2.1	9.6	12.7	11.2	2.9	1.1	15.5	1.7	3.7	0.0	0.3	4.1	1.7	2.4	1.5	1.7	4.2	20.3	3.3	6.5	2.7	7.6	8.4	14.1	3.3	8.3	1.5	2.2	0.7	19.6	2.4	8.5	1.9	3.2	2.3	4.5	1.5	1.1	1.3	6.6	1.3	2.5	13.8	3.6	25.5	0.5	4.2	2.4	1.0	12.8	3.3	1.9	0.4	2.0	2.3	0.2	16.9	29.4	10.7	0.0	1.0	0.6	0.0	0.0	1.9	0.2	0.2	1.1	0.3	1.3	0.2	0.5	0.0	0.1	1.4	0.8	0.5	0.0	2.6	0.7	0.0	0.5	0.7	0.0	0.0	0.3	0.0	0.0	0.9	1.2	0.7	0.3	0.0	0.0	3.0	0.0	30.9	0.1	0.0	1.7	0.0	0.2	0.0	0.5	0.0	0.0	2.1	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	17.4	6.1	0.0	0.7	0.0	0.0	2.3	0.1	0.0	29.4	0.2	26.5	0.4	17.5	23.8	0.1	0.2	16.7	23.8	0.6	16.9	0.1	2.0	6.1	10.7	2.1	12.7	1.1	15.5	3.3	6.5	3.3	8.3	8.5	0.5	3.0	6.2	1.9	0.6	1.1	0.0	15.1	0.0	0.0	0.0	1.8	7.9	0.1	0.0	0.4	201.0	0.6	0.0	0.0	0.2	2.0	1.4	0.8	1.1	0.9	1.0	0.0	0.0	1.3	2.9	43.8	0.3	4.3	5.0	8.2	0.0	0.0	0.2	0.0	0.4	0.7	0.2	0.0	1.4	1.0	1.0	1.5	0.5	84.1	0.2	0.7
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150001167	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	6.9	10.5	5.9	3.9	10.7	2.8	9.9	9.3	9.4	5.8	6.1	10.0	8.9	4.7	6.5	11.1	5.0	6.9	5.1	4.5	6.4	4.7	7.7	7.0	5.3	3.9	7.3	7.1	8.6	6.8	28.0	10.5	5.5	7.1	8.8	5.7	6.4	8.1	12.6	3.8	7.2	5.2	5.9	7.6	5.8	6.1	9.8	8.0	6.1	6.5	3.6	4.3	6.2	6.1	3.5	3.3	2.1	4.0	6.3	8.0	2.6	2.3	6.4	4.3	9.2	12.4	10.2	6.7	6.7	7.1	5.3	5.3	4.1	4.2	1.1	6.0	7.9	6.4	4.2	3.8	4.9	6.3	5.0	3.2	2.0	3.3	2.2	11.0	2.8	5.0	10.5	9.4	6.8	8.9	6.2	4.1	4.6	2.7	5.4	6.5	5.5	3.7	1.3	1.8	3.0	5.4	4.2	4.9	3.0	5.0	3.4	3.3	4.3	4.7	7.6	9.5	5.5	8.5	4.9	5.4	4.3	3.3	4.7	4.9	4.0	1.5	3.0	6.8	3.1	6.6	0.2	4.0	2.1	2.8	3.9	2.5	2.7	3.8	2.8	3.3	3.5	8.0	5.1	0.0	6.3	2.2	2.2	3.7	2.6	5.9	10.7	9.3	9.4	6.4	4.7	7.3	7.1	7.1	8.0	11.9	2.4	0.0	5.8	1.9	4.8	4.6	2.5	2.7	4.5	3.5	0.0	4.6	6.6	4.3	1.1	2.3	2.5	0.0	4.2	2.2	2.5	6.1	3.5	1.3	3.7	3.2	2.9	3.1	1.2	1.9	4.0	2.2	3.3	7.2	2.5	6.1	3.4	2.3	3.2	6.7	5.6	0.0	3.9	16.4	5.5	1.0	3.0	0.9	2.3	3.8
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.7	5.0	8.5	6.5	4.7	3.1	4.9	3.8	4.5	0.4	5.0	10.6	5.4	3.3	3.7	4.8	0.0	8.3	2.2	5.9	5.1	11.2	0.0	3.3	5.6	3.2	3.9	2.9	3.8	10.3	7.3	6.3	3.7	10.3	2.6	9.3	3.9	2.5	10.7	3.7	0.0	4.8	1.1	3.9	6.8	6.5	5.1	2.5	13.3	7.9	4.1	1.8	4.5	5.0	4.8	8.0	3.9	6.5	6.9	0.0	0.0	5.9	8.4	3.3	7.4	7.3	4.1	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2	35.7	20.0	26.8	20.9	22.1	26.8	33.6	25.5	16.0	18.2	17.4	33.4	24.3	38.1	26.7	27.1	28.6	27.3	0.0	20.7	31.7	23.0	23.7	33.6	28.2	24.1	11.1	26.0	22.1	26.4	38.0	31.9	22.9	18.6	47.7	22.5	36.1	20.0	26.2	23.3	53.2	41.2	19.4	35.7	161.5	75.2	29.9	39.4	34.1	25.0	17.4
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.4"	"Group enriched"	"Detected in many"	20	"Early spermatids: 425.4;Late spermatids: 1065.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA036538: AB_10670802, HPA060154: AB_2684212"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	4.1	4.0	8.2	2.9	15.7	1.9	4.3	10.7	19.5	4.7	3.3	12.4	0.7	1.8	7.6	4.9	3.9	4.9	4.2	6.3	8.7	8.7	4.5	1.2	4.5	3.3	8.8	11.7	10.7	2.3	6.5	7.1	4.1	16.2	4.9	3.0	3.4	2.1	5.9	8.4	2.2	2.4	6.8	9.0	2.9	2.4	51.4	7.5	1.2	5.1	1.7	2.6	3.4	3.3	3.5	2.0	2.1	2.0	6.0	6.7	1.4	1.6	1.8	11.3	10.4	6.3	6.7	1.2	3.4	7.5	6.0	11.0	4.0	1.3	7.5	9.3	5.3	13.3	2.9	6.3	10.2	6.3	17.0	8.4	5.1	3.8	1.9	5.0	0.6	2.5	9.0	1.3	10.0	6.1	10.2	8.2	2.9	2.2	7.3	8.9	0.9	2.2	2.4	7.8	0.6	2.5	6.2	12.3	1.2	3.6	1.8	10.5	11.0	3.5	1.4	7.7	15.2	1.6	3.8	10.5	8.0	0.0	2.4	7.2	8.7	11.4	4.0	4.3	3.8	3.4	1.9	2.0	2.1	2.2	1.3	3.2	3.5	3.2	4.1	1.5	3.5	3.2	2.0	0.6	6.0	0.7	2.0	6.7	1.4	8.2	15.7	10.7	19.5	8.7	8.7	8.8	11.7	16.2	7.5	3.0	4.6	2.2	8.0	1.3	29.0	8.8	0.0	2.7	7.9	1.8	9.8	3.8	1.7	4.8	425.4	11.3	0.5	0.0	0.9	3.3	5.4	2.7	9.2	0.0	2.4	15.9	12.1	12.9	3.1	1065.4	13.0	2.6	5.0	4.6	2.5	14.5	2.5	1.4	17.7	2.9	18.4	19.4	8.5	37.2	4.9	1.0	3.9	3.2	1.2	2.6
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu binding protein 2"	P38935	11	68903842-68940602	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	7.2	6.0	6.9	8.1	11.0	13.8	9.4	17.7	14.9	8.1	14.6	8.3	14.3	9.7	12.0	5.4	8.8	8.5	7.8	7.7	6.6	5.3	6.7	8.7	7.3	7.9	4.6	7.0	9.4	9.6	7.7	6.0	6.5	6.6	9.0	6.1	7.9	12.7	10.0	12.2	11.7	9.4	8.1	4.1	8.9	9.1	36.9	5.7	10.0	7.3	5.9	8.8	8.8	8.3	5.0	3.3	4.7	12.1	2.7	5.1	2.7	8.0	9.3	5.6	8.9	4.5	3.5	8.4	8.1	5.1	10.0	6.6	18.8	8.1	7.0	11.4	4.1	8.1	12.9	9.3	5.1	4.2	8.3	7.8	10.0	10.9	6.1	5.2	7.6	9.5	2.6	6.1	10.6	5.4	5.0	5.1	12.4	11.7	9.0	3.4	6.3	11.9	13.6	4.9	11.0	9.8	10.0	8.4	8.6	4.7	7.3	8.9	6.5	9.6	8.2	19.1	3.8	12.7	5.7	6.9	8.6	7.6	11.5	8.3	10.1	7.7	8.1	6.1	7.4	7.8	0.0	3.9	2.2	5.1	3.3	4.7	5.0	3.4	4.0	3.3	3.3	2.4	3.3	4.7	2.7	12.1	2.5	4.0	2.7	6.9	11.0	17.7	14.9	6.6	5.3	4.6	7.0	6.6	5.7	6.0	10.6	2.9	3.6	5.0	9.1	4.3	5.1	2.7	6.8	1.8	19.6	3.9	1.7	4.8	77.4	5.8	3.5	0.0	4.3	3.8	5.0	6.2	6.9	4.7	5.0	11.1	2.9	2.5	3.2	25.6	7.2	5.2	1.7	8.2	3.4	6.6	4.9	5.8	6.7	2.0	9.6	0.0	6.6	20.9	6.5	5.8	5.6	5.1	4.3	4.8
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191347-56357457	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 102.5"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 161.5;Horizontal cells: 74.7;Peritubular cells: 41.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.0;BJ hTERT+ SV40 Large T+: 11.3;SCLC-21H: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced					NA	NA					"CAB008387: AB_591430, HPA040878: AB_2677184"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	4.6	9.4	42.6	4.7	50.8	1.8	2.3	40.6	102.5	3.4	9.9	24.4	9.1	4.7	5.2	4.6	4.5	4.3	4.2	12.8	37.9	34.8	2.3	7.7	2.6	2.7	28.1	38.5	2.6	5.4	1.9	10.2	2.2	25.2	6.9	6.7	3.1	2.7	18.2	3.5	2.7	5.3	11.2	20.5	2.9	6.2	10.2	32.5	0.0	2.5	0.0	2.7	5.9	0.9	0.0	0.1	0.0	0.0	0.0	1.7	1.0	4.0	0.0	0.3	0.0	0.0	0.0	0.5	4.2	17.0	11.3	5.4	0.2	0.0	0.0	0.1	0.0	4.2	0.3	2.7	0.0	7.6	0.1	0.5	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.4	0.0	0.0	6.3	0.1	0.0	0.0	4.0	0.1	0.0	0.0	34.6	6.9	7.0	0.1	0.4	1.8	0.1	0.0	0.0	0.1	4.0	0.0	1.9	0.5	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.7	0.5	0.1	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.0	42.6	50.8	40.6	45.7	37.9	34.8	28.1	38.5	25.2	32.5	0.0	0.3	0.0	0.2	0.7	161.5	33.6	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	21.4	1.4	0.0	0.0	0.0	0.2	2.1	0.3	0.0	9.4	0.1	74.7	22.3	1.3	0.6	38.1	32.2	0.0	3.3	0.0	0.0	19.9	0.5	0.0	41.8	0.1	12.5	0.0	3.6	16.6	9.2	0.4	0.1	2.9	0.0	0.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 428.0;Early spermatids: 226.1;Late spermatids: 212.9;Rod photoreceptor cells: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA037605: AB_10672908, HPA037606: AB_10672498"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	9.0	12.6	9.3	18.4	9.4	16.0	3.0	17.9	10.1	12.9	12.7	15.5	14.7	17.9	13.0	11.0	12.7	12.0	10.3	10.5	11.1	17.7	8.5	5.4	12.4	4.9	13.8	7.7	12.1	11.1	9.0	19.5	19.1	11.6	16.7	8.9	14.6	11.7	10.1	7.8	7.1	7.0	6.6	5.9	13.7	9.6	11.1	7.0	5.7	7.8	10.8	15.7	14.3	8.7	10.3	10.9	12.0	9.1	18.0	15.4	9.6	14.8	16.4	4.2	5.0	10.6	7.5	8.8	10.2	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3	6.0	16.2	12.3	9.5	6.8	78.2	4.2	7.6	37.5	11.4	10.4	428.0	3.8	1.7	9.8	226.1	15.7	5.1	0.0	12.7	5.7	11.2	7.3	18.5	8.1	11.2	69.9	14.9	8.6	6.9	212.9	22.2	10.3	5.0	18.0	8.8	21.5	9.9	5.8	15.9	4.5	288.7	0.0	13.7	36.7	17.4	7.0	1.8	15.9	9.3	4.7
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.2	9.3	19.2	9.5	7.1	11.0	7.8	10.1	14.6	15.0	12.9	8.6	15.8	7.3	9.0	7.8	11.8	9.6	9.0	12.4	9.4	11.8	4.0	8.1	18.3	7.2	6.5	7.8	5.9	10.4	19.3	5.8	7.2	21.0	16.2	8.2	3.1	8.1	19.9	10.6	7.8	12.6	5.6	8.3	17.0	5.5	12.2	8.9	13.3	19.1	11.2	19.3	6.5	5.9	5.7	9.9	4.3	16.1	11.4	11.4	10.1	7.7	8.0	11.3	17.2	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1	0.0	5.9	5.4	11.8	20.4	12.7	3.7	20.4	20.1	10.3	10.4	13.7	8.1	5.0	17.9	77.4	35.6	18.8	0.0	10.2	17.9	10.3	10.3	4.6	39.5	5.8	20.6	41.5	26.4	6.3	21.4	8.1	4.7	8.5	3.6	15.0	11.3	13.3	18.2	10.6	10.1	9.9	6.5	12.3	14.2	17.9	23.8	18.5	10.2	15.6	15.5
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 142.8"	"Group enriched"	"Detected in many"	4	"Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"classical monocyte: 21.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	12.9	38.7	41.2	9.5	46.2	3.1	8.1	49.1	142.8	24.3	52.0	30.2	9.2	7.6	54.8	19.0	9.8	26.7	29.0	25.6	35.4	51.6	12.3	10.4	21.5	8.5	18.4	59.5	82.8	9.5	3.5	28.5	5.6	20.2	35.6	11.7	11.9	9.8	22.9	11.0	3.9	16.3	58.5	12.8	42.8	17.6	23.2	18.5	2.9	15.9	6.4	5.9	38.1	13.9	0.0	3.6	0.5	21.9	0.0	0.3	5.1	0.0	0.2	37.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.4	0.1	25.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.4	1.6	0.1	7.6	0.0	0.0	0.0	15.7	0.2	0.9	0.0	57.4	32.7	0.0	0.1	1.3	10.9	0.6	0.6	0.0	0.0	9.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	21.9	0.0	0.0	5.3	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	5.1	41.2	46.2	49.1	78.8	35.4	51.6	18.4	59.5	20.2	18.5	6.0	2.1	0.0	2.7	6.0	2.1	4.8	2.5	2.7	1.2	0.0	2.0	0.8	1.7	5.2	2.2	57.8	0.0	0.0	0.3	1.1	30.7	2.3	0.0	0.4	57.8	1.6	12.0	132.6	22.4	8.6	220.4	9.7	15.1	3.6	0.0	51.6	0.6	0.0	341.9	0.0	3.0	349.3	63.8	1.4	3.2	3.3	1.1	0.0	0.0	1.4
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988134-75018893	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 58.9;Spermatocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	5.4	13.4	3.7	10.5	6.9	17.0	5.4	7.9	9.1	4.0	3.9	3.0	4.1	3.6	5.4	4.8	3.9	4.4	3.6	5.9	4.0	4.5	4.3	6.7	8.7	9.0	3.8	6.6	7.2	7.3	15.1	11.2	3.1	4.2	9.7	5.4	5.6	4.8	4.6	19.1	6.7	4.7	4.0	3.5	5.5	5.1	44.6	3.0	19.0	6.8	3.5	7.5	4.5	3.1	3.2	3.8	5.8	6.4	1.2	4.2	2.2	4.6	4.0	3.4	6.6	2.6	2.5	3.8	4.5	2.9	5.2	4.0	13.7	3.9	13.3	4.6	3.6	6.6	4.3	8.2	5.8	7.9	7.0	4.4	10.9	7.4	5.6	2.9	17.2	10.6	3.0	4.9	5.2	8.1	3.4	3.7	19.0	17.7	10.0	5.9	5.0	16.9	8.9	4.2	9.1	5.4	14.8	9.0	11.7	6.4	4.9	6.3	4.0	6.9	4.6	20.2	4.2	9.8	4.4	5.6	6.5	6.5	4.3	4.5	8.2	8.0	26.6	1.9	8.9	5.5	2.1	6.4	5.8	4.1	3.7	3.0	2.8	3.2	3.9	3.8	3.2	3.5	4.2	3.3	1.2	4.6	2.7	2.3	2.2	3.7	6.9	7.9	9.1	4.0	4.5	3.8	6.6	4.2	3.0	3.0	5.8	2.2	1.8	0.5	7.2	7.3	2.5	2.7	4.5	1.8	58.9	1.8	0.0	1.0	5.7	1.6	1.3	0.0	2.6	1.2	1.5	2.7	1.1	7.2	4.8	11.1	6.9	4.3	8.6	5.3	1.4	4.5	0.0	4.6	2.9	2.9	2.7	0.0	1.8	3.3	5.8	0.0	2.2	32.5	1.7	0.5	1.1	3.5	3.2	0.4
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 24.6;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.1	6.2	1.5	8.2	13.6	15.1	0.0	2.9	11.1	2.9	3.5	0.0	3.2	0.0	1.3	5.2	3.0	3.3	0.5	0.5	0.6	1.6	4.7	0.4	0.1	0.4	6.9	0.3	4.3	7.2	6.4	3.2	0.9	6.9	3.8	0.0	0.0	0.0	2.0	0.5	0.0	0.0	3.0	2.0	0.1	0.0	0.1	0.0	4.2	3.1	2.2	7.5	0.5	0.2	6.7	0.6	2.1	1.2	5.0	13.1	2.1	6.3	3.5	1.5	0.3	0.0	8.0	0.1	5.4	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6	0.0	0.0	0.0	5.5	6.4	2.4	0.8	15.3	1.4	1.2	7.0	3.9	1.4	8.3	2.9	24.6	4.5	2.1	0.0	3.4	0.1	6.6	6.0	0.0	1.6	2.0	3.2	8.6	7.4	15.2	44.2	13.6	1.3	5.0	0.0	12.5	8.3	2.2	3.5	10.3	5.1	0.3	0.0	6.4	8.7	5.1	6.1	4.8	0.0	6.2	4.4
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	43.8	11.1	0.0	0.0	5.6	0.0	0.0	0.3	0.5	7.7	0.2	0.0	0.6	0.0	0.2	0.1	20.0	0.0	0.1	0.2	4.5	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.1	22.8	0.2	0.2	0.1	0.0	0.1	0.0	0.0	32.5	15.8	0.0	0.3	0.3	4.4	6.7	0.0	0.0	0.1	6.0	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4	0.0	0.0	0.0	1.0	0.9	20.9	2.6	0.0	0.0	0.0	0.0	51.1	0.0	1.7	1.0	46.0	0.3	0.5	0.0	4.5	0.5	0.5	5.5	0.0	0.0	0.1	3.2	9.7	0.0	0.0	40.7	0.3	0.0	0.0	1.0	0.7	68.3	2.0	5.5	0.4	0.0	92.6	12.9	2.1	7.0	1.3	0.0	0.3	0.0	2.5	0.3
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	7.9	13.2	18.2	17.6	8.9	5.4	18.5	10.8	8.5	11.0	11.7	14.6	6.4	8.5	7.9	6.6	23.8	8.3	17.4	7.3	5.6	12.1	11.9	9.2	34.4	15.6	9.8	13.6	22.8	9.3	13.7	9.3	9.8	26.9	28.8	8.6	8.9	16.4	10.2	7.9	3.7	14.1	18.8	16.2	20.9	6.8	7.3	7.2	15.3	18.8	14.9	19.9	6.1	15.2	10.7	23.3	10.4	12.4	20.1	12.0	14.5	10.2	13.1	11.2	7.1	7.1	15.0	5.0	9.3	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5	11.9	10.1	8.0	16.1	6.5	73.4	10.9	20.4	21.4	14.8	26.2	108.0	8.7	18.3	9.9	12.7	13.7	68.4	0.0	10.4	7.6	7.4	14.9	13.9	16.3	7.9	49.3	34.3	26.4	15.4	17.0	11.5	10.1	11.8	7.2	32.8	15.5	12.6	56.1	9.2	16.5	95.2	12.9	9.9	8.6	4.9	8.7	18.5	12.5	30.3	22.5
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479611-45522807	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 47.7"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 59.6;Late spermatids: 60.4"	"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018178	Uncertain					NA	NA					"HPA018178: AB_1857087"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	3.7	2.9	6.2	4.5	11.3	1.6	4.1	6.7	8.1	3.7	8.8	7.0	2.3	8.5	4.3	4.1	5.6	3.4	3.1	3.0	5.2	3.8	5.5	3.6	2.9	3.6	6.9	4.9	3.9	2.8	6.8	3.0	4.6	5.1	47.7	4.4	3.1	2.7	3.5	2.4	3.6	19.9	4.7	4.5	4.0	3.0	15.8	9.0	1.0	6.2	1.8	4.5	3.1	4.4	7.1	0.5	2.6	0.3	2.4	4.3	1.0	2.0	2.6	0.7	5.6	10.2	7.2	0.5	5.4	4.9	3.3	4.7	0.3	1.8	8.0	1.8	5.5	1.3	1.5	2.4	2.5	3.0	1.9	2.2	0.2	2.6	0.2	6.6	0.2	4.2	6.0	4.1	4.3	1.1	5.1	3.8	3.8	1.2	4.6	6.1	0.9	2.7	0.4	0.2	0.4	0.5	4.2	4.8	1.2	2.7	0.5	1.9	2.8	3.5	4.0	0.9	0.9	3.5	0.3	7.1	4.9	2.8	5.9	1.8	8.6	6.2	2.0	2.1	0.3	3.7	2.6	0.3	0.3	4.3	0.2	3.9	3.8	2.9	2.4	0.3	7.1	2.9	4.2	1.1	2.4	0.3	0.5	0.4	1.0	6.2	11.3	6.7	8.1	5.2	3.8	6.9	4.9	5.1	9.0	3.0	3.8	3.2	2.0	6.1	2.6	2.3	0.0	1.4	0.0	1.8	15.7	0.7	0.0	1.0	59.6	5.0	13.6	0.0	1.0	0.2	7.2	30.7	1.1	2.4	2.5	12.7	1.2	7.4	1.8	60.4	5.8	5.8	6.8	9.0	5.1	4.9	0.6	14.4	7.8	8.4	2.2	6.5	5.9	29.4	16.8	5.6	0.2	4.4	2.9	1.4
EPC1	Epl1	ENSG00000120616	"Enhancer of polycomb homolog 1"	Q9H2F5	10	32267751-32378798	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028931			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA028931: "	"unprognostic (6.94e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.93e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.80e-2)"	"unprognostic (3.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-3)"	17.3	10.0	13.2	19.9	14.3	35.0	19.4	45.3	16.3	20.1	18.0	15.6	13.6	10.6	21.4	15.1	11.7	17.3	12.4	13.5	13.0	10.5	12.3	13.9	13.7	20.5	14.1	10.1	25.4	19.9	20.4	35.7	12.5	12.6	17.2	16.1	15.8	15.1	14.7	22.0	16.8	15.5	21.5	14.3	18.9	13.2	10.2	17.8	41.2	17.9	14.4	19.9	19.1	17.8	12.7	11.1	16.1	6.1	6.6	9.1	3.1	8.0	8.3	17.1	14.4	8.1	11.6	6.7	9.4	5.7	10.3	10.1	5.7	9.6	14.7	6.3	9.5	5.0	7.7	9.0	7.4	7.6	12.1	8.5	12.7	7.0	7.0	8.9	8.6	14.5	9.7	12.4	6.8	5.0	11.9	9.4	9.9	10.6	18.4	9.8	7.9	15.9	6.2	3.8	8.0	3.2	18.0	13.9	7.0	8.4	7.6	13.1	13.5	8.3	6.2	12.6	9.3	6.0	14.3	9.7	7.4	10.6	5.1	7.6	7.9	6.0	15.5	7.2	13.8	6.8	14.6	6.1	10.9	8.6	4.0	9.1	10.7	8.6	7.8	3.9	12.7	8.9	8.1	16.1	6.6	5.8	11.1	8.7	3.1	13.2	14.3	45.3	16.3	13.0	10.5	14.1	10.1	12.6	17.8	38.7	44.0	77.3	86.8	25.3	99.6	29.1	45.9	42.8	43.3	38.4	64.8	30.6	8.3	43.7	7.1	51.7	46.2	23.3	38.1	32.8	45.2	61.4	82.1	31.6	31.0	108.1	94.6	41.1	43.7	8.9	87.8	51.5	38.8	56.9	46.9	54.5	39.7	45.2	64.0	15.9	84.6	97.0	49.1	82.2	32.8	21.8	38.6	107.8	41.2	54.7
PLEKHB1	"KPL1, PHR1, PHRET1"	ENSG00000021300	"Pleckstrin homology domain containing B1"	Q9UF11	11	73646178-73662819	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 220.2"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 324.0;Early spermatids: 111.8;Late spermatids: 139.9;Muller glia cells: 327.3;Rod photoreceptor cells: 320.5"	"Cancer enhanced"	"Detected in all"		"glioma: 59.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 33.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 33.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 36.2;OE19: 25.2;U-266/84: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.20e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (3.59e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.44e-2)"	2.0	4.3	87.5	4.3	85.7	1.6	5.8	18.4	144.2	4.2	5.9	120.2	0.4	6.3	2.5	8.3	3.3	12.5	5.8	7.0	89.2	72.8	6.5	1.7	8.0	4.8	143.1	48.7	1.9	11.4	45.4	12.9	1.5	70.1	5.1	5.3	27.8	25.9	5.4	4.8	1.3	7.0	2.5	220.2	2.9	10.1	5.6	69.5	0.0	14.5	0.0	4.4	2.3	0.7	6.9	0.3	0.4	0.1	1.5	33.1	9.9	0.3	0.9	2.3	1.8	1.0	0.3	0.1	0.1	0.0	0.1	0.1	4.0	7.7	0.0	9.9	0.2	0.3	0.2	1.2	0.2	0.2	5.1	6.1	0.0	0.4	36.2	0.6	0.0	0.1	0.3	0.0	0.1	0.0	2.0	0.0	9.4	0.1	5.1	0.1	2.9	2.4	0.1	1.5	25.2	0.5	1.8	0.0	1.2	0.3	0.7	5.8	1.4	0.0	0.1	0.6	1.7	2.7	0.4	0.0	0.0	1.1	0.0	0.7	8.6	13.8	5.1	1.4	0.0	0.3	0.0	0.1	0.4	6.5	0.0	15.9	6.9	16.1	11.8	0.2	2.9	33.1	18.4	0.3	1.5	0.0	0.3	9.3	9.9	87.5	85.7	18.4	47.9	89.2	72.8	143.1	48.7	70.1	69.5	6.0	9.1	0.5	1.0	0.3	41.4	7.7	20.4	44.2	4.5	7.0	324.0	0.4	10.0	27.2	111.8	0.5	0.7	0.0	0.7	0.1	0.9	6.2	11.5	0.0	2.2	19.1	60.3	1.8	0.0	139.9	2.3	1.0	10.1	1.0	9.0	327.3	4.7	3.7	0.7	9.9	320.5	0.0	1.0	2.8	1.1	0.1	0.1	4.4	4.1	1.4
ZNF17	"FLJ40864, FLJ46058, FLJ46615, HPF3, KIAA1947, KOX10"	ENSG00000186272	"Zinc finger protein 17"	P17021	19	57411163-57421939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (8.49e-3)"	"unprognostic (3.54e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.64e-2)"	"prognostic favorable (6.03e-4)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.32e-3)"	"unprognostic (8.85e-2)"	7.6	6.1	9.8	4.8	13.1	3.7	11.4	29.0	14.8	8.6	7.7	8.7	8.4	5.2	9.3	7.3	8.4	8.4	5.5	8.3	8.9	6.7	7.6	6.0	6.9	8.4	9.6	10.5	14.4	4.8	13.0	14.5	7.4	9.2	8.2	6.7	6.2	7.0	9.3	8.8	8.1	5.8	8.9	7.0	9.1	6.2	7.5	12.6	10.6	11.2	6.1	10.0	7.5	7.8	6.3	2.9	4.0	4.3	8.8	9.0	4.7	3.7	4.0	6.0	4.8	6.5	6.3	4.4	4.4	7.4	6.4	13.2	2.4	2.0	5.9	2.1	5.7	3.3	2.2	5.3	5.3	8.8	3.4	15.1	6.5	8.0	3.5	4.7	8.2	4.7	5.1	6.0	5.1	7.3	5.9	3.5	7.4	3.6	8.2	5.3	2.2	7.7	3.0	3.5	3.6	8.8	7.4	8.5	5.4	2.9	7.4	7.0	4.0	6.9	4.4	3.2	5.5	3.3	5.5	2.9	7.5	3.8	2.0	5.4	7.1	6.2	7.2	4.2	5.5	3.8	2.2	3.1	4.0	6.1	4.3	7.8	5.7	6.8	7.6	2.9	6.3	9.0	6.7	1.9	8.8	4.1	1.6	5.1	4.7	9.8	13.1	29.0	14.8	8.9	6.7	9.6	10.5	9.2	12.6	0.0	1.3	2.2	1.5	4.2	3.5	2.4	2.5	1.4	1.2	1.8	13.7	2.6	1.7	2.3	0.6	3.1	0.8	0.0	1.9	1.8	2.2	1.4	1.1	0.9	2.7	3.2	0.0	4.3	1.5	0.7	2.3	1.8	3.3	1.0	1.1	3.0	0.9	0.0	2.5	1.2	5.4	0.0	1.4	5.0	8.7	4.5	2.7	4.1	1.5	1.3
MEGF8	"C19orf49, EGFL4, FLJ22365, SBP1"	ENSG00000105429	"Multiple EGF like domains 8"	Q7Z7M0	19	42325609-42378769	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 34.1;Cone photoreceptor cells: 72.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049248	Approved					NA	NA		370000000			"HPA049248: AB_2680691"	"unprognostic (5.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (6.03e-4)"	"unprognostic (4.33e-2)"	"prognostic favorable (2.17e-7)"	"unprognostic (1.18e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	15.7	10.6	17.0	5.6	22.5	3.0	8.1	22.9	31.3	8.3	7.7	13.6	8.6	6.5	9.2	9.9	6.3	8.5	6.9	13.1	15.8	16.3	11.6	5.2	6.1	5.0	12.8	15.2	12.1	6.9	28.8	8.4	8.2	11.7	10.9	6.2	9.1	9.9	11.7	12.0	8.1	6.7	9.1	8.4	8.3	5.9	6.0	12.2	3.2	8.5	6.1	4.6	7.0	9.2	2.0	1.5	1.7	2.1	2.2	1.1	0.6	6.6	11.8	12.3	3.0	27.9	13.2	4.5	5.8	8.1	3.4	5.3	2.3	6.3	5.7	12.5	8.0	4.4	3.6	8.9	7.5	3.3	6.8	8.0	4.1	5.7	3.7	10.7	5.8	5.2	15.9	7.7	4.0	6.2	22.4	11.4	1.7	6.1	2.6	6.2	4.3	1.3	3.6	6.3	6.2	1.9	5.5	11.1	1.3	9.1	8.7	6.5	16.1	7.1	3.9	7.6	14.1	3.9	13.1	16.9	7.0	7.0	2.2	7.8	6.1	3.3	3.2	7.7	3.5	16.6	1.7	1.7	1.4	1.1	2.1	1.1	1.0	0.8	0.5	1.5	2.0	0.8	0.8	1.1	2.2	2.0	1.3	0.9	0.6	17.0	22.5	22.9	30.3	15.8	16.3	12.8	15.2	11.7	12.2	6.0	9.6	0.0	2.2	1.9	34.1	15.8	5.1	4.0	11.4	7.0	72.6	2.9	0.0	6.7	2.8	4.6	5.4	0.0	3.0	1.3	6.2	2.4	3.5	7.3	5.1	38.1	12.7	5.5	4.9	1.3	11.8	3.0	8.5	3.6	4.8	14.6	3.9	3.5	13.4	4.3	15.9	0.0	5.1	5.6	3.6	0.9	1.9	1.3	10.4	1.3
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719544-50756213	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	24.1	42.2	57.2	39.6	66.9	24.0	28.7	137.4	62.6	37.6	36.7	22.3	36.4	37.0	55.0	35.0	23.7	31.5	24.3	27.5	54.5	31.3	25.4	20.4	27.8	45.9	72.2	51.8	60.1	27.3	34.1	71.9	29.3	51.3	34.7	29.1	21.6	32.8	35.2	50.6	39.1	35.9	38.2	78.4	41.8	30.5	20.7	70.9	29.1	37.2	27.5	32.1	30.2	39.2	28.8	30.6	22.7	15.9	10.3	18.8	5.2	36.3	23.6	48.1	30.8	20.3	19.6	22.8	34.2	13.3	16.6	20.0	45.1	28.2	44.4	37.1	13.7	18.9	31.7	31.7	14.3	29.0	45.9	50.1	52.6	82.4	35.9	11.1	45.9	29.4	18.5	20.3	18.0	10.6	42.4	17.0	34.5	40.7	40.6	21.2	20.2	45.1	44.8	31.4	26.1	17.9	49.0	45.2	46.1	22.8	23.2	34.1	35.7	20.4	26.2	35.4	43.8	42.2	34.1	24.0	37.5	31.8	15.7	35.1	35.8	38.3	54.5	23.3	31.7	26.1	18.3	15.9	14.5	16.3	11.3	14.3	27.5	17.6	13.5	9.9	28.8	18.8	15.4	22.7	10.3	8.8	30.6	13.3	5.2	57.2	66.9	137.4	62.6	54.5	31.3	72.2	51.8	51.3	70.9	140.0	185.5	122.4	190.4	192.1	526.4	100.3	56.0	161.9	194.5	89.0	216.0	91.5	63.0	86.8	13.9	136.5	125.0	70.0	73.3	92.9	119.5	130.2	141.2	71.6	66.6	359.1	199.5	83.4	88.5	25.8	365.3	114.4	91.1	95.6	120.6	279.8	78.4	140.3	333.8	46.4	433.6	232.8	173.3	126.5	149.4	154.7	83.5	132.1	115.8	167.3
ZZEF1	"FLJ10821, KIAA0399, ZZZ4"	ENSG00000074755	"Zinc finger ZZ-type and EF-hand domain containing 1"	O43149	17	4004445-4143020	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Enterocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031778, HPA031790"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA031778: AB_10599831, HPA031790: AB_10600999"	"unprognostic (4.48e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.46e-2)"	11.3	11.7	8.0	13.5	10.2	21.1	10.5	14.4	14.3	11.3	23.8	17.5	9.2	17.7	11.6	11.0	12.8	9.9	11.1	10.7	7.7	7.7	8.8	9.6	12.1	15.6	8.3	8.4	12.0	15.3	18.0	12.6	13.1	11.3	11.4	17.3	17.6	10.1	11.8	37.7	13.9	42.4	10.9	7.5	16.1	12.8	8.1	9.7	22.5	12.1	6.5	14.2	12.4	9.8	1.5	1.8	3.8	3.4	1.1	4.2	1.5	10.5	16.5	6.0	8.1	15.0	8.5	7.2	9.2	11.6	10.8	10.5	8.1	3.7	10.1	6.2	12.3	7.2	12.1	12.0	6.3	11.0	11.7	12.5	9.6	13.3	5.3	10.2	8.1	19.2	10.9	8.5	10.6	12.5	5.6	13.8	10.2	7.0	10.3	6.7	7.2	10.1	4.8	3.6	10.2	6.4	11.3	7.3	4.3	6.1	10.9	4.7	7.0	10.4	6.5	8.9	6.2	6.4	6.2	16.2	9.5	4.8	11.8	12.0	4.5	2.4	5.2	9.5	7.3	8.8	2.8	2.3	2.3	3.2	3.2	4.2	1.5	2.2	2.0	1.8	1.3	1.5	2.5	3.8	1.1	3.4	1.7	1.4	1.5	8.0	10.2	14.4	14.3	7.7	7.7	8.3	8.4	11.3	9.7	53.6	63.9	15.9	4.6	6.4	30.7	15.7	20.4	26.8	45.5	8.7	92.3	6.0	0.0	6.4	43.0	14.8	92.3	0.0	9.7	5.4	7.4	9.7	24.4	11.5	10.5	38.1	12.7	24.5	24.0	17.3	13.8	14.5	11.8	7.2	30.4	16.0	11.9	29.4	9.2	4.1	53.7	6.5	10.3	10.4	11.3	8.8	7.4	20.8	24.7	7.6
ELMO2	"CED-12, CED12, ELMO-2, FLJ11656, KIAA1834"	ENSG00000062598	"Engulfment and cell motility 2"	Q96JJ3	20	46366049-46432985	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018811	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA018811: AB_1848126"	"unprognostic (1.19e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (8.81e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (6.10e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.20e-2)"	12.6	14.9	23.8	11.9	30.0	28.1	10.6	39.8	32.6	14.8	9.9	34.8	5.2	7.8	12.7	17.5	18.0	13.5	9.4	13.1	25.4	17.1	12.6	8.5	13.7	15.5	21.5	16.8	11.6	17.5	30.1	13.9	13.2	20.6	18.1	9.3	13.8	11.6	22.8	16.8	18.6	9.3	19.5	20.4	17.5	9.1	18.5	22.6	12.3	13.0	7.0	16.3	11.4	13.8	5.3	13.4	38.3	27.6	21.9	22.3	15.6	4.8	14.3	17.0	14.0	29.9	19.3	8.7	11.2	15.5	15.8	15.5	19.3	5.5	6.0	18.1	18.8	26.8	11.5	14.4	16.8	12.3	9.9	6.4	9.8	9.3	14.1	22.6	5.4	20.9	18.9	15.0	16.8	12.0	10.9	12.7	14.8	9.7	20.1	14.7	12.7	10.7	14.0	6.5	9.1	14.0	9.1	16.6	12.0	15.5	11.2	10.3	9.3	16.2	14.4	21.8	16.9	11.1	21.8	14.7	32.8	18.6	13.3	7.3	8.1	12.1	6.2	13.5	8.8	9.9	38.3	10.1	16.3	18.4	19.3	22.3	4.3	16.5	17.4	9.6	5.3	10.7	12.0	11.1	21.9	27.6	13.4	10.8	15.6	23.8	30.0	39.8	32.6	25.4	17.1	21.5	16.8	20.6	22.6	3.0	15.1	5.1	4.6	4.2	7.9	8.6	7.6	0.0	3.4	1.8	27.5	4.8	0.0	4.0	3.0	6.2	2.6	0.0	2.9	4.4	5.8	7.4	8.1	2.4	11.7	11.1	7.9	4.3	5.1	4.9	10.3	5.0	6.8	9.0	2.4	15.4	4.5	3.1	12.0	3.3	8.3	25.8	7.1	6.7	13.9	5.8	3.4	13.8	2.1	3.4
SMIM32		ENSG00000271824	"Small integral membrane protein 32"		5	136191468-136193134	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	9	"brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 233.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HaCaT: 2.3;SCLC-21H: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	0.0	1.2	2.2	0.0	0.0	0.0	7.8	0.0	5.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	9.8	0.0	0.6		26.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.1	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	1.5	0.0	1.4	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	6.1	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	233.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33299324	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	12.1	9.2	6.7	10.0	8.4	4.5	6.8	9.4	8.4	8.6	7.0	7.1	15.3	6.7	8.9	9.5	6.5	8.3	9.9	9.1	7.2	3.2	7.5	4.2	9.9	7.2	7.5	4.8	10.7	6.6	4.9	17.1	7.7	8.6	7.5	4.2	7.5	6.8	13.3	19.9	4.6	6.6	6.3	4.9	19.0	7.1	6.4	6.6	4.6	12.8	4.5	6.8	7.5	10.7	0.5	0.7	4.2	0.9	0.7	0.4	0.8	3.6	1.0	4.1	2.1	0.6	0.4	2.0	1.7	1.0	0.5	0.7	0.5	0.9	1.2	6.1	0.3	2.0	0.8	0.8	0.5	0.3	3.0	2.1	2.5	1.0	0.9	0.5	1.8	3.9	0.8	0.5	1.6	0.3	2.6	1.1	1.5	3.1	0.9	0.3	0.7	1.2	2.6	0.1	0.5	1.8	1.2	2.3	1.3	0.8	0.7	3.5	3.4	1.2	2.2	5.2	1.1	1.8	2.1	3.2	2.0	2.9	1.3	4.6	5.1	2.9	3.2	0.6	1.3	3.5	1.6	0.8	2.0	0.4	0.9	0.4	0.5	0.3	0.4	0.7	0.5	0.2	0.3	4.2	0.7	0.2	0.0	0.3	0.8	6.7	8.4	9.4	8.4	7.2	3.2	7.5	4.8	8.6	6.6	14.9	40.4	15.9	31.8	25.2	27.7	22.9	12.7	21.4	30.7	21.0	21.6	22.8	11.6	19.0	3.9	54.2	6.1	0.0	12.7	34.3	17.5	39.0	10.5	10.4	26.5	30.2	27.4	61.4	25.6	10.3	15.5	20.5	16.9	10.8	10.4	20.9	17.4	22.9	13.8	9.7	29.6	25.8	21.7	27.8	16.2	21.2	85.5	20.8	8.3	35.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA			Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.4	2.4	8.0	9.1	6.3	0.1	1.1	3.7	1.1	0.2	0.0	2.9	0.8	5.5	2.0	2.6	4.1	1.1	3.5	0.7	0.0	11.8	0.0	26.3	2.9	4.8	0.1	0.3	9.8	14.8	0.0	9.4	5.8	0.2	8.0	0.1	0.0	0.9	0.8	0.0	0.1	1.2	2.0	3.1	0.0	3.1	0.1	6.0	7.5	7.3	0.8	5.5	0.3	2.9	3.6	5.9	0.0	0.8	5.0	3.3	0.5	1.0	3.2	0.0	16.2	0.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9	3.0	2.9	0.0	3.6	0.8	20.5	7.0	0.0	6.7	2.3	5.2	27.5	0.0	0.0	0.6	23.2	3.1	0.3	0.0	0.6	0.0	2.5	5.8	1.1	1.7	0.2	19.1	5.8	2.5	0.3	16.0	2.8	0.1	1.7	0.0	1.3	8.3	0.3	0.0	4.9	0.5	38.2	0.0	2.3	0.5	0.7	2.0	0.0	0.0	1.5	2.1
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	7.8	14.8	18.4	7.9	15.8	7.5	9.1	20.0	19.5	13.5	11.9	14.1	17.4	9.8	11.2	14.9	13.6	33.5	11.4	8.9	17.1	20.6	13.0	11.9	9.3	8.1	14.2	12.1	19.0	24.6	15.3	16.4	7.9	14.8	13.1	9.4	13.4	19.1	16.3	9.3	11.8	9.5	13.5	11.7	7.5	8.9	23.7	11.0	12.3	18.2	8.7	9.8	11.6	13.9	6.2	6.7	3.5	10.0	12.8	6.9	3.8	10.9	11.1	9.4	13.8	12.7	7.1	5.0	15.2	11.7	25.8	15.8	7.0	4.3	10.6	6.3	9.9	8.3	9.8	12.0	8.4	12.5	8.5	24.2	5.3	10.1	16.7	11.3	10.5	12.8	6.4	8.8	13.9	8.2	6.3	15.7	7.9	7.0	7.4	11.7	11.5	10.2	12.1	2.7	14.7	10.2	11.9	11.5	6.6	14.2	3.6	16.4	8.8	12.7	11.3	18.0	4.4	11.6	16.7	9.1	15.0	16.2	7.8	11.1	8.3	6.7	8.4	12.5	9.0	10.8	2.6	5.4	2.4	6.8	6.4	6.8	4.5	6.6	5.2	6.7	6.2	6.9	3.4	3.5	12.8	10.0	6.7	2.8	3.8	18.4	15.8	20.0	19.5	17.1	20.6	14.2	12.1	14.8	11.0	11.9	16.4	13.9	9.0	14.1	17.4	7.1	22.9	33.5	11.4	17.4	27.5	18.3	33.2	14.5	5.0	9.0	15.5	0.0	12.7	15.1	10.4	8.9	9.2	9.6	11.6	25.4	8.6	11.1	8.1	6.0	16.7	9.5	10.1	8.2	12.6	16.9	11.3	15.2	20.1	14.7	22.1	6.5	14.4	54.6	39.2	15.4	14.1	16.0	14.4	8.8
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"		NA	NA			"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: AB_2684889"	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favorable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	10.3	12.2	18.6	12.8	21.8	10.4	12.0	20.0	23.1	8.9	10.5	13.2	13.8	11.2	9.0	10.4	10.5	13.3	10.3	9.7	18.5	14.3	14.0	14.1	9.3	10.8	15.4	9.1	7.3	9.4	16.4	10.1	28.9	16.5	10.5	5.8	12.4	13.9	12.8	9.9	15.9	11.4	7.1	12.7	11.3	13.6	64.8	14.4	9.9	14.3	5.5	9.3	9.5	16.2	3.9	3.4	15.7	3.0	1.9	3.4	1.4	9.0	20.3	7.0	20.2	13.7	7.3	29.7	10.8	9.1	10.8	7.0	14.9	12.8	9.3	18.8	6.8	19.4	18.2	9.8	6.0	3.1	29.5	12.3	8.9	20.8	9.5	7.8	5.8	17.3	9.1	9.5	9.4	7.2	7.4	5.8	11.2	7.9	22.8	6.4	23.0	6.5	15.8	9.5	7.4	20.2	13.2	7.5	15.1	7.5	12.4	11.2	13.6	13.1	18.0	11.7	7.4	19.7	2.5	9.3	30.0	20.8	22.6	7.8	18.3	33.5	7.8	21.4	5.0	18.2	1.7	3.0	5.3	2.7	2.8	3.4	2.8	2.3	2.0	3.1	3.9	2.6	2.2	15.7	1.9	2.3	3.4	1.6	1.4	18.6	21.8	20.0	23.1	18.5	14.3	15.4	9.1	16.5	14.4	3.0	9.1	11.8	16.0	12.8	13.4	4.4	10.2	9.4	4.5	12.2	11.8	40.6	13.3	33.8	157.3	14.0	21.2	0.0	23.3	58.9	21.7	17.8	2.3	8.9	21.4	19.1	15.5	9.8	9.1	445.6	17.8	11.8	13.5	20.8	13.8	33.6	24.9	14.0	15.2	15.2	6.0	25.8	12.5	157.6	37.2	13.2	100.0	12.8	13.4	18.0
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.6	7.2	3.2	15.1	19.9	6.5	5.5	6.1	7.5	4.9	5.1	3.5	2.6	2.2	18.0	13.1	6.5	4.0	4.2	8.6	3.8	11.1	9.9	17.0	3.3	7.8	10.8	2.5	25.7	7.8	9.9	4.7	4.2	7.1	19.2	9.0	2.4	12.5	3.8	10.7	3.4	8.1	6.8	6.8	17.4	5.4	1.0	5.6	11.3	6.7	1.6	9.1	0.4	6.6	11.5	11.6	5.0	5.4	19.3	6.9	4.2	22.8	5.1	11.2	13.3	2.5	11.2	5.1	5.2	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3	3.0	10.9	4.5	0.0	6.6	10.7	38.1	7.6	2.7	3.4	19.2	2.0	6.6	33.2	0.0	8.1	27.0	13.6	23.3	0.0	9.3	10.5	0.0	12.7	24.6	57.4	22.3	11.6	47.9	48.6	36.4	8.6	19.4	23.6	0.0	5.5	17.5	0.0	7.4	11.0	43.4	7.7	12.9	20.6	5.4	8.5	11.3	4.8	18.1	4.6	0.0
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					NA	NA		26000			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.32e-5)"	12.2	25.4	11.9	6.4	13.3	7.5	11.9	9.7	21.3	12.4	11.8	18.8	15.4	12.8	14.5	22.2	14.1	16.0	13.6	18.9	10.5	9.8	26.8	43.4	10.5	7.0	14.2	15.8	16.1	13.5	45.6	11.9	7.6	15.2	17.5	11.7	17.5	17.4	25.0	25.9	7.0	10.4	12.9	11.6	9.6	13.4	5.5	14.4	3.2	15.1	13.4	11.4	16.5	9.6	1.6	10.0	17.6	11.8	9.2	4.6	7.1	4.7	14.0	8.9	14.4	15.1	6.5	20.5	5.6	6.2	8.0	5.6	13.6	10.4	0.5	9.7	6.7	5.4	6.3	7.0	7.0	4.5	21.1	4.7	7.2	8.4	16.3	5.8	0.1	13.6	10.3	3.0	6.7	4.9	12.0	18.8	0.7	12.9	9.9	8.3	11.5	0.2	4.8	4.0	7.3	10.2	6.4	3.7	10.0	8.9	9.4	4.5	5.9	9.9	21.6	8.0	9.1	35.0	8.8	9.6	4.1	5.3	5.1	3.8	11.3	9.7	0.6	7.1	4.3	6.1	5.9	8.1	17.6	0.1	11.8	0.0	1.6	0.7	0.0	10.0	0.2	0.5	0.2	3.2	9.2	9.4	0.2	4.6	7.1	11.9	13.3	9.7	21.3	10.5	9.8	14.2	15.8	15.2	14.4	8.9	10.4	1.4	3.2	1.1	4.6	19.7	12.7	5.3	13.6	14.0	5.9	25.0	14.9	4.4	0.5	5.2	6.7	0.0	5.5	16.5	5.1	3.2	4.6	41.5	9.0	9.5	5.8	6.7	4.9	0.7	4.0	5.3	1.7	11.8	7.3	7.7	4.3	7.0	8.5	25.1	8.0	6.5	3.1	2.1	0.9	1.9	25.7	2.2	6.8	1.7
LRRC56	"DKFZp761L1518, FLJ00101"	ENSG00000161328	"Leucine rich repeat containing 56"	Q8IYG6	11	537527-554916	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 15.5;testis: 20.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 54.0;Late spermatids: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.2;Daudi: 3.0;Karpas-707: 5.9;SK-BR-3: 3.7;T-47d: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038728	Approved					NA	NA					"HPA038728: AB_10671864"	"unprognostic (2.77e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.28e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.29e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.17e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-3)"	0.6	0.7	2.4	2.9	9.6	1.1	0.6	3.2	1.7	1.6	1.7	1.2	8.1	0.9	1.2	9.1	2.1	4.6	5.0	0.5	2.1	1.6	1.7	0.8	7.8	3.0	0.5	1.3	3.4	4.5	0.4	15.5	0.6	2.8	1.9	0.8	1.7	2.2	2.0	1.1	4.8	2.8	0.5	0.4	1.0	3.6	20.8	0.7	0.3	1.8	0.1	5.3	1.0	0.8	0.5	0.1	0.2	0.3	0.3	1.2	0.7	0.0	0.0	0.1	4.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.5	0.0	3.0	0.0	0.0	0.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	1.5	0.1	1.7	1.0	2.6	1.0	1.9	0.0	0.3	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.3	1.5	0.0	1.5	1.7	0.0	0.0	1.2	0.5	0.0	0.8	0.5	0.0	3.7	0.0	0.2	4.6	0.1	0.1	0.7	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.3	0.1	0.5	0.1	0.6	0.1	0.1	0.1	0.6	0.0	0.3	0.1	0.0	1.2	0.7	2.4	9.6	3.2	1.7	2.1	1.6	0.5	1.3	2.8	0.7	0.0	4.3	1.7	1.5	1.4	1.5	0.4	2.5	5.3	2.3	3.5	15.7	0.1	0.0	0.8	54.0	0.0	1.3	0.0	0.4	0.1	0.3	1.7	0.0	0.0	0.2	6.4	12.0	0.6	0.8	96.6	1.1	0.0	1.7	0.0	2.2	2.5	0.5	0.9	1.1	0.7	6.6	0.0	0.0	4.4	2.1	0.6	0.5	1.5	0.5	0.6
GPATCH3	"FLJ12455, GPATC3"	ENSG00000198746	"G-patch domain containing 3"	Q96I76	1	26890488-26900466	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032078, HPA054973"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA032078: AB_10603671, HPA054973: AB_2682656"	"unprognostic (2.93e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (4.37e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.46e-2)"	"prognostic favorable (6.42e-4)"	"unprognostic (3.77e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.82e-2)"	11.7	14.5	13.1	10.2	13.6	31.8	13.0	19.5	20.9	9.4	11.7	15.8	11.8	13.0	11.8	14.5	11.6	10.3	12.0	9.6	11.6	10.9	10.9	14.8	10.5	12.4	12.6	10.8	11.8	11.8	12.0	10.1	13.3	13.6	10.3	10.1	10.1	10.4	10.5	21.5	16.0	11.7	10.4	12.1	15.4	12.0	17.2	16.2	16.9	10.1	10.5	11.7	10.5	12.2	12.4	17.4	22.4	16.8	8.1	16.0	12.8	8.9	7.4	7.0	11.1	6.7	6.5	9.5	7.0	8.0	14.1	12.3	9.8	10.7	8.3	7.8	6.9	7.4	9.4	11.6	12.9	7.4	9.3	17.5	16.0	16.2	20.8	9.5	11.1	11.2	10.0	12.0	14.1	7.5	6.1	9.1	11.3	18.8	11.0	5.8	8.2	9.4	21.6	16.3	10.4	11.2	12.0	9.9	13.2	7.1	4.9	9.2	11.3	13.6	12.0	20.9	7.9	10.6	11.6	9.3	9.1	10.5	12.2	7.9	14.2	19.4	11.0	8.2	16.0	7.9	22.4	16.8	19.7	16.0	13.7	12.9	12.4	13.3	14.0	17.4	12.1	14.0	13.2	7.1	8.1	15.8	13.3	11.4	12.8	13.1	13.6	19.5	20.9	11.6	10.9	12.6	10.8	13.6	16.2	3.0	4.6	13.4	4.8	8.7	5.6	3.1	2.5	2.7	2.3	0.0	11.8	13.7	5.0	9.3	0.6	6.8	9.9	0.0	10.7	8.1	6.2	3.7	5.7	5.1	9.5	4.8	10.9	8.0	7.6	1.0	4.9	7.3	8.5	18.0	4.7	5.6	8.3	7.0	6.7	6.7	4.8	6.5	7.1	8.9	22.9	8.5	25.2	10.2	5.2	4.2
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5385812	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles		NA	NA			Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	19.2	16.7	29.6	18.8	31.1	10.3	31.8	24.1	32.7	16.3	14.2	19.0	12.5	10.9	18.1	18.3	12.7	12.9	15.0	27.4	29.7	25.9	16.6	21.8	13.1	21.1	36.2	24.4	15.5	12.1	38.4	16.3	20.2	31.3	22.2	14.2	10.0	14.8	16.0	41.2	11.6	13.4	20.8	35.6	17.7	15.7	11.8	29.0	21.4	17.6	13.5	25.5	14.5	13.0	37.6	14.2	12.6	19.3	9.1	11.2	6.4	18.1	22.4	23.6	13.2	24.8	24.9	13.0	23.6	17.6	24.7	23.7	19.9	7.6	38.3	19.8	23.8	13.9	14.3	34.5	19.6	35.0	25.2	31.6	23.4	27.8	15.0	23.4	15.3	15.5	19.2	13.5	23.8	30.9	15.0	21.4	19.5	19.9	18.9	21.4	12.6	25.3	12.6	10.9	9.9	10.9	24.0	28.3	12.7	12.5	16.6	10.2	16.0	20.9	20.8	19.8	21.8	37.8	7.0	18.8	21.3	9.9	21.4	27.6	11.1	12.1	20.6	16.5	25.1	14.5	4.9	9.0	8.7	11.2	9.2	9.8	30.2	8.7	10.6	9.2	37.6	11.1	9.7	12.6	9.1	19.3	14.2	8.0	6.4	29.6	31.1	24.1	32.5	29.7	25.9	36.2	24.4	31.3	29.0	32.8	42.6	30.0	28.5	21.3	46.6	80.2	15.3	24.1	45.5	17.4	37.3	31.8	34.9	26.0	5.7	28.5	14.6	0.0	20.5	27.9	29.4	43.8	11.6	25.1	71.8	33.4	15.6	34.4	30.4	4.6	31.4	35.3	28.7	27.1	14.3	85.2	23.9	31.6	26.5	29.4	49.0	25.8	29.9	70.4	72.8	17.8	21.6	29.6	14.6	29.3
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 638.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		490000	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	14.1	43.7	28.3	44.5	78.9	37.6	21.6	35.1	35.8	25.5	29.2	8.3	16.0	6.1	36.9	30.5	8.3	6.6	6.8	13.8	11.2	22.9	24.9	6.6	15.0	10.4	53.9	2.7	75.9	71.5	28.9	19.4	13.4	42.8	21.4	10.1	23.3	24.9	18.3	18.5	4.8	13.1	18.5	23.2	9.0	6.1	21.6	25.2	13.1	10.6	20.3	33.8	16.8	10.4	18.8	30.9	14.3	47.6	37.6	21.5	10.3	18.2	7.8	26.0	27.7	6.3	34.6	11.0	13.3	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3	29.8	62.9	34.4	70.6	31.5	98.5	18.5	25.5	12.0	28.4	54.1	31.4	137.8	18.3	50.7	5.8	46.8	52.7	0.0	51.3	94.8	142.4	49.1	59.9	35.8	638.2	114.4	69.9	90.9	219.8	8.6	140.4	84.2	87.7	44.1	36.8	99.5	49.7	41.2	135.1	30.0	39.3	19.4	53.1	13.9	57.5	29.2	163.8	35.4	34.5	52.0
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338323-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	12.6	14.4	15.2	15.9	16.5	11.9	11.3	19.6	26.0	19.0	16.6	15.5	12.6	14.3	18.4	12.6	13.4	16.2	14.3	15.4	13.7	14.3	14.0	10.6	13.8	15.6	14.5	16.2	19.7	15.0	19.3	13.0	16.2	15.7	18.1	8.7	14.6	14.7	21.7	14.5	14.9	14.4	20.4	15.4	16.9	12.2	8.3	12.7	11.4	20.4	7.5	13.4	14.5	12.3	4.6	4.8	6.3	4.9	1.6	2.9	2.4	7.0	8.3	13.0	9.3	2.9	4.9	15.2	8.6	6.0	10.7	7.2	18.1	6.6	14.2	5.1	6.1	9.4	14.0	9.7	8.3	4.4	11.1	5.6	7.5	18.1	5.0	4.9	9.6	7.8	3.8	6.6	9.6	6.4	5.0	5.2	8.3	10.9	6.9	5.1	9.7	13.6	8.1	18.2	8.8	10.0	18.7	10.5	13.0	4.4	5.2	10.6	8.6	10.0	12.7	7.5	5.6	14.4	3.4	6.8	14.0	9.8	9.5	11.2	4.7	6.3	13.7	8.0	7.5	11.5	2.2	3.9	6.3	2.0	3.7	2.6	3.4	2.4	2.6	3.0	4.6	2.9	2.2	6.0	1.6	4.9	4.8	2.0	2.4	15.2	16.5	19.6	26.0	13.7	14.3	14.5	16.2	15.7	12.7	20.8	13.2	5.1	9.2	7.3	12.8	7.5	10.2	0.0	2.3	15.7	0.0	5.2	3.3	5.2	1.7	7.2	7.4	0.0	4.5	4.4	10.1	7.1	7.0	5.0	6.7	12.7	6.4	5.5	6.9	1.6	10.9	7.5	1.7	1.0	6.7	8.4	6.1	0.0	15.6	4.9	10.9	25.8	21.5	7.1	10.4	5.6	4.6	5.0	5.6	3.6
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1300000	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	26.2	15.3	34.7	41.3	30.7	32.7	6.3	28.0	25.9	39.8	36.5	18.6	9.4	11.4	22.7	44.3	19.4	17.2	24.4	26.5	37.8	20.7	12.3	20.9	28.9	18.0	26.3	12.9	22.2	31.1	12.8	31.6	11.0	24.6	33.5	18.7	19.6	29.8	40.6	38.9	29.0	9.7	12.4	26.6	34.1	26.2	32.0	26.3	19.4	16.7	27.4	17.5	25.3	15.5	11.5	17.5	22.1	12.5	25.9	47.0	13.1	62.9	26.1	20.6	21.1	16.8	31.5	19.6	17.6	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1	6.0	4.3	11.5	6.1	7.8	40.4	110.4	28.1	4.0	2.3	14.0	25.5	5.8	6.6	10.7	25.7	21.6	16.0	0.0	16.2	4.8	14.3	7.3	0.0	30.1	29.0	3.2	16.8	31.9	44.8	12.8	45.5	32.4	13.5	7.2	14.3	24.1	13.5	7.0	48.8	9.6	23.0	19.4	17.3	25.7	6.4	9.8	6.8	7.2	11.4	6.4
POLR3F	"RPC39, RPC6"	ENSG00000132664	"RNA polymerase III subunit F"	Q9H1D9	20	18467127-18484643	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049441, HPA050173, HPA072298"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510"	"unprognostic (4.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (8.87e-9)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (6.48e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.98e-3)"	8.6	7.8	8.1	6.0	11.9	4.4	8.0	24.6	15.3	9.9	7.5	8.7	8.5	5.6	11.6	6.5	11.0	9.6	6.7	14.2	8.7	10.1	11.2	7.3	5.9	8.8	7.8	12.9	12.5	7.3	4.5	9.8	8.0	13.9	9.2	6.4	6.7	7.5	7.4	12.0	6.2	5.0	9.0	8.5	6.3	6.7	10.0	7.7	6.3	16.3	7.2	9.1	10.7	6.5	3.1	3.2	1.9	4.5	3.3	6.4	4.1	6.5	6.7	7.0	8.8	5.7	6.9	12.6	9.7	6.8	12.5	9.6	8.4	6.7	5.1	4.1	9.4	8.3	9.0	9.2	8.0	8.2	5.0	7.7	3.7	2.6	3.6	8.1	11.0	6.3	4.4	5.2	18.7	8.6	6.0	5.6	4.5	9.4	4.5	8.6	7.1	9.2	4.7	9.9	6.7	15.3	6.5	15.3	5.6	5.6	2.8	14.6	9.6	7.5	12.6	15.7	4.9	5.8	7.4	5.4	12.9	6.3	9.6	13.6	2.3	15.3	4.0	5.4	5.1	9.3	0.1	2.1	1.9	4.3	4.5	6.4	2.8	3.9	1.2	2.2	3.1	4.1	2.1	0.8	3.3	1.9	3.2	3.4	4.1	8.1	11.9	24.6	15.3	8.7	10.1	7.8	12.9	13.9	7.7	8.9	3.7	5.4	3.0	7.9	17.3	7.3	2.5	12.0	4.5	1.8	9.8	8.6	8.3	7.0	15.9	6.5	2.9	0.0	5.9	10.3	6.7	3.5	5.7	4.5	6.7	11.1	6.4	6.7	7.0	4.1	5.8	6.9	5.0	11.8	3.1	12.5	6.4	0.0	9.6	9.8	17.4	12.9	5.5	17.7	22.0	9.9	6.1	8.5	3.9	2.7
C2orf70	LOC339778	ENSG00000173557	"Chromosome 2 open reading frame 70"	A6NJV1	2	26562582-26579532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.5;testis: 44.9"	"Group enriched"	"Detected in some"	16	"Early spermatids: 140.3;Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062453	Enhanced		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA062453: AB_2684769"	"unprognostic (5.44e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.40e-6)"		"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (4.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.08e-3)"	0.1	0.3	1.1	0.3	2.2	0.0	0.3	0.1	0.8	0.5	1.0	3.1	2.3	0.3	0.4	5.2	0.2	11.5	0.6	1.4	1.1	2.7	0.7	0.1	1.0	0.1	0.8	0.7	2.7	4.5	0.0	1.2	0.1	4.4	0.4	0.6	0.0	3.1	1.7	0.2	0.1	0.2	0.1	0.7	0.1	7.6	44.9	0.5	0.0	3.1	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	3.8	0.0	0.9	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.1	0.8	1.1	2.7	0.8	0.7	4.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	13.4	0.0	0.0	0.0	0.0	1.7	0.6	140.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.3	0.0	0.0	0.0	2.9	0.0	0.0	288.4	1.7	0.0	0.0	0.0	1.3	0.0	0.3	0.0	1.8	0.5	0.0	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361452-6368910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	22.1	27.3	18.4	22.5	18.8	20.1	19.9	16.6	20.9	16.1	23.2	17.9	22.2	25.4	16.9	15.1	26.6	15.3	19.2	28.9	17.4	16.7	28.5	64.7	15.5	35.5	19.0	15.2	23.7	32.7	11.6	18.5	18.4	13.6	19.1	14.1	18.6	26.3	23.4	73.1	17.8	26.0	14.8	16.7	21.2	21.3	21.1	11.4	54.8	27.0	25.1	25.3	20.7	23.2	29.7	37.5	14.9	20.0	27.6	46.3	32.9	31.6	21.1	15.4	28.1	9.7	13.5	16.0	18.8	13.8	26.8	24.1	16.9	11.6	31.9	29.3	15.0	15.3	19.8	15.3	23.7	10.2	33.1	47.9	23.5	18.6	25.0	26.3	21.2	31.1	17.1	17.4	18.6	20.8	18.4	26.0	42.3	23.3	43.3	17.5	37.0	36.3	22.2	22.2	24.5	49.5	25.6	18.6	48.4	19.9	17.7	25.5	24.5	11.9	29.2	27.6	10.0	15.0	30.4	18.2	17.8	16.5	41.6	35.4	55.6	46.4	30.7	24.3	30.0	28.2	5.5	20.0	10.5	28.0	17.7	33.2	28.3	39.9	34.5	24.1	29.7	35.2	34.1	14.9	27.6	12.1	37.5	46.3	32.9	18.4	18.8	16.6	20.9	17.4	16.7	19.0	15.2	13.6	11.4	20.8	35.7	37.2	49.7	40.0	30.7	40.3	58.6	36.1	17.0	41.8	11.8	60.5	122.7	78.4	82.6	46.3	64.7	23.3	84.4	102.0	37.0	67.2	25.4	81.5	71.6	20.6	33.9	49.1	31.4	188.9	39.4	35.5	52.3	93.8	43.9	34.4	88.0	56.1	40.7	126.3	20.5	12.9	36.0	68.8	45.8	32.4	48.3	53.2	60.6	56.1
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554904-137578935	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.7	12.1	14.0	16.4	8.2	10.7	15.9	17.8	13.3	12.7	21.5	14.3	5.9	14.2	17.8	9.4	18.2	10.3	12.6	14.0	7.6	11.1	11.0	10.4	13.0	19.1	11.5	17.3	20.8	14.1	14.9	10.5	12.8	15.6	11.9	10.8	16.1	15.4	9.6	13.5	12.2	14.6	9.0	16.0	11.8	10.1	18.6	11.2	13.8	5.8	13.9	10.9	11.7	10.8	14.2	15.6	9.2	9.3	13.5	8.8	7.1	7.5	12.2	10.9	8.8	6.7	14.1	7.1	6.9	12.0	10.2	14.9	7.1	14.0	12.8	7.4	8.9	17.1	14.1	12.1	9.6	11.2	16.5	5.9	10.1	5.4	10.0	13.2	12.7	6.9	10.8	8.0	15.2	9.8	15.9	11.1	11.8	7.5	8.3	20.2	10.0	14.4	14.0	25.8	15.9	17.9	6.4	11.4	9.9	6.7	13.9	12.6	10.9	9.3	7.9	7.7	13.4	13.1	7.5	9.5	7.7	10.9	13.6	6.2	11.9	15.6	4.9	9.1	8.9	15.6	8.9	9.7	10.9	9.2	11.6	10.8	13.5	12.7	10.4	9.5	11.5	11.7	2.3	9.3	6.4	14.2	9.3	8.8	12.1	16.4	15.9	17.8	14.0	7.6	19.1	11.5	12.8	18.6	6.0	14.0	13.7	10.0	14.8	19.0	12.6	5.1	9.4	7.9	1.8	47.1	18.3	3.3	8.7	1.3	11.7	5.1	0.0	8.1	11.4	11.8	10.7	10.4	5.8	10.5	15.9	6.4	8.6	5.7	4.5	15.3	6.9	8.5	10.8	10.6	17.1	10.1	8.0	14.9	4.2	57.2	19.4	13.0	20.5	25.6	16.6	10.2	16.2	13.9	9.1
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462572-1537107	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 19.0"	"Group enriched"	"Detected in some"	5	"B-cells: 29.8;Kupffer cells: 10.2;monocytes: 20.8;T-cells: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 33.9;MOLT-4: 16.7;NB-4: 16.7;RPMI-8226: 20.8;THP-1: 20.8;U-266/70: 28.5;U-698: 55.5;U-937: 17.2"					"Not detected"	"Not detected"			HPA003631	Enhanced					NA	NA					"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.80e-5)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favorable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	2.9	4.8	0.5	8.9	2.2	13.9	8.2	0.9	1.8	4.7	1.6	0.5	0.5	1.3	7.1	0.5	0.8	0.8	1.6	11.8	0.9	0.2	13.5	0.8	2.1	19.0	3.6	1.7	5.8	1.1	1.0	6.9	3.4	2.7	1.6	1.3	0.5	1.6	0.5	1.1	0.4	7.8	0.5	3.9	16.6	2.0	0.5	2.0	0.5	8.1	0.5	16.7	2.7	2.8	18.5	5.8	17.8	7.3	15.6	26.7	18.3	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	33.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.1	0.3	0.3	1.7	0.0	14.8	3.6	0.0	0.0	0.0	0.0	0.3	0.0	10.1	0.3	14.3	0.0	0.0	16.7	16.7	0.2	0.0	0.3	15.1	0.1	20.8	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.3	0.1	20.8	0.0	0.3	0.3	0.1	0.0	28.5	5.3	55.5	0.0	17.2	0.0	17.8	7.3	12.4	26.7	5.5	24.6	15.4	20.2	25.1	5.8	18.5	16.1	16.5	4.7	15.6	2.2	1.5	15.9	18.3	0.5	2.2	0.9	1.8	0.9	0.2	3.6	1.7	2.7	2.0	0.0	2.6	29.8	0.0	0.3	0.0	0.8	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.4	0.1	1.1	0.0	1.9	0.0	0.0	4.3	10.2	0.0	0.0	1.6	1.7	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	20.1	0.0	0.0
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	6.7	5.2	6.5	6.7	9.5	2.0	7.4	14.3	11.1	6.6	8.2	11.1	7.8	4.5	8.9	10.1	5.5	9.9	5.5	5.9	7.3	5.4	6.6	6.3	6.3	7.0	9.8	5.7	14.3	10.0	3.8	8.7	6.2	8.7	7.6	5.9	6.5	8.8	6.4	7.7	5.5	6.3	8.5	6.2	6.9	7.2	7.5	10.7	6.4	8.0	5.4	6.1	6.3	6.2	11.8	7.4	1.9	2.1	5.4	7.8	3.9	5.4	4.1	6.8	6.9	2.4	1.0	3.7	2.7	1.4	2.7	3.7	6.4	1.3	11.0	3.3	0.9	3.9	3.8	4.7	2.7	1.6	4.3	7.2	1.9	9.5	5.7	3.5	0.0	3.4	2.0	3.0	2.8	2.5	1.9	1.9	13.3	9.2	4.1	3.2	2.6	9.3	3.8	13.3	4.7	4.5	8.0	4.3	7.4	2.2	0.8	7.1	4.6	5.3	2.1	4.3	5.4	1.1	2.7	3.1	2.7	4.6	2.1	5.2	5.5	8.6	2.8	6.9	0.3	4.4	1.4	2.1	1.9	4.7	1.9	5.5	11.8	5.2	6.2	4.0	11.0	7.8	7.2	0.1	5.4	1.2	7.4	4.2	3.9	6.5	9.5	14.3	11.1	7.3	5.4	9.8	5.7	8.7	10.7	0.0	1.6	2.2	3.1	3.8	5.0	5.0	0.0	5.3	4.5	5.2	0.0	3.2	3.3	5.3	6.0	4.0	2.1	0.0	3.5	4.0	2.4	2.0	0.0	3.2	5.1	0.0	1.2	3.1	2.7	4.8	3.4	1.8	0.0	1.0	2.7	3.8	3.5	5.8	4.9	2.6	2.8	0.0	4.1	12.1	10.9	4.1	1.7	1.5	3.3	1.6
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.7	16.4	28.5	26.4	12.4	12.7	19.9	22.4	12.1	24.7	22.0	18.7	12.1	24.5	13.1	16.4	13.0	15.9	18.9	20.4	14.5	27.3	30.0	15.0	12.3	24.6	16.1	14.8	21.5	18.1	11.1	16.9	8.3	17.6	22.5	23.2	17.2	30.9	11.9	19.7	33.4	29.7	32.6	11.2	29.5	33.3	23.5	15.7	15.3	14.2	31.5	31.1	21.8	12.5	18.1	16.3	12.3	23.6	29.7	15.6	21.4	29.3	21.1	38.4	20.0	17.2	21.9	23.9	16.4	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	17.4	9.1	12.2	0.0	31.1	16.6	22.5	0.0	0.0	0.0	0.0	17.5	24.9	0.0	0.0	1.1	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	26.2	0.0	0.0	19.1	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.7	1.2	0.0	25.7	32.8	0.0	35.4	30.3	21.6	15.6	0.1	0.7	0.0	1.8	89.6	0.6	1.5	2.6	2.5	24.7	0.0	1.9	1.6	2.6	0.0	38.9	0.0	0.7	11.6	0.0	12.4	1.0	26.0	17.9	0.2	0.0	16.7	15.1	13.5	0.0	0.1	1.4	0.8	4.6	0.0	0.0	0.0	22.5	1.6	0.1	0.3	17.2	0.6	0.2	2.5	2.5	0.9	22.4	7.3	4.3	24.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3	223.4	31.0	5.2	0.8	2.1	0.0	3.5	5.1	2.7	14.8	8.7	0.0	0.4	11.6	4.4	0.9	11.3	147.6	0.0	25.2	0.6	18.5	2.7	0.0	93.7	11.5	0.0	12.1	28.8	29.3	0.2	16.1	25.7	1.7	1.8	25.6	1.0	24.6	48.9	4.9	8.4	0.0	12.9	11.3	0.4	0.6	1.1	1.1	1.3	42.4	0.9
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561647	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 87.1"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	7.4	10.1	9.0	7.0	8.9	0.9	5.2	8.2	13.1	16.5	12.2	8.7	10.5	7.2	29.0	7.7	6.5	18.6	6.9	7.3	7.9	5.7	3.5	2.5	15.2	3.4	5.3	10.3	14.7	3.9	3.2	5.8	18.2	10.6	14.8	15.2	7.8	4.6	9.8	12.4	14.9	7.5	18.0	4.8	6.9	14.6	6.8	9.0	27.6	11.3	3.6	3.8	11.8	8.7	4.1	0.0	4.4	0.0	1.9	5.1	0.8	0.0	5.9	11.8	0.2	4.3	1.8	5.2	0.1	0.5	0.4	0.7	22.1	2.1	0.4	0.7	3.4	0.4	0.1	2.4	0.0	0.8	1.0	1.3	0.0	1.0	32.9	0.4	0.0	0.0	1.0	0.9	0.9	0.2	0.7	1.0	2.2	0.0	0.5	0.6	0.1	5.7	0.0	2.3	36.5	0.2	4.1	0.6	0.0	1.1	0.1	3.7	2.4	0.2	0.1	2.0	9.1	0.4	0.1	2.6	2.3	4.3	3.3	0.7	0.0	1.2	1.5	1.1	0.2	1.1	4.4	0.0	0.0	0.3	0.0	0.8	1.0	2.3	0.4	0.0	4.1	5.1	0.8	0.0	1.9	0.0	0.0	0.0	0.8	9.0	8.9	8.2	13.1	7.9	5.7	5.3	10.3	10.6	9.0	0.0	7.0	0.0	1.2	10.0	3.8	8.1	2.5	1.4	10.3	0.0	3.9	14.3	0.0	1.0	27.8	3.8	2.8	0.0	0.7	87.1	17.5	4.1	0.0	1.9	3.3	1.6	5.2	1.3	0.0	11.2	6.1	0.3	16.9	1.8	18.7	3.5	0.7	3.5	10.3	0.6	1.9	12.9	5.9	5.4	12.6	4.8	11.9	0.0	16.8	1.1
AKT1S1	"Lobe, MGC2865, PRAS40"	ENSG00000204673	"AKT1 substrate 1"	Q96B36	19	49869033-49878459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021903, HPA043590, HPA064427"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"CAB021903: , HPA043590: AB_2678569, HPA064427: AB_2685261"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.60e-4)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.65e-1)"	22.2	22.9	16.2	11.9	18.1	10.7	13.8	12.9	19.9	16.9	15.3	21.3	20.1	18.8	17.1	13.5	21.1	14.7	14.6	20.1	15.1	12.6	15.0	43.0	11.7	7.2	17.4	11.3	15.5	17.3	19.1	14.7	25.7	18.3	15.1	13.0	14.8	17.2	19.2	72.7	21.2	16.3	15.8	13.7	10.5	16.2	13.5	21.4	7.4	17.8	20.5	10.5	15.4	29.5	1.9	3.5	5.0	4.3	2.0	3.0	1.3	23.4	28.5	8.3	19.2	17.8	19.1	14.8	21.1	23.9	20.0	17.4	15.3	15.7	4.7	10.9	23.9	15.1	16.2	14.4	24.0	11.8	10.5	40.0	5.6	16.4	14.5	15.9	4.9	9.3	23.5	22.3	21.7	24.7	15.0	18.5	5.7	18.6	6.2	18.0	16.5	4.6	12.2	21.8	28.7	41.5	5.6	11.7	14.2	19.9	16.7	19.5	22.7	18.1	32.3	12.9	10.2	16.9	9.7	17.7	41.5	21.6	11.9	20.7	9.1	22.3	5.0	24.0	9.1	19.7	0.4	3.1	2.4	2.1	4.0	1.4	1.2	1.6	2.3	2.3	1.9	1.4	2.3	5.0	2.0	4.3	3.5	3.0	1.3	16.2	18.1	12.9	19.9	15.1	12.6	17.4	11.3	18.3	21.4	0.0	3.5	10.4	23.0	13.1	11.4	5.0	30.6	0.0	2.3	10.4	2.0	54.1	38.1	28.9	22.9	16.1	47.2	46.7	35.0	41.2	27.7	36.6	4.6	32.6	27.1	9.5	28.8	11.6	19.4	9.0	22.2	18.2	11.8	32.5	33.0	28.6	28.4	31.6	26.9	40.7	10.7	25.8	30.1	11.6	13.4	17.6	108.7	9.6	31.9	23.8
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569346-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 132.4;Late spermatids: 434.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	10.7	11.9	14.2	11.8	11.8	13.7	8.0	13.8	16.7	8.8	15.3	15.5	12.1	20.5	11.5	9.6	12.0	13.5	14.5	17.2	13.1	10.6	11.2	12.4	10.3	19.9	12.1	11.5	12.9	14.7	8.4	14.0	7.8	11.2	11.8	9.0	11.0	13.8	10.1	32.5	9.5	14.4	14.2	11.0	13.9	13.0	24.6	8.3	21.6	13.7	8.3	10.0	10.4	13.3	6.1	5.4	12.6	5.4	15.1	6.8	2.8	7.8	5.9	6.0	6.3	11.4	2.9	2.5	4.5	6.2	3.8	3.0	1.8	11.9	4.1	9.1	5.6	5.2	5.8	1.7	2.8	4.1	12.2	3.6	2.8	2.3	1.4	3.0	3.9	12.7	5.9	6.3	4.0	4.9	6.5	3.8	5.6	2.9	9.6	4.2	4.7	11.1	4.3	2.2	7.7	1.9	9.5	2.4	6.2	6.6	2.5	8.6	9.6	1.6	11.8	9.9	1.8	12.9	6.5	2.9	3.3	3.6	3.8	3.5	13.8	9.6	4.4	10.1	3.4	5.6	12.6	3.9	8.3	4.8	3.9	5.8	5.5	5.6	5.4	3.9	6.1	4.8	4.4	6.0	15.1	5.4	5.4	6.8	2.8	14.2	11.8	13.8	16.7	13.1	10.6	12.1	11.5	11.2	8.3	6.0	1.9	17.1	10.5	5.7	19.5	8.5	17.8	20.1	6.8	15.7	17.7	6.3	41.4	19.2	132.4	11.1	34.5	0.0	27.4	7.9	13.1	9.8	4.7	18.7	21.4	20.6	19.5	14.1	22.9	434.2	18.4	15.6	16.9	28.9	25.1	28.0	19.6	32.3	18.7	38.4	25.5	6.5	12.5	25.3	7.9	6.1	3.9	20.3	22.1	5.7
POU6F1	"BRN5, MPOU, TCFB1"	ENSG00000184271	"POU class 6 homeobox 1"		12	51186936-51217708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.7"	"Low region specificity"	"Detected in all"							"HPA047021, HPA050411"	Enhanced		Supported	"Nuclear bodies,Actin filaments"		NA	NA			"Nuclear bodies"	"Actin filaments"	"HPA047021: AB_2679905, HPA050411: AB_2681119"	"unprognostic (4.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.58e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.11e-3)"	"unprognostic (4.45e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (2.48e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.33e-1)"	8.2	6.9	8.4	5.1	11.6	2.8	5.7	17.6	21.8	8.5	5.6	6.4	2.4	3.7	7.1	2.3	3.9	5.9	5.6	3.5	8.2	4.6	5.2	2.8	5.5	4.1	10.0	8.3	12.4	6.1	3.1	6.2	3.3	8.1	6.9	2.2	5.0	8.4	6.9	13.6	5.6	5.7	6.6	6.6	6.3	3.8	2.4	10.1	0.0	7.5	1.2	3.0	4.7	6.2	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.6	1.3	1.8	2.4	0.6	2.2	1.0	0.8	1.0	1.1	1.3	0.3	0.9	3.2	0.3	0.7	0.5	0.0	2.2	0.1	0.0	4.8	3.1	0.8	1.7	0.0	1.8	0.8	4.4	1.2	0.9	1.8	0.3	2.6	3.6	1.3	1.1	8.7	0.5	0.0	0.4	1.1	3.0	0.0	0.0	1.0	1.0	0.0	0.6	0.0	2.3	4.0	2.0	0.0	4.3	0.9	0.9	2.9	2.7	2.0	1.6	0.6	2.2	5.6	4.4	0.4	1.8	0.8	0.7	0.0	0.0	0.0	1.0	0.0	0.1	0.8	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	11.6	17.6	21.8	8.2	4.6	10.0	8.3	8.1	10.1	6.0	3.2	0.8	1.4	2.7	9.3	2.6	0.0	4.0	2.3	7.0	3.9	0.5	1.7	0.8	3.2	3.3	0.0	0.0	1.7	0.2	2.1	1.6	4.7	1.0	0.3	1.6	0.0	3.1	0.6	2.9	5.5	1.0	1.7	2.8	0.2	3.4	1.8	0.0	6.3	0.3	7.6	0.0	2.8	0.0	0.4	2.5	0.3	0.7	0.6	0.6
KBTBD7	DKFZP434E2318	ENSG00000120696	"Kelch repeat and BTB domain containing 7"	Q8WVZ9	13	41189833-41194566	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043709, HPA046861, HPA048914"	Uncertain					NA	NA					"HPA043709: AB_10961260, HPA046861: AB_2679843, HPA048914: AB_2680554"	"unprognostic (8.68e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (4.36e-2)"	"unprognostic (7.59e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (4.98e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	4.1	7.6	10.2	4.7	9.7	6.0	8.5	16.4	12.9	7.6	4.8	8.3	7.5	5.8	5.4	8.5	4.7	8.1	5.9	6.8	9.5	9.9	8.7	10.6	4.7	5.8	7.9	13.1	9.6	7.1	8.2	8.1	6.7	8.2	9.5	4.2	6.1	11.3	9.3	5.7	5.2	5.0	4.3	8.0	7.4	7.3	6.9	6.2	9.3	10.5	2.4	6.9	5.9	4.0	2.5	3.7	14.4	5.2	3.1	5.7	2.9	2.1	4.5	9.2	10.6	9.9	4.3	3.4	2.2	3.2	3.0	2.1	5.8	4.2	3.8	3.4	2.8	3.9	7.3	6.9	4.7	3.0	5.3	8.9	10.2	6.2	5.1	4.6	1.7	8.5	2.4	8.4	1.0	2.8	5.5	3.2	7.1	4.9	0.4	5.6	6.4	9.1	4.0	9.1	9.3	2.3	10.2	5.8	1.9	6.3	5.0	5.3	7.3	3.3	10.0	3.0	8.4	6.0	9.5	3.2	1.8	2.3	1.6	1.8	2.7	3.1	0.0	4.2	4.6	4.1	2.1	5.1	11.4	3.2	5.2	3.6	2.5	3.7	3.7	3.7	2.5	5.7	4.9	14.4	3.1	3.8	1.8	2.6	2.9	10.2	9.7	16.4	12.9	9.5	9.9	7.9	13.1	8.2	6.2	8.9	4.1	6.1	12.7	3.7	24.7	7.1	12.7	2.7	7.9	12.2	13.7	13.5	16.6	5.3	37.7	6.8	9.3	0.0	5.1	10.5	10.6	7.6	9.2	24.2	7.2	4.8	12.2	17.2	12.4	2.2	14.7	4.3	5.0	4.6	11.8	22.1	4.1	11.5	20.5	14.7	18.3	19.4	7.3	7.7	14.7	5.9	8.2	5.0	9.3	6.3
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165012-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 49.1;Intestinal endocrine cells: 34.5;Sertoli cells: 32.3;Smooth muscle cells: 97.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA007264: AB_1080053"	"unprognostic (2.13e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.04e-7)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.95e-2)"	4.5	7.4	6.1	2.3	15.8	2.5	4.2	23.1	26.6	1.4	2.2	0.5	0.6	3.3	1.9	4.1	1.5	2.3	1.8	2.2	9.3	5.3	13.6	3.3	1.4	2.7	2.6	13.1	1.5	2.0	1.4	5.7	1.0	4.9	2.8	2.7	1.1	1.8	3.6	1.7	1.9	2.5	2.2	3.3	8.3	7.2	1.4	1.9	0.3	2.3	0.0	2.9	2.0	1.9	1.4	1.0	4.7	0.9	0.9	1.0	0.3	0.3	0.5	0.6	1.2	0.2	0.2	0.7	0.2	0.3	0.5	0.5	0.5	0.5	0.7	0.3	0.1	1.4	0.5	0.1	0.1	0.2	0.6	1.0	0.6	1.1	0.5	0.1	0.4	2.3	0.2	0.1	0.2	0.1	0.3	0.0	0.7	0.7	1.2	0.2	0.6	0.4	1.3	1.6	0.2	0.6	0.7	0.9	0.4	0.4	0.6	17.2	1.5	0.3	0.3	0.2	1.0	2.2	0.3	0.3	0.4	2.2	0.6	0.3	0.8	0.4	1.6	0.3	1.8	0.4	3.8	0.9	1.2	1.0	0.7	0.8	0.8	0.8	0.8	0.3	1.4	0.8	0.9	4.7	0.9	0.8	1.0	0.5	0.3	6.1	15.8	23.1	22.1	9.3	5.3	2.6	13.1	4.9	1.9	6.0	2.4	0.0	3.0	1.0	49.1	2.6	0.0	1.4	2.3	1.8	3.9	0.4	0.0	0.0	7.0	4.0	0.0	0.0	0.0	0.3	2.2	3.0	2.3	0.8	1.1	6.4	34.5	3.7	1.0	3.0	0.9	2.6	5.0	1.8	7.2	1.7	0.6	0.0	0.7	17.4	3.9	32.3	97.1	0.7	1.9	1.0	0.8	1.5	0.4	3.1
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		67000000	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.4	0.0	0.9	0.6	8.2	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8	0.0	0.3	0.0	0.1	0.1	1.8	2.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.9	0.2	0.0	5.1	8.0	0.0	0.7	4.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	2.8	0.6	0.3	6.5	1.6	0.0	0.2	0.3	0.0	0.0	0.7	0.1
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX, non-homologous end joining factor"	Q9BUH6	9	136992418-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 112.4;Distal tubular cells: 111.0;Extravillous trophoblasts: 180.6;Syncytiotrophoblasts: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm		NA	NA		77000	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	14.0	10.2	20.7	17.2	18.4	28.0	15.6	14.7	25.4	11.9	17.8	16.4	10.3	22.0	10.6	12.9	14.1	11.8	14.3	12.4	19.4	16.9	14.2	18.2	12.9	24.2	20.7	12.5	10.1	25.9	9.4	17.1	17.1	16.0	16.0	4.9	9.9	24.8	15.7	15.8	19.5	18.1	7.1	25.3	27.8	28.0	6.4	14.7	34.5	16.4	11.5	15.0	11.5	10.3	8.3	56.3	4.1	12.6	19.1	36.2	13.5	10.2	11.5	1.8	7.0	3.3	3.0	27.5	7.9	4.8	5.3	2.9	5.0	7.5	9.3	13.9	2.0	2.0	16.4	0.6	5.9	0.4	23.7	16.4	7.2	5.9	4.2	5.0	10.3	16.1	2.2	5.6	1.8	2.3	0.9	4.8	17.0	10.7	2.7	1.1	22.6	10.8	16.8	11.1	11.9	35.3	14.1	3.8	26.2	3.5	5.3	8.8	11.0	6.8	16.9	9.0	0.3	20.2	8.7	6.3	2.5	7.8	12.0	9.3	5.1	4.5	6.2	4.5	11.8	9.4	4.1	10.8	4.1	36.2	12.6	31.1	8.3	20.2	31.2	11.0	7.8	11.2	25.6	3.7	19.1	6.4	56.3	15.1	13.5	20.7	18.4	14.7	25.4	19.4	16.9	20.7	12.5	16.0	14.7	14.9	25.1	0.0	0.0	0.0	0.0	0.0	0.0	21.4	13.6	38.4	0.0	112.4	111.0	40.3	0.0	0.0	0.0	0.0	37.7	180.6	0.0	0.0	11.6	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	61.3	0.0	0.0	33.7	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0
PKNOX1	PREP1	ENSG00000160199	"PBX/knotted 1 homeobox 1"	P55347	21	42974510-43033931	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004285, HPA057215, HPA065017"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004285: AB_2164128, HPA057215: AB_2683372, HPA065017: AB_2685405"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (4.54e-8)"	"unprognostic (2.03e-1)"	"unprognostic (8.03e-2)"	"unprognostic (3.67e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (9.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.31e-3)"	6.8	6.4	7.9	8.7	9.2	3.9	7.3	24.2	9.1	12.3	8.3	9.9	9.0	5.0	14.3	9.8	7.4	10.0	8.4	6.1	7.2	7.9	6.7	6.6	6.9	8.1	10.7	5.4	14.4	15.7	6.9	13.3	11.9	8.6	8.7	6.9	5.4	7.1	12.4	11.7	9.2	6.1	15.2	7.6	7.5	6.6	42.9	10.1	12.2	16.4	5.8	7.6	9.3	18.2	4.9	3.3	10.1	4.9	4.0	7.6	4.1	8.7	3.1	4.1	3.9	7.7	11.7	5.1	11.3	7.8	6.9	5.9	5.3	6.8	12.3	9.4	9.8	5.4	4.7	9.3	7.1	9.0	8.4	7.6	7.3	5.9	5.0	8.0	6.5	5.8	8.9	11.8	8.5	6.9	7.2	6.5	4.3	5.7	9.2	15.5	5.2	6.1	7.3	6.3	12.5	6.8	9.8	18.5	6.7	13.5	7.1	13.1	7.9	8.0	5.8	7.7	4.9	4.9	8.3	7.7	10.8	5.4	5.9	7.2	5.4	6.0	6.4	13.5	11.7	5.6	0.4	3.7	2.7	7.2	4.9	7.6	4.9	5.2	5.9	3.3	4.1	6.4	5.6	10.1	4.0	3.3	3.0	5.3	4.1	7.9	9.2	24.2	9.1	7.2	7.9	10.7	5.4	8.6	10.1	6.0	14.9	6.0	71.8	15.5	22.3	5.6	12.7	20.1	20.5	15.7	3.9	12.4	8.3	14.2	104.0	11.7	9.1	23.3	10.9	24.3	19.4	19.9	5.8	6.8	10.9	12.7	14.3	9.2	8.3	26.8	17.3	17.5	13.5	18.0	9.6	9.7	13.8	5.8	27.6	5.9	11.2	32.3	22.6	61.7	24.3	12.0	24.3	15.8	9.3	44.5
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.2	15.0	39.6	11.7	5.3	3.6	7.4	13.6	3.0	5.7	4.4	11.4	7.9	10.7	9.5	5.8	16.5	11.9	13.6	10.3	8.6	14.4	28.8	12.6	22.4	14.5	5.7	16.5	12.2	3.0	9.2	3.3	7.4	15.9	6.1	21.7	20.2	12.9	5.4	12.7	20.7	23.7	8.0	42.7	13.2	16.3	34.2	10.4	19.4	12.7	10.9	12.5	15.8	7.9	13.5	26.8	18.0	16.9	2.9	13.4	13.3	10.4	21.7	11.8	24.4	18.6	17.6	11.3	13.1	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6	32.8	10.5	28.2	25.1	16.3	29.6	46.2	20.4	24.1	9.1	57.6	31.4	31.7	101.2	15.6	27.8	14.6	14.3	23.3	21.0	26.9	15.5	23.7	20.9	35.9	18.2	41.3	54.3	17.8	9.5	7.0	12.4	11.6	8.5	10.8	27.6	51.1	14.4	21.0	19.4	81.2	35.9	32.3	15.3	62.7	19.8	23.8	19.8	28.7	31.9	22.3
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 117.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009798, HPA044617, HPA052450"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	19.5	20.4	61.3	15.7	45.6	17.6	16.6	103.0	117.9	15.2	14.8	22.4	11.5	10.5	21.1	18.7	19.7	16.0	15.7	27.1	61.0	65.1	8.6	8.9	20.0	15.9	66.2	47.9	19.8	14.8	25.2	17.0	17.9	50.7	16.3	14.1	14.1	16.9	19.7	28.2	22.4	12.8	23.1	56.0	18.3	13.8	14.3	23.2	7.9	13.8	13.0	18.1	15.7	14.9	7.3	10.4	12.4	8.6	4.1	10.9	3.1	16.4	22.1	42.7	23.3	28.9	31.6	19.7	38.8	31.9	36.5	24.9	18.9	18.0	21.8	20.2	41.8	16.2	27.5	26.0	20.5	34.6	26.3	13.1	12.2	26.1	19.1	32.9	23.9	24.3	22.9	33.3	27.5	33.5	38.9	31.3	15.5	18.2	25.1	31.7	27.7	16.0	21.1	13.7	26.3	40.9	15.4	18.0	10.7	22.7	36.5	50.4	28.2	31.5	16.0	25.6	27.6	14.1	11.8	45.5	27.1	13.4	37.1	21.5	20.1	14.0	24.2	31.0	13.8	29.0	7.6	5.8	12.4	10.3	6.0	9.5	6.4	9.3	10.9	6.8	7.3	7.9	7.2	7.0	4.1	8.6	10.4	8.4	3.1	61.3	45.6	103.0	90.3	61.0	65.1	66.2	47.9	50.7	23.2	41.7	27.5	24.9	39.0	23.1	133.1	34.0	22.9	16.0	14.8	19.2	49.1	19.5	8.3	42.1	4.2	42.8	13.0	0.0	26.7	27.4	32.1	34.5	32.4	15.6	26.3	130.3	43.0	31.9	18.1	11.4	35.6	24.1	37.1	46.9	20.2	42.5	49.1	14.4	45.3	3.4	89.3	25.8	40.6	36.8	78.0	15.4	35.2	28.9	14.7	31.8
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5;plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	6.1	4.5	7.4	3.8	7.2	2.8	8.5	9.6	12.8	6.1	7.4	4.0	1.3	3.0	9.2	6.0	4.5	4.3	4.0	7.0	7.1	6.3	5.9	5.1	5.4	3.1	7.0	7.7	6.0	4.0	6.6	8.6	4.3	5.1	6.0	4.6	4.4	3.8	7.4	4.1	3.0	4.0	11.7	7.0	4.9	4.8	5.2	3.6	8.9	4.0	3.1	3.4	5.2	3.8	1.0	4.4	3.5	0.2	1.2	1.2	0.3	5.1	2.8	9.1	12.9	7.4	5.3	3.0	6.8	4.7	8.6	9.8	3.2	2.2	3.4	4.3	4.6	9.8	2.3	9.9	5.5	11.3	3.7	5.7	6.2	5.8	4.0	3.5	7.7	0.8	4.3	2.6	8.5	2.9	4.9	10.5	6.7	8.0	0.4	9.5	1.5	6.5	9.7	3.4	0.1	5.8	11.2	11.6	0.0	4.3	2.8	6.3	12.1	4.6	0.8	5.1	9.5	2.5	4.8	7.4	12.9	8.6	0.9	10.6	3.3	3.3	4.4	2.9	4.5	6.0	3.5	0.1	0.0	0.6	0.2	0.3	0.5	0.2	1.2	0.7	1.0	0.1	0.5	0.0	1.2	0.1	4.4	0.5	0.3	7.4	7.2	9.6	12.8	7.1	6.3	7.0	7.7	5.1	3.6	6.0	0.6	1.4	2.2	0.2	6.7	7.0	0.0	6.7	0.0	0.0	2.0	0.6	0.0	0.9	0.4	4.2	0.3	0.0	2.3	2.8	1.6	1.0	3.5	0.0	1.4	4.8	1.2	1.8	2.9	0.9	1.7	1.1	3.3	3.6	0.3	4.1	1.2	0.0	3.2	3.7	3.9	0.0	1.4	4.2	7.5	0.3	0.3	0.5	1.0	0.5
APBB3	FE65L2	ENSG00000113108	"Amyloid beta precursor protein binding family B member 3"	O95704	5	140558268-140564781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005571, HPA076196"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA005571: AB_1844912, HPA076196: "	"unprognostic (7.63e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.98e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.67e-2)"	4.2	5.6	7.5	4.3	9.2	3.3	3.4	26.6	23.8	4.5	4.3	8.2	5.7	2.0	4.7	6.3	4.2	6.0	7.8	8.2	9.7	13.1	3.3	3.4	3.2	2.6	7.9	7.3	4.3	3.5	8.2	11.0	5.7	10.9	5.9	3.6	8.7	8.8	7.4	2.5	3.4	2.8	4.1	4.2	4.7	4.4	11.8	5.5	2.0	6.7	3.3	3.4	3.8	2.3	1.4	1.8	7.7	3.6	0.7	1.4	1.1	0.6	0.7	0.5	2.9	0.0	1.2	5.8	1.4	1.7	2.1	3.9	1.9	1.7	2.4	3.3	2.5	1.3	1.1	0.0	2.2	0.6	2.3	1.2	0.9	5.2	0.1	3.5	0.8	1.0	7.6	0.9	1.8	1.4	0.5	1.5	5.6	0.4	6.6	2.2	1.4	0.3	1.8	1.2	0.7	3.6	0.4	0.7	1.4	1.8	1.5	9.0	4.5	3.8	1.3	5.1	0.3	4.0	3.9	1.1	0.4	1.0	0.0	0.2	2.5	1.9	0.3	0.9	0.6	0.8	7.7	1.4	0.0	1.4	3.6	0.9	0.5	1.0	1.3	1.0	1.4	0.6	1.3	3.3	0.7	0.6	1.8	1.0	1.1	7.5	9.2	26.6	17.4	9.7	13.1	7.9	7.3	10.9	5.5	3.0	9.4	3.4	2.8	2.5	22.6	1.9	12.7	1.4	6.8	5.2	0.0	9.5	5.0	3.3	48.3	5.8	5.0	0.0	1.4	10.2	4.1	2.9	10.4	14.3	11.9	17.5	5.2	7.4	29.1	31.3	5.2	10.2	6.8	4.6	3.6	12.4	2.3	3.2	4.6	3.1	15.7	0.0	3.1	8.4	6.0	2.5	9.8	4.4	2.8	2.4
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 32.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 32.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	12.0	17.1	32.5	10.5	39.9	14.1	6.6	17.7	51.2	14.0	11.1	10.8	5.1	6.0	12.7	8.4	8.4	9.7	13.7	10.4	37.0	22.3	5.5	18.0	10.0	5.4	11.8	17.9	15.2	12.4	11.7	22.7	11.5	12.3	18.5	5.1	11.8	13.1	15.1	23.1	16.2	5.7	16.8	10.5	10.6	9.3	7.6	9.4	0.5	7.7	4.4	3.3	9.8	8.1	0.0	2.9	32.3	7.2	0.0	0.3	2.3	8.8	5.5	3.0	12.6	12.8	12.3	0.8	15.8	14.7	9.8	10.1	1.0	1.6	1.7	9.4	20.1	2.0	1.6	1.7	4.7	5.3	4.6	3.2	0.5	3.8	1.0	6.7	0.5	18.0	11.0	8.6	8.4	1.6	14.2	6.6	2.8	8.5	14.1	8.2	13.1	0.2	2.4	3.3	3.0	30.7	0.2	0.4	4.8	4.6	4.2	3.3	10.9	6.6	5.7	3.3	1.0	8.2	11.3	7.6	22.2	4.7	37.5	8.3	8.8	5.4	0.6	21.6	8.1	8.7	0.8	7.2	3.7	0.3	6.7	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	32.3	0.0	4.4	0.1	0.3	2.3	32.5	39.9	17.7	51.2	37.0	22.3	11.8	17.9	12.3	9.4	6.0	8.8	0.5	5.5	0.0	5.1	0.0	7.6	2.7	2.3	3.5	11.8	0.5	1.7	6.2	11.0	6.9	0.0	0.0	7.6	2.1	2.1	16.2	2.3	6.7	4.0	7.9	16.4	8.0	9.7	8.2	13.3	3.9	0.0	0.0	2.5	15.3	7.5	0.0	15.6	1.3	6.3	6.5	0.0	1.8	4.9	0.0	2.4	0.0	0.8	4.1
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458329-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 21.4;monocytes: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	17.6	23.5	37.6	12.6	34.8	15.1	18.1	12.1	27.5	22.4	14.9	34.4	23.6	15.9	19.2	26.1	19.0	31.0	20.6	21.2	30.9	22.7	23.0	26.4	15.4	15.5	28.6	17.2	27.6	35.9	27.7	22.1	15.4	20.8	29.8	10.2	32.1	49.1	25.5	15.3	19.7	15.8	16.4	25.2	14.7	17.9	10.6	17.0	40.5	36.0	17.2	17.6	18.7	19.2	19.2	30.3	15.3	18.5	21.5	24.0	16.5	6.1	29.3	17.8	20.1	22.8	17.5	13.4	6.6	12.3	6.6	5.4	15.2	11.7	6.0	11.8	15.2	10.1	9.1	7.2	17.1	6.4	23.7	17.0	8.4	13.8	21.3	14.6	3.0	8.3	24.6	18.3	8.8	13.1	31.8	13.1	15.9	3.3	21.5	16.7	41.7	10.3	7.7	12.7	16.1	15.6	10.4	20.1	9.0	17.5	26.0	10.5	26.4	8.8	14.6	18.1	16.6	19.5	8.1	8.1	16.0	13.2	6.2	6.4	32.9	11.4	7.0	17.2	7.9	14.1	15.3	18.5	12.2	18.1	14.2	15.9	19.2	16.0	17.6	19.4	18.8	22.4	19.4	13.0	21.5	12.0	30.3	24.0	16.5	37.6	34.8	12.1	27.5	30.9	22.7	28.6	17.2	20.8	17.0	3.0	3.4	0.0	0.4	0.8	1.7	0.4	0.0	21.4	5.7	1.8	2.0	1.1	1.7	4.1	1.3	1.1	3.4	0.0	3.5	1.2	1.2	1.6	1.1	0.8	1.4	0.0	1.7	0.6	3.5	1.3	2.0	1.4	0.0	9.0	4.4	1.5	5.0	3.5	1.1	3.1	1.8	0.0	1.2	0.1	0.2	1.1	1.5	1.5	4.5	0.3
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.5	12.9	10.8	10.7	18.2	18.4	9.2	24.8	14.9	15.4	21.7	19.8	24.4	23.0	13.1	20.4	14.9	17.1	16.5	18.6	29.2	17.7	15.3	22.6	12.6	16.0	12.7	13.3	11.0	18.1	15.6	18.9	9.8	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	10.6	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8	23.8	10.5	11.8	13.7	13.9	37.4	8.9	15.3	17.4	10.3	12.2	84.4	15.7	5.0	12.1	69.3	16.6	12.9	23.3	11.3	13.2	13.6	16.1	19.6	10.6	10.8	28.6	26.5	17.8	11.8	11.8	19.5	10.7	18.6	14.4	12.2	22.0	16.3	8.6	15.6	10.3	70.3	19.4	11.5	17.9	22.6	16.4	23.0	23.5	11.0	13.3
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415"	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	10.0	4.3	9.7	8.1	5.7	10.8	11.3	8.0	16.1	12.6	14.1	2.8	7.1	8.1	10.1	7.0	9.7	18.2	10.1	13.8	4.6	24.5	8.5	15.3	16.6	6.9	16.2	5.8	5.4	11.4	16.7	5.3	6.7	10.3	3.7	11.7	1.7	9.8	11.4	6.3	13.2	16.1	6.6	17.6	7.4	9.2	13.2	8.0	7.6	10.2	12.3	10.0	11.8	19.0	5.6	6.7	6.7	7.5	7.2	12.9	10.2	12.6	4.2	4.5	7.6	10.2	11.8	14.5	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9	8.9	6.7	12.6	9.5	5.6	25.1	12.4	5.1	9.4	5.7	10.4	15.7	20.8	23.2	18.2	0.8	11.9	11.4	23.3	16.7	17.5	10.3	9.9	9.2	16.6	13.8	12.7	12.0	15.4	11.8	1.7	14.1	8.3	8.5	17.2	9.8	11.0	16.7	10.5	15.9	22.8	26.2	6.5	11.7	18.2	13.2	8.4	12.8	10.1	15.3	8.2
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		19000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.5	32.1	13.2	18.1	57.0	21.0	25.0	24.7	34.4	28.1	17.5	12.9	30.3	18.0	20.6	51.7	10.1	25.9	8.8	27.0	24.9	56.9	9.1	9.6	22.8	19.7	27.4	9.1	25.0	23.3	24.7	23.5	37.1	43.6	25.3	22.1	12.3	21.9	45.1	12.7	9.4	11.0	6.2	35.2	12.7	13.2	14.6	42.6	62.6	30.6	3.5	8.7	34.8	44.3	20.2	12.9	20.3	14.0	25.1	24.9	18.7	12.6	24.1	20.6	9.6	0.9	45.9	16.1	18.1	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6	56.6	73.4	64.0	249.7	77.5	39.6	397.7	150.3	17.4	43.3	191.9	58.9	369.3	157.5	241.9	107.0	71.4	453.8	23.3	66.5	164.5	100.7	311.9	89.7	297.9	171.6	31.8	172.2	51.5	68.0	184.1	115.3	93.1	77.6	423.8	144.6	37.1	129.2	196.4	124.8	276.8	38.8	103.5	102.3	100.5	34.7	76.5	554.7	68.2	215.2	275.4
TMEM198	"MGC99813, TMEM198A"	ENSG00000188760	"Transmembrane protein 198"	Q66K66	2	219543663-219550595	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 20.6;Intestinal endocrine cells: 18.4;Muller glia cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 17.3;SH-SY5Y: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042385, HPA062897"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA042385: AB_2677972, HPA062897: "	"unprognostic (2.59e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.89e-4)"	"unprognostic (6.39e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	3.0	9.4	14.4	3.1	10.3	0.9	2.3	14.2	22.0	3.3	2.6	4.1	1.4	16.1	4.0	2.5	2.7	2.5	3.9	3.4	16.5	5.2	3.0	2.6	2.4	1.8	4.1	11.9	10.9	20.0	5.2	13.0	2.6	6.2	4.0	1.8	3.0	7.0	4.3	3.5	2.2	6.4	3.5	7.5	1.8	4.7	5.0	4.9	0.0	4.0	0.5	1.9	3.8	1.2	0.2	2.6	0.1	0.0	0.8	0.4	0.4	0.5	0.1	4.8	8.2	1.0	0.9	4.3	2.5	1.3	2.0	1.7	10.5	1.4	2.1	2.4	1.5	5.0	2.9	1.7	1.2	0.4	7.1	2.0	1.7	2.1	8.6	1.5	0.6	4.0	2.1	0.7	0.9	2.3	2.2	0.0	1.5	6.2	7.0	1.2	1.0	0.1	0.5	6.2	0.8	0.7	0.2	2.9	2.4	1.2	1.1	17.3	15.0	0.6	1.7	4.1	0.9	0.2	3.3	0.1	2.2	0.9	2.0	1.0	6.7	1.9	2.2	2.0	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	2.6	0.0	0.4	14.4	10.3	14.2	22.0	16.5	5.2	4.1	11.9	6.2	4.9	0.0	1.4	0.0	1.1	0.1	8.1	1.6	0.0	0.0	0.0	0.0	2.0	0.8	1.7	2.7	0.7	0.0	1.0	0.0	7.0	0.6	2.2	0.8	0.0	1.5	0.2	20.6	18.4	0.0	0.3	1.3	2.6	0.0	1.7	1.0	0.9	9.8	1.8	0.8	4.6	1.6	6.5	0.0	2.8	9.2	3.1	0.1	2.4	0.5	0.1	0.3
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536172-42544449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease mutation, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		300000000			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	21.1	21.0	10.2	8.4	15.9	10.7	18.3	5.5	11.4	16.9	17.1	19.1	16.3	14.8	19.3	20.6	11.9	14.6	21.4	11.5	10.7	5.9	31.3	50.1	16.3	12.5	21.6	8.0	20.4	38.9	10.6	12.7	23.5	12.1	14.8	10.2	20.9	32.4	12.3	9.1	13.2	17.3	10.1	13.5	22.5	17.0	9.8	20.5	8.9	20.7	8.9	12.3	16.1	12.7	4.8	6.0	3.8	5.8	4.3	5.8	2.4	6.0	21.1	4.2	9.6	42.1	14.0	14.3	9.2	21.9	9.7	12.4	5.7	15.6	7.7	9.4	14.1	21.5	14.7	3.8	4.4	2.2	5.9	7.8	4.2	10.9	11.7	14.1	5.0	10.9	16.6	6.9	5.3	6.6	10.7	12.6	1.4	6.1	15.6	10.7	14.5	0.8	8.6	4.9	12.9	2.7	3.2	9.2	17.9	12.8	13.9	6.4	9.7	5.0	6.9	7.8	6.4	32.1	5.3	9.8	23.6	3.9	9.3	5.9	20.8	9.3	6.4	14.4	5.5	16.7	2.3	5.5	3.8	5.6	3.7	5.8	4.8	2.4	3.1	4.5	4.6	4.3	3.5	2.5	4.3	5.8	6.0	0.5	2.4	10.2	15.9	5.5	11.4	10.7	5.9	21.6	8.0	12.1	20.5	11.9	8.5	6.7	5.2	2.5	13.3	3.9	20.4	0.0	2.3	17.4	3.9	19.9	3.3	13.8	0.2	8.7	20.2	0.0	28.2	11.7	13.8	9.4	2.3	35.8	31.7	14.3	6.4	28.3	21.0	1.9	18.4	10.9	15.1	5.4	15.9	12.0	16.3	2.9	12.0	31.2	6.4	6.5	8.2	0.4	5.3	3.0	15.4	5.0	10.2	4.7
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.2	6.2	13.8	3.0	10.1	1.0	8.4	3.0	18.2	6.0	6.4	6.9	12.4	7.9	5.0	6.4	5.1	9.0	8.1	11.3	13.2	10.2	8.1	6.6	8.9	2.1	8.3	9.6	7.5	12.5	22.9	11.9	5.4	9.1	7.4	4.4	8.9	13.3	10.8	6.9	4.0	8.0	8.1	5.7	4.7	11.4	6.1	7.3	1.1	8.2	2.8	4.5	7.4	3.7	0.6	1.7	3.0	1.3	2.6	0.6	0.4	6.7	10.2	5.5	5.6	2.3	2.0	0.0	3.7	5.1	5.1	3.4	9.9	11.8	0.0	7.1	3.6	13.0	25.3	5.0	4.8	1.7	0.3	5.6	0.1	15.4	7.3	5.5	3.3	12.6	1.4	9.0	2.5	6.3	5.6	3.2	0.0	6.7	0.0	2.9	15.4	0.1	1.0	8.0	13.9	14.1	0.0	9.6	11.2	4.9	9.1	8.4	12.4	6.6	9.3	6.9	4.5	7.1	3.0	3.8	1.9	8.6	9.1	4.2	5.2	12.3	0.2	4.0	0.6	4.8	0.0	1.3	3.0	0.4	0.4	0.0	0.6	0.2	0.0	1.7	0.4	0.0	0.0	0.3	2.6	0.6	0.3	0.6	0.4	13.8	10.1	3.0	18.2	13.2	10.2	8.3	9.6	9.1	7.3	3.0	4.8	0.0	2.0	1.9	10.1	7.3	17.8	2.7	2.3	7.0	7.9	0.4	5.0	5.2	0.2	2.3	5.2	0.0	2.9	0.7	2.3	4.1	2.3	4.9	4.8	1.6	6.3	4.3	2.4	0.0	1.1	1.1	3.3	0.0	9.7	7.2	6.1	7.0	1.8	3.9	7.7	0.0	1.7	0.3	3.6	1.5	0.2	0.0	6.5	2.3
GPR119	"GPCR2, hGPCR2"	ENSG00000147262	"G protein-coupled receptor 119"	Q8TDV5	X	130384440-130385447	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.5;pancreas: 8.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"pancreatic cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 2.7;Hep G2: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																"prognostic favorable (6.93e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN, adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Cytotrophoblasts: 8.3;Hofbauer cells: 7.9;monocytes: 15.4;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Supported	"Nuclear membrane,Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: AB_2685008"	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	8.5	6.7	8.0	11.9	8.5	17.3	21.3	11.9	9.8	6.0	9.9	9.0	7.3	14.9	7.9	8.6	8.8	8.0	6.6	4.9	8.8	4.7	9.8	13.3	12.5	13.5	12.5	6.3	6.8	11.1	5.3	9.2	7.7	9.8	10.1	6.5	4.8	9.1	9.3	12.4	15.8	12.4	9.8	8.5	17.0	9.7	9.1	9.8	12.2	12.6	7.5	9.0	7.2	7.0	3.0	2.7	7.6	2.9	0.7	1.8	1.2	8.9	13.1	5.1	8.3	3.5	5.9	10.2	8.0	4.5	8.0	7.3	8.5	6.3	6.4	4.5	5.3	7.9	11.6	5.3	6.7	3.8	3.9	17.4	5.3	7.3	12.1	5.3	5.7	11.1	3.0	8.7	3.6	4.2	5.9	12.7	8.7	6.5	6.3	5.1	7.8	10.7	13.3	5.6	7.1	11.3	6.8	6.7	7.0	3.1	5.7	6.8	8.0	9.4	10.4	10.9	10.4	7.1	10.3	8.0	10.8	6.2	8.2	7.6	8.5	5.9	4.8	7.9	4.9	5.3	4.2	2.4	7.6	1.8	2.9	1.1	2.5	1.2	1.4	2.7	3.0	0.8	0.8	4.3	0.7	1.9	2.7	1.6	1.2	8.0	8.5	11.9	9.8	8.8	4.7	12.5	6.3	9.8	9.8	8.9	5.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.3	1.8	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	4.5	7.0	0.0	0.0	5.8	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	5.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457822	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1030.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	29.1	47.7	29.0	20.0	38.0	38.4	22.9	30.5	45.9	21.0	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72.0	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12.0	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.1	14.9	7.2	15.5	18.2	22.7	10.8	21.7	25.9	15.9	16.9	9.2	17.9	9.5	19.8	21.3	8.1	12.3	5.5	16.6	5.8	16.6	12.0	7.9	15.8	12.2	30.0	9.9	15.9	20.6	22.0	12.4	12.1	19.4	19.3	13.1	16.2	25.8	11.7	13.4	19.6	16.8	11.5	8.2	13.1	9.0	10.3	22.3	15.0	13.3	20.9	30.3	12.1	12.6	35.2	3.5	14.9	16.2	23.2	21.1	16.3	44.9	14.2	58.1	22.8	9.4	40.4	18.6	18.7	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6.0	13.6	6.9	6.1	29.0	38.0	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4	38.7	26.7	33.5	31.1	33.1	37.4	40.3	53.5	13.4	14.8	41.8	25.5	47.8	68.0	49.1	229.6	25.1	103.4	163.5	56.3	38.0	42.3	43.5	34.5	55.5	48.0	12.7	45.0	38.1	35.1	1030.1	92.6	36.5	50.6	50.5	58.2	45.3	60.0	59.6	68.6	86.4	28.5	71.1	28.3	142.6	29.6	35.9	66.6	27.7	54.3	44.3
BRICD5	"C16orf79, MGC21830"	ENSG00000182685	"BRICHOS domain containing 5"	Q6PL45	16	2209253-2211950	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 29.7;testis: 42.8"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA063522			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA063522: AB_2685029"	"prognostic favorable (9.74e-4)"	"unprognostic (7.12e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.34e-3)"	"unprognostic (7.56e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (8.06e-5)"	2.0	4.0	3.2	3.7	4.9	3.0	2.0	29.7	5.3	2.0	2.0	2.0	2.0	5.4	2.8	2.0	2.0	1.6	2.0	2.9	3.5	4.4	2.9	2.0	2.1	4.6	3.1	2.8	2.0	3.0	2.2	3.6	2.9	2.5	2.4	0.5	9.9	3.7	4.0	9.1	2.7	5.2	2.0	3.3	6.3	2.7	42.8	2.0	2.4	6.1	2.0	2.0	2.0	2.0	0.8	0.6	2.3	0.8	0.8	1.7	0.4	2.8	5.6	7.7	4.4	1.2	1.3	14.1	2.7	0.5	1.5	2.3	7.1	7.0	1.6	1.8	0.5	1.8	7.6	1.0	1.0	1.1	5.2	3.4	1.7	13.4	1.8	0.7	0.7	4.4	1.5	2.1	2.3	0.5	2.3	0.9	6.4	1.9	4.0	0.6	7.6	4.8	10.8	7.5	0.9	3.2	14.8	5.8	5.0	1.7	2.2	5.4	4.9	2.7	3.4	2.6	3.7	3.4	4.0	2.2	7.4	6.0	6.4	2.3	12.1	5.2	4.0	1.4	4.5	3.5	0.4	0.7	2.2	0.6	0.8	0.3	0.3	0.3	0.1	0.6	0.8	1.7	0.4	2.3	0.8	0.2	0.4	0.4	0.4	3.2	4.9	29.7	5.3	3.5	4.4	3.1	2.8	2.5	2.0	3.0	4.1	0.0	0.5	0.3	10.7	0.4	0.0	4.0	0.0	5.2	23.6	1.6	0.0	0.8	2.1	1.1	1.8	0.0	0.5	0.7	1.0	0.8	4.6	1.0	1.1	4.8	1.2	1.8	2.2	5.9	1.1	2.5	1.7	1.0	1.2	4.3	0.7	0.0	2.5	0.3	11.0	0.0	0.5	3.9	1.9	1.0	0.7	0.0	2.3	0.4
MAST3	KIAA0561	ENSG00000099308	"Microtubule associated serine/threonine kinase 3"	O60307	19	18097793-18151692	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.5"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 21.5;Late spermatids: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035061, HPA035062"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035061: AB_10670585, HPA035062: AB_10671508"	"unprognostic (5.94e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (1.93e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-3)"	4.6	3.5	20.7	8.3	36.1	12.3	1.8	1.1	72.5	3.8	5.3	19.0	0.2	9.1	3.6	4.9	2.2	4.9	3.1	2.1	19.7	9.3	3.6	6.4	4.6	9.9	13.0	33.6	4.6	14.3	7.1	7.7	2.6	13.0	2.7	4.4	0.7	4.6	4.2	2.6	6.9	8.8	3.0	7.9	11.4	3.9	2.1	12.5	1.8	2.4	0.3	9.4	3.3	2.4	4.4	10.3	23.2	9.7	5.8	8.4	3.1	3.3	5.0	2.3	10.1	6.8	5.5	5.5	3.4	2.2	2.4	3.5	5.0	4.7	8.7	5.2	3.4	2.6	1.8	3.3	1.9	1.7	7.4	4.1	4.0	5.2	7.9	5.8	2.1	13.3	6.3	5.7	3.6	1.4	3.3	1.1	6.0	4.0	5.7	2.7	6.0	4.4	7.0	2.4	7.4	6.2	12.1	2.0	6.4	1.8	1.5	3.8	6.2	4.8	2.8	2.0	1.7	3.2	4.9	4.0	3.1	3.3	13.0	1.4	6.2	8.4	8.0	6.8	11.2	2.8	0.1	4.5	9.4	8.4	5.6	6.2	4.1	4.7	3.3	2.1	4.4	3.7	6.4	23.2	5.8	9.7	10.3	5.0	3.1	20.7	36.1	1.1	72.5	19.7	9.3	13.0	33.6	13.0	12.5	6.0	10.3	7.8	0.7	0.5	3.2	1.1	7.6	0.0	3.4	8.7	2.0	0.5	3.3	2.8	9.1	1.6	20.0	0.0	9.2	1.2	2.2	0.8	2.3	12.5	6.9	0.0	2.4	7.4	21.5	24.6	3.7	7.9	5.0	6.4	6.9	0.8	6.1	8.6	6.3	8.7	0.6	0.0	1.8	0.6	2.8	1.9	0.3	9.6	8.6	0.6
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 186.8;Kupffer cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HaCaT: 27.4;RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.6	15.8	2.0	5.0	3.6	3.3	24.3	3.0	3.5	4.4	2.5	8.8	8.8	0.0	8.3	4.4	3.8	27.4	0.7	10.7	0.2	8.0	2.0	0.0	19.3	13.3	4.6	6.6	2.4	5.4	4.6	5.5	2.6	0.6	3.7	0.9	10.9	0.5	1.0	15.1	0.5	1.4	3.8	4.1	5.5	2.9	7.5	10.9	0.2	24.4	4.5	2.0	9.6	9.2	2.4	0.1	12.8	9.0	4.8	5.4	6.5	5.7	2.7	0.7	0.0	0.1	4.1	6.7	3.5	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1	29.8	22.2	2.2	14.1	30.7	3.8	30.8	79.0	8.1	21.6	8.7	23.6	24.3	1.7	11.9	4.5	17.5	46.7	23.3	12.2	27.0	17.3	15.8	1.1	186.8	29.1	31.8	9.2	72.4	115.8	14.1	30.0	27.5	11.8	5.4	24.8	42.2	14.1	34.5	19.8	16.2	21.2	19.4	17.9	0.7	12.3	40.9	20.0	13.1	23.9	26.0
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 73.5;Late spermatids: 189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010598, HPA076008"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA010598: AB_1079616, HPA076008: "	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.6	7.7	7.2	6.8	3.5	3.2	11.5	6.5	3.6	6.9	6.3	12.0	5.0	8.1	5.9	3.5	7.5	11.2	7.4	5.2	3.0	13.0	11.6	5.8	5.5	9.2	7.3	8.4	10.3	3.7	5.7	6.2	3.8	3.8	8.1	8.5	10.8	11.2	3.3	10.9	15.3	9.9	15.9	5.2	7.1	13.7	7.3	10.6	4.5	6.0	13.2	14.7	9.3	9.1	7.1	5.6	8.4	7.8	5.9	6.9	9.9	14.3	10.1	21.1	15.7	10.3	5.7	10.4	8.4	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9	3.0	12.9	7.5	7.0	16.4	17.6	3.0	5.1	13.4	7.9	8.7	11.8	19.8	6.6	16.0	73.5	9.8	12.3	0.0	15.5	13.7	7.1	11.8	6.9	9.3	12.6	25.4	21.2	10.4	9.8	189.7	13.0	8.3	6.8	11.8	14.3	10.4	13.0	5.8	17.3	10.2	21.3	6.5	7.2	35.8	35.3	13.6	30.4	7.5	10.8	7.4
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.4	1.3	4.1	3.2	4.9	4.0	2.6	3.2	3.2	1.6	2.5	1.6	3.5	9.6	2.1	4.1	2.9	2.9	0.5	10.8	2.8	7.6	1.6	7.5	6.9	2.7	3.6	9.8	31.3	3.9	1.5	3.6	4.5	17.9	4.9	17.6	1.0	13.2	1.8	4.7	11.3	16.9	0.6	6.4	1.5	5.6	2.9	4.2	5.3	4.9	3.1	2.4	1.3	7.2	3.0	3.4	3.6	13.5	6.8	4.4	1.6	7.9	2.5	6.0	1.5	4.2	1.9	8.8	2.4	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3	6.0	18.4	16.7	5.1	14.8	2.6	4.4	5.1	6.7	3.4	5.2	2.0	6.8	0.0	3.7	0.5	7.9	8.0	0.0	0.9	3.1	5.6	2.8	23.0	2.9	15.2	4.8	12.6	12.9	45.9	0.4	9.5	38.5	3.3	16.2	9.0	4.0	2.3	43.6	7.4	1.6	3.7	0.0	6.6	1.6	7.7	15.2	10.3	23.5	10.4	4.2
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 489.9;skeletal muscle: 343.4"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 412590.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1073.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		1300000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27.0	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56.0	343.4	56.4	51.1	40.0	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	111.2	179.1	238.3	230.3	487.6	188.0	175.6	145.1	117.7	82.5	124.6	192.6	251.5	232.6	121.5	213.4	84.9	422.7	31.5	298.5	111.8	180.1	161.5	166.8	1073.7	370.2	106.1	140.2	187.4	275.7	441.7	42.5	152.4	270.3	91.3	232.4	155.7	226.9	226.0	240.8	102.5	404.1	62.3	220.6	114.0	107.2	72.6	194.8	336.5	310.9	89.2	147.6	119.5	294.8	209.6	367.9	205.2	568.6	225.1	200.0	173.5	188.5	102.0	115.3	114.6	131.1	106.4	283.3	131.3	489.9	409.1	476.0	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4											1343.0	1746.9	18282.0	6995.6	5999.6	0.0	412590.4	19500.5	2813.3	2462.5	17642.7	0.0	0.0	3143.4	3272.8	866.0	2789.7	27604.7	22029.3	4281.1	0.0	1817.5	4991.0	2029.2	43011.4	0.0	0.0	6162.7	12438.4	17929.8	4401.0	7095.7	4687.5	4875.7	4595.3	21499.4	0.0	3881.8	14501.3	4815.7	15512.8	0.0	6946.2	3920.2	6682.3	8100.4	5859.1	0.0	11198.1	21247.6	11593.6
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472841-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	6.1	5.5	11.0	15.9	10.0	11.6	9.2	31.9	14.4	6.1	9.2	9.2	11.0	15.1	10.9	12.8	5.0	7.8	6.6	4.0	10.0	8.5	9.0	8.1	6.5	10.5	6.8	9.8	8.9	7.8	6.3	13.3	4.6	7.6	16.4	12.5	14.8	10.3	13.8	8.9	13.3	12.6	8.5	8.6	11.2	8.4	17.6	8.1	8.4	9.3	4.8	10.1	4.1	5.6	3.9	14.2	2.0	1.6	4.1	7.0	2.1	11.2	3.8	6.2	11.2	1.8	2.1	8.6	5.8	2.2	3.5	7.7	6.4	7.7	8.6	4.9	2.6	4.1	5.7	3.5	3.3	4.9	3.9	6.0	6.5	10.6	10.8	3.1	4.4	14.9	2.3	3.0	7.5	3.3	2.3	3.7	11.1	9.7	8.4	3.2	10.7	5.3	11.9	6.3	5.3	6.0	7.0	5.9	9.0	4.6	3.5	6.2	6.8	4.1	11.2	6.5	3.7	3.0	7.0	6.9	6.7	8.2	10.0	5.6	5.1	7.0	10.8	10.6	8.0	7.2	2.0	1.6	1.5	2.7	1.1	2.9	2.7	3.4	2.9	5.6	3.9	7.0	4.2	0.4	4.1	1.4	14.2	5.3	2.1	11.0	10.0	31.9	14.4	10.0	8.5	6.8	9.8	7.6	8.1	0.0	4.6	4.2	3.8	4.8	17.5	1.7	2.5	6.7	4.5	1.8	13.7	4.0	1.7	3.6	21.1	5.6	4.7	23.3	4.8	3.0	3.4	2.5	3.5	2.9	5.6	6.4	5.2	0.6	4.4	6.4	3.1	6.6	6.8	2.8	5.1	10.9	3.5	4.5	4.2	3.4	13.5	0.0	4.2	10.6	3.8	4.5	1.8	4.8	5.6	3.0
SCAP	KIAA0199	ENSG00000114650	"SREBF chaperone"	Q12770	3	47413694-47477126	"Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004713	Approved					NA	NA					"HPA004713: AB_1079868"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.33e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-3)"	11.1	47.4	15.9	10.7	21.4	11.3	15.0	23.7	28.7	13.8	18.2	22.6	13.9	17.8	17.7	14.8	17.8	16.0	14.5	10.9	16.9	11.5	13.5	34.1	11.3	17.1	15.6	12.2	18.8	22.1	26.3	15.2	16.9	17.3	13.1	16.0	19.3	16.0	14.2	15.6	26.2	17.1	14.9	11.6	15.0	15.5	19.5	18.5	18.8	15.4	9.4	12.0	18.5	13.6	6.7	7.7	18.3	6.4	7.5	10.5	4.7	10.6	15.1	16.4	25.3	29.8	15.8	29.2	10.5	15.5	17.6	16.7	20.1	17.6	17.8	15.3	17.8	18.0	11.6	23.0	22.1	18.3	12.2	16.6	30.7	21.2	21.7	29.0	18.3	18.4	19.7	23.8	22.3	24.6	14.2	15.0	17.8	20.8	12.4	14.1	15.1	20.0	27.1	17.1	22.2	22.6	11.8	15.0	21.3	13.9	21.1	11.3	21.2	15.4	19.6	10.2	22.6	17.0	20.2	12.8	16.2	19.4	22.2	14.6	12.3	13.4	10.3	15.3	17.0	11.9	5.8	6.4	6.7	7.8	5.7	10.5	6.6	6.6	7.0	7.7	6.7	7.5	7.3	18.3	7.5	4.5	6.2	8.0	4.7	15.9	21.4	23.7	28.7	16.9	11.5	15.6	12.2	17.3	18.5	0.0	13.6	7.5	8.1	10.3	20.9	12.4	10.2	12.0	12.5	19.2	27.5	18.7	0.0	12.3	11.1	8.8	38.3	0.0	13.0	12.3	12.7	8.4	6.9	39.9	14.1	50.9	11.5	6.7	7.9	21.9	18.1	10.1	23.6	2.8	17.8	17.8	9.6	28.6	20.1	10.5	30.9	32.3	9.2	15.3	23.5	10.2	66.1	10.0	24.1	6.3
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	8	"liver: 117.0"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 361.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;memory B-cell: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.7	3.5	4.0	0.3	4.8	1.4	1.0	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117.0	1.6	0.7	2.0	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4.0	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5.0	0.3	1.1	0.8	0.7	1.2	0.9	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.6	1.0	1.9	4.1	1.9	0.5	0.7	0.3	0.4	2.0	0.6	0.1	1.3	0.6	0.3	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	42.3	3.1	0.0	0.8	5.5	1.3	0.3	1.1	7.5	0.7	1.8	0.3	5.2	1.0	0.3	0.2	8.6	0.1	0.5	0.5	0.2	0.2	1.1	2.3	0.3	0.1	1.5	0.0	0.9	0.2	1.3	0.7	2.8	0.5	1.0	0.3	0.0	0.1	11.5	1.4	0.2	1.1	1.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	4.0	4.8	4.9	5.4	6.5	1.1	2.0	2.9	4.8	2.3	6.0	3.8	6.0	4.8	2.6	7.2	1.7	38.2	5.3	4.5	26.2	7.9	3.6	53.0	5.4	4.2	2.1	4.6	46.7	3.3	13.8	3.3	1.1	1.1	361.8	1.2	1.6	7.9	11.6	9.5	0.5	2.8	1.4	3.3	0.0	7.3	7.7	2.3	7.0	1.8	54.1	6.9	0.0	2.0	18.7	4.4	4.1	4.2	2.1	12.1	2.7
TBXA2R		ENSG00000006638	"Thromboxane A2 receptor"	P21731	19	3594506-3606840	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"Ito cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.9;U-2197: 8.6;U-937: 7.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077366			Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077366: AB_2686836"	"unprognostic (1.59e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.17e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (7.17e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (4.32e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.02e-1)"	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8.0	4.7	6.0	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5.0	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	3.0	0.8	2.3	1.8	0.1	0.3	0.1	4.4	1.2	2.3	0.1	0.9	0.0	0.9	0.2	1.0	2.9	11.9	0.3	1.2	0.0	5.3	1.1	0.0	3.0	0.0	1.7	0.9	0.0	4.5	0.4	0.4	0.2	0.2	1.5	0.1	0.1	2.6	0.1	0.0	0.2	0.0	0.1	0.2	1.7	0.2	0.4	0.1	0.3	1.8	5.1	2.6	4.8	1.1	8.6	2.8	0.2	0.3	0.2	4.0	7.4	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0.0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9	0.0	0.0	1.3	0.1	0.5	0.4	0.8	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.7	0.0	0.0	35.0	1.2	0.0	0.3	0.0	1.7	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.1	0.0	3.1	0.1	1.3	0.5	0.1	0.0	0.0	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.0	8.9	0.1	0.0	24.4	0.0	0.1	4.0	0.0	7.0	15.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5	0.0	0.0	0.0	0.1	0.3	21.4	2.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.0	0.0	17.5	0.0	0.0	0.0	2.2	0.9	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.4	0.0	20.6	0.0	0.9	3.8	1.5	0.4	0.0	0.0	0.0	0.0
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.8"	"Group enriched"	"Detected in many"	16	"Early spermatids: 137.6;Late spermatids: 456.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEK 293: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060789	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060789: AB_2684366"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	1.2	0.9	24.2	1.4	47.8	0.8	1.0	0.8	26.5	1.1	1.3	1.1	0.0	1.0	1.3	6.6	1.0	1.6	0.9	0.8	29.5	8.3	1.0	0.8	1.4	1.4	7.7	10.2	1.1	1.0	1.7	0.8	1.3	3.6	2.0	1.6	4.1	0.9	1.5	1.6	3.0	1.6	1.2	1.0	1.1	1.4	7.1	5.1	0.0	1.7	0.0	1.3	1.5	0.0	0.5	0.5	0.3	1.1	0.0	2.2	0.3	0.3	0.8	1.9	0.8	0.3	0.5	11.4	0.5	0.1	0.5	0.7	0.9	0.6	0.4	1.5	0.1	0.2	1.1	0.3	0.2	0.0	0.1	13.4	0.0	1.6	0.0	0.1	0.3	0.6	0.1	0.6	0.3	0.4	0.1	0.0	0.9	0.9	0.6	0.0	1.0	0.0	0.1	3.6	0.0	2.6	2.1	0.4	0.4	0.0	0.1	0.3	3.2	0.2	0.0	0.2	0.6	1.3	1.6	0.7	0.3	0.7	3.5	0.8	3.2	2.2	0.6	0.2	1.7	0.4	0.0	0.7	0.0	0.7	1.1	0.8	0.3	1.2	0.6	0.5	0.5	0.7	1.1	0.3	0.0	0.7	0.0	2.2	0.3	24.2	47.8	0.8	26.5	29.5	8.3	7.7	10.2	3.6	5.1	8.9	0.3	1.3	2.5	1.8	18.1	1.6	2.5	2.7	6.8	0.0	9.8	1.3	1.7	1.7	137.6	1.6	4.7	0.0	0.5	1.0	2.7	2.1	1.1	1.0	1.0	9.5	5.2	1.8	0.3	456.0	3.4	1.5	1.7	0.0	6.3	7.2	0.5	3.5	1.8	0.3	14.9	6.5	3.9	14.0	9.6	3.6	1.5	2.9	5.0	0.9
ZNF429		ENSG00000197013	"Zinc finger protein 429"	Q86V71	19	21496682-21556270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004139			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004139: AB_2667147"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.96e-8)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.48e-1)"	6.3	14.3	12.0	4.8	13.1	4.3	11.2	15.3	14.2	10.2	6.7	12.3	10.3	5.4	7.5	12.4	6.2	10.8	5.6	4.9	9.6	7.6	11.3	11.1	6.4	9.0	12.6	8.6	14.3	14.3	17.7	24.1	7.4	12.3	8.7	8.9	8.4	9.3	8.2	5.2	11.0	6.2	5.7	9.1	10.6	8.4	11.3	12.9	7.5	16.6	5.1	7.5	7.8	7.5	7.2	2.7	10.4	2.4	9.2	9.5	2.8	0.3	0.9	5.2	6.1	3.6	3.7	4.7	2.7	2.0	3.8	5.8	0.6	3.3	4.4	7.6	1.8	3.3	1.4	3.0	1.2	7.5	1.3	3.6	0.8	0.7	1.6	1.9	4.6	1.8	3.3	1.8	2.3	0.7	3.5	0.2	7.0	7.2	0.9	5.9	3.2	11.0	2.9	5.3	0.1	1.7	5.0	2.9	1.8	4.2	5.2	8.6	3.5	0.2	0.2	1.8	10.8	6.1	2.9	0.6	0.5	1.1	4.3	2.0	0.7	3.6	5.9	0.3	0.4	1.7	10.0	1.8	8.4	4.9	2.2	5.3	7.2	6.8	6.5	1.6	6.4	9.5	8.6	10.4	9.2	2.4	2.7	4.1	2.8	12.0	13.1	15.3	14.2	9.6	7.6	12.6	8.6	12.3	12.9	26.8	9.9	1.5	5.8	2.5	13.6	4.8	5.1	17.4	14.8	7.0	5.9	7.7	18.3	6.3	27.6	5.0	4.0	0.0	4.4	6.1	5.8	5.1	3.5	5.4	3.0	3.2	6.4	6.7	2.1	3.9	10.6	4.3	5.0	1.8	5.6	10.0	5.0	6.2	5.6	10.6	7.6	19.4	5.1	14.2	16.8	1.8	5.7	10.2	5.8	3.1
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.3	14.5	14.0	19.8	20.7	11.4	19.0	16.9	19.8	21.2	23.5	15.2	12.8	29.3	7.9	18.1	30.8	8.6	28.8	17.3	26.0	19.7	17.5	30.2	19.1	12.4	18.8	22.3	14.6	12.2	26.2	26.4	35.9	12.1	15.9	14.1	23.8	20.1	18.7	9.9	22.5	9.2	23.8	15.5	22.0	8.4	16.0	24.4	12.4	19.4	6.1	16.6	16.6	20.9	16.2	17.3	10.6	15.9	15.1	12.9	18.7	19.2	26.5	26.3	50.8	37.1	14.1	18.7	16.1	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4	32.8	22.3	31.1	35.9	45.2	56.4	60.0	30.6	37.5	58.0	27.9	82.5	31.2	24.9	23.6	8.2	33.8	20.3	23.3	37.3	30.6	28.0	46.9	42.9	36.5	23.8	54.0	16.0	35.0	26.4	4.7	38.6	33.2	28.7	41.5	22.9	39.7	33.1	22.9	40.7	25.6	73.6	25.8	35.4	140.0	77.3	47.2	44.6	50.1	26.5	58.6
RFX2	FLJ14226	ENSG00000087903	"Regulatory factor X2"	P48378	19	5993164-6199572	"Predicted intracellular proteins, Transcription factors"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"neutrophil: 18.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.3;SCLC-21H: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048969	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048969: AB_2680577"	"unprognostic (1.31e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.72e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	6.7	2.0	8.4	5.3	9.4	8.6	6.4	8.3	7.0	6.9	11.3	7.2	0.7	4.1	15.7	7.0	9.0	22.0	6.4	5.4	9.5	3.6	1.9	2.5	10.0	2.1	4.4	4.0	7.2	5.3	2.9	12.9	2.2	9.9	4.1	2.6	3.1	2.4	3.3	2.5	6.6	5.7	14.8	9.0	2.1	5.9	51.5	7.5	4.1	3.0	12.1	3.1	8.7	5.3	0.3	1.6	18.3	2.0	0.5	0.5	0.6	4.0	3.3	5.3	10.3	2.8	1.6	3.1	2.6	3.6	2.2	3.5	1.4	5.1	4.6	2.8	3.4	4.8	6.4	1.3	5.2	3.0	1.1	0.8	7.2	3.3	1.4	3.2	3.1	16.3	1.9	4.5	4.9	2.6	2.7	3.3	6.4	4.6	0.2	2.2	2.0	6.2	4.3	1.4	5.6	2.0	1.7	3.2	0.5	2.8	7.9	20.1	2.5	2.5	2.0	1.4	0.6	3.4	3.5	4.8	0.9	4.6	3.6	2.6	6.7	2.2	2.6	2.8	11.6	1.9	0.0	2.0	0.8	0.1	0.4	0.0	0.3	0.4	0.3	1.6	0.1	0.4	0.5	18.3	0.5	1.1	0.0	0.0	0.6	8.4	9.4	8.3	7.0	9.5	3.6	4.4	4.0	9.9	7.5	23.8	40.1	2.2	23.8	23.5	3.3	7.2	15.3	120.5	40.9	3.5	2.0	5.2	3.3	3.9	120.3	9.9	3.0	0.0	1.5	5.4	9.7	5.5	44.0	2.0	7.0	0.0	13.2	6.7	8.7	146.0	7.5	13.6	6.8	5.4	4.4	5.5	2.3	1.5	3.9	1.5	3.6	25.8	14.6	95.0	13.0	19.3	4.7	4.9	5.2	17.3
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 22.3;SiHa: 23.0"									HPA063062			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.6	8.7	0.5	7.0	2.8	1.3	12.1	1.6	1.8	2.8	3.9	6.4	7.5	1.7	3.8	1.6	8.1	8.7	5.8	4.3	3.3	2.2	7.1	0.9	22.3	2.9	4.7	1.4	1.5	1.3	8.1	1.9	9.9	4.8	0.7	3.2	4.0	1.1	2.6	6.2	2.1	1.4	0.6	6.3	3.8	0.8	0.0	9.4	8.4	9.1	3.0	2.1	23.0	18.0	4.4	1.9	8.3	1.8	0.4	0.5	2.5	5.9	2.0	3.8	7.4	0.1	1.8	3.6	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7	8.9	5.1	2.7	5.9	6.8	6.5	5.2	20.4	6.7	3.4	15.7	11.8	16.6	1.7	8.8	1.4	3.0	46.4	0.0	4.5	4.8	4.0	12.8	0.0	5.9	4.0	9.5	6.9	1.3	8.7	2.3	6.1	2.6	5.0	0.0	12.6	8.7	5.4	25.9	3.9	23.2	7.4	0.0	1.9	7.2	2.5	5.5	6.9	2.9	16.1	7.8
DOPEY1	"dJ202D23.2, KIAA1117"	ENSG00000083097	"Dopey family member 1"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 37.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	9.7	8.7	15.7	11.3	19.5	5.5	13.3	25.2	21.2	11.9	9.5	10.1	10.1	9.5	13.9	9.5	9.5	12.0	8.9	10.6	15.2	7.0	8.9	7.5	9.1	8.3	10.9	12.9	17.7	12.1	20.3	21.7	7.3	17.3	12.4	11.0	9.0	13.8	14.9	12.7	16.6	11.7	9.5	13.1	9.5	9.5	14.9	12.8	10.7	16.9	8.5	8.9	12.2	10.7	2.3	2.8	1.4	1.4	1.2	4.1	1.3	3.7	2.7	9.1	8.2	8.2	8.7	4.3	6.4	5.3	4.4	6.4	5.8	0.9	7.3	4.6	6.9	5.5	5.0	9.1	6.9	5.5	6.3	10.3	6.1	3.7	2.1	4.5	8.9	6.4	6.9	9.7	6.1	15.9	5.8	6.4	11.4	12.6	5.4	4.7	3.5	2.6	4.0	1.9	2.7	5.5	7.3	6.9	2.6	5.8	10.5	16.4	3.0	4.8	3.0	1.2	6.8	4.8	5.1	10.7	5.5	2.0	5.6	4.9	6.8	4.8	4.2	3.0	4.1	4.3	0.1	1.3	1.4	1.9	1.4	1.6	2.3	1.6	4.1	2.8	1.9	3.0	1.4	0.2	1.2	1.2	1.2	1.5	1.3	15.7	19.5	25.2	21.2	15.2	7.0	10.9	12.9	17.3	12.8	17.9	7.8	3.2	6.1	10.2	24.8	8.1	2.5	14.7	15.9	3.5	37.3	3.7	1.7	5.4	4.0	6.2	10.2	0.0	7.6	0.9	3.7	2.9	15.1	4.3	3.5	11.1	9.8	8.6	6.9	2.7	9.8	6.4	1.7	1.0	8.3	6.3	4.5	11.8	8.9	4.1	42.6	6.5	4.2	23.8	16.0	8.5	2.9	6.9	8.1	5.9
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"		17	81395475-81466332	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 22.2"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 47.8;Cone photoreceptor cells: 21.6;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 11.0;MOLT-4: 13.6;NB-4: 46.8;REH: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023386, HPA076910"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA023386: AB_1859537, HPA076910: AB_2732325"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	4.8	5.0	3.0	8.3	8.1	3.6	22.2	7.4	5.1	3.1	10.6	1.1	6.0	4.5	2.3	2.5	3.8	5.6	2.2	4.8		2.8	1.1	4.4	1.1	8.5	5.7	6.0	4.3	5.3	3.2	1.6	4.9	4.4	1.5	9.5	6.1	3.8	6.2	4.4	5.5	4.0	3.2	4.9	3.6	4.4	10.4	9.6	2.5	1.6	0.5	3.7	4.4	0.0	1.1	1.4	0.1	0.0	0.0	0.0	1.7	3.0	2.2	7.3	0.8	1.2	1.0	1.3	1.1	0.7	0.4	0.5	0.8	0.0	2.0	1.5	1.0	1.8	1.0	0.8	0.1	0.0	3.3	2.4	0.7	0.9	0.7	11.0	2.3	2.0	0.3	0.6	0.6	1.1	0.8	2.8	1.7	0.0	0.3	1.0	13.6	46.8	0.1	1.1	2.0	14.3	1.5	0.0	0.9	0.1	10.2	1.6	1.6	0.0	5.8	0.2	0.3	8.8	1.0	4.0	0.5	2.1	0.6	0.0	0.0	0.0	0.0	5.1	0.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0											6.0	9.6	0.0	1.4	0.0	47.8	5.8	15.3	4.0	6.8	3.5	21.6	0.1	1.7	2.8	0.5	4.7	3.2	0.0	3.7	0.1	4.3	1.3	0.0	3.0	0.5	31.8	8.1	4.9	5.1	0.0	6.9	1.3	0.0	1.0	4.2	7.5	1.6	0.0	5.3	0.8	16.8	0.0	2.0	1.5	7.8	0.0	0.0	0.0	4.5	0.7
ASPHD1		ENSG00000174939	"Aspartate beta-hydroxylase domain containing 1"	Q5U4P2	16	29900375-29919864	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.3"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.1;Cholangiocytes: 25.5;Exocrine glandular cells: 17.6;Intestinal endocrine cells: 28.3;Pancreatic endocrine cells: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.4;HeLa: 21.0;Hep G2: 28.8"	"Low region specificity"	"Detected in all"							HPA045175	Uncertain					NA	NA					"HPA045175: AB_10959899"	"unprognostic (1.58e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.34e-3)"	"unprognostic (6.96e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.37e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (5.55e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.03e-2)"	1.8	5.5	32.0	2.0	38.6	1.5	2.2	22.0	52.3	2.2	2.4	16.2	0.0	5.1	2.4	1.5	1.4	2.6	12.8	1.5	32.5	17.1	2.3	1.6	2.0	1.6	29.8	19.4	1.8	11.6	2.3	10.6	1.6	17.1	2.5	2.3	0.3	7.0	2.1	1.6	1.4	3.4	2.7	24.6	1.5	15.8	4.3	13.4	0.0	1.4	0.0	1.7	1.8	0.0	0.5	0.0	0.0	0.0	0.8	0.3	0.0	1.2	6.3	0.0	4.7	0.0	0.6	0.3	7.0	1.5	4.6	3.2	15.4	20.4	2.5	17.0	3.2	4.6	0.7	0.6	1.2	0.9	0.3	0.9	1.4	21.0	28.8	9.5	0.1	16.1	5.5	1.2	7.0	0.3	5.4	0.2	3.8	0.0	4.4	1.1	12.2	0.2	0.1	9.5	3.7	5.6	0.3	0.0	0.9	4.1	0.1	16.6	8.6	0.1	10.2	1.6	0.0	3.3	4.4	0.5	2.5	5.3	0.0	1.8	0.3	0.1	0.1	10.1	16.3	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	32.0	38.6	22.0	26.3	32.5	17.1	29.8	19.4	17.1	13.4	0.0	6.1	0.0	3.3	0.6	20.1	0.1	25.5	0.0	0.0	1.8	3.9	0.0	1.7	12.4	1.9	0.2	0.9	0.0	17.6	0.2	0.6	7.7	1.1	0.0	4.3	6.4	28.3	0.0	0.0	0.2	0.3	0.1	1.7	0.0	3.0	0.8	21.8	0.0	0.7	1.9	8.5	0.0	0.5	1.1	1.0	0.5	0.2	0.0	1.9	2.3
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105704-13279590	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 94.2;Hepatocytes: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HUVEC TERT2: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Enhanced					NA	NA					"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	17.6	9.2	16.7	5.1	14.4	1.0	18.7	20.4	18.8	13.4	12.5	12.8	8.0	3.1	15.1	13.3	6.9	15.4	10.2	23.6	14.7	12.8	16.0	68.7	9.5	3.5	14.5	12.4	22.3	4.5	11.4	21.7	20.0	14.8	16.9	5.2	9.6	5.4	20.3	14.7	3.2	5.3	21.0	18.6	9.2	7.3	9.5	17.0	0.0	10.2	6.5	2.3	12.1	24.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	6.9	9.3	26.2	11.5	17.9	16.5	5.3	7.0	7.3	6.2	5.9	0.0	0.0	0.0	2.0	17.3	6.4	0.1	7.6	3.8	10.1	0.0	4.5	4.6	9.5	1.6	9.3	0.0	2.5	12.0	1.6	4.4	2.9	15.9	23.7	0.0	0.1	0.0	5.4	1.8	0.0	0.1	11.1	0.0	3.8	0.0	6.4	0.0	6.2	3.8	3.2	12.1	5.5	1.2	6.7	18.5	3.5	0.0	18.9	6.4	1.2	2.1	5.4	0.0	0.0	0.0	3.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	16.7	14.4	20.4	15.1	14.7	12.8	14.5	12.4	14.8	17.0	29.8	6.4	0.0	8.1	4.5	26.0	94.2	0.0	45.5	22.7	7.0	37.3	11.0	1.7	3.9	3.5	46.7	0.0	0.0	1.7	19.9	22.4	13.4	1.1	66.0	4.6	25.4	1.7	39.9	0.6	2.7	22.5	1.6	16.9	1.0	0.0	42.9	2.8	0.0	31.8	14.4	26.0	38.8	27.8	4.8	8.9	3.4	9.0	0.0	0.0	3.2
MLLT6	"AF17, FLJ23480"	ENSG00000275023	"MLLT6, PHD finger containing"		17	38705542-38729803	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 244.7;Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 215.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004021	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004021: AB_1853995"	"prognostic favorable (4.18e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.12e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-3)"	6.5	7.6	10.0	10.3	10.6	7.3	6.3	14.1	16.9	6.2	6.8	7.2	11.1	7.2	9.2	8.6	5.5	10.3	9.2	7.5	9.7		5.8	1.2	8.5	11.8	8.5	9.6	13.0	9.0	12.8	10.1	4.8	7.2	7.3	5.7	10.0	10.3	12.5	22.3	8.5	8.9	8.2	8.1	11.7	6.7	4.1	9.2	6.3	7.2	4.8	10.1	5.5	11.5	1.4	0.9	2.0	0.8	2.8	6.0	1.7	5.8	6.5	6.6	14.4	7.3	6.6	3.4	3.6	6.7	4.5	5.4	2.4	11.5	16.6	5.3	4.3	6.4	15.2	4.2	7.5	4.0	17.7	11.5	6.1	10.8	10.6	3.5	9.3	8.3	6.7	7.7	3.9	8.9	10.9	7.3	12.6	10.1	14.0	3.8	4.9	18.2	9.0	0.8	5.0	3.4	10.8	9.0	15.3	5.2	13.5	14.8	16.4	3.8	12.6	10.7	4.3	12.4	6.8	9.6	5.2	7.8	7.3	6.6	23.9	7.8	11.2	7.7	8.6	5.5	1.7	0.8	0.4	6.0	0.5	4.6	1.4	3.2	4.2	0.4	1.4	3.1	4.1	2.0	2.8	0.3	0.9	1.7	1.7											44.7	51.0	32.0	22.5	27.1	244.7	23.4	30.6	14.7	36.4	31.4	192.4	15.0	10.0	20.0	2.7	38.7	26.1	0.0	35.9	4.1	20.2	29.7	35.9	9.4	12.0	112.8	47.7	31.9	18.3	3.1	43.4	18.1	18.6	23.4	30.0	32.6	28.3	21.0	39.6	13.5	215.1	32.3	25.4	16.1	23.5	25.5	32.0	48.9	37.7	23.0
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390431-6394998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 155.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;fHDF/TERT166: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2000000				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	14.7	21.4	12.4	10.9	18.7	5.4	10.7	17.2	32.4	14.5	17.4	30.6	15.7	14.3	12.2	15.0	11.6	7.9	18.5	26.8	14.5	13.2	47.1	77.5	17.1	10.7	17.4	15.9	12.9	19.9	35.4	23.8	23.1	21.6	17.6	12.9	23.3	21.5	18.5	20.9	19.7	15.8	14.9	17.8	11.7	13.3	7.4	14.1	18.8	20.2	10.3	11.8	12.5	11.4	3.2	1.8	3.4	2.7	6.8	11.4	3.1	4.6	3.7	2.8	7.6	41.6	21.7	5.0	17.6	27.3	8.0	9.7	6.4	3.3	1.2	8.2	41.0	17.4	1.9	2.4	3.6	3.8	5.9	2.8	1.4	6.0	1.7	18.6	1.0	11.0	28.6	6.9	7.4	5.0	29.6	17.6	0.5	2.5	8.8	17.1	4.7	0.0	1.8	1.1	6.5	6.6	0.3	1.6	1.9	6.9	1.7	4.9	2.8	7.9	5.5	10.8	3.8	2.1	1.9	15.2	29.9	3.2	17.3	4.1	11.3	12.0	0.9	27.7	3.0	13.3	1.8	2.7	3.4	6.9	2.1	5.6	1.6	5.9	5.5	1.4	3.2	11.3	11.4	2.7	6.8	0.6	1.8	4.8	3.1	12.4	18.7	17.2	32.4	14.5	13.2	17.4	15.9	21.6	14.1	23.8	15.6	18.0	17.3	7.0	11.9	31.1	22.9	2.7	9.1	24.4	23.6	33.4	10.0	42.6	42.2	13.5	58.4	0.0	33.0	11.7	31.4	37.7	10.4	72.3	30.5	19.1	22.8	27.6	12.7	155.2	10.6	8.6	52.3	4.6	17.5	16.4	24.7	17.5	12.7	60.8	4.9	0.0	24.5	1.2	1.8	6.9	28.7	20.3	10.9	12.0
ULK3	"DKFZP434C131, FLJ90566"	ENSG00000140474	"Unc-51 like kinase 3"	Q6PHR2	15	74836116-74843346	"Enzymes, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 75.1;Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040474	Approved					NA	NA					"HPA040474: AB_2677003"	"unprognostic (3.67e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.18e-2)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	7.0	11.7	11.8	8.4	15.4	2.9	7.4	21.3	20.4	7.9	13.8	9.0	9.0	7.9	5.3	9.5	33.9	6.7	9.6	14.1	11.8	8.9	13.4	9.3	6.4	7.9	11.2	15.3	4.9	14.7	12.1	12.3	5.7	21.1	8.2	14.4	10.4	10.4	7.4	19.1	24.6	20.3	7.2	5.8	9.9	11.1	6.0	7.6	4.2	6.1	10.9	13.7	8.6	10.6	3.8	4.2	3.8	7.8	5.8	12.6	4.9	3.9	10.7	5.6	9.7	6.4	4.2	3.7	3.1	4.5	6.5	7.1	4.2	8.9	8.5	6.0	3.5	7.5	4.0	15.6	4.3	2.7	16.2	15.4	25.2	13.6	5.1	9.3	6.0	16.2	5.5	8.6	5.7	5.4	2.4	9.8	11.8	6.9	9.2	5.3	5.8	4.4	6.2	6.2	9.3	5.5	13.0	6.8	16.1	4.2	5.0	10.4	13.2	6.1	5.8	19.3	5.9	8.4	15.1	5.5	8.7	5.6	8.6	6.7	12.8	11.6	6.2	4.9	17.7	7.5	3.8	3.6	1.4	12.6	7.8	10.1	3.8	7.4	10.3	4.0	3.5	8.1	5.5	0.9	5.8	6.2	4.2	9.7	4.9	11.8	15.4	21.3	20.4	11.8	8.9	11.2	15.3	21.1	7.6	8.9	11.7	3.7	6.8	9.0	75.1	15.1	7.6	2.7	2.3	12.2	15.7	7.1	16.6	9.2	0.8	8.4	42.8	0.0	10.2	2.5	7.3	8.4	20.7	11.0	13.7	84.2	10.9	13.5	6.3	1.5	12.0	6.5	5.0	19.0	17.8	18.4	10.1	16.4	11.0	13.3	54.3	0.0	7.6	9.4	19.8	19.1	4.8	17.0	20.4	7.2
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629565	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	13.5	18.4	12.2	13.3	17.8	35.7	17.8	22.9	22.6	16.3	12.1	19.2	12.1	16.3	15.5	12.1	17.8	18.9	12.7	17.5	11.9	10.3	20.1	24.6	13.0	17.0	16.8	11.4	29.6	34.3	11.9	12.2	14.6	13.3	15.2	5.3	13.6	28.7	18.1	18.0	19.5	13.8	13.7	13.4	18.8	22.8	30.2	15.8	24.8	21.4	13.2	15.9	18.6	15.6	15.2	9.0	9.9	14.1	8.9	16.7	13.8	15.5	14.3	8.7	11.3	9.2	6.9	17.0	9.2	10.8	16.3	16.6	18.4	10.3	10.5	18.2	8.5	11.9	13.8	12.3	13.3	4.2	18.5	15.8	14.0	12.1	16.1	11.9	18.5	12.7	12.1	11.1	11.5	8.3	8.8	9.9	22.8	12.5	28.2	5.0	17.3	17.3	28.9	19.7	9.8	28.3	19.4	11.0	18.4	6.5	12.3	12.4	14.2	10.4	10.2	9.0	6.0	13.0	16.5	9.7	7.5	12.3	16.9	15.4	48.6	28.6	15.3	12.8	15.8	11.1	8.3	12.2	9.9	14.8	11.6	13.6	12.3	13.8	11.0	9.0	15.2	16.7	12.6	7.3	8.9	14.1	7.8	15.8	13.8	12.2	17.8	22.9	22.6	11.9	10.3	16.8	11.4	13.3	15.8	0.0	2.6	13.7	12.3	17.4	13.6	0.8	22.9	0.0	3.4	45.4	11.8	36.8	29.9	16.2	26.4	13.5	25.0	0.0	30.1	23.1	15.3	13.9	19.6	36.5	17.5	3.2	17.9	14.7	16.5	13.5	26.2	9.3	25.3	31.5	17.7	13.8	14.4	14.4	20.5	74.5	11.3	38.8	18.8	34.6	47.5	15.6	55.2	20.3	16.2	12.7
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	11.3	12.5	11.1	16.4	13.6	15.1	12.1	18.6	15.3	10.2	13.0	17.3	15.0	13.8	12.1	10.7	15.9	11.3	13.3	20.1	11.4	10.2	14.8	27.5	13.6	16.7	14.1	7.5	12.0	14.1	20.4	14.1	16.1	12.4	18.7	11.1	15.1	24.1	14.8	46.6	13.3	16.8	11.3	11.2	16.0	12.7	12.4	14.5	28.1	21.7	21.0	17.3	14.5	10.4	14.5	20.8	9.6	13.4	10.5	8.0	10.3	10.2	11.7	9.6	10.7	5.4	3.8	18.1	9.8	5.3	6.9	7.6	6.4	10.8	11.6	10.1	6.4	5.4	10.1	5.2	7.2	4.6	16.8	2.9	17.7	10.8	8.6	7.0	7.7	13.7	4.2	6.0	9.2	6.6	5.7	6.5	8.0	21.5	9.7	4.9	7.4	13.6	7.7	11.0	11.8	19.9	25.7	9.1	9.1	7.2	8.5	14.1	12.4	8.7	13.3	8.6	6.0	7.7	15.8	5.5	9.8	5.8	6.5	19.8	29.1	10.9	6.8	9.1	13.6	8.0	7.6	13.3	9.6	8.0	13.4	6.7	10.8	5.7	7.9	20.8	14.5	6.3	5.6	8.1	10.5	12.4	11.7	6.5	10.3	11.1	13.6	18.6	15.3	11.4	10.2	14.1	7.5	12.4	14.5	3.0	17.5	21.4	22.4	11.6	21.0	16.9	7.6	5.3	4.5	15.7	11.8	28.2	18.3	16.4	6.2	12.1	18.8	0.0	9.4	16.4	10.8	20.5	28.7	14.8	15.4	9.5	17.3	5.5	15.2	8.9	5.2	14.1	11.8	12.6	16.6	19.2	12.1	17.3	5.3	13.5	30.2	6.5	9.9	22.9	13.6	12.8	59.6	13.8	15.2	19.9
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	16.8	22.1	21.3	19.6	20.7	17.9	32.2	39.0	52.7	13.0	15.8	18.5	20.6	23.1	17.2	13.3	18.6	16.2	17.3	25.6	19.8	18.3	18.7	40.6	19.0	32.8	19.8	22.4	16.8	23.7	19.7	26.7	14.9	19.4	19.8	11.7	20.2	26.3	18.2	47.3	25.8	20.0	21.2	20.4	21.2	22.5	37.8	17.3	21.1	21.1	11.7	18.5	15.6	13.6	9.8	12.3	16.0	10.3	6.4	14.3	8.5	16.2	9.5	15.0	19.0	11.1	11.9	13.5	16.3	17.4	17.4	17.7	8.0	10.1	19.6	8.0	16.0	9.6	13.3	9.2	12.1	6.6	10.1	17.0	10.4	18.4	19.8	14.5	24.5	28.8	17.6	13.1	10.5	5.6	13.8	15.2	16.7	10.6	17.2	12.6	26.3	16.7	17.8	6.2	10.3	11.9	23.6	11.5	12.8	12.8	19.3	9.4	12.7	16.7	26.0	13.1	5.8	9.4	18.7	17.4	16.3	14.8	13.5	10.7	18.5	4.4	17.3	17.0	12.0	22.4	4.0	9.6	6.3	10.8	10.3	12.7	9.5	7.6	11.5	9.8	9.8	7.4	9.5	16.0	6.4	7.4	12.3	14.3	8.5	21.3	20.7	39.0	52.7	19.8	18.3	19.8	22.4	19.4	17.3	20.8	19.4	29.5	12.3	7.8	42.7	15.3	30.6	13.4	13.6	26.2	53.0	14.5	26.6	17.5	58.7	14.3	27.1	0.0	27.9	9.9	9.7	16.4	32.2	48.4	13.8	62.0	25.8	19.6	21.9	27.9	18.1	15.0	10.1	25.2	20.5	22.7	26.7	28.1	18.7	15.3	43.8	25.8	11.2	65.7	42.4	7.4	23.8	20.3	16.2	13.9
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell type enhanced"	"Detected in many"	7	"Intestinal endocrine cells: 43.8;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	24.4	11.0	13.3	4.7	2.6	1.6	0.1	3.6	1.0	1.5	0.7	1.1	0.6	9.0	0.5	0.8	1.2	3.8	0.5	0.3	0.8	2.0	0.1	6.9	6.8	4.7	1.0	1.0	12.1	0.3	0.3	0.0	1.0	17.5	3.3	0.0	1.7	0.0	0.1	12.7	0.5	7.8	0.5	4.5	4.6	1.1	0.3	4.9	3.4	4.9	7.4	1.0	0.9	2.2	6.1	3.4	1.3	3.1	1.3	1.6	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4	3.0	7.9	4.7	3.2	2.4	4.9	1.4	2.5	6.7	5.7	0.0	2.0	7.5	19.9	1.2	8.5	2.4	17.0	0.0	3.6	5.4	2.8	1.9	1.1	2.0	5.1	3.2	43.8	4.9	8.9	1.9	4.0	7.0	3.3	0.0	22.4	32.9	1.2	8.6	3.5	1.1	3.8	0.0	3.1	0.0	0.2	3.8	0.7	11.5	23.7	2.3
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 371.4;Muller glia cells: 111.8"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.7;Karpas-707: 42.0;U-266/70: 21.0"									"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: AB_2685262"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	19.5	2.5	2.4	39.9	3.1	15.1	16.4	0.9	2.8	19.1	6.1	5.3	5.6	4.0	16.2	10.2	12.4	7.6	15.5	8.6	4.9	1.8	6.3	3.4	19.1	31.2	4.2	1.9	4.5	2.3	2.2	2.9	8.3	5.2	10.2	5.7	6.3	8.1	11.3	17.8	35.2	18.3	13.1	6.8	34.4	4.4	6.9	3.2	15.9	13.7	11.9	30.8	17.5	16.8	5.3	4.6	16.8	7.5	3.8	7.0	3.7	6.3	0.0	0.0	0.0	3.4	4.7	0.7	2.6	2.5	1.0	2.2	0.1	2.4	2.2	9.9	2.5	0.3	2.8	0.0	10.3	1.6	23.7	0.0	0.6	2.0	0.2	3.1	0.0	0.7	2.8	6.6	8.7	6.4	3.5	11.1	0.4	5.5	42.0	5.1	0.0	0.0	1.8	0.0	0.0	0.1	2.4	1.6	9.9	0.0	2.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.2	10.8	2.2	1.3	1.3	0.4	21.0	6.7	1.7	3.6	0.3	0.1	13.8	6.3	4.4	6.0	4.5	6.6	4.4	4.9	6.1	4.6	5.3	5.5	5.0	16.8	3.8	7.5	0.4	7.0	3.7	2.4	3.1	0.9	2.8	4.9	1.8	4.2	1.9	5.2	3.2	0.0	8.5	24.6	6.0	15.8	56.5	3.9	2.5	10.7	15.9	7.0	3.9	0.6	3.3	0.4	371.4	16.8	0.0	0.0	0.0	0.8	24.2	1.2	3.5	0.2	6.0	81.0	74.8	31.9	19.2	46.3	23.6	25.8	6.8	1.0	0.0	111.8	5.1	0.0	26.5	0.4	10.1	6.5	13.3	14.2	10.0	21.8	1.3	35.5	0.0	7.6
ANKRD13B	FLJ25555	ENSG00000198720	"Ankyrin repeat domain 13B"	Q86YJ7	17	29589769-29614761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 23.2;Horizontal cells: 15.9;Late spermatids: 30.2;Leydig cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.7;SH-SY5Y: 32.3;SK-BR-3: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051886, HPA063748"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA051886: AB_2681652, HPA063748: AB_2685112"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (7.58e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (9.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.36e-3)"	8.0	6.6	10.2	4.2	14.3	2.6	12.0	34.9	28.6	7.2	4.2	16.4	2.6	2.7	12.3	3.5	5.4	9.9	7.5	6.4	12.4	9.3	1.7	1.1	3.9	3.6	14.7	10.0	10.5	3.6	5.5	6.9	2.7	7.7	5.2	2.7	3.4	4.8	4.8	8.5	10.0	3.3	8.2	13.7	3.1	3.5	16.1	12.7	2.0	2.8	2.2	2.2	7.2	8.5	0.7	0.3	0.0	0.0	0.1	1.6	0.1	3.7	7.8	8.4	17.8	4.7	4.4	2.7	1.0	0.6	1.4	1.7	3.5	0.6	4.2	3.5	1.6	3.6	13.8	4.9	4.0	0.2	7.0	16.8	2.2	15.4	3.0	1.8	2.0	2.4	4.1	5.3	1.4	2.7	4.8	6.2	7.6	3.5	3.5	1.5	3.5	10.5	5.0	6.7	4.1	6.1	17.0	5.1	11.7	1.7	1.6	28.7	32.3	3.1	24.8	2.8	0.7	4.0	2.5	4.4	3.7	4.1	4.0	3.7	5.8	7.5	5.1	2.6	6.8	2.7	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.6	0.3	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	10.2	14.3	34.9	17.5	12.4	9.3	14.7	10.0	7.7	12.7	0.0	0.0	0.0	0.7	1.4	4.4	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.7	1.4	23.2	1.5	0.0	0.0	0.5	0.1	1.6	1.0	0.0	0.8	0.1	15.9	2.9	1.8	0.0	30.2	13.6	0.0	0.0	0.0	0.5	1.4	0.6	0.0	7.1	0.0	5.0	0.0	1.4	6.0	4.1	1.5	0.1	0.0	1.0	1.1
RBM5	"H37, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088908-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	33.8	25.9	34.1	43.7	37.8	37.7	37.0	51.2	38.9	38.5	33.1	47.7	41.3	25.1	53.2	45.9	28.9	40.5	27.6	28.5	31.1	25.0	30.4	26.9	30.3	41.2	38.1	38.4	63.5	36.3	37.7	58.6	40.3	30.3	41.5	33.5	40.4	35.7	37.9	45.9	54.5	34.7	37.9	41.1	47.0	30.9	36.4	39.5	41.4	42.0	28.5	45.5	31.8	36.6	14.3	12.2	29.6	14.4	14.0	20.1	10.3	9.7	12.1	43.8	19.0	18.3	26.7	10.3	29.8	18.0	22.2	15.7	12.1	11.3	23.0	10.3	19.4	21.9	8.6	29.6	14.4	23.9	21.4	10.8	28.9	41.2	10.8	22.7	26.4	23.4	23.7	16.4	24.1	23.8	38.3	23.5	23.7	19.7	15.5	20.8	8.7	26.8	17.9	15.7	16.7	13.8	14.6	19.2	11.8	16.1	49.1	6.3	14.6	24.5	10.7	14.8	31.2	9.9	25.4	26.6	14.8	15.5	20.4	17.2	21.5	31.4	24.4	11.0	16.2	17.0	29.6	14.0	18.5	17.5	14.4	16.6	13.7	15.8	18.1	12.2	14.3	20.1	15.8	26.1	14.0	14.0	9.3	18.4	10.3	34.1	37.8	51.2	38.9	31.1	25.0	38.1	38.4	30.3	39.5	65.5	105.1	31.8	36.7	28.4	88.7	39.5	17.8	100.4	86.4	36.6	172.8	40.3	10.0	22.5	120.2	50.7	39.5	0.0	18.1	21.2	40.9	41.1	64.9	37.6	27.8	89.0	70.6	55.3	39.9	150.2	59.5	45.4	42.2	37.9	45.1	49.6	24.7	36.8	54.5	7.6	131.6	32.3	43.2	48.9	34.1	29.6	68.3	55.8	33.6	34.9
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993421	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1"	"Cell type enriched"	"Detected in some"	69	"Intestinal endocrine cells: 827.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 40.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062293	Supported					NA	NA					"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favorable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	4.6	0.3	0.3	2.0	0.0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0.0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.9	1.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	2.7	0.0	1.1	3.3	0.0	1.3	0.0	0.0	0.2	0.0	827.9	0.0	0.0	6.2	0.0	0.0	1.7	0.0	3.6	0.0	11.9	8.6	0.0	0.0	0.8	0.0	0.0	0.5	3.0	0.3	0.2	0.0	1.5	0.0
MT-ATP6	"ATP6, ATPase-6, MTATP6, RP, Su6m"	ENSG00000198899	"Mitochondrially encoded ATP synthase membrane subunit 6"	P00846	MT	8527-9207	"Disease related genes, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 419.0;skeletal muscle: 475.3"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 108059.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 419.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1186.6"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (2.97e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.64e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-3)"	85.2	89.2	126.0	25.1	159.3	20.1	29.6	45.2	81.2	20.1	60.3			75.6	23.5	30.9	42.8	19.8	24.6	309.5	122.3	90.2	154.4	166.8	18.0	19.3	102.8		26.5	54.7	36.2	22.0	34.1		37.6	59.4		66.8	35.6	475.3	62.5	52.6	27.9	61.3	20.7	58.4	27.7			22.4		18.6	23.0	15.7	110.2	58.9	419.0	88.2	72.3	90.5	35.3	100.8	166.4	116.2	182.2	221.8	50.9	75.9	148.7	27.1	20.1	34.0	195.6	110.9	179.7	63.2	80.2	31.2	219.8	12.1	116.0	37.3	128.3	105.3	157.3	1186.6	338.6	37.7	93.1	203.9	83.0	102.9	36.1	34.9	141.5	35.7	100.8	103.4	131.1	78.3	284.0	57.3	247.9	30.5	77.4	68.9	72.2	49.5	110.7	208.9	256.0	66.4	85.2	53.3	113.7	107.5	199.3	121.6	319.6	188.2	82.0	121.2	135.4	106.1	58.0	76.5	124.6	71.6	198.7	45.8	419.0	88.2	156.1	56.6	66.3	71.6	106.0	64.7	71.1	47.5	110.2	76.5	90.5	100.1	72.3	67.8	58.9	47.6	35.3											1381.7	1526.0	11633.9	5315.5	2578.7	0.0	108059.0	10741.3	2731.6	2651.3	6092.6	0.0	0.0	1593.2	1756.2	808.5	1505.8	13591.3	14997.7	2949.2	0.0	1371.6	3985.7	1952.8	21340.2	0.0	0.0	3847.9	7623.7	10387.2	3622.6	7103.8	2816.3	2404.1	3082.2	11928.5	0.0	2519.5	9780.9	4668.2	10316.3	0.0	6202.4	2943.8	6022.8	4841.7	2653.0	0.0	6498.2	11027.9	6485.3
RMND5B	"FLJ22318, GID2, GID2B"	ENSG00000145916	"Required for meiotic nuclear division 5 homolog B"	Q96G75	5	178130996-178150565	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 149.7;Late spermatids: 317.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047778	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047778: AB_2680153"	"unprognostic (2.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (7.66e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.22e-8)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.43e-2)"	"unprognostic (5.78e-2)"	12.2	12.6	11.6	7.3	13.7	7.7	9.7	10.4	18.8	11.4	11.8	16.2	9.1	9.0	16.2	11.8	36.7	12.8	12.5	17.2	11.4	9.0	11.3	13.1	11.5	11.1	14.5	16.7	11.8	16.9	12.8	15.7	11.3	13.0	12.2	8.2	16.1	15.8	11.9	23.4	18.0	11.7	18.7	9.1	10.5	12.0	42.0	9.2	11.2	14.3	13.0	18.2	11.5	14.0	13.2	8.5	22.4	13.8	2.2	12.8	7.2	6.4	10.9	7.5	18.1	9.7	1.0	22.4	5.4	6.1	7.9	9.5	12.8	9.6	14.1	10.8	4.0	9.1	9.0	7.4	11.3	3.1	39.5	9.9	14.4	13.0	6.7	10.3	6.9	5.4	2.0	9.1	5.5	9.4	4.9	8.2	4.9	12.0	10.0	2.6	56.9	5.0	4.2	9.6	8.6	6.8	6.2	5.4	9.7	7.3	10.5	7.7	10.8	7.2	24.8	12.6	6.4	17.3	10.0	5.6	4.8	7.1	4.4	6.7	14.5	13.4	11.6	6.0	7.0	6.5	9.2	9.7	22.4	4.2	11.2	1.8	11.1	8.5	4.8	5.7	13.2	12.8	7.6	6.8	2.2	13.8	8.5	12.5	7.2	11.6	13.7	10.4	18.8	11.4	9.0	14.5	16.7	13.0	9.2	11.9	5.8	15.6	17.3	8.5	46.1	20.9	20.4	4.0	5.7	29.6	49.1	27.9	19.9	17.7	149.7	10.6	18.7	46.7	16.6	24.1	15.3	18.0	4.7	11.9	18.8	46.1	8.6	14.7	10.7	317.0	26.7	11.0	6.8	24.4	13.7	29.1	16.2	13.6	23.7	16.5	53.1	12.9	14.2	79.2	34.1	11.7	37.2	10.0	16.2	17.6
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 84.3;Early spermatids: 174.5;Late spermatids: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041311: AB_2677402, HPA048238: AB_2680324"	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favorable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favorable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	7.1	11.1	8.5	6.5	13.2	2.3	7.6	13.5	12.2	11.7	6.8	10.0	10.8	4.1	12.7	16.2	7.8	26.5	11.6	21.0	8.7	9.8	12.4	6.3	9.9	4.0	8.9	8.9	12.8	12.9	23.2	22.0	3.5	10.1	8.9	4.6	11.0	16.2	12.6	18.8	4.2	4.2	8.4	7.5	4.2	7.6	16.1	6.4	1.7	15.5	5.5	5.2	6.6	5.1	2.5	4.8	4.3	5.0	0.0	3.7	2.3	10.8	8.8	1.1	5.5	5.1	4.0	9.4	2.2	5.5	8.9	2.6	8.8	8.3	0.6	6.0	4.5	5.4	10.8	3.6	6.4	2.0	0.0	6.5	2.3	5.6	10.0	5.8	1.3	1.8	5.2	3.7	6.7	3.1	3.8	5.3	3.8	8.7	1.2	3.8	26.1	1.5	5.5	7.3	6.9	4.6	0.4	10.2	0.6	11.2	5.3	9.3	6.7	11.5	6.2	13.1	1.0	11.7	5.1	3.7	5.5	6.4	3.0	5.1	2.0	3.3	0.0	14.0	1.7	9.6	4.3	3.1	3.7	1.8	5.0	1.8	1.2	2.8	3.7	4.4	2.5	2.3	2.0	4.0	0.0	3.1	4.8	3.5	2.3	8.5	13.2	13.5	12.2	8.7	9.8	8.9	8.9	10.1	6.4	20.8	9.9	0.5	4.2	1.0	8.8	6.4	28.1	84.3	15.9	21.0	19.6	2.6	11.6	14.7	174.5	4.5	4.3	0.0	9.6	3.0	3.3	6.4	2.3	3.6	3.3	25.4	5.8	4.9	0.0	126.7	13.0	3.3	5.0	1.8	5.4	11.4	10.1	3.5	7.1	23.0	25.1	6.5	3.7	18.9	13.6	2.3	1.4	0.0	5.0	4.8
PHKA2	"PHK, PYK"	ENSG00000044446	"Phosphorylase kinase regulatory subunit alpha 2"	P46019	X	18892300-18984598	"Disease related genes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002912	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002912: AB_10961321"	"unprognostic (3.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.07e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.68e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.16e-2)"	"prognostic favorable (2.96e-5)"	9.5	8.6	4.0	9.8	8.3	10.8	7.9	10.9	5.9	8.7	7.7	7.8	4.5	10.1	8.5	5.4	5.8	8.3	10.9	8.6	4.2	3.7	6.2	29.4	5.4	14.1	7.1	3.6	14.5	13.1	8.8	16.9	11.6	6.9	8.3	5.2	9.5	7.4	12.4	6.0	6.9	10.1	4.9	6.6	8.5	6.9	12.4	5.4	29.6	9.2	3.4	9.1	7.2	10.4	3.0	3.2	9.9	5.6	4.2	3.4	2.6	8.4	7.9	4.6	7.7	6.3	5.9	13.0	3.7	3.1	5.4	6.0	8.3	5.5	9.8	2.8	4.7	8.6	7.8	8.3	9.5	5.9	4.9	8.7	11.8	12.3	10.0	4.5	11.0	15.2	9.8	6.4	6.6	9.6	9.0	5.6	10.4	3.9	6.1	3.7	8.6	11.5	18.4	5.7	3.8	8.7	9.2	9.6	10.9	3.5	3.7	4.0	6.2	11.3	11.5	5.0	16.2	14.4	6.4	9.9	7.4	4.3	7.9	5.7	6.0	5.0	7.5	4.2	6.0	4.0	5.1	4.6	9.9	3.2	5.6	3.4	2.5	2.6	2.3	3.2	3.0	3.2	3.0	8.2	4.2	3.6	1.7	3.2	2.6	4.0	8.3	10.9	5.9	4.2	3.7	7.1	3.6	6.9	5.4	8.9	14.6	6.2	5.3	5.8	9.7	19.0	15.3	1.4	4.5	8.7	9.8	14.3	0.0	5.1	4.3	5.8	7.7	23.3	4.4	14.6	5.1	5.9	1.1	44.0	6.8	4.8	4.1	19.0	17.6	4.7	6.9	6.4	5.0	1.0	6.5	23.5	6.5	9.5	7.4	3.9	12.4	0.0	3.4	5.4	7.2	4.1	8.8	4.6	11.9	3.3
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918476	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.9;Late spermatids: 28.7;Suprabasal keratinocytes: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA061915			Approved	Nucleoli		NA	NA			Nucleoli		"HPA061915: AB_2684635"	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favorable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	3.6	2.9	3.6	3.2	4.7	4.0	7.3	17.2	5.7	6.2	15.7	2.3	5.1	7.8	5.6	4.2	11.0	4.7	4.0	4.2	3.3	2.7	9.2	3.9	4.9	2.9	2.6	3.2	5.4	7.4	3.9	4.1	5.8	4.2	6.1	10.1	3.6	5.5	8.7	7.4	18.6	18.5	2.1	2.4	3.6	11.7	26.4	3.9	2.9	5.4	7.0	6.6	5.0	7.9	4.9	3.6	1.4	5.8	6.3	8.4	4.1	6.7	3.2	4.4	6.4	4.3	3.7	7.4	2.9	2.3	4.6	4.8	6.5	2.6	5.7	3.7	2.3	6.7	7.9	7.0	9.9	5.8	0.0	3.6	3.3	3.7	8.6	3.3	0.0	6.3	2.9	11.1	4.1	8.8	3.8	3.5	13.8	5.8	0.1	3.6	6.8	8.6	3.7	2.9	8.0	5.6	8.0	13.5	1.3	6.3	11.1	2.2	3.3	4.2	7.9	2.7	6.5	4.9	5.5	2.7	3.2	3.1	7.3	4.0	1.2	6.5	2.8	2.6	0.9	2.5	0.0	3.3	1.4	6.5	5.8	5.4	4.9	7.1	6.7	3.6	4.9	8.4	7.4	1.2	6.3	3.1	3.4	7.1	4.1	3.6	4.7	17.2	5.7	3.3	2.7	2.6	3.2	4.2	3.9	0.0	4.0	0.0	17.8	19.1	1.9	2.5	2.5	4.0	10.3	0.0	5.9	3.6	3.3	2.8	74.9	1.4	11.8	0.0	2.0	3.4	2.5	3.4	0.0	1.6	1.9	1.6	0.0	1.8	1.0	28.7	2.3	1.9	5.0	1.8	5.0	1.6	1.4	7.0	2.8	2.4	2.6	0.0	3.9	4.1	11.5	25.1	5.5	0.0	6.0	8.9
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 13901.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100.0	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39.0	10.4	24.9	46.0	36.8	32.4	27.6	33.0	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23.0	31.5	84.4	50.3	22.0	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171.0	287.8	409.7	453.0	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197.0	381.4	302.0	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818.0	223.7	258.1	558.8
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 972.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"		NA	NA			Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: AB_2679244"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.9	26.5	20.8	39.5	21.5	33.8	52.2	29.9	31.9	22.9	31.8	25.1	50.5	21.2	48.7	36.7	15.4	20.1	12.8	41.7	6.5	25.8	60.9	19.8	34.6	30.2	37.0	19.6	43.6	44.1	40.2	20.6	13.1	44.1	23.5	41.3	41.4	50.5	19.9	61.6	35.6	58.7	42.5	33.2	38.5	37.4	17.3	72.4	30.8	24.2	23.1	42.1	21.0	17.3	37.3	16.5	20.4	57.2	27.4	28.7	26.2	55.9	22.7	38.6	22.2	24.6	64.8	31.5	25.4	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9	8.9	1.4	107.1	128.1	84.6	57.2	2.0	71.4	2.7	5.7	96.0	13.7	219.4	210.5	151.9	314.6	76.6	289.8	233.6	111.8	173.9	174.8	132.3	54.0	55.9	208.7	93.8	197.7	79.8	159.9	972.7	188.7	127.3	192.3	254.3	108.6	104.6	130.6	224.5	155.6	222.1	41.3	97.0	149.9	203.6	97.7	103.1	261.7	163.0	127.0	126.6
RNPC3	"FLJ20008, KIAA1839, RBM40, SNRNP65"	ENSG00000185946	"RNA binding region (RNP1, RRM) containing 3"	Q96LT9	1	103525691-103555239	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 95.4;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052434			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052434: AB_2681832"	"unprognostic (1.87e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-5)"	"unprognostic (9.00e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (7.82e-4)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.25e-4)"	19.8	18.5	42.1	16.7	52.4	15.3	20.7	53.4	41.2	22.3	17.8	19.1	22.2	16.4	24.2	40.7	11.9	25.8	15.4	20.1	33.5	12.7	19.4	10.9	17.0	22.4	25.6	28.6	27.2	29.6	25.1	42.5	9.0	24.4	17.5	16.3	17.2	26.9	18.2	28.9	26.6	19.3	13.8	24.5	20.3	16.1	11.0	33.0	15.5	37.9	14.0	18.3	18.7	18.4	33.6	26.3	61.3	23.1	9.3	19.2	3.2	7.0	5.7	12.3	6.1	7.6	13.5	8.2	9.8	6.5	7.9	11.8	6.1	12.0	13.4	15.7	4.8	4.7	14.3	7.5	7.7	9.3	8.7	14.2	14.0	29.9	6.1	5.4	18.5	12.1	12.4	11.8	6.7	4.7	11.6	7.2	11.7	8.7	15.6	9.0	3.9	10.5	9.4	8.0	6.8	8.7	14.6	11.4	10.5	10.4	7.6	13.1	6.4	6.6	9.2	9.8	7.1	6.2	8.6	9.6	8.6	8.5	4.6	6.3	11.7	3.9	11.8	15.1	14.4	4.3	42.7	23.1	15.3	13.5	10.7	9.8	24.6	16.1	12.2	6.7	33.6	19.2	17.5	61.3	9.3	12.1	26.3	10.7	3.2	42.1	52.4	53.4	41.2	33.5	12.7	25.6	28.6	24.4	33.0	26.8	37.9	11.5	17.0	6.6	95.4	16.9	12.7	62.9	43.3	26.2	125.7	6.4	13.3	8.2	22.1	16.6	19.7	0.0	9.0	3.6	9.1	9.5	19.7	8.6	6.7	58.8	16.3	14.1	21.9	3.6	23.0	16.8	15.1	15.4	16.3	53.0	9.0	12.5	20.1	4.3	145.9	25.8	11.2	18.2	8.1	7.9	9.2	17.5	12.1	11.7
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		160000			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.6	21.5	18.5	31.3	29.9	16.5	34.6	16.7	23.8	26.1	38.0	20.3	28.3	13.4	70.9	35.9	45.2	24.3	27.1	15.5	14.4	12.2	28.0	7.7	27.7	20.1	37.7	12.4	56.9	22.0	26.6	24.5	14.1	28.5	36.1	10.3	9.2	37.9	17.1	33.1	9.0	18.8	6.9	33.4	22.1	13.9	12.3	34.7	27.6	19.0	18.4	19.2	14.6	59.7	31.4	18.0	26.3	30.6	27.9	19.1	17.2	32.4	27.2	54.7	58.8	15.8	22.7	26.9	19.1	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2	35.7	60.5	43.2	34.7	26.9	103.3	32.9	58.6	68.3	39.8	92.5	45.2	127.4	16.6	60.6	1.4	40.9	65.9	0.0	45.6	84.9	39.2	41.1	75.1	34.5	216.4	122.3	85.5	57.1	139.0	4.3	38.3	101.8	69.2	65.9	52.9	70.3	39.9	58.6	40.0	42.5	46.1	64.7	33.5	33.9	5.6	28.7	164.3	38.7	44.1	39.7
MC1R	MSH-R	ENSG00000258839	"Melanocortin 1 receptor"	Q01726	16	89912119-89920977	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 17.3;Melanocytes: 16.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.2;SK-MEL-30: 25.1;T-47d: 13.7"															NA	NA						"unprognostic (3.90e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.39e-7)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.26e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.20e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.16e-2)"	1.7	2.7	4.0	2.6	9.3	1.0	1.1	13.9	9.2	4.4	2.2	1.6	3.2	2.5	2.4	4.2	2.0	3.9	3.9	3.7	0.9	2.0	3.2	0.8	1.8	2.2	1.7	1.8	3.8	1.9	1.3	13.8	5.0	4.5	3.8	1.0	2.0	2.2	2.4	1.4	9.0	2.5	2.7	2.2	1.6	2.5	13.1	2.6	1.3	7.0	0.8	1.1	2.6	1.8	0.3	1.5	0.0	0.2	0.0	0.9	0.2	2.2	8.5	1.7	2.2	1.5	2.7	2.1	2.5	2.1	1.8	1.2	2.1	2.2	1.6	3.5	2.6	1.0	5.0	0.9	0.6	0.7	0.9	2.5	0.3	3.1	5.7	0.3	0.5	2.1	3.8	1.2	2.7	0.9	1.6	1.5	0.5	1.8	2.3	1.2	13.2	0.0	11.4	1.7	2.1	1.5	1.1	2.1	1.6	1.7	1.1	3.1	1.6	3.2	1.1	25.1	1.0	13.7	1.9	1.0	3.0	6.8	1.6	1.0	10.0	5.6	0.8	3.9	6.3	8.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.2	4.0	9.3	13.9	9.2	0.9	2.0	1.7	1.8	4.5	2.6	3.0	1.7	0.0	0.5	2.1	5.3	0.8	2.5	0.0	1.2	1.8	7.9	1.1	0.0	0.7	0.6	1.0	1.3	0.0	1.5	1.6	1.9	1.7	17.3	1.5	0.7	6.4	4.1	3.1	0.3	0.9	0.6	1.6	16.9	0.0	2.3	2.3	1.0	1.1	0.4	0.1	2.6	0.0	1.6	6.5	3.0	2.0	3.8	0.0	1.0	0.6
MVB12B	"C9orf28, FAM125B, FLJ00001"	ENSG00000196814	"Multivesicular body subunit 12B"	Q9H7P6	9	126326849-126507041	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043683, HPA049383"			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA043683: AB_2678616, HPA049383: AB_2680737"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.82e-2)"	"unprognostic (9.59e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.12e-3)"	5.6	5.5	15.2	4.3	21.2	10.7	5.0	7.3	22.9	6.3	6.1	52.0	2.4	3.7	5.9	3.3	4.3	10.2	3.9	4.6	22.8	15.3	3.4	4.0	17.7	5.9	31.1	9.8	6.6	3.3	8.8	5.3	14.8	28.2	5.9	6.4	5.8	3.1	9.0	21.4	3.3	4.2	6.6	62.2	10.3	4.0	5.4	28.8	4.8	5.7	1.5	2.6	6.9	3.2	0.4	2.0	0.2	1.5	0.1	5.7	1.4	2.9	4.0	21.9	12.0	0.7	0.2	13.0	2.4	2.0	4.4	0.8	3.4	0.1	0.0	1.5	2.3	6.5	1.3	6.7	1.1	2.7	4.8	4.2	1.0	0.7	14.9	1.8	1.9	0.9	1.7	2.2	0.9	0.0	3.7	3.4	15.9	0.0	0.0	3.2	2.3	3.1	6.1	4.8	0.5	5.5	4.6	12.0	0.0	0.2	12.0	5.5	10.1	4.0	2.9	2.5	9.6	2.9	11.7	4.9	5.0	3.7	2.8	5.0	0.0	0.0	1.2	1.4	8.7	2.6	0.0	1.5	0.2	3.1	0.4	5.7	0.2	1.4	5.0	2.0	0.4	0.3	2.2	0.1	0.1	0.4	0.1	0.0	1.4	15.2	21.2	7.3	15.9	22.8	15.3	31.1	9.8	28.2	28.8	6.0	5.3	0.0	2.8	3.2	8.8	3.1	5.1	9.4	1.2	1.8	3.9	10.2	0.0	1.1	0.5	4.8	1.3	0.0	1.2	1.8	3.8	1.2	6.9	5.0	1.4	9.5	2.4	1.3	18.0	1.7	2.6	4.0	0.0	1.8	2.1	8.8	0.9	5.9	6.0	0.0	5.5	0.0	1.8	1.4	3.3	2.3	2.9	4.4	2.3	1.4
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
SPECC1L	"CYTSA, KIAA0376"	ENSG00000100014	"Sperm antigen with calponin homology and coiled-coil domains 1 like"	Q69YQ0	22	24270817-24417740	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA070614	Uncertain		Supported	"Actin filaments"		NA	NA			"Actin filaments"		"HPA070614: AB_2686287"	"unprognostic (3.54e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-3)"	"prognostic favorable (7.92e-4)"	"unprognostic (3.15e-3)"	"unprognostic (6.20e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.41e-1)"	15.0	15.5	21.6	16.9	19.5	12.7	22.1	46.5	24.4	20.1	17.1	12.3	19.0	8.6	20.7	16.6	19.7	18.2	15.7	20.2	19.5	16.0	15.7	16.9	19.1	12.6	15.8	12.1	25.8	15.0	22.6	23.1	20.4	20.5	23.4	19.0	12.2	16.8	22.2	17.0	11.0	13.7	24.1	17.8	13.9	14.3	33.8	19.2	17.1	27.3	8.9	14.6	17.5	32.5	6.5	7.0	8.6	6.9	2.4	6.7	3.3	13.9	10.9	20.4	11.3	20.1	19.8	7.0	19.8	16.5	17.9	17.9	11.8	3.9	20.4	4.8	18.6	14.2	12.7	18.7	11.5	21.4	11.9	10.2	13.3	6.2	11.0	13.3	23.3	12.8	16.5	9.4	15.9	16.9	14.1	20.7	8.8	11.1	8.8	19.0	8.2	12.0	8.6	10.0	10.5	8.3	10.9	21.1	7.3	9.1	11.0	17.8	18.5	17.4	13.3	11.6	18.9	8.6	6.6	21.6	38.2	21.6	9.2	13.6	10.5	9.9	9.1	11.0	8.9	13.7	6.7	4.5	8.6	6.7	6.9	5.2	5.3	4.5	3.1	4.4	6.5	5.7	5.6	6.1	2.4	2.9	7.0	3.1	3.3	21.6	19.5	46.5	24.4	19.5	16.0	15.8	12.1	20.5	19.2	14.9	17.6	9.7	2.4	3.2	7.9	12.6	12.7	16.0	10.3	12.2	9.8	6.1	1.7	5.7	26.1	9.0	10.5	0.0	6.3	2.6	6.3	4.8	16.1	10.4	6.1	9.5	13.8	19.0	7.6	61.1	15.0	4.4	13.5	16.2	12.8	5.8	7.6	14.4	12.7	4.4	8.2	12.9	8.9	23.0	26.7	2.8	4.9	5.7	6.9	3.5
ZNF516	"HsT287, KIAA0222"	ENSG00000101493	"Zinc finger protein 516"	Q92618	18	76358190-76495190	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"THP-1: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015792	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA015792: AB_1859314"	"prognostic favorable (7.09e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.63e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	4.2	5.4	8.3	5.7	9.9	15.1	4.7	2.0	4.8	20.8	5.9	4.5	18.6	4.1	25.2	8.0	6.3	15.8	3.9	3.5	5.1	2.9	3.4	5.1	5.0	4.2	4.7	3.9	17.0	4.6	8.7	10.8	2.6	6.4	7.3	1.8	13.1	6.4	13.3	8.6	6.3	4.1	9.1	3.3	6.3	4.5	18.6	4.6	3.0	4.8	4.0	4.9	8.0	10.9	0.4	1.6	12.2	2.2	1.0	0.6	0.4	1.5	1.7	12.4	16.3	3.7	5.5	1.5	9.4	7.9	2.0	3.8	3.5	5.7	8.1	2.0	10.0	5.1	3.3	6.8	9.0	1.4	0.0	5.3	0.7	0.0	7.6	9.1	5.3	5.4	10.4	4.1	4.3	4.5	2.8	2.3	3.4	0.0	0.0	2.0	3.2	0.1	9.5	6.2	1.0	0.4	3.5	1.3	4.1	3.2	7.0	12.5	7.7	0.1	0.0	10.1	5.2	2.0	21.7	1.5	4.7	8.2	0.1	0.9	0.0	0.2	6.2	2.8	3.7	12.0	2.7	2.2	3.0	0.1	1.5	0.6	0.1	0.2	0.1	1.6	0.4	0.6	0.3	12.2	1.0	1.6	1.0	0.0	0.4	8.3	9.9	2.0	4.8	5.1	2.9	4.7	3.9	6.4	4.6	8.9	8.5	3.9	14.0	17.3	14.8	7.6	7.6	9.4	2.3	1.8	29.5	0.2	3.3	4.9	69.3	9.0	5.2	0.0	2.5	0.3	10.2	10.7	1.1	11.3	7.1	3.2	12.1	8.0	20.3	27.6	28.1	14.9	11.8	8.2	5.4	6.5	4.5	5.3	32.9	4.4	29.5	12.9	17.3	3.4	33.4	17.7	0.5	2.9	3.5	17.5
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.9;HeLa: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (4.09e-5)"	7.8	14.2	16.9	10.9	17.4	9.4	8.1	20.3	18.8	12.5	9.4	12.4	24.8	19.6	13.6	13.4	8.7	16.6	13.5	6.7	15.4	9.7	11.7	9.8	12.5	9.9	13.9	14.8	15.9	15.2	17.5	26.0	6.8	13.7	13.8	7.8	12.4	16.7	21.5	9.7	11.6	17.0	9.6	9.6	11.7	14.7	9.0	16.1	8.3	18.1	5.2	9.4	11.0	9.8	3.5	2.3	2.3	1.2	6.6	9.0	3.4	4.7	12.4	5.1	3.2	3.0	2.7	6.1	4.3	2.3	0.8	1.6	2.6	5.9	3.4	2.1	1.2	3.7	5.4	1.3	3.1	0.4	5.9	27.9	3.6	21.4	1.4	1.8	2.7	6.3	1.8	8.0	1.1	3.5	5.0	2.7	4.0	3.0	4.4	1.1	5.3	1.5	1.5	1.8	2.9	4.9	4.2	1.2	6.1	2.7	10.4	4.9	6.9	2.1	4.2	2.7	1.0	4.3	3.6	3.0	8.2	2.6	1.4	2.2	7.5	8.5	2.8	6.5	2.9	1.9	0.0	1.2	0.6	3.3	0.9	4.9	3.2	5.4	3.8	2.3	3.5	9.0	5.6	2.3	6.6	0.9	0.6	3.2	3.4	16.9	17.4	20.3	18.8	15.4	9.7	13.9	14.8	13.7	16.1	11.9	14.2	12.3	10.5	7.1	36.2	5.5	12.7	13.4	2.3	10.4	31.4	5.0	3.3	6.8	16.9	6.4	15.4	0.0	4.8	3.0	6.1	9.5	4.6	8.3	4.1	28.6	16.1	7.4	3.5	19.1	9.8	3.3	10.1	1.0	10.7	18.1	5.6	8.5	12.4	7.9	46.3	19.4	3.2	8.9	3.4	7.2	5.4	12.8	10.5	6.0
DCAF15	"C19orf72, MGC99481"	ENSG00000132017	"DDB1 and CUL4 associated factor 15"	Q66K64	19	13952492-13961449	"Predicted intracellular proteins"	"Immunity, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068351			Approved	Vesicles,Mitochondria		NA	NA			Mitochondria	Vesicles	"HPA068351: AB_2685977"	"unprognostic (6.91e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.72e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.97e-4)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (7.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	10.3	6.5	10.4	15.1	8.5	27.5	11.1	20.1	13.3	13.9	12.7	8.7	8.9	10.7	11.4	8.4	14.7	11.3	10.0	11.0	12.1	7.0	11.1	13.1	14.8	19.4	9.0	8.5	10.3	8.4	11.0	10.7	18.6	8.8	10.4	8.4	9.8	10.0	9.1	13.3	21.0	13.8	8.2	7.4	21.4	9.9	41.0	6.5	29.2	10.7	16.5	23.4	9.9	12.8	2.2	2.8	5.1	2.2	0.8	3.6	1.3	15.6	9.7	25.6	14.0	2.7	4.0	11.7	10.8	7.6	22.7	22.7	17.2	6.7	14.5	12.6	10.4	13.4	14.3	16.2	10.2	8.1	17.4	28.9	17.8	16.2	17.8	5.8	14.7	26.3	5.3	9.6	16.7	7.6	8.2	11.3	23.5	18.7	21.4	9.9	23.8	26.2	27.3	30.4	10.6	15.3	24.2	9.0	9.9	12.1	12.1	16.4	16.9	9.7	7.0	8.8	11.0	9.0	19.0	7.8	15.6	11.6	24.5	20.1	15.1	16.6	15.1	10.0	21.5	13.4	1.2	2.0	5.1	2.1	2.2	1.6	2.1	1.7	2.4	1.2	2.2	0.9	2.4	4.1	0.8	1.4	2.8	3.6	1.3	10.4	8.5	20.1	13.3	12.1	7.0	9.0	8.5	8.8	6.5	0.0	0.0	16.4	8.1	4.2	15.5	0.9	5.1	0.0	2.3	8.7	7.9	10.8	1.7	9.7	4.0	8.3	6.3	0.0	9.1	12.7	6.4	4.9	1.1	3.2	13.4	14.3	7.5	9.2	6.0	7.8	17.0	8.8	1.7	14.4	6.1	8.4	7.9	7.0	11.3	3.3	13.2	6.5	4.7	25.1	23.7	8.5	11.6	12.2	6.8	9.2
SMIM29	"C6orf1, LBH, MGC57858"	ENSG00000186577	"Small integral membrane protein 29"	Q86T20	6	34246380-34249470	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 67.8"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 61.3;Ductal cells: 41.8;Hofbauer cells: 88.6;monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA037659, HPA037660"	Uncertain					NA	NA					"HPA037659: AB_2675591, HPA037660: AB_10671881"	"unprognostic (2.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (7.98e-4)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.66e-1)"	9.6	18.5	42.0	10.4	21.8	9.9	12.4	14.8	36.8	10.5	7.6	15.2	4.6	7.1	9.1	24.4	13.3	11.5	12.3	19.0	34.6	34.4	7.9	6.0	13.3	13.5	35.7	16.5	8.8	10.7	7.0	12.2	10.0	25.7	9.7	4.8	12.5	7.5	13.6	7.8	29.2	6.7	8.3	23.9	15.2	9.4	5.2	14.0	5.8	15.2	8.3	11.0	16.0	9.3	22.4	10.4	67.8	15.0	9.8	15.8	11.0	8.9	9.9	2.0	11.7	24.7	20.6	2.0	9.2	19.5	8.5	10.4	2.4	3.4	5.0	7.4	8.2	16.1	5.5	3.7	8.8	2.5	12.9	6.4	3.7	2.5	6.8	13.7	4.4	23.3	11.2	8.4	12.0	12.8	10.8	13.6	3.8	4.8	25.0	19.3	5.7	4.6	8.0	0.7	10.9	7.3	1.6	1.3	7.7	10.2	11.5	9.5	4.5	0.9	6.6	24.0	1.7	4.8	5.2	10.0	19.4	5.3	22.4	7.7	15.9	22.4	1.6	11.4	8.7	28.3	15.3	15.0	67.8	15.8	10.7	10.3	22.4	12.6	13.5	10.4	21.8	8.7	12.5	38.7	9.8	7.6	8.8	15.3	11.0	42.0	21.8	14.8	36.8	34.6	34.4	35.7	16.5	25.7	14.0	8.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	12.5	29.6	0.0	30.4	61.3	41.8	0.0	0.0	0.0	0.0	20.4	10.4	0.0	0.0	11.6	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	77.5	0.0	0.0	25.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0
MIS12	"hMIS12, KNTC2AP, MGC2488, MTW1"	ENSG00000167842	"MIS12, kinetochore complex component"	Q9H081	17	5486285-5490814	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 87.1;Late spermatids: 183.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044482	Approved					NA	NA					"HPA044482: AB_10963834"	"unprognostic (3.86e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.41e-2)"	"prognostic favorable (8.00e-4)"	"unprognostic (4.13e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (3.65e-2)"	13.4	14.4	15.7	15.9	25.3	16.5	16.8	13.7	19.1	14.1	12.6	15.3	18.6	12.6	16.0	35.8	12.9	17.6	11.0	12.0	17.2	11.9	16.0	19.9	12.9	20.5	25.6	13.1	15.2	18.6	12.7	24.2	14.8	17.9	13.9	15.5	12.0	13.0	18.6	16.6	11.1	16.7	14.3	18.9	23.2	14.2	18.1	21.6	25.7	20.7	9.0	21.8	13.7	10.9	11.2	12.1	5.9	11.5	14.2	15.8	9.3	9.7	10.8	24.6	15.1	10.3	10.1	12.6	14.2	10.7	21.9	19.9	10.3	7.5	24.4	12.1	7.5	10.6	22.0	19.2	13.2	22.7	14.0	12.9	13.6	21.1	12.0	18.1	7.9	16.8	10.2	20.5	18.6	28.8	10.6	11.4	19.1	14.7	25.0	13.9	5.9	17.4	8.2	13.7	12.6	9.8	16.1	23.6	11.9	8.9	10.0	8.5	16.8	14.7	7.1	15.1	18.5	10.6	6.8	7.4	14.2	11.3	12.0	17.6	11.9	10.5	13.9	12.5	11.8	12.7	5.5	8.0	5.9	13.9	8.9	15.3	11.2	12.3	14.1	9.0	9.9	15.8	14.7	4.2	14.2	11.5	12.1	7.8	9.3	15.7	25.3	13.7	19.1	17.2	11.9	25.6	13.1	17.9	21.6	11.9	15.4	13.8	23.7	11.4	14.5	6.1	17.8	10.7	11.4	5.2	13.7	10.2	19.9	8.6	87.1	11.9	8.6	0.0	6.3	11.7	11.2	17.1	32.3	9.7	8.9	4.8	20.5	8.6	10.6	183.3	5.5	11.1	10.1	6.4	9.8	17.5	8.4	14.0	8.9	7.0	19.5	19.4	12.2	18.4	10.0	15.7	18.3	19.2	8.6	18.7
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.2	7.4	10.1	8.3	10.4	9.9	19.0	8.4	13.6	8.8	8.7	12.5	7.3	14.6	3.7	16.0	13.4	16.2	11.9	8.5	9.0	7.0	6.3	4.6	14.7	10.2	12.4	6.8	6.3	10.7	6.4	11.2	13.8	8.8	10.1	13.0	8.1	8.0	10.0	11.5	6.1	5.8	13.9	9.2	6.2	7.4	19.1	8.2	3.9	8.2	5.1	7.8	9.8	6.1	4.8	12.5	11.1	4.0	10.4	14.4	8.7	8.6	5.7	4.5	10.0	14.2	8.2	4.0	6.4	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9	20.8	25.6	10.8	4.8	6.6	26.0	26.6	7.6	21.4	12.5	10.4	35.3	12.8	11.6	9.5	39.6	8.7	6.3	0.0	6.2	19.5	9.1	6.5	8.1	5.0	7.8	23.8	16.1	12.3	8.7	99.6	14.4	7.4	11.8	8.2	7.9	10.4	10.9	8.4	10.6	7.5	25.2	19.4	8.0	18.9	17.8	7.5	17.6	7.1	9.9	6.5
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 304.4;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol		NA	NA			Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favorable (7.90e-4)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.7	9.0	7.6	9.3	7.1	5.8	17.1	9.6	14.4	13.2	15.1	7.8	6.9	11.9	11.4	9.9	6.7	13.2	7.9	12.2	10.6	6.4	21.9	6.5	15.0	21.8	11.0	10.0	9.3	7.8	6.6	12.6	5.9	6.3	13.4	8.5	8.8	6.9	9.5	31.5	11.8	14.8	10.5	9.9	10.5	16.0	11.9	15.8	15.1	15.5	10.2	7.0	7.8	21.8	9.2	7.2	17.1	8.7	7.9	8.1	9.0	10.1	8.8	13.9	7.5	8.1	16.1	19.6	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3	11.9	23.7	12.6	12.5	18.7	8.9	10.6	2.5	25.4	29.6	17.4	9.8	26.7	23.2	11.4	304.4	9.9	23.2	0.0	21.4	32.3	12.9	24.0	12.7	19.5	25.4	19.1	15.6	9.2	22.4	1171.9	16.1	24.0	11.8	42.3	15.6	9.8	16.8	15.0	21.9	32.7	8.4	0.0	12.5	127.4	23.3	20.1	63.2	26.2	19.6	12.4
AKAP8L	"HAP95, NAKAP95"	ENSG00000011243	"A-kinase anchoring protein 8 like"	Q9ULX6	19	15380048-15419141	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042485, HPA042546"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042485: AB_2678019, HPA042546: AB_2678046"	"unprognostic (9.52e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (1.08e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (8.04e-4)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.34e-3)"	13.9	20.6	25.6	12.1	35.8	55.1	14.3	51.0	30.3	17.9	15.9	20.6	20.0	10.7	15.3	26.8	13.6	18.7	13.4	23.4	24.6	17.9	14.8	16.3	17.0	17.3	25.4	22.3	23.9	10.7	23.6	25.6	18.8	23.9	17.6	13.0	19.7	13.7	17.8	31.9	17.8	12.0	14.6	19.5	16.4	13.7	28.5	30.0	15.5	18.0	13.8	18.7	15.1	16.6	4.2	3.0	5.9	2.7	0.7	3.6	1.3	12.8	13.5	20.3	9.4	17.7	20.7	10.6	11.7	13.2	19.7	17.5	22.9	19.0	11.7	20.0	13.9	17.7	14.7	28.2	16.1	16.1	19.8	23.1	22.6	14.3	17.2	31.7	20.1	14.8	18.3	27.4	16.2	20.3	23.3	14.1	18.6	25.7	23.4	11.8	18.6	20.7	19.1	15.9	17.4	23.8	24.5	11.5	14.0	14.8	9.3	18.6	12.3	14.0	15.7	18.3	24.5	11.4	19.4	17.5	12.2	8.6	18.8	19.0	35.9	21.1	24.3	10.1	21.2	11.8	0.1	2.7	2.2	1.2	1.4	3.4	1.4	1.5	1.9	3.0	4.2	1.7	2.6	5.9	0.7	1.8	1.9	3.6	1.3	25.6	35.8	51.0	30.3	24.6	17.9	25.4	22.3	23.9	30.0	6.0	12.8	20.3	41.3	28.0	58.9	6.3	15.3	40.2	29.6	33.2	72.6	28.4	21.6	27.4	21.7	22.4	12.9	23.3	27.6	22.3	23.6	28.7	12.8	13.1	14.6	74.7	24.5	9.8	11.9	6.8	24.5	27.6	25.3	28.9	12.9	40.5	25.6	14.8	27.6	13.2	80.3	25.8	46.4	66.1	49.6	34.4	52.2	27.5	13.6	36.6
PPP1R21	"CCDC128, FLJ16566, KLRAQ1"	ENSG00000162869	"Protein phosphatase 1 regulatory subunit 21"	Q6ZMI0	2	48440598-48515391	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036791, HPA036792"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036791: AB_10671713, HPA036792: AB_2675317"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (4.59e-6)"	"unprognostic (9.23e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (6.60e-2)"	9.0	10.4	16.4	8.9	18.7	8.1	7.9	16.2	21.6	8.3	8.8	15.0	7.9	7.0	15.8	18.8	11.2	13.5	9.8	8.9	13.2	12.2	25.6	10.4	10.0	10.9	17.7	13.6	12.7	7.3	35.5	11.9	11.3	14.4	10.8	9.8	8.4	6.8	10.2	6.4	9.5	9.0	11.9	12.0	11.0	9.4	8.4	15.9	10.4	19.5	2.4	10.8	12.7	8.8	7.7	5.6	14.1	6.0	3.8	7.9	2.3	13.8	6.7	5.8	7.1	14.5	10.8	15.2	8.2	9.3	5.0	6.1	3.7	8.7	9.4	13.6	11.5	9.8	7.7	4.8	7.4	10.6	12.0	4.1	10.1	5.7	8.9	10.1	4.5	8.1	13.5	6.8	9.1	11.2	12.8	12.7	4.8	4.0	15.8	13.7	7.6	8.6	7.3	14.6	9.9	7.1	7.2	15.5	10.2	10.6	9.2	7.7	4.8	15.2	4.0	14.7	15.9	7.2	7.3	11.3	5.4	6.7	4.8	6.5	11.8	3.3	8.6	8.6	10.1	7.1	14.1	5.4	8.5	4.4	6.0	3.5	5.9	5.2	5.1	5.6	7.7	7.9	6.4	13.0	3.8	5.1	3.5	5.0	2.3	16.4	18.7	16.2	21.6	13.2	12.2	17.7	13.6	14.4	15.9	20.8	13.9	9.9	27.6	9.3	8.6	9.2	7.6	26.8	9.1	24.4	2.0	18.6	5.0	9.1	1.9	11.3	9.5	0.0	7.4	13.6	10.8	14.2	11.5	12.3	28.7	27.0	18.0	12.9	18.0	4.0	11.2	16.4	11.8	19.0	9.6	20.1	9.9	8.6	19.4	45.5	6.2	12.9	17.6	9.1	12.1	12.3	22.7	10.9	8.0	22.7
CERS4	"FLJ12089, LASS4, Trh1"	ENSG00000090661	"Ceramide synthase 4"	Q9HA82	19	8206736-8262421	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 63.6;Muller glia cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 21.6;NB-4: 39.0;U-937: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033734, HPA054729"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB033734: AB_2132977, HPA054729: "	"unprognostic (5.96e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (1.48e-2)"	"unprognostic (3.32e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.77e-1)"	"prognostic favorable (9.63e-5)"	"unprognostic (6.08e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.08e-3)"	6.2	6.7	17.5	10.5	22.9	2.5	21.6	14.5	19.3	13.2	6.8	24.3	7.8	4.6	9.9	41.8	26.4	11.9	7.7	9.7	16.1	10.8	16.5	32.4	12.9	12.2	26.9	13.3	13.8	56.7	11.6	10.1	2.2	16.8	22.4	3.2	26.2	34.8	12.8	2.1	20.9	6.1	8.5	20.3	8.6	9.9	8.4	29.0	6.4	38.1	9.5	15.9	9.3	13.2	13.3	2.7	16.9	4.4	13.5	5.2	3.5	0.1	0.9	0.9	10.2	0.3	0.0	0.7	1.3	3.4	1.5	0.7	7.6	0.8	15.9	11.3	0.0	4.0	5.5	6.6	0.1	0.7	14.0	5.2	3.1	0.1	21.6	13.2	0.0	8.7	5.1	8.5	3.6	7.8	4.3	0.1	7.3	2.2	0.5	0.0	0.3	1.2	39.0	10.4	0.0	3.8	19.2	0.2	1.2	2.5	0.0	3.9	5.2	1.7	0.3	5.5	7.2	7.5	3.6	0.0	1.2	3.3	7.6	0.0	10.0	8.0	12.2	0.0	24.4	1.1	5.9	4.4	16.9	5.2	2.3	3.9	13.3	3.0	3.1	2.7	12.1	2.8	2.6	14.0	13.5	1.5	2.6	3.5	3.5	17.5	22.9	14.5	19.3	16.1	10.8	26.9	13.3	16.8	29.0	6.0	12.5	16.4	11.3	16.0	23.7	3.0	12.7	16.0	15.9	1.8	17.7	2.2	6.6	15.6	1.1	6.0	0.0	0.0	26.2	0.4	11.8	36.8	12.7	63.6	12.8	11.1	23.0	6.7	9.8	4.6	13.3	5.6	25.3	29.7	0.2	146.0	15.3	0.0	15.2	35.3	25.4	6.5	10.3	0.7	1.7	22.6	2.4	17.5	0.6	9.8
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182175-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	68	"Early spermatids: 532.1;Late spermatids: 1222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	6.2	9.2	11.7	9.5	13.9	12.8	6.9	12.5	13.8	7.4	8.5	12.9	7.3	8.2	11.2	6.5	11.5	10.7	8.5	5.5	10.0	6.4	7.7	5.6	7.5	11.7	10.0	9.8	9.5	8.6	13.2	15.9	5.0	9.2	8.3	5.1	11.2	8.7	9.3	6.0	16.1	10.2	7.7	6.9	10.1	8.7	12.5	10.4	10.8	10.9	4.9	10.8	12.0	7.0	1.1	1.1	0.5	0.9	0.3	2.6	1.0	7.5	5.6	3.1	7.4	8.8	5.2	4.2	3.0	5.4	4.9	4.6	1.8	3.2	6.3	5.9	4.8	4.4	5.5	2.6	6.4	2.3	7.6	2.4	6.9	6.0	2.8	5.7	4.3	11.4	7.1	13.5	4.0	3.6	4.3	7.1	11.1	3.6	8.4	4.3	7.0	8.7	6.3	0.5	14.7	3.6	12.9	2.1	6.2	3.7	7.9	5.3	7.6	4.0	4.9	6.8	2.8	8.3	9.8	6.5	12.3	8.5	3.6	5.7	8.0	7.5	5.1	3.1	7.7	5.5	0.0	0.9	0.3	1.2	0.5	1.3	1.1	0.7	2.6	1.1	0.8	0.6	1.4	0.5	0.3	0.4	0.9	2.5	1.0	11.7	13.9	12.5	13.8	10.0	6.4	10.0	9.8	9.2	10.4	0.0	8.0	4.4	2.2	5.7	9.5	4.4	12.7	4.0	4.5	3.5	11.8	2.7	3.3	3.1	532.1	5.8	7.4	0.0	5.4	1.5	2.8	1.9	2.3	5.5	10.6	11.1	5.8	9.2	5.7	1222.3	10.3	4.6	3.3	4.6	6.5	9.5	4.8	0.0	7.8	4.6	10.0	12.9	3.9	9.3	9.7	4.8	2.2	4.9	6.2	2.4
FBXO46	"20D7-FC4, Fbx46, FBXO34L"	ENSG00000177051	"F-box protein 46"	Q6PJ61	19	45710629-45730904	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049390	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA049390: AB_2680742"	"unprognostic (9.02e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (9.33e-2)"	"prognostic favorable (5.44e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.13e-2)"	"prognostic favorable (8.11e-4)"	"unprognostic (9.77e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (5.09e-6)"	7.4	7.4	13.8	12.9	13.1	10.4	9.8	10.4	15.7	11.2	10.3	8.6	10.6	9.6	15.7	10.0	20.7	10.7	7.3	8.7	13.3	4.8	7.6	10.5	7.7	17.2	13.9	10.1	17.1	12.6	8.4	10.4	12.3	10.2	10.1	9.7	8.6	11.0	9.0	12.8	12.8	11.4	10.9	9.7	15.8	13.3	11.5	13.0	13.6	12.8	9.2	17.1	10.0	12.4	5.9	2.6	7.1	2.3	1.1	3.7	1.2	7.0	11.0	8.5	9.9	2.2	4.0	9.7	3.7	2.1	2.9	3.4	9.1	9.3	12.3	5.0	2.0	4.2	10.3	6.3	4.7	2.2	15.1	13.3	10.0	37.1	4.9	3.3	4.4	12.9	3.3	4.3	5.0	3.1	7.5	4.4	15.3	7.8	15.0	2.4	6.7	10.2	5.1	5.4	6.6	3.8	13.8	4.7	11.4	3.5	8.5	8.5	7.5	5.9	12.5	4.9	8.5	10.6	5.5	4.9	6.3	5.7	3.4	6.0	14.4	19.9	8.2	7.0	6.2	5.1	7.1	2.3	2.3	3.7	1.8	2.5	4.0	2.8	2.5	1.5	5.9	2.6	3.0	6.7	1.1	2.1	2.6	2.6	1.2	13.8	13.1	10.4	15.7	13.3	4.8	13.9	10.1	10.2	13.0	8.9	4.5	6.0	9.3	23.1	2.8	4.5	7.6	5.3	4.5	7.0	2.0	7.1	1.7	5.5	2.3	4.5	10.4	0.0	4.2	13.6	3.8	7.1	3.5	16.3	3.1	11.1	7.0	4.9	4.3	2.2	5.2	3.6	5.0	3.6	11.7	4.0	5.8	11.8	1.8	1.7	2.7	0.0	3.9	6.0	3.8	31.2	10.4	4.8	8.6	9.6
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252251	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 63.9"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	6.5	4.7	11.5	8.9	10.6	5.2	6.3	9.0	15.8	4.1	5.9	6.2	5.1	8.4	4.5	5.5	5.8	4.8	7.6	5.9	10.4	9.0	4.6	5.4	9.0	11.0	6.8	12.8	4.0	63.9	4.2	10.2	7.7	9.8	6.9	4.9	8.0	29.5	5.0	6.9	5.4	8.1	4.6	8.5	11.2	9.3	3.3	7.0	6.4	5.9	5.9	6.4	5.1	5.4	3.4	4.1	6.1	7.4	1.6	8.7	3.1	3.0	4.2	5.9	12.8	5.1	3.1	4.4	6.3	3.5	5.0	6.2	4.0	3.8	2.5	10.2	7.2	6.2	1.9	4.0	2.9	2.1	5.9	5.7	3.6	5.9	4.2	6.1	4.3	7.0	5.4	2.4	4.8	3.8	4.7	17.5	10.5	2.3	14.1	3.8	4.9	6.2	4.5	2.3	6.0	4.1	5.2	6.0	17.6	3.8	3.3	10.7	11.9	3.7	11.2	5.9	4.5	3.4	6.2	17.9	4.8	8.2	12.2	5.2	18.0	6.4	1.2	9.9	3.8	8.9	2.6	4.7	1.4	3.9	5.2	2.4	3.4	5.1	3.1	2.9	3.2	8.7	7.2	6.1	1.6	7.4	4.1	5.1	3.1	11.5	10.6	9.0	15.8	10.4	9.0	6.8	12.8	9.8	7.0	8.9	17.3	10.5	1.9	2.1	33.6	8.2	7.6	5.3	6.8	5.2	100.1	4.4	1.7	5.7	2.0	17.9	11.8	0.0	11.4	7.4	4.1	5.1	8.1	6.7	11.2	30.2	28.2	18.4	21.9	1.6	6.6	7.6	1.7	10.8	20.9	10.0	9.0	11.4	3.2	2.9	66.4	0.0	4.4	4.2	3.8	1.6	2.9	10.2	6.0	2.5
LENG1		ENSG00000105617	"Leukocyte receptor cluster member 1"	Q96BZ8	19	54155161-54159882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043541	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA043541: AB_10961190"	"unprognostic (8.75e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.73e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.22e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-2)"	9.6	8.0	8.2	8.0	11.1	6.1	7.3	10.1	9.5	7.5	10.8	11.5	10.8	7.6	13.4	8.7	6.1	11.9	9.6	12.7	8.2	7.9	7.6	7.2	8.9	6.3	11.2	7.6	10.3	9.7	7.3	8.5	7.3	10.3	9.3	10.7	6.6	21.6	10.4	13.1	9.9	14.8	7.5	10.8	21.8	8.8	12.3	13.1	10.1	10.8	7.6	6.8	8.2	15.8	3.8	3.2	4.1	3.3	2.8	3.8	0.8	0.1	0.4	5.7	0.2	0.6	0.2	0.4	0.8	0.1	0.6	0.3	0.2	0.0	0.0	0.2	0.0	0.5	8.3	0.3	0.2	0.2	5.1	1.3	0.0	0.5	0.1	0.0	0.0	0.5	3.9	0.7	0.2	0.5	0.2	0.1	0.5	0.1	0.0	4.8	0.6	0.4	0.5	0.0	0.2	0.6	0.0	0.1	0.8	0.5	0.5	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.1	0.7	0.4	0.4	0.2	0.4	0.1	0.2	0.0	5.6	0.1	2.7	1.0	2.7	4.1	2.5	3.3	2.8	1.6	3.7	3.8	2.2	3.8	3.7	2.9	3.7	2.8	1.6	3.2	2.7	0.8	8.2	11.1	10.1	9.5	8.2	7.9	11.2	7.6	10.3	13.1	17.9	9.1	29.1	20.5	18.3	10.2	6.4	15.3	18.7	6.8	17.4	0.0	24.4	19.9	18.7	76.0	20.3	33.5	0.0	24.7	12.4	18.9	14.1	54.2	15.5	26.7	6.4	25.9	25.8	16.2	6.4	20.8	26.0	20.3	26.2	20.4	14.5	21.8	17.8	14.2	21.2	13.9	38.8	26.8	23.1	29.4	18.7	35.8	35.5	16.6	14.7
C3orf62	FLJ43654	ENSG00000188315	"Chromosome 3 open reading frame 62"	Q6ZUJ4	3	49268602-49277909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 25.0;testis: 76.9"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043328			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043328: AB_10795613"	"prognostic favorable (3.93e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.20e-4)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (7.23e-2)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.29e-5)"	"unprognostic (2.46e-1)"	"unprognostic (4.79e-1)"	"prognostic favorable (1.62e-5)"	4.2	5.5	3.2	4.4	4.0	7.4	2.7	6.6	4.8	3.8	3.6	2.8	4.4	3.1	3.5	4.9	3.7	4.1	5.0	3.5	3.7	4.3	2.7	2.8	3.9	4.5	3.3	4.0	8.0	4.7	2.4	4.5	2.6	3.6	4.1	2.3	5.7	4.4	2.2	3.7	3.5	2.7	3.6	3.6	7.0	2.6	76.9	3.3	2.2	3.7	2.2	3.3	4.8	7.5	1.2	1.6	25.0	3.2	0.6	1.0	0.7	4.8	2.9	6.9	8.7	5.7	5.2	3.9	2.9	4.9	2.6	3.9	4.1	3.7	9.6	4.6	4.4	5.4	3.8	3.5	3.2	3.0	8.5	4.0	6.3	6.1	4.6	2.0	8.9	11.9	4.0	9.5	3.8	7.1	4.5	3.1	5.6	7.1	7.3	2.2	3.0	6.6	6.4	4.9	3.8	4.2	5.0	3.6	5.0	4.3	11.2	5.3	7.2	8.0	6.1	10.4	5.4	3.1	9.9	3.5	3.6	8.8	6.1	5.3	6.7	10.9	8.3	2.7	8.6	4.9	1.5	3.2	3.4	0.8	1.2	0.9	1.2	0.9	0.8	0.7	0.9	0.9	0.8	25.0	0.6	1.4	1.6	1.0	0.7	3.2	4.0	6.6	4.8	3.7	4.3	3.3	4.0	3.6	3.3	8.9	17.3	3.0	3.1	6.1	11.5	7.8	7.6	9.4	11.4	10.4	21.6	5.2	0.0	4.1	9.1	5.8	4.3	0.0	3.4	3.6	5.3	5.4	2.3	5.7	9.0	4.8	5.2	8.0	17.3	12.8	8.1	9.2	8.5	9.0	8.6	6.5	4.3	3.5	8.1	4.9	13.5	0.0	3.8	64.4	6.5	7.5	3.4	6.4	6.3	2.0
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007529, CAB015343"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB015343: AB_2195009, HPA007529: AB_2667853"	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favorable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favorable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	11.6	12.6	17.1	7.7	14.7	13.9	16.7	12.2	24.9	8.4	10.4	13.9	11.4	7.9	10.9	11.3	12.9	10.0	9.6	12.6	15.2	13.0	10.3	9.0	10.9	7.0	12.6	15.6	9.8	14.8	11.0	9.7	6.5	12.4	9.6	8.8	10.6	11.9	9.3	16.9	13.4	7.5	15.0	13.2	7.3	9.2	13.8	9.0	13.4	13.8	6.1	6.0	12.1	7.3	9.7	15.5	5.2	12.6	13.9	13.5	8.7	7.3	13.5	24.4	9.1	13.3	14.1	11.9	15.7	9.8	10.4	10.8	12.4	9.3	13.9	2.1	16.2	7.7	15.6	6.7	5.8	13.3	16.1	13.1	7.2	9.9	4.7	13.4	2.0	4.0	11.9	5.9	23.2	11.2	12.1	15.2	14.8	7.4	10.2	23.1	4.3	14.2	2.7	5.1	7.0	10.1	23.5	27.7	6.4	12.0	3.4	4.8	12.3	13.6	1.7	7.1	8.3	10.7	5.0	11.9	11.2	7.9	12.7	9.3	9.0	12.2	2.5	20.0	6.7	15.2	2.4	8.2	5.2	9.5	8.7	9.9	9.7	12.3	10.1	15.5	8.9	10.4	13.5	1.0	13.9	12.6	10.4	8.9	8.7	17.1	14.7	12.2	24.9	15.2	13.0	12.6	15.6	12.4	9.0	3.0	3.0	1.4	3.9	2.6	7.6	3.6	0.0	5.3	3.4	1.8	0.0	4.2	11.6	8.3	1.1	3.2	2.2	0.0	6.0	3.1	4.6	2.4	0.0	2.6	8.0	15.9	1.7	8.0	3.2	1.0	3.7	3.6	5.0	13.6	2.8	10.8	5.8	0.0	4.9	4.9	5.3	0.0	3.8	14.0	4.7	2.0	2.9	2.5	3.1	2.0
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922028-48958386	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/70: 187.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	23.5	27.5	32.4	26.8	40.9	38.4	21.9	35.0	52.4	21.3	22.9	28.2	23.4	30.5	25.5	26.8	20.5	25.1	20.9	16.6	29.8	31.3	22.6	24.5	25.2	30.8	25.4	29.8	30.0	25.4	29.6	26.8	23.1	29.4	24.0	17.8	20.4	26.9	27.4	24.4	24.5	29.1	27.1	21.4	34.5	22.3	12.7	24.0	34.8	24.5	14.4	27.2	22.1	22.7	7.8	6.3	8.6	5.1	18.6	7.5	3.5	6.2	9.5	4.4	11.0	7.5	6.8	5.2	5.5	6.5	7.0	7.6	4.7	7.0	7.0	3.6	6.9	6.1	7.7	6.7	5.6	6.5	8.2	8.1	5.3	9.6	5.4	6.4	5.0	5.9	7.5	5.2	7.2	4.9	7.7	5.5	5.8	6.7	11.1	4.9	6.3	7.9	10.9	8.0	2.3	7.5	6.3	6.5	9.1	4.9	5.6	4.3	7.6	7.3	4.7	7.3	10.8	6.3	4.6	7.8	4.6	5.8	12.0	4.5	187.1	46.7	6.7	7.0	7.1	3.1	5.2	3.4	7.0	7.0	5.1	5.8	7.8	5.5	6.0	4.8	6.0	5.2	7.5	8.6	18.6	4.7	6.3	7.0	3.5	32.4	40.9	35.0	52.4	29.8	31.3	25.4	29.8	29.4	24.0	8.9	21.1	23.0	19.4	19.7	31.7	8.5	10.2	17.4	17.0	26.2	25.5	11.3	8.3	13.0	1.5	18.5	26.4	0.0	15.9	12.0	16.5	23.0	6.9	22.9	14.5	27.0	46.2	18.4	24.7	1.5	19.2	19.5	25.3	21.6	26.6	16.0	17.8	15.8	22.3	20.3	25.0	12.9	13.3	5.9	10.9	22.3	25.7	30.9	17.4	22.8
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Muller glia cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	3.3	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	10.8	2.3	0.0	0.1	0.0	0.9	1.2	0.0	0.0	2.7	0.2	27.5	2.7	1.7	0.0	5.2	0.2	8.3	0.2	0.6	0.2	0.0	4.0	0.0	0.4	5.5	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5	17.9	3.5	0.0	0.6	0.2	0.2	8.9	2.5	1.4	0.0	0.0	2.0	0.1	0.0	2.2	0.0	4.4	5.3	0.0	2.7	0.1	1.1	0.8	0.0	3.4	0.5	0.0	1.2	9.2	0.6	0.0	1.1	0.8	0.0	0.0	2.9	31.4	2.6	0.0	2.1	3.1	1.0	6.5	2.3	0.1	1.1	1.0	0.1	0.0	3.5	0.1
EFNB3	"EPLG8, LERK-8"	ENSG00000108947	"Ephrin B3"	Q15768	17	7705202-7711378	"Cancer-related genes, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 6.7;Early spermatids: 6.8;Intestinal endocrine cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.0;AN3-CA: 17.8;hTERT-RPE1: 18.3;SH-SY5Y: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001623	Approved					NA	NA					"HPA001623: AB_1848026"	"unprognostic (5.17e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.20e-2)"	1.7	2.8	10.6	1.1	26.5	0.4	4.3	1.1	34.6	4.8	1.0	4.0	0.0	0.8	12.3	1.0	2.2	6.7	1.8	1.1	10.9	19.0	1.4	2.3	1.5	0.7	3.0	11.8	3.2	1.8	1.1	3.0	1.8	4.3	2.7	1.1	1.4	1.7	1.0	0.8	6.9	1.0	4.7	1.3	0.5	1.3	2.1	2.1	0.0	1.2	0.1	1.4	2.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	30.0	17.8	0.5	0.4	0.2	0.3	3.9	2.6	1.7	1.1	1.8	0.0	0.6	1.1	0.2	0.2	7.6	3.7	1.5	0.0	3.7	0.1	0.0	0.0	0.8	0.0	0.0	1.7	0.7	0.8	0.6	18.3	0.2	0.3	0.0	0.0	0.5	2.8	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	4.1	0.4	1.9	15.7	0.0	0.0	0.6	5.5	1.6	0.0	0.0	1.8	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	26.5	1.1	26.3	10.9	19.0	3.0	11.8	4.3	2.1	0.0	0.0	0.0	4.1	3.7	0.4	1.6	0.0	6.7	1.2	0.0	0.0	0.2	0.0	0.8	6.8	0.1	0.0	0.0	0.2	0.8	2.7	1.3	1.1	0.0	0.4	4.8	6.4	3.7	0.0	4.2	4.4	0.0	0.0	0.0	0.0	1.3	0.3	0.0	3.2	0.0	0.6	0.0	0.8	0.2	0.2	2.5	0.2	0.0	0.0	0.6
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	6.9	6.9	8.1	10.3	8.0	13.3	6.8	11.8	10.7	7.4	7.2	10.6	6.8	6.8	8.4	8.4	7.9	25.6	7.7	6.8	7.5	6.6	9.4	6.6	8.7	12.7	7.9	5.8	7.8	12.0	6.1	7.6	8.1	7.8	5.3	7.3	7.8	6.6	6.6	9.8	8.1	7.7	7.8	5.4	12.5	7.2	11.4	8.3	22.8	7.6	6.6	12.8	7.5	6.2	4.7	6.6	20.0	5.8	4.2	8.5	3.5	11.2	21.1	15.2	15.2	4.6	4.3	8.9	7.3	7.8	24.0	22.4	12.2	7.0	13.5	7.7	6.5	10.6	12.5	17.4	12.9	18.5	8.1	22.6	6.2	14.0	10.2	4.1	4.8	8.1	3.4	5.0	21.1	4.8	3.6	15.5	16.2	5.9	4.4	9.5	10.2	13.8	11.6	8.1	8.9	10.6	18.3	10.0	7.9	8.8	4.0	7.0	10.6	11.5	6.2	6.1	7.9	8.4	5.1	5.4	9.5	10.1	0.0	18.8	3.5	8.9	7.1	8.6	8.2	11.6	20.0	5.2	4.6	5.4	5.8	6.3	3.3	4.2	6.0	4.7	4.7	3.8	4.4	2.7	4.2	2.3	6.6	8.5	3.5	8.1	8.0	11.8	10.7	7.5	6.6	7.9	5.8	7.8	8.3	3.0	4.3	9.3	4.9	3.4	4.6	2.3	2.5	32.1	3.4	10.4	5.9	9.2	3.3	8.2	2.6	4.0	3.4	0.0	8.8	14.2	3.8	1.7	1.1	4.9	6.8	1.6	2.9	3.1	7.0	1.3	2.3	4.4	3.3	9.0	5.2	6.3	5.5	3.5	2.1	5.6	6.2	0.0	4.7	13.3	6.7	4.0	3.4	5.3	6.3	3.1
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"		No	No			"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.37e-5)"	10.5	26.2	23.2	10.2	24.9	8.9	18.6	37.6	20.8	9.6	12.0	18.0	14.9	12.0	12.4	23.9	9.4	14.7	15.0	13.9	19.9	19.1	13.8	15.6	11.1	16.0	26.8	22.3	18.7	7.8	12.2	38.7	11.5	21.3	19.6	13.1	12.2	9.7	14.8	7.6	10.9	12.0	11.0	21.5	15.5	14.0	14.5	28.6	15.9	21.5	5.5	13.5	14.4	11.3	19.4	13.3	24.6	10.6	16.9	19.7	9.4	9.3	10.4	11.7	8.6	11.1	17.8	5.3	9.7	21.9	11.0	20.1	7.2	11.6	3.3	12.4	12.4	15.2	5.2	5.1	9.6	13.3	5.3	12.2	13.2	12.7	5.4	9.7	8.5	9.0	20.1	12.8	13.3	26.9	21.3	14.2	10.0	2.7	3.3	20.9	3.1	9.2	3.6	5.7	5.4	7.7	5.6	9.3	6.5	10.7	25.9	8.4	13.4	19.6	7.2	4.5	12.0	11.7	12.4	11.1	10.1	12.5	5.5	11.5	16.3	14.8	9.6	9.2	5.9	10.7	24.6	10.5	6.6	16.2	10.6	18.2	13.8	16.4	15.9	12.4	19.4	19.7	17.2	7.9	16.9	9.0	13.3	17.7	9.4	23.2	24.9	37.6	20.8	19.9	19.1	26.8	22.3	21.3	28.6	14.9	14.4	12.9	14.5	3.5	41.4	25.8	20.4	24.1	10.3	10.4	25.5	11.6	29.9	20.2	11.2	13.5	15.4	0.0	24.4	5.9	15.4	23.8	10.5	21.5	15.3	20.6	11.6	16.0	20.5	5.1	17.8	15.0	20.3	19.8	17.5	25.6	19.2	20.1	20.8	33.8	29.7	6.5	11.3	14.3	18.3	5.1	10.8	27.3	11.3	16.5
MRPL57	MRP63	ENSG00000173141	"Mitochondrial ribosomal protein L57"	Q9BQC6	13	21176645-21179084	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039779, HPA059370"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039779: AB_10673362, HPA059370: AB_2683993"	"unprognostic (1.00e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.68e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.78e-2)"	14.0	28.8	23.2	13.8	21.4	16.2	16.5	16.1	22.6	14.6	15.3	12.6	12.9	18.4	13.4	21.0	16.1	17.3	18.7	29.3	20.5	24.7	24.8	40.9	15.0	16.5	21.3	17.9	19.6	30.2	12.3	26.8	12.5	17.1	21.6	12.3	15.1	23.2	18.8	48.0	15.3	17.5	16.4	17.8	16.6	18.1	20.2	13.0	26.4	25.1	24.7	13.8	13.4	12.8	26.1	43.9	23.0	31.5	21.8	32.8	28.8	7.9	14.6	10.3	9.3	7.9	6.5	10.8	9.6	6.0	9.2	6.9	19.1	14.8	4.6	11.3	6.0	7.2	13.8	9.0	9.2	6.9	12.1	15.0	21.0	10.4	21.3	11.7	11.5	10.5	6.6	10.2	7.3	6.9	5.6	8.7	19.0	9.1	6.1	6.4	27.9	25.0	30.4	7.5	26.0	17.1	15.2	15.5	8.1	11.2	9.8	20.6	9.6	7.8	9.8	14.1	7.2	9.9	10.8	6.0	4.8	8.9	10.1	8.5	8.5	6.8	8.2	4.2	13.6	11.9	17.8	31.5	23.0	22.8	24.4	25.8	26.1	29.0	24.3	27.5	25.8	32.8	26.1	4.8	21.8	20.1	43.9	28.8	28.8	23.2	21.4	16.1	22.2	20.5	24.7	21.3	17.9	17.1	13.0	74.5	108.6	101.9	96.1	0.0	88.1	472.9	142.7	148.5	103.5	167.5	43.2	199.3	431.0	129.5	227.3	87.5	174.6	233.6	212.5	168.5	71.9	127.0	69.4	399.2	201.5	73.1	143.6	104.3	112.5	263.9	106.7	94.5	0.0	186.7	167.4	115.5	147.0	171.7	93.0	484.9	81.9	51.8	53.6	92.6	52.4	0.0	186.6	94.7	179.9	93.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884806-7912760	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Approved	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Nucleoplasm, Nucleoli, Centriolar satellite"		"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	10.4	12.9	31.7	24.3	26.0	18.7	12.5	12.1	28.3	41.1	21.1	4.1	22.5	8.2	46.3	16.1	15.1	25.0	20.0	8.7	30.4	14.2	15.2	2.3	13.1	19.0	8.4	28.4	27.3	15.1	28.5	21.0	8.0	10.7	32.9	11.1	20.7	19.4	23.0	3.3	16.2	14.0	23.3	6.9	14.6	15.8	11.3	5.1	40.6	19.7	7.5	17.7	20.6	28.9	1.6	4.0	4.1	3.5	2.7	7.8	3.6	12.2	30.5	17.9	23.7	21.8	18.3	9.6	14.3	19.2	12.1	13.0	5.9	10.3	34.5	10.9	21.0	9.8	16.6	33.6	15.1	15.3	17.5	19.6	16.7	39.6	0.7	11.7	4.8	32.9	24.1	8.1	16.3	10.9	32.3	22.5	15.8	11.1	0.6	11.3	12.1	13.1	5.5	2.8	12.9	11.3	38.6	21.8	5.2	12.1	29.8	12.2	16.5	35.5	13.8	6.9	5.1	15.9	7.8	28.1	26.3	20.7	6.4	20.5	2.6	0.4	19.5	13.4	13.5	22.4	0.6	2.7	4.1	7.0	1.7	5.5	1.5	6.7	6.6	2.1	1.6	7.8	5.1	2.1	2.7	3.5	4.0	3.6	3.6	31.7	26.0	12.1	28.3	30.4	14.2	8.4	28.4	10.7	5.1	29.8	57.4	11.5	44.3	32.4	61.2	9.7	17.8	24.1	37.5	76.8	7.9	15.1	14.9	21.3	8.9	17.5	12.0	0.0	20.6	16.7	30.0	67.6	38.2	2.1	8.4	42.9	54.5	18.4	21.1	13.0	41.1	14.7	8.5	54.1	12.6	11.3	23.7	7.0	53.7	7.5	15.6	25.8	27.2	12.9	50.5	17.9	13.7	34.6	25.9	53.1
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 396.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.2	29.3	21.0	19.3	57.3	22.4	42.5	18.5	36.9	34.5	24.6	39.0	29.1	15.1	32.0	39.9	18.0	23.7	26.2	20.7	20.1	18.3	24.5	14.5	30.9	34.3	28.5	27.3	22.3	26.0	31.5	28.4	32.0	49.5	27.9	21.2	23.2	39.1	23.7	26.7	16.7	32.3	21.5	33.0	41.8	19.7	17.2	32.0	26.8	12.5	22.6	13.3	27.2	27.2	27.2	28.3	25.7	60.1	15.0	15.1	11.5	16.4	22.1	19.2	25.5	11.4	28.0	26.7	24.1	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4	44.7	80.8	67.3	61.3	48.7	74.0	8.5	150.3	68.3	56.9	96.0	60.9	216.3	44.7	170.3	31.1	66.5	86.5	23.3	146.9	396.1	82.6	106.0	90.0	177.6	129.7	55.6	136.3	84.7	56.3	11.1	96.1	63.5	116.4	114.6	123.9	72.9	148.7	108.7	94.0	116.9	81.3	25.8	72.2	66.7	41.7	47.0	197.7	84.1	139.6	60.7
FIZ1	"FLJ14768, ZNF798"	ENSG00000179943	"FLT3 interacting zinc finger 1"	Q96SL8	19	55591371-55601970	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074026			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074026: AB_2686653"	"unprognostic (1.97e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.43e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.51e-3)"	"unprognostic (8.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (7.02e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (2.02e-4)"	10.9	8.6	13.9	9.3	16.6	5.8	12.4	17.0	17.8	10.2	10.9	13.6	10.4	10.4	14.5	13.0	8.0	10.9	11.1	10.0	13.7	11.2	11.5	8.1	9.7	8.0	14.2	9.1	12.1	15.4	21.1	13.9	8.6	9.2	11.7	8.7	14.7	14.3	15.5	18.2	10.6	10.7	16.0	12.3	10.5	13.7	9.4	10.8	9.5	14.4	8.6	9.4	9.4	17.6	2.5	3.4	1.9	3.0	2.1	2.6	0.9	7.2	15.5	10.7	7.6	6.2	4.3	12.2	6.1	4.2	7.0	5.3	8.6	8.2	12.7	5.7	3.8	3.8	7.3	7.4	7.7	6.9	10.0	19.4	9.8	10.5	7.5	6.3	8.3	9.3	5.0	12.6	6.0	7.2	6.7	3.5	8.0	12.0	5.9	5.1	6.4	14.7	6.2	11.7	8.8	11.1	15.4	10.0	6.9	7.0	13.4	14.3	16.3	9.6	7.0	6.4	6.6	7.2	9.9	5.5	6.6	10.8	2.4	7.4	15.5	22.8	8.3	9.4	7.9	7.2	0.1	1.7	0.2	1.0	3.0	1.0	2.5	2.6	1.5	1.2	1.5	1.3	1.9	1.9	2.1	1.1	3.4	1.0	0.9	13.9	16.6	17.0	17.8	13.7	11.2	14.2	9.1	9.2	10.8	8.9	0.6	1.4	3.0	3.0	13.9	4.8	10.2	8.1	3.4	5.2	3.9	3.4	0.0	3.4	0.5	3.2	4.8	0.0	3.4	3.0	2.8	3.1	0.0	5.1	4.0	12.7	9.7	3.7	3.0	0.6	2.8	3.4	0.0	1.8	4.2	8.8	4.7	3.5	3.2	4.1	13.7	0.0	2.3	2.6	2.2	1.9	2.9	2.2	5.1	2.7
KATNB1		ENSG00000140854	"Katanin regulatory subunit B1"	Q9BVA0	16	57735730-57757250	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041165, HPA041839"	Enhanced		Supported	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Microtubules	"HPA041165: AB_10795584, HPA041839: AB_10795598"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (2.89e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.54e-1)"	6.9	9.1	15.3	9.3	21.4	18.7	6.3	13.2	29.0	7.0	7.4	8.8	6.7	9.4	6.6	5.8	11.0	18.7	5.9	8.5	16.0	14.5	5.8	10.3	8.0	8.8	9.3	14.1	7.0	9.4	9.5	8.0	7.9	10.6	6.3	5.2	6.2	11.9	8.0	7.1	21.4	8.5	6.0	6.9	8.0	9.1	32.7	8.1	10.8	7.2	10.3	8.6	7.4	6.4	5.8	9.8	24.6	11.6	8.4	12.4	10.5	7.4	13.7	7.5	9.7	4.2	3.7	13.3	5.3	7.0	13.9	7.7	11.4	6.7	6.1	10.6	3.4	5.1	10.1	10.1	10.6	6.3	4.1	28.7	8.0	7.6	15.6	4.4	17.3	29.9	3.8	6.5	10.9	6.4	5.8	8.2	22.3	15.6	3.0	5.5	8.0	25.0	22.5	13.2	5.4	23.8	20.1	9.4	22.0	4.2	3.7	38.1	11.4	8.6	10.4	6.2	3.1	3.9	8.9	5.8	9.8	8.6	8.5	11.4	7.0	5.5	7.4	13.6	13.4	6.0	24.1	10.1	24.6	12.4	11.2	12.4	5.6	10.5	9.9	9.8	5.8	10.1	10.0	15.5	8.4	11.6	7.4	10.9	10.5	15.3	21.4	13.2	29.0	16.0	14.5	9.3	14.1	10.6	8.1	3.0	5.6	3.7	6.3	8.0	8.0	1.7	5.1	14.7	4.5	5.2	5.9	14.7	10.0	10.8	86.6	5.3	9.2	0.0	11.9	10.0	8.5	6.7	4.7	3.8	8.6	17.5	4.6	5.5	5.3	24.3	7.2	5.3	6.8	6.4	8.3	8.7	7.8	3.5	4.6	5.9	9.4	6.5	5.0	25.9	8.3	12.0	6.4	11.7	11.9	8.2
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178222-38230671	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	18.3	15.6	28.9	15.3	26.5	23.4	20.3	16.1	37.7	23.2	14.6	22.5	11.8	12.7	23.3	19.8	9.6	19.4	15.5	18.2	27.9	36.7	23.8	11.8	22.4	15.8	34.6	19.4	17.8	11.1	9.5	19.7	33.7	29.8	29.3	16.7	16.4	10.0	16.1	10.6	4.5	13.7	22.9	33.1	17.6	11.8	21.7	15.3	13.4	23.2	5.9	10.2	17.3	16.0	14.4	21.0	27.0	23.4	34.2	27.8	20.8	11.5	12.4	27.5	17.8	19.0	19.0	9.6	19.0	19.7	18.8	24.8	9.8	18.4	9.1	19.2	17.3	57.6	12.6	15.1	14.4	28.6	8.2	13.1	18.5	6.9	13.4	16.8	20.3	21.7	17.8	7.1	19.9	15.9	21.6	34.1	25.2	21.0	16.0	28.8	7.1	11.4	32.7	19.4	9.7	9.9	14.1	25.6	4.2	26.3	10.9	11.1	25.9	6.5	17.3	17.9	39.7	12.1	26.9	23.2	12.9	18.5	20.1	26.7	17.1	17.2	3.4	26.2	36.2	41.9	14.4	23.4	27.0	27.8	20.0	12.7	14.4	11.7	20.5	21.0	14.1	9.9	19.4	26.3	34.2	21.5	14.9	11.6	20.8	28.9	26.5	16.1	37.7	27.9	36.7	34.6	19.4	29.8	15.3	17.9	38.9	35.0	46.4	18.4	8.0	15.9	12.7	17.4	15.9	29.6	11.8	43.7	26.6	28.6	97.7	36.8	10.2	0.0	30.1	76.6	25.5	61.8	23.1	10.5	57.9	4.8	20.6	48.5	50.4	71.1	17.0	44.7	25.3	13.6	20.3	25.1	30.1	22.9	24.4	41.1	11.2	12.9	41.8	40.2	33.6	14.2	35.4	46.8	21.1	42.2
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.8"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 51.6;Horizontal cells: 46.1;Ito cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;HHSteC: 6.5;SCLC-21H: 14.1;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006136	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	9.8	11.3	18.5	2.7	15.1	1.0	6.8	5.0	17.6	7.9	6.3	10.2	3.7	8.9	11.7	5.9	2.6	8.1	14.6	7.9	15.7	15.2	3.8	20.6	6.5	2.8	15.2	11.3	5.1	44.8	7.8	18.6	10.7	15.6	13.7	1.4	9.9	19.5	8.2	3.4	8.5	6.2	4.7	9.6	11.5	10.5	6.0	15.0	0.0	9.7	0.7	1.3	3.8	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.5	2.8	0.3	0.0	0.0	0.5	0.0	5.6	0.0	1.4	0.4	1.3	0.0	0.0	1.2	1.8	0.0	0.0	3.0	6.5	0.0	2.1	0.3	0.0	0.0	0.0	2.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	14.1	12.7	0.0	0.0	0.0	2.7	0.3	2.1	0.0	0.6	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.5	15.1	5.0	17.6	15.7	15.2	15.2	11.3	15.6	15.0	6.0	12.0	0.0	1.8	1.6	4.3	7.7	20.4	0.0	0.0	0.0	2.0	0.1	0.0	20.6	1.9	11.9	0.0	0.0	32.6	0.1	4.3	12.6	0.0	51.6	0.8	46.1	8.1	57.7	6.5	6.0	8.3	0.5	8.5	1.8	3.4	28.9	30.9	0.0	10.6	0.3	2.7	0.0	5.0	15.4	8.2	2.8	0.0	1.7	0.1	3.3
SDSL	"cSDH, SDS-RS1"	ENSG00000139410	"Serine dehydratase like"	Q96GA7	12	113422237-113438276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.2"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 13.2;monocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.6;MCF7: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005740	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA005740: AB_10601486"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (8.58e-4)"	"unprognostic (2.93e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.33e-2)"	3.1	15.3	4.2	3.8	5.1	1.4	2.8	1.5	7.1	2.6	7.1	5.5	6.2	10.0	2.5	9.7	1.3	4.6	5.2	7.2	3.6	6.1	15.5	53.2	2.8	2.8	9.5	4.2	4.6	15.3	5.0	7.6	3.1	7.8	4.2	5.0	4.6	4.9	4.5	2.1	0.7	7.8	2.9	8.8	3.0	5.2	7.0	2.6	1.5	20.3	1.3	1.6	4.0	1.5	1.1	13.2	0.3	7.1	1.3	0.2	1.7	3.6	14.2	2.0	6.0	0.4	0.9	1.4	2.1	0.5	2.2	1.9	6.1	3.8	0.2	10.7	3.4	6.2	3.7	0.9	4.8	0.8	8.6	3.6	9.1	3.4	2.6	12.0	1.1	22.6	1.9	6.8	5.5	8.2	2.6	3.3	0.0	7.1	2.8	2.7	38.7	0.0	4.5	2.1	3.9	6.1	0.0	3.0	6.8	5.9	4.4	0.6	0.2	8.8	10.0	8.5	1.9	12.3	10.4	3.0	2.7	5.3	12.1	1.8	0.6	0.5	0.1	11.6	3.7	3.3	0.1	6.5	0.0	0.0	7.1	0.0	1.1	0.0	0.0	13.2	0.1	0.0	0.0	0.3	1.3	0.9	12.8	0.2	1.7	4.2	5.1	1.5	7.1	3.6	6.1	9.5	4.2	7.8	2.6	0.0	6.1	8.6	2.1	0.8	0.2	15.7	25.5	0.0	0.0	27.9	2.0	11.4	66.3	30.4	0.4	2.9	43.5	23.3	17.7	2.6	3.8	6.0	43.8	118.4	93.1	3.2	30.5	4.9	12.3	1.1	2.6	14.9	3.3	174.9	28.9	19.5	17.4	40.3	5.3	76.8	1.5	0.0	5.7	0.0	0.2	0.5	6.1	4.3	25.5	4.3
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276872	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;testis: 45.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 41.1;Muller glia cells: 64.8;Peritubular cells: 33.6"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 7.5;SH-SY5Y: 23.4"									"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	2.0	11.2	21.9	2.1	31.8	1.3	3.3	32.7	56.4	4.7	2.2	6.6	0.0	1.9	6.0	7.8	1.5	1.6	2.0	2.0	22.3	23.1	1.5	1.3	1.5	1.3	13.0	24.0	5.0	2.1	1.3	23.1	1.3	19.8	3.7	2.0	1.4	2.3	5.4	1.4	1.3	2.4	4.3	11.0	1.3	1.5	45.9	8.4	0.0	3.4	0.0	1.3	2.1	1.1	0.7	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	21.9	31.8	32.7	31.9	22.3	23.1	13.0	24.0	19.8	8.4	0.0	0.0	0.0	0.3	0.1	41.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.4	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.2	1.6	0.0	0.0	0.0	11.5	7.8	0.6	0.0	0.0	0.0	64.8	0.0	0.0	33.6	0.0	5.6	0.0	0.9	2.8	1.7	0.3	0.3	0.0	0.0	0.1
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.7;salivary gland: 26.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 54.2;Late spermatids: 207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7"	"Not detected"	"Not detected"							HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.4	3.7	5.0	2.3	5.1	4.2	3.0	7.7	8.7	3.9	1.4	0.2	5.9	2.1	1.9	5.9	1.3	1.8	3.3	15.3	3.8	4.3	2.2	8.8	2.9	1.0	1.6	4.2	6.4	7.7	6.2	25.7	1.5	1.7	4.5	0.9	2.1	26.0	6.4	0.6	3.3	1.6	1.2	2.2	2.1	4.6	4.7	0.6	0.1	1.9	0.6	2.7	3.3	1.9	0.0	0.0	6.7	0.2	0.0	0.9	0.1	0.7	0.8	1.0	0.3	2.2	1.7	1.5	3.9	0.5	0.2	0.6	0.7	0.7	0.4	0.6	5.5	0.0	1.4	0.1	0.5	0.3	0.1	0.8	2.1	0.6	0.8	3.1	0.0	7.3	1.8	6.7	0.1	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.7	0.1	0.6	0.3	1.9	0.8	0.3	0.2	2.9	0.3	0.3	0.1	0.5	0.6	2.3	0.3	0.5	0.7	1.1	0.5	0.3	0.7	0.6	0.5	0.6	0.6	0.1	0.5	0.1	0.3	0.0	0.2	0.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.7	0.0	0.1	0.0	0.0	0.1	5.0	5.1	7.7	8.7	3.8	4.3	1.6	4.2	1.7	0.6	0.0	2.2	0.9	2.5	1.5	0.5	12.3	0.0	0.0	1.2	0.0	0.0	0.3	1.7	0.3	54.2	0.7	0.0	0.0	1.1	1.6	2.2	2.2	11.5	3.4	0.9	4.8	0.0	0.6	1.5	207.3	1.4	4.3	1.7	0.0	1.6	0.0	0.8	0.0	1.1	1.6	0.6	0.0	3.1	1.0	1.1	1.1	4.3	0.7	0.2	0.9
KDM2B	"CXXC2, Fbl10, FBXL10, JHDM1B, PCCX2"	ENSG00000089094	"Lysine demethylase 2B"	Q8NHM5	12	121429097-121581015	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071257			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071257: "	"unprognostic (7.67e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.74e-6)"	"unprognostic (1.16e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (8.64e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.82e-2)"	6.2	6.3	13.9	20.1	15.7	14.9	7.0	31.1	25.1	9.2	7.6	12.3	5.2	8.2	9.9	7.3	14.4	10.8	7.9	5.8	11.8	7.2	6.6	10.2	9.5	21.3	14.3	15.1	14.1	8.2	13.0	8.2	7.2	12.2	6.6	7.7	8.1	9.1	6.8	11.7	18.9	13.1	8.1	13.2	16.3	7.4	9.8	14.5	27.0	8.2	5.5	20.9	11.1	11.6	11.5	5.0	4.2	3.6	2.6	8.3	4.0	6.7	8.6	17.0	5.2	4.7	4.9	17.4	6.7	9.1	9.8	8.3	11.7	3.8	33.1	9.9	6.1	5.2	5.9	18.1	6.6	7.4	13.7	11.7	19.1	7.8	10.4	5.2	22.3	14.8	3.9	4.0	8.8	6.7	9.8	7.0	16.6	14.4	4.7	5.0	10.0	24.2	26.8	27.3	5.4	7.0	27.9	8.6	16.3	5.4	13.1	18.6	11.0	11.5	6.8	6.8	14.8	12.8	24.5	8.8	10.2	7.6	9.7	6.5	11.0	9.7	32.3	9.3	17.5	6.3	4.2	3.6	2.8	8.3	3.2	6.3	11.5	6.6	4.8	5.0	10.6	5.9	7.5	0.5	2.6	1.9	4.8	5.5	4.0	13.9	15.7	31.1	25.1	11.8	7.2	14.3	15.1	12.2	14.5	0.0	11.7	22.7	5.0	15.0	19.7	13.0	15.3	2.7	4.5	10.4	11.8	5.7	10.0	6.6	41.3	7.3	4.7	0.0	5.0	9.1	9.4	5.4	13.9	12.2	21.8	14.3	5.2	8.0	16.4	37.2	7.2	21.0	15.1	64.1	4.7	3.9	5.1	5.9	6.7	3.3	13.8	19.4	9.9	5.1	13.9	13.2	5.5	17.8	6.6	5.4
PAF1	"F23149_1, FLJ11123, PD2"	ENSG00000006712	"PAF1 homolog, Paf1/RNA polymerase II complex component"	Q8N7H5	19	39385852-39391195	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041875, HPA043637"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041875: AB_2677720, HPA043637: AB_2678592"	"unprognostic (5.33e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (6.65e-2)"	"unprognostic (4.21e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.73e-1)"	28.9	33.2	30.7	30.6	32.9	33.7	34.1	35.1	40.0	28.5	25.4	39.5	25.8	23.5	27.3	31.0	30.0	30.1	27.1	32.6	31.1	28.3	27.9	47.9	23.7	27.6	32.7	29.9	42.2	26.0	45.0	35.1	27.1	34.9	32.7	22.0	22.7	27.1	41.0	50.9	22.4	24.4	26.3	36.2	32.7	26.5	59.1	28.5	31.5	32.1	25.4	31.7	28.1	24.7	31.5	16.5	24.5	21.1	21.8	25.1	15.4	35.8	46.6	30.7	16.3	19.8	16.8	12.5	29.9	28.3	35.6	34.5	38.1	19.4	28.8	21.1	24.7	21.1	12.6	33.1	25.1	29.3	32.3	38.8	28.3	29.4	24.9	21.4	24.0	27.0	16.9	17.3	29.5	19.3	22.5	26.0	25.4	21.9	23.9	29.2	40.7	27.2	15.9	10.8	30.0	15.7	27.7	30.2	20.1	26.6	41.0	26.0	17.5	32.3	21.4	16.2	16.0	20.4	20.6	24.3	21.5	28.3	22.1	32.9	26.0	23.4	24.7	21.3	21.1	19.7	21.1	15.0	24.5	24.0	21.1	25.1	31.5	20.1	23.8	16.5	29.3	23.0	20.7	24.1	21.8	18.7	15.7	19.4	15.4	30.7	32.9	35.1	40.0	31.1	28.3	32.7	29.9	34.9	28.5	20.8	44.0	34.7	55.8	47.6	13.9	30.2	10.2	87.0	37.5	21.0	7.9	33.0	11.6	21.6	22.6	17.9	21.4	0.0	23.8	24.7	29.8	29.1	49.7	23.6	21.5	7.9	25.3	12.9	13.1	25.1	32.5	25.7	21.9	25.2	18.0	21.4	21.3	14.1	26.2	19.5	14.2	12.9	34.0	84.6	24.5	43.0	53.5	23.5	16.1	30.6
R3HCC1	DKFZp564N123	ENSG00000104679	"R3H domain and coiled-coil containing 1"	Q9Y3T6	8	23270120-23296279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023073, HPA023153"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	No			Cytosol	Nucleoplasm	"HPA023073: AB_1855987, HPA023153: AB_2237834"	"unprognostic (5.80e-2)"	"unprognostic (4.70e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (7.46e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.02e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (8.66e-4)"	"unprognostic (7.65e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.43e-1)"	14.8	14.2	21.4	14.8	20.9	18.4	24.6	16.5	36.3	13.9	18.4	26.0	14.8	14.5	16.4	18.2	12.5	17.9	16.4	23.8	21.5	16.9	13.2	16.6	18.8	15.9	30.1	16.3	22.1	50.3	16.0	14.7	10.4	20.7	14.8	12.0	15.3	24.8	20.7	36.6	16.3	14.4	18.3	33.7	13.0	16.9	17.4	21.4	15.8	13.6	14.7	13.9	12.9	12.6	28.5	29.7	41.6	27.1	29.7	36.5	25.7	21.2	26.7	21.5	20.8	9.2	12.5	14.6	14.0	13.6	24.1	17.6	18.5	10.0	21.5	15.0	17.3	16.5	16.0	22.6	26.2	16.3	13.7	22.2	20.0	18.4	15.5	21.8	13.6	15.0	14.8	20.8	20.6	9.7	17.8	18.4	24.4	23.1	18.2	14.1	17.4	30.7	22.8	17.1	23.0	19.5	21.0	26.2	12.8	11.5	23.4	27.5	23.7	16.0	19.1	22.9	15.4	17.4	16.4	15.6	22.2	18.5	18.4	28.6	13.4	11.9	22.1	17.2	19.1	27.4	17.8	27.1	41.6	36.5	22.6	31.5	28.5	29.6	30.4	29.7	21.0	23.2	26.6	16.6	29.7	24.2	27.7	30.5	25.7	21.4	20.9	16.5	36.3	21.5	16.9	30.1	16.3	20.7	21.4	23.8	14.3	5.2	14.0	13.3	22.4	21.3	17.8	24.1	10.3	5.2	25.5	16.1	48.0	25.7	28.8	17.9	24.9	0.0	43.9	18.7	27.2	9.6	22.0	17.3	25.7	17.5	18.4	12.9	13.7	72.6	16.4	14.0	20.3	15.4	21.3	35.2	32.4	19.2	20.5	24.7	93.2	12.9	29.3	43.5	32.0	14.2	6.4	20.0	22.8	9.9
VPS18	"KIAA1475, PEP3"	ENSG00000104142	"VPS18, CORVET/HOPS core subunit"	Q9P253	15	40894430-40903975	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040701	Approved					NA	NA					"HPA040701: AB_10794145"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.69e-3)"	"unprognostic (2.12e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.61e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.06e-2)"	13.3	15.9	11.3	11.0	17.3	29.6	9.5	17.5	29.2	11.1	11.4	17.6	4.4	10.7	15.6	14.5	11.7	12.5	12.3	15.8	12.0	13.3	13.4	13.7	12.4	12.3	13.7	17.1	13.2	9.0	14.4	13.1	14.4	17.3	12.2	6.8	19.0	12.7	14.3	15.5	11.7	11.2	13.2	11.3	16.4	12.3	8.6	10.9	15.6	12.3	7.9	11.4	13.1	13.3	10.5	13.4	15.0	12.7	9.3	13.0	9.2	5.6	13.4	6.6	11.2	21.5	9.2	9.0	11.8	17.2	14.5	17.9	16.9	3.4	3.0	11.3	14.0	18.5	14.9	13.7	13.3	6.2	6.9	9.2	13.4	13.0	9.6	19.0	11.1	17.9	15.9	7.0	14.6	8.1	6.9	15.2	6.9	9.2	7.7	12.2	7.3	7.5	12.3	8.7	5.8	9.2	15.4	7.5	5.6	11.9	30.1	7.6	7.6	8.5	16.7	7.8	8.4	10.4	12.6	14.9	14.8	7.8	14.8	7.6	7.7	11.4	8.3	16.3	12.3	7.3	7.6	12.7	15.0	13.0	9.0	10.9	10.5	6.8	10.0	13.4	8.2	7.2	7.5	14.4	9.3	11.8	5.8	11.4	9.2	11.3	17.3	17.5	29.2	12.0	13.3	13.7	17.1	17.3	10.9	3.0	7.4	2.9	2.3	2.2	8.9	5.9	2.5	1.4	4.5	7.0	5.9	6.0	3.3	16.7	0.8	5.2	10.3	0.0	6.7	3.4	4.2	3.1	6.9	9.7	18.1	6.4	11.3	8.0	11.6	0.7	6.6	4.9	8.5	10.0	5.1	6.3	10.9	6.2	9.2	9.1	6.7	6.5	3.1	2.9	5.5	1.8	9.0	7.5	3.8	3.7
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	34.1	46.2	40.0	22.3	36.3	32.5	57.5	32.9	47.1	55.1	40.6	17.3	66.1	22.7	63.7	48.5	38.2	55.3	54.2	61.1	30.9	35.3	38.0	43.3	34.2	47.5	35.3	23.2	132.1	116.3	14.1	49.9	26.5	23.1	58.6	20.7	42.5	52.9	73.4	45.5	42.6	22.3	45.3	21.7	22.8	30.9	25.9	16.3	91.6	50.8	29.3	34.1	50.6	78.1	33.4	43.5	11.8	15.8	17.6	52.6	30.8	14.2	42.0	49.2	48.3	34.0	40.8	16.3	18.8	46.7	16.4	26.1	16.6	24.4	4.4	15.0	29.3	21.1	13.8	18.7	23.3	3.9	25.5	38.9	38.1	34.6	23.5	64.7	15.5	37.5	48.8	27.9	12.6	17.3	32.2	27.5	36.1	13.0	38.8	15.1	42.8	32.5	20.1	87.8	23.8	15.4	36.3	43.9	65.2	21.8	36.0	21.9	64.2	30.3	31.0	37.7	24.3	7.8	82.3	28.8	33.0	31.3	13.1	27.9	28.8	23.2	23.6	34.0	0.4	22.0	11.8	3.9	3.6	38.8	6.4	25.6	25.2	43.8	41.0	5.8	33.4	52.6	42.9	1.6	17.6	15.8	43.5	38.1	30.8	40.0	36.3	32.9	47.1	30.9	35.3	35.3	23.2	23.1	16.3	59.6	118.9	155.2	220.4	234.9	85.7	193.7	191.1	83.0	124.0	116.9	23.6	106.7	310.0	168.6	133.9	186.1	158.5	0.0	372.0	184.2	224.0	232.5	145.5	244.6	58.5	35.0	299.7	176.1	78.4	224.0	419.7	91.0	219.4	62.3	387.2	96.5	211.2	244.1	354.7	163.1	67.1	284.6	342.1	44.5	93.2	187.9	129.0	231.0	327.3	202.6
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 148.3"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA					"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	2.6	12.8	36.9	2.5	39.4	1.7	1.9	41.9	148.3	2.2	2.9	7.5	0.0	2.0	2.5	2.0	2.5	2.1	2.9	3.5	39.9	49.6	1.9	1.8	1.9	1.8	17.7	32.8	1.8	2.8	4.9	13.2	2.3	24.1	2.2	2.2	1.9	2.3	2.6	2.5	1.8	3.0	3.1	7.3	1.7	2.0	2.4	5.2	0.0	1.8	0.0	1.7	2.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.2	20.4	24.8	1.2	0.0	2.1	0.4	0.8	0.4	0.0	1.0	0.1	14.6	1.3	2.0	0.3	6.0	0.0	0.7	0.1	0.9	0.0	0.3	14.8	3.8	0.0	0.3	9.1	0.0	0.2	0.7	13.4	0.0	0.8	0.0	0.1	0.5	0.9	0.1	0.0	1.8	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	12.1	1.4	0.0	0.0	0.2	0.2	0.0	0.2	0.4	4.9	0.1	1.3	3.0	1.1	0.1	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	36.9	39.4	41.9	70.3	39.9	49.6	17.7	32.8	24.1	5.2	0.0	0.0	0.0	0.2	0.0	92.0	0.4	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	47.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	72.1	0.3	0.0	0.0	0.0	22.8	0.0	2.7	2.6	0.9	0.1	0.1	0.0	0.0	0.0
TPGS1	"C19orf20, GTRGEO22, PGs1"	ENSG00000141933	"Tubulin polyglutamylase complex subunit 1"	Q6ZTW0	19	507497-519654	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.2;SH-SY5Y: 21.5;U-266/70: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-1)"	"unprognostic (2.51e-3)"	"unprognostic (7.05e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (8.71e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.84e-3)"	22.2	10.2	12.1	7.4	11.5	9.4	7.8	6.3	19.8	8.8	13.8	11.8	12.7	18.7	11.0	10.3	8.2	7.1	11.5	6.0	14.2	8.7	18.3	11.4	9.7	6.0	11.6	10.1	8.9	11.8	5.9	9.0	7.2	8.2	10.4	3.3	8.4	10.7	7.9	23.5	8.4	13.0	6.5	8.9	16.6	19.9	7.5	10.0	11.5	11.8	7.0	6.8	7.3	7.3	5.8	1.3	6.0	1.3	1.6	5.9	0.6	7.9	1.0	0.3	1.6	0.1	0.4	4.6	5.1	0.9	0.8	0.6	0.4	1.7	6.9	4.3	0.4	0.1	5.0	0.0	0.1	0.0	9.5	21.2	1.9	1.2	0.6	0.6	3.3	7.0	0.8	0.6	0.0	0.0	0.3	0.5	1.2	7.6	1.9	0.3	1.6	5.7	9.1	4.1	0.1	8.7	5.4	2.5	7.0	0.2	0.3	6.7	21.5	2.3	0.6	9.7	0.0	1.4	1.9	4.9	2.9	5.1	7.0	4.1	20.9	6.0	3.0	4.1	3.1	2.6	0.3	1.3	6.0	1.5	0.7	0.9	3.7	1.8	3.3	1.3	5.8	1.7	0.7	1.5	1.6	1.3	1.1	5.9	0.6	12.1	11.5	6.3	18.7	14.2	8.7	11.6	10.1	8.2	10.0	32.8	39.3	25.4	27.2	24.0	30.4	4.0	40.8	20.1	28.4	38.4	23.6	27.2	64.6	3.3	6.1	28.6	81.8	0.0	7.6	10.7	35.1	23.3	32.3	33.4	45.9	27.0	53.4	34.4	47.9	3.1	26.7	36.6	30.4	1.8	34.1	45.2	4.5	31.6	29.4	102.9	29.2	32.3	47.6	7.2	3.8	31.0	40.4	37.4	26.2	28.9
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3"	"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	40.5	0.0	2.2	1.6	24.3	2.4	1.3	2.0	1.6	4.8	0.0	0.0	0.0	4.5	0.0	13.8	0.0	9.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.6	0.9	8.2	0.0	0.0	0.0	0.0	0.0	1.4	7.8	0.0	0.0	4.5	10.5	0.0	0.0	2.5	0.0	9.0	0.0	1.5	0.0	7.9	16.3	0.0	6.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2	101.3	59.1	0.0	14.0	179.6	0.5	2.4	0.0	10.7	30.7	7.0	0.0	23.0	23.2	0.1	3.9	0.5	0.5	0.0	0.0	17.1	12.8	15.9	1.1	0.0	2.8	0.0	0.0	0.0	0.0	8.9	0.0	1.3	18.6	0.0	1.5	0.2	0.5	1.9	0.0	0.5	2.4	0.0	16.9	0.7	3.8	114.7	12.7	0.0	1.9	9.2
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.2	2.7	0.8	20.9	0.0	0.0	1.0	0.0	0.2	0.5	0.2	0.4	1.9	15.8	1.6	0.5	12.2	1.4	10.8	3.3	0.8	13.4	8.3	32.6	0.8	5.9	0.8	4.5	0.6	0.6	3.3	0.1	1.1	0.0	0.5	9.4	0.3	2.0	0.0	3.6	9.5	0.1	6.0	0.9	2.9	2.9	0.4	0.4	1.7	3.9	4.9	5.9	2.0	0.6	11.0	6.2	4.5	1.9	0.0	0.0	1.5	1.7	0.5	38.6	4.5	6.8	0.3	14.5	2.0	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0	0.0	1.1	24.2	0.8	2.3	3.8	5.6	0.0	2.7	0.0	5.2	3.9	0.1	11.6	2.0	2.0	0.4	0.8	0.0	7.4	0.2	1.1	2.5	0.0	12.5	7.1	0.0	3.4	0.6	17.8	3.3	2.6	25.0	1.7	64.9	0.3	4.8	3.0	0.0	30.8	50.8	1.4	0.0	0.0	0.5	0.7	2.6	0.1	1.5	0.2	1.0
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 38.1;Late spermatids: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	5.6	8.0	4.1	7.0	12.1	4.5	8.3	10.5	11.3	4.9	6.0	12.5	13.2	6.1	9.9	19.4	6.7	5.7	6.1	3.2	4.4	5.2	5.6	12.9	4.8	8.6	3.5	5.8	5.5	11.3	7.8	17.3	4.1	8.3	5.6	8.3	9.3	5.7	11.3	5.7	19.9	6.9	6.3	5.3	7.7	6.4	19.8	3.7	8.8	9.2	4.5	12.3	5.9	5.3	2.5	3.8	0.9	3.5	1.9	3.3	0.7	5.8	5.3	3.2	11.6	7.1	5.4	4.0	3.6	4.1	2.5	3.3	6.8	11.1	5.7	2.4	3.1	2.3	7.7	3.5	3.1	3.1	6.6	2.7	5.4	8.5	3.7	2.9	4.4	4.5	8.4	3.2	2.2	7.4	2.8	3.3	14.7	3.0	6.1	3.3	6.4	2.3	3.7	1.7	2.9	4.9	3.3	2.5	2.3	3.7	7.1	2.4	2.3	5.2	3.6	2.4	3.4	4.8	1.1	2.6	4.9	4.5	2.7	3.1	2.6	3.9	7.2	3.3	5.2	2.7	0.1	1.4	0.9	1.9	0.4	1.2	1.5	2.1	2.5	2.0	2.5	1.9	3.3	0.7	1.9	3.5	3.8	1.4	0.7	4.1	12.1	10.5	11.3	4.4	5.2	3.5	5.8	8.3	3.7	3.0	3.5	2.2	2.3	1.5	8.8	1.7	7.6	2.7	5.7	5.2	11.8	2.8	0.0	3.2	38.1	1.7	4.2	0.0	2.8	1.5	2.0	1.4	1.1	7.4	2.2	11.1	5.8	5.5	2.4	22.4	1.7	2.7	0.0	5.4	3.3	5.8	3.2	3.5	2.1	1.5	9.2	12.9	1.1	10.2	6.6	1.0	1.1	2.5	4.1	0.9
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.0	0.0	13.2	3.0	11.6	3.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.2	0.1	6.3	0.0	0.1	0.0	0.0	12.5	4.4	0.1	22.3	0.5	0.0	20.7	1.5	10.3	0.0	0.0	0.4	0.0	3.2	0.0	3.9	5.9	0.1	0.0	0.1	0.0	10.6	0.0	5.9	1.4	0.0	0.1	0.1	0.0	12.8	1.1	0.7	0.1	21.0	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	28.1	20.5	5.2	0.0	0.4	6.6	2.3	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.0	4.7	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.6	3.6	0.2	0.7	2.5	0.6	2.0	0.1	4.7	0.9	0.0	0.8	0.2	0.0	9.5	1.1	1.2	91.1	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.5	0.8	0.0	0.1	7.4	0.6	44.0	0.1	5.0	0.4	0.0	21.2	6.8	3.8	0.3	0.3	25.4	1.3	0.9	1.0	3.1	1.2	7.2	0.0	0.8	0.0	2.2	20.4	38.9	0.3	2.6	1.7	1.2	0.7	0.2	0.0	2.0	2.1	20.5	1.1	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5	23.8	26.4	13.7	11.8	12.7	10.1	57.9	22.9	46.8	14.8	29.6	82.5	0.4	1.7	10.0	4.8	11.7	11.0	23.3	10.8	0.1	8.7	29.4	22.0	18.8	9.1	0.0	31.2	31.3	44.9	3.5	7.8	19.2	10.1	1.0	32.6	14.2	11.1	28.1	7.8	7.3	62.2	6.5	9.5	0.7	2.5	19.3	0.2	62.3	25.2	14.4
FKRP	"LGMD2I, MDC1C"	ENSG00000181027	"Fukutin related protein"	Q9H9S5	19	46746046-46776988	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043115, HPA060454"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA043115: AB_2678324, HPA060454: AB_2684281"	"unprognostic (4.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.59e-3)"	"prognostic favorable (8.98e-4)"	"unprognostic (3.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-2)"	13.7	10.7	12.4	12.5	17.5	12.6	9.6	7.4	25.2	10.5	11.5	12.8	13.7	7.8	15.7	8.7	8.3	12.7	10.1	13.1	9.8	12.2	10.7	10.8	11.6	11.0	11.5	11.1	13.3	13.2	12.9	16.9	16.5	14.1	13.6	7.3	13.0	17.8	13.2	23.6	9.6	9.7	13.4	9.1	14.7	10.3	13.0	11.1	8.8	13.5	7.8	7.9	12.3	10.2	6.9	5.0	5.4	4.2	5.6	4.5	2.4	8.4	18.1	12.4	8.7	11.0	12.2	11.1	21.6	14.6	8.9	14.0	11.5	14.7	7.6	12.1	12.4	14.7	9.0	4.6	10.1	8.2	14.9	15.4	8.0	8.7	7.2	9.7	6.2	13.8	13.5	8.7	10.9	10.7	10.4	11.6	4.2	8.0	7.7	8.9	3.8	4.5	15.2	12.1	5.3	4.5	12.3	7.7	2.8	5.6	18.1	8.5	16.2	10.8	5.3	7.1	8.6	6.4	4.9	11.9	13.2	14.0	4.8	17.3	8.2	9.8	7.2	10.7	5.0	17.6	3.4	4.2	2.5	4.1	2.5	2.8	4.6	3.0	4.5	2.6	6.9	3.7	4.5	5.4	5.6	2.6	5.0	1.6	2.4	12.4	17.5	7.4	25.2	9.8	12.2	11.5	11.1	14.1	11.1	8.9	6.1	0.8	4.3	0.7	9.7	13.7	7.6	10.7	6.8	5.2	5.9	7.9	5.0	4.3	7.3	3.9	3.5	23.3	2.1	4.7	4.1	3.6	1.1	13.4	6.3	3.2	7.5	9.2	11.4	9.9	5.2	1.8	5.0	4.6	4.6	6.8	4.9	3.1	3.9	5.8	10.7	6.5	4.7	9.1	4.3	1.4	15.7	5.0	3.6	3.4
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 28.1;Cone photoreceptor cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.9	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.9	3.8	1.2	2.8	0.0	0.9	0.0	0.2	13.3	0.3	0.0	1.1	0.1	0.3	10.7	0.7	23.7	2.4	1.4	1.0	0.4	1.8	0.0	0.2	2.9	0.0	7.2	0.3	0.0	0.1	0.0	0.1	2.8	0.6	4.7	0.3	0.2	1.0	0.6	4.4	0.0	2.9	0.2	0.0	0.0	3.5	0.0	0.5	8.4	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4	0.0	1.4	0.5	8.2	0.1	28.1	2.0	2.5	9.4	11.4	0.0	19.6	0.1	3.3	6.3	15.2	0.3	0.4	0.0	7.0	0.2	0.4	3.3	0.0	0.4	3.5	6.4	10.9	2.5	0.0	10.4	0.6	1.2	10.1	1.8	1.5	0.9	5.4	0.0	0.4	9.8	3.9	0.0	1.4	0.5	0.3	1.0	0.2	4.3	0.6	5.8
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 50.5;SK-BR-3: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710"	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	14.0	33.0	4.1	25.4	8.4	15.4	7.1	5.2	16.5	4.5	11.0	6.7	27.3	8.8	4.9	4.1	4.2	40.0	4.7	13.8	1.1	5.4	2.0	4.8	27.4	7.0	10.5	0.6	9.2	12.0	5.9	6.3	3.9	3.5	5.1	20.1	9.3	31.6	1.0	34.5	11.6	8.1	5.5	10.8	6.6	8.3	3.0	50.5	3.6	7.3	4.9	20.2	6.1	49.0	14.5	3.0	16.6	9.3	5.8	2.4	12.2	5.8	3.2	9.3	0.8	4.0	14.2	6.9	12.6	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2	6.0	17.5	8.2	12.6	8.2	22.4	7.3	17.8	5.3	11.4	19.2	27.5	4.6	1.7	13.5	1.8	8.9	29.9	0.0	20.4	13.9	14.1	19.0	14.9	58.7	10.6	55.6	28.7	12.9	10.4	3.0	27.6	8.3	8.5	13.6	18.3	29.8	13.8	13.5	10.3	5.4	29.3	12.9	10.4	11.3	5.8	15.9	16.6	7.5	21.1	21.3
KCTD13	"FKSG86, PDIP1, POLDIP1"	ENSG00000174943	"Potassium channel tetramerization domain containing 13"	Q8WZ19	16	29905012-29927035	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Autism, Autism spectrum disorder, Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043524	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA043524: AB_2678528"	"unprognostic (6.97e-2)"	"unprognostic (9.06e-3)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (9.05e-4)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.49e-3)"	5.7	5.4	20.4	12.3	28.4	9.5	5.6	11.4	26.0	6.0	6.6	16.0	6.2	11.5	7.2	13.2	5.8	6.3	13.1	3.8	24.4	11.4	6.1	4.2	4.3	13.5	15.7	14.7	8.0	5.7	9.2	11.9	5.3	10.5	7.4	10.6	6.1	6.9	9.6	3.1	15.1	9.9	4.3	9.7	9.7	9.2	33.9	15.7	6.4	10.5	3.6	11.0	5.6	5.7	3.9	2.5	8.8	2.8	2.9	5.7	1.6	6.0	11.0	3.5	7.4	1.8	2.7	7.9	3.2	0.6	0.9	3.2	4.8	11.5	12.1	3.9	2.7	5.8	10.1	3.2	3.5	2.3	5.1	7.4	2.7	7.8	2.6	0.8	4.3	6.8	4.3	5.5	6.2	1.4	2.5	2.2	7.2	5.8	6.5	4.0	6.9	5.2	4.9	4.1	2.9	2.5	9.5	3.7	3.2	2.5	6.7	9.4	3.2	3.5	4.9	8.6	4.0	5.2	2.7	5.4	4.5	3.3	8.7	5.0	6.2	2.3	4.6	3.6	8.1	6.3	4.9	2.8	7.4	3.0	2.3	3.5	2.2	5.7	4.6	2.5	3.9	5.0	4.0	8.8	2.9	2.7	2.1	4.0	1.6	20.4	28.4	11.4	26.0	24.4	11.4	15.7	14.7	10.5	15.7	0.0	11.9	5.7	4.5	5.4	7.7	3.0	7.6	4.0	2.3	0.0	7.9	4.8	3.3	6.3	14.1	3.3	4.5	0.0	3.8	4.3	5.0	6.0	2.3	1.6	6.7	4.8	7.5	5.5	3.2	6.0	5.8	4.9	8.5	5.4	7.0	4.8	8.4	7.8	6.0	2.1	5.6	0.0	6.1	21.6	15.1	8.0	5.6	7.7	5.5	6.1
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;U-266/84: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	5.0	6.9	6.2	7.0	5.2	7.2	34.9	5.7	4.7	3.8	2.9	4.7	4.5	10.7	6.6	10.7	4.2	2.8	4.7	3.0	2.8	7.2	9.9	6.3	4.1	20.0	5.7	0.1	2.7	7.1	5.5	7.8	4.4	5.2	3.5	4.4	17.9	11.4	2.6	16.2	4.0	6.8	6.5	4.0	14.1	5.4	2.0	15.4	2.2	6.6	5.4	9.9	4.1	14.4	3.3	5.6	6.1	4.4	9.4	4.2	10.6	3.5	0.7	22.8	31.2	4.2	7.9	3.2	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5	3.0	22.7	41.9	6.8	10.2	106.3	163.4	28.1	12.0	7.9	3.5	182.6	7.8	6.6	5.7	2.1	20.1	2.0	23.3	11.1	36.0	17.8	15.7	14.0	38.5	19.4	222.5	9.8	28.3	52.6	3.4	15.5	24.7	6.8	3.6	13.6	16.7	7.9	0.0	21.2	4.7	119.9	25.8	33.0	1.8	1.5	6.8	18.2	16.2	7.6	10.7
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455856	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	10.5	20.8	6.3	12.2	7.8	7.2	10.4	12.6	9.2	10.7	9.8	9.3	8.2	5.6	9.9	8.7	8.2	9.1	9.0	10.5	6.2	5.7	11.9	10.0	8.0	15.3	6.8	5.7	17.4	8.1	13.3	20.7	11.7	9.0	11.4	7.2	11.0	10.0	10.4	14.6	8.7	9.8	8.0	8.4	14.4	8.4	10.7	7.4	18.5	14.3	8.3	13.4	10.2	9.2	10.1	4.6	6.8	4.7	5.5	9.7	2.9	4.3	3.3	7.1	4.6	8.7	9.2	3.7	6.5	9.8	8.5	8.4	3.1	4.5	12.2	5.2	5.6	5.8	4.4	8.6	4.8	8.9	7.0	3.8	7.3	5.4	4.2	5.6	8.8	18.0	7.1	6.5	6.7	7.0	7.5	6.7	8.2	9.6	10.7	8.6	5.1	8.0	6.3	3.6	6.9	2.4	6.2	8.2	4.3	7.0	2.7	5.8	4.8	6.3	6.9	7.1	7.1	4.3	9.5	5.1	6.4	5.6	8.2	5.1	9.9	4.2	10.3	5.4	6.7	7.1	5.4	3.7	6.8	5.7	4.0	5.4	5.8	6.3	6.4	4.6	10.1	9.7	8.7	2.3	5.5	4.7	4.5	7.8	2.9	6.3	7.8	12.6	9.2	6.2	5.7	6.8	5.7	9.0	7.4	3.0	9.4	10.0	8.0	3.8	9.2	9.2	7.6	22.7	7.9	5.2	7.9	9.6	10.0	5.1	20.9	7.1	3.5	0.0	4.8	8.1	6.4	4.9	7.0	4.0	9.1	6.4	0.0	10.4	5.6	5.8	12.0	8.4	6.8	7.2	4.5	9.1	4.7	6.0	7.4	8.8	13.2	0.0	8.2	20.0	12.8	3.3	9.6	13.1	5.2	4.7
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Group enriched"	"Detected in all"	9	"Early spermatids: 436.9;Late spermatids: 1305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	26.4	8.2	27.3	45.6	18.8	14.2	19.6	12.0	15.5	23.5	25.8	23.5	13.9	26.3	13.7	17.5	8.8	14.1	29.0	15.5	16.1	14.0	39.5	32.7	23.6	24.4	18.5	19.2	23.4	22.8	15.6	18.1	10.6	18.3	22.7	30.1	39.7	18.8	8.8	32.9	31.4	33.1	35.5	66.8	8.8	30.6	20.0	31.5	14.4	15.4	50.6	39.5	12.7	14.6	20.4	18.5	25.4	55.7	13.4	10.7	20.0	11.8	11.8	20.6	25.8	38.2	4.7	27.6	9.0	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3	11.9	17.1	31.9	30.7	16.7	29.1	32.5	30.6	5.3	6.8	17.4	13.7	84.7	72.9	52.9	436.9	20.2	33.8	23.3	48.1	97.9	40.2	39.5	13.8	24.5	56.1	30.2	50.3	24.5	35.6	1305.6	41.4	26.0	32.1	61.3	43.7	33.2	40.4	43.6	55.5	45.1	21.9	51.8	26.8	102.4	30.2	18.1	89.5	30.2	50.7	28.0
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 239.6;Late spermatids: 372.4;Spermatocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	18.2	17.3	15.2	19.7	19.7	14.6	12.8	18.3	25.3	20.3	16.4	21.1	15.2	15.8	19.7	14.4	16.7	14.8	17.9	26.8	16.0	15.6	16.1	29.2	16.8	22.0	15.4	15.6	19.3	16.4	16.5	20.4	12.8	20.6	18.5	8.3	16.3	24.4	16.9	40.7	41.3	17.6	16.4	13.1	19.9	17.1	50.8	12.2	23.2	16.8	17.3	18.6	16.9	14.1	1.0	7.5	6.0	5.5	1.4	3.9	1.2	8.4	14.7	4.8	5.5	10.9	13.6	12.8	13.9	3.4	4.1	2.2	9.2	7.1	9.7	15.4	4.7	3.6	10.9	5.6	6.2	1.6	11.6	21.0	8.3	4.2	31.2	4.9	10.4	15.0	9.9	4.8	4.5	11.5	3.1	3.5	11.3	12.9	5.3	7.2	11.8	10.4	17.9	11.9	3.7	20.8	7.9	6.6	7.7	4.4	7.0	12.5	20.3	5.5	6.3	9.1	2.2	7.3	8.4	9.0	10.1	5.7	10.0	12.2	15.3	11.2	7.6	11.7	8.2	5.5	1.2	1.8	6.0	1.4	4.1	3.6	0.9	2.3	3.8	2.4	1.0	1.6	1.9	1.7	1.4	5.5	7.5	3.9	1.2	15.2	19.7	18.3	25.3	16.0	15.6	15.4	15.6	20.6	12.2	8.9	10.9	22.3	14.0	10.2	31.0	55.8	20.4	10.7	4.5	12.2	31.4	18.9	49.7	18.3	239.6	14.6	14.7	0.0	15.7	12.5	15.8	12.4	5.7	13.1	22.8	25.4	3.4	10.4	12.6	372.4	24.5	13.7	15.1	30.7	15.7	39.8	19.8	10.5	22.6	22.6	37.7	25.8	18.6	93.2	21.0	15.6	14.8	7.1	14.0	10.5
PTOV1		ENSG00000104960	"Prostate tumor overexpressed 1"	Q86YD1	19	49850735-49860744	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 255.0;Late spermatids: 494.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051812, HPA075125"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051812: , HPA075125: AB_2732280"	"unprognostic (2.70e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (9.20e-4)"	"unprognostic (4.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.27e-2)"	"unprognostic (6.70e-2)"	24.1	49.1	31.6	23.7	33.6	26.8	27.3	37.8	47.1	23.7	20.9	32.5	28.4	25.0	29.9	28.1	16.3	24.9	24.6	23.5	31.1	34.1	24.9	29.3	19.1	22.5	32.2	30.3	34.3	39.3	26.9	40.1	24.5	28.5	32.6	7.3	19.5	44.6	27.4	70.2	23.6	28.8	14.3	29.0	28.9	27.3	27.4	27.9	24.8	33.0	18.6	11.4	18.9	30.4	7.9	9.9	9.5	3.5	6.0	5.1	1.5	11.8	24.7	25.1	26.9	3.5	5.8	15.4	14.7	13.1	13.8	14.5	13.4	20.7	12.9	14.1	7.3	9.4	13.3	9.3	11.4	3.3	33.6	62.0	8.3	19.2	20.8	9.1	6.8	17.1	11.0	7.4	5.8	2.4	9.3	11.4	18.4	19.4	15.7	6.3	14.7	30.7	31.1	16.1	8.6	22.6	37.4	10.2	18.0	11.9	21.0	32.6	35.6	12.6	14.8	6.2	6.6	14.4	7.6	16.4	16.5	27.3	9.8	11.9	16.6	9.9	16.9	17.0	9.7	20.8	7.9	3.5	5.0	3.6	3.0	4.7	7.9	4.0	3.1	2.4	7.8	5.1	4.7	9.5	6.0	1.7	9.9	1.6	1.5	31.6	33.6	37.8	47.1	31.1	34.1	32.2	30.3	28.5	27.9	35.7	25.5	28.4	70.8	32.4	46.5	25.7	61.1	32.1	27.3	41.8	17.7	90.7	76.3	25.5	255.0	32.2	66.7	23.3	22.8	72.7	56.7	80.2	15.0	50.8	43.9	33.4	95.7	33.7	24.0	494.5	59.5	28.7	42.2	10.8	58.5	74.1	33.9	46.3	75.7	105.6	42.1	58.2	48.4	33.9	59.8	31.7	128.5	22.4	50.2	60.4
HDAC10	DKFZP761B039	ENSG00000100429	"Histone deacetylase 10"	Q969S8	22	50245183-50251405	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, DNA damage, DNA recombination, DNA repair"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB045977	Supported					NA	NA					"CAB045977: AB_11124034"	"unprognostic (1.53e-1)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.43e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (4.74e-11)"	"unprognostic (2.21e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.38e-3)"	8.9	9.3	10.1	14.7	10.3	16.9	6.8	10.9	8.8	8.6	13.9	4.7	14.6	12.9	7.7	13.5	10.2	7.9	13.1	4.0	8.4	6.1	11.4	15.1	8.2	12.5	4.9	8.8	7.8	15.0	6.4	13.2	7.0	6.1	10.2	3.7	8.8	18.6	12.9	9.2	12.1	14.2	7.1	4.4	17.1	14.2	2.4	4.7	16.1	9.3	7.6	19.2	8.2	7.7	1.1	3.1	5.4	4.2	1.1	1.9	2.5	4.2	2.4	0.6	3.5	3.0	2.4	7.8	2.8	2.4	1.6	0.9	4.4	4.6	2.7	4.0	2.1	1.5	7.0	1.5	4.2	0.3	3.5	3.9	5.9	6.2	7.3	5.3	6.9	19.3	5.0	3.1	1.5	0.9	3.2	3.0	5.6	4.1	4.2	1.4	13.0	3.8	17.3	1.4	4.5	5.2	9.2	2.3	17.0	2.5	7.1	1.9	4.6	2.9	1.0	4.9	0.8	8.0	11.2	4.7	2.8	4.0	4.7	1.7	5.2	1.8	2.3	4.5	4.4	2.1	0.8	4.0	5.4	1.9	4.2	1.6	1.0	0.9	1.2	3.1	1.1	0.8	1.0	2.0	1.1	2.3	2.7	1.6	2.5	10.1	10.3	10.9	8.8	8.4	6.1	4.9	8.8	6.1	4.7	0.0	4.3	9.8	4.4	7.7	5.4	0.6	7.6	4.0	2.3	14.0	15.7	9.3	6.6	5.7	1.8	5.6	25.6	0.0	3.4	13.2	8.5	3.2	4.7	6.7	18.7	0.0	20.1	9.2	21.1	6.3	10.3	10.8	8.5	17.2	14.6	2.6	5.7	17.0	7.4	13.3	6.8	0.0	3.7	0.9	2.3	8.3	8.6	30.6	14.4	3.1
SPHK2		ENSG00000063176	"Sphingosine kinase 2"	Q9NRA0	19	48619291-48630717	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 66.9;Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049062			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049062: "	"unprognostic (5.33e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (4.45e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.30e-4)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (1.18e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.06e-2)"	9.3	8.9	12.6	9.9	13.0	5.2	5.1	13.6	22.0	7.2	12.9	13.4	4.9	33.2	7.4	4.2	4.9	7.3	7.8	4.7	22.5	14.8	19.3	15.2	6.1	8.7	26.3	14.9	9.1	7.2	15.0	9.5	4.1	22.3	8.7	6.2	7.2	7.5	8.0	6.1	4.3	22.2	4.9	14.1	8.4	11.3	17.2	13.7	4.0	9.1	3.1	5.3	6.2	12.4	10.4	7.4	12.5	9.4	7.2	7.0	4.2	4.1	11.9	4.4	8.1	4.9	2.0	8.4	4.5	3.8	5.2	6.3	20.3	5.4	7.7	3.1	2.9	3.1	3.1	4.1	3.6	0.7	8.7	9.8	8.5	5.2	7.0	7.7	5.4	9.4	3.7	2.0	3.6	2.5	2.5	2.9	10.5	5.5	6.9	2.6	4.3	12.8	33.8	5.9	3.1	5.8	11.8	3.6	5.0	2.4	2.8	16.1	12.7	4.3	6.8	4.3	2.6	3.7	3.7	4.5	7.5	4.2	5.8	8.9	13.3	15.3	8.5	4.3	6.3	6.7	12.5	8.3	3.6	6.0	9.4	5.9	6.5	4.8	5.8	7.4	10.4	6.6	7.0	3.3	7.2	7.4	6.6	4.6	4.2	12.6	13.0	13.6	22.0	22.5	14.8	26.3	14.9	22.3	13.7	6.0	7.7	5.4	4.8	3.0	66.9	1.0	7.6	2.7	4.5	10.4	72.6	5.9	1.7	5.3	8.2	6.4	28.6	0.0	4.4	5.3	5.2	5.4	4.6	17.3	7.6	42.9	15.5	4.9	10.7	9.0	15.3	6.3	3.3	7.2	9.2	22.9	6.0	11.5	12.0	13.5	83.3	6.5	5.4	18.7	6.4	2.5	3.8	16.6	12.8	3.6
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	1.8	4.7	5.5	6.3	5.2	4.3	4.6	2.1	3.4	2.4	2.0	8.5	2.1	1.2	2.0	5.4	7.9	3.0	7.8	5.2	3.5	2.4	3.7	2.0	1.4	7.7	3.5	0.6	4.3	6.0	3.6	3.4	3.4	5.9	3.3	5.5	3.9	2.0	3.8	4.5	2.9	1.7	6.0	3.5	3.3	3.1	4.8	0.4	3.9	1.8	1.4	4.1	4.0	3.8	4.9	17.9	4.4	1.4	2.5	2.8	5.4	4.8	0.8	1.9	0.5	0.8	3.2	1.7	3.0	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4											17.9	13.3	0.0	4.1	2.6	9.7	2.3	0.0	24.1	13.6	0.0	0.0	34.3	5.0	1.1	0.0	3.1	0.7	0.0	0.6	2.0	1.8	2.5	2.3	1.7	3.4	4.8	4.1	3.1	0.3	0.0	2.0	1.1	0.0	1.0	1.2	10.2	1.2	0.0	3.2	2.6	2.0	6.5	1.7	0.0	1.4	1.9	21.9	1.3	1.7	1.7
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8"	"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.8	4.9	8.6	0.0	0.0	0.0	28.9	2.8	1.7	2.7	2.4	0.0	0.0	0.0	1.2	0.9	2.7	1.0	0.0	13.9	3.4	0.0	0.4	0.0	0.0	7.2	3.3	0.0	2.1	3.4	11.1	0.0	5.2	12.3	0.4	0.0	0.6	0.0	2.9	0.0	0.0	0.0	10.2	0.0	1.0	0.0	0.0	0.0	9.0	7.3	2.6	4.1	0.0	8.7	2.1	14.8	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2	20.8	9.6	0.9	22.5	20.8	15.6	4.1	10.2	32.1	14.8	17.4	2.0	125.8	36.5	9.2	51.1	18.0	0.0	0.0	4.2	49.4	8.3	25.0	0.0	17.5	11.0	9.5	7.5	7.4	3.8	11.1	6.6	1.9	8.5	0.0	1.5	8.3	4.4	0.0	6.0	15.4	11.0	19.4	16.0	21.2	5.9	6.0	227.6	0.0	0.0	9.2
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA035159: AB_2674499, HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	13.4	12.9	16.4	14.6	16.9	23.8	13.5	22.3	24.6	14.8	30.0	20.2	15.9	30.5	15.3	14.2	22.2	13.1	22.2	11.6	16.2	13.3	20.0	28.5	15.2	27.3	18.8	17.9	14.1	29.1	18.6	18.0	22.2	15.6	14.7	18.5	11.3	17.3	14.2	15.9	23.4	34.7	24.5	17.5	22.6	21.8	9.5	13.9	23.0	30.0	12.9	19.3	14.7	16.6	29.1	20.5	36.6	27.8	30.7	32.5	25.4	10.6	7.3	8.3	11.7	8.9	9.4	11.6	10.8	12.7	15.6	15.5	16.3	9.1	8.6	11.5	18.4	12.7	7.4	7.7	13.7	12.5	13.3	12.0	19.8	12.0	14.1	18.2	10.5	22.9	7.7	30.2	15.3	36.6	8.8	10.4	19.1	11.5	24.6	15.2	18.4	17.3	22.1	4.3	14.8	8.4	10.8	5.0	14.8	14.7	9.0	18.2	8.2	5.2	8.8	12.0	9.8	7.5	22.3	11.0	15.7	14.8	18.1	15.3	10.2	3.3	15.5	15.4	20.8	12.2	17.7	21.7	28.6	32.1	27.8	28.0	25.4	29.3	31.3	16.4	29.1	26.7	32.5	36.6	30.7	21.9	20.5	30.2	25.4	16.4	16.9	22.3	24.6	16.2	13.3	18.8	17.9	15.6	13.9	20.8	26.3	36.4	21.1	24.2	13.5	11.1	25.5	8.1	9.1	19.2	13.7	22.5	48.0	34.1	3.4	27.0	133.2	0.0	57.4	20.0	23.7	23.5	32.3	35.5	29.9	7.9	38.6	14.7	29.1	5.5	29.7	26.7	33.7	13.6	57.3	20.9	46.6	94.7	28.0	57.5	14.9	25.8	33.0	5.7	13.0	31.6	42.9	46.7	47.7	24.8
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994949-40043529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.4;seminal vesicle: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.1	0.2	0.1	2.8	0.2	0.8	4.7	0.2	0.3	2.6	6.9	0.1	29.4	3.0	0.2	7.5	15.4	1.1	4.0	1.5	0.2	0.1	4.8	2.1	1.0	0.1	0.2	0.1	0.5	14.4	2.6	2.6	0.5	0.1	6.3	3.1	0.4	7.8	33.3	0.1	13.8	12.5	0.8	0.2	0.1	5.9	24.9	0.1	1.3	12.6	12.8	8.1	3.0	4.1	0.7	0.5	2.7	0.4	0.6	0.3	0.1	4.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	7.6	0.0	9.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	23.0	0.0	7.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.3	0.0	0.0	0.0	0.0	0.1	11.0	24.3	0.0	0.2	2.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.3	2.2	0.6	0.3	0.5	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	11.8	25.4	0.5	5.1	2.5	2.7	1.2	22.7	0.0	0.1	3.3	8.6	20.7	0.8	31.6	0.0	13.2	0.1	1.6	13.1	1.1	1.0	0.2	0.0	12.6	0.0	0.8	52.5	1.7	0.9	1.7	0.0	18.3	1.0	11.4	20.1	2.1	5.0	0.7	0.0	0.8	7.2	2.2	30.2	1.1	0.0	12.7	15.2
BEX4	"BEXL1, FLJ10097"	ENSG00000102409	"Brain expressed X-linked 4"	Q9NWD9	X	103215092-103217246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 37.9;HMC-1: 45.9;K-562: 53.1"					"Low region specificity"	"Detected in all"			"HPA045105, HPA051935"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045105: AB_10966792, HPA051935: AB_2681667"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.03e-1)"	"unprognostic (6.33e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.54e-14)"	"unprognostic (1.62e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.33e-2)"	9.8	36.8	63.8	8.6	71.4	21.5	20.8	53.6	68.8	20.7	14.3	29.5	11.5	6.4	25.5	99.8	17.7	24.5	14.8	35.1	61.6	77.6	34.9	5.1	15.8	10.7	54.3	54.7	38.8	12.6	40.7	34.1	29.4	50.5	30.1	10.1	18.0	27.1	32.1	2.5	7.5	8.7	20.9	51.2	23.1	9.6	16.2	24.4	8.6	47.8	3.5	12.3	14.1	11.5	12.9	28.3	36.7	10.4	34.0	25.7	15.0	0.0	0.0	23.5	0.0	6.0	4.1	21.0	5.5	4.7	10.4	19.2	0.0	0.3	0.0	9.3	3.8	8.8	0.1	9.4	1.2	11.5	0.0	8.8	37.9	0.0	0.0	18.4	28.4	45.9	15.5	3.1	5.4	0.0	11.6	12.0	14.8	53.1	0.1	3.1	0.1	19.8	0.2	28.4	0.0	1.6	0.0	6.8	0.1	9.5	0.5	17.5	26.8	1.9	0.3	1.1	23.9	0.9	0.3	0.3	1.3	8.4	0.2	0.0	3.0	1.3	0.0	3.9	0.0	1.1	36.7	8.6	14.8	12.1	10.4	10.1	12.9	14.7	12.2	18.2	12.6	25.7	20.2	1.9	34.0	8.5	28.3	13.5	15.0	63.8	71.4	53.6	68.8	61.6	77.6	54.3	54.7	50.5	24.4	32.8	30.2	36.0	116.3	24.3	176.9	67.8	43.3	36.1	56.9	94.2	23.6	266.1	253.7	53.3	2.2	46.6	6.3	0.0	12.2	138.8	44.1	99.1	108.3	0.8	81.6	209.7	60.6	49.1	47.6	6.7	58.7	61.3	109.6	191.2	37.7	161.0	15.3	24.6	57.7	144.4	67.7	51.8	44.8	22.8	14.5	21.1	304.7	33.2	28.0	91.2
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"		NA	NA			"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	4.2	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	10.9	1.9	11.7	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	12.6	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1	32.8	16.0	27.0	17.0	3.7	46.9	14.4	12.7	21.4	22.7	14.0	33.4	18.5	11.6	16.1	39.6	17.9	14.2	0.0	9.5	11.4	15.4	13.7	11.5	11.3	9.2	31.8	29.7	25.2	15.6	39.9	17.3	10.9	8.5	14.4	12.0	27.7	9.7	16.5	21.2	8.6	46.3	32.3	7.2	26.0	19.1	4.0	12.2	15.2	13.4	9.7
RASIP1	"FLJ20401, RAIN"	ENSG00000105538	"Ras interacting protein 1"	Q5U651	19	48720587-48740721	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 65.2;Ito cells: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.2;HeLa: 7.3;HUVEC TERT2: 21.6;SiHa: 11.5;TIME: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077251	Approved					NA	NA					"HPA077251: AB_2732337"	"unprognostic (9.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (7.17e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.46e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	29.0	4.8	3.0	3.5	3.1	1.0	17.9	4.2	3.2	9.0	4.7	2.7	3.6	3.6	10.6	2.7	4.5	6.6	7.0	11.4	5.1	1.7	4.8	4.7	18.0	4.7	3.4	1.2	5.9	8.0	2.3	2.8	10.8	5.4	7.1	1.2	6.6	3.0	4.1	9.3	4.4	3.6	5.9	2.0	17.0	6.4	4.0	2.7	0.5	7.3	10.1	2.1	4.5	17.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	5.4	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.6	0.5	1.3	0.0	0.0	1.4	0.1	1.2	0.0	0.0	8.2	0.1	7.3	0.2	1.2	0.0	0.4	1.3	0.7	0.0	0.0	0.0	21.6	0.8	0.7	0.0	0.0	0.4	0.0	0.7	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.5	4.0	0.2	11.5	0.0	0.0	0.1	0.0	0.0	29.4	0.0	0.2	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	3.1	4.2	3.2	5.1	1.7	3.4	1.2	5.4	2.7	0.0	2.2	1.4	3.6	5.8	0.8	4.2	2.5	1.4	0.0	1.8	0.0	0.3	0.0	0.7	3.8	65.2	0.0	0.0	0.6	1.7	2.3	2.8	0.0	1.3	0.5	6.4	0.0	84.1	9.2	4.6	9.5	0.8	18.6	0.0	0.0	1.7	1.0	0.0	10.6	0.3	0.5	19.4	5.1	0.9	10.2	5.3	0.2	0.0	0.0	5.6
LYRM9	"C17orf108, HSD24"	ENSG00000232859	"LYR motif containing 9"	A8MSI8	17	27878314-27894752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 66.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 20.4"									HPA023051	Uncertain					NA	NA					"HPA023051: AB_10602333"	"unprognostic (1.31e-1)"	"unprognostic (6.20e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.75e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.93e-3)"	9.2	19.2	29.3	3.5	33.8	3.7	12.4	9.3	35.9	8.0	5.4	8.9	12.3	5.3	10.0	23.1	5.1	13.7	8.3	14.2	25.2	21.8	16.0	7.2	8.0	8.4	15.9	28.3	19.1	14.4	12.6	11.5	3.3	16.9	9.2	3.8	14.7	11.8	14.6	12.7	9.4	6.1	7.6	10.5	8.4	6.9	12.0	6.3	4.3	28.4	6.0	5.5	4.6	4.5	13.7	4.6	8.7	7.6	4.5	16.4	6.1	0.7	0.8	3.9	4.1	8.2	8.9	6.4	1.8	3.1	0.7	0.6	7.9	2.0	0.5	7.1	2.4	0.6	0.2	0.5	2.5	0.6	7.2	2.1	3.0	0.2	0.5	12.1	0.1	1.4	12.0	3.7	0.7	3.4	3.6	1.7	9.9	0.8	0.7	5.2	5.5	1.8	0.4	2.4	3.4	0.2	1.9	0.3	0.0	5.7	1.8	2.9	2.9	5.9	7.2	8.8	2.0	20.4	1.8	2.6	1.6	1.2	4.4	0.9	2.9	0.6	0.1	1.8	0.7	1.8	5.7	3.3	2.6	6.7	5.9	6.4	7.6	8.9	7.0	4.6	13.7	16.4	11.3	8.7	4.5	7.6	2.8	9.8	6.1	29.3	33.8	9.3	35.9	25.2	21.8	15.9	28.3	16.9	6.3	8.9	8.9	5.2	7.8	5.8	16.6	13.3	12.7	16.0	2.3	50.6	13.7	15.4	66.3	9.0	3.3	8.0	2.1	0.0	20.8	5.9	9.5	6.7	11.5	9.9	8.5	15.9	8.6	13.5	5.1	1.5	17.3	9.9	37.1	19.8	4.8	26.1	7.8	3.5	21.9	23.9	13.7	25.8	8.1	40.1	32.2	5.6	3.8	13.8	6.4	4.1
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8;pituitary gland: 49.1;skin 1: 70.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 151.1;Cytotrophoblasts: 92.7;Melanocytes: 276.7;Suprabasal keratinocytes: 155.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 25.5"	"Lineage enriched"	"Detected in single"	58	"T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 23.4;SCLC-21H: 47.7;SH-SY5Y: 23.2;SK-MEL-30: 22.3;TIME: 56.4;U-698: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	1.4	16.1	8.9	2.8	44.8	1.0	4.2	32.2	32.0	4.7	5.1	3.1	0.4	4.4	5.3	2.6	17.2	12.7	1.3	3.8	6.0	31.9	1.3	0.7	1.4	2.3	15.8	19.2	29.5	1.6	0.5	49.1	20.9	38.8	14.4	4.8	7.6	4.5	12.5	1.0	70.0	3.8	4.7	6.2	1.8	5.3	9.8	4.4	3.7	0.8	4.3	2.6	10.2	8.3	0.0	0.0	0.4	0.0	0.3	25.5	6.9	0.0	0.0	0.2	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.9	0.1	0.9	0.6	23.4	1.5	0.1	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.3	0.0	0.6	0.0	4.0	6.2	0.0	0.0	0.3	0.0	1.8	0.1	2.8	0.0	0.1	0.0	0.0	0.1	0.0	1.3	47.7	23.2	0.1	0.0	22.3	2.0	0.2	0.0	56.4	0.0	3.7	0.0	0.0	0.0	0.1	20.3	0.0	0.0	0.1	0.0	0.0	0.0	19.2	0.0	25.5	0.0	18.0	15.6	0.0	0.0	4.7	12.0	0.4	0.3	0.0	0.0	1.7	6.9	8.9	44.8	32.2	32.0	6.0	31.9	15.8	19.2	38.8	4.4	8.9	0.0	0.0	71.8	77.0	151.1	0.0	0.0	1.4	5.7	0.0	3.9	92.7	0.0	0.0	30.8	0.5	0.0	0.0	0.0	13.3	7.6	12.1	1.1	0.0	7.4	7.9	2.4	1.8	0.0	35.3	2.8	1.7	276.7	0.0	0.0	6.4	0.2	0.0	5.3	3.7	17.4	0.0	2.1	2.3	12.8	155.8	64.2	11.5	0.0	80.5
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.8	3.0	2.2	0.0	1.1	2.0	0.0	0.1	0.0	0.0	0.0	5.9	3.3	3.6	8.7	0.9	17.5	1.0	1.4	3.2	0.1	0.0	3.4	16.2	1.6	2.4	5.4	0.0	0.0	9.7	2.6	4.2	1.0	3.4	6.2	0.0	1.2	0.0	2.2	0.5	0.0	0.1	2.8	5.2	10.5	0.0	3.6	0.0	1.5	0.5	16.8	6.3	6.9	0.7	0.0	2.0	1.8	2.0	6.1	2.6	4.4	11.4	0.4	0.4	8.1	1.3	8.3	0.0	3.3	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9	8.9	1.9	3.7	0.7	0.5	75.3	26.7	12.7	5.3	1.2	7.0	96.2	0.1	0.0	2.2	0.0	1.4	0.0	0.0	3.1	0.2	1.0	0.7	1.1	4.2	2.5	49.3	14.5	17.2	4.7	0.0	0.9	0.5	0.0	0.0	0.0	12.8	2.9	0.0	3.5	2.6	37.1	0.0	0.8	0.0	0.2	0.1	0.2	0.0	0.0	0.8
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"gdT-cell: 20.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051617, HPA075900"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051617: AB_2681553, HPA075900: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favorable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	13.6	18.4	19.4	12.1	25.9	17.3	10.6	25.3	31.2	17.3	12.8	21.0	18.8	11.0	19.0	12.0	39.3	19.9	16.5	23.7	15.8	16.2	16.9	13.2	14.1	13.5	14.3	19.1	20.7	24.0	33.8	33.2	13.5	15.8	35.4	12.4	22.3	15.3	16.9	29.5	41.5	11.7	19.3	12.8	14.2	15.7	24.4	17.1	25.2	35.8	18.8	21.0	12.3	20.7	1.9	4.2	2.1	2.1	7.8	20.6	3.6	12.9	28.5	21.0	24.5	18.9	15.3	11.9	14.1	15.9	19.6	16.8	21.3	12.2	14.2	20.8	17.2	15.0	14.5	26.6	17.9	16.2	6.4	25.5	11.8	24.1	30.4	10.6	13.4	15.7	18.7	13.7	24.0	10.7	13.2	19.4	16.5	14.5	11.7	15.4	31.8	14.9	16.2	28.2	7.0	13.6	27.9	26.0	14.6	12.3	13.6	26.6	17.8	14.2	12.1	8.7	17.6	21.7	10.2	20.5	19.8	12.0	12.4	14.4	12.5	11.3	14.5	8.2	15.0	14.5	1.0	2.1	2.1	20.6	1.9	15.2	1.9	2.4	10.3	2.7	1.6	2.5	6.7	1.6	7.8	2.0	4.2	2.5	3.6	19.4	25.9	25.3	31.2	15.8	16.2	14.3	19.1	15.8	17.1	17.9	22.9	5.6	6.3	16.4	42.3	23.4	10.2	25.4	15.9	12.2	88.4	6.4	5.0	10.2	2.0	12.8	10.9	0.0	9.9	3.8	13.3	16.1	18.5	12.5	9.2	25.4	28.8	15.4	12.3	4.0	17.8	6.4	3.3	8.2	15.9	13.3	13.1	8.6	14.9	7.9	30.3	12.9	7.2	19.1	14.9	18.1	3.5	27.7	11.1	6.2
ATOX1	HAH1	ENSG00000177556	"Antioxidant 1 copper chaperone"	O00244	5	151742316-151772532	"Predicted intracellular proteins"	"Copper transport, Ion transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 744.7;Proximal tubular cells: 898.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055036			Approved	"Nucleoplasm,Plasma membrane"		NA	NA		27000	Nucleoplasm	"Plasma membrane"	"HPA055036: "	"unprognostic (5.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.53e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-1)"	27.0	37.2	43.1	25.6	40.4	23.4	39.1	22.8	38.5	29.0	23.9	29.7	32.3	30.2	21.4	37.6	28.4	24.5	33.4	27.7	37.5	45.7	50.5	96.1	21.3	48.9	54.3	37.0	16.2	29.0	31.5	23.0	25.6	35.2	25.7	24.4	25.0	34.7	29.8	12.8	26.3	31.6	28.1	46.5	34.1	21.0	28.7	33.8	24.5	36.3	29.7	44.8	27.2	22.1	22.5	49.9	43.3	54.8	20.1	22.8	24.2	14.1	23.3	13.7	9.5	36.6	30.0	18.1	25.6	29.0	25.8	35.2	31.5	30.6	28.5	31.2	43.8	57.9	13.2	16.6	64.1	21.2	18.3	28.4	12.5	15.1	32.0	34.1	17.2	14.3	38.7	13.5	32.3	21.3	19.1	37.7	17.9	10.3	84.2	39.0	34.7	12.7	38.2	7.8	31.7	48.9	7.8	15.8	44.0	24.7	12.3	18.0	10.6	21.9	62.6	95.4	16.2	30.6	21.1	42.2	26.8	21.3	32.6	44.3	69.6	61.1	17.0	36.3	11.7	110.2	27.5	48.7	43.3	18.3	54.8	16.7	22.5	16.6	15.8	39.1	16.2	13.2	14.3	36.4	20.1	37.4	49.9	22.8	24.2	43.1	40.4	22.8	38.5	37.5	45.7	54.3	37.0	35.2	33.8	53.6	54.1	119.1	60.7	60.1	20.6	93.1	175.8	60.2	37.5	200.7	13.7	132.7	459.3	179.7	119.0	146.1	314.3	70.0	138.4	184.0	143.5	107.5	72.6	744.7	575.7	23.8	144.8	249.2	183.4	241.2	76.8	138.6	226.0	621.2	138.5	98.0	246.1	221.7	97.2	898.1	22.2	90.5	140.1	71.6	147.1	93.1	99.3	57.9	140.1	99.5
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539211-100568219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"salivary gland: 154.3"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 35.8;Ito cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced					NA	NA					"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	4.8	13.6	9.2	5.5	12.5	3.8	3.7	8.8	9.6	6.6	8.7	6.6	8.5	7.0	7.1	4.5	14.3	7.7	7.9	5.1	9.1	5.1	7.1	21.4	4.7	5.6	7.2	8.6	11.3	9.7	3.4	8.4	2.7	7.7	5.9	6.9	4.0	154.3	9.5	3.8	11.7	6.5	5.7	10.0	11.7	5.5	6.8	7.5	4.0	6.5	3.7	10.9	5.2	4.7	1.4	1.0	4.5	0.4	1.1	4.5	1.1	6.3	10.3	1.3	3.1	9.5	5.0	1.8	3.0	8.3	4.9	5.1	9.0	5.8	4.1	10.2	3.6	21.5	5.3	1.5	3.1	2.2	14.1	4.1	1.2	4.7	19.4	3.8	1.3	7.2	8.2	2.4	3.9	4.4	3.0	13.2	2.7	3.7	5.6	3.9	5.6	5.1	4.7	0.9	17.8	4.3	2.5	1.5	3.6	2.8	3.3	1.9	2.3	5.9	8.6	2.7	2.2	2.4	1.8	3.3	6.1	4.1	15.1	3.2	3.5	17.7	1.5	4.6	3.8	3.4	3.6	0.1	4.5	3.8	0.4	3.3	0.7	3.8	4.5	0.2	1.4	1.3	1.7	0.9	1.1	0.1	1.0	3.0	1.1	9.2	12.5	8.8	9.6	9.1	5.1	7.2	8.6	7.7	7.5	0.0	3.8	7.0	5.7	1.8	1.3	8.4	30.6	0.0	2.3	24.4	2.0	1.3	10.0	10.5	1.3	11.4	14.7	0.0	10.1	1.4	3.3	4.4	2.3	35.8	1.3	3.2	25.4	65.7	5.7	1.8	5.2	1.7	3.3	10.8	11.2	2.7	6.4	8.6	8.5	1.9	1.4	12.9	3.3	5.7	8.5	4.6	0.7	10.1	12.0	6.4
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606490-50611831	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 49.7;Proximal tubular cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 82.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	11.8	2.8	0.8	9.7	1.9	3.7	38.0	0.6	1.1	5.2	7.5	0.7	15.6	5.9	6.8	5.9	7.4	4.5	6.4	20.8	1.3	1.0	26.1	36.2	20.5	6.4	1.2	0.2	10.6	11.3	1.9	8.6	47.6	3.8	5.6	5.3	2.8	18.4	19.6	54.0	7.0	6.3	2.8	3.5	7.6	5.5	2.5	1.4	13.8	31.3	7.1	7.0	5.9	5.4	0.4	2.8	7.3	4.0	0.8	23.3	8.1	0.6	0.2	0.7	1.5	0.1	0.9	0.6	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.5	0.2	0.3	0.7	1.2	1.0	0.0	82.0	0.2	4.9	0.4	0.6	0.5	0.6	6.0	3.9	0.4	0.1	0.3	0.0	0.1	0.5	19.3	0.1	0.1	3.7	1.0	4.4	0.7	2.2	0.7	0.4	0.3	5.0	1.6	0.7	0.4	1.2	0.2	10.0	0.1	0.2	5.6	4.0	0.1	0.2	0.6	0.7	0.3	0.1	0.1	0.0	0.1	5.9	0.1	7.3	4.0	5.3	14.3	2.4	22.2	0.4	23.3	17.8	2.8	0.1	18.3	17.5	3.5	0.8	1.5	1.8	13.9	8.1	0.8	1.9	0.6	1.1	1.3	1.0	1.2	0.2	3.8	1.4	3.0	29.7	0.0	7.1	7.1	0.5	10.9	0.0	1.4	11.4	17.4	0.0	7.6	49.7	10.0	0.8	3.0	5.8	0.0	14.1	3.8	6.1	2.7	1.1	6.0	11.2	0.0	2.4	2.5	13.2	0.2	7.8	18.8	1.7	23.4	8.4	0.0	10.1	7.0	3.5	40.0	0.1	12.9	5.1	0.5	1.4	7.9	13.3	20.1	12.3	4.2
NDUFA3	B9	ENSG00000170906	"NADH:ubiquinone oxidoreductase subunit A3"	O95167	19	54102728-54109257	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 1041.5;Late spermatids: 1291.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 38.9"	"Low region specificity"	"Detected in all"							HPA046976	Supported					NA	NA					"HPA046976: AB_10960994"	"unprognostic (3.04e-2)"	"unprognostic (4.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (9.91e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.24e-2)"	"prognostic favorable (4.80e-4)"	17.7	20.8	47.4	15.4	50.9	21.8	22.0	17.3	36.5	12.8	22.6	13.7	21.5	31.8	11.7	25.1	15.8	17.1	20.0	66.1	40.9	33.1	29.7	37.2	20.8	26.9	43.3	31.1	12.9	34.0	22.2	25.5	12.3	29.5	15.9	25.8	13.9	27.0	24.7	95.7	42.4	27.6	15.7	26.8	14.7	23.7	32.6	19.6	16.1	19.5	34.7	16.6	16.3	15.1	20.9	27.3	21.7	16.7	17.1	16.4	18.8	5.4	4.7	4.7	6.4	6.2	5.7	3.7	4.6	5.0	3.7	4.2	5.9	4.0	4.3	3.1	4.1	3.6	3.4	3.7	8.9	1.7	6.5	19.6	4.8	6.3	6.6	4.4	5.3	2.0	3.7	8.8	3.2	4.3	2.5	6.7	4.2	2.6	3.1	3.7	17.4	4.9	6.2	3.9	38.9	9.0	2.2	2.5	9.0	2.7	13.6	7.8	4.1	4.3	10.3	2.5	5.8	12.0	5.2	5.9	4.9	2.4	2.1	7.5	4.7	3.5	2.5	5.4	5.0	2.3	17.2	16.3	21.7	15.0	16.7	15.0	20.9	15.5	15.6	15.8	19.8	16.3	16.4	15.9	17.1	13.7	27.3	15.4	18.8	47.4	50.9	17.3	36.5	40.9	33.1	43.3	31.1	29.5	19.6	89.3	115.3	159.2	44.9	35.3	34.7	1041.5	244.5	190.1	113.7	373.4	9.8	147.2	691.4	171.8	409.1	107.4	555.4	163.5	167.0	149.5	119.0	58.2	112.2	459.8	264.7	22.3	288.8	206.2	255.7	1291.0	151.0	163.3	207.5	272.3	310.4	63.8	191.8	343.7	133.0	664.3	46.3	84.1	82.1	132.9	71.5	54.6	124.1	142.2	317.6	56.7
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	41.1	46.0	67.4	39.8	73.7	57.1	34.0	79.5	80.2	36.1	42.2	39.4	51.2	55.1	55.3	67.7	38.3	43.2	43.4	35.3	64.4	44.7	46.6	47.1	33.2	46.4	62.4	45.8	48.6	35.2	44.8	54.0	40.6	60.3	46.2	52.8	39.4	42.3	45.2	46.6	53.7	55.9	50.2	47.4	46.0	41.4	54.1	69.3	53.5	51.0	29.6	54.6	33.3	46.5	11.4	15.6	13.1	9.8	12.0	9.0	2.8	25.7	28.9	64.0	50.6	30.1	33.8	41.7	26.8	26.5	36.7	35.2	34.6	48.6	46.2	14.4	33.8	41.2	41.0	71.4	37.0	51.1	39.5	27.2	35.7	41.4	89.5	33.7	55.4	49.1	39.3	37.2	27.3	32.2	55.8	40.1	40.1	33.4	36.3	35.0	49.1	58.1	67.8	70.1	32.3	33.1	58.2	24.8	27.9	41.5	53.6	44.3	34.6	34.4	32.0	27.2	45.5	24.2	40.2	33.8	25.7	32.8	25.1	34.0	43.4	30.0	54.9	15.2	45.5	29.8	13.1	9.8	8.9	7.3	7.0	5.9	8.7	7.3	6.3	7.6	11.4	9.0	8.5	11.9	12.0	7.7	15.6	7.9	2.8	67.4	73.7	79.5	80.2	64.4	44.7	62.4	45.8	60.3	69.3	32.8	49.6	74.5	72.7	140.2	113.5	11.8	99.3	25.4	35.2	120.4	137.4	57.9	11.6	47.7	43.5	69.2	70.8	23.3	49.1	55.5	69.1	73.0	23.1	97.3	54.7	73.1	155.0	58.3	81.4	34.5	75.1	76.0	50.6	58.7	95.5	69.4	49.3	88.5	56.3	31.1	80.6	71.1	69.2	26.5	29.2	157.2	52.5	43.6	98.9	93.2
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001629-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.1"	"Cell type enhanced"	"Detected in some"	9	"Endothelial cells: 4.6;Intestinal endocrine cells: 9.1;Leydig cells: 4.4;Peritubular cells: 7.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 3.3;HL-60: 8.7;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042798, HPA050888"	Uncertain					NA	NA					"HPA042798: AB_2678173, HPA050888: AB_2681263"	"unprognostic (1.74e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.70e-4)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.20e-1)"	3.7	0.5	0.9	4.7	0.5	0.3	1.9	1.7	1.0	2.3	4.6	0.5	2.2	4.8	5.1	2.3	1.6	0.8	34.1	1.9	1.5	0.8	1.8	0.7	12.9	0.4	0.4	0.2	6.1	0.5	0.3	1.5	1.0	2.3	2.7	1.2	1.4	1.8	1.6	2.3	1.1	3.8	5.0	0.4	6.2	4.5	0.6	0.0	0.3	2.6	3.6	0.7	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	1.7	1.0	1.5	0.8	0.4	0.2	2.3	0.0	0.0	1.4	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	4.6	0.0	0.0	0.5	0.0	1.6	0.1	0.0	0.0	0.1	0.0	9.1	3.1	0.3	3.9	4.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	6.5	1.7	0.2	0.5	0.4	0.1	0.0	0.0	0.1
ROGDI	FLJ22386	ENSG00000067836	"Rogdi homolog"	Q9GZN7	16	4796968-4802950	"Disease related genes, Predicted intracellular proteins"			"Amelogenesis imperfecta, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.4"	"Cell type enhanced"	"Detected in all"	6	"Bipolar cells: 179.4;Rod photoreceptor cells: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 21.6;intermediate monocyte: 15.8;myeloid DC: 17.3;non-classical monocyte: 15.0;plasmacytoid DC: 8.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 17.3;monocytes: 21.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041000	Uncertain					NA	NA					"HPA041000: AB_10794077"	"unprognostic (1.74e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.79e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.71e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.71e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.08e-2)"	6.0	9.4	17.1	7.5	23.2	30.7	4.1	23.9	34.1	3.3	10.5	45.4	4.4	22.4	4.5	3.3	8.2	5.1	9.0	13.6	21.0	14.2	10.2	13.3	8.6	4.0	22.7	17.4	3.0	12.8	5.5	12.0	4.4	26.4	10.2	4.1	12.3	14.8	7.1	27.1	4.1	14.9	4.5	20.1	8.7	18.9	4.8	21.5	1.7	2.6	4.1	5.2	6.4	4.2	0.8	17.3	2.3	21.6	1.7	1.9	9.5	4.9	5.9	1.2	12.5	2.7	0.8	14.2	4.8	0.6	1.0	0.5	3.2	6.4	3.0	5.4	5.9	0.3	9.2	3.9	4.8	1.1	2.2	5.7	2.0	10.6	7.9	4.6	3.4	2.4	0.9	2.6	3.8	2.1	5.9	5.7	2.8	2.1	1.3	5.7	23.6	4.1	13.5	3.8	3.3	6.8	9.2	10.4	11.3	7.2	6.0	19.5	7.9	19.2	12.7	2.1	3.7	12.7	7.8	9.5	2.3	6.4	16.3	2.0	6.0	8.2	1.9	2.6	11.2	0.8	2.0	21.6	2.3	0.7	15.8	1.9	0.8	1.4	1.6	17.3	0.8	1.5	1.5	1.6	1.7	15.0	8.1	1.8	9.5	17.1	23.2	23.9	34.1	21.0	14.2	22.7	17.4	26.4	21.5	17.9	5.6	7.8	22.5	4.5	179.4	48.2	20.4	12.0	10.3	26.2	104.1	39.8	33.2	20.2	23.1	13.2	35.4	23.3	14.0	60.7	8.6	15.0	5.7	15.8	56.6	23.8	49.8	25.2	27.3	30.7	6.4	25.4	11.8	48.7	24.7	72.0	14.7	20.1	18.0	66.6	130.1	6.5	13.0	6.5	24.3	5.1	25.6	8.7	21.3	15.6
TIMM13	"Tim13, TIMM13B"	ENSG00000099800	"Translocase of inner mitochondrial membrane 13"	Q9Y5L4	19	2425624-2427894	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048985	Uncertain		Supported	"Nucleoli fibrillar center,Mitochondria"		NA	NA			Mitochondria	"Nucleoli fibrillar center"	"HPA048985: AB_2680589"	"unprognostic (5.47e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.15e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (8.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.91e-2)"	"prognostic favorable (3.88e-5)"	"unprognostic (4.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.47e-2)"	18.5	38.2	21.7	21.3	19.9	25.0	15.7	15.9	28.6	14.6	26.4	18.5	19.8	43.0	14.2	20.4	32.5	17.1	22.9	28.1	20.6	19.1	29.4	49.8	13.6	20.7	23.1	19.3	22.5	57.0	9.7	16.9	21.5	21.1	20.6	14.7	16.7	32.7	26.1	56.6	22.3	34.5	13.7	17.3	21.7	25.6	33.3	17.4	23.6	20.0	44.6	18.5	15.7	17.4	21.1	72.7	10.5	36.1	19.6	21.0	24.5	29.0	30.5	11.1	21.9	6.3	6.3	15.3	17.0	6.0	12.5	9.2	43.9	14.8	17.5	6.1	5.6	9.2	21.5	17.2	23.1	3.5	16.1	60.4	14.6	29.6	33.4	18.0	28.2	16.0	14.8	12.5	13.7	9.4	8.6	15.0	23.2	29.5	26.3	4.9	12.1	33.2	38.8	31.0	23.7	44.8	25.1	8.9	47.1	12.1	25.0	41.3	38.0	7.7	31.4	19.5	5.2	20.9	31.4	14.0	14.8	16.4	27.6	33.8	41.5	21.3	18.3	15.2	38.7	22.4	6.3	36.1	10.5	14.5	33.2	17.8	21.1	16.6	15.2	32.6	19.9	21.0	17.9	2.3	19.6	19.5	72.7	16.3	24.5	21.7	19.9	15.9	28.6	20.6	19.1	23.1	19.3	21.1	17.4	47.6	68.0	116.2	113.2	207.0	40.2	121.0	165.6	61.6	52.4	123.9	3.9	298.1	356.4	234.7	53.8	96.6	287.7	46.7	331.2	342.2	152.2	160.2	61.1	358.4	276.3	25.4	184.3	95.2	160.0	96.5	119.0	123.6	214.2	119.0	243.4	60.1	263.5	192.9	93.0	418.3	36.8	51.8	100.2	95.0	119.4	241.4	237.7	84.3	327.1	151.1
WIPI2	"ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984"	ENSG00000157954	"WD repeat domain, phosphoinositide interacting 2"	Q9Y4P8	7	5190188-5233826	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019852, HPA021488"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019852: AB_1846589, HPA021488: AB_1846591"	"unprognostic (5.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (7.69e-5)"	"unprognostic (1.96e-3)"	"unprognostic (9.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (4.96e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (9.78e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.05e-6)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.98e-2)"	24.5	23.6	33.9	17.8	34.7	32.7	21.9	30.6	47.4	20.6	21.7	27.8	17.4	20.3	24.4	23.1	25.4	25.3	20.5	30.5	27.9	27.2	23.5	27.5	21.9	22.3	26.0	31.2	25.0	30.8	28.7	23.2	27.0	26.1	25.0	17.2	25.0	34.7	25.5	28.3	31.8	18.2	22.9	25.6	22.0	23.0	49.3	26.0	26.6	24.1	15.9	23.4	22.9	20.5	6.1	6.9	13.0	6.3	2.6	9.2	2.2	27.2	17.4	17.1	29.1	26.3	27.6	26.3	24.3	28.0	26.0	27.5	16.9	25.4	19.5	18.7	30.4	32.4	20.0	17.2	19.8	20.3	10.0	26.7	13.3	17.6	18.6	26.0	20.8	14.6	29.0	23.9	29.5	16.4	26.0	36.1	26.8	37.6	17.7	23.5	28.3	15.8	36.1	35.5	14.6	25.6	26.1	24.4	32.0	17.1	13.3	21.3	32.1	17.8	30.7	21.1	29.9	18.8	39.8	28.6	16.6	35.0	27.7	18.1	31.8	29.6	22.2	27.1	24.2	24.5	0.3	4.9	13.0	5.1	6.3	3.1	5.6	6.7	9.1	4.5	6.1	8.5	5.4	9.9	2.6	4.2	6.9	9.2	2.2	33.9	34.7	30.6	47.4	27.9	27.2	26.0	31.2	26.1	26.0	35.7	26.9	47.2	36.3	48.8	67.7	25.4	25.5	21.4	17.0	17.4	58.9	79.1	61.3	36.3	146.8	28.9	32.1	46.7	36.2	84.9	33.8	70.9	31.1	55.0	59.9	44.5	37.9	47.9	51.5	127.3	39.4	39.2	42.2	65.9	47.0	87.1	45.2	38.5	52.6	60.3	50.4	51.8	32.0	181.0	130.5	62.0	126.1	42.4	42.2	42.4
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.1	8.6	8.3	9.3	18.8	16.2	7.5	14.5	7.4	8.7	7.7	0.4	4.9	4.0	8.1	9.4	24.3	1.5	7.2	8.9	10.7	9.3	4.9	5.5	23.4	1.5	9.5	0.5	4.8	12.2	5.0	22.8	11.1	14.0	10.3	13.9	5.5	6.3	14.6	7.6	3.9	1.7	7.1	6.7	11.9	2.3	3.9	9.8	7.2	0.2	47.7	23.2	24.4	12.1	41.2	7.7	1.8	1.7	15.4	9.9	5.0	19.5	5.4	13.6	22.3	5.5	19.5	5.9	9.1	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3	23.8	57.7	0.8	7.5	10.3	111.5	13.2	0.0	17.4	12.5	3.5	147.3	2.1	6.6	12.0	1.6	21.6	0.0	0.0	7.4	4.6	12.7	9.7	4.7	0.4	3.7	79.4	43.8	20.9	2.7	1.5	19.0	3.2	10.1	1.0	8.8	24.1	5.7	0.0	41.8	8.6	147.7	12.9	12.3	17.7	6.8	6.6	20.5	0.9	0.6	5.5
PALM	KIAA0270	ENSG00000099864	Paralemmin	O75781	19	708939-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.6;brain: 56.5"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	35	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	47.6	11.8	49.1	5.1	39.9	2.2	11.3	13.3	56.5	22.7	8.2	12.4	4.2	9.2	10.7	6.7	5.8	17.7	7.2	9.6	37.7	18.9	21.9	3.5	9.0	2.2	19.2	28.1	21.2	2.1	1.2	10.2	17.6	11.9	12.2	2.7	6.1	5.9	18.6	7.0	6.9	7.5	9.0	14.7	10.5	3.6	8.2	12.5	0.0	3.3	3.3	1.9	5.0	8.4	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	4.4	8.6	16.5	1.3	0.1	1.2	1.1	0.0	1.1	0.3	1.0	0.0	0.0	15.3	0.1	0.1	1.5	4.3	0.0	0.2	0.0	8.5	0.0	3.5	5.4	6.0	0.0	0.1	3.9	0.0	0.7	0.0	2.4	0.6	1.9	3.0	0.1	1.1	8.7	0.6	5.1	3.5	0.8	2.4	27.2	0.0	0.1	0.4	0.0	0.9	17.5	4.4	0.0	0.1	2.8	1.5	4.1	0.0	0.0	9.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	49.1	39.9	13.3	44.4	37.7	18.9	19.2	28.1	11.9	12.5	0.0	1.7	1.4	5.5	6.4	7.6	3.6	0.0	0.0	3.4	5.2	11.8	0.8	44.7	1.6	1.1	26.3	2.1	0.0	0.2	2.5	21.8	8.7	0.0	0.2	0.8	23.8	0.0	46.6	2.2	5.3	44.8	1.6	16.9	0.0	0.0	69.4	0.3	0.3	42.5	43.5	4.2	0.0	13.3	0.9	1.3	6.0	1.6	0.0	0.0	5.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 1616.5"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	2.3	1.2	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	21.0	0.0	0.0	0.9	0.2	155.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	70.0	0.2	0.0	0.0	0.1	0.0	1616.5	0.0	4.8	1.7	61.4	65.7	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.1
ZNF689	FLJ90415	ENSG00000156853	"Zinc finger protein 689"	Q96CS4	16	30602558-30624012	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.7;Late spermatids: 41.2;Spermatocytes: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054095, HPA055385"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Nucleoplasm, Nucleoli fibrillar center"		"HPA054095: AB_2682377, HPA055385: AB_2682801"	"unprognostic (5.62e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	5.9	5.7	5.6	4.7	7.5	7.8	15.0	7.5	10.7	7.4	6.2	8.6	5.4	6.7	8.5	4.1	3.7	6.4	6.1	5.2	4.7	4.5	5.2	6.3	4.9	5.2	8.0	4.9	8.0	7.2	11.8	7.7	4.6	4.8	6.1	4.6	7.7	4.8	7.1	6.7	3.8	6.7	6.0	4.8	7.3	5.7	28.2	8.2	11.4	6.7	4.3	6.5	6.8	4.6	4.4	9.6	2.7	10.5	9.3	6.0	4.4	3.5	6.3	8.8	9.2	3.8	3.8	4.4	4.4	6.4	7.2	7.0	7.4	2.8	10.2	6.9	3.8	5.2	2.7	11.0	4.8	5.8	8.3	18.7	8.6	5.5	11.3	4.0	8.4	6.6	3.6	4.6	4.9	4.9	3.9	5.0	9.4	10.1	5.9	4.6	5.3	15.5	8.0	10.0	2.8	6.5	19.6	8.5	9.1	3.0	3.5	11.1	6.7	3.2	5.8	5.0	4.6	6.1	7.4	3.9	9.4	4.0	4.5	6.0	10.9	12.5	12.3	3.4	9.3	9.0	0.2	6.8	2.7	5.9	10.0	4.3	4.4	5.0	6.0	9.6	3.7	4.5	4.2	0.4	9.3	10.5	3.6	4.7	4.4	5.6	7.5	7.5	10.7	4.7	4.5	8.0	4.9	4.8	8.2	3.0	1.3	10.9	4.5	1.4	7.9	3.9	10.2	1.4	0.0	1.8	5.9	3.5	0.0	5.4	39.7	6.7	6.1	0.0	5.9	3.0	4.5	4.5	13.9	5.0	4.3	9.5	5.8	5.5	3.5	41.2	7.5	4.4	0.0	1.8	5.5	5.2	4.7	3.5	9.9	3.5	5.9	0.0	4.5	48.6	7.7	0.9	0.7	5.0	6.0	2.3
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	7.9	0.0	31.2	18.5	0.0	1.1	0.0	12.1	14.4	0.0	0.0	0.0	0.0	2.2	21.3	0.0	0.0	0.0	11.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	11.8	8.4	4.1	4.5	0.0	0.1	0.0	8.0	0.1	10.6	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5	0.0	0.0	0.5	0.1	0.2	53.7	6.3	0.0	0.0	0.0	0.0	82.5	0.0	1.7	0.1	7.7	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.6	0.0	5.5	14.2	10.2	2.6	0.0	0.0	0.0	0.0	4.7	0.1	0.0	4.6	0.0	54.5	6.5	3.0	0.4	3.0	0.3	0.0	0.0	0.0	0.0
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Cell type enriched"	"Detected in many"	11	"Intestinal endocrine cells: 997.5"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 66.7;SH-SY5Y: 102.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	66.7	102.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3.0	3.7	0.0	8.2	3.8	86.9	51.2	0.0	8.1	1.2	66.3	19.6	0.0	1.7	0.4	6.1	3.4	1.7	0.0	0.3	0.0	2.3	2.3	0.0	0.0	0.1	71.5	997.5	0.0	0.3	6.0	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0.0	1.4	3.0
ZNF383	FLJ35863	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	9.1	7.5	9.3	10.4	12.1	6.9	10.7	20.4	10.8	9.1	8.2	12.6	10.4	7.5	11.6	7.8	8.9	8.2	6.1	9.6	8.7	6.9	9.3	7.4	7.2	11.3	14.2	6.5	12.9	9.2	9.4	11.0	6.5	11.8	9.6	7.4	8.7	8.5	8.7	14.0	11.8	9.5	10.8	13.7	10.8	8.4	10.5	12.1	13.2	11.4	5.7	11.9	10.2	9.4	11.4	4.0	6.3	5.4	5.7	11.6	4.8	3.8	8.7	6.1	9.2	7.6	7.8	4.0	5.2	7.2	5.3	8.0	4.0	4.6	5.2	8.0	5.0	4.9	3.8	5.0	7.0	7.8	7.2	5.4	7.8	6.5	3.2	8.5	9.0	8.6	10.0	6.0	5.1	10.0	6.9	4.8	7.4	4.0	2.7	6.8	1.6	7.7	4.1	5.4	7.5	3.0	5.6	10.9	4.6	4.6	10.8	7.3	5.4	8.4	5.0	7.3	8.2	5.9	5.3	3.0	7.0	4.7	4.8	5.0	8.5	8.0	10.0	1.0	4.3	6.3	3.6	4.1	6.3	7.6	4.7	10.7	9.8	7.2	9.2	4.0	11.4	11.6	9.1	5.0	5.7	5.4	3.8	7.0	4.8	9.3	12.1	20.4	10.8	8.7	6.9	14.2	6.5	11.8	12.1	3.0	4.1	6.5	3.7	2.4	8.3	11.7	2.5	2.7	2.3	1.8	13.7	3.4	1.7	3.0	7.3	4.2	4.1	0.0	3.1	3.6	2.9	3.9	5.7	2.1	3.1	14.3	2.4	6.2	5.0	2.5	6.1	4.8	8.5	4.6	4.5	7.3	2.6	3.5	7.1	3.7	9.5	12.9	5.1	4.8	5.3	2.9	4.1	7.2	5.0	3.3
CHMP6	"FLJ11749, VPS20"	ENSG00000176108	"Charged multivesicular body protein 6"	Q96FZ7	17	80991598-81009517	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023001, HPA024460"	Approved					NA	NA		32000			"HPA023001: AB_1848689, HPA024460: AB_1848691"	"unprognostic (6.05e-3)"	"unprognostic (2.25e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.99e-4)"	"unprognostic (5.67e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.40e-3)"	14.6	13.6	12.5	22.2	12.8	8.0	14.2	11.8	19.5	14.5	18.0	17.3	14.9	13.5	21.1	15.5	17.9	15.2	14.9	17.9	12.1	10.3	16.1	24.9	13.9	12.9	13.1	11.2	14.0	14.7	19.4	12.9	21.4	14.5	14.9	16.4	15.6	15.8	14.8	41.2	16.2	17.3	20.7	12.4	20.2	14.8	8.4	10.8	14.7	14.8	19.7	16.6	12.9	13.6	12.2	15.6	37.9	23.0	18.8	18.9	17.5	13.4	21.8	16.4	9.9	8.8	9.1	11.4	13.4	15.1	22.8	16.8	5.4	7.5	13.9	10.7	21.1	14.2	9.3	3.5	15.3	16.2	6.6	12.0	11.4	4.4	18.6	13.2	13.7	14.4	9.6	10.7	14.1	15.4	14.3	31.6	14.2	11.8	11.7	11.7	12.7	16.9	14.1	5.3	3.6	13.7	13.4	14.6	9.3	12.9	18.6	5.4	16.4	10.0	15.7	15.1	13.8	14.0	10.6	17.9	31.8	18.0	9.3	17.9	7.1	1.7	7.1	13.5	8.4	14.7	25.8	19.7	37.9	18.9	20.0	12.1	12.2	11.6	15.4	15.6	10.8	12.9	11.4	12.4	18.8	23.0	14.8	9.0	17.5	12.5	12.8	11.8	19.5	12.1	10.3	13.1	11.2	14.5	10.8	6.0	9.4	16.4	7.2	5.5	18.9	0.8	17.8	10.7	14.8	14.0	3.9	35.2	11.6	32.8	1.1	16.8	34.1	0.0	38.3	29.5	16.4	7.1	20.7	14.9	35.8	9.5	20.3	15.4	24.7	1.9	9.5	12.2	15.1	37.9	15.8	18.4	25.9	24.6	12.0	16.5	39.5	12.9	9.2	9.7	11.5	5.1	42.1	15.2	16.7	7.8
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
